{"heart failure with preserved ejection fraction": 12.474405385131833, "peak early diastolic mitral flow velocity": 1863.073206238915, "peak early diastolic mitral annular velocity": 2794.5118248286108, "heart failure with reduced ejection fraction": 1.6674375748347814, "global left ventricular longitudinal systolic strain": 828.1003121555804, "heart failure and reduced ejection fraction": 0.7890310174331995, "\u03b2 - adrenergic receptor blocker therapy": 207.14690515498876, "left anterior descending coronary artery occlusion": 310.50219016328447, "scale prospective randomized multicenter trial paradigm": 103.50379471503142, "heart failure or coronary heart disease": 46.08649621168452, "ring annuloplasty for ischemic mitral regurgitation": 184.01139987635284, "heart rate and aortic blood flow": 0.09484086683071546, "emergency department in acute heart failure": 0.024816602683569944, "dose nesiritide in acute heart failure": 11.524593110171617, "canine model of chronic heart failure": 0.02792555024957947, "mice model of hypertensive heart disease": 11.52217587529077, "biventricular pacing on left heart twist": 11.508224645644297, "porcine model of right heart failure": 11.527107738212084, "valve plasty for degenerative mitral regurgitation": 34.50349992981565, "valve plasty and annular size reduction": 23.015609810458532, "blocker therapy in chronic heart failure": 0.02590749066772688, "kinase a nor soluble guanylate cyclase": 34.5026293935707, "diastolic pressure and myocardial oxygen consumption": 23.016863882634254, "ejection time in acute heart failure": 0.026387633761171536, "resynchronization therapy in mild heart failure": 11.52464889650213, "arterial coupling in hypertensive heart failure": 23.02318707708523, "control via the targeting of chromatin": 11.523803325285431, "stress echocardiography and cardiopulmonary exercise testing": 11.517195894979395, "crossover study with masked outcome assessments": 0.01245029921229469, "time interval between local myocyte depolarization": 23.00061637400848, "filling time by controlling heart rate": 0.009516584483498538, "increase in the ratio of peak": 0.03691964734800245, "endothelial function in chronic heart failure": 11.525110187067128, "rat model of postischemic heart failure": 11.526632680482248, "reduction program for congestive heart failure": 11.516834438198053, "hospital stay for congestive heart failure": 11.516835986620473, "plateau phase of ventricular action potentials": 11.515653866088243, "kidney infection or urinary tract infection": 0.0026504613221309575, "oxygen uptake and higher metabolic exercise": 11.517539401191343, "heart failure and mechanical support devices": 0.028748239534770473, "implementation strategies in improving physician adherence": 0.012532671600711082, "exercise protocol with respiratory gas analysis": 0.012424748653039584, "heart failure with systolic dysfunction treatment": 11.52470839372064, "recommendations on the treatment of anemia": 2.8813232144762138, "nucleolin as a regulator of growth": 2.8799179095392446, "plasticity in the setting of disease": 2.8839314930290287, "apoptosis during the development of pacing": 2.880994750538307, "dogs during the development of heart": 0.007686007512995267, "apoptosis in the pathogenesis of heart": 5.760074085427879, "physician at the time of discharge": 0.0062926672740364065, "survival from the time of inclusion": 0.00643731111745683, "survival at the time of admission": 0.006346070095103079, "levels at the time of admission": 0.006386105051420475, "observation at the time of surgery": 0.006252224815635962, "association of the score with death": 0.008776982908778702, "time from the treatment of heart": 0.008180599475410772, "variation in the use of guideline": 0.008993033122136042, "hospitalization through the date of death": 0.006237076752223418, "% with the majority of patients": 0.011566784494789355, "resistin as a link between inflammation": 2.876524419864929, "adaptation of the myocardium in response": 2.8837307141555355, "case of a patient with diagnosis": 0.00758703400222918, "peptides at the point of care": 0.006314265052689377, "values before the administration of contrast": 0.00592513790677594, "dysfunction during the onset of heart": 0.007852211956610736, "data on the potential of diuretics": 2.8811574489300718, "hrqol in a cohort of patients": 0.009328592850078796, "supplementation during a program of exercise": 2.880097525156189, "insight into the potential of mirnas": 0.0059392737925123545, "trends in the risk of heart": 0.010752429774176099, "improvements in the treatment of heart": 0.010689418466112401, "causes for a worsening of heart": 0.007422506263473514, "strategies for the treatment of end": 0.007495788375283388, "role in the progression of heart": 0.010466836336749243, "periods on the basis of heart": 0.007707599183940532, "reduction in the ratio of phosphocreatine": 2.8839788190984805, "review of the effects of air": 0.009667404043526593, "impact of the intervention on adherence": 0.006255129250629263, "women with a history of hypertension": 0.00744646190008616, "preserved left ventricular ejection fraction": 4228.276889140241, "early diastolic mitral flow velocity": 1552.5359697359368, "post - myocardial infarction heart": 690.6494413592321, "left ventricular assist device implantation": 345.09201731806627, "left ventricular diastolic end diameter": 690.0903736729719, "post - acute care transfer": 0.5046194179731884, "- acute care transfer policy": 0.49734485034057285, "chronic advanced heart failure patients": 0.5817956696710419, "annular size reduction by surgery": 124.22250368681718, "dual energy x - ray": 0.1148247223908821, "clinical practice guidelines grading system": 86.2569592231531, "restrictive red blood cell transfusion": 0.004097358486323346, "red blood cell transfusion strategy": 0.004717818325210503, "low left ventricular ejection fraction": 86.29046105785052, "identified strong reliable mortality predictors": 86.26040415656162, "recapitulates conserved developmental chromatin remodeling": 172.49461246222165, "conserved developmental chromatin remodeling events": 86.25343595623411, "left bundle branch block pattern": 0.011162173457365785, "preserved left ventricular ejection fractions": 86.2819345481789, "low co - morbidity burden": 0.11939420360177491, "novel heart failure mice model": 0.09845153647441668, "left ventricular assist device use": 86.27523136398081, "acute right ventricular pressure overload": 172.51754305911226, "vascular endothelial growth factor blockade": 86.25129460446878, "- adrenergic receptor blocker therapy": 86.37294398212659, "assessing left ventricular filling pressure": 86.27248518055754, "stable severe systolic heart failure": 86.34773928611077, "early transmitral blood flow velocity": 86.25368848249485, "early diastolic mitral annulus velocity": 258.74763264668053, "estimating pulmonary capillary wedge pressure": 86.25363680958826, "tricuspid annular plane systolic excursion": 258.7438904007471, "undergoing left ventricular assist device": 86.27248743337253, "shortens left ventricular ejection time": 86.27982588308026, "impaired cardiac metabolic gene expression": 86.26551066516771, "impaired cardiac energy metabolism gene": 0.01813059295216263, "cardiac energy metabolism gene expression": 0.01990384558650663, "using cardiac magnetic resonance t1": 0.019833312693447118, "cardiac magnetic resonance t1 mapping": 0.01654470000710289, "cardiac magnetic resonance t1 time": 0.01886066309755401, "outperformed left ventricular ejection fraction": 86.28652125686608, "+9.2 \u00b1 9.5 % increase": 172.54847717236473, "restoring mitochondrial oxidative phosphorylation capacity": 258.74267350535354, "isolated coronary artery bypass grafting": 172.49766782356994, "pathological cardiac gene expression programme": 0.01944784506930909, "using trichrome blue histologic analysis": 172.5001924671942, "induced pulmonary artery systolic pressure": 86.26511106479286, "impaired right ventricular pump function": 86.27007558091162, "targeted pulmonary arterial hypertension medication": 86.25530639300035, "selective \u03b2 - blocker metoprolol": 172.61247855478467, "increased vascular endothelial growth factor": 86.25733336814574, "vascular endothelial growth factor protein": 86.25264358379154, "left bundle branch block type": 0.014665482445957806, "improved left ventricular filling pressure": 86.27534310475859, "left ventricular filling pressure response": 86.27451071083672, "proximal left anterior descending artery": 172.50353838899764, "vasopressin type 2 receptor antagonist": 172.5045337513813, "acute ischemic right heart failure": 86.34810539399915, "mean \u00b1 sd testosterone levels": 86.26025702414913, "ejection fraction 63 % \u00b1": 86.31934822099677, "reduced left ventricular ejection fraction": 86.29346618895582, "single center retrospective observational study": 0.013963026149783939, "receiving ventricular assist device support": 86.26633638645004, "chronic \u03b2 - adrenergic receptor": 172.61834563293428, "acute autonomic nervous system modulation": 0.008048512265068725, "dual x - ray absorptiometry": 86.35975276970748, "relative appendicular lean mass index": 86.25466511200574, "non - linear hr variability": 0.11756439744224004, "- linear hr variability measures": 0.11705379553030741, "non - ischemic heart failure": 86.45472599542711, "- ischemic heart failure samples": 86.45305625446755, "symptomatic chronic advanced heart failure": 86.34460089210964, "post - myocardial infarction patients": 172.66219177964894, "- myocardial infarction heart failure": 172.7045056594349, "myocardial infarction heart failure patients": 172.6378073257302, "large idiopathic dilated cardiomyopathy cohort": 258.7443723036232, "obese body mass index categories": 0.011496304053542895, "overweight body mass index strata": 0.010497001764596834, "decreased mitochondrial energy production precede": 86.25100632262789, "reduced mitochondrial complex v activity": 86.25725411806584, "provided left ventricular function assessment": 86.27617495821488, "using cardiopulmonary exercise testing guide": 0.01618205430884712, "cardiopulmonary exercise testing guide exercise": 0.022036000119595774, "prospective randomized multicenter trial paradigm": 86.25271236141177, "ambulatory patients with heart failure": 0.13835541079509112, "medical treatment for heart failure": 0.08700769015291272, "young adults with heart failure": 0.10991189948187517, "precapillary ph with heart failure": 55.305160181440684, "dependent patients with heart failure": 0.13889219733342922, "beneficial effect of exercise training": 0.08038328423610616, "intensive transitions of care program": 0.07385677821289392, "deficient adult patients with heart": 0.06207098185516165, "many multisite studies in practice": 31.082150473403946, "complementary model system of zebrafish": 31.0895459795482, "recent hospital discharge in patients": 0.0509371921725019, "natriuretic peptide levels in patients": 31.100202492761007, "effects via stimulation of endothelial": 31.090058807918453, "predictive cutoff value for plasma": 31.061675153682728, "predictive cutoff value for admission": 31.06194566493292, "hypertensive heart disease by angiotensin": 62.12265247546718, "acute kidney injury during spironolactone": 31.05340777242373, "ventricular filling pressure in patients": 31.103315835510493, "systolic pressure relationship in heart": 31.101453153128052, "isolated hr reduction by ivabradine": 31.055197236178376, "isolated hr reduction in patients": 0.050227307104862666, "higher serum levels of brain": 31.091355087767717, "higher serum levels of creatinine": 62.13962452047052, "structured exercise programme for patients": 0.032554992831482304, "embryonic gene programs in heart": 0.049639574643155854, "medications among outpatients with heart": 31.094804891000884, "resistant volume overload in heart": 31.09905610692231, "cardiac resynchronization therapy in dialysis": 31.08871905795091, "acute heart failure in patients": 0.08342295792038863, "coronary artery disease in patients": 31.101678298327474, "accurate risk stratification of patient": 31.09416097824862, "acute care surgery in heart": 0.05320053047381374, "extracorporeal membrane oxygenation as bridge": 62.100827530747324, "right heart failure with therapy": 0.06481197782028816, "deleterious \u03b21ar overstimulation in heart": 0.04879886255198981, "discharge among patients with heart": 0.06344636573777168, "readmission among patients with heart": 31.111882467046236, "proportional hazard models with time": 0.03241386248139047, "outcomes among patients with heart": 0.06564754121287228, "- adrenoceptor blockade with esmolol": 62.16591591616003, "congestive heart failure in survivors": 31.114010754469, "- hct exposure to anthracyclines": 31.106533515083697, "large outcomes trial of heart": 0.060465308741618644, "recent onset af at risk": 0.007834287707179768, "congestive heart failure in humans": 31.113887781786346, "composite quality measure for heart": 0.031226105562192352, "volume within strata of hospital": 0.04280868702208039, "myocardial infarction patients with heart": 62.16167395925827, "indeterminable anaerobic threshold in heart": 62.145603400051456, "systolic heart failure after pressure": 31.088077494498197, "respiratory gas analysis at baseline": 0.006057309219856593, "little hr reduction with beta": 0.02972988594820539, "% of patients with heart": 0.0523824183501079, "treatment of anemia in patients": 13.8399331684503, "anemia in patients with heart": 13.84098162736715, "quality of life in patients": 0.04024797301504848, "symptoms in patients with heart": 0.04191966460122705, "management of patients with heart": 0.04536929491066519, "global changes in chromatin subproteomes": 27.613564457983898, "mortality in patients with heart": 0.04323989387822198, "common applications of readmission metrics": 13.817543191160622, "differential impact on hospital performance": 0.0025856412225155343, "different approaches to computing readmissions": 13.80733663770584, "medical management of heart failure": 0.03292877384862471, "protective effects of exercise training": 0.020048372633276332, "limited mortality at hospital discharge": 0.003875786630025534, "mild restriction of leaflet motion": 0.017819569773074365, "prognostic factor in heart failure": 13.828651885214981, "reliable measure of health status": 0.01846696787969984, "equivalent dose of metoprolol succinate": 27.616851315949148, "acute treatment of heart failure": 0.03434193262525089, "independent association between spironolactone use": 13.80165927512039, "proangiogenic effects of b act": 13.817286578833382, "cardiac angiogenesis in heart failure": 13.830299987671246, "responsible diagnosis of heart failure": 0.032323480495750304, "twofold increase in lung weight": 0.014954690019205142, "groups versus the sham group": 0.013146045455113095, "left ventricle in heart failure": 13.829662715631944, "rates across the respective age": 0.012063365481061981, "outcomes in patients with heart": 0.042804682803752894, "standard error of measurement value": 0.01810445076867451, "excessive secretion of arginine vasopressin": 41.415354850103824, "cardiac dysfunction during insulin resistance": 0.004514033427749158, "care for patients with heart": 0.03354193055689967, "older patients with breast cancer": 0.020417559001097537, "trend toward an inverse association": 0.0020323884918765508, "promising biomarker in heart failure": 13.828124030506288, "higher frequency of diabetes mellitus": 0.018821434688720114, "predictive value for heart failure": 0.020240404274819233, "frequent comorbidities in heart failure": 13.828096455997873, "myocardial dd of collagen deposition": 27.617044774457863, "significant decrease in re -": 0.03336502614816043, "heterogenous improvement in ejection fraction": 0.017766927704293965, "compelling improvement after device implantation": 0.0025131685446285307, "human resistin in heart failure": 13.82844201277722, "fold induction of serum resistin": 27.616471836164727, "free probability after catheter ablation": 13.800957585965136, "clinical burden in adult medicine": 0.015594306432977493, "cellular responses to heart failure": 0.022338080918318515, "molecular scaffolds in heart pathology": 13.821087202143993, "beneficial adaptation to stress conditions": 0.008222731380935157, "prognostic indicator in heart failure": 13.828342386446373, "epigenetic changes in chromatin structure": 27.613703863095175, "ventricular tissue from control animals": 13.803966685987604, "contemporary trends in heart failure": 0.028802454610397224, "thromboembolic events in heart failure": 13.82870567611762, "sympathetic control of heart rate": 0.026934317773568528, "prospective assessment of body composition": 0.0184069151049101, "slower increase in heart rate": 0.023236332823930547, "diuretic use in heart failure": 13.828686252178668, "remarkable increase in camp hydrolysis": 13.813991277433857, "efficacy of eplerenone in patients": 13.838640196497943, "similar improvements in shuttle walk": 0.014789497375543463, "emotional status in heart failure": 0.029095175467159673, "potential candidates for cell therapy": 0.007030232420169341, "better tools for risk stratification": 13.806752026504705, "dietary interventions in heart failure": 0.029051923149970096, "significant difference in outcome ratings": 0.015837326018472753, "older adults with heart failure": 0.027707353083047583, "significant improvement in outcome ratings": 0.016046602563696857, "reciprocal regulation in mouse hearts": 0.014567852401917176, "physician within the first month": 0.011660682572271475, "trend toward a higher baseline": 0.006741526964709184, "right ventricle in heart failure": 13.828776949076996, "statistical standards in biomarker studies": 13.814200592041665, "new targets in disease management": 0.016195979529570605, "therapeutic targets for heart failure": 0.020324584437168492, "ventricular hypertrophy in heart failure": 27.629442312178117, "impact of carvedilol and metoprolol": 27.63583247053796, "inappropriate therapy in heart failure": 0.030040326821529198, "absolute risk of heart failure": 0.03393569077365506, "elevated levels of plasma norepinephrine": 13.817875581145962, "advanced stages of heart failure": 0.03237594569260717, "elevated levels of plasma catecholamines": 13.817848357761074, "mortality within a few years": 0.008085323825629395, "various measures of hr dynamics": 0.01785131506814162, "linear measures of hr variability": 0.01800643790466745, "early measurement of hr variability": 0.018172807304741693, "routine measurement of hr variability": 0.01783570499459212, "clinical tool for risk stratification": 13.807829644115671, "bioinformatic analysis of microarray data": 13.818122126488005, "worldwide increase in life expectancy": 0.015246397101680638, "public reporting on quality aims": 0.002078716745843821, "modest effects on heart failure": 0.016496055218287325, "standard therapy with beta blockade": 0.014197705704934957, "marked decreases in heart failure": 0.028845184623392518, "significant alterations in energy metabolism": 0.015327320551075448, "expenditure on health per capita": 0.002153444371074029, "greater risk of heart failure": 0.0340111039666008, "cardiac dysfunction with conduction abnormalities": 13.815033553856786, "contextual factors on physician adherence": 0.0022353343731333123, "patients with an implantable cardioverter": 27.620579330257545, "nosignificant changes in control group": 13.815859697936327, "systolic function in hfpef patients": 13.823014543188103, "common form of heart failure": 0.03246921991979298, "patients with respect to alterations": 0.006922863477488633, "respect to alterations in body": 0.005576940348464132, "changes in nps or adiponectin": 3.4542283463673975, "requires a presence of signs": 0.005715994204609016, "presence of signs and symptoms": 0.00924816125769791, "treatment of anemia and iron": 3.4593665348363505, "literature in the english language": 0.006202650779313825, "language on anemia and iron": 3.454979034629865, "treatment in patients with heart": 0.010749305348080624, "harms of treatments for anemia": 3.4555884916771036, "treatments for anemia in adults": 3.454836430133639, "anemia in adults with heart": 3.458462656691213, "agents in adults with anemia": 3.4566120334556447, "life in patients with heart": 0.01051228548640093, "transfusions in patients with heart": 3.4602147833994823, "conditioning for patients with heart": 0.00819075500987041, "predictors of mortality in patients": 3.460057569147894, "predictors of mortality in heart": 3.4600643115542598, "analysis of a new chromatin": 3.455758439279577, "studies in the complementary model": 0.006499975930450344, "hospitals in an extreme decile": 0.003974213181640619, "discharge in patients with heart": 0.010456595648149268, "readmission to hospital for heart": 3.4551520314186797, "studies with a contemporaneous control": 0.004742020833229528, "mortality for recently discharged patients": 0.00367364580058967, "reductions in the composite end": 0.006464792554932381, "evaluate the relationship between sex": 0.003081872598524644, "levels with the greatest difference": 0.005998307127750072, "cause of morbidity and mortality": 0.009734745501677546, "application in the clinical setting": 0.006530596290404692, "catheterization during the same period": 3.4528031849360605, "comparison of predictors of heart": 3.4604818778108624, "death in patients with versus": 0.008929164244183807, "study the impact of self": 0.007585448406566438, "counseling on the primary outcome": 0.003242818691159731, "correlation between changes in hdl": 0.00397969657791634, "determination of a predictive cutoff": 3.455512501439898, "weight with a high incidence": 0.0046437989610303605, "deaths in the experimental procedures": 0.006274896308006018, "% in women and men": 0.010243035024034404, "practice for a limited number": 0.002761897518705501, "prolapse of a degenerative mitral": 6.905427588979461, "lesions in the major branches": 3.4560999795124974, "hypertension with vasodilators and diuretics": 6.907640104832597, "reasons for the modest reduction": 0.004157533372949599, "reduction by the surgical ring": 0.0033671048709576056, "evaluation of the surgical indications": 0.007085388401201271, "approach for the acute treatment": 0.004590182709547161, "safety of spironolactone in adults": 3.4579316099255824, "adults with newly diagnosed heart": 0.005120358447389161, "patients with a median follow": 0.0065765484803734595, "risks of hospitalization or death": 0.005505913948146349, "outcomes for patients with heart": 0.008499976252924762, "relevance in the clinical follow": 0.006709912122957135, "nonsurvivors with a similar distribution": 3.454317605442976, "relationship as a possible index": 0.0019472847734152228, "% of the left ventricle": 3.4591297028584393, "implantation of a novel bottleneck": 0.005781358791564836, "levels to survival in patients": 0.007615073911951581, "indicator in patients with heart": 0.010395247142206895, "investigate the association of hypoalbuminemia": 3.4569611837318464, "approaches to these difficult problems": 0.0021393598858675026, "differences in presentation and outcomes": 0.00865953718962951, "minutes of exercise per week": 0.004875457371853229, "improve the management of patients": 0.009087155517087955, "embolism to the pulmonary arteries": 3.45453382343211, "quality of life for people": 0.005950680678220004, "life for people with heart": 0.00640097291085881, "assess the benefits of participation": 0.007140349354967617, "participation in a structured exercise": 0.0052291290294798135, "programme for patients with heart": 0.008201664616323684, "relation to sustainability with commissioning": 0.005032590627142737, "assess the association between frailty": 0.0030842743753964723, "association between frailty and risk": 0.005575340033359878, "assessed the association between frailty": 0.003128808993563874, "improving the prognosis of patients": 0.008985968539741934, "use of antagonists and inhibitors": 3.459181180839604, "induction of a fetal gene": 0.005730934070859426, "mir-25 by a specific antagomir": 3.451708415918689, "expression of the bhlh transcription": 3.456966013939676, "base of treatment of heart": 0.010966852158579718, "includes the use of angiotensin": 3.457103953661969, "blockers in case of angiotensin": 3.4579561348672065, "cause of death in patients": 0.010153218888487615, "death in patients with type": 0.008889043560186608, "action through activation of p38": 3.454283924512712, "variation in rates of guideline": 0.00813436188601743, "treatment for outpatients with heart": 3.4565175924924363, "examine the association between treatment": 0.003387016616480934, "rates of treatment with angiotensin": 3.457899626021004, "medications for patients with heart": 0.008214644637001096, "quality of care for patients": 0.00793519040658611, "trastuzumab in the adjuvant setting": 6.905879538442797, "age of the entire cohort": 0.007322356285921769, "mortality in women with heart": 0.008965685754525665, "recommendations for patients with heart": 0.008220537353853091, "scores with mortality among postmenopausal": 3.453514901976569, "assessments of patients with heart": 0.01123155662382251, "age of patients with heart": 0.011386161333920414, "rate for patients with heart": 0.008440605189926275, "outcome in patients with heart": 0.010537487264622614, "assess the relationship between pathobiology": 3.45286343526408, "disease in patients with thalassaemia": 3.4586480376416193, "verify the impact of heart": 0.008995314407824478, "fraction on the clinical response": 0.0037537163439579795, "results of patients with baseline": 0.009629683300563342, "site of the elastic n2bus": 3.4568407619309682, "strain as a major predictor": 0.0018420173575786486, "failure during an average follow": 0.0025963158828280633, "reduction in the primary end": 0.00663256489121646, "reduction in the primary outcome": 0.006566351416667274, "component of the primary outcome": 0.007283644762250548, "ratio for the primary outcome": 0.00452432398433453, "fibrillation in patients with heart": 3.460276025595834, "administration of doxorubicin in rats": 3.4578420533765426, "contents in addition to cytochrome": 3.4553220712890096, "alleviating the decrement of heart": 6.908530023436232, "risk for the primary outcome": 0.004700367077738091, "events after adjustment for age": 0.0020513747313426135, "kinases into a linear pathway": 3.451191793129375, "improve the potential for success": 0.004141649240739123, "frame of a patient consultation": 0.005905497453597117, "advantage of the faster turnaround": 0.007021630155124941, "rethinking the quality of outcome": 0.007332400151334225, "improve the quality of care": 0.007459596982836232, "investigating the role of bets": 0.007117113280703542, "model of neurohormonally induced heart": 3.456356089172438, "induction of a substantial subset": 0.005685949901957633, "t1 in swine with heart": 0.008525389869171288, "percentage of fibrosis of heart": 3.4604643586577915, "increase by means of stress": 0.005098243395477467, "echocardiography as a possible measure": 3.451619554376699, "use of devices in heart": 0.010003082635676043, "become a cornerstone of heart": 0.0075378156709131425, "attention in the medical literature": 0.006315498457062753, "hemostasis in patients with heart": 3.4602113805053207, "dosages of carvedilol or metoprolol": 10.354639331091981, "events in patients with heart": 0.010560917313758175, "medications to adults with heart": 0.007012644803415666, "thirds of patients with heart": 0.011220997048875931, "protein in the left ventricle": 3.4565074394327633, "contractility of the left ventricle": 6.9070849629560485, "addition to the left bundle": 0.005013164407070418, "delay the onset of myofiber": 3.4569419606730833, "test the effects of treatment": 0.007594150984311288, "effects of treatment with ivabradine": 3.457822548061241, "treatment with ivabradine on exercise": 3.454042853910884, "filling in patients with heart": 0.010439217081766393, "delay the onset of symptoms": 0.0072002878092746955, "rate at the same exercise": 0.003596270268325638, "correlates of increase in exercise": 0.008436332069948831, "angiography with a primary diagnosis": 0.004597698591719746, "eliminate the need for angiography": 0.004033391631233392, "angiography in a substantial proportion": 0.004866443834987097, "stratification of patient with heart": 3.459427584200252, "subject of this brief review": 0.004719981260813252, "reduced the rise in camp": 0.006470607819099138, "underuse of eplerenone in patients": 3.4596023461855077, "analysis of subgroups of patients": 3.4606540040134854, "hospitalization for hyperkalemia or discontinuation": 3.4521064597460644, "explore the relation of hemoglobin": 3.4568653023567637, "effects of hrqol from exercise": 0.005336323447415116, "structure in patients with heart": 0.010434867476342567, "alterations in markers of skm": 0.00796387007103572, "medicine as an adjunctive treatment": 3.4509724166993565, "cardiomyopathy in patients with heart": 3.4602624178394077, "enzymes in patients with heart": 0.010402368676012722, "patients with newly diagnosed heart": 0.006903108597963674, "variables with an important contribution": 0.0036233299432784586, "evaluating the effect of interventions": 0.007211728920067963, "year of oht in recipients": 0.007984849655500113, "interval from transplantation to consultation": 3.4523993758091764, "interval from consultation to operation": 0.00253378256376402, "oxygenation as bridge to recovery": 3.4521621542256735, "bridge to recovery in infarction": 3.4554093608501653, "diagnosis of a posterior wall": 3.4555761281344126, "half of patients with heart": 0.01121805019923143, "given the lack of improvement": 0.007166270759322458, "improvements from baseline in peak": 0.004304823121123586, "agents in combination with anticoagulants": 3.456506756522987, "biomarkers in patients with heart": 3.4602454068417874, "bolus of metoprolol or atropine": 10.354612110601735, "reduce the rate of death": 0.007550536345333306, "rate of death or hospitalization": 0.00575053729223146, "ratings from admission to discharge": 0.0025046126858433108, "insight on the possible contribution": 0.003033914857070238, "contribution of nursing to outcomes": 0.006634196312163674, "highlighting the contribution of nursing": 0.007067533063581189, "readmission after discharge among patients": 3.452303548103521, "rates of death and readmission": 3.4593881472153285, "analyze the effect of follow": 0.007366808582100162, "discharge on the primary outcome": 0.003307412247535379, "visits with a familiar physician": 0.004556651289307747, "hospitalizations in patients with heart": 0.010426186908898117, "demonstrated no change in type": 0.004018372479502807, "instability in patients with heart": 0.010395352409944887, "aim of the present study": 0.00754696132320066, "definitions of the distinctive components": 0.00703399681786206, "components of the right heart": 0.009060410506834472, "consensus on a universal definition": 0.001630372085163738, "insight into mechanisms of disease": 0.004754194674439512, "result of shortcomings in research": 0.007957955616920934, "provide an overview of biomarker": 3.454640175901904, "plasma by use of immunoprecipitation": 3.454919761541868, "fragments of the full length": 0.007072212834449892, "development of a next generation": 0.0057414870405372905, "evaluate the effects of carvedilol": 3.457059795769357, "effects of carvedilol and metoprolol": 6.909001526365326, "blockers on the primary endpoint": 0.0031963172188974307, "investigate the occurrence of heart": 0.008934747384161631, "users of bisphosphonates and raloxifene": 6.90881061331238, "% in the exposed group": 0.008335676151257368, "reduce the risk of heart": 0.009403703952847254, "alterations by metoprolol in heart": 3.455878370930644, "examine the reversibility of heart": 3.4587510386479483, "rates of changes in pressure": 0.008374841927479554, "reduction in the elevated levels": 0.006541390553874288, "assess the association between psoriasis": 0.0030774691081189394, "disease from the general population": 0.003527257072190212, "events as subjects without psoriasis": 0.0007476800399684436, "levels in patients with pad": 0.008681844581781579, "remodeling of the arrhythmia substrate": 3.456942761532771, "activation of the renin- angiotensin": 6.90680957479829, "form the foundation of management": 0.007152515558057207, "foundation of management of patients": 0.01072546655363423, "revascularization with angioplasty and stenting": 10.35734027608737, "guidelines on evaluation and management": 0.005277614922186418, "controls during this same time": 0.0006600222662002391, "race as an independent predictor": 0.000915681691154988, "investigate the association between race": 0.003079627175872924, "association between race and outcomes": 0.005457306512373285, "explored an interaction with exercise": 0.003939652793686821, "af at risk for stroke": 0.0021297013235654226, "control as an initial approach": 0.00100866023833433, "increase in incidence and prevalence": 0.00850253868952974, "causes of death and hospitalisation": 0.009380145449959368, "consequence of the worldwide increase": 0.007171081373341548, "preclude the provision of life": 0.007147649928418253, "estimated the odds of future": 0.007153222402828414, "point of death or hospitalization": 0.0055567015319275504, "analyze the relationship between length": 0.0030366259407899024, "relationship between length of stay": 0.004753573820930148, "length of stay and rehospitalization": 3.4590257182895594, "declines in length of stay": 0.00796879733734894, "decrease in length of stay": 0.0080196767698356, "outcomes of care for patients": 0.008075233262870388, "costs for patients with heart": 0.008223429760829728, "outcomes for medically managed diseases": 0.0016662391255450463, "reduction in mortality and hospitalizations": 0.008867327199997494, "provide the background for aldosterone": 3.4538759926295968, "improvement in survival of patients": 0.010013035037142126, "survival of patients with heart": 0.01134336159287534, "failure in the hypertrophied heart": 3.4596444697754194, "rates of glycolysis and glucose": 3.459102888014715, "progression from hypertrophy to heart": 3.4541643402791573, "search of the electronic databases": 0.007051851927548893, "assessing the link between air": 0.002929428162138082, "patients in the terminal phase": 0.008152816617277712, "requires the collaboration of professionals": 0.007055061478979769, "aims of the present consensus": 0.007093575144099199, "safety of these antihyperglycemic agents": 3.454474522921823, "users of saxagliptin or sitagliptin": 6.90479759596472, "assess the impact of implementation": 0.007195708010312618, "reduce the number of patients": 0.00897189999287779, "shocks at end of life": 0.004994362388990464, "objective of this clinical trial": 0.005078939903368633, "patients as control without exercise": 0.002948956315028564, "training of the lower limbs": 0.007288433867810876, "evaluation of the muscular strength": 0.007087527103532465, "association in the usual care": 0.006486595619180984, "impact the effect of exercise": 0.007620847855324114, "assessed the impact of hr": 0.0072210184696669955, "treatment of patients with heart": 0.01157858101910157, "reduce the risk of hospital": 0.0076594403497817695, "evaluations at baseline and months": 0.005336850202960108, "effect on quality of life": 0.005105773479964635, "improvements in functioning and use": 0.008487487462215781, "advancement of the pathophysiologic state": 3.456851039651282, "95 % confidence interval": 77.12618996036696, "left ventricular ejection fraction": 62126.23531397867, "patients with heart failure": 38.79019507526454, "estimated glomerular filtration rate": 8349.506412257355, "left ventricular assist device": 2484.6160165376714, "chronic obstructive pulmonary disease": 0.34188182213182783, "preserved left ventricular ejection": 1104.4055066112842, "left bundle branch block": 0.13979987175653746, "right ventricular contractile reserve": 2208.1012033423526, "diastolic mitral annular velocity": 3311.94725873591, "- brain natriuretic peptide": 1105.4600561624184, "x - ray absorptiometry": 621.7884612986082, "hour cumulative urine volume": 0.0402460715980182, "left ventricular assist devices": 621.1505641695342, "95 % confidence intervals": 0.4568279909239947, "vascular endothelial growth factor": 621.0038118092438, "post - myocardial infarction": 1242.8305434548402, "standard cardiac rehabilitation care": 0.15371745444142187, "standard criteria cardiac transplant": 0.1297031462847504, "early diastolic mitral flow": 1242.0195950720986, "diastolic mitral flow velocity": 1242.0112539791521, "peak early diastolic mitral": 1242.0251211131472, "end stage heart failure": 0.7046767678099675, "patients with chronic heart": 0.7162731843867695, "energy x - ray": 0.36665749241278917, "low left ventricular ejection": 276.0984837675596, "proteins alter chromatin structure": 275.99846879413775, "receive cardiac resynchronization therapy": 276.05974822256627, "left ventricular ejection fractions": 276.0864236792501, "diastolic mitral valve tethering": 552.0020916950942, "posteriorly displaced papillary muscles": 551.9729051561495, "- myocardial infarction heart": 552.5133841073709, "left ventricular filling pressure": 276.07169296912843, "pulmonary capillary wedge pressure": 276.0110975244354, "showed good diagnostic performance": 0.018760572538437645, "annular plane systolic excursion": 551.9946408042218, "pulmonary arterial systolic pressure": 552.021667562593, "proximal left anterior descending": 552.0045210212821, "ejection fraction \u226435 %": 276.1993635446289, "ventricular assist device implantation": 276.04342365561985, "left ventricular ejection time": 276.0951719886316, "95 % confidence level": 0.20735825113539946, "angiotensin converting enzyme inhibitors": 551.9898408965247, "cardiac magnetic resonance postcontrast": 276.036872620881, "cardiac magnetic resonance t1": 0.0507919111792613, "heart magnetic resonance imaging": 0.15853451775999503, "ventricular longitudinal systolic strain": 552.0349685433299, "non - fatal stroke": 0.3767222134104963, "predicting adverse cv events": 0.024617924732121703, "left ventricular diastolic function": 552.0759590683243, "mitochondrial oxidative phosphorylation capacity": 827.976020565169, "coronary artery bypass grafting": 551.9882084062792, "channel mrna splice variants": 0.00588920412674626, "acute right heart failure": 0.3215965038951948, "angiotensin converting enzyme inhibitor": 551.9871204710205, "multivariate logistic regression analysis": 276.010944424534, "left ventricular diastolic end": 552.0706753880737, "ventricular diastolic end diameter": 552.0421087395443, "\u03b2 - adrenoceptor blockade": 552.3501735820832, "angiotensin receptor neprilysin inhibitor": 551.995018638511, "risk of heart failure": 0.6768685806369745, "major public health problem": 0.016518675353970124, "ischemic heart failure samples": 276.2864620759381, "early rhythm control therapy": 0.05192905140334887, "post - acute care": 0.40298409342318064, "- acute care transfer": 0.3975265543637215, "acute care transfer policy": 0.034557941914385513, "chronic advanced heart failure": 0.3155532652337765, "advanced heart failure patients": 0.4480617564671662, "myocardial infarction heart failure": 552.2911001718335, "primary study end point": 0.06810200896644247, "heart failure disease management": 0.32702601818869836, "failure disease management programs": 0.17891440260076716, "patients with heart disease": 0.3229857760865987, "objective of this study": 0.23027397163807886, "standard error of measurement": 0.2010083191382616, "heart failure in patients": 0.4071782437924166, "patients with acute heart": 0.2211853263719233, "patients with advanced heart": 0.21691065832627507, "treatment of heart failure": 0.2613959696003792, "patients with systolic heart": 108.02889327509486, "hospital adverse events averted": 0.008401643937405567, "national patient safety initiatives": 0.006599035807197044, "cachectic heart failure patients": 69.1067871036262, "dual energy x -": 0.09166542577960715, "non - diabetic patients": 0.13050573362155257, "non - cachectic chf": 69.08928356020014, "heart failure show preserved": 0.0771745221282539, "mild clinical diastolic dysfunction": 69.01186836885765, "- dilated left ventricle": 138.09311863824678, "adult patients with heart": 0.13786920949882223, "congestive heart failure exacerbation": 138.06753750302374, "clinical practice guidelines grading": 69.00441797737221, "practice guidelines grading system": 68.99946238401958, "restrictive red blood cell": 0.002937948265641908, "red blood cell transfusion": 0.0032105283756545897, "blood cell transfusion strategy": 0.0037535647289987737, "term mortality rates compared": 0.01887237282520981, "relative risk among trials": 0.014798547101597176, "data supporting iron use": 0.00667215856749546, "right ventricular assist devices": 69.01230051939572, "modern acute heart failure": 0.07743265434410321, "baseline glomerular filtration rate": 69.00647623089627, "identified strong reliable mortality": 0.010918500700870418, "strong reliable mortality predictors": 69.00632377889748, "acute heart failure randomized": 0.07938868423226736, "heart failure randomized trial": 0.07736398262866345, "renal function in patients": 0.11637617442189419, "renal function end point": 0.013754543735672553, "cardiac chromatin identifies nucleolin": 138.00506477861202, "heart failure involves changes": 0.07622901162236619, "conserved developmental chromatin remodeling": 68.99930590927633, "developmental chromatin remodeling events": 69.00268105568097, "conducted extensive functional characterization": 0.004295809699190773, "displayed severe developmental impairment": 0.0033588871603810223, "bone morphogenetic protein 4": 69.00042657118851, "limited data regarding risk": 0.01359655988203192, "data regarding risk factors": 0.014560584984294397, "present study population comprised": 0.012377484130214923, "proportional hazards regression modeling": 0.0027810369703520016, "coronary artery bypass surgery": 69.00221029929666, "increased systolic blood pressure": 69.01211038777475, "bundle branch block pattern": 0.001382189057598602, "improved outcomes among patients": 0.04856311777200248, "term mortality as patients": 0.056227828996646384, "interaction term analysis showed": 0.009694831698937144, "day readmission rates using": 69.00663330291901, "produce different hospital rankings": 0.0036078450052422877, "rm interventions included home": 0.003490466382460833, "interventions included home telemonitoring": 68.99987452688346, "chronic heart failure induced": 0.08012849213179322, "rapid right ventricular pacing": 69.0098222355478, "pump sternal sparing approach": 68.9978216153311, "pump dysfunction requiring pump": 0.006984403491378322, "dysfunction requiring pump replacement": 0.006499976420207368, "ambulatory patients with heart": 0.13768576278870723, "- blocker dose changes": 0.0982795750334696, "\u03b2 - blocker dose": 69.09468575380745, "- blocker dose increase": 0.09792339371905458, "\u03b2 - blocker uptitration": 138.088897625747, "type natriuretic peptide levels": 69.0064520471025, "involving ventricular assist devices": 69.00949472232188, "congestive heart failure declined": 69.07194798229764, "determined chf visit rates": 0.0034972795057042908, "congestive heart failure visits": 69.0728444243035, "heart failure visits declined": 0.07534968801384996, "normal systolic ventricular function": 138.01412819799071, "low systemic vascular resistance": 0.005653311056860413, "abnormal liver texture changes": 0.004051019735099323, "primary outcome of death": 0.09709051106269659, "chronic heart failure promotes": 0.07733976980290252, "heart failure promotes restoration": 0.07312307101959604, "protective effects via stimulation": 0.005004726891694127, "novel heart failure mice": 0.0757684405296212, "heart failure mice model": 0.07775974683164971, "using simple experimental procedures": 0.004666572368158714, "predict heart failure risk": 0.08266888147390675, "prevalent coronary heart disease": 69.04284330091258, "simpler laboratory report model": 0.00441204000566578, "temporary right ventricular support": 69.01165371306817, "chronic decompensated heart failure": 69.07372803870109, "right ventricular assist device": 69.01268273771613, "purpose of this study": 0.10212473932674457, "ventricular assist device use": 69.01263754147635, "selected cardiac surgery patients": 0.050881079591588274, "used speckle tracking echocardiography": 137.99774565360212, "acute right ventricular pressure": 69.01690180101826, "right ventricular pressure overload": 138.0096182047078, "left ventricular midpapillary level": 138.0113883871803, "varying regional strain contributions": 0.001566665358683975, "medical treatment for heart": 0.07350111198598426, "size reduction by surgery": 0.015437449423326755, "successful mitral valve plasty": 137.9975421546213, "grade 4/6 holosystolic murmur": 206.98927707218473, "underwent mitral valve plasty": 137.99882025054293, "preserved mitral valve opening": 69.00462272094495, "mitral filling flow volume": 69.00476195014474, "limited mitral valve opening": 69.00186064371995, "diastolic mitral leaflet motions": 137.9991599409066, "after aggressive medical treatment": 0.016480555987058984, "heart failure clinic outpatients": 69.0701911880183, "available outpatient models use": 0.006413915996948507, "month risk of death": 0.10212625151598086, "model included blood urea": 69.00347267480993, "included blood urea nitrogen": 69.00054759546632, "demonstrated excellent risk stratification": 69.00833251617999, "resources within health systems": 0.0044714696630032665, "median left ventricular ejection": 69.02343567634011, "uncontrolled hypertension identify patients": 0.04124441561413373, "demonstrated high internal consistency": 0.005844576791127186, "internal consistency among patients": 0.04033826936870036, "offers excellent prognostic ability": 68.99893128990723, "interleukin receptor family member": 68.9994123219439, "left ventricular systolic dysfunction": 138.01949042445034, "lowest cardiovascular event rate": 0.010206017764086004, "highest cardiovascular event rate": 0.010312304431817281, "sst2 measurement identifies patients": 0.03848847110578505, "soluble guanylate cyclase altered": 206.98989904522858, "maximal ventricular power index": 138.00627772276812, "right heart filling pressures": 0.04206790889080407, "right ventricular fractional area": 138.00609995182822, "echocardiographic score allowed prediction": 69.00068003434004, "lv assist device implantations": 69.00011490309255, "93 heart failure admissions": 0.07367242805222499, "symptomatic systolic heart failure": 138.07100589360218, "diagnosed systolic heart failure": 69.07481546955574, "baseline serum creatinine level": 137.99874355840723, "% confidence interval 0.77": 69.04056218017173, "incident systolic heart failure": 69.07463129460663, "endothelial growth factor blockade": 69.00015169308556, "growth factor blockade prevents": 0.0031534231678149566, "myocardial infarction heart contributes": 138.0377852671742, "- adrenergic receptor blocker": 69.09237733463182, "adrenergic receptor blocker therapy": 69.00752570111175, "revealed reduced cardiac diameters": 0.017798217569139588, "b act via activation": 0.0021948147306682323, "heart failure via activation": 0.07498391685618068, "oxidase inhibition preserves left": 69.00549501687303, "inhibition improves cardiomyocyte bioenergetics": 137.99555288466013, "stable severe systolic heart": 69.04293292818346, "severe systolic heart failure": 69.07698125992513, "early transmitral blood flow": 69.00193070636801, "transmitral blood flow velocity": 69.00100391826288, "early diastolic mitral annulus": 206.99708603771654, "diastolic mitral annulus velocity": 206.9961592496114, "estimating pulmonary capillary wedge": 68.99937578435892, "decompensated systolic heart failure": 138.07073367364836, "detecting normal filling pressures": 0.0028714928310727226, "arterial systolic pressure relationship": 138.004050675811, "right ventricular contractile function": 138.01156788959412, "tricuspid annular plane systolic": 206.99497690314303, "type natriuretic peptide assessment": 69.00419304389207, "downward regression line shift": 0.0016791685634744518, "fractional flow reserve measurements": 68.99891314816598, "positron emission tomography imaging": 137.99344201434565, "emission tomography imaging showed": 68.99923560742945, "competitive collateral growth patterns": 0.0010253475727313717, "selective heart rate reduction": 0.04522891709086001, "preoperative serum albumin levels": 206.99432061088459, "% confidence interval 0.290": 69.04028995095463, "instituting mechanical circulatory support": 68.99977556541405, "underwent aortic valve surgery": 0.00609724612829489, "patients underwent lvad implantation": 0.040461061268927824, "1 dacron patch closure": 0.0038000680973552794, "transcatheter aortic valve procedure": 68.99957186409063, "bioprosthetic aortic valve replacement": 68.99956695160353, "young adults with heart": 0.10213137364718733, "adults with heart failure": 0.13674586398968547, "population within cardiac rehabilitation": 0.01540314047118689, "increased right grip strength": 0.00961286061899436, "acute heart failure complicating": 69.07380058646568, "complicating precapillary pulmonary hypertension": 137.9981418815208, "major right ventricle overload": 137.99922749167177, "right ventricle overload leads": 137.9975671076076, "arterial tonometry study tested": 138.00425512521372, "precapillary ph with heart": 69.0961917260957, "radial artery tonometry variables": 137.9955564040195, "reconstructed aortic pressure curve": 0.005026626459481672, "right atrial mass removal": 69.00395317094086, "right atrium mass presented": 69.00215852093096, "brief hypothermic circulatory arrest": 68.99714461593098, "advanced chronic organ failure": 0.041347201826633116, "median body mass index": 0.010026689743546953, "relative minimal detectable change": 0.0026913491011367574, "failure risk among patients": 0.08435679451024466, "non - biological disease": 0.0997757394966951, "secondary outcome measures related": 0.007060117421806239, "aim of this study": 0.10219524996935322, "non - frail participants": 0.09478167330051135, "sub - groups based": 0.09598688474334457, "vasopressin receptor antagonist therapy": 138.002691986467, "beneficial new therapeutic approach": 0.0039329646585447, "healthy heart muscle cells": 0.04060938907933818, "heart muscle cells developed": 0.0420872433794837, "evoked spontaneous cardiac dysfunction": 0.01637720987221509, "converting enzyme inhibitors intolerance": 68.99916967875551, "past decades several studies": 0.00392781713412172, "beta blockers decrease mortality": 0.012634207157115798, "insulin receptor substrates 1": 69.00393994368571, "causes myocardial insulin resistance": 69.00376757582293, "box class o-1 signaling": 0.0037275336755105293, "impaired cardiac metabolic gene": 69.01031148549791, "cardiac metabolic gene expression": 69.01173008760539, "impaired cardiac energy metabolism": 0.013214335703261018, "cardiac energy metabolism gene": 0.013826029832941452, "energy metabolism gene expression": 0.004644772966994024, "neonatal rat ventricular cardiomyocytes": 138.00364214164148, "chronic insulin exposure reduced": 0.011246666358825045, "optimal combined treatment measure": 0.009327308150951199, "multivariable hierarchical regression models": 69.00062840197836, "level prescription rates ranged": 0.004683796593322502, "adjusted median rate ratio": 0.014535659917267189, "angiotensin receptor blockers therapy": 69.00923325721489, "reduced ejection fraction exists": 0.02164971963747964, "cardiotoxicity among older patients": 69.03868335462751, "adjuvant setting improves outcomes": 69.00462614753599, "chf among older patients": 0.041754854218236756, "older breast cancer patients": 0.04002191208830655, "non - hf populations": 0.09316015062361836, "mortality among postmenopausal women": 69.00788623781999, "proportional hazards models adjusted": 0.005659627954960597, "higher dash diet scores": 0.006128188638200454, "extended criteria cardiac transplantation": 69.00959412437764, "extended criteria cardiac transplant": 0.013413504483704366, "undergoing isolated heart transplant": 0.0407904039008468, "criteria cardiac transplant recipients": 0.01377238536255978, "criteria cardiac transplant survival": 0.015876936370121587, "post - transplant mortality": 0.10201991307461301, "advanced heart failure therapy": 0.08052247256047741, "post - transplant morbidity": 0.09441152753879124, "heart failure readmission quality": 69.07419232476025, "failure readmission quality improvement": 69.03901855229456, "readmission quality improvement initiative": 69.00407507679297, "hospital quality improvement initiative": 0.00891437851160014, "heart failure nurse practitioner": 0.07319603908252839, "readmission rate for patients": 69.0670216471014, "myocardial extracellular matrix accumulation": 206.99438930552287, "estimate myocardial extracellular matrix": 206.99437141002548, "using cardiac magnetic resonance": 0.015866650154757696, "magnetic resonance t1 mapping": 0.001957456503471034, "cardiac magnetic resonance imaging": 0.013306267189136313, "magnetic resonance imaging including": 0.003557110565692772, "resonance imaging including t1": 0.0028853329939346277, "imaging including t1 mapping": 0.0026752184839557132, "magnetic resonance t1 time": 0.003810226975831929, "right ventricular ejection fraction": 69.02472151609045, "recommend cardiac resynchronization therapy": 69.01478657158583, "end systolic volume index": 69.01281588455487, "rat metabolic risk model": 69.00952815806647, "important metabolic risk factors": 69.00987498814271, "preserved ejection fraction development": 0.021793553152709966, "high muscle strip stiffness": 69.00131192810761, "rats developed heart failure": 0.07634285123228408, "patients with atrial fibrillation": 138.09570705006792, "systolic mitral annulus velocity": 206.99751898447622, "containing chronic heart failure": 0.07739800270587574, "receiving implantable cardioverter defibrillator": 206.994566547702, "refractory congestive heart failure": 138.06794583990202, "diuretic resistant volume overload": 137.99763523039036, "transplant ineligible patients receiving": 0.03982209714208655, "post - pd initiation": 0.09257555582398765, "severe right ventricular dysfunction": 69.01648002561312, "stage congestive heart failure": 69.07228817049085, "dependent patients with heart": 0.1383567459616299, "ii receptor blocker use": 0.007624820548374132, "demonstrated superior reverse remodeling": 0.004798293491319414, "certain dialysis patients demonstrated": 0.04029297446651267, "sodium dash diet improves": 0.0034494713034882215, "dietary sodium restriction improves": 0.0027129964561277676, "parametrized diastolic filling formalism": 206.99376656697302, "pre - post comparisons": 0.09334239148093643, "connected elevated resistin levels": 69.00207224810013, "mouse model lacking murine": 69.00038189365561, "model lacking murine resistin": 137.99691115608027, "increased cardiac mrna levels": 0.020188530482872787, "cell adhesion genes compared": 69.00317122664411, "treated breast cancer patients": 0.040727764463732594, "patients maintaining sinus rhythm": 69.03553511421426, "larger randomized control studies": 0.009339460363715706, "heart failure in rats": 0.1448537131251966, "anti - neoplastic agent": 69.0877576423311, "mitochondrial oxidative stress induced": 137.99845983537068, "restoring mitochondrial oxidative phosphorylation": 206.99187172452793, "significant cardioprotection via inhibition": 69.00297881703155, "isolated coronary artery bypass": 69.00168213931371, "heart failure \u226490 days": 69.070938383336, "developed acute kidney injury": 0.007925539409782231, "% confidence interval 1.38": 69.04042606787907, "paediatric heart failure concern": 0.07302623895802034, "new onset heart failure": 0.0752943521724985, "targeting specific effector molecules": 0.0018963193239753904, "% intermediate frail according": 0.038760977442842515, "acute heart failure trials": 0.07958327962197065, "adverse event rates remain": 0.0063912230064929985, "selecting appropriate end points": 0.005718532003608784, "faster turnaround times provided": 0.0009625360915780371, "measuring heart failure care": 0.07701446441989723, "inhibition halts heart failure": 69.07060780739222, "pathological cardiac gene expression": 0.015276585332914084, "cardiac gene expression programme": 0.01494717951947741, "activating transcription factor networks": 68.99919024240111, "promoting transcriptional pause release": 68.9966134781589, "abrogate pathological gene expression": 69.00038234233172, "quantify myocardial t1 changes": 69.00472816968289, "similar left ventricular tissue": 69.01587529456192, "using trichrome blue histologic": 137.99597853667635, "trichrome blue histologic analysis": 137.99698530139543, "quantify diffuse myocardial changes": 69.0047958789892, "myocardial delayed enhancement imaging": 69.0020817821674, "contractile reserve in patients": 69.10547725566644, "induced pulmonary artery systolic": 69.0085551885226, "pulmonary artery systolic pressure": 69.00916822097814, "diagnosed pulmonary arterial hypertension": 69.00365262555047, "chronic thromboembolic pulmonary hypertension": 69.00603345563809, "impaired right ventricular pump": 69.01044102044742, "right ventricular pump function": 69.0153820202005, "stable targeted pulmonary arterial": 69.00212925149341, "targeted pulmonary arterial hypertension": 69.00343583717569, "pulmonary arterial hypertension medication": 69.00385992944224, "arterial hypertension medication underwent": 69.00297350793883, "remained independent prognostic markers": 69.00085567065764, "regulates cardiac sodium current": 0.01318476430843616, "systolic human heart failure": 69.0756575316576, "increases alternative mrna splicing": 68.99722143563615, "human induced pluripotent stem": 69.00087642461028, "induced pluripotent stem cell": 69.00049805455448, "receptor potential cation channel": 69.00157379360219, "potential cation channel m7": 68.99864860114067, "intrinsic left ventricular dysfunction": 69.01820740042052, "chronic pulmonary arterial hypertension": 69.00739434703507, "characteristics yielded hazard ratios": 0.006791821475176713, "requires new prevention strategies": 0.003404711908209404, "nonselective \u03b2 - blocker": 138.08848929581603, "selective \u03b2 - blocker": 69.09216978658634, "\u03b2 - blocker metoprolol": 138.08985023351528, "stable heart failure patients": 0.11154515304747414, "secondary outcomes included markers": 0.009763105732582827, "competing priorities impact prescribing": 0.0022707511233595453, "primary care clinicians caring": 0.006503333304804151, "increased vascular endothelial growth": 69.00418974839361, "endothelial growth factor protein": 69.00123087654376, "volume conductance catheter system": 69.0015218393092, "coronary artery ligation augmented": 137.99691738937463, "bundle branch block type": 0.004184836248472218, "block electrical activation sequence": 0.0019286787497257635, "slows myofiber shortening velocity": 137.99474027794707, "lower body mass index": 0.011458068495999714, "lower fat mass index": 0.010276617753363337, "greater antecedent weight loss": 0.002356594319901563, "lean body mass ratio": 0.010422722504037592, "increased body mass index": 0.01343661803427395, "ivabradine increased exercise capacity": 69.01276276149666, "improved left ventricular filling": 69.01674082049519, "ventricular filling pressure response": 69.01206101896109, "abnormal exercise hemodynamic status": 69.00711322375729, "simple validated clinical tool": 0.007171090793808839, "left anterior descending artery": 69.0061063670705, "simple clinical prediction rule": 0.0077845972639921275, "japanese heart failure patients": 0.11033498408399459, "congestive heart failure patients": 69.10862426014852, "diminished cyclic adenosine monophosphate": 137.99317402131527, "augmented cyclic guanosine monophosphate": 137.9931754237286, "fluorescence resonance energy transfer": 68.99788755703284, "stimulation via catecholamine infusions": 137.99461323224386, "synthesis via nitric oxide": 137.99407126826793, "intracellular antiadrenergic therapeutic strategy": 137.99489343002995, "high risk for hyperkalemia": 69.03645600934209, "pre - specified analysis": 0.09577281695132622, "exercise training in patients": 0.11796755172191456, "using linear mixed models": 0.0063060022348942184, "beneficial effect of exercise": 0.09846732447571421, "implantable cardiac arrhythmia devices": 69.01096163184836, "total cost per patient": 0.00877595435997722, "severe heart failure appears": 0.07591853331535232, "skeletal muscle sarcomere structure": 68.9988641159894, "co - ordinated fashion": 0.09124938282780887, "systemic adverse events evaluation": 0.006625261661591508, "accepted peak oxygen consumption": 0.003736575840862614, "refractory right heart failure": 69.07277528077105, "after percutaneous coronary revascularization": 206.99874341643283, "extra corporeal membrane oxygenation": 137.99360759465108, "acute ischemic right heart": 69.04322581449416, "ischemic right heart failure": 69.07406807261731, "non - diastolic abnormalities": 69.09343213209381, "first acute myocardial infarction": 138.00563792905695, "linked administrative health data": 0.00568634063589585, "mean \u00b1 sd testosterone": 69.0047385524948, "\u00b1 sd testosterone levels": 69.00597047032588, "incremental shuttle walk test": 0.0024525383426647457, "testosterone group showed improvements": 0.00892704263217026, "tendency toward lower mitral": 69.00252830531731, "transforming growth factor beta": 0.003763354728764075, "anterior descending coronary artery": 137.9971882150204, "descending coronary artery occlusion": 137.9972562694299, "cell differentiation toward cardiomyocyte": 68.99809240959847, "optimizing cardiac progenitor function": 0.017236638260629215, "displayed permanent periodic breathing": 0.0005044717577069414, "anti - inflammatory effects": 0.09437776073600881, "stable coronary artery disease": 69.00794689001948, "improve cardiac autonomic balance": 0.013757200202672971, "time domain heart rate": 0.04524896741199563, "domain heart rate variability": 0.04367295534140479, "power spectral analysis indicated": 0.004835258711441124, "improves cardiac autonomic balance": 0.013554184208889878, "chronic systolic heart failure": 69.07855719104035, "patients underwent device implantation": 0.042373983899205714, "renal function in children": 0.07933748218629053, "stage heart failure supported": 0.07410729321960792, "pediatric mechanical cardiac support": 0.014530540403339284, "receiving ventricular assist device": 69.01055532729688, "ventricular assist device support": 69.01207780264572, "patients receiving extracorporeal membrane": 69.03559445656926, "receiving extracorporeal membrane oxygenation": 137.99477992866161, "extracorporeal membrane oxygenation membrane": 137.99433272042577, "membrane oxygenation membrane support": 69.00025826813818, "ecmo+vad group included patients": 0.04511949917722631, "sensitive outcome change scores": 0.005786965930159305, "older adults with heart": 0.10327826471008128, "using standardized nursing terminologies": 69.00036133955965, "standardized nursing terminologies makes": 68.9971459870492, "retrospective descriptive research design": 0.001831836098772733, "future prospective experimental research": 0.0026771638652319145, "influences cardiac hypertrophic response": 69.00975252992006, "- adrenergic receptor agonist": 69.09088664469337, "- adrenergic receptor stimulation": 69.09149596592482, "cardiac plasma membrane levels": 0.01617205552332602, "first month after discharge": 0.010693847673748032, "better outcomes among patients": 0.047126282487827346, "post - translational state": 69.08909953259848, "- adrenergic receptor blockade": 69.09136337645334, "adrenergic receptor blockade reduces": 69.00073420916691, "- adrenergic receptor activation": 69.09177060508088, "post - translational states": 69.08895924951577, "total myosin binding protein": 69.00015009589093, "mutant ri\u03b1 proteins demonstrated": 0.003588918903477684, "myocardium displays altered expression": 68.99962717874546, "post - translational modification": 69.08929884958873, "autonomic nervous system activity": 0.0034837823302194836, "acute \u03b2 - adrenoceptor": 138.09134748888823, "acute autonomic nervous system": 0.006304445035964279, "autonomic nervous system modulation": 0.0020225672300431667, "related congestive heart failure": 69.07318873266576, "developing congestive heart failure": 69.07138532388575, "pre - hct exposure": 0.0916552618773099, "anti - oxidant defence": 69.08739349812605, "chf predictive model performed": 0.0056195470191465055, "right heart circulatory failure": 0.07639087632470618, "foster collaborative research initiatives": 0.0009790318149032718, "class angiotensin receptor neprilysin": 138.00077176760732, "receptor neprilysin inhibitor composed": 69.00025643167562, "angiotensin receptor antagonist valsartan": 206.99500328646525, "preserved ejection fraction outcomes": 0.02595926315102552, "ejection fraction outcomes trial": 0.024409085398841922, "guided clinical trial design": 0.008968013319617716, "reduced skeletal muscle mass": 0.009465384870255628, "underwent cardiopulmonary exercise testing": 0.011219930585187048, "dual x - ray": 0.09128203834054974, "single tertiary referral centre": 0.0009825607719404193, "skeletal muscle mass assessed": 0.0061495129666943055, "relative appendicular lean mass": 69.00007639050699, "appendicular lean mass index": 69.00286388926405, "low skeletal muscle mass": 0.0070612799860119025, "skeletal muscle mass correlated": 0.005134675693170069, "skeletal muscle mass t": 0.003887333011311899, "sarcopenic range muscle wasting": 68.99867219742798, "659 heart failure patients": 69.10671904458499, "performed confirmatory factor analysis": 69.00431980557956, "used exploratory factor analysis": 0.009547147039071245, "separate sub - sample": 0.09164967066909369, "showed excellent fit indices": 0.003126587944863432, "concentric left ventricular hypertrophy": 138.0114656461032, "outcome data among groups": 0.011208876552970991, "lower systolic blood pressure": 69.01013183823649, "elevated cardiac filling pressures": 0.013911266579503312, "heart failure patients undergoing": 0.11121336029114752, "undergoing either cardiac resynchronization": 69.010422308784, "nationwide retrospective cohort study": 0.012713175583842485, "20 weeks mi animals": 0.003299952713179217, "elevated levels of plasma": 0.09285772830437253, "- myosin heavy chain": 69.08754716067479, "complete reverse cardiac remodeling": 0.013918463155347841, "using general linear models": 0.0064329700770898845, "higher diastolic blood pressure": 69.00895539775291, "body mass index levels": 0.011460524702603697, "coronary artery calcium scores": 69.00139520043123, "% confidence interval 0.50": 0.04438193663821907, "share many risk factors": 0.01124387021394459, "logistic regression analysis established": 0.0060977270251139255, "hospital readmission reduction program": 69.00384543702255, "day readmission rate following": 69.00606758623537, "readmission rate following hospital": 69.00614044910503, "rate following hospital stay": 0.008792205332299121, "indicating possible suboptimal care": 0.004857849117063308, "intensive transitions of care": 0.09150716023919388, "- urbanized midwestern state": 69.08735311394506, "non - linear measures": 0.09483045188002363, "non - linear hr": 0.09323697734115499, "- linear hr variability": 0.09204956188537729, "linear hr variability measures": 0.0028135518347277306, "term fractal scaling exponent": 137.99530094959448, "- sudden cardiac death": 0.10725259953205848, "trials using hr variability": 0.006286083554307889, "- defined inclusion criteria": 0.09350909999070628, "end stage kidney failure": 0.0415694273148959, "adequate blood pressure control": 0.009211948388128943, "showed modest clinical benefit": 0.009987043779333604, "reveals several key genes": 0.0014996214522534606, "non - ischemic heart": 69.12852229563653, "- ischemic heart failure": 69.16177884027327, "functional enrichment analysis revealed": 0.00894197535083439, "longitudinal analysis using medicare": 69.00447572618842, "analysis using medicare data": 69.00662872615256, "retrospective matched cohort study": 0.013605206490660458, "score matched control group": 0.012383935608263851, "negative binomial regression models": 69.00059997975269, "contemporary chronic heart failure": 0.07726434202422666, "socioeconomic status versus whites": 0.005719767861329283, "given similar cardiovascular mortality": 0.014504117696506717, "optimal therapy including anticoagulation": 69.004703865439, "modern rhythm control therapy": 0.011187640421702033, "blinded outcome assessment trial": 0.006705767847982444, "term ventricular assist device": 69.01203089453297, "stage heart failure fall": 0.07400098729448838, "advanced structural heart disease": 0.045751223514764856, "requires special therapeutic interventions": 0.003545236358295299, "ventricular action potential duration": 69.00846251770298, "type channel isoforms known": 69.00105604136172, "common inpatient medical conditions": 0.005403191486275477, "derived composite quality measure": 0.0061232168802888565, "higher estimated glomerular filtration": 69.00277262807192, "non - aa participants": 0.09450979034446658, "attain maximal spironolactone dose": 137.99704679539462, "achieved study drug dose": 0.012690124844982454, "derive less clinical benefit": 0.009143917769869845, "free shotgun proteomics approach": 68.99793631430285, "associated signaling pathway changes": 0.013659471375680833, "pathway changes using ingenuity": 0.007227041159825812, "changes using ingenuity pathway": 0.007227041159825812, "using ingenuity pathway analysis": 0.008227072721572321, "congestive heart failure phenotypes": 138.06760556206495, "ingenuity pathway analysis noted": 0.005278000614042339, "care transfer policy led": 0.004650495538789866, "ami without major complications": 0.004610436893825393, "costs across volume groups": 0.008032748846997697, "physician volume within strata": 0.006543245022447469, "symptomatic chronic advanced heart": 69.04042221298256, "- myocardial infarction patients": 138.12821117871545, "infarction heart failure patients": 69.10916844081733, "large idiopathic dilated cardiomyopathy": 206.99264171471165, "idiopathic dilated cardiomyopathy cohort": 206.99459425801408, "including negative coronary angiography": 69.00108221468047, "heart failure treatment eras": 0.08014143948331696, "severe left ventricular dilatation": 138.01334918417857, "end point including death": 0.011627610507114429, "recent enrollment period represented": 0.003530759541799914, "42 % risk reduction": 0.04937025684887176, "maximal cardiopulmonary exercise test": 69.00708306714938, "cardiopulmonary exercise test investigations": 0.01040784662538245, "peak respiratory quotient \u22641.05": 68.99881150908635, "at multivariable logistic analysis": 0.010553806221486349, "reduced peak oxygen uptake": 0.009408996674080192, "kidney index score value": 0.007982167502832349, "secondary study end point": 0.015201134028082031, "associations among cardiorespiratory fitness": 68.99940516678988, "measures included body mass": 0.008242824436160558, "included body mass index": 0.010305048994904382, "maximal treadmill exercise testing": 138.00215395008675, "obese body mass index": 0.00880589313469248, "body mass index categories": 0.008384607986249907, "overweight body mass index": 0.00819412607382208, "body mass index strata": 0.008196933215963459, "decreased mitochondrial energy production": 69.00066928975478, "mitochondrial energy production precede": 68.99904288703142, "reduced mitochondrial complex v": 69.00420771457641, "mitochondrial complex v activity": 69.00018069215321, "decreased mitochondrial oxidative metabolism": 137.9970474344368, "guide health service planning": 0.0027955728287080437, "relevant health service provision": 0.0029520389901697085, "health service provision related": 0.004686690423905089, "total expenditure on health": 0.01081146355234535, "raised blood glucose levels": 0.005518961226921432, "lower gross national income": 0.003967980270715379, "national income per capita": 0.0020069041172023913, "renal chloride channel gene": 69.00112433430952, "tac cardiac functional deterioration": 0.01534995035018291, "health system data partners": 0.006362847903319869, "without prior cardiovascular disease": 0.013154758653072394, "prospective studies evaluating implementation": 0.004831527870397659, "studies evaluating implementation interventions": 0.005171385355728974, "left ventricular function assessment": 69.02020823579525, "25 heart failure patients": 0.11097691255548373, "experiencing distressing implantable cardioverter": 137.99588394206557, "carotid baroreflex activation therapy": 137.99990146683803, "primary safety end point": 0.009255533149584532, "primary efficacy end points": 0.008232159864714652, "minute hall walk distance": 0.0016245383148010407, "trend toward fewer days": 0.003100377428169111, "using cardiopulmonary exercise testing": 0.01269025242435035, "cardiopulmonary exercise testing guide": 0.009776971087135327, "exercise testing guide exercise": 0.016948601102664725, "testing guide exercise rehabilitation": 0.009899382370450143, "exercise patients used \u03b450%w": 0.04895040295083997, "patients used \u03b450%w intensity": 0.041228026222226946, "reduced long axis function": 0.013582637740492686, "other cardiovascular risk factors": 0.01710516272875316, "peripheral oedema allows assessment": 0.0020468261965928373, "regular physical activity controls": 0.002902281064608154, "physical activity controls acquired": 0.003020153913168312, "acquired cardiovascular risk factors": 0.01540769765434413, "exercise prevents cell senescence": 69.00550397754772, "certain malignancies including cancer": 68.99838782405426, "aerobic exercise per week": 69.00662898731358, "recommendations confer health benefits": 0.003986165582344372, "cardiac disease including heart": 0.0568199836542997, "disease including heart failure": 0.08080018085724507, "pre - participation screening": 0.09176997438679745, "detect congenital accessory pathways": 68.9976020521243, "week aerobic training period": 69.00102226976635, "integrated dynamic resistance training": 0.003672760668038056, "perceived social support score": 0.0052754698221016754, "higher exercise time associated": 0.022470291692044047, "% confidence interval 0.99": 69.04063023458123, "% confidence interval 0.66": 0.04410936579148451, "exercise training improves outcomes": 0.01746865746645641, "implement exercise training therapy": 0.015885660447061946, "recent onset heart failure": 0.07544085695690428, "blocker hypo - response": 69.09052497887087, "hr reduction with beta": 0.06578791487028388, "hr<70 versus \u226570 bpm": 137.99704183152073, "elevated left atrial pressure": 69.01079597806559, "atrial pressure improve symptoms": 69.00534196410383, "canadian special access programme": 0.0004149629612081427, "6 min walk test": 0.008188139491648174, "min walk test distance": 0.005019253783253394, "incessant ventricular tachycardia storm": 138.00266802760922, "prospective randomized multicenter trial": 69.00203587524611, "randomized multicenter trial paradigm": 69.00122206420447, "stabilized chronic heart failure": 0.0772748687961762, "- specified subgroup analyses": 69.0885711220426, "stable chronic heart failure": 0.07841803023912675, "failure among older persons": 0.039579368146023516, "urban academic medical center": 0.0026095180372815554, "indicate worse heart failure": 0.07342650990349885, "percent lean body mass": 0.005135461072876381, "related serious adverse events": 0.00777791782559413, "among obese older patients": 0.04256728947482116, "aerobic exercise training increased": 69.01209916736339, "exercise training increased peak": 0.017532144487171518, "left ventricular assist system": 69.01634804901086, "88 % performance goal": 0.03932248083650597, "adverse events included reoperation": 69.00430954345003, "favorable adverse event profile": 0.0038211194159096682, "management programs in heart": 0.11130202244605245, "influence medical resource use": 0.005713917192705654, "diagnosis of heart failure": 0.0908470462622773, "target patient population is": 0.010770684563622169, "appropriate risk stratification is": 38.822996758591216, "patients with an implantable": 38.87160952165107, "development of heart failure": 0.091217822401732, "treatment for heart failure": 0.06000976021699942, "dilated by another disease": 38.82085161006285, "ventricular ejection fraction was": 38.837284647278025, "aortic valve replacement is": 0.008432614665659293, "receptor antagonist therapy is": 38.8225373204471, "programs in heart failure": 0.08104221707766289, "maintenance of sinus rhythm": 38.860546637289794, "velocity to peak early": 0.02442181697528044, "failure with reduced ejection": 0.062419895154661766, "patients at high risk": 0.031357884747390735, "effect of exercise training": 0.05598772684710701, "extracorporeal life support is": 38.82006490391862, "hospitalization for heart failure": 0.058134732283087076, "abnormal hr variability have": 0.0030303677604141205, "magnetic resonance angiography is": 0.007746864399592059, "sickle cell disease has": 38.81560157505936, "secondary end point was": 0.015973990438208824, "mass index categories were": 0.01719667967318458, "overall improvements for patients": 0.01631090716451847, "failure patients with respect": 0.033703095573210336, "body composition with regard": 0.016211740771517418, "total adiponectin at baseline": 17.251855493883024, "symptoms of heart failure": 0.04047640914719136, "iron deficiency in adult": 0.01805529617947957, "english language on anemia": 17.25095297405696, "anemia treatment in patients": 17.27811180114072, "language trials of blood": 0.022864233862839783, "observational studies of transfusion": 0.022799265998284312, "small trial of patients": 0.03188416258143135, "ischemic conditioning for patients": 17.265557185188165, "better ways to deal": 0.009767813274289435, "current predictors of mortality": 17.273569122873557, "use of implantable cardioverter": 34.52149657689923, "high confidence in estimates": 0.01938830784667147, "independent predictors of mortality": 17.273520030708056, "strong predictors of mortality": 17.27332070371586, "cystatin c from enrollment": 17.251675892232395, "change in cystatin c": 17.267379515595533, "multihospital study to promote": 17.2609771530643, "multisite studies in practice": 17.267856045411616, "cellular plasticity in cardiomyocytes": 34.516189961489474, "global changes in chromatin": 17.26785955735462, "quantitative proteomics to identify": 17.259051006386677, "model system of zebrafish": 17.27193622199745, "ischemic events in patients": 17.277407996707606, "factors for the development": 0.020960789913243582, "therapy with a defibrillator": 17.272908086648044, "risk for subsequent heart": 0.018454128986141988, "term mortality in patients": 0.029748698617812215, "term mortality after hospitalization": 0.005409395221725039, "p value for age": 0.0053726215441211155, "outcomes in heart failure": 0.037436303545243924, "decrease in cd34+vegfr2 +": 0.018279760754620483, "cell decrease in cd34+vegfr2": 0.018212071706008866, "common applications of readmission": 17.271810679190224, "differential impact on hospital": 0.0029195256860368064, "different approaches to computing": 0.009887635564415112, "hospital discharge in patients": 0.028045189496123626, "beneficial effect on mortality": 0.00458722348073972, "significant difference between numbers": 0.002674965520834412, "blocker therapy in patients": 0.028926975089119587, "blocker uptitrations in patients": 17.27654554220731, "clinical outcome in patients": 0.02929579778127675, "peptide levels in patients": 0.028334961687323246, "similar among all subgroups": 17.25122497579785, "mortality among these subgroups": 17.252912102157204, "medical management of heart": 0.03234634213449172, "management of heart failure": 0.040642068678884286, "heart failure in children": 0.035982354029145375, "important cause of morbidity": 0.023173064615073433, "cognitive impairment at hospitalization": 0.0025446071001724996, "limited ability to augment": 0.010035312807805424, "protective effects of exercise": 0.024557520586740794, "molecular pathways in patients": 0.02738248306267857, "lower stimulation of phosphorylation": 17.272140158316027, "higher amount of malondialdehyde": 0.022764168263338984, "cutoff value for plasma": 17.25635034736723, "cutoff value for admission": 17.256500631395117, "year survival of patients": 0.03215980936878443, "area under the curve": 0.013581644485878825, "cause mortality in patients": 0.02991339162185737, "model of hypertensive heart": 17.28118639812522, "heart disease by angiotensin": 17.263352583490555, "therapeutic targets for hhd": 0.007189688931903025, "atherosclerosis risk in communities": 0.020031760267231923, "largest increases in incidence": 0.01795408759579146, "area under the receiver": 0.013530251049201214, "over a mean follow": 0.008087154214521192, "heterogeneous group of patients": 17.281636680793618, "year survival in patients": 0.028013431013679695, "limited mortality at hospital": 0.004505627687838, "effectiveness limits in models": 0.018509698072759397, "limited number of patients": 0.03162555169007147, "noninvasive surrogates for changes": 17.25659295644279, "annuloplasty for ischemic mitral": 51.75497801408559, "combination of annular size": 17.271291637397987, "history of successful valve": 0.022490055916350067, "restricted without any clear": 0.0006515445620258593, "mild restriction of leaflet": 0.022261570150222128, "opening without any clear": 0.0006728522865862586, "risk stratification for death": 17.25932205728755, "complex set of variables": 0.02213921496006404, "hospitalization within the prior": 0.014768854283227918, "available data to predict": 0.010563318197203428, "renal disease in outpatients": 17.269138307376913, "prognostic factor in heart": 17.277000231342438, "hazard models for time": 0.008939553430246936, "preserved and reduced ejection": 0.0281742730164546, "valid measure of patients": 0.03139722385632804, "reliable measure of health": 0.022635809048776614, "equivalent dose of metoprolol": 17.271968129811178, "benefits across all study": 0.0036635545936037164, "acute treatment of heart": 0.03411279060527446, "vasodilator effects in vivo": 34.51665819147173, "conscious dogs with tachypacing": 17.264741935826276, "echocardiographic predictors of response": 34.520962423841596, "strain of left ventricle": 17.27322876394786, "echocardiographic score for prediction": 17.25682407495892, "57\u00b122 months of follow": 17.2725115124993, "randomized trials to reduce": 0.010935694435837919, "independent association between spironolactone": 17.251305713727042, "kidney injury during spironolactone": 17.25078914625657, "beneficial effects of beta": 0.023052757783404404, "therapy on cardiac function": 0.007350914042758114, "remodeling in heart failure": 0.03635054695172606, "progression to heart failure": 0.027940835927146048, "cardiac function in b": 0.021882718013069413, "proangiogenic effects of b": 17.271589457458546, "coronary perfusion in b": 34.51647970291112, "positive effects of b": 0.022545359849996283, "cardiac angiogenesis in heart": 17.279060359412767, "responsible diagnosis of heart": 0.03158972544339872, "higher risk of death": 0.02615425903018601, "twofold increase in lung": 0.01848148807518515, "groups versus the sham": 0.01509828421022493, "patients with severe heart": 0.034977532499556145, "filling pressure in patients": 0.02816161406918874, "flow velocity over tissue": 0.0008653180215361043, "transthoracic echocardiography with measurement": 34.51423572000262, "predictive value of e": 0.022356347062431507, "pressure relationship in heart": 0.028247752629964082, "line shift in nonsurvivors": 17.266835064957842, "distribution along the regression": 0.013651365943481288, "hazard ratios for variables": 0.008198568208405279, "heart failure in pigs": 0.035924314284226794, "antiarrhythmic medication to prevent": 17.258963584041222, "severe ischemia after bottleneck": 17.25170932450683, "rate reduction with ivabradine": 17.266689304129883, "left ventricle in heart": 17.27826376936364, "ventricle in heart failure": 17.285191507112856, "hr reduction by ivabradine": 17.2526168141109, "hr reduction in patients": 0.027633520181168256, "albumin levels to survival": 17.260281509188587, "prognostic indicator in patients": 17.276579645849846, "postoperative mortality in patients": 17.278296052609736, "postoperative survival of patients": 17.280962993226336, "patients with preoperative hypoalbuminemia": 34.52326336051245, "normalization of albumin levels": 17.271954332341842, "subgroup analysis of patients": 17.281380295527878, "effective way to improve": 0.010307517281317314, "rates across the respective": 0.014238651177882566, "important outcomes in patients": 0.02897106176563522, "prognostic value in patients": 17.27684358855868, "patients with precapillary ph": 17.274014219492095, "ph with heart failure": 0.03373251234385287, "prognostic factors at admission": 17.251852768897542, "serum levels of brain": 17.272063072510065, "serum levels of creatinine": 34.521101646233845, "prognostic factor in patients": 17.27696651931061, "large limits of agreement": 0.02211624003770012, "exercise programme for patients": 0.018053393166190028, "significant improvements with others": 0.01676195199767038, "risk for heart failure": 0.027151935694638873, "mean age of participants": 0.023623589765586185, "associated with a higher": 0.025000328387465628, "sd decrease in score": 0.018511548078181235, "cardiovascular disease at baseline": 0.004896079919768014, "excessive secretion of arginine": 34.520012476597884, "marked resistance to pressure": 0.010806396337359792, "vivo inhibition of mir-25": 17.271359666898686, "murine myocardium to heart": 34.517302633574836, "mammalian myocardium with impact": 17.265220249681125, "gene programs in heart": 0.02752667263395607, "treatment of chronic heart": 0.034094653664125715, "receptor blockers in case": 0.01906696911599666, "major cause of death": 0.02416695665436543, "insulin action through activation": 0.0007739638710613245, "cardiac dysfunction during insulin": 0.005355869274805202, "level variation in use": 0.01895025489721281, "outpatients with heart failure": 17.28294762471214, "level variation in rates": 0.018915876664724485, "practice rates of treatment": 0.0246184262094258, "older patients with breast": 0.02541513065990971, "in this large cohort": 0.019931687635626916, "dietary recommendations for patients": 0.0163034602549891, "dietary patterns with outcomes": 0.01722780857884675, "diet scores with mortality": 0.018242536345791146, "lower mortality in women": 0.020776694259537522, "trend toward an inverse": 0.0021716602059017698, "association with functional capacity": 0.01740253338918984, "promising biomarker in heart": 17.27634041295657, "cohort of ambulatory patients": 0.03202224499849555, "hazard ratios for log2": 17.257090685010887, "higher frequency of diabetes": 0.023356831335873855, "day readmissions as part": 17.25190893693526, "outpatient assessments of patients": 0.031324441966347205, "average age of patients": 0.032125873128196605, "medication changes at follow": 0.0034841740089126766, "heart disease in patients": 0.03802911879181887, "predictive value for heart": 0.01648588016723488, "improved time to death": 0.011895547069076971, "frequent comorbidities in heart": 17.27630594482105, "myocardial dd of collagen": 34.52127211370867, "cardiovascular events in patients": 0.028889653697609576, "reduction in the primary": 0.03208819340127571, "volume overload in heart": 17.277220941941536, "significant decrease in re": 0.018998911537820982, "average length of stay": 0.02226568211404148, "viable option in refractory": 17.26687576080559, "resynchronization therapy in dialysis": 17.268691011874953, "heterogenous improvement in ejection": 0.020271683532739795, "% increase in ejection": 0.029756288203085783, "compelling improvement after device": 0.0028184874001895345, "dietary approaches to stop": 0.009818544465792056, "quantified via the parametrized": 17.26270792851885, "human resistin in chemotherapy": 17.26740409420312, "human resistin in heart": 17.276737890795236, "fold induction of serum": 17.27127261077466, "resistin levels in women": 17.267988498035713, "direct effects on macrophages": 17.251475221318376, "atrial fibrillation in patients": 34.52606857285473, "free probability after catheter": 0.0019818700881345267, "strain rate at systole": 17.252039826754164, "strain rate at diastole": 17.252039826754164, "sinus rhythm at follow": 17.25199127312732, "mitochondrial dysfunction in doxorubicin": 34.51761881571844, "possible mechanism of cardioprotection": 17.271278471416665, "cardioprotective effect of nicorandil": 34.52069463459132, "cumulative administration of doxorubicin": 17.271348553892732, "last dose of doxorubicin": 17.271661802565255, "nucleotides contents in addition": 17.267071310793423, "cytotoxic effect of doxorubicin": 34.520796708390414, "early risk of stroke": 0.024862949964473302, "secondary outcome of death": 0.023816535712292003, "death from any cause": 0.004181335443294918, "cardiovascular events after adjustment": 0.003766963452670224, "history of myocardial infarction": 34.521937685145424, "clinical burden in adult": 0.019446488081108097, "cardiac transplants in children": 0.02061974265379672, "cardiac symptoms in children": 0.021041596400621993, "small subgroup of children": 17.271190676707455, "cardiomyopathic restriction to flow": 17.259139464037492, "particular topics of debate": 0.021820794104552257, "cellular responses to heart": 0.019107975971608984, "molecular scaffolds in heart": 17.276325323762762, "beneficial adaptation to stress": 0.010058739302290213, "linear pathway to facilitate": 0.009944837979148934, "promising field of investigation": 0.021948572051912155, "prognostic indicator in heart": 17.276613357881676, "according to the biological": 0.02309238497721869, "feasible alternative to ascertain": 0.00976865023543104, "pharmacologic studies of therapeutics": 34.52088938544928, "measurement of natriuretic peptides": 17.271699805213014, "hospital quality of care": 0.02433603722245015, "pathological changes in cardiomyocytes": 17.267956112717467, "epigenetic changes in chromatin": 34.51689936412831, "cardiac tissue from mice": 0.005689839420730841, "crucial role in chromatin": 17.267586802658943, "control via the targeting": 0.01460015536173491, "tidal respiration for quantification": 34.504946251903355, "myocardial t1 in swine": 17.26797841711999, "swine model of tachycardia": 17.271784723727777, "ventricular tissue from control": 17.25479506240218, "percentage of myocardial collagen": 34.52138507237024, "failure without the use": 0.0233403943980178, "new approach to assess": 0.010266573229336287, "contemporary use of devices": 0.022969835860209013, "patients with systolic dysfunction": 17.276411599273494, "cause of cardiovascular hospitalization": 0.02455833351112361, "important role in downregulation": 17.26773837864958, "mechanisms behind the development": 0.013912966755075381, "distinct populations of patients": 0.031337596041662405, "contemporary trends in heart": 0.027188443086707363, "further adjustment for patient": 0.008273677597563258, "risk of thromboembolic events": 17.274096017140675, "thromboembolic events in heart": 17.277067469970735, "equipotent dosages of carvedilol": 51.76927985124054, "thromboembolic events in patients": 17.277033757938906, "impact prescribing of guideline": 0.022667338068266787, "parasympathetic tone by pyridostigmine": 34.50125632375166, "therapeutic alternative to slow": 0.010085023172773596, "sympathetic control of heart": 0.032402771668314415, "term administration of pyridostigmine": 17.271727523117587, "goal of this study": 0.025534250640477478, "prospective assessment of body": 0.02283990998047493, "over a median follow": 0.008036674932525424, "ventricular filling in patients": 17.27873649278902, "significant improvement between baseline": 0.0038019453285741333, "simultaneous reduction in exercise": 0.020262539667299864, "increase in the ratio": 0.03301846797408984, "slower increase in heart": 0.027780290481266935, "heart rate during exercise": 0.013703670326510917, "independent correlates of increase": 0.022818592472633757, "term treatment with ivabradine": 17.267236016410507, "clinical tool to predict": 0.011342689874929313, "artery disease in patients": 0.029052816322942834, "% of the patients": 0.05381214684031193, "substantial proportion of patients": 0.03130041023223217, "failure patients in addition": 0.036109650989105534, "diuretic use in heart": 17.277043190047046, "congestive symptoms in patients": 17.2770540126001, "risk patient with heart": 0.02838472172988709, "patient with heart failure": 0.03491576165307532, "risk stratification of patient": 17.274503619086794, "adrenergic responses in cardiomyocytes": 34.51634167947272, "remarkable increase in camp": 0.018393081667072018, "catecholamine infusions in rats": 34.51618941691724, "specified analysis of subgroups": 17.272131247432856, "high risk of hyperkalemia": 17.274266352930695, "health status in patients": 0.028062459908463427, "group effects on hrqol": 0.003655069849182754, "beneficial effects of hrqol": 0.022729784502808277, "cost analysis of rhythm": 0.023373710419920403, "treatment strategies in patients": 0.02921710535100893, "care expenditures of patients": 0.03221186822635447, "sarcomere structure in patients": 17.2763694800997, "detrimental alterations in skm": 0.017861571116470857, "severe perturbations in components": 17.26754455271908, "sarcomeric microstructure at baseline": 34.500551497456044, "dilated cardiomyopathy in patients": 34.525762418585465, "adjunctive treatment for patients": 17.26695271168913, "metabolic enzymes in patients": 17.276360105914605, "exercise parameters for diagnosis": 0.00914037801051812, "partial pressure of end": 0.02386330096740775, "care surgery in heart": 0.028451789617726903, "optimal treatment for end": 0.009698766497471367, "membrane oxygenation as bridge": 17.251312680766393, "cardiac arrest in need": 0.02064805645738765, "heart failure with therapy": 0.0352269751112154, "mortality outcomes of heart": 0.034874051430784564, "hazard ratio for death": 0.010280310331298349, "fatality rate for patients": 0.017318905422505006, "week program of exercise": 0.024093569496066218, "similar improvements in shuttle": 0.018363303770944944, "form quality of life": 0.023339578575789447, "emotional status in heart": 0.027554344157660428, "potential candidates for cell": 0.007293327757849145, "cardiac arrest in humans": 0.02056555895254058, "better tools for risk": 0.009207908028561626, "antiplatelet agents in combination": 17.267034326066955, "evidence points to alterations": 0.010376641874284965, "absorption function in patients": 0.02844777387053536, "dietary interventions in heart": 0.02750027876117346, "ventricular cardiomyocytes in response": 34.51888911334873, "prognostic biomarkers in patients": 34.525830444347754, "great number of studies": 0.022730557189915054, "sham levels by dnx": 0.0037455718204735733, "intravenous bolus of metoprolol": 34.52045585052568, "resynchronization therapy in heart": 17.277905366409783, "therapy in heart failure": 0.03736878544896775, "observational study in children": 0.02018374184997924, "steady improvement in egfr": 0.01829659982980184, "ecmo+vad group until day": 0.0020050056077705204, "steady decline in egfr": 0.017764575686894418, "social mandate to ensure": 0.00963629448881415, "significant difference in outcome": 0.01976490851456335, "inpatient records of patients": 0.03136574584050802, "significant improvement in outcome": 0.02002650419609348, "outcome ratings from admission": 0.0033714610996575284, "possible contribution of nursing": 0.02217738022470074, "nursing care to outcomes": 0.012259100080548264, "expressed in the heart": 0.040435539690489054, "simultaneous activation of \u03b21ars": 0.022093270523125794, "reciprocal regulation in mouse": 0.017957690457589444, "\u03b21ar overstimulation in heart": 0.027076624831893777, "physician continuity on death": 0.003224963189095719, "urgent readmission after discharge": 17.25160998248722, "lower rates of death": 0.02455885212273389, "influences outcomes after discharge": 0.003702655311881087, "time diagnosis of heart": 0.03215947799997439, "hazard models with time": 0.017803715332561875, "dependent covariates to analyze": 17.259124848759164, "physician within the first": 0.014286573116750825, "western blots with site": 17.26466360989174, "repolarization instability in patients": 17.27617190476771, "min records of surface": 0.022451606580554943, "surface ecgs at baseline": 0.002302721798915899, "trend toward a higher": 0.007560124144337522, "adrenoceptor blockade with esmolol": 34.513912582274855, "larger fluctuations in beat": 0.017824123893556414, "heart failure in survivors": 0.035989211244423364, "hct exposure to anthracyclines": 17.258700137232452, "right ventricle in heart": 17.277156561169956, "common language to describe": 0.010168809638945628, "neprilysin inhibitor in heart": 17.276376720383606, "pilot trial of heart": 0.03190218724645956, "trial of heart failure": 0.040618586281311944, "outcomes trial of heart": 0.03336594196866148, "therapeutic implications of biomarkers": 17.271560043275436, "statistical standards in biomarker": 17.26694311634003, "new targets in disease": 0.01962360676978894, "progression of heart failure": 0.04018943493737266, "target genes by sequence": 0.0031180476760196345, "untranslated region of messenger": 17.27094925950056, "therapeutic targets for heart": 0.016591105370171454, "system inhibitors in heart": 0.027653011233288734, "exercise capacity in adults": 0.020641961911476363, "cardiac filling during exercise": 0.0061089169829286, "natriuretic peptides in plasma": 17.26755307596508, "patient plasma by use": 0.004881382471160099, "ventricular hypertrophy in heart": 34.52798826504635, "similar rates of hypertension": 0.023622143727542514, "inappropriate therapy in heart": 0.02873578335062233, "failure patients with devices": 0.03408147638949373, "different types of beta": 0.022338620777190253, "risk of inappropriate therapy": 0.02576433052055957, "general use of beta": 0.022991690315295278, "lower rate in patients": 0.029157263676607863, "absolute risk of heart": 0.03360498829077967, "different mechanism of action": 0.02226031531414065, "refill compliance for etidronate": 17.255949160071758, "subcellular alterations by metoprolol": 34.50142817227315, "negative rates of changes": 0.02344441873215908, "elevated levels of epinephrine": 17.272089800471807, "mrna level for \u03b2": 17.256936589834492, "cardiac performance by \u03b2": 17.25573660404943, "advanced stages of heart": 0.0316553069394698, "partial reversal of changes": 0.02273295982765882, "embedded within the population": 0.014098179222390437, "cardiovascular events for psoriasis": 0.008617975284331043, "cardiovascular events as subjects": 0.004133978284950494, "diastolic dysfunction in patients": 17.278213475895047, "consecutive patients with pad": 0.025152959996970953, "highest quartile of e": 17.271092296684824, "suboptimal care of patients": 0.032212833181423435, "transitions of care program": 0.023031216543045394, "management training of patients": 0.03229667667562238, "patients with congestive heart": 17.283857910590136, "rate variability in risk": 0.021410627021954082, "stratification of cardiac patients": 17.283224064806465, "mortality within a few": 0.008961481618714498, "various measures of hr": 0.022265117186693068, "linear measures of hr": 0.02230441222767505, "early measurement of hr": 0.022512373977767855, "measurement of hr variability": 0.02222929219767806, "routine measurement of hr": 0.02209099609008089, "clinical tool for risk": 0.010554930042266666, "percutaneous revascularization with angioplasty": 51.76292361682175, "clinical benefit for patients": 0.017889130614269597, "treatment plans for patients": 0.017813892083156344, "bioinformatic analysis of microarray": 17.271944533817162, "telehealth system with care": 17.265940392349684, "inpatient admissions from baseline": 0.0033291477841224, "hospital days for participants": 0.00817453376574488, "fewer admissions for individuals": 0.007129302304425243, "telehealth technology has potential": 17.24994861576521, "black race in patients": 0.02736027291466385, "differential response to exercise": 0.012076022937638703, "treatment of atrial fibrillation": 34.52264990090274, "patients with recent onset": 0.025528347760404826, "onset af at risk": 0.0040991314598335556, "electrocardiographic device to monitor": 17.25917591193919, "patients with ventricular assist": 17.27679694967381, "dependent increase in incidence": 0.01886952767891214, "hospitalisation among the elderly": 0.014023161716070369, "worldwide increase in life": 0.019025106968428778, "heart failure at rest": 0.01969047799151788, "potent inhibition of l": 0.022262162505846287, "heart failure in humans": 0.0359208930873947, "complex situations in pediatrics": 17.266926360386496, "cell disease has life": 0.002900017469862959, "public reporting on quality": 0.0025020119700606227, "quality measure for heart": 0.017093167409303188, "best quintile of hospitals": 0.022032397040011812, "best quintile of performance": 0.022127960519855674, "composite measures of quality": 0.02331946365322385, "efficacy of mineralocorticoid receptor": 17.271971530770106, "receptor antagonists in heart": 17.27704013316762, "higher throughout the trial": 0.014764062497088252, "higher rates of hyperkalemia": 17.272767822044138, "lower rates of hypokalemia": 17.272517843903135, "end point of death": 0.02432927532923905, "pathway analysis of pressure": 0.023918820976824247, "modest effects on heart": 0.011805443846569999, "pathway alterations in tac": 0.01801495410263657, "increase rehospitalization of medicare": 34.52082059470324, "immediate declines in length": 0.0179175159928258, "day decrease in length": 0.018822395082450184, "day reduction in hospital": 0.019607796903193003, "hospital length of stay": 0.02283282691082424, "higher rate of rehospitalization": 17.273179860565396, "urgent need to improve": 0.010158393534778796, "better outcomes for patients": 0.01781059565720717, "standard therapy with beta": 0.01759409482751948, "infarction patients with heart": 17.28399395575734, "significant reduction in mortality": 0.021388496606587426, "survival rates of patients": 0.03253292273776819, "substantial improvement in survival": 0.018955957330095332, "reduction versus the previous": 0.014858772607728854, "marked decreases in heart": 0.02724185560295149, "term continuity of care": 0.023511836209909334, "anaerobic threshold in heart": 17.27623920712556, "test investigations at study": 0.004209010039893854, "failure mortality in men": 0.028823993615319565, "men without a history": 0.00733265739964162, "mortality risk in men": 0.02229295369213134, "heart failure after pressure": 0.020816831168934395, "significant alterations in energy": 0.018989188663818022, "development of cardiac hypertrophy": 17.27461506165505, "% increase in e": 0.027870391797536653, "% decrease in %": 0.03672119924425018, "significant decrease in insulin": 0.01923437210163721, "membrane translocation of glucose": 0.022025582057358765, "mitochondrial oxidation of glucose": 34.520472941433646, "greater risk of heart": 0.033699254781961833, "air pollution on heart": 0.011142266052044637, "heart failure in mice": 0.036350020612482034, "cardiac dysfunction with conduction": 17.268639168186986, "considerable number of patients": 0.03136274121441553, "palliative care of patients": 0.03217880395031061, "overall management of patients": 0.03186713670225033, "systematic review to identify": 0.01041561509049731, "physician adherence to class": 0.010704113754566124, "care education at discharge": 0.002776478977699009, "contextual factors on physician": 0.002624293664609121, "timing of implantable cardioverter": 34.520793623494356, "sound mind to engage": 0.009621393781330985, "defibrillator deactivation at implant": 34.50014386188073, "broader discussions about end": 0.0011016978220556232, "defibrillator shocks at end": 17.252019870725135, "failure hospitalizations in patients": 0.03602767255321602, "exercise rehabilitation in patients": 0.029189595294705703, "exercise rehabilitation in patient": 0.021005140197487084, "nosignificant changes in control": 17.268490349811742, "systolic function in hfpef": 17.26940047457869, "subtle changes on exercise": 0.00440417127050814, "lower volumes of exercise": 0.024648766746131742, "cardiac death in athletes": 0.0217114408531136, "nontraumatic death during sport": 17.251329396800656, "training for heart failure": 0.025371295646392556, "\u00ae system in heart": 17.276494106330563, "exercise training for heart": 0.018519627722238717, "high barriers to exercise": 0.012479746643125792, "exercise training on outcomes": 0.005659897650002447, "greater impact on patients": 0.011681051661219587, "individualized approaches to implement": 0.009752072057606831, "beta blockers on exercise": 0.0043601543698159025, "gas analysis at baseline": 0.003331492871583166, "target doses for beta": 0.007233029855063611, "former versus the latter": 0.014228340686420043, "kg increase in patients": 0.02827223470889991, "transseptal catheterisation with transoesophageal": 34.51372542830637, "echocardiography evaluations at baseline": 17.25176126511519, "gastrointestinal bleeding at month": 0.0019170232254458635, "haemodynamic outcomes in patients": 17.27775203876665, "first results of studies": 0.023532783011277578, "failure with systolic dysfunction": 17.275858520043343, "common form of heart": 0.03177189972345207, "reduced quality of life": 0.024689631370189424, "total score with exercise": 0.01847936148165747, "significant effect on quality": 0.004123339311853743, "term support to patients": 0.02016892872175137, "effectiveness ratios from user": 0.0027029007944507945, "term improvements in functioning": 0.018508011960136763, "effectiveness analyses of disease": 0.023830394436612456, "medical management to alleviate": 0.010730093326434027, "trends in patient safety": 0.004832273674917905, "decade of national efforts": 0.00547330670598121, "database to assess national": 0.0025056681826795923, "trends in adverse event": 0.004638393088852924, "decline in adverse event": 0.004628724035026966, "ulcers in surgical patients": 0.006802736229013855, "attention to these problems": 0.0026587872531467585, "progress in some areas": 0.004414956436749888, "talk between the heart": 0.005998743102800795, "tissue in cachectic heart": 4.319085518838381, "alterations in body composition": 0.00462326999246819, "changes in body composition": 0.004779286192649643, "biomarkers of neurohormonal stimulation": 8.630101012504479, "unaltered in all groups": 0.004829432820435156, "prevalence of heart failure": 0.01004742452668804, "combination with other factors": 0.004146727015950743, "in the general population": 0.007866907974072896, "fraction of a non": 0.0076672511737463376, "evidence of diastolic dysfunction": 4.318379604266826, "recommendations on the treatment": 0.0042128664668114055, "deficiency in adult patients": 0.006814641277163332, "literature in the english": 0.007743863934216695, "evaluated for this guideline": 0.002196093232596673, "audience for this guideline": 0.0020820557650037827, "patients with coronary heart": 4.320985735247138, "recommends against the use": 0.0035129865514047973, "benefits of anemia treatment": 4.318279182288997, "adults with heart disease": 0.006743389425298486, "trials of blood transfusions": 4.317989120014874, "data on study design": 0.0011854883611262378, "occurred in a small": 0.0061250752828493574, "patients with the acute": 0.00981006171287002, "trials of intravenous iron": 0.005657427363119828, "made in the pharmacological": 4.320016063830482, "resort to cardiac transplantation": 4.315435306445179, "admitted to the hospital": 0.005908108731048278, "deal with this worldwide": 0.00422005003860198, "impact on medical resources": 0.0006607931852339966, "role of the emergency": 0.008933400227714518, "department in acute heart": 0.007062316138181096, "categorization in the emergency": 4.3200418303897195, "studies in this area": 0.004984834679512123, "mortality in heart failure": 0.009495079347082571, "evaluated before the use": 0.003638049456860314, "association between any predictor": 0.0004674453881081723, "study other potential predictors": 4.313121817563483, "nesiritide in acute heart": 4.319353223924435, "failure with renal dysfunction": 0.006546096165921132, "randomized in an open": 0.00504101516175813, "ratio to the dopamine": 0.006099625792921961, "randomized in a double": 0.006180222570422596, "ratio to active treatment": 0.003196923178019819, "compared with the pooled": 0.007511674880977702, "change in serum cystatin": 8.629119342430762, "nesiritide on secondary end": 4.313017514358507, "participants with acute heart": 0.0066103838086750185, "participating in a multihospital": 4.318310707759192, "adoption of heart failure": 0.010008507929327268, "lessons for nurse leaders": 0.0016860545448452082, "studies in practice settings": 0.004710156901847955, "involvement in a multisite": 4.3183069148307105, "proteomics of cardiac chromatin": 8.630776373618467, "nucleolin as a regulator": 4.314384330380146, "changes in global gene": 0.004720479718743514, "accessibility on a genomic": 0.0020273971136226224, "known about the global": 0.003364993900527718, "changes in chromatin subproteomes": 8.62921208017897, "plasticity in the setting": 4.3200456454679905, "proteins in this subproteome": 4.317111171090393, "expression during cardiac hypertrophy": 4.313472070403841, "defects in cardiac looping": 0.005140579098025637, "analysis of a new": 0.007373005813405497, "subproteome in the normal": 4.32008872086528, "studies in the complementary": 0.00793792062244342, "associated with the development": 0.00785850910347132, "development of ischemic events": 4.318176806005083, "patients with ischemic cardiomyopathy": 8.630943422249526, "effect on the efficacy": 0.0039463530924084495, "efficacy of the device": 0.008955853961213596, "interventions during the trial": 0.003811497001218427, "predictors for the development": 4.317444019849596, "pattern on the baseline": 0.003949717914110203, "attenuated after the development": 4.316154995629279, "ies in this population": 0.0048633554219175285, "difference in the risk": 0.00838506375767731, "mortality in this population": 0.0053898540985987935, "attenuated in the older": 4.320122015462508, "outcome in heart failure": 0.009154471590916473, "involved in the process": 0.007754034114431942, "process of endothelial repair": 4.317792826441259, "factor in cardiovascular diseases": 0.004790201801156058, "association between serial measurements": 0.00044886157642372776, "associated with an increase": 0.005070682103216339, "mortality in nondiabetic patients": 4.319556998826366, "basis for these differences": 0.001986234517807543, "implications of metric choice": 0.005506066199689422, "choice for common applications": 0.0018061344827986804, "applications of readmission metrics": 4.317854690717054, "impact on hospital performance": 0.0007740944628467652, "differences in longitudinal performance": 0.0045980919102555475, "hospitals in an extreme": 0.004959280955330073, "approaches to computing readmissions": 4.314751222044096, "choice for these applications": 0.001911999490114805, "monitoring after recent hospital": 0.0006953051926203901, "hospital for heart failure": 0.006387112216119737, "potential to deliver specialised": 0.0024907345882751427, "needs of the heart": 0.011119497486739068, "studies with a contemporaneous": 0.005691975481505634, "support to the control": 0.006094679797019435, "apoptosis in a canine": 4.318316430808414, "model of chronic heart": 0.008260049181813264, "apoptosis during the development": 4.3159984485148595, "dogs during the development": 0.0037274923043876984, "levels of these genes": 0.005943527327536674, "genes by western blot": 0.0007280113539704533, "method from autopsy samples": 0.0006173438840483107, "unchanged during the pacing": 0.0036408094224742245, "compared to the control": 0.006252912960828842, "found in the normal": 0.007917740291891573, "numbers of apoptotic cells": 4.317805320273079, "apoptosis in the pathogenesis": 8.632309609176716, "pathogenesis of heart failure": 4.322300446767152, "failure in this model": 0.007138645426634345, "activation of other systems": 0.0056633043172729415, "incidence of pump dysfunction": 0.0058500667404984075, "uptitration after a hospitalization": 4.314582168650948, "months after an index": 0.0012738019234125905, "increase of \u226510 %": 4.3202483131349, "reductions in the composite": 0.007812332929963827, "uptitration of neurohumoral blockers": 8.63013949910585, "patients with low co": 0.006442874699577469, "associations with inhospital outcomes": 4.3165817235753545, "findings from the get": 0.003918724678946508, "differences in plasma b": 0.004532653556661088, "levels with the greatest": 0.00741128949960762, "patients above the median": 0.0058019569863156425, "p for heterogeneity =": 0.0019415689855440087, "in a large registry": 0.006094669323106747, "difference in the ability": 0.007851833219966221, "guidelines for the recognition": 0.005034968226538358, "children with undiagnosed heart": 0.0062607114604203914, "application in the clinical": 0.008123430400724687, "recommendations for advanced management": 0.001964644148908558, "assessment of cognitive impairment": 0.005564337473280978, "documented by the physician": 0.00410408490295641, "physician at the time": 0.0039030596555930355, "discharge in a cohort": 0.006284574717893315, "cohort of elderly patients": 0.007995958127744144, "association of cognitive impairment": 0.005581039849637171, "intubations for congestive heart": 8.628680514851656, "treatment of congestive heart": 4.320645262243976, "presenting to the emergency": 0.005758803582844349, "year of the study": 0.009433247566631563, "% of all ed": 0.008022673029957659, "rates of annual ed": 0.005634620701515864, "context of significant liver": 0.0057295426817447065, "catheterization during the same": 4.315895975369608, "incidence of abnormal liver": 0.005552633493245443, "compared with the pediatric": 0.007524260287702237, "disease in the adults": 0.008241490667729664, "derangement with hemodynamic features": 8.628465230641664, "ability to augment cardiac": 0.003139994576740304, "predictors of heart failure": 4.322342976793454, "recognized as a major": 0.002216928794136373, "cause of cardiovascular morbidity": 0.005948230870737005, "risk for adverse outcomes": 0.002760158493510218, "patients having heart failure": 0.006932460503738467, "counseling on the primary": 0.0038676324434344994, "followed for a median": 0.003482723009639339, "predictors of primary outcome": 4.3181174489494065, "adherence to prescribed medications": 0.0024818903741940374, "indicators of functional status": 0.0058090450283367675, "common to both patients": 0.004981004572317146, "adherence to prescribed therapy": 0.0028216753700295812, "stimulation of endothelial cell": 4.317889358395663, "patients with cardiovascular disease": 0.006872211578045125, "effects of exercise training": 0.006239836197571207, "proteome of hdl particles": 4.31773345678138, "effect on hdl function": 0.0009124369187425555, "determination of a predictive": 0.0070953552918976166, "value for plasma n": 0.001977723779331957, "admission to the emergency": 0.005835004133982956, "survival from the time": 0.004175355965228165, "age of the patients": 0.011316232643069782, "patients in this study": 0.00766872374409322, "survival at the time": 0.003975207597760547, "levels at the time": 0.00403526003223664, "differences in those parameters": 0.004680040250329829, "wk after the procedures": 4.316109090483739, "increases in lung weight": 0.004504571529444356, "weight with a high": 0.00575403729010207, "deaths in the experimental": 0.007789160487173594, "upregulated in the hearts": 4.320068861766911, "addition of salt loading": 0.005568590614633784, "measured with a high": 0.005811094715996052, "incorporated in a laboratory": 0.006058782633435546, "results in an excellent": 0.005057076573244761, "failure after the insertion": 4.318228513582336, "insertion of a left": 4.319812117840922, "shock after myocardial infarction": 8.625452407630725, "conjunction with a temporary": 0.005505680744373201, "support at the time": 0.0039756797221521855, "duration of biventricular support": 4.317962830649338, "survival to hospital discharge": 0.002800455350695058, "mortality at hospital discharge": 0.0011374557277837225, "based on a systematic": 0.0021899560574379826, "evidence on clinical effects": 0.0010933282724585208, "recommendations on the basis": 0.0037890171175642786, "% for medical therapy": 0.004513360541929295, "practice for a limited": 0.0034128025271116256, "patients in many regions": 0.006769229907532252, "limitations in economic models": 0.004594492515621472, "lack of canadian data": 0.005654176744835464, "point to the importance": 0.0057993549057241455, "effects of biventricular pacing": 4.317961144528362, "pacing on left heart": 0.0032725919857421798, "strain in a porcine": 4.318354555944521, "model of right heart": 0.008183488064071995, "understanding of the mechanism": 0.008842613280850873, "taken of the left": 0.009239681009909694, "in an open chest": 0.004917229075911264, "changes in rs synchrony": 4.316904051218974, "history of successful mitral": 4.317930594771181, "plasty for degenerative mitral": 8.626406692283123, "patients with a history": 0.007866590473018987, "improve such functional ms": 4.31268782824497, "prolapse of a degenerative": 4.31937014887069, "sound in the apex": 0.007745573883724964, "disappeared and postoperative echocardiography": 8.630602462557746, "opening with a mitral": 4.317922143798704, "obtained by a continuity": 0.002346044889820144, "flow by continuous wave": 0.0008227810643739655, "resulting in a significant": 0.006304118186132715, "lesions in the major": 4.320121049590095, "disappeared with a reduction": 0.005654165813933111, "reduction in blood pressure": 0.004898822559550157, "improvement of the mitral": 4.321330498307198, "observation at the time": 0.003826527538598005, "reasons for the modest": 0.0050450330392671095, "reduction by the surgical": 0.0041841710382165415, "restriction of leaflet motion": 0.005505277262304769, "motion by the leaflet": 0.00402325523536648, "disappeared after the surgery": 0.0038594354436561123, "patient with successful valve": 0.00430745248361936, "years after valve plasty": 4.3131214181201925, "according to the guideline": 0.0058245463563736475, "patients with functional ms": 4.3187581854481945, "addition to the leaflet": 0.005799030841910425, "patient with a history": 0.005820476698714333, "evaluation of the surgical": 0.008844127946889959, "hospitalization in heart failure": 0.009210907758137609, "date for the cohort": 0.005166777870010239, "history of atrial fibrillation": 8.630250638350407, "factor in heart failure": 0.00907338980308713, "included in the analyses": 0.007931483914052425, "patients with an egfr": 0.006700156379574682, "epidemic of heart failure": 0.010013266026673007, "class in both patients": 0.007039056675777523, "measure of health status": 0.0057547023547410555, "responsiveness to clinical change": 0.002884787081775028, "concentrations of the interleukin": 4.321055032504352, "therapy in chronic heart": 0.007410020994258202, "prognosis in heart failure": 0.009057872555263344, "doses of \u03b2 -": 4.323623058956689, "subjects with heart failure": 0.008509070676571369, "examined as a function": 0.002516985754491686, "function of baseline sst2": 0.006019076263542573, "dose of metoprolol succinate": 8.630254020810288, "patients with low sst2": 0.006422199872385733, "patients with high sst2": 0.00643627473998161, "ratios for cardiovascular events": 0.002196936124168764, "approach for the acute": 0.005287064862096277, "effects of a novel": 0.007292673269591854, "hearts in experimental models": 0.004653425444122466, "rise in the peak": 0.007875933036597409, "inhibition of protein kinase": 0.005675853067055248, "dogs with coronary microembolization": 8.628583267241222, "left and right heart": 0.008961436678457032, "efficacy of a novel": 0.007192606215529165, "donor to enhance myocardial": 4.314980603994229, "predictors of reverse remodeling": 4.31794976731732, "remodeling after cardiac resynchronization": 4.313591095002309, "studies of echocardiographic predictors": 8.630337178989206, "response after cardiac resynchronization": 4.313577371833984, "association of the score": 0.008997847154555889, "hospitalization during 57\u00b122 months": 4.312921738343471, "remodeling with a sensitivity": 0.005642889945739042, "spironolactone for systolic heart": 8.628939818565602, "failure in clinical practice": 0.007069066404007924, "patients with baseline serum": 4.318758530316292, "association between spironolactone use": 4.312953980864603, "patients with a median": 0.007954840815049423, "rates of severe hyperkalemia": 4.318136946679978, "injury during spironolactone use": 4.312834526956102, "within a diverse community": 0.001722072114012171, "spironolactone in clinical practice": 4.3172074642489315, "angiogenesis in the post": 4.320119234855028, "contributes to the progression": 0.005760996653269602, "crucial for the transition": 0.005020193856041493, "transition from compensatory hypertrophy": 4.312944044500822, "hypertrophy to cardiac failure": 4.317665133614263, "weeks after b treatment": 0.0009670377193633627, "effects of b act": 0.00562805210411859, "start of the treatment": 0.009212263786962164, "b on cardiac function": 0.0014641128188488959, "angiogenesis in heart failure": 4.321263852178376, "enhancement of cardiac angiogenesis": 4.318463915956218, "effects of this therapy": 0.006330345850344989, "cohort of all adults": 0.005967726469662872, "visit in the subsequent": 0.0077638148457415705, "hospitalized at the time": 0.003916233069548277, "management of acute heart": 0.00823287603702452, "function in cardiac volume": 0.005690200220351412, "myocytes with volume overload": 8.628701939880468, "increase in lung weight": 0.004660623422385646, "versus the sham group": 0.0039263273618204315, "velocity of circumferential shortening": 4.317835667809924, "occurred in the absence": 0.00782318276859045, "changes in the maximum": 0.007932503774715747, "improvement in contractile function": 4.317230063251572, "paralleled by any attenuation": 8.625247465514647, "patients with a left": 0.00829948568022787, "measurement of transmitral flow": 4.31789388951693, "relationship in heart failure": 0.009044740494583186, "relevance in the clinical": 0.008121545368279018, "two- to threefold increase": 0.0025736802789498654, "increase in cardiac risk": 0.005866562061604919, "retained in the multivariate": 4.320048144914304, "nonsurvivors with a similar": 4.317877668618987, "relationship as a possible": 0.002205624773168249, "index of the length": 0.009046363070606727, "affected by the quality": 0.00421170640000903, "crucial for the development": 0.005134326396697822, "coated with a polytetrafluoroethylene": 4.317764051404, "formed in a bottleneck": 0.006057906129381935, "implanted in the proximal": 4.320052553567223, "medication to prevent sudden": 0.002487172564618021, "time of the bottleneck": 0.008939054793300816, "timing of myocardial infarction": 8.630461951328938, "modulated by the duration": 4.316327819723066, "duration of antiplatelet medication": 4.317847792235874, "% of the left": 0.011582832465236094, "ventricle in the proximal": 8.63235214065011, "wk after the stent": 8.628358408677975, "implantation of a novel": 0.00720122086195526, "stent in the proximal": 8.632326622634368, "feasible for the development": 0.00512737674981875, "afterload of the heart": 4.323397032821755, "derived from the pressure": 0.004149334402921862, "ivabradine in the shift": 4.320063447486829, "included in the echocardiographic": 4.3202183541505015, "reduced in the ivabradine": 4.320404028964105, "resulting in a higher": 0.00627794071729375, "unloading of the heart": 0.011118687771895638, "contribute to the beneficial": 0.005802036836822586, "effect of isolated hr": 0.005672017754703266, "relation of preoperative serum": 8.63008193842955, "recognized as a prognostic": 4.314490541199377, "hypoalbuminemia with postoperative mortality": 8.628991905974361, "support on postoperative survival": 4.313012772298226, "analyzed in both groups": 0.004756972836261852, "normalization of albumin level": 4.317869112642603, "attention to albumin levels": 4.31493452253423, "correction of aortic valve": 0.005633629492292803, "in the present report": 0.00784540801682606, "sternotomy for aortic valve": 4.314115620824285, "revision by open surgery": 0.0007975648099494474, "surgery for aortic valve": 0.0019380081822148257, "improvement in functional capacity": 0.004945872909962072, "approaches to these difficult": 0.002658633714263715, "alternatives to conventional surgery": 0.0025010395085948525, "outcomes of young adults": 0.005995399132506049, "across the respective age": 0.0035863012275930643, "compared with the referent": 4.319781468761453, "effects of nordic walking": 0.005651556387369974, "care on functional capacity": 0.0010346910938659783, "alternative for this population": 0.0021397949980333625, "time in acute heart": 0.007190349080406498, "patients with pulmonary hypertension": 0.006539889200805566, "measured from the reconstructed": 0.003983477327000235, "patients with unfavorable outcome": 0.0064154202261699515, "at the second evaluation": 0.0037176981617120255, "confirmed in this cohort": 0.0049487674650546595, "located in the left": 0.008205565411056033, "followed by the right": 0.0042710479124256, "embolize to the pulmonary": 4.3181375699033655, "report of a patient": 0.007404666866336377, "embolism to the pulmonary": 4.318158837630028, "prolapse through the tricuspid": 8.627922192335227, "performed on the same": 0.003870374789395521, "occurred in the total": 0.00791138982966026, "sample from the first": 0.003980174251868627, "trial with large limits": 0.004096595996670352, "information to the first": 0.00578768947974109, "for the total sample": 0.0051135316181129, "error of measurement value": 0.005592593852644399, "found between the first": 0.0038298306189946743, "found for the subgroups": 4.3173956412590355, "patients with advanced copd": 0.006326072223483896, "values of standard error": 0.005582007338153294, "practice with these populations": 0.00420236126987809, "patients with rheumatoid arthritis": 8.63077755872671, "elevations in tumor necrosis": 4.316701269470633, "agents to treat rheumatoid": 4.314711298009379, "use of loop diuretics": 4.317946819551405, "antagonist with similar baseline": 4.3165259246739875, "subjects with a history": 0.005600606962016873, "associated with a dose": 0.006187624130270943, "compared with no use": 0.004579640724972292, "associated with a risk": 0.006592984347696813, "people with heart failure": 0.00838740652816266, "interventions in chronic disease": 0.005166960563508406, "participation in a structured": 0.006045671973815937, "improvements in functional capacity": 0.004848251754403193, "sustainability of the intervention": 0.008822333809860873, "completion of the study": 0.009350502130245181, "failure in older adults": 0.006843646313323351, "during a median follow": 0.002268184588397966, "vasopressin in congestive heart": 8.631453275638336, "contribute to the pathophysiology": 4.318055235681174, "pathophysiology of congestive heart": 8.632506883105869, "inhibitors of the renin": 4.321135929991174, "secretion of arginine vasopressin": 12.942294443926137, "potential for deleterious effects": 0.0019354361339253509, "reactivation of embryonic gene": 0.005548747561952803, "phenotype of pathological hypertrophy": 8.63017771702933, "induction of a fetal": 0.007083033922419963, "mir-25 by a specific": 0.0023615161170479826, "myocardium to heart failure": 4.319246803598692, "expression of the bhlh": 0.008895233037864781, "impact on embryonic gene": 0.0006192892713548892, "prevalence of chronic heart": 0.008115249158704303, "% in the adult": 0.010119943719866726, "blockade of the neuro": 0.008806614919043658, "neglected for a long": 0.0034117427804874804, "time from the treatment": 0.004469380248010956, "documented in a number": 0.006090173948327204, "diabetes to heart failure": 0.007078188926157628, "features of heart failure": 0.010013506345134569, "mechanism of cardiac dysfunction": 0.006512667290950696, "dysfunction during insulin resistance": 0.000705741477283407, "association between treatment variation": 0.0009041723875904533, "calculated for each therapy": 0.002110750834258764, "treatment of a patient": 0.007804360747206786, "% for \u03b2 -": 4.322160711997164, "variation in the use": 0.007953345258189793, "exists in the outpatient": 0.0077648030612798465, "patients with breast cancer": 0.006268555848745952, "trastuzumab in the adjuvant": 8.632309608091214, "age of the entire": 0.008974437345719692, "% in nontrastuzumab users": 4.319088155881171, "cohort of older breast": 0.005762411748263956, "plays in the development": 0.007859223801629433, "women with heart failure": 0.008469694543786196, "associations of dietary patterns": 0.005513850144717665, "hospitalization through the date": 0.003615940746508687, "quartiles of the dash": 4.321042425094486, "toward an inverse association": 0.0006030451649268299, "support for the concept": 0.0051396373056852565, "signaling in the myocardium": 4.320103633315723, "biomarker in heart failure": 4.321268105506605, "outcomes in a cohort": 0.00659029353387951, "study of exercise training": 0.006646498270325989, "analyzed in a subset": 0.0060720913944163, "patients with evaluable plasma": 4.318550209247631, "measures of functional capacity": 0.005930066326955045, "ratios for log2 ng": 4.3140260935607655, "adjustment for clinical variables": 0.002142094319392597, "changes in the c": 0.00797236273924492, "experience with extended criteria": 0.00395208058169877, "excluded from the transplant": 0.00397116601407837, "outcomes with this strategy": 0.0046382153661962446, "compared with the patients": 0.009849391081750212, "frequency of diabetes mellitus": 0.0056537042777802075, "adjustment for baseline characteristics": 0.0020110739841519513, "alternative for advanced heart": 0.00414639239199466, "therapy in select patients": 0.007137062430114837, "part of a heart": 0.009407577245493196, "part of a hospital": 0.007227247741661341, "days of hospital discharge": 0.005811600634744356, "review of all heart": 0.008128568645910479, "rate after the initiative": 0.004078316661558765, "patients had blood work": 0.0027626844802942285, "discrepancy between the discharge": 0.003729504744327096, "parallel with an increase": 0.004555392848021253, "pathophysiology of heart failure": 4.322317459645908, "enrolled in this prospective": 0.004870692637747354, "times below the median": 0.003467242614545125, "risk of cardiac events": 0.0069421336196361485, "rest of the group": 0.00911018882406125, "risk of heart disease": 0.008772844498395872, "compliance in a single": 0.006099494700886163, "value for heart failure": 0.006291164055088003, "treatment in most subjects": 0.00500978253454881, "year for heart failure": 0.006307309753377348, "choice of chelation regimens": 8.630016800308297, "impact of ejection fraction": 0.006554700980146704, "fraction on the clinical": 0.00458681253074241, "response to cardiac resynchronization": 4.315537043505351, "therapy in mild heart": 0.00720187835995062, "evaluated in which patients": 0.007046758274837264, "determined by a blinded": 0.0023202831766143874, "improvement in the clinical": 0.008261128521216455, "fraction in a rat": 0.00652656118042797, "comorbidities in heart failure": 4.321272358762473, "importance for myocardial dd": 4.314253766290571, "dd of collagen deposition": 4.3177591532826565, "rats after heart failure": 0.005068130235176955, "weeks with repeat metabolic": 4.3162943065415, "site of the elastic": 4.32105095241371, "strain as a major": 0.002260075052324255, "predictor of cardiovascular events": 0.005959528556217369, "relationship with adverse cardiovascular": 0.004341705838181528, "events in atrial fibrillation": 8.629390395594006, "cardiology in a university": 4.318304305017529, "method for cv events": 0.001893603568273217, "hospitalisation for heart failure": 0.006229695164996113, "hospitalisations for heart failure": 4.318503852244804, "failure during an average": 0.002979550068117678, "benefit in the prediction": 0.007868451905486629, "outcomes after cardiac resynchronization": 4.313862534150688, "duration on the effectiveness": 0.0038268573679510216, "effectiveness of cardiac resynchronization": 4.318540428457372, "assessed in a large": 0.006221935011313277, "associated with a significant": 0.0062762595657053725, "patients in atrial fibrillation": 8.631517143213681, "reviewed by a panel": 0.0023281316936664105, "included in this study": 0.005471272087282724, "component of the primary": 0.00891866503229802, "ratio for the primary": 0.005469514059902998, "benefit from implantable cardioverter": 8.6253729059276, "failure with peritoneal dialysis": 4.318403543233568, "overload in heart failure": 4.321289371062372, "therapy in severe end": 0.005229828953692031, "% with the majority": 0.009557085785035675, "improvement in diuretic response": 4.316975674588501, "decrease in re -": 0.010172399140016341, "hospitalization from an average": 0.0013059825028278042, "treatment of diuretic refractory": 8.630505131308652, "consequences of cardiac resynchronization": 4.318501051966123, "assessment of these patients": 0.0081020164609852, "evidence of reverse remodeling": 0.005743532588941485, "improvement in ejection fraction": 0.005552164907591864, "increase in ejection fraction": 0.005576373089808933, "improvement after device implantation": 0.0007816377466179805, "risk for adverse events": 0.00258484175953516, "coupling in hypertensive heart": 4.3191196772661575, "failure of cardiovascular reserve": 0.007929107447756345, "reserve in multiple domains": 0.00448650728107164, "function with echocardiographic measures": 4.31667623178, "constants through the analysis": 0.003626620423834041, "defined as the ratio": 0.004239247724551448, "mediator of insulin resistance": 4.317864844418122, "levels with the development": 0.0075389504674299454, "severity of heart failure": 0.01001348533449891, "understanding of the role": 0.00891250676900341, "role of human resistin": 4.317999692208549, "resistin in heart failure": 4.321297876778214, "transgenic for the human": 4.31734458966036, "induction of serum resistin": 8.630122300135845, "controls not expressing human": 0.0005386991661001264, "decline in ejection fraction": 0.00541915887186501, "fraction in these women": 0.005168802276948856, "contribute in the development": 0.007898644799239657, "resistin as a link": 4.314433658424682, "outcomes of catheter ablation": 4.318175191050056, "ablation of atrial fibrillation": 12.94251558979292, "safety of catheter ablation": 4.317877930566436, "ablation for atrial fibrillation": 12.938727502144127, "factor for clinical deterioration": 0.002166309595804549, "performed in a consecutive": 0.006218696638880108, "probability after catheter ablation": 4.312766908864677, "treated with a composite": 0.005705552087944635, "composite of repeat procedures": 0.005580912677643216, "ablation in this cohort": 4.317230225945696, "agent in the treatment": 0.008203012401863916, "treatment of several cancers": 0.005938945774271434, "in the present study": 0.008373296173399204, "addition to cytochrome c": 4.314776605829218, "decrement of heart rate": 4.320391804133579, "state of mitochondrial oxidative": 8.630122726363059, "doxorubicin against the growth": 4.315674960205702, "effective against the development": 0.0035468051969262185, "improvement of hemodynamic perturbations": 8.630189447367162, "infarction after coronary artery": 8.625377050323433, "from the swedish web": 0.0038697011502444095, "risk for the primary": 0.005689567926657448, "intervals for cardiovascular events": 0.0021586594260971453, "introduced into the statistical": 0.003377074624337726, "adjustment for all confounders": 4.314212380242707, "events during the first": 0.0038786496447846056, "failure in the young": 0.009971479976060552, "burden in adult medicine": 0.004491658603873618, "cause of heart failure": 0.010200528119588395, "result of congenital lesions": 8.630056001480941, "most of these lesions": 4.318039957170257, "expand on the management": 0.0038834302144215116, "management of congenital heart": 4.320243625510069, "lesions in this review": 4.317137188968117, "failure from cardiomyopathic restriction": 4.315055100991995, "aetiologies in some cases": 4.316704110846166, "debate in paediatric heart": 0.006773760006545967, "responses to heart failure": 0.006963789187032742, "scaffolds in heart pathology": 4.319047347886948, "cardiomyocytes to detect mechanical": 4.314768650739439, "adaptation of the myocardium": 4.3210761680673375, "response to new conditions": 0.0026034228340585186, "adaptation to stress conditions": 0.0025105180141638886, "kinases into a linear": 4.31394301979747, "investigation for the development": 0.0051231441412672414, "development of therapeutic strategies": 0.005776018562558541, "deals with the case": 0.007253436790852076, "case of a patient": 0.007412492328833298, "based on the history": 0.0038927723059488327, "diagnosis of multiple myeloma": 4.317841406277189, "frailty in heart failure": 0.009002586812805677, "indicator in heart failure": 0.008976671437896825, "defined as a biological": 0.0022157120074030746, "evaluated in the same": 0.007861338237724613, "defined as the proportion": 0.0039046303856958096, "increase in the deficit": 0.007932715994974198, "as the biological phenotype": 4.316159017541538, "future of acute heart": 0.008118201441892004, "decade of acute heart": 0.008082949353991061, "disappointments in large phase": 0.004507900658577345, "role of appropriate timing": 0.005641599318248256, "timing of patient enrollment": 0.005797164570990142, "success in future trials": 0.004610940200561206, "peptides at the point": 0.0037728545247111044, "care in the emergency": 0.008015204807192313, "tool in the diagnosis": 0.007839710860623256, "diagnosis of acute heart": 0.008166475118667593, "mixed on the absolute": 0.003765822013856707, "risk of adverse outcomes": 0.006548246142303226, "outcomes in other patients": 0.007260450204467424, "measured at the point": 0.003853171537884897, "nps to clinical care": 0.0030179554581981544, "delivery in the emergency": 0.007778416537923459, "risk of acute heart": 0.008648430439756175, "frame of a patient": 0.0073612397211415504, "processes of care delivery": 0.0057333605585414655, "advantage of the faster": 0.008773025170241557, "quality of outcome measures": 0.005952089580286875, "quality of care outcomes": 0.006304479915786959, "objective of the measure": 0.008841693494467286, "expansion to other conditions": 0.002564452477427436, "mortality in modern society": 0.00495417927439505, "consequence of pathological remodelling": 4.317801249541212, "remodelling of the heart": 4.323414046568869, "at the molecular level": 0.003808782829726817, "targets for the prevention": 0.005037908952383126, "set of transcription factors": 4.317890343538468, "occur through an interplay": 0.0005690598065533226, "interplay between these transcription": 4.312877519214731, "changes in chromatin structure": 4.3169956925828235, "resulting in the suppression": 0.007760395422113951, "profiling of cultured cardiomyocytes": 4.317797254606675, "cardiomyocytes in the presence": 4.320096244625185, "induction of a substantial": 0.007094720168831079, "effects on systemic blood": 0.0007169722885575268, "analysis of cardiac tissue": 0.006459360632529927, "bets in the mouse": 0.0077737902405928426, "readers in cardiac biology": 0.005128321793181963, "manipulation of cardiac gene": 0.006240814668211092, "mri during tidal respiration": 8.624833564950045, "quantification of myocardial t1": 4.318026967181877, "swine with heart failure": 0.008445823363774488, "purpose of this article": 0.005825315007857466, "sequence to quantify myocardial": 4.3150028143093175, "changes in a swine": 0.006232448428929095, "minutes after the administration": 0.003801980994042494, "administration of a gadolinium": 4.31936315348286, "compared between the baseline": 0.004172668768213363, "fibrosis of heart failure": 4.322304700095382, "tissue from control animals": 0.0008750157341878054, "found between the baseline": 0.0039646011359573494, "values before the administration": 0.003416304662026488, "administration of contrast agent": 0.005527442847325762, "animals with heart failure": 0.008473951856544443, "tissue from healthy control": 0.0008744674683023636, "use of a contrast": 0.007270217281023715, "increases in the percentage": 0.007775962319452515, "echocardiography as a possible": 4.314480024080415, "in this prospective study": 0.005386036700292255, "panel of noninvasive assessments": 4.317757224246683, "basis of the assumption": 0.008794840806882046, "according to an exercise": 0.003396355928011703, "relevance in pulmonary hypertension": 0.004745825861158452, "tool for prognostic assessment": 4.314142102343334, "assessment in pulmonary hypertension": 0.004808919659513175, "devices in heart failure": 0.009064249689768364, "cornerstone of heart failure": 0.010013594988484007, "detection of fluid overload": 4.317792763223494, "portion of the health": 0.008914709493974514, "achieved in the development": 0.007877553965304188, "splicing of the type": 4.321229605967735, "trapped in the endoplasmic": 4.320005479685381, "expression of exogenous variants": 4.317889955093685, "involved in the reduction": 0.007897258674588875, "failure in pulmonary hypertension": 0.006937071977705679, "attention in the medical": 0.007878082171433853, "used in the management": 0.008109649714649088, "concentrating on the pathophysiologic": 4.316007683478224, "failure in the setting": 0.009971044290675572, "setting of pulmonary embolism": 4.317947799577306, "trends in heart failure": 0.008997237018962913, "fraction after myocardial infarction": 8.625908017237279, "occurred in the epidemiology": 0.007815618773247797, "epidemiology of myocardial infarction": 8.630458333776218, "changes in patient presentation": 0.004920838931974215, "change in the case": 0.007887838823725398, "events in heart failure": 0.009183759152335921, "levels of various serum": 4.318004169206496, "resulted in a lower": 0.006274991257842581, "reduction of sympathetic activity": 0.005766395666666798, "caring for these patients": 0.004242218052189599, "drugs for heart failure": 0.006260300320657146, "indicated in the patient": 0.008060657803145844, "structure of medical records": 0.005661351643348534, "documentation of contextual reasons": 0.005532746826903645, "dysfunction during the onset": 0.003976798969810903, "onset of heart failure": 0.010102905765416923, "control of the heart": 0.011350072292696675, "increase in parasympathetic function": 4.317241511883263, "effects of the acetylcholinesterase": 4.321214620822272, "pyridostigmine on sympathovagal balance": 8.625004948701973, "function in the onset": 0.008176518808178775, "wk of pyridostigmine administration": 8.630089985556728, "control of heart rate": 0.00835335091229804, "protein in the left": 0.008305003183141276, "means of the pressure": 0.008994821063423617, "contractility of the left": 4.321526907587248, "dysfunction during the progression": 0.003921251938737147, "delay in dyssynchronous heart": 4.319093237073036, "addition to the left": 0.00624099981214193, "type of electrical activation": 0.005718260020846835, "behavior of the heart": 0.011118139502451121, "interval between local myocyte": 4.312807726929168, "models of dyssynchronous nonfailing": 8.630183699933767, "simulated in all models": 0.004798010838287054, "changes in myofiber dynamics": 4.316916307881095, "onset of myofiber shortening": 4.317882403975416, "prognosis in advanced heart": 0.006959244700740861, "function on body composition": 0.0009254719310179151, "assessment of body composition": 0.005692921912475105, "associated with a lower": 0.006238626198039807, "mediated by a higher": 0.0025672620031077153, "surrogate of enhanced catabolism": 4.317758407708322, "cardioprotective in the context": 4.320021617071325, "inhibition on hemodynamic status": 4.312908730651689, "tolerance in heart failure": 0.008980946986372723, "ivabradine on exercise capacity": 4.313365478666125, "optimization of diastolic filling": 4.318017799560371, "days in this double": 0.00488073968012378, "assessment of myocardial function": 4.31844522283446, "difference in heart rate": 0.00716780017357055, "rate at the same": 0.004004598522373217, "time at the baseline": 0.004035264496092903, "increase in heart rate": 0.0072574072761701506, "treatment in exertional increase": 4.317319692775667, "increase in exercise capacity": 0.005223203577156538, "increase in peak oxygen": 0.004793415285450242, "reflected by the ratio": 0.0043448272716362524, "absence of coronary artery": 4.317992083836288, "failure of unclear etiology": 4.319996134707274, "cause of systolic heart": 4.320581204935809, "angiography with a primary": 0.005658182247463031, "stenosis in the left": 4.320498819727294, "validated in a separate": 0.006061370170763592, "patients in the derivation": 0.010077984657653073, "in the prospective validation": 0.007795187959838155, "angiography in a substantial": 0.006066829686068725, "experience of a vasopressin": 4.319369182031975, "indication in japanese heart": 0.006785490679931333, "indicated for the treatment": 0.005464015940661084, "treatment of severe hyponatremia": 4.318348817393076, "hyponatremia in most countries": 4.316769391028674, "use in heart failure": 0.009160675713762192, "data on the potential": 0.003989737031594865, "occur in the absence": 0.007785214402777303, "absence of fluid overload": 4.317804844006091, "knowledge on diuretic use": 4.312913348188221, "therapy to implantable defibrillators": 8.627416963677565, "appropriate to the level": 0.00584433784425317, "subject of this brief": 0.005797492084261424, "leading to a remarkable": 0.004031055510988962, "increase in camp hydrolysis": 4.316864775560754, "stimulation of cgmp synthesis": 4.3177717148047305, "overexpression in healthy cardiomyocytes": 8.629079411940154, "rise in camp levels": 0.004640536039127823, "mechanism during cardiac stress": 0.0010908841111765411, "hospitalized for a cardiovascular": 0.003618200534208708, "discontinuation of study medication": 0.006089088004335737, "endpoint in all subgroups": 4.3169726660002565, "subgroups at high risk": 4.3134545677014975, "factor for poor outcomes": 0.002192539853868633, "hrqol in a cohort": 0.006199798317969836, "trial of exercise training": 0.0062171117809360745, "according to the intention": 0.005742773664869746, "hrqol from exercise training": 0.001172780027158829, "failure from the province": 0.006078948896699131, "compared from a single": 0.0025191035592062117, "% of total expenditures": 0.007919115937398009, "hospitalizations for noncardiovascular diagnoses": 4.313992288124026, "drugs in the rate": 0.00808706713175633, "influence on the overall": 0.0037545958840752886, "perturbations in skeletal muscle": 4.316790214948636, "reversal of detrimental alterations": 0.005510450958807928, "alterations in sarcomeric microstructure": 8.629022039089591, "markers of skm growth": 0.005539189750566391, "medicine as an adjunctive": 4.313264857349358, "treatment for dilated cardiomyopathy": 8.626797849009575, "patients with dilated cardiomyopathy": 8.630905152061928, "studies on biomedical treatment": 0.0010945572467908056, "performed on the overall": 0.0038695677750584306, "effects on effective rate": 0.0010003468126535118, "improvement in effective rate": 0.004986711099748845, "observed in the studies": 0.00801749886359116, "treatment in all patients": 0.007431725082259984, "compared with the controls": 0.007562012600934903, "intolerance in heart failure": 0.008985507562739917, "feature of chronic heart": 0.008074556178628081, "update on cardiopulmonary exercise": 0.0009571295485076342, "attention in the interpretation": 0.007752216521652913, "interpretation of cardiopulmonary exercise": 0.0059882756138283765, "variables with an important": 0.0045049787157837775, "assessment with the inclusion": 0.007297070281182787, "surgery in heart transplant": 0.006942081996552315, "transplantation with medical therapy": 4.316720259566415, "consultation for abdominal problems": 0.0017119487926790407, "man with cardiac arrest": 0.004600584346574374, "need of cardiopulmonary resuscitation": 0.005530154171098228, "diagnosis of a posterior": 4.319425083358638, "obstruction of the right": 0.008963275401478638, "admitted to the intensive": 0.0057503407874340134, "based on the acute": 0.004129960817765076, "failure with therapy refractory": 4.3187559145044405, "team for an extra": 0.0021293588167639334, "days after the emergency": 0.0038882345468071447, "focused on the importance": 0.0037588712140811066, "importance of diastolic dysfunction": 4.318271387809329, "dysfunction in the pathophysiology": 4.320337380345198, "abnormalities in cardiovascular function": 0.0050547176419728675, "discussion of novel treatment": 0.005965758008920017, "promise for the future": 0.005023851174376043, "outcomes of heart failure": 0.010395670475087167, "impact on the incidence": 0.0038896525753306854, "hospitalized with an index": 0.0046843761854078085, "associated with a multivariate": 4.3183386254599485, "days of the index": 0.009098283590246599, "declines in the incidence": 0.007786528728461445, "problem with high mortality": 0.004630032754207117, "attention to these high": 0.002858452066123619, "therapy during exercise rehabilitation": 0.0011830609190101116, "rehabilitation in male patients": 0.006859606192243298, "data for key health": 0.0020062817422623978, "improvements in shuttle walk": 0.004508144504108047, "observed in both groups": 0.004806908858005905, "exercise with testosterone group": 0.004737321635914681, "baseline in peak oxygen": 0.004833909913157911, "quality of life domains": 0.005842087840937947, "apparent in the exercise": 0.008230393563416294, "exercise with placebo group": 0.0047969034830304, "shows for the first": 0.00506379276780383, "supplementation during a program": 4.314204383565712, "program of exercise rehabilitation": 0.006042930593775065, "impact on a range": 0.002191215865935623, "range of key health": 0.005675895747670406, "stimulation of peripheral muscles": 0.005552129230234488, "status in heart failure": 0.009080555870613353, "function in chronic heart": 0.0073876205700348085, "completion of training protocol": 0.005605360851519083, "lack of effective evidence": 0.005712578592885321, "therapies in these patients": 0.007015329731421653, "decline in atrial explant": 8.629121905206699, "functions after myocardial infarction": 8.625435722844468, "majority of potential candidates": 0.005562837851858997, "candidates for cell therapy": 0.00210524802282231, "phenotype of cardiac explant": 8.630763613850817, "used as a control": 0.0025606402939393385, "selected on the basis": 0.003780423100152149, "basis of left ventricle": 4.31827899699571, "expression of pluripotency markers": 4.317907143563539, "protocols for clinical application": 0.0020716079201561132, "breathing with no heart": 0.006439131260678212, "advantage of the period": 0.008878224637495184, "part of this study": 0.006362730472121726, "excluded from the final": 0.00390692984148514, "presented in this report": 0.004805092283437554, "phase of a pb": 0.0070905971231678775, "effect on pb characteristics": 0.0006460419126216833, "perfusion of the carotid": 8.63333769681957, "originating from the central": 0.0038960779279201352, "absence of atrial fibrillation": 8.630232114835614, "options for these patients": 0.004257192825049781, "patients in sinus rhythm": 4.319132313819341, "tools for risk stratification": 4.314552857892684, "need for antiplatelet agents": 4.314019183883931, "nutrition in heart failure": 0.008972439678594516, "recognized as a multisystem": 4.3143842206540945, "disease with important comorbidities": 4.316679098851538, "alterations in intestinal morphology": 4.31675645489284, "overview of the sonographic": 4.321050735097434, "knowledge of nutritional abnormalities": 0.005507139934803239, "effects in the treatment": 0.008350432286945406, "interventions in heart failure": 0.009049060821043814, "target of further heart": 0.007907803095691661, "response to an increase": 0.0031496621105066716, "increase in ventricular wall": 4.317500422225757, "patients with coronary artery": 4.318741659629919, "derived from a great": 0.002212196860565386, "amount of recent data": 0.005694906204807516, "associated with the extent": 0.0077483449365649566, "information for an unfavourable": 0.002150145688998326, "balance in conscious rabbits": 0.004471511229960276, "rabbits with chronic heart": 0.006517923471925608, "hallmark of chronic heart": 0.008085717099809717, "levels by renal dnx": 0.0010597675066491554, "compared with the sham": 0.0075498896939881575, "due to a withdrawal": 0.004076102785201505, "withdrawal of sympathetic tone": 0.005560764938569204, "increase in parasympathetic tone": 4.316932304644643, "measured after an intravenous": 0.0010397062922608512, "response to intravenous atropine": 4.314798083318183, "reduction of sympathetic tone": 0.005708679953397361, "failure with a narrow": 0.007697036514693956, "failure with a wide": 0.007694887312894356, "patients with a narrow": 0.00783530632223193, "futility on the recommendation": 0.0037413317046561616, "recommendation of the data": 0.00895733608102835, "followed for a mean": 0.0034953428301382804, "effects of ventricular assist": 4.318601554217842, "oxygenation on renal function": 4.313216036222721, "function in pediatric heart": 0.007132934951508546, "support on renal function": 0.0010821294817861865, "impact of ventricular assist": 4.318547293304298, "comparison of baseline characteristics": 0.005764543166079399, "patients in the ecmo+vad": 0.010069499135932372, "decline in renal function": 0.004950572094493769, "group in the first": 0.008143066809913281, "basis of these data": 0.005888431632296303, "mandate to ensure effective": 0.0024982299037586146, "accountable for the outcomes": 0.005370412267634198, "outcomes of nursing care": 0.0061269247726937195, "aspects of nursing care": 0.005764822736947309, "difference in outcome ratings": 0.004694992849488942, "improvement in outcome ratings": 0.004760391769871473, "findings from this study": 0.001517949287107357, "insight on the possible": 0.0037682098580235023, "contribute to the advancement": 0.005751349092949907, "treatment of older adults": 0.00612724813286492, "contribution of nursing care": 0.005760613270098341, "actions on adenylyl cyclase": 8.624974669697894, "regulated by the actions": 0.004017313680557713, "action on camp production": 0.00044512062173503305, "regulation in mouse hearts": 0.004543990284685088, "model of postischemic heart": 4.320262572037038, "restoration of cardiac plasma": 0.00621915775894252, "overstimulation in heart failure": 0.008972812502045735, "impact of physician continuity": 0.005678827358421384, "continuity further influences outcomes": 0.0004998298750043321, "databases for all adults": 0.002035049228376684, "within the first month": 0.003559472003947464, "discharge on the primary": 0.003948374388904059, "year before the index": 0.0036500508688982972, "in the first month": 0.0078818186823938, "visits with a familiar": 0.005611322811747312, "modulation of repolarization instability": 4.3177460424776, "aim of the present": 0.008854843853460416, "records of surface ecgs": 0.005476839064107294, "expressed as the sd": 0.003835595470892501, "calculated as an index": 0.0012540614344716703, "toward a higher baseline": 0.0020746509376870278, "compared with the hfvt(-": 0.007507464980139946, "consequence of heart rate": 0.00813016666823818, "survivors of haematopoietic cell": 4.317820494863734, "association between the development": 0.0038629727908211257, "syndrome of right heart": 0.008013058634754065, "definitions of the distinctive": 0.008776424429797168, "components of the right": 0.00897515902397598, "consensus on a universal": 0.0020300717158379467, "definition of right heart": 0.00800433216406921, "nomenclature for right heart": 4.316482354905972, "failure with a view": 0.007688681812702781, "education in an effort": 0.00490034647276188, "inhibitor in heart failure": 0.009002564881999006, "composed of a neprilysin": 4.3193571031343465, "promise in a pilot": 0.0060529507263062075, "tested in a large": 0.006110520451065403, "treatment of acute heart": 0.008528197651318615, "defined as the rapid": 0.0039002891174199496, "signs of heart failure": 0.01002497398777951, "situation in which diagnosis": 0.0046826297014424785, "principles of pharmacologic treatment": 4.3181960914350075, "biomarkers in chronic heart": 4.319357195694389, "understanding of chronic heart": 0.008092360006567989, "progressed from the concept": 0.003879699876713137, "focus of research investigations": 0.0055205754345484795, "window into the pathophysiology": 4.315665196936262, "biomarkers in the treatment": 4.32049902695113, "shortcomings in research studies": 0.004666878237061399, "standards in biomarker studies": 4.3169169213326075, "potential of a multimarker": 4.319423588284857, "micrornas in heart failure": 0.008968580670401308, "targets in disease management": 0.005007087502088485, "mortality in western society": 0.0049446639429037344, "subclass of cardiovascular diseases": 4.317995991038559, "expression of target genes": 0.005667714178584733, "role in diverse aspects": 0.004579506906954368, "aspects of cardiac remodeling": 0.0063035080721197696, "overview of these mirnas": 0.0056971500765185, "role in cardiac pathogenesis": 4.317543714774156, "insight into the potential": 0.003457745833230438, "targets for heart failure": 0.006253833715152044, "inhibitors in heart failure": 0.009045071530502068, "evidence for the treatment": 0.0055583103050405504, "target in the treatment": 0.008221471199929378, "evidence for these drugs": 0.0020712782508723977, "quantification with dual x": 0.0039037188743586636, "measured by the rate": 0.004416586757560265, "presence of separate scale": 0.005519263789620973, "validity of individual scales": 0.005506592541084138, "understanding of the structure": 0.008841143923637627, "use in clinical practice": 0.005057505153296519, "contribute to the misdiagnosis": 0.0057471611952819935, "misdiagnosis of heart failure": 0.010009385160015247, "consistent with this result": 0.0042768358028003285, "fragments of the full": 0.008786551789154707, "improved with the use": 0.0075311680885426155, "development of a next": 0.0071717944615274755, "region of this molecule": 0.005805275700001143, "hypertrophy in heart failure": 4.321336148918722, "occur in these patients": 0.00702725613001914, "ratio of systolic blood": 4.31849785507124, "metoprolol on the endpoint": 4.316105568585204, "metoprolol on inappropriate therapy": 4.313190341121257, "blockers on the primary": 0.00397415036590824, "endpoint of inappropriate therapy": 0.005891432474578207, "patients during a follow": 0.004483033698418301, "adherence in this study": 0.005369266217934834, "occurrence of heart failure": 0.010009253575215843, "% in the exposed": 0.0100860270369051, "% in the control": 0.010310066579722808, "used for the same": 0.005221973066296418, "trends in the risk": 0.008327125696158946, "reduction in this risk": 0.0054707198321376676, "reversal of cardiac dysfunction": 0.006462045339486376, "metoprolol in heart failure": 4.321331896747989, "reversibility of heart failure": 4.32227917904049, "changes in pressure development": 0.0049640254095874945, "levels of plasma norepinephrine": 4.3180055293035435, "reduced in the infarcted": 4.320365750312459, "improvement of cardiac performance": 0.006386183615415704, "blockade at advanced stages": 0.0005067231411182775, "stages of heart failure": 0.010012454589389933, "reduction in the elevated": 0.007960046515811883, "levels of plasma catecholamines": 4.317997021995766, "factor for cardiovascular disease": 0.002419054133541946, "hazards of cardiovascular events": 0.005950781022854797, "disease from the general": 0.004293655760262782, "presence of diastolic dysfunction": 4.318278907517516, "patients with peripheral artery": 0.006369703128534423, "defined by an ankle": 0.001248444890781208, "associated with the highest": 0.0077463931122385985, "program for congestive heart": 4.316457374353278, "stay for congestive heart": 4.31643981408287, "patients with this condition": 0.006560574226037852, "located in a community": 0.006043124882925749, "diagnosis of congestive heart": 4.320283539711325, "monitoring of the patient": 0.00909260445574727, "patient by the health": 0.004433235068136647, "documented for those patients": 0.004194528964514092, "participating in the pilot": 0.0077675432412734535, "cost of the intervention": 0.008865038892916592, "failure in a non": 0.008350068854635528, "variability in risk stratification": 4.317344406643907, "within a few years": 0.002000165018827921, "years after an ami": 0.0011947493180852347, "measures of hr dynamics": 0.005563013676338374, "measures of hr variability": 0.0056016658025072, "power of various measures": 0.005561804047071206, "remodeling of the arrhythmia": 0.008900194444574626, "tool for risk stratification": 4.314565201629715, "form of peripheral arterial": 4.317879265499639, "resulting in the activation": 0.007819940498017729, "activation of the renin-": 4.321101882519545, "provide more concrete data": 0.0003458502470077352, "analysis of microarray data": 4.318163164527501, "interactors of the degs": 0.008764167623098292, "part of the network": 0.008772100115107455, "types of heart failure": 0.010016445038808951, "effects of care management": 0.006026080692652165, "effects of an intervention": 0.006152592459773431, "individuals with congestive heart": 4.318675191199262, "system with care management": 0.004353675363544669, "relationship between the intervention": 0.003766907202561189, "reductions in the number": 0.007788235047699826, "baseline to the study": 0.006497571811469285, "controls during this same": 0.000675618290048556, "number of hospital days": 0.005766393606091127, "outcomes in chronic heart": 0.007426900518327244, "race as an independent": 0.001102155469294679, "outcomes in a contemporary": 0.006415315568983207, "association with exercise training": 0.004587799648807287, "interactions with exercise training": 0.004499364581680304, "% to usual care": 0.005024423225769013, "interaction with exercise training": 0.004550272501865608, "risk for all outcomes": 0.0028490339249801298, "prevalence of modifiable risk": 4.318338314217636, "safety of rhythm control": 0.005860496090851303, "therapy in a prospective": 0.006454145055937249, "end of the trial": 0.009182296697950431, "trial for the composite": 0.005189218538990028, "outcome of cardiovascular death": 0.006176303876437208, "counted as a coprimary": 4.314376305476745, "control as an initial": 0.0012258555715026556, "therapy by antiarrhythmic drugs": 4.313380869601272, "implantation of a long": 0.007276605087337789, "use of these devices": 0.00597235044622309, "bleeding in this population": 0.004892889000474592, "asked about the management": 0.0034381647534735328, "management of gastrointestinal bleeding": 0.005657286502352286, "array of diagnostic procedures": 0.005581568573828787, "treatments for this complication": 0.002034290001749336, "understanding of this topic": 0.005806130682211371, "management of end stage": 0.005946085027789273, "consequence of the worldwide": 0.008787650203997365, "increase in life expectancy": 0.004753382829347542, "improvements in the treatment": 0.008232608734063403, "failure in recent years": 0.006967832501592451, "phase of the disease": 0.009197309071218103, "patients with end stage": 0.006560622045641685, "causes for a worsening": 0.00333224043010507, "worsening of heart failure": 0.010039159470775192, "strategies for the treatment": 0.005523859943685341, "treatment of end stage": 0.006241406642083367, "phase of ventricular action": 4.31836180191222, "coupling in the myocardium": 4.320078072740642, "family of monomeric g": 4.317754655373537, "ability to inhibit cardiac": 4.315409832318822, "inhibition of both channels": 0.005683136222877828, "movement of both channels": 0.005599674872108216, "rule out the possibility": 0.0033157352834695657, "mistargeting or altered regulation": 4.313222235693026, "age of legal majority": 0.005678426199017681, "reporting on quality aims": 0.0006545354497105682, "measure for heart failure": 0.0062615065008437614, "variance in future hospital": 0.00462945015794129, "cohort of older patients": 0.008083530307927907, "treated at an acute": 0.0012673309150212147, "hospitals on the basis": 0.003802061116060132, "performance on the composite": 0.003862805063964802, "mortality at the worst": 0.004201533258923115, "hospital in the worst": 0.007903473409295288, "variation in future mortality": 0.0050154134393610396, "spironolactone in severe heart": 4.319279963746713, "antagonists in heart failure": 4.3212808650571315, "race by treatment interaction": 0.0012494846334078693, "differences in baseline characteristics": 0.004779008276160371, "categories of actin cytoskeleton": 8.630036380297774, "parallel with global attenuation": 4.3162179097880795, "attenuation of mitochondrial proteome": 12.942392260781038, "% of nonmitochondrial protein": 4.320177819914271, "effects on heart failure": 0.005134209713768476, "attenuation of global proteomics": 8.63006426741189, "alterations by the mitochondrial": 4.31640454632368, "many of the pathway": 0.008812221412768256, "drugs for the treatment": 0.005469956209415618, "length of stay increase": 0.005714383634650377, "rehospitalization of medicare fee": 8.630040589764576, "policy as a quasi": 0.002108023082286428, "associated with an absolute": 0.004923312384851249, "reduction in hospital length": 0.004790192803324708, "admissions to acute care": 0.002946195297566607, "strata of hospital volume": 0.005853427386973369, "relationship between physician volume": 0.0007077971711633097, "antagonism in heart failure": 0.008972812502045735, "role in the progression": 0.007898735540018664, "groups with heart failure": 0.008614939928865629, "therapy with beta blockade": 0.00437173602022579, "randomized to the aldosterone": 4.318141816345624, "background for aldosterone antagonist": 8.626290671547988, "patients with reduced ejection": 0.007073813713611505, "prognosis of a large": 0.0072036508352072, "followed during the past": 0.0036680498676698835, "periods on the basis": 0.0037598798108055957, "basis of heart failure": 0.010031989434768039, "devices at final evaluation": 0.0005020539779174214, "enrollment of older patients": 0.007938852992250478, "dysfunction during the years": 0.004165361754402034, "predictor of favorable outcome": 0.005704892324995818, "decreases in heart failure": 0.008994058297902091, "improvement in the prognosis": 0.007968858249646642, "cardiomyopathy during the past": 4.315924255234886, "replicated in the real": 0.007739345546420822, "value of indeterminable anaerobic": 8.630081756170643, "threshold in heart failure": 0.008980946986372723, "investigations at study enrollment": 0.0009804213513110328, "achievement of anaerobic metabolism": 4.3177796307054415, "composite of cardiovascular death": 0.006054080209456295, "diet in renal disease": 0.005077630097137783, "obtained for the secondary": 0.005041460496837452, "number of cardiovascular risk": 0.006312369114179182, "history of cardiovascular disease": 0.006141159299208628, "duration of maximal treadmill": 8.630092483338377, "during a mean follow": 0.002280804408896908, "matched for the same": 0.005058642380610001, "activity with the goal": 0.007312014621010935, "development of systolic heart": 4.320515990416414, "alterations in energy metabolism": 0.004535616140927284, "changes in energy metabolism": 0.004691632341108737, "contribute to the development": 0.005873089635459189, "failure in the hypertrophied": 4.322205233109707, "overload as a result": 4.31445045271266, "result of an abdominal": 0.00597425815475079, "rates of energy substrate": 4.3179490315354245, "assessment of cardiac function": 0.006582778067923324, "decrease in % ejection": 0.007334714111653654, "evidenced by a significant": 0.0025422245207935494, "translocation of glucose transporter": 0.005480874893656021, "reduction in mitochondrial oxidation": 8.629216531761802, "accompanied by an increase": 0.0013617733592488639, "increase in myocardial glycolysis": 8.629440621603957, "concomitant with a reduction": 4.3179159788701575, "reduction in the ratio": 0.008230299157762778, "development of cardiac insulin": 0.0063542048192430705, "changes in the development": 0.008056174220167566, "contribute to the progression": 0.005785134769609911, "hypertrophy to heart failure": 4.319310593754942, "reality of heart failure": 0.010006139421844893, "planning in the prevention": 0.007753247251721594, "adequacy of relevant health": 0.005621264222628548, "search of the electronic": 0.008780896490246777, "developed and nondeveloped countries": 4.318363296911801, "confirmation on other populations": 0.0005458217220316205, "link between air pollution": 0.00036084150385512563, "factor for cardiovascular health": 0.002165768322058146, "review of the effects": 0.009038847842639058, "effects of air pollution": 0.005650569404424321, "pollution on heart failure": 0.004978129439970714, "professionals in public health": 0.004567630305742491, "regulator of cytoskeletal actin": 8.630015397670572, "dysfunction with conduction abnormalities": 4.316493091611357, "mass in the transgenic": 4.3201528708236, "decreases in ejection fraction": 0.005425649204630146, "future of advanced heart": 0.007947214720066074, "developments in diagnostic procedure": 0.0045106637068127245, "addition to palliative care": 0.00270788521824265, "patients in the terminal": 0.010158308543492763, "recognition of advanced disease": 0.005964230806059105, "vital in the determination": 0.00773404099840268, "determination of therapeutic options": 0.005571039881779687, "professionals from multiple disciplines": 0.0005985105433917096, "experienced in the management": 0.007914947322377507, "access to therapeutic options": 0.002506652403319362, "aims of the present": 0.008855128952196019, "results about the risk": 0.004006546559678906, "uncertainty about the safety": 0.0033837332036866473, "safety of these antihyperglycemic": 4.318056078587172, "recorded as the principal": 0.0038271113879080605, "ratios from the disease": 0.0043376782618804325, "effectiveness of implementation strategies": 0.005618879597265794, "recommendations in heart failure": 0.009009777262471392, "search in the databases": 0.007771401534760843, "impact of the intervention": 0.008932221718148564, "adherence to the cpgs": 0.0057444864459935165, "proportion of eligible patients": 0.007825606964708093, "impact of implementation strategies": 0.005690246312837919, "factors on physician adherence": 0.0006689426206733657, "findings through briefing reports": 0.00011320755638342989, "perceptions of implantable cardioverter": 8.630186193289877, "recommendation for implantable cardioverter": 8.626410098917374, "perspective on the timing": 0.0037487424750940203, "decisions about implantable cardioverter": 8.624711537187043, "identified in this study": 0.005451769289471362, "information on implantable cardioverter": 8.625142633894027, "change in clinical status": 0.00500957830634491, "objective of this clinical": 0.006199203568060296, "efficacy of carotid baroreflex": 8.630079808399664, "reduction of sympathetic outflow": 0.005670816032829504, "improvements in the distance": 0.007823032147859009, "associated with a trend": 0.006054164273206172, "burden of heart failure": 0.010025237156085564, "patient with chronic heart": 0.006796765045285091, "changes in control group": 0.005182151823790305, "half of these patients": 0.008026512485105414, "function in hfpef patients": 0.007107711635989413, "women with a history": 0.005561230829231699, "cornerstone in the assessment": 0.007811496739508405, "extent of the symptoms": 0.008898068824827226, "presence of peripheral oedema": 0.005528647596022423, "assessment of the patient": 0.009135483926283687, "reduction in adverse events": 0.0049173221831966376, "events from coronary artery": 4.313292098740831, "beyond the cardiovascular system": 0.003640138851529038, "cancer of the prostate": 0.008795016254393238, "exercise below these recommendations": 0.0007849138131520552, "abnormalities of the heart": 0.011152715266163515, "cause of nontraumatic death": 4.3182090310235495, "sport in young athletes": 0.004476000486466109, "screening of young athletes": 0.005514283733280671, "ability to detect congenital": 4.314725921482836, "system in heart failure": 0.00904041824229371, "training of the lower": 0.009106442087930173, "quality of life score": 0.005962468378052096, "evaluation of the muscular": 0.008810517716398375, "resulted in an improvement": 0.005082838980802044, "improvement in peak work": 0.004703408129533524, "quality of life assessment": 0.005896499174710263, "safe in this trial": 0.004932709837510139, "intervention with augmented feedback": 0.003945396495566335, "benefits in exercise capacity": 0.005103565581127346, "validation in larger studies": 0.004639344647668039, "adherence with exercise training": 0.004538061872023187, "association between social support": 0.0005916528825002941, "surveys to assess social": 0.0024960424604715354, "levels of social support": 0.005839677732323388, "interaction between the randomization": 4.315973564774253, "corresponded to a borderline": 4.316286665816157, "hospitalization in the exercise": 0.008460639435092237, "association in the usual": 0.007860866325191364, "patients with lower btes": 0.006437581947552315, "therapy in clinical practice": 0.0052390258017762665, "readmissions in heart failure": 4.321289371062372, "effect on heart rate": 0.0032278571478539866, "impact of hr reduction": 0.0057209833466991405, "reduction with beta blockers": 0.004222297056320403, "blockers on exercise capacity": 0.0011509877569861708, "capacity in recent onset": 0.004717305907610257, "protocol with respiratory gas": 0.003907576614416347, "participated in a quality": 0.006240459375420077, "quality of care programme": 0.005931590370035609, "interventions to reduce elevated": 0.0026192969533122713, "risk of hospital admission": 0.006284818463904558, "efficacy of therapeutic left": 0.006092614307492517, "enrolled under the canadian": 0.003402799446208021, "guidance under general anaesthesia": 4.312327692267039, "implanted in all patients": 0.007010770582347819, "reduced from a mean": 0.0026541339082425007, "hospital with gastrointestinal bleeding": 0.004099922024329686, "shift in the treatment": 0.008189067725601932, "problem of current cardiology": 4.317819677035676, "occurred in the therapy": 0.008176495325665797, "therapy in recent years": 0.005137791899360793, "effect of natriuretic peptides": 4.3180229199664435, "decrease in primary endpoint": 0.00465025163711417, "contributed to this study": 0.0033130166644529664, "form of heart failure": 0.010019074704294379, "determinant of reduced quality": 0.006022207114842364, "correlated with the change": 0.007374334452972155, "change in thigh muscle": 0.004592138285611875, "rotor with wide blood": 0.0040001039542232435, "aim of this single": 0.005849079899057702, "adults with ejection fraction": 0.004978207406083397, "effectiveness of disease management": 0.006053504084766142, "based on a modified": 0.0021557098343080146, "projections of resource use": 0.005667312388684237, "pairs of virtual cohorts": 4.317749835404112, "estimates of resource use": 0.005678888982129886, "ratios from user inputs": 0.000633235415982015, "effectiveness of heart failure": 0.010051743357846525, "program in which short": 0.004664700910787074, "value to the health": 0.005923237723776791, "providers with a tool": 0.005516248094079466, "analyses of disease management": 0.00606637242102766, "nurses in all settings": 0.004684258295029423, "advancement of the pathophysiologic": 4.321055076510694, "95 % confidence": 73.01240146144481, "% confidence interval": 47.55007936128033, "left ventricular ejection": 59841.55591935954, "chronic heart failure": 59.29563745969704, "ventricular ejection fraction": 49747.320217492335, "methods and results": 70.34756035958102, "preserved ejection fraction": 13.305154295117749, "congestive heart failure": 40613.838224203384, "patients with heart": 49.78267896545494, "95 % ci": 17.081577092234447, "heart failure patients": 33.10049522519837, "acute heart failure": 20.923670747645566, "reduced ejection fraction": 5.791944449093327, "systolic heart failure": 13262.248991274802, "type natriuretic peptide": 11644.253715421914, "cardiac resynchronization therapy": 8747.60827910347, "glomerular filtration rate": 7452.324982006208, "ventricular assist device": 7453.032914244518, "body mass index": 0.8632934508356717, "acute myocardial infarction": 12523.892686056704, "estimated glomerular filtration": 6261.670568618858, "advanced heart failure": 6.7649244003107265, "left ventricular assist": 5176.139898589544, "quality of life": 5.658007333263224, "ventricular assist devices": 4192.307794499577, "right heart failure": 4.615960166051053, "failure with preserved": 4.860772912940606, "\u03b2 - blocker": 3316.4177844611454, "stage heart failure": 3.551946932463628, "early diastolic mitral": 6624.027161293972, "converting enzyme inhibitors": 2535.7095326815697, "type 2 diabetes": 0.3335239054370297, "coronary artery disease": 2535.997574498808, "rhythm control therapy": 0.4055507705806565, "systolic blood pressure": 1863.180015145702, "adjusted hazard ratio": 0.3165561083583695, "brain natriuretic peptide": 1863.011448690164, "angiotensin receptor blockers": 1863.087895965927, "cardiac magnetic resonance": 0.34284540046001377, "induced heart failure": 2.046189527488163, "peak oxygen uptake": 0.10223264811447327, "idiopathic dilated cardiomyopathy": 5588.776929505333, "coronary heart disease": 1294.5495362049658, "obstructive pulmonary disease": 0.17496708877230524, "left ventricular dysfunction": 1294.0901455253559, "proportional hazards models": 0.07183464828843426, "acute kidney injury": 0.10881144439695323, "- adrenergic receptor": 1295.4515855107263, "severe heart failure": 1.4180986905081716, "ischemic heart failure": 1295.0803004190702, "day readmission rate": 1293.8547960935591, "cardiopulmonary exercise testing": 0.17852962620764967, "% of patients": 1.9468865169634153, "left bundle branch": 0.10026558052540699, "bundle branch block": 0.014279307317874785, "\u03b2 - blockers": 829.1061588829396, "annular size reduction": 828.0006636711222, "adjusted odds ratio": 0.10143458736421164, "left ventricular filling": 828.1726749476451, "angiotensin converting enzyme": 1655.9548364444347, "mineralocorticoid receptor antagonists": 1655.9581197215991, "criteria cardiac transplant": 0.16044850196692134, "quality improvement initiative": 0.0743278178380331, "implantable cardioverter defibrillator": 2483.9229028942523, "ventricular contractile reserve": 1656.0384779035617, "diastolic mitral annular": 2483.948203096398, "mitral annular velocity": 1655.960568913134, "peak oxygen consumption": 0.04436325443736718, "extracorporeal membrane oxygenation": 1655.9254634657675, "mechanical cardiac support": 0.17114178578811154, "sudden cardiac death": 0.19707737931048358, "skeletal muscle mass": 0.04611339084942666, "defibrillator deactivation discussions": 1655.9415838355785, "disease management programs": 0.11364119934042176, "adverse event rates": 0.04089603154696705, "x - ray": 0.6148347763345292, "- ray absorptiometry": 466.34092209549937, "peripheral vascular disease": 0.05379042360880208, "hour cumulative urine": 0.006476316253435278, "cumulative urine volume": 0.028718831463480244, "coronary artery bypass": 465.75404987868615, "among older patients": 0.2818452659730981, "cd34+vegfr2 + cells": 0.017180012050133073, "primary end point": 0.05240549767250749, "morbidity and mortality": 0.7043667294039768, "% confidence intervals": 0.2784582037325016, "predictive cutoff value": 465.7395575052149, "materials and methods": 0.6428165759934379, "mitral valve plasty": 931.4805728251495, "developed heart failure": 0.5061583946261818, "aggressive medical treatment": 0.06487466229832767, "successful valve plasty": 465.742661109501, "mitral valve opening": 465.75459676494694, "mean pressure gradient": 0.04077469301275375, "heart failure hospitalization": 0.5180044490685755, "assist device implantation": 0.03390346606909029, "vascular endothelial growth": 465.7415394706028, "endothelial growth factor": 465.7468919211289, "- myocardial infarction": 932.1124974373553, "myocardial infarction heart": 931.7532366602092, "chronic myocardial ischemia": 931.5149412057534, "standard cardiac rehabilitation": 0.08857124536230097, "cardiac rehabilitation care": 0.10826301347389686, "mean ejection fraction": 0.12153219722528304, "optimal combined treatment": 0.05816208984931856, "breast cancer patients": 0.25805932197359016, "dash diet scores": 0.016741914563811654, "standard criteria cardiac": 0.08901397829577379, "magnetic resonance imaging": 0.01368875488674398, "risk of heart": 0.9042208500650871, "adverse cv events": 0.03789376986760267, "converting enzyme inhibitor": 465.7379765091888, "ventricular diastolic function": 931.5772349672665, "transverse aortic constriction": 465.7356936027127, "pulmonary arterial hypertension": 465.77059190246916, "human heart failure": 0.5015803627770534, "diastolic mitral flow": 931.5015549468761, "mitral flow velocity": 465.7585107187899, "acute \u03b2 -": 466.39008435237383, "low testosterone status": 0.0374789999218441, "improves exercise capacity": 0.07746322239483382, "heart rate variability": 0.29349478278199637, "group included patients": 0.3045566194462776, "hospitalized older adults": 0.034893122363830464, "- adrenoceptor blockade": 466.34374222579953, "end stage heart": 0.2905126960976683, "cardiopulmonary exercise test": 0.06900266931457609, "study end point": 0.09952224311056299, "cardiovascular risk factors": 0.10320631743904181, "risk of death": 0.5385020326486761, "failure with reduced": 0.42036685918071537, "length of stay": 0.361827898635426, "energy x -": 0.2744100629102963, "lv diastolic dysfunction": 207.01424988505875, "adults with heart": 0.30446208985358647, "management of patients": 0.3815247776492131, "implantable cardioverter defibrillators": 620.9768471500959, "right ventricular assist": 207.03230944525757, "preserve renal function": 0.025407122719277336, "compared with placebo": 0.20582114630812262, "cystatin c level": 206.99645084077707, "proteins alter chromatin": 206.9960860187154, "alter chromatin structure": 206.99477285430436, "gene expression profile": 0.011038207996428061, "receive cardiac resynchronization": 207.02687761371635, "acute coronary syndromes": 207.0095442257632, "among study patients": 0.14767703280399253, "subsequent heart failure": 0.21999432098819835, "outcomes among patients": 0.13863562874171725, "circulating progenitor cells": 0.006065818466993734, "improved functional capacity": 0.025260571585697916, "recent hospital discharge": 0.015269455468148273, "implanted monitoring devices": 0.007584122382524778, "medical support provided": 0.015963321502142594, "95 % cri": 0.14117005861350784, "ventricular ejection fractions": 207.0421751103127, "recommended target dose": 0.012418299439673692, "- blocker uptitrations": 207.2667231345744, "- blocker dose": 0.28531250854854434, "natriuretic peptide levels": 207.01037145939154, "in heart failure": 0.43049187217926277, "predict inhospital mortality": 207.0170477609427, "pediatric heart failure": 0.21939867413768105, "systemic vascular resistance": 0.007304440924902199, "minute walk test": 0.007826927513776989, "induced no production": 0.019170659774045792, "hypertensive heart disease": 207.1228231010478, "heart failure risk": 0.24599552241190226, "operating characteristic curve": 0.0019080677112839452, "integrated discrimination improvement": 0.008423896356108204, "net reclassification improvement": 0.008995349508269409, "requiring biventricular support": 206.99952240332306, "transplantation eligibility status": 206.99819023516469, "functional mitral stenosis": 413.9976709928591, "ischemic mitral regurgitation": 620.980520952789, "diastolic mitral valve": 414.00095729262836, "mitral valve tethering": 207.00159998662093, "anterior leaflet opening": 206.99245150642253, "posteriorly displaced papillary": 413.9791010740931, "displaced papillary muscles": 206.99032250848552, "left ventricular dilatation": 414.031744261429, "diastolic volume index": 207.02147287641256, "mitral filling flow": 207.00374885601417, "clear organic lesion": 206.9904455734553, "cause medical hospitalization": 0.027235421093824957, "month event rates": 0.015134266840085724, "stage renal disease": 0.03058315120321731, "cardiovascular event rate": 0.030071840505904814, "high sst2 treated": 0.017821347293216626, "multiparametric echocardiographic score": 413.9887697914554, "global longitudinal strain": 0.005965904798123334, "left atrial area": 207.01959810130109, "newly diagnosed heart": 0.11557641424898427, "diagnosed heart failure": 0.22039841937313198, "fold increased risk": 0.04493963945604831, "ventricular filling pressure": 207.03112707772146, "mitral annulus velocity": 413.98850896413455, "pulmonary capillary wedge": 206.9977221533915, "capillary wedge pressure": 207.00056882725397, "good diagnostic performance": 0.007537468649428731, "annular plane systolic": 413.9955743508025, "plane systolic excursion": 207.00478680674104, "pulmonary arterial systolic": 414.00564968200973, "arterial systolic pressure": 414.00849635587224, "left anterior descending": 207.0132177335788, "heart rate reduction": 0.13528892033513076, "effective arterial elastance": 413.98941429859997, "ejection fraction \u226435": 207.03686939517397, "fraction \u226435 %": 207.12545750874557, "isolated hr reduction": 0.010536888350553315, "aortic valve replacement": 0.009344496183940584, "exercise per week": 0.029509769802932313, "hand grip strength": 0.0034549457141166413, "ventricular ejection time": 207.04873634234883, "higher serum levels": 207.01274285428545, "higher furosemide dose": 207.00824580622475, "right atrial myxoma": 413.9939884939448, "% confidence level": 0.1270018930357743, "vasopressin receptor antagonist": 413.99014240619266, "embryonic gene programs": 0.006214127557246148, "median rate ratio": 0.03812163961306925, "adjusted hazard ratios": 0.021593672842596112, "extended criteria cardiac": 0.03656789948765131, "chronic kidney disease": 0.03488471028024443, "magnetic resonance postcontrast": 206.99381955515412, "myocardial extracellular matrix": 620.9827616642048, "magnetic resonance t1": 0.00425902287781214, "pulmonary vascular resistance": 0.013846357659549599, "heart magnetic resonance": 0.1170760201370333, "mild heart failure": 0.22163273738017764, "clinical composite response": 0.02642699084021586, "underlying myocardial dd": 207.00505712748338, "longitudinal systolic strain": 207.00872687292434, "- fatal stroke": 0.276535791852628, "consecutive case series": 0.006336946758652531, "e - wave": 0.2748826596587397, "serum resistin levels": 413.99360535246313, "aortic blood flow": 0.013452233514078697, "adenine nucleotides contents": 413.9790842312712, "mitochondrial oxidative phosphorylation": 620.9752141846121, "oxidative phosphorylation capacity": 413.98816804723356, "creatine kinase activity": 206.99577539309084, "preoperative renal dysfunction": 207.01261665723501, "artery bypass grafting": 206.9952681117348, "primary isolated cabg": 0.010090870534091429, "onset heart failure": 0.22328356367418373, "maladaptive cardiac remodelling": 414.01418097179874, "severe pulmonary hypertension": 0.023607871116447406, "pulmonary hypertension patients": 0.12771703288712372, "unfolded protein response": 0.01032889438489218, "channel mrna splice": 0.002798293075791385, "mrna splice variants": 0.002024862383141709, "acute right heart": 0.13542187580592618, "cardiac sympathetic activity": 0.04167557294865694, "stable heart failure": 0.22222300626512972, "adrenergic receptor haplotype": 413.9895299303998, "dyssynchronous heart failure": 207.20917384779415, "lean body mass": 0.014427730079115159, "clinical prediction rule": 0.022485561006440613, "multivariate logistic regression": 206.99568200716337, "logistic regression analysis": 0.017014521975169138, "worsening renal function": 0.026447939740507773, "\u00b1 6 %": 207.13001527253869, "chinese herbal medicine": 0.0009640445639588456, "ventricular diastolic end": 414.03036389193045, "diastolic end diameter": 207.0140820200852, "acute care surgery": 0.029953833094965434, "refractory cardiogenic shock": 413.98131217647096, "key health outcomes": 0.026720096554386077, "shuttle walk test": 0.006953468021281604, "functional electrical stimulation": 0.014417576297374671, "minute walked distance": 0.0038054663802749417, "transforming growth factor": 0.007414384819138682, "mesenchymal transition markers": 0.003415062908395715, "cardiac autonomic balance": 0.036591180074844055, "worsening heart failure": 0.22022374153138066, "early physician follow": 0.022656735293617784, "proportional hazard models": 0.022723109741376063, "autonomic nervous system": 0.0056646073618574, "\u03b2 - adrenoceptor": 414.26079373891866, "angiotensin receptor neprilysin": 413.9946327367266, "receptor neprilysin inhibitor": 207.0005798519241, "inappropriate implantable cardioverter": 413.9892619245789, "patients receiving carvedilol": 207.10678431123483, "% lower rate": 0.13822860173516244, "retrospective cohort study": 0.03777222343532606, "myosin heavy chain": 206.9901530282558, "peripheral artery disease": 0.026356251101557045, "health care system": 0.022385240602027394, "major public health": 0.011948105436061243, "public health problem": 0.007266834290484891, "heart failure samples": 0.22059098927700985, "functional enrichment analysis": 0.02433711866906095, "early rhythm control": 0.02101323534416128, "terminal heart failure": 0.22285535093758985, "versus best quintile": 0.011521226022928106, "combined end point": 0.018634831945794544, "global proteomics changes": 207.0009862701025, "ingenuity pathway analysis": 0.015175201084889862, "- acute care": 0.2976113350562636, "acute care transfer": 0.025656462004236526, "care transfer policy": 0.0126697286897537, "without major complications": 0.013831310681476179, "across hospital volume": 0.021381478319007306, "hospital volume groups": 0.027425143954642683, "chronic advanced heart": 0.13088944680986248, "infarction heart failure": 207.2150928695747, "primary study end": 0.047525145759311466, "kidney index score": 0.020390833162728158, "lower total expenditure": 0.016181166948706763, "health per capita": 0.01213864791867749, "assisted gait therapy": 0.019145980336047495, "peak quadriceps force": 206.99683650049957, "adverse events occurred": 0.020456392272859142, "versus \u226570 bpm": 413.9911254945622, "right interatrial shunting": 413.9882730417036, "principle cohort study": 0.03692924665435747, "min walk test": 0.013085588295362742, "aerobic exercise training": 207.01996802162168, "obese older patients": 0.12022246292370332, "- primary outcome": 0.28825561662897525, "heart failure disease": 0.23781310193543195, "failure disease management": 0.13245251638230265, "mortality in patients": 0.24276650150178136, "associated with mortality": 0.1647288890525813, "outcomes in patients": 0.23823305280939497, "treatment of heart": 0.2750727496647626, "characteristics and outcomes": 0.21399187937267683, "safety and efficacy": 0.20366014365953264, "patient population is": 0.024608172555130717, "predictors of mortality": 92.1240632547519, "reduce the risk": 0.0843330341536824, "patients with preserved": 0.13797122569804918, "survival of patients": 0.1695942442496692, "effectiveness and safety": 0.12979719967428427, "in this study": 0.11363834970630304, "quality of care": 0.12616500693071542, "death or hospitalization": 0.030308807948579587, "compared with metoprolol": 92.08656593685689, "barriers to exercise": 0.06196705503432372, "national efforts dedicated": 0.0002838607459569143, "improve patient safety": 0.005838669848426386, "patient safety remain": 0.00491797846478386, "assess national trends": 0.0015995280532853, "conditions requiring surgery": 0.0023187690611502654, "large study sample": 0.007971279645535156, "hospital adverse events": 0.00625071414300111, "adverse events averted": 0.00426093768423114, "measurable overall improvements": 0.0009739817146032353, "considerable national attention": 0.000539336797999944, "national patient safety": 0.0048621880612581695, "patient safety initiatives": 0.004755653509272286, "cross - talk": 0.06834416551685991, "cachectic heart failure": 51.80198721450033, "increased energy expenditure": 0.004660386219978168, "b natriuretic peptides": 51.749022444505485, "tested the hypothesis": 0.040403270668271755, "fat free mass": 0.002755272021539565, "body fat distribution": 0.0023236407012167436, "dual energy x": 0.0006269558925667118, "- diabetic patients": 0.09637783316485338, "- cachectic chf": 51.8154612030988, "prior myocardial infarction": 103.50046907890143, "stable body weight": 0.003032085339772103, "diagnosis of heart": 0.09468551948750226, "heart failure show": 0.0549246025482468, "major underlying mechanism": 0.002445786610529094, "clinical diastolic dysfunction": 51.75814121714186, "diastolic dysfunction leading": 51.75389633203855, "guidelines based definition": 0.0023053519005567067, "dilated left ventricle": 103.50171686524294, "treatment of anemia": 51.818671425268164, "clinical practice guideline": 0.006430552951798795, "provide clinical recommendations": 0.005767351745711285, "guideline included mortality": 0.009072152291486515, "heart failure exacerbation": 51.80193617021942, "venous thromboembolic events": 103.49746449300929, "ischemic cerebrovascular events": 103.49843407907811, "target patient population": 0.0054535505766023125, "deficient adult patients": 0.028697974922578258, "clinical practice guidelines": 0.006025437653412411, "practice guidelines grading": 51.74873473715198, "guidelines grading system": 51.74876545577378, "restrictive red blood": 0.0014042121650891073, "red blood cell": 0.0021529423891783655, "blood cell transfusion": 0.0023923788333637215, "cell transfusion strategy": 0.0014769976400902593, "trigger hemoglobin threshold": 51.747787429856515, "higher hemoglobin levels": 51.752828446156286, "clinical trial registries": 51.753711491267644, "observational studies suggests": 0.0031135175336004977, "liberal transfusion protocols": 0.0004525526471902367, "term mortality rates": 0.01037014525583621, "less aggressive protocols": 0.0015455303840745736, "combined relative risk": 0.008048880595360249, "risk among trials": 0.010447760070789205, "decreased mortality rates": 0.009841618246206704, "acute coronary syndrome": 51.752483668515765, "intravenous iron found": 0.0020353199306834143, "term exercise tolerance": 0.007887422860858324, "stimulating agent therapy": 0.004983821122600568, "data supporting iron": 0.0026989784052909704, "supporting iron use": 0.0028797460470942953, "higher transfusion thresholds": 0.003041664621633634, "consistently improve mortality": 0.007578336070051461, "improve mortality rates": 0.009690095076334549, "remote ischemic conditioning": 51.74861151586424, "heart failure clinical": 0.05922687072085493, "failure clinical trials": 0.03274977434234601, "enriching patient identification": 0.0035955296874343942, "modern acute heart": 0.03163061522920993, "appropriate risk stratification": 51.75508831594672, "implantable cardiac defibrillator": 103.50528036558636, "many current predictors": 51.7489913923391, "reviewers selected citations": 0.0005430496273067312, "using multivariable regression": 0.003702721919843932, "baseline glomerular filtration": 51.751061796526265, "10 % increase": 0.03142593875502817, "strong reliable mortality": 0.006689215761791918, "reliable mortality predictors": 51.75456630382348, "failure randomized trial": 0.029818737656692306, "small studies suggest": 0.003508617882175863, "function in patients": 0.08529253963187296, "min without bolus": 51.75048797456317, "controlled clinical trial": 0.006918060349702652, "1:1 allocation ratio": 51.751645761017855, "pooled placebo group": 0.005175076662126043, "decongestion end point": 51.751603950694374, "serum cystatin c": 103.49579554009384, "renal function end": 0.009428067560374318, "function end point": 0.00832631661720673, "secondary end points": 0.003940299653714314, "end points reflective": 0.0036469422765032593, "conclusion and relevance": 0.0721886077929916, "nesiritide enhanced decongestion": 103.49558955899452, "improved renal function": 0.0079676055395271, "heart failure guidelines": 0.055263484379000485, "many multisite studies": 51.749777946897865, "improving patient outcomes": 0.008680591299865342, "specific research questions": 0.001487951689030936, "utilizing voluntary testimonies": 9.472155370409769e-05, "extend beyond meeting": 0.00026150713564738673, "beyond meeting magnet": 7.285872187333312e-05, "cardiac chromatin identifies": 51.75645949430236, "chromatin identifies nucleolin": 103.49533985633235, "failure involves changes": 0.028967509401969356, "global gene expression": 0.0028621442630110197, "coordinate dna accessibility": 9.972177196245215e-05, "accompany heart failure": 0.05469811731443565, "present study tests": 0.007933115392019054, "conserved developmental chromatin": 51.74805075914689, "developmental chromatin remodeling": 51.7494286499775, "chromatin remodeling events": 51.75191133402637, "used quantitative proteomics": 51.75036432257602, "extracted via detergent": 0.0010284047303229086, "using strong acid": 0.002602500751157466, "exhibited altered expression": 0.00253994077574369, "extensive functional characterization": 0.0029926939007099704, "nearly abolished protein": 0.0014245186580049778, "abolished protein expression": 0.0029410053856644388, "gross morphological development": 51.748990995696936, "severe developmental impairment": 0.0024283922163060613, "abnormal chamber patterning": 51.747788201998304, "bone morphogenetic protein": 51.748602326640125, "protein 4 expression": 0.004558886233070929, "decreased rrna transcription": 51.74906904094394, "new chromatin subproteome": 103.49588948230027, "diseased mouse heart": 0.02896171532850733, "complementary model system": 0.003207942271455003, "genomic reprogramming events": 51.74997201341962, "myocardial ischemic events": 103.50195409852745, "events in patients": 0.08366009820368149, "limited data regarding": 0.0033466641522211377, "data regarding risk": 0.00931268878233286, "regarding risk factors": 0.0087960658596935, "present study population": 0.009133664628624971, "proportional hazards regression": 0.0019855304848476513, "identify risk factors": 0.00929983830084247, "included previous revascularization": 51.74937561037666, "artery bypass surgery": 0.0026856762288574427, "percutaneous coronary intervention": 103.4970146552264, "increased systolic blood": 51.7564325433473, "branch block pattern": 0.00073117343284585, "dependent analysis showed": 0.0056756027470839555, "contemporary heart failure": 0.05469048540510737, "increased increase rate": 0.009992164915218, "interaction term analysis": 0.0056378835856029826, "patients \u226475 years": 51.77882667808504, "older age group": 0.007867660915498387, "associated with outcome": 0.05521510698493605, "cd133 + cells": 0.0019088902277925636, "increased functional capacity": 0.00863408186997634, "patients without diabetes": 0.031241208187897593, "noted differential relations": 0.0006601258560014782, "three readmission metrics": 51.74938706105296, "day readmission rates": 51.7525984729193, "three disease groups": 0.007608205546461614, "average hospital rates": 0.004581161970163453, "extreme decile according": 0.0006879832852580021, "correlations among metrics": 0.0022755626365742413, "hospital longitudinal change": 0.003767566369514859, "produce different hospital": 0.002607741866697957, "different hospital rankings": 0.002636164023804505, "readmission metric choice": 51.748824155311034, "deliver specialised care": 0.0030887769071754854, "heart failure population": 0.05603311180337256, "strategies improve outcomes": 0.007021445058718418, "searching relevant articles": 0.00026098792348484536, "observational cohort studies": 0.0048709619760234565, "contemporaneous control group": 0.006880206526107753, "interventions included home": 0.002617849786845625, "included home telemonitoring": 51.748940133354886, "structured telephone support": 0.0020781989719927275, "delivered via human": 0.0019898682557185857, "reaching statitistical significance": 51.747569835461874, "% credible interval": 0.030552328447223342, "generally improved health": 0.0037109580903719255, "showed beneficial trends": 0.0026861428798793207, "recently discharged patients": 0.02882977640772883, "induced dilated cardiomyopathy": 103.49839977247802, "right ventricular pacing": 51.75722407058818, "interventricular septum biopsies": 155.24211935579484, "21 beagle dogs": 51.74784239748719, "development of heart": 0.09517988767344185, "evaluated protein levels": 0.0052440821973185475, "moderate heart failure": 0.05555917276191384, "pump sternal sparing": 51.74794657478135, "sternal sparing approach": 51.74775820090278, "dysfunction requiring pump": 0.004630292022993131, "requiring pump replacement": 0.0013047072254029506, "isolated pump replacement": 0.0016643188523026752, "angiotensin system blocker": 51.75100266314732, "hospitalized for heart": 0.049333152361857674, "in ambulatory patients": 0.08148550378998219, "in consecutive patients": 0.08188431100416993, "blocker dose changes": 0.005587567832963545, "blocker dose increase": 0.005320431847152275, "compared with patients": 0.07843665977028018, "patients without uptitration": 51.77726458425831, "higher heart rate": 0.03473555471008197, "better renal function": 0.006889979076395747, "- blocker uptitration": 51.8169870310918, "low co -": 0.07078408442985924, "- morbidity burden": 0.06897455117334436, "predicts clinical outcome": 0.007010454275190824, "explored sex differences": 0.0018216079307196936, "determine prognostic significance": 51.74955863174995, "patients with reduced": 0.0788694771318116, "compute odds ratios": 51.7488615650298, "37 % female": 0.028974704581719, "48 % female": 0.02887026226728585, "65 % female": 0.028515081963619508, "higher admission median": 0.005373644920688821, "difference among reduced": 0.007125936020752239, "difference among preserved": 0.005865273344093311, "women vs men": 0.0027497553262122113, "article presents guidelines": 0.0009652835833936872, "early medical management": 0.004880949621959909, "emergency room practice": 0.001301207556293034, "undiagnosed heart disease": 0.03306018193472364, "received surgical palliation": 51.74800602844549, "advanced management involving": 0.003359134095899022, "involving ventricular assist": 51.755973013509006, "elderly patients hospitalized": 0.029567399692393706, "consecutive patients seen": 0.029188854292987267, "determined chf visit": 0.0004209538064125629, "chf visit rates": 0.002286452156522407, "performed regression analyses": 0.0032449416380209723, "\u00b1 14 years": 51.75544590160749, "heart failure visits": 0.05591636117922556, "% relative decrease": 0.029676588962583166, "annual ed visits": 0.001267700664420381, "better chf treatments": 0.0010891413385914392, "systolic ventricular function": 103.50960146417817, "significant liver disease": 0.008007289179692095, "traditional heart failure": 0.054767572152138094, "low systemic vascular": 0.0033799657630015746, "preserved cardiac index": 0.014156790997811437, "case cohort analysis": 0.005979215227036464, "mean catheterization findings": 51.74981262982246, "central venous pressure": 51.75036294276504, "pressure 18 \u00b1": 51.75471850658452, "\u00b1 3 mm": 51.75500480179305, "index 2.7 \u00b1": 51.75441595496625, "\u00b1 0.7 l": 51.751924655443375, "abnormal liver texture": 0.0006567106633583795, "liver texture changes": 0.0025812582471682337, "similar cardiac index": 0.012563383058859224, "cardiac index compared": 0.014984636312938959, "distinct circulatory derangement": 51.74784320424038, "hemodynamic features similar": 51.74910819124534, "augment cardiac output": 0.00875209715130436, "hospitalization or death": 0.017048704471076016, "versus without preserved": 0.007320403721021544, "outcome of death": 0.07110678362809926, "final multivariate models": 51.749802806984206, "80 % adherence": 0.029007077692532385, "co - morbidities": 51.815658256744186, "training in patients": 0.08258679203502996, "failure promotes restoration": 0.02663805394989175, "density lipoprotein functional": 51.75039098347479, "lipoprotein functional properties": 51.75032441310847, "effects via stimulation": 0.0034501821648388396, "mediated protective effects": 0.0030329677741385832, "respective molecular pathways": 0.0011565815617092243, "in healthy individuals": 0.054089825097545535, "significantly improved hdl": 0.004650829030721522, "improved hdl function": 0.005978014354979414, "mediated dilatation improvement": 51.750387695435116, "mediated vascular effects": 0.003392597637306083, "exerts beneficial effects": 51.750165508311056, "time of admission": 0.06831968505114977, "first research done": 0.0016723641655429248, "\u00b1 10.3 years": 51.754957096235046, "non - survivors": 0.0699682461819041, "\u00b1 11.07 years": 51.754957096235046, "85.9 % sensitivity": 51.775907315076495, "39.1 % specificity": 51.775655273417215, "optimal cutoff level": 51.74921743044878, "novel heart failure": 0.05539923660458549, "heart failure mice": 0.05607521863630317, "failure mice model": 0.03011556080893201, "mouse heart failure": 0.055202731318921616, "new therapeutic targets": 0.002262013525595987, "simple experimental procedures": 0.00112342500616226, "combining salt loading": 0.0007503838828222542, "showed significant decreases": 0.004989030094014803, "infusion mouse model": 0.003258046703950551, "predict heart failure": 0.05515090534612726, "various cardiovascular diseases": 0.003436136209970517, "cardiac troponin t": 51.75583123011371, "antihypertensive medication use": 51.750200143814524, "prevalent coronary heart": 51.777327325044254, "participants developed incident": 0.003163807834138553, "simpler laboratory report": 0.0010644385168152191, "laboratory report model": 0.0032600902117891455, "clinical characteristics results": 0.007374981165275629, "right ventricular support": 51.758599257740784, "chronic decompensated heart": 51.778852153496956, "decompensated heart failure": 51.802038257912756, "hybrid system consisting": 0.0010025533147009263, "requiring isolated lvad": 0.0012636243022996177, "required biventricular support": 51.749775350290506, "\u00b1 11.9 days": 51.752789194027656, "however biventricular dysfunction": 51.7514894846266, "assist device use": 0.005103272463996715, "using simulation models": 0.004385359722582403, "studies per outcome": 0.005774633806509938, "made policy recommendations": 0.0006826576099858532, "meet traditional cost": 0.0007655583917170749, "using historical data": 0.004537974335486903, "number of patients": 0.09399192394102332, "canadian data point": 0.0030122131199073966, "left heart twist": 0.03406145507075496, "improves cardiac output": 0.009668903537582596, "selected cardiac surgery": 0.010057696474368025, "cardiac surgery patients": 0.03776957879779576, "used speckle tracking": 51.75010253062446, "speckle tracking echocardiography": 103.4955884229642, "right ventricular pressure": 51.75936416882719, "ventricular pressure overload": 103.50487461583069, "inferior vena cava": 103.49467686433356, "pulmonary artery snared": 0.0033157471869699907, "ventricular midpapillary level": 103.50288062810401, "varying atrioventricular delay": 51.74783346698116, "regional circumferential strain": 51.748071539058834, "left ventricular base": 51.7600981601574, "mixed linear models": 0.002352997406213888, "free wall rs": 0.0009289627056754172, "open chest model": 0.0025271460495392235, "varying regional strain": 0.000983455751967472, "regional strain contributions": 0.0009239926692212409, "reflect postsystolic function": 51.75152446204053, "treatment for heart": 0.053569138093798416, "successful mitral valve": 51.750562317931525, "degenerative mitral regurgitation": 103.49692338091654, "mild mitral regurgitation": 103.49732640577946, "significant mitral stenosis": 103.4996164046535, "degenerative mitral valve": 51.7506041616206, "third heart sound": 0.028267634447904533, "underwent mitral valve": 51.75152088987275, "2 chordal ruptures": 51.75027704298742, "underwent triangular resection": 51.748663371357296, "postoperative echocardiography confirmed": 103.49596676220287, "preserved mitral valve": 51.753203416030104, "mitral valve area": 51.75066699389685, "filling flow volume": 0.004599414364906302, "\u00d7 velocity time": 51.749897063889975, "velocity time integral": 0.002654800274001652, "without major concerns": 0.002807983776149675, "limited mitral valve": 51.75113185811135, "coronary angiography revealed": 51.74995128472795, "diastolic mitral leaflet": 103.499321279057, "mitral leaflet motions": 51.74937775950503, "cardiac murmurs disappeared": 0.008757886869274811, "echocardiography 4 months": 51.75156668775908, "surgical ring implantation": 0.0017695367955209834, "reports demonstrating development": 0.001798711997789078, "following ring annuloplasty": 51.748096542152965, "surgical indications need": 0.0010425907352161739, "fixed ring size": 0.0007971932451222518, "requires careful evaluation": 0.0010368815294618495, "heart failure clinic": 0.05499805390886753, "failure clinic outpatients": 51.77443914169893, "most heart failure": 0.05547139867176566, "risk stratification models": 51.756404169524394, "available outpatient models": 0.002505296477380756, "collected clinical data": 0.00693701914685044, "quality improvement database": 0.004553404798033701, "reached primary outcome": 0.004054132529483945, "arbitrary start date": 0.00016362056055906478, "model included blood": 0.0053164607316901705, "included blood urea": 51.750359914620006, "blood urea nitrogen": 51.748677003262145, "concordance c statistics": 51.74798078406172, "demonstrated excellent risk": 0.008553011828035886, "excellent risk stratification": 51.75472946344624, "readily available data": 0.002567143137353913, "resources within health": 0.002933965530269371, "within health systems": 0.0032920406791495903, "important prognostic factor": 51.75097088779689, "composite end point": 0.004875740448210883, "uncontrolled hypertension identify": 0.0028301984912771144, "hypertension identify patients": 0.030832011789288252, "commonly used criterion": 0.002866846242161991, "used criterion standard": 0.0035519001982505134, "using spearman correlations": 0.0024272862496898993, "category among patients": 0.030006640593086786, "high internal consistency": 0.00286350890458233, "consistency among patients": 0.030070580143057028, "excellent prognostic ability": 51.74919821360588, "interleukin receptor family": 51.749535049251655, "receptor family member": 0.0022711960821577815, "affect sst2 concentrations": 0.0004351809192502682, "concentrations identify benefit": 0.0020722720503156414, "heart failure attributable": 0.054800731347064306, "ventricular systolic dysfunction": 103.50895715605652, "post hoc analysis": 0.004337201354516669, "baseline sst2 status": 0.003944056087191435, "daily equivalent dose": 0.0022887392762621873, "low sst2 titrated": 51.749752962718084, "lowest cardiovascular event": 0.0038591366771257565, "lowest cumulative hazard": 0.003755355066104819, "highest cardiovascular event": 0.003938851677924215, "highest cumulative hazard": 0.0038350700669032784, "intermediate odds ratios": 0.001827157698447393, "therapy exerted dose": 0.006520340262333024, "measurement identifies patients": 0.02886635332933879, "exerts positive inotropic": 103.49493601868826, "in adult mouse": 0.054074582078494096, "adult mouse ventricular": 51.75547462252061, "mouse ventricular myocytes": 103.50231962318759, "dependently increased sarcomere": 103.49870950514952, "protein kinase a": 0.020957213687766856, "soluble guanylate cyclase": 155.24196622468907, "left ventricular end": 51.7632594390889, "myocardial oxygen consumption": 51.751911737350156, "increasing ejection fraction": 0.012252905270750809, "maximal ventricular power": 103.50196651775289, "ventricular power index": 51.75706295497124, "in conscious dogs": 0.053363193116337554, "provided venoarterial dilation": 103.495124888834, "right heart filling": 0.031299925318311314, "heart filling pressures": 0.029211893967935654, "stroke volume index": 0.006239987996130854, "arterial pressure declined": 51.75170799647571, "enhance myocardial function": 51.75516314875959, "involved single parameters": 0.0012104823662925021, "standard echocardiographic measurements": 51.749188829573626, "underwent baseline echocardiography": 51.752080826152365, "\u226515 % reduction": 51.77727396532322, "months of follow": 0.0702464921221516, "lv reverse remodeling": 0.0019296111300695516, "diastolic dimension index": 51.75283263872414, "right ventricular end": 51.75993781450784, "diastolic area index": 51.75315383741282, "right atrial area": 51.75157790074422, "ventricular fractional area": 103.502235926171, "fractional area change": 51.749078690722996, "change \u226535 %": 51.77672005367636, "echocardiographic score allowed": 51.74984808556641, "score allowed prediction": 0.002354345698468032, "18 heart transplantations": 51.776089759025965, "lv assist device": 0.0027981319436660907, "assist device implantations": 51.75008617731942, "93 heart failure": 0.054848879026074, "heart failure admissions": 0.0550535668567675, "heart failure admission": 0.05576091711594448, "initial functional class": 0.005006733355305615, "undergo reverse remodeling": 0.002028279356085608, "predicts clinical outcomes": 0.009465705819924935, "symptomatic systolic heart": 103.52681054467276, "diagnosed systolic heart": 51.77966772663794, "previous spironolactone use": 51.75055948993877, "baseline serum creatinine": 103.49789101400134, "serum creatinine level": 103.49645731512076, "serum potassium level": 51.74932160786809, "incident systolic heart": 51.77952959542611, "growth factor blockade": 0.0022132503813700015, "adrenergic receptor blocker": 51.751160887531725, "receptor blocker therapy": 0.007896863193037566, "improve myocardial perfusion": 103.49947038724699, "induced myocardial infarction": 103.50212363051722, "heart failure rats": 0.05566544164275452, "week treatment period": 0.007071530973812079, "reduced cardiac diameters": 0.012726461330994138, "improved cardiac function": 0.014436741981637875, "increased cardiac angiogenesis": 51.76008435583948, "vivo coronary perfusion": 155.24410960263708, "reduced cardiac fibrosis": 51.760269977385704, "untreated failing hearts": 0.0014054391396492282, "act via activation": 0.0016461110480011742, "adenoviral vector encoding": 51.747439337767965, "histological analysis revealed": 51.751092869311805, "treated plus ad": 0.002256164378139346, "promotes cardiac angiogenesis": 51.75610091711779, "failure via activation": 0.028033688327330226, "emergency department volume": 0.003373810699748894, "influences patient outcomes": 0.008488275884859897, "925 ed visits": 0.0013190183152859195, "exhibited higher risk": 0.010095781074819276, "exhibited worse outcomes": 0.005474190668374573, "repeat ed visits": 0.0014076843843961063, "oxidase inhibition preserves": 51.74846060037355, "left ventricular systolic": 103.511047543248, "cardiac volume overload": 51.758942460935316, "decrease mitochondrial respiration": 103.49671410011258, "inhibition improves cardiomyocyte": 51.749376618119356, "improves cardiomyocyte bioenergetics": 103.49564497817038, "acf \u00b1 allopurinol": 103.49886092783443, "37 % increase": 0.030824708557236735, "lv ejection fraction": 0.01182721572440943, "maximal systolic elastance": 155.24630267153321, "isolated cardiomyocytes using": 51.75124174064588, "extracellular flux analyzer": 103.49478000296851, "hospitalizations in patients": 0.08163914213078058, "severe systolic heart": 51.78129206941499, "early transmitral blood": 51.750239502319445, "transmitral blood flow": 51.74998787897626, "blood flow velocity": 0.0033117630841161786, "diastolic mitral annulus": 155.24635437748765, "decompensated systolic heart": 103.5266063797074, "sided cardiac catheterization": 51.756050399175805, "transmitral flow velocities": 51.748751266160575, "mitral annulus velocities": 103.49646374440371, "\u00b1 8 %": 51.78053355444977, "negative predictive value": 0.0016321826751466474, "negative likelihood ratio": 0.004642653368120092, "detecting normal filling": 0.0019026132735128016, "normal filling pressures": 0.002002328967965001, "systolic pressure relationship": 51.754576162697475, "ventricular contractile function": 103.50633687949542, "derived pulmonary arterial": 51.75111050236456, "tricuspid annular plane": 103.49522068003374, "better disclosing prognosis": 0.001807826108838688, "natriuretic peptide assessment": 51.75089861244007, "downward regression line": 0.0011294024253000038, "regression line shift": 0.0011604450271643372, "improves prognostic resolution": 51.7496188322441, "bottleneck stent model": 51.7501956601223, "large animal model": 0.00306278087389761, "novel therapeutic approaches": 0.002375357832625795, "novel percutaneous one-": 51.74824280618401, "myocardial ischemia using": 103.50077886712951, "proximal circumflex artery": 103.49610664537963, "given antiarrhythmic medication": 51.74823649368555, "prevent sudden death": 0.004033045936660706, "fractional flow reserve": 51.74893227575821, "flow reserve measurements": 0.0017436855114397404, "positron emission tomography": 103.49462529371351, "emission tomography imaging": 51.747793465383495, "showed severe ischemia": 51.7513033609997, "complete coronary occlusion": 103.49656581494912, "significant collateral growth": 0.0036985674176993745, "competitive collateral growth": 0.0006769216816723047, "collateral growth patterns": 0.0007405980401700785, "model 4 wk": 51.75170960587947, "vessel disease model": 0.007298379954241605, "novel bottleneck stent": 51.74870218039578, "novel porcine model": 51.75033479290501, "reversible myocardial ischemia": 103.49860548556762, "new therapeutic approaches": 0.002274119282541017, "selective heart rate": 0.03209908369510635, "isolated heart rate": 0.03281124392534371, "ivabradine reduces afterload": 103.49544089047919, "pressure volume relation": 0.005409996238805432, "ivabradine 7.5 mg": 51.74881184527649, "total arterial compliance": 51.750213604327826, "ivabradine improves tac": 51.74891836257075, "preoperative serum albumin": 155.24314015804507, "serum albumin levels": 103.49814616012898, "investigate the association": 0.041460519615533604, "consecutive patients undergoing": 0.029568249958391704, "preoperative clinical characteristics": 51.753190887049584, "normal albumin concentration": 51.74883971858277, "normal albumin levels": 51.75129135974018, "albumin levels compared": 51.754080809788405, "decreasing albumin levels": 51.75039823851631, "aortic valve insufficiency": 0.0021932600144711598, "onset aortic insufficiency": 0.002090947350823452, "mechanical circulatory support": 0.0025436286847879777, "underwent aortic valve": 0.0033651966444070503, "aortic valve surgery": 0.0032991717056368693, "patients underwent lvad": 0.029376876109907482, "underwent lvad implantation": 0.0022426827323726844, "requiring surgical intervention": 0.0015575340553763439, "after medical therapy": 0.011192205377146316, "aortic valve procedures": 0.0027449525278298815, "bioprosthetic valve replacement": 51.74885885868734, "1 dacron patch": 0.0027048133112822785, "dacron patch closure": 0.00019312487626039793, "aortic valve repairs": 0.0021377418521412567, "patients underwent transcatheter": 51.77671596576657, "transcatheter aortic valve": 51.74943052341048, "aortic valve procedure": 0.0023398084113196898, "experienced significant improvement": 0.005258366871097405, "aortic valve oversewing": 51.74937947912957, "bioprosthetic aortic valve": 51.74943052341048, "restoring functional capacity": 0.004651958995768278, "various transcatheter approaches": 51.747978416060285, "less invasive alternatives": 0.0013987170697198391, "5 age groups": 0.005659119324055368, "youngest age group": 0.006823637141854965, "year mortality rates": 0.009602655658955203, "respective age categories": 0.0029021183955807157, "referent age group": 51.753812530222085, "beyond divergent etiology": 51.74769900976098, "younger patients exhibited": 0.029001335336426456, "higher hospitalization rates": 0.007845859625039215, "within cardiac rehabilitation": 0.010167368393690378, "\u00b1 11.4 years": 51.75500814051597, "functional capacity assessed": 0.00628175954978349, "nordic walking led": 0.000658789130209008, "higher functional capacity": 0.007287640502189862, "reported physical activity": 0.0019130910841496534, "\u00b1 118.5 minutes": 103.4990992800017, "\u00b1 125.6 minutes": 103.49915032428261, "increased right grip": 0.006622951508039298, "right grip strength": 0.0031272753471213604, "\u00b1 3.5 kg": 51.753295088993696, "\u00b1 3.1 kg": 51.75334902553342, "fewer depressive symptoms": 51.7491000765673, "peak aerobic capacity": 51.75096363872791, "improving functional capacity": 0.004996612534133858, "precapillary pulmonary hypertension": 51.75121627807154, "experiencing heart failure": 0.05474021384154899, "major right ventricle": 51.75157113405017, "right ventricle overload": 103.49814007569758, "decreased stroke volume": 0.004819841976087372, "arterial tonometry study": 103.50279827083634, "carries prognostic value": 51.749599889201036, "radial artery tonometry": 103.49605560804633, "artery tonometry variables": 51.749277169945564, "reconstructed aortic pressure": 0.003516331800216108, "aortic pressure curve": 0.003720240543458514, "73 % sensitivity": 0.028869749711896382, "89 % specificity": 51.77580366660381, "other prognostic factors": 51.751533145317254, "higher oxygen flow": 0.0047071474007176406, "documented prognostic factors": 51.75052341312427, "atrial myxoma complicated": 103.49619913050299, "cardiac benign tumors": 0.008558449398851774, "pulmonary arterial vasculature": 103.49768846855468, "pulmonary arteries treated": 0.003912444290190323, "right atrial mass": 51.75292251764421, "atrial mass removal": 51.75062584050548, "right atrium mass": 51.75154469712788, "left pulmonary artery": 0.008874583207542103, "right pulmonary artery": 0.005552958626488981, "surgical tactics included": 0.0022851504612620014, "hypothermic circulatory arrest": 51.74771743488789, "advanced chronic organ": 0.004566525841107359, "chronic organ failure": 0.029750060095377135, "chronic renal failure": 0.031691237826477786, "64 % men": 0.029042252568226, "median body mass": 0.004778242984450863, "intraclass correlation coefficient": 103.49523885084098, "error of measurement": 0.06622220889529057, "minimal detectable change": 0.0013673615704438914, "statistical improvement occurred": 0.0029767633245295745, "third trial added": 0.001996458156020337, "similar values found": 0.0032945117638419853, "daily clinical practice": 0.005568199158322735, "represents true change": 0.001355244754293126, "risk among patients": 0.03682372035381603, "rheumatoid arthritis starting": 103.49468685443796, "tumor necrosis factor": 51.748596273778034, "treat rheumatoid arthritis": 103.49476158375215, "- biological disease": 0.07333033757121027, "biological disease modifying": 0.005259006108804746, "modifying antirheumatic drug": 51.74768558315293, "propensity score decile": 0.0019518477450430733, "oral glucocorticoid dosage": 51.74738513545283, "similar baseline covariates": 51.75145545208221, "1\u22645 mg hr": 51.74815148410492, "current economic climate": 0.0011369812337352371, "within acute hospital": 0.006459160265118781, "acute hospital facilities": 0.005420617934625879, "specific health interventions": 0.003661716863490181, "structured exercise programme": 0.00619828168553962, "secondary outcome measures": 0.003768620459110205, "intervention post study": 0.00870440872897477, "overall significant improvements": 0.003922740168696712, "demonstrated significant improvements": 0.005222448163012057, "showing minor improvement": 0.001881008433517513, "participant satisfaction responses": 0.00044465843302641286, "body composition study": 0.008941330579171599, "adverse health outcomes": 0.008079940584258394, "\u00b1 3 years": 51.757270713241944, "- frail participants": 0.06958478792407245, "per sd decrease": 0.001983194506925563, "sub - groups": 0.07039489187968015, "activated neurohormonal systems": 51.74811523814641, "sympathetic nervous systems": 0.001329144689191645, "improved clinical outcomes": 0.01102811961167081, "various physiologic processes": 51.74776504366166, "receptor antagonist therapy": 51.75447573175456, "new therapeutic approach": 0.002240696985368348, "pathological heart disease": 0.03346772235696791, "mutant mice overexpressing": 51.74896930702581, "otherwise healthy heart": 0.02876780179473954, "healthy heart muscle": 0.029550467761688244, "heart muscle cells": 0.029973735753154228, "fetal gene program": 0.0016271663510455201, "specific antagomir evoked": 51.7482687983392, "spontaneous cardiac dysfunction": 0.012232388594108252, "bhlh transcription factor": 51.749005122232994, "postnatal mammalian myocardium": 51.74774663789464, "programs in heart": 0.08161241390801638, "enzyme inhibitors intolerance": 51.74886842567004, "beta receptor blockers": 0.004489442711065219, "negative inotropic effect": 51.74956446786365, "past decades several": 0.000522991714447532, "decades several studies": 0.002937996173004772, "blockers decrease mortality": 0.008506735526048463, "causes heart failure": 0.0549896325105153, "insulin receptor substrates": 51.750298031567525, "regulating cellular metabolism": 0.0007598432194811581, "causes myocardial insulin": 51.75196566433756, "myocardial insulin resistance": 51.75248417420036, "reduced ventricular mass": 51.760356319182534, "developed cardiac apoptosis": 51.757491600021154, "box class o-1": 0.0019282639846847265, "impaired cardiac metabolic": 51.756766010129574, "cardiac metabolic gene": 51.757224780726844, "metabolic gene expression": 51.75033883807738, "impaired cardiac energy": 0.0094008657023669, "cardiac energy metabolism": 0.009401918380854274, "energy metabolism gene": 0.0019107947480476294, "metabolism gene expression": 0.003050275046128567, "activated protein kinase": 0.0019820415738150865, "using neonatal rat": 0.0026796084464947665, "neonatal rat ventricular": 51.754677987819804, "rat ventricular cardiomyocytes": 103.50268082425137, "chronic insulin exposure": 0.0042180480445162295, "prevented insulin action": 0.0011228597524300403, "medications among outpatients": 51.749921156832116, "combined treatment measure": 0.0064879635642121885, "multivariable hierarchical regression": 51.74861426302564, "hierarchical regression models": 51.75011426684533, "randomly selected practices": 0.0010339910147796891, "level prescription rates": 0.003412863371616402, "adjusted median rate": 0.0066916355797009865, "receptor blockers therapy": 0.008003911171364425, "care for patients": 0.0510285780856826, "adjuvant setting improves": 51.74878366806108, "setting improves outcomes": 0.0061815652762466184, "iii breast cancer": 0.000570144777742391, "included descriptive statistics": 0.002074421919490262, "among trastuzumab users": 51.75014684857396, "weekly trastuzumab administration": 51.748164168320365, "older breast cancer": 0.001913320846906732, "further studies need": 0.003566668745855671, "current dietary recommendations": 0.001772128887421514, "- hf populations": 0.06836864591640271, "therefore evaluated associations": 0.0020106792063168265, "mortality among postmenopausal": 51.75547588087112, "among postmenopausal women": 51.74959669424481, "last participant contact": -0.00013110142992379421, "calculate hazard ratios": 0.0040754966294129814, "dash diet score": 0.002859654290436998, "diet score components": 0.0030525134008018776, "whole grain intake": 0.00012207164216326933, "higher dash diet": 0.0038979048891155024, "modestly lower mortality": 0.009222436783283376, "data provide support": 0.004703956039573671, "dietary recommendations developed": 0.002442037846161627, "potentially promising biomarker": 51.7484304193151, "term clinical outcomes": 0.011114843780893635, "evaluable plasma samples": 51.74844960803995, "assess the relationship": 0.04173197962532545, "in univariable analysis": 51.803394466386166, "in multivariable models": 0.05518891629771979, "significantly affect reclassification": 0.003375199499660292, "criteria cardiac transplantation": 51.75716349629339, "undergoing isolated heart": 0.029674649434769655, "isolated heart transplant": 0.02993402077027041, "cardiac transplant recipients": 0.00967813876651116, "identify clinical variables": 0.006031773431142754, "clinical variables contributing": 0.005334625931322802, "additional risk associated": 0.01355017368680813, "underwent heart transplant": 0.030396165696255036, "underwent standard criteria": 0.002705477296789593, "cardiac transplant survival": 0.011256552022182514, "included listing criteria": 0.002430625352772977, "- transplant mortality": 0.07535825105317928, "heart failure therapy": 0.05913151314576035, "- transplant morbidity": 0.06965196190131295, "heart failure readmission": 51.80305894382353, "failure readmission quality": 51.777439994255374, "readmission quality improvement": 51.75282003869206, "hospital quality improvement": 0.006449514981024959, "retrospective chart review": 0.0017312967894977651, "heart failure discharges": 0.05469890682340589, "heart failure nurse": 0.05484677367149953, "failure nurse practitioner": 0.026692779997091007, "rate for patients": 0.05185541634620297, "extracellular matrix accumulation": 103.49498391431706, "extracellular matrix using": 103.49725885549604, "resonance t1 mapping": 0.0009642591987846673, "confirmatory diagnostic tests": 51.748338816692204, "imaging including t1": 0.0016030772048165442, "including t1 mapping": 0.0015501968172260444, "invasive hemodynamic assessments": 51.74805026667303, "resonance t1 time": 0.002353837053055338, "left ventricular biopsies": 103.50742567899356, "pulmonary arterial coupling": 51.75096108254991, "right ventricular ejection": 51.762730208774954, "present preliminary study": 0.007945747481790217, "abnormal cardiac t2": 0.008915734180814717, "values determined changes": 0.0033623694895735163, "remove heart iron": 0.02871991553432731, "current guidelines recommend": 0.0016313417073571396, "recommend cardiac resynchronization": 51.75660654038729, "severe systolic dysfunction": 51.756658095189934, "blinded core laboratory": 0.0005301543608372966, "30 % subgroup": 51.77778701129614, "end systolic volume": 51.756870139092946, "systolic volume index": 51.756388020251734, "\u00b1 17.6 ml": 51.75208170977682, "\u00b1 42.4 g": 51.75182230805556, "time to death": 0.03392321006365836, "reverse remodeling parameters": 0.002437655018037083, "produced reverse remodeling": 0.0022545392379908187, "similar clinical benefit": 0.006970233251535975, "clinical benefit compared": 0.00939148650561571, "myocardial titin hypophosphorylation": 155.24579249592864, "rat metabolic risk": 51.75490152706243, "metabolic risk model": 51.756893796353054, "important metabolic risk": 51.75579849115115, "metabolic risk factors": 51.75625695482151, "myocardial diastolic dysfunction": 103.5043705360898, "ejection fraction development": 0.01338887581658885, "collagen cross -": 51.81584533280335, "fpassive)-sarcomere length relations": 0.000732975683312001, "small muscle strips": 0.0012543822163940805, "increased lung weight": 0.0049205898324543905, "left ventricular dd": 51.76003554592448, "high muscle strip": 0.0034917287921347475, "muscle strip stiffness": 51.74840117460815, "elastic n2bus segment": 51.74742801976167, "rats developed heart": 0.030813262895345583, "week time span": 0.002204879496356628, "left ventricular mechanics": 51.760084485716945, "predicting cv events": 0.0029875837963101335, "observational cohort study": 0.009394384446364607, "index beat method": 0.0032011528821620045, "proportional hazards analyses": 0.0017295846925695667, "\u00b1 10 months": 51.75426137597448, "in direct comparison": 0.05329241296286974, "systolic mitral annulus": 155.24737417863628, "containing chronic heart": 0.03160462650053933, "prior stroke score": 0.0030975647449111134, "additional prognostic benefit": 51.74985691236113, "echocardiographic systolic parameters": 103.49967572126805, "scale clinical trial": 0.006642342279631913, "receiving implantable cardioverter": 103.49751409179663, "refractory congestive heart": 103.52451550439764, "diuretic resistant volume": 51.750376938089104, "resistant volume overload": 51.7505810856879, "provide potential benefit": 0.002823248330817805, "clinical status hospitalizations": 0.00648363399004122, "transplant ineligible patients": 0.02912309297083704, "ineligible patients receiving": 0.028948419365699467, "clinical data reviewed": 0.007152756572733233, "- pd initiation": 0.06827498311521026, "\u00b1 6.0 %": 51.77978566441468, "right ventricular dysfunction": 51.76028419643318, "average weight loss": 0.0013762256917686248, "admissions per patient": 0.005076261564946277, "reduced average length": 0.005200383649969199, "\u00b1 2.3 days": 51.75283865929084, "objective criteriabased institution": 51.74782346135322, "diuretic refractory severe": 103.49731545791595, "demonstrated favorable outcomes": 0.00651054513120118, "improved clinical status": 0.007685879423299286, "treatable pdrelated complications": 51.747949196055735, "stage congestive heart": 51.777772252339275, "potentially higher risks": 0.003450228195332981, "bundle branch morphology": 51.748047112114655, "angiotensin ii receptor": 51.75111492608595, "ii receptor blocker": 0.003413474890949974, "receptor blocker use": 0.005718615411280599, "observed among dialysis": 0.003487275900589423, "among dialysis patients": 0.030534150304827708, "\u00b1 9.2 %": 103.52697320024643, "derived absolute improvements": 0.001708526816259626, "year event rates": 0.0039983921301702426, "superior reverse remodeling": 0.0020787964297265013, "\u00b1 9.5 %": 51.779683839890936, "9.5 % increase": 0.03032746327774071, "certain dialysis patients": 0.028699807161121443, "demonstrated compelling improvement": 0.003388572737254305, "worsened echocardiographic outcomes": 51.752942922568785, "sodium dash diet": 0.0015692603396597722, "improves diastolic function": 51.75522462252429, "hypertensive heart failure": 51.80234450015064, "dietary sodium restriction": 0.0010169042041394318, "restricted dietary approaches": 0.001008742478946808, "stop hypertension diet": 0.0030279533116719494, "central blood pressure": 0.004259943058650722, "via radial arterial": 103.4966772566467, "radial arterial tonometry": 155.24324211029892, "parametrized diastolic filling": 103.498036879854, "diastolic filling formalism": 103.49803687985403, "mitral inflow velocity": 51.74978762677459, "previously published techniques": 0.00045042529543384195, "- post comparisons": 0.06953164573069032, "brachial systolic pressure": 103.50110342042032, "diastolic function improved": 51.75597021052991, "\u00b1 8.1 g": 51.751821781716224, "\u00b1 37 g": 51.75231850065647, "restricted dash diet": 0.0013616776447065468, "humanized male mice": 51.7494015436285, "recent clinical studies": 0.007761368812458214, "connected elevated resistin": 51.74895388595672, "elevated resistin levels": 51.75151893106697, "humanized mouse model": 51.750138287619336, "model lacking murine": 51.74973181376646, "lacking murine resistin": 103.49543877557277, "stimulated resistin levels": 51.75075471295059, "resistin levels similar": 51.75191473452112, "- fold induction": 0.068676482796, "expressing human resistin": 51.74913298492636, "cardiac mrna levels": 0.011059027745030179, "cell adhesion genes": 51.748594285620015, "showed dramatic induction": 0.001980283073220333, "also examined resistin": 51.74984814858128, "examined resistin levels": 51.751360839685134, "treated breast cancer": 0.0024427101284762616, "women undergoing anthracycline": 51.7487429167541, "efficacy and safety": 0.07331765171743175, "maintenance of sinus": 51.813095631737134, "free success rates": 0.002731325300373231, "pharmaceutically assisted success": 51.74763060438139, "assisted success rate": 0.004137935651577049, "major complications occurred": 0.0028453729302728107, "lv systolic indices": 51.751266424876746, "early transmitral flow": 51.75010985386935, "patients maintaining sinus": 51.77568478434477, "maintaining sinus rhythm": 51.74854822244137, "larger randomized control": 0.004581724136643022, "randomized control studies": 0.006830684250537966, "ameliorates mitochondrial dysfunction": 103.4993201646263, "- neoplastic agent": 51.81570746893034, "mitochondrial dysfunction induced": 51.75422259239265, "without doxorubicin treatment": 51.75477358093583, "caspase 3 expression": 51.751225229339575, "oxidative stress markers": 51.74875242908727, "mitochondrial oxidative stress": 103.49665440338589, "also preserved phosphocreatine": 51.75148507367551, "restoring mitochondrial oxidative": 103.49605430869228, "cardioprotection via inhibition": 51.749184054398256, "apoptotic signaling pathway": 51.74876713529959, "mitochondrial ultrastructural changes": 103.49823353136782, "solid ehrlich carcinoma": 8.630015620671786e-05, "changes without affecting": 0.004044504848378756, "isolated coronary artery": 51.75105900811642, "heart failure \u226490": 51.80193617021942, "failure \u226490 days": 51.77499953818719, "logistic regression models": 0.0029790911426507017, "developed acute kidney": 0.005562134534780661, "enormous clinical burden": 0.004861322863654783, "atheromatous coronary disease": 103.50106524425956, "paediatric cardiac transplants": 0.00866185380859516, "congenital heart lesions": 103.52308660054088, "poor myocardial function": 51.75543254761885, "poorly contracting ventricles": 0.0002988969388017144, "paediatric heart failure": 0.05474968793464112, "heart failure concern": 0.05466811612754689, "versus dilated cardiomyopathy": 103.49905728007485, "new onset heart": 0.030026888600506396, "anthracycline treated survivors": 51.74986256814405, "childhood malignant disease": 0.004999591367938106, "certain stimuli mediate": 0.00023915988428849892, "specific signalling pathways": 0.0018466123146536112, "erk1/2 signalling pathway": 0.0009163781612531548, "targeting specific effector": 0.0013722470222186692, "specific effector molecules": 0.0010296927557290228, "erk1/2 scaffold proteins": 51.7483587749814, "therapeutic strategies capable": 0.002368155045853468, "hypertensive cardiomyiopathy based": 103.49657969236054, "inducible myocardial ischemia": 155.2456904082353, "normal coronary arteries": 51.7500680324798, "typical amyloidotic pattern": 51.747519056087334, "important prognostic indicator": 51.7498102674146, "weak grip strength": 0.0008776949576142974, "unintentional weight loss": 0.0010878836233469275, "age 71 \u00b1": 51.754190584275094, "61 % male": 0.02899811433926055, "% intermediate frail": 0.02862086608586186, "intermediate frail according": 0.0009074172576987515, "0.1 unit increase": 0.002436724993485937, "% increased risk": 0.03909644170086034, "measures predicted death": 0.0048542900324766705, "equally predict mortality": 0.006959949502970968, "heart failure trials": 0.056375277779969125, "therapeutics including calcium": 51.7485867233978, "recent studies including": 0.004329483094351842, "selecting appropriate end": 0.003915316022188793, "appropriate end points": 0.0041386610253926984, "failure in patients": 0.10752183194933357, "risk of developing": 0.07243864504800875, "developing heart failure": 0.05482203586592158, "clinical care delivery": 0.007674363416792687, "produce test results": 0.0031160541362745043, "community outpatient settings": 0.0007332429684560012, "designed clinical trials": 0.006563997011716402, "take full advantage": -5.1125184057678e-05, "faster turnaround times": 0.00017310398619592578, "measuring heart failure": 0.05479230992950455, "heart failure care": 0.05761666322909114, "operationalized hospital quality": 51.75191364039122, "expected future expansion": 0.0007303107514480653, "inhibition halts heart": 51.7765119800153, "halts heart failure": 51.80193617021942, "involves cardiac hypertrophy": 51.75701162634165, "family bromodomain proteins": 51.748462927923576, "lysine reader proteins": 51.748351143937924, "signal transduction cascade": 51.747681658677735, "neurohormonally induced heart": 51.77768276783267, "induced heart disease": 0.03519987309710004, "pathological gene induction": 0.0016785117621056981, "gene expression profiling": 0.0025898551026153974, "in vivo experiments": 51.80066806742053, "several pathological changes": 0.003188196056745288, "including cardiac hypertrophy": 51.75801640676559, "systemic blood pressure": 0.004291523224902864, "detailed transcriptional analysis": 51.75047066746594, "pathological cardiac gene": 0.009884654022487675, "cardiac gene expression": 0.010999116597708164, "gene expression programme": 0.0027516570129495982, "further molecular analysis": 0.004397005083669785, "molecular analysis revealed": 0.004262613051728039, "mediated signal transduction": 51.74829465907412, "activating transcription factor": 51.74926007612555, "transcription factor networks": 51.74913772790828, "including nuclear factor": 0.002487974190130005, "activated t cells": 0.0012454552385632491, "promoting transcriptional pause": 51.7474803816146, "transcriptional pause release": 51.74736723011469, "implicates epigenetic readers": 103.49478762456467, "cardiac gene control": 0.012252938340885583, "dependent signal transduction": 51.74854218778655, "abrogate pathological gene": 51.74871397177159, "pathological gene expression": 0.002998711373027102, "breathing pulse sequence": 0.0006022625481957259, "quantify myocardial t1": 51.75116457312421, "myocardial t1 changes": 51.75318961896306, "induce heart failure": 0.05474837208658912, "t mri scanner": 8.261579239582351e-05, "chelate contrast agent": 51.7478282035994, "heart failure scans": 0.054697064636132955, "heart failure myocardial": 51.805456189668774, "failure myocardial tissue": 51.77775998424194, "left ventricular tissue": 51.76054358981245, "trichrome blue histologic": 103.49460739823729, "blue histologic analysis": 51.75045093067083, "heart failure t1": 0.05464812484367276, "\u00b1 94 ms": 103.49916428736469, "contrast agent administration": 0.0009153359014520082, "\u00b1 171 ms": 155.24635313817555, "myocardial collagen compared": 103.50218649722262, "healthy control animals": 0.0037997980236994214, "diffuse myocardial changes": 51.75324040094279, "myocardial changes associated": 51.759624622713936, "myocardial delayed enhancement": 51.751105119579805, "delayed enhancement imaging": 0.0007532718004424597, "significant myocardial fibrosis": 103.50145242123494, "induced pulmonary artery": 0.005404394068431115, "pulmonary artery systolic": 51.754225918249844, "artery systolic pressure": 51.75493758671546, "diagnosed pulmonary arterial": 51.75085190317854, "thromboembolic pulmonary hypertension": 51.7512673206155, "right ventricular pump": 51.757321931938975, "ventricular pump function": 51.759197477450215, "targeted pulmonary arterial": 51.750689311897446, "arterial hypertension medication": 51.75095636806354, "including stress echocardiography": 51.75005391167275, "\u00b1 1.8 years": 51.75520836141224, "factors predicting survival": 0.003892862873641291, "minute walking distance": 0.0011494786891352584, "year survival rates": 0.00516434244343863, "remained independent prognostic": 51.75008188313108, "independent prognostic markers": 51.74989827310751, "preserved systolic function": 51.75818286958287, "interesting therapeutic concepts": 0.0012353811176103989, "alone diagnostic devices": 0.002381118177627474, "commoner among women": 51.74959669424481, "poses significant challenges": 0.003158454362186083, "regulates cardiac sodium": 0.008966785408608688, "cardiac sodium current": 0.009787799649259094, "systolic human heart": 51.78029927321433, "alternative mrna splicing": 51.74767428129026, "generating variants encoding": 0.0006022521293219939, "human induced pluripotent": 51.75056154509386, "induced pluripotent stem": 51.749574291881714, "pluripotent stem cell": 51.74818306777375, "protein kinase r": 0.002031239325618357, "exogenous variants induced": 51.74988317102268, "receptor potential cation": 51.75058233502366, "potential cation channel": 51.748986450855504, "cation channel m7": 51.747886055553735, "kv4.3 mrna levels": 0.0026003001183717185, "mrna levels resulting": 0.0029441763011109857, "multiple cardiac genes": 0.009293278614607854, "normal cardiac function": 0.013667995152899959, "receives little attention": 0.0005027534244067557, "requires diagnostic procedures": 0.0019571212734719916, "chronic pulmonary arterial": 51.75365819429199, "acute pulmonary embolism": 51.752794019050356, "examine clinical circumstances": 0.005213590082457547, "clinical circumstances common": 0.006140994778660865, "pulmonary embolism represent": 51.749609442602946, "particularly high mortality": 0.00930618136705752, "possibly affect outcomes": 0.00515532238160335, "data describing trends": 0.0025650751019489194, "evaluated temporal trends": 0.001820458678388609, "characteristics yielded hazard": 0.004278563769661034, "yielded hazard ratios": 0.004076022968426141, "requires new prevention": 0.0013881365966484352, "new prevention strategies": 0.0021162650250599784, "versus selective beta": 0.003916358315095676, "nonselective \u03b2 -": 103.56514739131723, "selective \u03b2 -": 51.81790775939494, "- blocker metoprolol": 51.81770148691799, "various serum factors": 51.74964350204901, "label crossover study": 0.0070849538765145065, "masked outcome assessments": 0.0024822272075083157, "secondary outcomes included": 0.006762459437290066, "outcomes included markers": 0.006979505790660373, "157 % \u00b1": 51.77968489256952, "\u00b1 13 %": 51.78003585205661, "receptor haplotype status": 51.750978772361734, "often contextual factors": 0.0024667397612428256, "competing priorities impact": 0.0015507200087844237, "priorities impact prescribing": 0.0016128165259370925, "performance measurement systems": 0.002020207110405168, "health care systems": 0.005153896004781084, "primary care clinicians": 0.004831981388076802, "identified biomedical reasons": 0.002485216579219457, "reasons for nonprescribing": 51.7679248058262, "clinician interviews identified": 0.0017417235789978138, "reasons per patient": 0.005248565828037698, "common contextual reasons": 0.002463616975046853, "prevents ventricular dysfunction": 51.75809697572751, "elevated sympathetic activity": 0.0029272432653444334, "reduced parasympathetic control": 51.75463785647943, "experimental evidence suggests": 0.0022163019043095955, "acetylcholinesterase inhibitor pyridostigmine": 103.49529015829154, "following myocardial infarction": 103.50029200330926, "cardiac sympathovagal balance": 51.756078810966514, "tachycardic response caused": 51.74885933614533, "bradycardic response caused": 51.74885933614533, "basal heart rate": 51.779440801573784, "reduced sympathetic control": 0.007807039148283377, "growth factor protein": 0.003022637975031886, "suggesting myocardial angiogenesis": 103.498598381733, "volume conductance catheter": 51.7502793286192, "conductance catheter system": 51.748507130876895, "higher stroke volume": 0.006234142422259436, "coronary artery ligation": 103.49753543552758, "reduced sympathetic tone": 0.005484528775875089, "attenuating cardiac remodeling": 51.75717544581276, "prolonged electromechanical delay": 51.747885565676526, "branch block type": 0.0028331588260010624, "altered ventricular structure": 51.75552433709761, "reduced wall stiffness": 51.75225009072571, "local myocyte depolarization": 103.49470366518028, "myofiber shortening onset": 51.749174869438534, "dyssynchronous failing heart": 51.776397876842836, "induced remodeling aspects": 0.003959864114431169, "constructed additional models": 0.002320364631839042, "four remodeling aspects": 0.002036658312569232, "branch block electrical": 0.000781426470123766, "block electrical activation": 0.001245491710467647, "electrical activation sequence": 0.0011599888565445658, "slows myofiber shortening": 103.4952901487394, "myofiber shortening velocity": 51.74876716308455, "activated lateral wall": 0.0008966457132801327, "myofiber dynamics delay": 51.74793371248965, "thus giving rise": 0.0004483136409807694, "right ventricular function": 51.76092850455483, "previous studies investigating": 0.002611510253627349, "abnormal body composition": 0.0024520435268429487, "underwent prospective assessment": 0.0028906792948533437, "circulatory assist device": 0.003104126643355556, "lower body mass": 0.005851777048790434, "lower fat mass": 0.004965688991813152, "fat mass index": 0.005109005351603771, "greater antecedent weight": 0.0013657042730961392, "antecedent weight loss": 0.0011386647346059067, "body mass ratio": 0.007463428443621106, "increased body mass": 0.007335689202496111, "lower event rate": 0.007107555200747698, "higher fat mass": 0.005103159777732354, "free mass index": 0.004894299131027592, "additive adverse impact": 0.003247407078890151, "diastolic filling time": 51.75254174899068, "controlling heart rate": 0.03214775858311342, "ivabradine 5 mg": 51.74971966835085, "demonstrated significant improvement": 0.006393902029718602, "\u00b1 1.8 mets": 51.75177284192227, "\u00b1 1.9 mets": 51.75151973455782, "\u00b1 6.1 ml": 51.752081446607136, "\u00b1 3.3 ml": 51.75208065709824, "ratio of peak": 0.07129311850199094, "velocity to peak": 0.031102271833960082, "corrected chronotropic response": 51.748601243128206, "ivabradine increased exercise": 51.75787176130632, "increased exercise capacity": 0.011671551689705108, "filling pressure response": 0.004670880577560882, "therapeutic treatments targeting": 0.0019670704529600783, "targeting abnormal exercise": 0.006738425047814746, "abnormal exercise hemodynamic": 51.753991215415425, "exercise hemodynamic status": 51.754877911263804, "validated clinical tool": 0.0051612603989726865, "undergo coronary angiography": 51.7494277511081, "undergone coronary angiography": 51.74942722476932, "% diameter stenosis": 51.77606202954084, "anterior descending artery": 51.74891911302166, "defined prediction rule": 0.002047855404882553, "separate cohort recruited": 0.00246940314827451, "electrocardiographic q waves": 51.74737618684367, "nondiabetes risk factors": 51.75574655109094, "independent predictor identified": 0.002783530825867251, "prospective validation cohort": 0.0029534752463828253, "98 % sensitivity": 0.028668472662749488, "18 % specificity": 51.77620195577288, "100 % sensitivity": 0.029205681171885767, "simple clinical prediction": 0.0054577437621780005, "accurately identify patients": 0.0289894380570883, "potentially significant cost": 0.004247355204848715, "significant cost savings": 0.0037440656912071553, "japanese heart failure": 0.05464812484367276, "type 2 receptor": 0.007378543626744865, "2 receptor antagonist": 51.752930822254086, "optimal diuretic therapy": 51.752636242955944, "serum sodium levels": 51.750857069021905, "newly introduced drug": 0.0006614289544942082, "relieve congestive symptoms": 51.75013275800279, "adverse neurohormonal activation": 51.749782943541646, "accurate risk stratification": 51.754637904220246, "associated treatment strategies": 0.013008363383428923, "human failing hearts": 0.0023876921335810436, "diminished cyclic adenosine": 51.74754142632979, "cyclic adenosine monophosphate": 103.49478000557396, "augmented cyclic guanosine": 51.74754247813979, "cyclic guanosine monophosphate": 103.49472896129305, "negative cross talk": 0.0005577700439095953, "fluorescence resonance energy": 51.7482822725955, "resonance energy transfer": 0.0011276223988832686, "video edge detection": 0.00029861112577328616, "stimulation via catecholamine": 51.74867187880716, "via catecholamine infusions": 103.49540137016837, "camp hydrolytic activity": 51.748484730282954, "blunted cardiac \u03b2": 51.75819543465516, "cardiac \u03b2 -": 51.826267029287244, "in diseased cardiomyocytes": 51.801231321150915, "via nitric oxide": 51.748265405825194, "nitric oxide donors": 51.7475398473122, "partially restored \u03b2": 51.750135838185564, "healthy cardiomyocytes reduced": 51.75275387619227, "inotropic effect following": 51.74958759582862, "following acute \u03b2": 51.753357216089114, "affecting basal contractility": 103.4950802096779, "induced hypertrophic responses": 51.74977872696371, "important defense mechanism": 0.0018943573072879823, "antagonizing excessive \u03b2": 51.749784330973874, "excessive \u03b2 -": 51.81785566243629, "activating myocardial pde2": 51.75106301871766, "antiadrenergic therapeutic strategy": 51.74888202714669, "eplerenone in patients": 51.82862121451616, "receiving optimal therapy": 0.005734385736816677, "- specified analysis": 0.07135446483348268, "major safety measures": 0.0035944657478650037, "primary composite endpoint": 0.002730060603896778, "meeting specific inclusion": 0.0013017238845315783, "treatment group effects": 0.011477128857478917, "linear mixed models": 0.002352997406213888, "mixed models according": 0.0024987118900673794, "effect of exercise": 0.07314146684824549, "control vs. rate": 0.008100887509721166, "similar efficacy outcomes": 0.006914367784582735, "2 treatment strategies": 0.009511838434173669, "health care expenditures": 0.004884234095662699, "control treatment strategies": 0.009399966352936011, "trial resource utilization": 0.002184636474016676, "\u00b1 9 years": 51.75530884521622, "86 % male": 0.028999956524917457, "26 % \u00b1": 51.780057694802785, "fewer cardiac procedures": 0.009506108979852327, "lower costs related": 0.004662670780153763, "cardiac arrhythmia devices": 0.009810404906416654, "cost per patient": 0.0052798434199617635, "therapeutic strategy used": 0.004314799008343507, "overall financial burden": 0.0005093515822544223, "skeletal muscle sarcomere": 51.74845669277008, "muscle sarcomere structure": 51.748893396269175, "skm mitochondrial structure": 51.74915323838276, "improved mitochondrial structure": 51.75091666952633, "maximum oxygen consumption": 0.0011812872718086325, "western blot analysis": 0.0032334040699244023, "report severe perturbations": 51.75007759157334, "associated protein complex": 0.008180493302400983, "- ordinated fashion": 0.06818893919455582, "reach statistical significance": 0.0005409436742450082, "initial results warrant": 0.0020507055689453504, "improving muscle function": 0.005522396383222345, "versus biomedical treatment": 0.008663753576169452, "showed significant improvement": 0.006507218529555417, "most adverse events": 0.005033692702270975, "adverse events observed": 0.005266657689262971, "without special treatment": 0.007008805729542009, "systemic adverse events": 0.004513518708660633, "adverse events evaluation": 0.004665846411711073, "apparently healthy volunteers": 0.0006074920425938249, "key biosynthetic enzymes": 51.747771362518996, "lower median activities": 0.004185206596771107, "newly diagnosed patients": 0.02879296746676396, "cardiopulmonary exercise variables": 0.007010715969473736, "widely accepted peak": 0.0018379442359372149, "accepted peak oxygen": 0.002461450550416649, "exercise oscillatory ventilation": 51.75322769911189, "different mechanisms underlie": 0.0010057785711555477, "different pathophysiological origin": 51.74798231745518, "heart transplant recipients": 0.02942366045465799, "orthotopic heart transplantation": 51.77625786772613, "including intravenous inotropes": 51.748740640538614, "inflammatory abdominal problems": 0.000822969439411788, "abdominal problems occurred": 0.001242553074986019, "consultation and/or operation": 0.00081640101847557, "patients undergoing oht": 0.028761895374687877, "with similar incidence": 0.048520830231107835, "refractory right heart": 51.77813758504942, "posterior wall infarction": 103.4970051039192, "cardiac catheterization showed": 51.75763522591095, "right coronary artery": 51.75258642785199, "percutaneous coronary revascularization": 155.24390544114527, "hemodynamically stable situation": 51.74839036334233, "intensive care unit": 0.0032866345168617995, "therapy refractory cardiogenic": 103.49946781940562, "extra corporeal membrane": 51.74771347869974, "corporeal membrane oxygenation": 103.49518833637319, "emergency cardiac catheterization": 51.75648502861138, "extracorporeal life support": 51.75117917638326, "ischemic right heart": 51.77910717893411, "successful reperfusion therapy": 51.752086624627196, "early research focused": 0.002190472873575051, "- diastolic abnormalities": 51.81857263201905, "careful clinical evaluation": 0.00517835850054695, "invasive haemodynamic assessment": 51.748600598198436, "in this review": 0.05820509200437224, "novel treatment strategies": 0.007324471393473431, "linked administrative health": 0.002140382598394587, "administrative health data": 0.003984024961208018, "controlled feasibility study": 0.007591673249056478, "without intramuscular testosterone": 51.74921093717057, "intramuscular testosterone supplementation": 103.4950338928931, "collected preliminary data": 0.0025553430825333012, "age 67.2 years": 51.753245231886055, "mean \u00b1 sd": 51.753147156510416, "\u00b1 sd testosterone": 51.751877552626034, "sd testosterone levels": 0.003007057979056742, "\u00b1 2.6 nmol": 103.49880672725564, "incremental shuttle walk": 0.0005714615009883264, "100 % compliance": 0.02919936511259423, "group showed improvements": 0.006288524113442672, "elderly male patients": 0.029030783305490804, "peripheral muscles improves": 0.0016708616197563387, "improves endothelial function": 51.753132945782156, "impaired systolic function": 51.75573541393152, "fraction 63 %": 0.03412185040118089, "63 % \u00b1": 51.77978171687364, "rated depression scores": 0.0008855717436937285, "mediated dilatation diameter": 51.74886819115152, "toward lower mitral": 51.751849394551016, "lower mitral e": 51.75192910442195, "also improves exercise": 0.007994323908887525, "growth factor beta": 0.0027230583122107403, "improve cardiac functions": 0.009772228339099884, "derived progenitor cells": 0.0018203022808113006, "cardiac explant c": 51.756455825560806, "descending coronary artery": 51.75039894397672, "coronary artery occlusion": 103.49779064824753, "developed infarcted animals": 51.74952275764147, "left ventricle end": 51.75683610873939, "atrial explants produced": 103.49648301389396, "\u03b2 receptor type": 51.75412625304359, "differentiation toward cardiomyocyte": 51.74777005816472, "kit+ cell phenotype": 51.748648733737795, "optimizing cardiac progenitor": 0.00871289548406505, "cardiac progenitor function": 0.012876959885418846, "cell expansion protocols": 0.001036049477732521, "study breathing control": 0.009971812323927742, "following cardiac arrest": 0.008940968373272316, "pulseless ventricular fibrillation": 155.24997169503337, "newly implanted cardioverter": 51.74895467547799, "class iii heart": 0.03012489083865534, "iii heart failure": 0.05464812484367276, "permanent periodic breathing": 0.00028758066430050047, "final data analysis": 0.005403270107549981, "cerebral blood flow": 0.0025959063252188556, "primary oscillations originating": 51.74909991862674, "central pattern generator": 0.0004651708856278874, "treating heart failure": 0.0548465105022812, "much work remains": 0.00030532504591515667, "including better tools": 0.00196290200451684, "increasing evidence points": 0.0023780741976303084, "different gastrointestinal regions": 0.0008894971251697339, "disturbed intestinal barrier": 0.0002470648848998681, "chronic inflammatory state": 0.003846543312422128, "particularly poor prognosis": 0.0018868279749931025, "- inflammatory effects": 0.07067255773402864, "heart failure research": 0.05520427272818114, "stable coronary artery": 51.751155016874435, "ventricular wall stress": 51.75561614729233, "providing prognostic information": 51.74867172114763, "unfavourable clinical outcome": 0.006859955733417215, "unilateral renal denervation": 51.74943024393217, "renal denervation improves": 51.75034652397916, "improves autonomic balance": 0.0017069105300089485, "increased sympathetic tone": 0.005349947168396945, "sympathetic tone resulting": 0.0016114532340118014, "protective mechanisms remain": 0.0010100464772576576, "unilateral renal dnx": 0.002091154275516035, "present study used": 0.01046949490632601, "white rabbits undergoing": 0.0009224137742824276, "undergoing renal dnx": 0.0026483733399123807, "four treatment groups": 0.007856971753128605, "examined several markers": 0.0017171756519462813, "several markers indicative": 0.0011610379147200202, "time domain heart": 0.03014134891305798, "domain heart rate": 0.032143811046575814, "power spectral analysis": 0.0031791747353633114, "spectral analysis indicated": 0.00368014702880557, "heart rate response": 0.033263620751204814, "cardiac sympathetic tone": 0.009726304677930992, "cardiac vagal tone": 51.75640399958767, "suggest renal dnx": 0.0027335974058720026, "renal dnx improves": 0.003007434322504079, "chronic systolic heart": 51.7824740177514, "randomized trial involving": 0.0036095520226031887, "left ventricular dyssynchrony": 103.50737463558113, "patients underwent device": 0.030811568082615898, "underwent device implantation": 0.003677374705081102, "primary efficacy outcome": 0.004807334799780397, "safety monitoring board": 0.0015389768301580765, "at study closure": 0.011365403913543794, "primary outcome occurred": 0.004845469909141871, "hospitalization for heart": 0.051069100848581954, "single center retrospective": 0.0011255273836959893, "retrospective observational study": 0.007606954418330746, "receiving ventricular assist": 51.75648180349995, "assist device support": 0.004683468341024352, "patients receiving extracorporeal": 51.77628776871809, "receiving extracorporeal membrane": 51.74859272920762, "membrane oxygenation membrane": 51.748308364706276, "oxygenation membrane support": 51.749785627394786, "improvement in egfr": 0.05479876316669294, "renal dysfunction improves": 0.006577709412256655, "sensitive outcome change": 0.003641987858084641, "outcome change scores": 0.004146575830986078, "preliminary descriptive study": 0.007347275636383527, "ensure effective practice": 0.0021029704832255863, "using standardized nursing": 0.002982959293981021, "standardized nursing terminologies": 51.747894500399774, "retrospective descriptive research": 0.0011147262136983348, "descriptive research design": 0.0010192109619231774, "statistically significant improvement": 0.005179183531674757, "study provide insight": 0.007833662649270762, "sensitive outcome measures": 0.003619445566966858, "prospective experimental research": 0.0015198651139911822, "regarding effective treatment": 0.006991915826909292, "older adults hospitalized": 0.003877013595981163, "reciprocal downregulation influences": 51.74789740655295, "influences cardiac hypertrophic": 51.75605040264959, "cardiac hypertrophic response": 51.75706181207377, "cardiac gene therapy": 0.013909719922597867, "classic signaling paradigms": 51.74818700230148, "human embryonic kidney": 0.001893888896204639, "adrenergic receptor agonist": 51.75004287007789, "show reciprocal regulation": 0.0006200994009506106, "undergoing chronic \u03b2": 51.75360274148688, "chronic \u03b2 -": 51.821066072773654, "adrenergic receptor stimulation": 51.75049986100147, "postischemic heart failure": 51.80193617021942, "cardiac plasma membrane": 0.009528741524122796, "plasma membrane levels": 0.0036703140158360556, "produces beneficial effects": 0.0028211570017347585, "deleterious \u03b21ar overstimulation": 0.00015234507070147312, "discharge among patients": 0.030990281393594974, "readmission among patients": 51.77838378357436, "linked administrative databases": 0.0007816827262870335, "saw unfamiliar physician(s": 51.74751088729755, "month observation period": 0.002259420096090742, "altered protein kinase": 0.002134632445829249, "- translational state": 51.81566796569608, "adrenergic receptor blockade": 51.75040041889787, "reduces total mortality": 0.007770344447510222, "halt disease progression": 0.005357134101940376, "dependent protein kinase": 0.0025873579626700715, "adrenergic receptor activation": 51.750705840368525, "- translational states": 51.81556275338404, "human myocardial tissue": 51.75239913528908, "total myosin binding": 51.74884407241359, "myosin binding protein": 51.74881044956818, "site specific rii\u03b1": 0.0010836062649873745, "vivo phosphorylation sites": 103.49569477373981, "specific monoclonal antibodies": 0.0011846651804871039, "monoclonal antibodies showed": 0.0018876712156865227, "mutant ri\u03b1 proteins": 0.0011717654888452032, "failing myocardium displays": 51.748237830272686, "displays altered expression": 0.002075046954232637, "- translational modification": 51.81581745343877, "heart failure prone": 0.05469469611130129, "signifies repolarization lability": 103.4946773906728, "nervous system activity": 0.002204763038812159, "10 heart failure": 0.055796329622112964, "spontaneous ventricular tachycardia": 103.50212152761667, "structurally normal hearts": 0.0018010519200185814, "beat qt interval": 0.0026208033891920047, "rate atrial pacing": 51.75312452202006, "isoprenaline infusion increased": 51.75188030851504, "heart rate variation": 0.032403752126825655, "nervous system modulation": 0.0011088517136799213, "related congestive heart": 51.77844767397045, "haematopoietic cell transplantation": 103.4961409128212, "developing congestive heart": 51.77709511738544, "pre - hct": 0.06859726132215065, "- hct exposure": 0.06826629852797042, "16 candidate genes": 0.001072622680645741, "- oxidant defence": 51.81543436077656, "control study design": 0.01003205118724143, "cumulative anthracycline exposure": 51.74819654322097, "stem cell source": 0.0008997500352732777, "doxorubicin efflux transporter": 103.49523935634005, "chf predictive model": 0.002652138856950206, "predictive model performed": 0.004214660264359879, "propose fundamental definitions": 0.0002844243828502247, "right heart circulation": 0.030896110941310548, "right heart circulatory": 0.03084928171466215, "heart circulatory failure": 0.05495411954336223, "foster collaborative research": 0.0006471850670378402, "collaborative research initiatives": 0.0006908606237487658, "class angiotensin receptor": 51.7530355676098, "natriuretic peptide system": 51.75085461559222, "atrial natriuretic peptide": 103.49881156085888, "neprilysin inhibitor prodrug": 103.49523911401062, "angiotensin receptor antagonist": 103.49891337519229, "receptor antagonist valsartan": 103.49733143310912, "large outcomes trial": 0.007157286988101979, "ejection fraction outcomes": 0.016513158315325516, "fraction outcomes trial": 0.012290526617604988, "improve clinical symptoms": 0.007115975341920058, "term survival rates": 0.005931832040319638, "underlying clinical trials": 0.006762115859219275, "new pharmacologic targets": 51.748583043756625, "purely hemodynamic disorder": 51.747787944905326, "interconnected molecular pathways": 0.001120011577622676, "maladaptive molecular processes": 51.7482917815816, "molecular biomarkers provide": 51.74905256486394, "important therapeutic implications": 0.002565953141719481, "guided clinical trials": 0.006400356331822506, "potential therapeutic implications": 0.002517062157963313, "strict statistical standards": 0.00030362102192356194, "guided clinical trial": 0.006466859129332073, "clinical trial design": 0.006631552471369316, "fastest growing subclass": 51.747530621025334, "small noncoding rnas": 51.74762978590046, "heart failure development": 0.056209784935852186, "provide brief insight": 0.0010283961031273383, "novel therapeutic targets": 0.002363252075680765, "aldosterone system inhibitors": 51.74947631649088, "carries significant morbidity": 0.0038088332891662345, "direct renin inhibitors": 51.74863637527474, "neutral endopeptidase inhibitors": 51.748304077584194, "skeletal muscle abnormalities": 0.0015759255153934685, "peripheral muscle pump": 0.0019794932131010244, "promoting cardiac filling": 0.009308244434488118, "acquired heart failure": 0.05473652948009288, "reduced skeletal muscle": 0.005334554838018626, "mass and/or metabolic": 51.750062029059094, "design and patients": 0.09969555492499556, "underwent cardiopulmonary exercise": 0.0076727838917491865, "lean mass quantification": 0.0022196603400485328, "dual x -": 0.0683157646555884, "magnetic resonance spectroscopy": 51.74835280109521, "australian reference data": 0.0025713790081043097, "single tertiary referral": 0.000586431333564326, "tertiary referral centre": 0.0002481056607929127, "appendicular lean mass": 51.749406142624835, "lean mass index": 0.004859871572289535, "matched reference values": 0.001852163017592431, "low skeletal muscle": 0.0035314761748358315, "muscle mass t": 0.0026608090356014056, "young normal reference": 0.001924698216405531, "normal reference mean": 0.003118052189478109, "sarcopenic range muscle": 51.748853646924196, "clinically significant wasting": 0.003506027882544129, "muscle aerobic capacity": 51.75015752024116, "postexercise phosphocreatine resynthesis": 155.24201726636454, "adults versus controls": 0.004864413149189936, "659 heart failure": 51.80193617021942, "performed confirmatory factor": 51.750108276375386, "confirmatory factor analysis": 51.75167733277726, "used exploratory factor": 0.004028782470027439, "exploratory factor analysis": 0.004439543041902603, "separate scale dimensions": 0.0004956863224027713, "separate sub -": 0.06838995562615, "sub - sample": 0.0685604471405215, "individual scales showed": 0.0020449975403218786, "excellent fit indices": 0.0007117007700476987, "contrasting groups validity": 0.002435116989659445, "type natriuretic peptides": 51.751268614984475, "common consensus regarding": 0.002010318127329675, "-80 \u00b0 c": 103.4951320130726, "mass spectrometric analysis": 51.75218410699971, "customized homogeneous sandwich": 51.74733619565973, "sandwich alphalisa \u00ae": 51.747489325897014, "alphalisa \u00ae immunoassays": 103.49478026526971, "terminally processed forms": 51.74756457212303, "low apparent concentration": 0.0027075066151110404, "terminally truncated fragments": 51.74764403949383, "targeting nonterminal epitopes": 103.49507072605056, "central glycosylated region": 51.74765559060231, "left ventricular hypertrophy": 103.50844636490434, "relative wall thickness": 0.0014467626908214672, "data among groups": 0.00617596636854627, "lower systolic blood": 51.7549486311936, "less renal impairment": 0.0033925154926271236, "elevated cardiac filling": 0.010182443584835743, "cardiac filling pressures": 0.009466372279788825, "equivalent adverse outcomes": 0.006458404767710549, "carvedilol and metoprolol": 103.56754256848001, "\u00b1 1.1 years": 51.75500340346526, "significantly decreased risk": 0.011059781949617644, "inappropriate therapy compared": 0.008812391898989923, "inappropriate shock therapy": 0.005371870550132951, "inappropriate therapy caused": 0.005335553515048576, "nationwide retrospective cohort": 0.0025885880813969553, "general population comprised": 0.0018214677460457063, "proportional hazard analyses": 0.004536976196376212, "commonly used bisphosphonates": 51.75025750304515, "observed across refill": 0.0018288907816533858, "across refill compliance": 0.001222289783592248, "refill compliance strata": 0.0007040705810637072, "increasing refill compliance": 0.0009771536240135465, "p for trend": 0.013092195141001503, "matched control subjects": 0.004498766816836941, "weeks infarcted rats": 51.749502861567066, "20 weeks mi": 0.0019850792879097055, "weeks mi animals": 0.0015342544019140366, "posterior wall thickness": 51.748134702092074, "dopamine without affecting": 0.0022241364207271283, "increased mrna level": 0.005249024921207672, "reverse cardiac remodeling": 0.01038833875672801, "incident cardiovascular events": 0.005904353460142408, "independent risk factor": 0.008882976677750338, "shown inconsistent results": 0.0023032693115865076, "subclinical atherosclerosis using": 51.749919503538266, "general linear models": 0.002448223287860637, "8,009 reference subjects": 51.74864636259262, "higher diastolic blood": 51.75406630083092, "diastolic blood pressure": 51.753980619565354, "mass index levels": 0.007106558256254166, "adjusted carotid intima": 103.49604951347952, "coronary artery calcium": 51.75034816373389, "artery calcium scores": 0.002074352079780036, "predominantly mild disease": 0.00576596432395809, "subjects without psoriasis": 0.0027334397211202137, "share many risk": 0.0068251527045705045, "many risk factors": 0.008474491820252216, "patients with pad": 0.07465252540720904, "transmitral e -": 51.81592188727006, "hospital readmission reduction": 51.75227371837171, "readmission reduction program": 51.750843782498094, "rate following hospital": 0.006194517848923678, "following hospital stay": 0.002798777353285595, "possible suboptimal care": 0.0034947278768304845, "significant economic considerations": 0.003302095300789232, "center pilot project": 0.0005006616479122504, "cardiac specialty hospital": 0.010647681856448491, "ensure adequate self": 0.00036937928220799973, "percent relative reduction": 0.0027184176633258308, "net economic savings": 0.0004575177604641765, "urbanized midwestern state": 51.747392722016656, "abnormal hr variability": 0.0010679120136340408, "- linear measures": 0.06962137185870666, "reflecting rapid r": 0.0005951509027053608, "r interval oscillations": 51.75003935515417, "- linear hr": 0.06842626595455518, "linear hr variability": 0.0009150579718943144, "hr variability measures": 0.0018060113636292662, "term fractal scaling": 51.749187666820106, "fractal scaling exponent": 103.49462555688307, "better prognostic information": 51.74929464842887, "fatal arrhythmia events": 0.0029336602836744566, "future randomized trials": 0.003796367115248012, "trials using hr": 0.0041036572062531345, "using hr variability": 0.0029874097294345587, "- defined inclusion": 0.06948067473762104, "defined inclusion criteria": 0.0020097115508910662, "routine clinical tool": 0.005053125023242422, "renal artery stenosis": 51.75085923112718, "peripheral arterial disease": 51.75377556502799, "pathophysiologic mechanism stems": 51.748149152048384, "renal underperfusion resulting": 51.74962151274304, "end stage kidney": 0.004733194957304447, "stage kidney failure": 0.027953177321752155, "computed tomographic angiography": 51.74774664310516, "magnetic resonance angiography": 0.0014217903578954993, "adequate blood pressure": 0.004082354570721398, "blood pressure control": 0.006815030110795615, "preventive measures form": 0.0014113653771197978, "based percutaneous revascularization": 103.49652866457946, "modest clinical benefit": 0.005857042645900326, "small retrospective studies": 0.0031192777730079183, "randomized clinical trials": 0.007887105207497433, "clinical trials failed": 0.0063606180692485585, "concrete data regarding": 0.0025063989368228675, "determining individualized assessment": 0.0011073317055681556, "several key genes": 0.001083671372229156, "key genes related": 0.0022618194626718513, "differentially expressed genes": 51.74826861762401, "- ischemic heart": 51.84489025467609, "programmed cell death": 0.0043108294811681665, "longitudinal analysis using": 0.0060177049846553265, "analysis using medicare": 51.752847171735894, "using medicare data": 51.75183996680515, "healthcare utilization effects": 0.0023555084226031205, "combined care management": 0.005379615892590105, "retrospective matched cohort": 0.0032576112615104345, "matched cohort study": 0.009849238755838971, "demonstration participating clinics": 0.00027915927176589496, "score matched control": 0.005285133880198568, "matched control group": 0.007590273555538456, "driven telehealth system": 51.74853817953844, "year study period": 0.009325028928016366, "negative binomial regression": 51.74859294635638, "binomial regression models": 51.75011426684533, "% lower risk": 0.03761252954715466, "quarterly inpatient admissions": 0.0007537972742188163, "driven telehealth technology": 51.74773741669416, "improve health outcomes": 0.007621768626589424, "contemporary chronic heart": 0.03150438098930252, "exercise training response": 0.008661702161430602, "without exercise training": 0.008913841305102772, "identified black patients": 0.029803251244269247, "less ischemic etiology": 103.4973080025564, "lower socioeconomic status": 0.0039908369889050275, "status versus whites": 0.004241149273055228, "minute walk distance": 0.0011818328860333741, "after multivariable adjustment": 0.006066920324090511, "similar cardiovascular mortality": 0.01068972811831383, "modifiable risk factors": 51.75574655109094, "lower exercise performance": 0.009424907246147533, "optimal therapy including": 0.006137766010164607, "therapy including anticoagulation": 51.753020381530234, "major cardiovascular complications": 0.004950556625383337, "prevent adverse outcomes": 0.006488657038292714, "adverse outcomes related": 0.007840687289123245, "preserve atrial structure": 51.749657996635214, "maintain sinus rhythm": 51.748535590374864, "delayed rhythm control": 0.0039391853051962055, "otherwise effective rate": 0.005122016453878047, "effective rate control": 0.007868376750668508, "new antiarrhythmic drugs": 51.74860960134714, "modern rhythm control": 0.003907342014188932, "reduce cardiovascular complications": 0.004500556310556364, "recent onset af": 0.0019325178740054409, "mandated usual care": 0.003510784611018806, "blinded outcome assessment": 0.0032356701521809076, "outcome assessment trial": 0.004930394490545332, "composite primary outcome": 0.004705797757516176, "underlying heart disease": 0.03346561700073126, "care plus rhythm": 0.0043186887287417, "operated electrocardiographic device": 51.74891822988415, "key secondary outcomes": 0.005257126744993642, "secondary outcomes include": 0.0053034297556288955, "include cognitive function": 0.004688158864410451, "prevent cardiovascular complications": 0.0038444509255491054, "cardiovascular complications associated": 0.010105017320003382, "term ventricular assist": 51.75758847892702, "health care providers": 0.004820821745186886, "significant gastrointestinal bleeding": 0.003659415210652852, "called end stage": 0.003952034151987631, "advanced structural heart": 0.02950826699588842, "structural heart disease": 0.03305307636147593, "minimal physical exertion": 0.0005259489281262125, "maximal medical treatment": 51.754609995298594, "medical treatment according": 0.007414525190011892, "year mortality rate": 0.011196026482028294, "special therapeutic interventions": 0.0022216583626243997, "correct reversible causes": 0.000580938056539855, "poor patient compliance": 0.004409285327027708, "describe current strategies": 0.002281360111488448, "ca2 + currents": 0.0011038792709455241, "influx via l": 0.0012246746108209312, "ventricular action potentials": 51.75458561675298, "monomeric g proteins": 51.74860846201097, "regulates ventricular action": 51.754635871525, "ventricular action potential": 51.7556354932447, "action potential duration": 0.0019720046339843185, "inhibit cardiac l": 51.75615064120966, "type channel activity": 0.004040865564166749, "occurring rad variant": 0.00019812596037837262, "type channel isoforms": 51.75018327031363, "95 % inhibition": 0.03631219997812081, "type channel inhibition": 0.00386386598171034, "ethically complex situations": 0.0005669745623236347, "religious beliefs preclude": 0.00018023135389083871, "involving young adults": 0.0020795586274777187, "sickle cell disease": 51.75289244505008, "urgently recommend blood": 0.0014805205399452252, "recommend blood transfusions": 51.74882250332505, "composite quality measures": 0.004544412693214401, "inpatient medical conditions": 0.0025217153670154513, "select better hospitals": 0.0014200962060567912, "individual quality measures": 0.0040403460080341725, "inferior hospitals based": 0.002346932346687547, "derived composite quality": 0.004059385974705305, "composite quality measure": 0.0038823334745742553, "composite measure predicts": 0.0014980510797490284, "future hospital mortality": 0.008846287173930968, "older patients treated": 0.03131885463922139, "acute care hospital": 0.008321015590750276, "existing quality indicators": 0.0027413188962612895, "race influences efficacy": 0.0019205135133919934, "functional class iv": 0.004772043460527251, "myocardial infarction compared": 103.50371729173817, "- aa participants": 0.06938087570703888, "non - aas": 0.06962358049344972, "attain maximal spironolactone": 103.49579866339577, "maximal spironolactone dose": 103.497736419923, "achieved study drug": 0.007531160483544474, "study drug dose": 0.009279482554131267, "less clinical benefit": 0.006757164745334358, "free shotgun proteomics": 51.74803259901016, "shotgun proteomics approach": 51.748064194734, "tac)-induced heart failure": 0.05464812484367276, "associated signaling pathway": 0.007863049393794511, "signaling pathway changes": 0.003809599780892404, "changes using ingenuity": 0.004859621498891239, "using ingenuity pathway": 0.0030387267319032466, "heart failure phenotypes": 51.80198721450033, "mitochondrial damage induced": 51.75066678208506, "mitochondrial proteome changes": 103.4981824879554, "84 % protection": 0.028694784314063068, "nonmitochondrial protein changes": 51.75093809901831, "included significant amelioration": 51.75207179708876, "actin cytoskeleton pathways": 103.49528988209673, "induced proteomic alterations": 51.75003892253456, "perturbed mitochondrial function": 103.50001551702886, "potential clinical application": 0.005850683698598282, "targeted peptide drugs": 0.0021340697649337758, "treatment heart failure": 0.06005608714172485, "stay increase rehospitalization": 51.75010835233691, "skilled nursing facilities": 0.000564612982402762, "quasi - experiment": 0.068211834787859, "1.56 percentage points": 51.74815363457826, "0.81 percentage points": 51.7482046762538, "urinary tract infection": 0.0003446752313571207, "patients undergoing procedures": 0.02941541414869501, "medically managed diseases": 0.00035071781131857304, "acute care hospitals": 0.006931607408718482, "costs across volume": 0.0038428195204193473, "across volume groups": 0.005486816425757717, "examined physician volume": 0.004457130476654622, "volume within strata": 0.003893538168187137, "higher readmission rates": 51.75334875355206, "among noncardiologist physicians": 51.74971408224128, "major clinical trials": 0.007586441869726708, "clinical trials designed": 0.006563997011716402, "analyze clinical outcomes": 0.009568051472030017, "clinical outcomes using": 0.011641192738055037, "myocardial infarction patients": 103.52803627059444, "aldosterone antagonist eplerenone": 155.24303808250897, "aldosterone antagonist therapy": 103.49997821271538, "improving survival rates": 0.004526577508806192, "contemporary therapeutic options": 0.0014387634838404213, "thus examined changes": 0.0035296795637786435, "dilated cardiomyopathy cohort": 103.4983513954761, "73 % men": 0.0291490738313542, "negative coronary angiography": 51.74966480085128, "4 enrollment periods": 0.0022682815270613802, "heart failure treatment": 0.06005608714172485, "failure treatment eras": 0.03190183029768244, "patients receiving angiotensin": 51.777767624844856, "angiotensin receptors blockers": 103.49784195829737, "final evaluation increased": 0.004685117074404095, "trend toward enrollment": 0.0010697715614308237, "point including death": 0.005496814715916051, "recent enrollment period": 0.002461789756810437, "powerful independent predictor": 0.001362538479217416, "42 % risk": 0.03520508851361516, "% risk reduction": 0.03683667570677459, "reflecting marked decreases": 0.0006443530107838387, "controlled randomized trials": 0.0038540180690298086, "indeterminable anaerobic threshold": 103.49482657423648, "maximal cardiopulmonary exercise": 51.75404435810603, "stable clinical conditions": 0.006145397371428043, "exercise test investigations": 0.007295735724277918, "peak respiratory quotient": 0.0018205864390156237, "respiratory quotient \u22641.05": 51.74743960093748, "urgent cardiac transplant": 0.009626571620879671, "secondary end point": 0.004454556914576615, "multivariable logistic analysis": 0.0036414821207900578, "reduced peak oxygen": 0.00664867379670769, "higher metabolic exercise": 51.75642324961207, "index score value": 0.0053283698103110035, "at multivariable analysis": 0.0077624849930431625, "ventilatory efficiency slope": 51.747578520042964, "secondary study end": 0.010513010279681427, "independent prognostic role": 51.750886151611724, "heart failure mortality": 0.060966108963847944, "among cardiorespiratory fitness": 51.74924972257999, "versus unfit men": 0.0037858551035842387, "cardiovascular disease underwent": 0.00908777641991676, "measures included body": 0.0044176345124473234, "included body mass": 0.004987012422968935, "maximal treadmill exercise": 103.50087329851792, "treadmill exercise testing": 51.753970125460214, "obese body mass": 0.0038626455278100084, "mass index categories": 0.004799620718988823, "overweight body mass": 0.0034038202321572085, "mass index strata": 0.004658864641273988, "risk factors present": 0.009260889777631013, "decreased mitochondrial energy": 51.750216777143066, "mitochondrial energy production": 51.749180339012916, "energy production precede": 0.0008203211127874, "energy metabolism precede": 0.0010450170148442214, "cardiac hypertrophy secondary": 51.7572123701153, "abdominal aortic constriction": 51.748409610792436, "energy substrate metabolism": 51.74828228041085, "in vivo assessment": 51.801526228016556, "demonstrated diastolic dysfunction": 51.75508239495345, "20 % increase": 0.031218444109558346, "16 % decrease": 0.02956581554939928, "% ejection fraction": 0.039990531548842564, "marked cardiac insulin": 0.009515562235177145, "2 weeks post": 0.005139531709332781, "weeks post -": 0.07032316634985847, "plasma membrane translocation": 0.00112079587719746, "myocardial glycolysis rates": 103.50040020371704, "reduced mitochondrial complex": 51.75315578593231, "mitochondrial complex v": 51.748938834207706, "complex v activity": 0.0016736749541234927, "decreased mitochondrial oxidative": 103.49727568975253, "mitochondrial oxidative metabolism": 103.49646394752445, "early metabolic changes": 51.75164015404404, "guide health service": 0.0020895834924605926, "health service planning": 0.0019051363544855234, "relevant health service": 0.002123519257358021, "health service provision": 0.001988550210684343, "reduced gross income": 0.00440085561809486, "including lower risk": 0.010596073881797341, "raised blood glucose": 0.0015389208018193553, "blood glucose levels": 0.004142388242064122, "gross national income": 0.0003775272396178024, "income per capita": 0.001311554741776296, "renal chloride channel": 51.74987564673829, "chloride channel gene": 51.74885365954759, "reported greater risk": 0.0078704884998561, "ambient air pollution": 0.0003265058532071944, "recognised risk factor": 0.008145825707037486, "new systematic review": 0.0023872046608908555, "common disorder associated": 0.008062771208505572, "aggravate cardiovascular health": 0.004824313092679601, "exacerbates heart failure": 0.05469890682340589, "cytoskeletal actin dynamics": 103.49482525839028, "produced cardiac dysfunction": 0.012353930824332301, "mildly increased heart": 0.03238765618360786, "increased heart mass": 0.03405110324660279, "eliminated cardiac hypertrophy": 51.756916907382205, "cardiac functional deterioration": 0.011512462762637182, "mechanical support devices": 0.0033856622175031806, "collaboration among cardiologists": 51.74929734566827, "medical staff responsible": 0.001655597420032925, "regarding appropriate referrals": 0.0009282111565235811, "present consensus report": 0.001556099525183213, "information regarding conditions": 0.001041536745437621, "recent postmarketing trials": 51.74977495011119, "hospitalized heart failure": 0.05582010140978411, "user cohort study": 0.009147319654341514, "18 health insurance": 0.002442115822670522, "health system data": 0.004752144643615766, "system data partners": 0.0030064150251102777, "acting insulin products": 0.0008763285541634344, "principal discharge diagnosis": 0.0021740660159819077, "553 saxagliptin users": 103.49551400437242, "124 sitagliptin users": 51.74837830233041, "disease risk score": 0.013353584550147459, "saxagliptin versus sitagliptin": 103.49813865494866, "saxagliptin versus pioglitazone": 103.49788345091288, "saxagliptin versus insulin": 51.751309409689426, "stratified hazard ratios": 51.75136617283263, "sitagliptin versus pioglitazone": 103.49788345091288, "sitagliptin versus insulin": 51.751309409689426, "1:1 propensity score": 51.74924015455347, "prior cardiovascular disease": 0.008349935055671349, "large cohort study": 0.009766078410055109, "selected antihyperglycemic agents": 51.74817522133384, "improving physician adherence": 0.0019684192853529512, "systematic review protocol": 0.001989127307993129, "identify implementation strategies": 0.002295092302355729, "improve physician adherence": 0.002693623637364735, "include prospective studies": 0.003408403485791434, "prospective studies evaluating": 0.003335283520602862, "studies evaluating implementation": 0.00291277720908663, "evaluating implementation interventions": 0.001455667880652972, "common underlying characteristics": 0.0030047384313882913, "recommended pharmacological treatment": 51.753346377975205, "left ventricular function": 51.76425012913589, "ventricular function assessment": 51.75949551456522, "include clinical outcomes": 0.009539352124034322, "determine patient awareness": 0.004434769914177315, "analyze interview data": 0.002431674022883929, "25 heart failure": 0.05512957119728962, "setting and participants": 0.07306983265756553, "felt implantable cardioverter": 103.49676876041413, "previously established preferences": 0.0009371642088261911, "within broader discussions": 0.0014945057655493203, "life treatment preferences": 0.007652910239843295, "defibrillator deactivation preferences": 103.49649947785574, "distressing implantable cardioverter": 103.49682086755129, "carotid baroreflex activation": 103.49544271182643, "baroreflex activation therapy": 51.752535967059444, "decreased parasympathetic activity": 51.750112611244816, "parasympathetic activity contribute": 51.74928218402849, "centrally mediated reduction": 51.74977390553557, "increased parasympathetic activity": 51.752873353058774, "chronic stable guideline": 0.005185872669386396, "directed medical therapy": 0.006116909441936421, "receive ongoing gdmt": 0.0003846527544535672, "gdmt plus bat": 0.0003835990274054751, "primary safety end": 0.006053809620808302, "safety end point": 0.005230550193265213, "primary efficacy end": 0.005800536918018193, "efficacy end points": 0.004463020229612803, "hall walk distance": 0.0009003179591199151, "control group patients": 0.03493253776569781, "\u00b1 3.1 points": 51.75209827895985, "functional class ranking": 0.004816246205194736, "significantly reduced n": 0.009329250957739866, "toward fewer days": 0.0019403682057117266, "fewer days hospitalized": 0.0028334564278684263, "improves functional status": 0.0052129474771781545, "heart failure hospitalizations": 0.05520931055398724, "using cardiopulmonary exercise": 0.008775525271121664, "exercise testing guide": 0.006822579070592576, "testing guide exercise": 0.006822579070592576, "guide exercise rehabilitation": 0.006682372730696507, "standard clinical practice": 0.006190642268881311, "prescribe exercise rehabilitation": 0.006540295595216692, "limited maximal cpet": 51.74853006823405, "control without exercise": 0.01023161241091422, "5 exercise patients": 0.034947695164620866, "patients used \u03b450%w": 0.030823930456724012, "used \u03b450%w intensity": 0.0028179064473470247, "12 w rehabilitation": 0.001817835488829564, "two groups patients": 0.030598846789609765, "distance 6 minutes": 0.003703190669103022, "guiding exercise rehabilitation": 0.00653924291709803, "newer imaging techniques": 0.0005967194944091057, "reduced long axis": 0.005972395093962653, "long axis function": 0.005970026580766961, "other cardiovascular risk": 0.011221122090676931, "single diagnostic test": 0.0026230907675404216, "thorough medical history": 0.0020686606194346277, "standing blood pressure": 0.004063932797377717, "jugular venous pressure": 103.49737946847256, "peripheral oedema allows": 0.000629071936887196, "oedema allows assessment": 0.0010265494204177656, "heart failure nurses": 0.05489676267029503, "local cardiology services": 51.74722878823521, "regular physical activity": 0.0015221393489166235, "physical activity controls": 0.0021767107984561156, "acquired cardiovascular risk": 0.009948023284870159, "50 % reduction": 0.030773566862722312, "recent evidence suggests": 0.0027232051676706883, "exercise prevents cell": 0.006839937785039506, "prevents cell senescence": 51.74823911140438, "developing certain malignancies": 51.74749746462949, "certain malignancies including": 51.748470413766306, "malignancies including cancer": 51.748755359809216, "even lower volumes": 0.0029769727505952522, "recommendations confer health": 0.0023108619869537488, "confer health benefits": 0.002495265081917278, "established cardiac disease": 0.013583543041886845, "cardiac disease including": 0.014410738425919488, "disease including heart": 0.03415626011406632, "including heart failure": 0.05579498500274857, "rare with.estimates ranging": 51.74761587867418, "aged recreational athletes": 0.0009260953785632624, "sudden cardiac deaths": 0.009341422789891743, "cardiac deaths occur": 0.009392987329384076, "- participation screening": 0.06835233291008609, "detect congenital accessory": 51.74764087972224, "congenital accessory pathways": 51.74805182745479, "limited value given": 0.0019620086196995125, "small pilot study": 0.007582712555503014, "week aerobic training": 51.74947063271915, "aerobic training period": 51.750399203254624, "trainings per week": 51.748776616070074, "integrated dynamic resistance": 0.0012457348864646813, "dynamic resistance training": 0.002616438294465737, "patients underwent testing": 0.03011904015704858, "combined training resulted": 0.0025017636504570786, "peak work rate": 0.005437511033648092, "+ 61 %": 0.02936507034002927, "+ 44 %": 0.029565021126022932, "resistance training intervention": 0.0029702845139169716, "augmented feedback resulted": 0.0006398678444452255, "assess social support": 0.003123882927472325, "perceived social support": 0.0022589242159168263, "social support score": 0.0037595325537112204, "indicated higher levels": 0.005783498165927184, "higher btes indicated": 0.0031831980475554656, "higher exercise time": 0.010417715018164814, "for cardiovascular death": 0.026427903685548426, "usual care group": 0.007464399475017062, "poor social support": 0.002471753985388413, "lower exercise time": 0.010280244232245613, "training improves outcomes": 0.00721262134343634, "facilitate individualized approaches": 0.0008564060930790027, "implement exercise training": 0.007430857033208868, "exercise training therapy": 0.01188109567305742, "recent onset heart": 0.03013676718881073, "blocker hypo -": 51.816629739362696, "hypo - response": 51.816674153608346, "standardized exercise protocol": 0.006292484608827408, "respiratory gas analysis": 0.0032212891364560787, "recommended target doses": 0.001372569262952269, "resting hr<70 bpm": 51.747846093892385, "hr<70 versus \u226570": 51.75028915635198, "similar dose uptitration": 51.750994651364046, "significantly larger hr": 0.003061308909397785, "larger hr reduction": 0.001996515145287471, "lower resting hr": 0.0029523345672288455, "in recent onset": 0.054907361075148355, "aggressive dose uptitration": 51.74987540787224, "little hr reduction": 0.0020314778840014136, "left atrial pressure": 51.757129905894345, "atrial pressure improve": 51.75263934874643, "pressure improve symptoms": 0.0051874769484993675, "canadian special access": 9.995417900621348e-05, "special access programme": 0.00031122222090610704, "transoesophageal echocardiographic guidance": 103.49548555965586, "procedural adverse events": 0.004260411344940949, "3 month follow": 0.006422376707397429, "6 min walk": 0.004873162362725897, "walk test distance": 0.0021316893650627413, "right atrial pressure": 51.7538082813133, "pulmonary arterial pressure": 51.75305067066269, "ventricular tachycardia storm": 103.50195050189687, "failure 2 months": 0.031024730761166096, "post - procedure": 0.06952717185241607, "right interatrial shunt": 51.749830997029896, "interatrial shunt demonstrates": 51.74759115389462, "demonstrates initial safety": 0.0014527012471344074, "scale randomised studies": 51.750031901461455, "receptor neprilysin inhibitors": 51.75065504276306, "neprilysin blocks renin": 103.49512413971543, "supports natural vasodilatory": 51.747482210883966, "prospective randomized multicenter": 51.74973325070077, "randomized multicenter trial": 51.75081603774087, "multicenter trial paradigm": 51.749335341759334, "stabilized chronic heart": 0.03151227606826468, "20 % decrease": 0.029966148840144865, "specified subgroup analyses": 51.7483062280898, "typical adverse event": 0.0024288233081059428, "long time become": 0.0035159672343756674, "stable chronic heart": 0.032369647150477576, "systolic dysfunction treatment": 51.759990234711324, "among older persons": 0.0032406505806501593, "factorial trial conducted": 51.74931086448324, "academic medical center": 0.00187399725720019, "initially screened participants": 0.0013395358735321852, "older obese participants": 0.003211264776502875, "higher scores indicate": 0.0035767714115441888, "indicate worse heart": 0.028626006898756655, "worse heart failure": 0.05492727635495271, "by main effects": 0.010387040327160984, "main effects analysis": 0.005391299359566516, "kg body mass": 0.004877648639450489, "statistically significant change": 0.004572911761394002, "percent lean body": 0.002087111989984191, "intermuscular fat ratio": 51.75210090194771, "serious adverse events": 0.004306970761951124, "conclusions and relevance": 0.07148221297559193, "training increased peak": 0.007260236608972671, "ventricular assist system": 51.756600374476925, "centrifugal flow pump": 51.74915562770877, "magnetically levitated rotor": 103.49482920593061, "support)-derived performance goal": 0.001179622672645585, "optimal medical management": 0.003928316371213951, "% received transplants": 0.02847876563716422, "survival 92 %": 0.03029557209536822, "88 % performance": 0.029249815481056724, "% performance goal": 0.029342938497078717, "significantly reduced mortality": 0.013422333731926705, "reduced mortality risk": 0.017385691604080537, "key adverse events": 0.004438779519478883, "adverse events included": 0.005944112211775309, "events included reoperation": 51.75160388049656, "month survival rates": 0.004949517023289817, "favorable adverse event": 0.0026466765338749405, "adverse event profile": 0.0025611607104102166, "influence medical resource": 0.0019802973741986155, "medical resource use": 0.00410257917891727, "based simulation tool": 0.002025450681693478, "cohort study designs": 0.009131802984103831, "virtual cohorts used": 51.75020724827175, "replicating resource use": 0.00259640209328055, "debilitating chronic disease": 0.008164221674559893, "enhancing medical management": 0.00351815120144653, "ultimately reduce morbidity": 0.001578527738069623, "play a role": 0.009330718832935169, "symptoms of heart": 0.042215711961202926, "anemia in patients": 23.035078862721825, "anemia and iron": 23.030967147546995, "life in patients": 0.03685805368592124, "symptoms in patients": 0.03664225811196012, "confidence in estimates": 0.024703178696641827, "male sex were": 0.008702305769725374, "change in cystatin": 23.02292561087355, "processes of care": 0.030521443354802422, "changes in chromatin": 23.02366974078751, "development and disease": 0.03453337847895814, "development of ies": 0.029766950381616246, "failure or death": 0.018037624420936833, "mortality as patients": 0.017920318415417514, "outcomes in heart": 0.03816223782527302, "decrease in cd34+vegfr2": 0.023927540481726343, "patients with diabetes": 0.033899771751844665, "percent of hospitals": 0.02947090161694528, "review and network": 0.032296104782271906, "provided during office": 0.0017310923910487668, "therapy in patients": 0.03802726432113497, "mortality and readmissions": 23.033555893186275, "outcome in patients": 0.03702606554073247, "relationship between sex": 0.002515984062689881, "levels in patients": 0.03719033623948348, "management of heart": 0.042436591336793505, "550 dyn s": 22.998954183467454, "death in patients": 0.037573364771522774, "prescribed therapy were": 0.010138482582701808, "loading and uninephrectomy": 23.03067775398643, "group of patients": 0.043342181916346506, "survival in patients": 0.03687005658894431, "bridge to transplantation": 23.011937747490514, "use and outcomes": 0.03481083286957239, "develops after ring": 0.002466055937115551, "reduction by surgery": 0.004958960378543661, "old man had": 0.0017741765217087406, "after the surgery": 0.020495952151957958, "incidence and predictors": 23.03110908719593, "need of diuretics": 23.028153084486252, "observed in patients": 0.036504086771356, "associated with heart": 0.036083851223804156, "safety of spironolactone": 23.028727753209726, "associated with risk": 0.026593409643580833, "risk of hyperkalemia": 23.031207238808676, "remodeling in heart": 0.03671456236724919, "progression to heart": 0.02550161433447585, "effects of b": 0.029991256444393176, "function and remodeling": 0.034211798607582444, "outcomes for patients": 0.02344265879608013, "seen in medium": 0.023728535057132176, "ischemia and heart": 23.043169705864244, "reduction with ivabradine": 23.02056557144165, "ventricle in heart": 23.03516917591542, "months of treatment": 0.0322063631089755, "assessed by echocardiography": 23.00358403384486, "prognosis in patients": 0.036510870683915786, "ph with heart": 0.03322384955675162, "tonometric indices were": 23.006965225973733, "test in patients": 0.036598177189545035, "chronic disease such": 0.003867135817096203, "frailty and risk": 0.03492983125042063, "risk for heart": 0.024449747357799617, "assess the association": 0.018633127983099837, "association between frailty": 0.002420468398135197, "years of age": 0.03172051767855937, "number of studies": 0.030360747492375068, "cause of death": 0.031653478625265824, "outpatients with heart": 23.03217733271447, "blockers and \u03b2": 23.032153825594165, "adjusted for demographics": 0.009546935488604157, "rates and risk": 0.03572713441220428, "mortality in women": 0.026547388806752812, "associated with outcomes": 0.025631270457631184, "reclassification of risk": 0.032230972408143335, "performed at baseline": 0.0037496656166138885, "impact of heart": 0.042237086823180586, "imaging on chelation": 23.001218841379085, "disease in patients": 0.038170269804733925, "failure and arrhythmias": 23.042273891569252, "morphology and duration": 23.030882605107053, "duration and extent": 0.032126389318726356, "examined the impact": 0.018657883224272746, "majority of patients": 0.04165927097029648, "inhibitor or angiotensin": 23.00444778105856, "occurred during follow": 0.003251702169523676, "failure in rats": 0.03574934912404096, "adjustment for age": 0.010238381336691055, "cardiac remodelling is": 23.006649061260447, "biological phenotype had": 23.000884613030962, "as a result": 0.011358199043671007, "point of care": 0.030786825285891384, "cause of mortality": 0.03292275409402806, "baseline and heart": 0.04539461948655259, "in the study": 0.044300964452600074, "reserve in patients": 0.036160235159586836, "on the basis": 0.01998837613596904, "diagnostic features such": 0.0007130846489205863, "mortality and morbidity": 0.03478354219278898, "cardiac washout was": 23.010063073016155, "treatment with carvedilol": 23.02213638186204, "contextual factors such": 0.0011560338854560346, "delay the onset": 0.01832142868498628, "treatment with ivabradine": 23.022159063963876, "response to exercise": 0.01592046568117513, "proportion of patients": 0.04164968567900536, "patient with heart": 0.03480151530238154, "efficacy of eplerenone": 23.02836568019859, "risk for hyperkalemia": 23.011004104681778, "subgroups of patients": 23.04056200183402, "inclusion and exclusion": 0.03190516674830864, "advances in treatment": 0.025991181279301685, "limited data are": 0.0030720915777436007, "given the lack": 0.017891628070146527, "program of exercise": 0.031961426408024775, "exercise with testosterone": 0.023486685246656376, "risk for stroke": 0.012298509914736282, "important comorbidities such": 22.999747892100263, "recent data is": 0.005240660823357108, "compared with sham": 0.02259673027428246, "therapy in heart": 0.03807221369690479, "occurs in patients": 0.03612270173772442, "function in children": 0.025561564646742314, "admission to discharge": 0.013688129025391455, "contribution of nursing": 0.02940392038033854, "physician continuity further": 0.0009214782851146132, "month after discharge": 0.003127679232984998, "form the foundation": 0.017782067634612445, "trial of heart": 0.04240528147336371, "symptoms and signs": 0.032416888853315354, "progression of heart": 0.041833079681444674, "matched and sex": 0.03240430317564653, "impact of carvedilol": 23.028746080329334, "treated with bisphosphonates": 23.020383623622962, "reversed by metoprolol": 23.003039737464736, "internal diameter were": 0.008274143589933154, "levels of plasma": 0.030522763810418106, "care of patients": 0.042882502164977195, "transitions of care": 0.030437017881752685, "measures of hr": 0.029604037409159387, "measurement of hr": 0.029367542726025063, "management and telehealth": 23.0313949197266, "training on outcomes": 0.0049292538638228325, "worsening of heart": 0.0417893502757488, "patient population has": 0.002745654777676342, "ability to inhibit": 23.011759671199645, "efficacy of mineralocorticoid": 23.028320310206297, "major complications had": 0.0025242288281599494, "rates of patients": 0.04254182102606488, "fit men had": 0.0021102399821103833, "prevention and treatment": 0.034240998943585184, "expenditure on health": 0.0030251001396612714, "cardiac pathophysiology is": 23.006717112196586, "patient care is": 0.006855843772435387, "assess the impact": 0.01877034644712745, "clinical outcomes such": 0.004401254357029719, "end of life": 0.03132912702388159, "assess the safety": 0.018638612676714766, "\u00b1 14 m": 23.000969605534962, "primary symptoms are": 0.003102811574476478, "risk factors such": 0.0040429509112930445, "active individuals are": 0.002049601389518655, "recreational athletes more": 0.0006986946322143925, "training for heart": 0.022075560626804526, "% to +": 0.02570391699563893, "support and barriers": 0.032674685647677004, "reduction with beta": 0.021929304956761292, "admitted to hospital": 0.013840565138603104, "evaluate the cost": 0.018300510535523402, "use and quality": 0.0338772138276772, "use of evidence": 0.030799075758915065, "database to assess": 0.0033193772051144012, "improvements for patients": 0.0054125006443453, "admitted with pneumonia": 0.005248514977596524, "patients with respect": 0.008296156798973725, "respect to alterations": 0.0032433807505689396, "alterations in body": 0.0061081153564033555, "associated with changes": 0.006151774452968909, "changes in body": 0.0063161369566452925, "neurohormones and adipokines": 11.507323264621864, "associated with body": 0.006052583467716964, "composition with regard": 0.005238487449317071, "chf and individuals": 0.007996107409482709, "follow up body": 0.000865856797350513, "correlation to changes": 0.0034952536381399443, "associated with plasma": 0.005960706236373995, "adiponectin at baseline": 5.750473817699895, "correlate to changes": 0.003455554557126685, "changes in nps": 0.006150710815456558, "nps or adiponectin": 5.750896533130207, "adiponectin during follow": 5.750422531528496, "prevalence of heart": 0.010458357643487667, "requires a presence": 0.002232038895494876, "presence of signs": 0.007335778187637033, "signs and symptoms": 0.008104222213328838, "developed this guideline": 0.0007347340574822535, "guideline to present": 0.003387893347992408, "present the evidence": 0.004681913215992639, "deficiency in adult": 0.005963620234070755, "language on anemia": 5.750317658018987, "includes all clinicians": 0.0003344718660614203, "grades the evidence": 0.004597846293473394, "evidence and recommendations": 0.008156272402322588, "use of erythropoiesis": 5.757234361317318, "agents in patients": 0.009058095244638669, "benefits of anemia": 5.757104691685545, "treatment in patients": 0.009609546524279798, "evaluate the benefits": 0.004582876337402439, "benefits and harms": 0.008023966899161024, "harms of treatments": 0.007335662663551211, "treatments for anemia": 5.75202330531586, "anemia in adults": 5.7557984654295, "trials of blood": 0.007608811901045813, "agents in adults": 0.006086844993681146, "adults with anemia": 5.755084528650249, "studies of transfusion": 0.00756575592168483, "data on study": 0.0015518566081259596, "assessed for quality": 0.002696919336058278, "trial of patients": 0.010590083024398471, "tolerance and quality": 0.00822966515373334, "trials of erythropoiesis": 5.757170140474647, "associated with harms": 0.0059097849984563995, "transfusions in patients": 5.7587186766099485, "confounded by indication": 0.0009360703589057015, "failure and iron": 0.010918941422884508, "warrants further study": 0.000866810282322249, "anemia and heart": 5.760820780540417, "conditioning for patients": 0.00534529596059611, "fraction and patients": 0.011694148039721925, "ways to deal": 0.003179737238047456, "identification and enrollment": 0.007976115661902145, "as the authors": 0.005093957395748566, "review and meta": 0.00811919196130838, "mortality in heart": 0.009721897404013708, "conducted a meta": 0.0022243807503789484, "analysis to identify": 0.0036267879589672244, "addressed the association": 0.004544488458903652, "predictor and mortality": 0.008684514966806113, "found for age": 0.002640657364141638, "shocks during follow": 0.0007292975747989141, "hours of admission": 0.007415804025619416, "within each strategy": 0.00019557559485292004, "treatment or placebo": 0.0019120408252117761, "change in serum": 5.755782441788896, "c from enrollment": 0.0008486159586783171, "dopamine or nesiritide": 5.750998584828206, "study to promote": 0.0039603793130160835, "adoption of heart": 0.010406468847006635, "lessons for nurse": 0.002249448068825349, "studies in practice": 0.00624767184202102, "issues and strategies": 0.008050613338988046, "individuals and organizations": 0.00800008311446468, "testimonies and conversations": 0.00793632885805994, "conversations with participating": 0.005197561405941904, "benefits of involvement": 0.007353460566964643, "regulator of growth": 0.0073336691644718, "plasticity in cardiomyocytes": 11.505374172363235, "mechanisms to coordinate": 0.0032416574545575225, "structure by changing": 0.0009876621180859994, "altering the gene": 0.0045304032972596706, "growth and plasticity": 5.75768542326446, "setting of disease": 0.007855212050446278, "proteomics to identify": 5.753005863546346, "abundance during disease": 0.0008972249642517466, "of these proteins": 0.007692746880742849, "hypertrophy and failure": 5.760687553928223, "knockdown of nucleolin": 5.756983877131529, "hearts of fish": 0.007353780964848554, "looping and myocyte": 5.757652891882658, "underlying these defects": 0.0003844594355198435, "system of zebrafish": 5.757062674944991, "examine the role": 0.0046563394587312, "shared between development": 0.0006125728151303931, "factors and outcomes": 0.008625220376899466, "identify the effect": 0.004715109180195161, "compared with defibrillator": 5.755416040614534, "mortality after hospitalization": 0.0015975589280421937, "years after hospitalization": 0.0012772850802412552, "among the study": 0.005396908688044143, "value for age": 0.002596390093079776, "changes in circulating": 0.006195847651187616, "outcome in heart": 0.009267753729125576, "evaluated the association": 0.004693088001321267, "capacity and outcomes": 0.00863550480582022, "min in peak": 0.006252958338978291, "found an interaction": 0.0008547582652464151, "cfus and diabetes": 0.00810613909774807, "requires further examination": 0.00016589056438003286, "applications of readmission": 5.757100151035887, "impact on hospital": 0.0009279506697598165, "change and correlation": 0.008106498490008503, "correlation between performance": 0.0005862920951065453, "deciles and level": 5.757759892811781, "level of agreement": 0.007411032319870132, "conditions and metrics": 0.008038582766508717, "using the ppr": 0.004681393053408791, "approaches to computing": 0.003240575536166403, "rankings and impact": 0.008094072278157645, "placed on readmission": 5.750370819994435, "discharge in patients": 0.009121697024394207, "readmission to hospital": 5.75323547727605, "hospital for heart": 0.005577941229396596, "potential to deliver": 0.0033155709373733308, "care and management": 0.00846288135080361, "way to meet": 0.0031714600601605867, "outcomes for adults": 0.0028894144480625097, "supplemented by hand": 0.0009282927281040974, "extracted and validity": 0.007971001005984102, "trial of implanted": 0.007507126922152129, "met the inclusion": 0.004461742382828487, "effect on mortality": 0.0014502937704087761, "investigation of apoptosis": 5.75700647375454, "participation of apoptosis": 5.757005510222511, "development of pacing": 0.007498420844821719, "blot and dna": 0.007937235233993286, "increased in heart": 0.00947349584811918, "increased in dogs": 0.006360768267292799, "weeks of pacing": 0.007440944074017264, "band of activated": 0.007303884897243052, "difference between numbers": 0.000552759798566413, "favour of apoptosis": 5.7569876770051405, "pathogenesis of heart": 5.760129053964107, "attributed to activation": 0.0032753300042992735, "incidence of pump": 0.00740339175513648, "failure or driveline": 5.753829070032034, "avoids a redo": 5.751852249882335, "used this technique": 0.0007691995367017726, "technique to exchange": 0.0032220425650783956, "loss and transfusion": 0.007998887356075974, "deaths or strokes": 0.0012460076625808866, "blocker and beta": 0.008169087914653846, "blockers at guideline": 0.0007356639891300813, "assesses the impact": 0.00458019664351881, "uptitrations in patients": 5.758713005119679, "correction for age": 0.002508526154278836, "hospitalized with heart": 0.00843618200764472, "failure and associations": 0.010897924320730577, "differences in plasma": 0.0060435380755481174, "levels between reduced": 0.0011943062003438064, "evaluate the relationship": 0.004609004747444442, "relates to sex": 0.003280383599954601, "accounting for hospital": 0.0024596884595201466, "compared with men": 0.005674313838525569, "fraction and sex": 0.008662195714324871, "among all subgroups": 5.750256894031617, "p for heterogeneity": 0.0014175624728132799, "among these subgroups": 5.750268702483493, "failure in children": 0.008860312530292314, "cause of morbidity": 0.007596656395521869, "mortality in childhood": 0.006604054007704207, "practitioners in office": 0.005905357670809448, "based or emergency": 0.001417442185514737, "disease and symptoms": 0.008611729535213396, "relationships with mortality": 0.00588894759102458, "read the article": 0.0044416859827790655, "impairment at hospitalization": 0.0008261010337166635, "time of discharge": 0.007580467730884423, "analyzed the association": 0.004591057332412262, "mortality or readmission": 5.751711940911424, "patients as having": 0.003826780032931099, "for each year": 0.002363366086373271, "calculated the percentage": 0.00452810020477782, "perform a control": 0.0024653063095638286, "patients with failing": 0.008355646203374352, "ability to augment": 0.0032468008104694656, "comparison of predictors": 5.75706777106463, "predictors of heart": 5.760185760665842, "patients with versus": 0.008611167349572669, "ability to identify": 0.003329055903133196, "studied the patients": 0.007584106282055312, "patients having heart": 0.006305072279554903, "study the impact": 0.0053463938431223485, "impact of self": 0.007453266586809924, "gender and adherence": 0.008015200296559173, "stimulation of endothelial": 5.757097005745978, "impaired in patients": 0.009065198868561955, "effects of exercise": 0.008152133195143402, "evaluate the impact": 0.004664704734190145, "pathways in patients": 0.009070957310160468, "incubated with hdl": 5.7548708286181816, "malondialdehyde and hdl": 0.007937235233993286, "assessed by flow": 0.0012295437811512214, "proteome of hdl": 5.756972563102568, "profiled by shotgun": 5.750612962674882, "stimulation of phosphorylation": 5.757091335220519, "amount of malondialdehyde": 0.007284064004519891, "bound to hdl(nyha": 0.0032007014935933444, "effect on hdl": 0.000748295534833756, "correlation between changes": 0.0007467339408446874, "changes in hdl": 0.006150710815456558, "production and flow": 0.008091889830541352, "improved the hdl": 0.004613273817143878, "value for plasma": 0.0023897537784439045, "value for admission": 0.002439848454406109, "measured in plasma": 0.006106343982994045, "patients with dyspnea": 5.757999068340429, "time of inclusion": 0.007506693671545096, "point for predicting": 0.0023611343039350976, "years after admission": 0.0010778258824008218, "disease by angiotensin": 5.751317055684095, "investigate the pathophysiology": 5.754233495114385, "targets for hhd": 0.002266431082016862, "develop a novel": 0.00228456606465521, "infusion and uninephrectomy": 5.757692590577733, "infusion and salt": 0.008015960851841785, "shortening and increases": 0.008009441373025488, "increases in lung": 0.005935470556318716, "after the addition": 0.005079475045341586, "addition of salt": 0.007396956373828605, "model to study": 0.004206562925521813, "study the transition": 0.005210488491278969, "transition from compensated": 0.0007798903571754583, "approach to predict": 0.0032878442728016513, "risk in communities": 0.0066489252121259106, "increases in incidence": 0.0059805750635814284, "associated with incident": 0.005921973858503762, "age and race": 0.008295260214229574, "% in women": 0.009064106279939085, "women and men": 0.008056374037215557, "survival after left": 0.001410272707249785, "lvad and patients": 0.011048489340512705, "survival to hospital": 0.003620905267695438, "mortality at hospital": 0.001403572437146991, "eligibility for heart": 0.005367934863673357, "reviewed the evidence": 0.004642719188724137, "effects and cost": 0.008223184827425435, "complications after implantation": 0.0007535768556828056, "status and device": 0.008234631691171572, "limits in models": 0.006107808559361089, "conclude that evidence": 0.0007583870115765699, "selected and program": 0.00803720901515325, "infrastructure and budget": 0.007933871487522365, "effects of biventricular": 5.757224842788398, "establish a control": 0.002465394032182437, "analysis of twist": 0.007638011061162475, "correlated with twist": 0.005301652833822599, "correlated with rs": 0.005279814669963805, "surrogates for changes": 0.0024876373621448788, "changes in rs": 0.006150710815456558, "lack of correlation": 0.00734814393655715, "correlation of remaining": 0.00732826605324283, "muscles with left": 0.005817169191542162, "report the case": 0.004563690023988863, "reported in patients": 0.009052100906188793, "hypertension with vasodilators": 5.755080558171994, "vasodilators and diuretics": 11.507351621590747, "reduction in blood": 0.006237291470093377, "demonstrated a reduction": 0.0025136853651229543, "in this patient": 0.006725002892330875, "surgery by echocardiography": 5.7508379740339794, "time of surgery": 0.0076016256367435735, "confirmed no findings": 0.00035309410524829183, "restriction of leaflet": 0.007336072327699416, "resection and edge": 5.7576561072282395, "at this time": 0.0011185802177681387, "as the mitral": 5.754958633394395, "closure and opening": 0.007971350365070613, "at the time": 0.005091424474274218, "years after valve": 0.00109585771198406, "at this point": 0.001018016409874715, "evaluated in patients": 0.0091614709994226, "stratification for death": 5.752346157344817, "hospitalization in heart": 0.009343001952087093, "set of variables": 0.007326739425918765, "using a quality": 0.0026936049434348385, "curves and log": 0.007945888335129603, "data to predict": 0.0034772594018621203, "predictors of end": 5.757410165538021, "disease in outpatients": 5.7561583701051315, "factor in heart": 0.00915964467868645, "equation and patients": 0.011059569440941263, "models for time": 0.0026229866057218176, "constructed and predictors": 5.7577317579170755, "associated with time": 0.006086370050130554, "epidemic of heart": 0.010412812976800957, "measure of patients": 0.010450013130143517, "differences between patients": 0.003643297385513492, "tested with interaction": 0.005288737302819394, "curves for death": 0.002613371190857026, "p=0.27 for interaction": 0.0022903418827191833, "measure of health": 0.007523636206038678, "including the establishment": 0.004548887839644553, "prognosis in heart": 0.009138955014921403, "doses of \u03b2": 5.757261621559792, "subjects with heart": 0.00840721917666544, "bb at enrollment": 0.0005199823219317521, "regimen and sst2": 0.007931417441872984, "function of baseline": 0.008025435018056764, "dose of metoprolol": 5.757306689371966, "found for heart": 0.005494277619082812, "across all study": 0.0011457668423340687, "effects in vivo": 5.755854058782159, "limited by chemical": 0.0010056947157476473, "instability and cogeneration": 5.757635556049673, "cogeneration of nitrite": 11.506665563224217, "report on effects": 0.0008415586054617912, "inhibition of protein": 0.00752246256620117, "dogs with tachypacing": 5.754891906516779, "assessed by end": 0.0014534733042468662, "donor to enhance": 0.003217687011738481, "predictors of response": 5.757192399052025, "score for predicting": 0.0024511162938550234, "score for prediction": 0.0024796160911347053, "identify the association": 0.0046337602248006475, "score with death": 0.00574546718377838, "trials to reduce": 0.003469541879277206, "mortality in adults": 0.00673940980911373, "studied the effectiveness": 0.004523628944800335, "spironolactone in adults": 5.7558268170922, "identified all adults": 0.0006173669992408882, "regression with time": 0.00547905663463905, "covariates to evaluate": 5.752996832238939, "association between spironolactone": 5.75034918109499, "use and death": 0.008566727297897994, "risk of hospitalization": 0.008352517675399507, "injury during spironolactone": 5.750189909216989, "cohort with incident": 0.0054449841239839845, "use of spironolactone": 5.757313752050527, "associated with risks": 0.005901160269268462, "risks of hospitalization": 0.00760532553377276, "benefits of spironolactone": 5.7571330433482455, "effects of beta": 0.007605471871297004, "perfusion by enhancing": 5.750635209827188, "at the end": 0.005250422102274091, "function in b": 0.006354380712505531, "compared with vehicle": 0.0056061513734656215, "weeks after b": 0.000688498926034252, "treated with drug": 0.005418748148452635, "encoding a decoy": 0.0021592498571873777, "perfusion in b": 5.755607451165524, "compared with b": 0.005592616283439667, "angiogenesis in heart": 5.758746927845738, "vary by emergency": 0.0009789543899459447, "interventions to improve": 0.0034226720196423458, "increased in human": 0.006460026654918573, "human and rat": 0.00807429329089954, "myocytes with volume": 5.755174865984664, "regurgitation and aortocaval": 11.507357292695055, "in the setting": 0.010356517328804379, "setting of increased": 0.0077749031034395205, "increase in lung": 0.006143539746907102, "absence of changes": 0.00755990778017852, "function and efficiency": 0.008415344609000147, "explain the failure": 0.007364461684797187, "inhibition to improve": 0.0034286635215349855, "symptoms and hospitalizations": 0.008140177876338868, "usefulness of tissue": 0.007341479201084912, "imaging for assessing": 0.00227353557218039, "pressure in patients": 0.009303133767136398, "velocity over tissue": 0.00015415851200548266, "catheterization and transthoracic": 11.507351621590747, "echocardiography with measurement": 5.755046568292458, "compared with e": 0.005632460529537341, "aucs of e": 0.0073080640534818, "using a cutoff": 5.752133378093328, "value of e": 0.007406832646419824, "performance for detecting": 0.002338421629178157, "relationship in heart": 0.009121445600681195, "function and prognosis": 0.008513264075004717, "end of diastole": 5.757336444944439, "provides an index": 0.0009728962199630223, "shift in nonsurvivors": 5.755604878539456, "along the regression": 0.004524671068183005, "ratios for variables": 0.002375991531774599, "failure in pigs": 0.008840965948652788, "using a stent": 5.752144720205457, "medication to prevent": 0.003272175167847738, "duration of antiplatelet": 5.757062949879115, "measurements and positron": 5.7576526579541465, "ischemia after bottleneck": 5.750339127860426, "wk after stenting": 11.500037856603686, "afterload of patients": 5.760100802728317, "among the patients": 0.007747666422803952, "placebo or ivabradine": 5.751077880506849, "calculated at baseline": 0.0008369132086160087, "measured by arm": 0.0010647339357229215, "reduction by ivabradine": 5.7508722713703, "reduction in patients": 0.009211173393722752, "levels to survival": 0.0036831280287564026, "indicator in patients": 0.009019449514490255, "association of hypoalbuminemia": 5.757118190287665, "characteristics and laboratory": 0.008083888553332823, "hypoalbuminemia before surgery": 5.749885681469383, "impact of normalization": 0.007442393263454029, "analysis of patients": 0.010738741032784035, "levels by correcting": 5.750890629363443, "way to improve": 0.0032973509399552765, "evaluated for lvad": 0.0023702454505864817, "insufficiency after left": 0.0012127344134708741, "accompanied by heart": 0.004075751147327741, "capacity and symptoms": 0.008266747221434452, "failure and sepsis": 0.01086977203932131, "oversewing or leaflet": 5.750924860568553, "determine the characteristics": 0.004619323876388592, "adhere to medication": 0.003257002871866052, "% in ages": 0.009019853044989886, "etiology and comorbidities": 11.507396991776066, "differences in presentation": 0.005985980489803933, "presentation and outcomes": 0.008462572817013497, "walking in patients": 0.009046256229891237, "minutes of exercise": 0.007960365542607924, "symptoms of anxiety": 0.00742439062529404, "care in improving": 0.0062653647075381355, "improve the management": 0.004754471252282113, "value in patients": 0.009107430417434257, "obtained at admission": 0.0006476008421339677, "specificity for identifying": 5.751944114832157, "factors at admission": 0.0007771571970538185, "levels of brain": 0.007593303647393913, "levels of creatinine": 5.757272828221986, "dose and oxygen": 0.008231379465589363, "dobutamine or norepinephrine": 11.500595204838621, "admission and follow": 0.008404024504730188, "factor in patients": 0.009148407334743994, "present a case": 0.002309840646035042, "presented with prolapse": 5.754890415425255, "time to complete": 0.003390178261997897, "sample and subgroups": 5.757714222317969, "limits of agreement": 0.007296781272191155, "populations to define": 0.003223387452655318, "change in repeated": 0.006043021409821547, "associated with elevations": 0.005898471355489165, "elevations in tumor": 0.005903020919093821, "showed no benefit": 0.0005532053424824598, "worsening of disease": 0.007847437716201638, "studied the risk": 0.005222733230941936, "among a group": 0.002794812186166026, "receiving these agents": 0.0004432710002771617, "agents to treat": 0.0032440540506537313, "enter the study": 0.005191865771472154, "stratified by propensity": 5.750624305751918, "use of loop": 0.007535397391238898, "elevated in subjects": 0.006094803549253265, "test for interaction": 0.0024312243556092092, "exercise to improve": 0.0039696842361641085, "life for people": 0.0023623257955767783, "people with heart": 0.008245000312120492, "assess the benefits": 0.0046107582149941565, "benefits of participation": 0.007365242065485706, "programme for patients": 0.005363478638018234, "capacity and quality": 0.008402100045346422, "satisfaction and sustainability": 0.007947262656826761, "found in quality": 0.006316385080421533, "improvements with others": 0.005248421957511736, "evidence of perceived": 0.007465538861121478, "met in relation": 0.005905182368987153, "relation to sustainability": 0.003210027139694903, "sustainability with commissioning": 0.005188353113480946, "programmes on completion": 0.0005755487135178443, "impact of frailty": 0.007470807749578164, "assessed the association": 0.004732506359387296, "age of participants": 0.007688267505743565, "risk after adjusting": 0.0013559882544998242, "decrease in score": 0.006170516026060412, "controlled for death": 0.0026627443927906376, "based on diabetes": 0.0009014750778212419, "disease at baseline": 0.0012977085411285335, "change in c": 0.006083157079724428, "role of vasopressin": 5.7571672205253925, "approaches to improving": 0.003285126781246109, "improving the prognosis": 0.004585826290038744, "prognosis of patients": 0.010509843789347193, "interruption of activated": 0.007307773937429257, "use of antagonists": 5.757274059047505, "antagonists and inhibitors": 5.7577776215341405, "secretion of arginine": 11.506665563224217, "reactivate the transcription": 5.754172633499097, "driving these gene": 0.00042008429043264135, "human and mouse": 0.008107880432948873, "developed a phenotype": 5.752080202439935, "resistance to pressure": 0.003575382916575835, "dysfunction and induction": 0.008350683477924468, "inhibition of mir-25": 0.00738151817680011, "sensitized the murine": 11.50382602351728, "myocardium to heart": 5.756057529739493, "integrate with micrornas": 0.005188879259407929, "micrornas to induce": 0.0031964920531881826, "induce the expression": 0.004603229492315176, "myocardium with impact": 5.755067774118182, "epidemiology and treatment": 0.008543791424046095, "use of bisoprolol": 5.757234361317318, "% of subjects": 0.010498733908687562, "base of treatment": 0.007876061644159259, "includes the use": 0.004691588324807655, "use of angiotensin": 5.757404461169621, "blockers in case": 0.006111890333538342, "case of angiotensin": 5.7572267279204254, "blockers and mineralocorticoid": 5.757789010553496, "effectiveness of bisoprolol": 5.757040325391062, "bisoprolol in reducing": 5.755628470389266, "patients with type": 0.00854429954291067, "diabetes to heart": 0.006499376842780451, "hallmark of type": 0.007534750583203964, "metabolism and survival": 0.008191427536114293, "determine the role": 0.004678202235101283, "mice and liver": 0.008101384978002547, "features of heart": 0.010413133401416372, "expression and activation": 0.008185623244899694, "action through activation": 0.00016731108528468303, "activation of p38": 5.75705751125608, "dysfunction during insulin": 0.0008454311330841277, "resistance and type": 0.008271053205991322, "variation in use": 0.006187123320839462, "use of recommended": 0.007590938311919847, "variation in rates": 0.006175663910010021, "rates of guideline": 0.007626273213670765, "treatment for outpatients": 5.752556691764871, "examine the association": 0.004607309221004659, "association between treatment": 0.0011606602761115358, "variation and practice": 0.008063194361363922, "rates of treatment": 0.00811377182081943, "treatment with angiotensin": 5.755653156247304, "determined for patients": 0.005377394130335559, "describes the likelihood": 0.00444408679647988, "patient with given": 0.005587502252179933, "% for angiotensin": 5.755226808227242, "% for \u03b2": 5.755311825613758, "use of guideline": 0.007637732624500207, "medications for patients": 0.005385112005813921, "component of improving": 0.007333527587690289, "patients with breast": 0.0083224684345072, "use of trastuzumab": 5.757268388232639, "associated with cardiotoxicity": 5.755631199027302, "associated with trastuzumab": 5.755631199027302, "diagnosed with stage": 0.005316882018174167, "treated with chemotherapy": 0.005402759675230325, "% in nontrastuzumab": 5.758719694298026, "increased the risk": 0.005632128787461063, "rates of trastuzumb": 5.757211558829452, "treated with trastuzumab": 5.755124261427287, "confirm the role": 0.00460983138535344, "frequency of administration": 0.007343086877961398, "development of trastuzumab": 5.757185779296178, "scores and mortality": 0.00870550128388902, "women with heart": 0.008354717666285207, "recommendations for patients": 0.005394933200567246, "based on data": 0.000957298616053001, "evidence on associations": 0.0007532219079232326, "patterns with outcomes": 0.005703049308519796, "scores with mortality": 0.0059517369886217635, "date of death": 0.007669152354465169, "calculated from food": 0.0008110472195816734, "for a median": 0.0045291656504805634, "years of follow": 0.008004403909048075, "biomarker in heart": 5.758752598950044, "study of exercise": 0.008694349292149777, "associated with measures": 0.006019946871433951, "associated with death": 0.006271836694912691, "ratios for log2": 5.752006697132601, "outcomes after adjustment": 0.001155092030729348, "risk as assessed": 0.0016089358501583794, "assessed by changes": 0.0013598800790853487, "expand the transplant": 0.004528796683253244, "pool by matching": 0.0009288494828883975, "donors and recipients": 0.007970474377570605, "age or comorbidity": 5.751165375277652, "paucity of data": 0.0075098451983756885, "contributing to survival": 0.003410226358474187, "second to determine": 0.003288362713506682, "associated with assignment": 0.0058981204627522365, "frequency of diabetes": 0.007481618362031515, "in a multivariate": 5.757783770309086, "change in readmissions": 5.755782441788896, "readmissions and follow": 5.758041434774883, "visits as part": 0.0007955460356772098, "quantify the change": 0.004592243300566413, "readmissions as part": 5.750415684743244, "assessments of patients": 0.010413298650516274, "days of hospital": 0.007635765646427835, "known about patient": 0.0004279873590351421, "quantified the change": 0.004580900995468647, "events at follow": 0.001116239083727656, "age of patients": 0.010670973167346116, "cardiologist or heart": 0.004325966266368739, "percent of patients": 0.010417972752295425, "patients had blood": 0.0036865678059006435, "decreased in parallel": 0.006060889354759555, "testing and medication": 0.008075823645652295, "changes at follow": 0.0010939515675888478, "pathophysiology of heart": 5.760151737802447, "relationship between pathobiology": 5.750237051914006, "pathophysiology and prognosis": 5.757794689567156, "patients with suspected": 0.008298817713970253, "patients with confirmed": 0.008324484527151574, "quantified by tissuefaxs": 0.0009313051477885196, "associated with prognosis": 0.006006213173010944, "treatment and risk": 0.009288000989182895, "patients with thalassaemia": 5.757993396753662, "verify the impact": 0.004590165392900527, "value for heart": 0.0054500103480209505, "changes in treatment": 0.006751595515240124, "year for heart": 0.005471537945740077, "choice of chelation": 5.7569903953693125, "influence the risk": 0.005198849742848569, "compliance with treatment": 0.005823001366995744, "impact of ejection": 0.008093942607653053, "prolongation and ejection": 0.008611383105543248, "assess the effect": 0.004739630951169473, "results of patients": 0.010588387070657486, "patients with baseline": 0.008583653232428434, "trend for improvement": 0.002462862367989574, "compared with subjects": 0.005693873070917201, "contributes to heart": 0.00634155269348112, "comorbidities in heart": 5.758758269957867, "dd of collagen": 5.7570009195889895, "deposition and titin": 5.757669905774524, "rats after heart": 0.003819298588139553, "groups of rats": 0.007623670797818647, "weeks with repeat": 0.005303692154629832, "assessed at euthanization": 5.750365773968667, "contributions of titin": 5.757022202174217, "measure of left": 0.007956407470354332, "examine the ability": 0.00453458845210888, "measured by index": 0.001354378395252381, "stroke and hospitalisation": 0.008038727396504835, "hospitalisation for heart": 0.00536805182789843, "hospitalisations for heart": 5.755066927934309, "duration on outcomes": 0.0011437089568419553, "mortality or heart": 0.00502232205975119, "for this substudy": 5.75237194382802, "extent of benefit": 0.007409141624569175, "support the use": 0.00488294556982347, "needs further investigation": 0.0001132680931167134, "overload in heart": 5.7587809530244, "complications of therapy": 0.00783983524983696, "decrease in re": 0.005994075137561936, "hospitalizations and length": 0.00805989417805528, "option in refractory": 5.75562048839082, "usefulness and consequences": 0.007952320087742132, "therapy in dialysis": 0.006446601912616109, "deferred in dialysis": 0.005954002375802252, "lack of benefit": 0.007417150480540072, "performed a case": 0.0023943003510316424, "matching for age": 0.002514168403508503, "blocker and angiotensin": 5.757941544792211, "assessed for evidence": 0.0025850862165159704, "improvement in ejection": 0.006757227844246598, "in the case": 0.010381824187715055, "increase in ejection": 0.006789505420536024, "compared with dialysis": 0.005654970251252387, "improvement after device": 0.0009345259019585977, "stiffness and function": 5.7581155657050305, "approaches to stop": 0.003233294604168232, "patients with treated": 0.008502787861993657, "consumed the dash": 0.004428007749305669, "resistin in chemotherapy": 5.75568102844815, "failure in humanized": 5.7585286453762965, "treated for breast": 0.0024532424816700745, "mediator of insulin": 5.757057568387536, "development and severity": 0.008110519093480845, "severity of heart": 0.010413105387235494, "resistin in heart": 5.758792293978855, "resistin but transgenic": 11.49972620170502, "basal and inflammation": 5.757675402107861, "induction of serum": 5.757057338704042, "controls not expressing": 0.0005979292685779641, "treated with doxorubicin": 5.755141273582475, "levels in women": 0.006223771201487819, "elevation in resistin": 5.755669773287318, "correlated with decline": 0.005305131062944668, "decline in ejection": 0.00657988646327746, "effects on macrophages": 5.750472270788588, "link between inflammation": 0.0004786383006078716, "outcomes of catheter": 0.007828550610646186, "fibrillation in patients": 5.758820746937201, "investigate the efficacy": 0.004579954163708565, "safety of catheter": 0.00743220329915166, "patients with compensated": 0.008311535118060953, "probability after catheter": 0.0006175076968064927, "ablation and factors": 5.757842930878448, "relating to maintenance": 0.003204735680441566, "strain and strain": 0.0080726096499539, "echocardiography at baseline": 5.750564548423012, "months after ablation": 5.750493314968324, "lack of hypertension": 0.0075125904493124, "associated with maintenance": 0.005902534590414061, "rate at systole": 5.750606598028927, "rate at diastole": 5.750606598028927, "rhythm at follow": 0.0009367290318057066, "composite of repeat": 0.007368603706412385, "procedures and pharmaceuticals": 0.008004089121117908, "pharmaceuticals in patients": 0.009014216543469886, "verify the benefit": 0.004547208558952583, "dysfunction in doxorubicin": 5.756043844777172, "mechanism of cardioprotection": 5.75705134382574, "effect of nicorandil": 5.757188196744986, "administration of doxorubicin": 5.7570709600719905, "doxorubicin in rats": 5.755760182744874, "h after receiving": 0.0005159680855110745, "dose of doxorubicin": 5.757249988457811, "sacrificed and hearts": 0.008015400641352493, "excised for estimation": 5.751927275807685, "contents in addition": 0.005986093635957438, "addition to cytochrome": 5.752973705292168, "alleviating the decrement": 11.503814680440247, "decrement of heart": 5.760100696995224, "induced by doxorubicin": 5.750907475180292, "contents by restoring": 0.0009244938360308717, "capacity and creatine": 5.757819187813125, "effect of doxorubicin": 5.757233564421721, "development of doxorubicin": 5.757202791451366, "rats as indicated": 0.0008182450213878147, "indicated by improvement": 0.0011553897822931128, "months of isolated": 0.007540885851304718, "risk of stroke": 0.008125411010408081, "rehospitalization for stroke": 5.752046132175922, "estimate the risk": 0.005188325604215918, "adjusting for confounders": 5.751944114832158, "days of follow": 0.007763525886004032, "events after adjustment": 0.0009213363854292707, "increased in patients": 0.009462258504176722, "patients with estimated": 0.008392736096688027, "burden in adult": 0.005973413151793568, "cause of heart": 0.010662495767354806, "transplants in children": 0.0059333889260813, "symptoms in children": 0.006074006841689725, "subgroup of children": 5.7570255877330725, "restriction to flow": 0.003347816304081268, "comprise those children": 0.0002550633844166509, "topics of debate": 0.007273598034850752, "diagnosis and management": 0.008251631742005994, "responses to heart": 0.006346843857280603, "survivors of childhood": 0.007322478078103476, "scaffolds in heart": 5.758718570876855, "ability of cardiomyocytes": 5.757102176220505, "cardiomyocytes to detect": 5.752985723476169, "myocardium in response": 5.75576490834405, "workload during stress": 0.0004413690367206166, "adaptation to stress": 0.0032741323775922733, "leading to heart": 0.006356254591605518, "number of cases": 0.007365090580935177, "requires a signalosome": 5.751889550528461, "drives the assembly": 0.004426691999525856, "pathway to facilitate": 0.0032811512694478073, "role in determining": 0.006069116589097317, "field of investigation": 0.00728865198182462, "patient with diagnosis": 0.0056851613357547775, "frailty in heart": 0.009065240691644516, "indicator in heart": 0.009030686858432712, "accumulation of deficits": 0.007301781374491521, "method has strengths": 0.00016374824279503865, "strengths and limitations": 0.007942146649698001, "proportion of deficits": 0.0073121300634930095, "sex and ejection": 0.008685013396396367, "alternative to ascertain": 0.003228005499145658, "shaping the future": 0.004476968624288537, "characterized by disappointments": 0.0009252247650986551, "studies of therapeutics": 5.757241771006584, "agents and antagonists": 5.757725067140815, "antagonists of endothelin": 11.50671660403144, "highlighted the role": 0.004593694142382993, "points and sites": 0.007989647306346211, "strategies to improve": 0.003444853744842181, "improve the potential": 0.004669614849531486, "potential for success": 0.0023554000296745307, "levels of nps": 0.007557142042758762, "patients at risk": 0.004358637947105632, "embolism or diabetes": 5.751093764914769, "like other biomarkers": 5.749876745360664, "measurement of nps": 0.007341885681506266, "systems for measuring": 0.002280083142639544, "settings to monitor": 0.0032274211591333136, "monitor the risk": 0.005188062435829045, "use of protocol": 0.00755232384941311, "within the time": 0.004739514531436683, "accelerate the throughput": 0.004428358738165143, "throughput and disposition": 0.007937089125123012, "rethinking the quality": 0.004704592550819361, "quality of outcome": 0.007803329895476779, "mortality and readmission": 5.758451343771702, "hospitals to improve": 0.00338768593954025, "improve the quality": 0.00483460423229644, "fibrosis and inflammation": 5.757692415710239, "associated with chromatin": 5.75565388170795, "family of acetyl": 5.756978464161429, "activate a signal": 0.002174597590121015, "set of transcription": 5.757008485833969, "changes in cardiomyocytes": 5.755934446194492, "bets from chromatin": 5.750508463598636, "suppression of downstream": 0.0072905553581131865, "investigating the role": 0.0045936356604551086, "role of bets": 0.007440191848091974, "hypertrophy of cardiomyocytes": 11.506875379517513, "achieved through knockdown": 0.00010233215850344488, "presence or absence": 0.0012547492665572902, "abrogated the induction": 5.754144073772527, "induced in mice": 0.00628804557065365, "toxicity or effects": 0.0014216381263733886, "tissue from mice": 0.0009567545150593404, "targets of bets": 0.007317214613740873, "role in chromatin": 5.755824790111145, "factor of activated": 0.00744190624656001, "via the targeting": 0.004552651040536602, "targeting of chromatin": 5.7570785604929435, "respiration for quantification": 5.751938735848999, "t1 in swine": 0.005903020726097573, "swine with heart": 0.008322889426269598, "sequence to quantify": 0.0032473007651900084, "model of tachycardia": 5.757244647538844, "implanted with pacemakers": 5.7549104406514155, "min to induce": 0.0033779088278967717, "percentage of fibrosis": 5.757038572476178, "fibrosis of heart": 5.760134725068412, "tissue from control": 0.0011122559514754396, "administration of contrast": 0.0073368893394955, "animals with heart": 0.008360394083296205, "compared with tissue": 0.005649065604324948, "without the use": 0.004841923073909547, "associated with increases": 0.005914023486179272, "technique for detecting": 0.0022566400918920078, "approach to assess": 0.00334998294190899, "increase by means": 0.0011510367476853054, "means of stress": 0.007359101555904077, "used for factors": 0.002698388186025534, "terms of medication": 0.007344516175099004, "in the multivariate": 5.760058813946466, "adjusted for age": 0.0026499920595509825, "age and sex": 0.008296722239597286, "increase during exercise": 0.0012473114634381731, "use of devices": 0.007651905224354714, "devices in heart": 0.009147457860928097, "become a cornerstone": 0.002161000831381634, "cornerstone of heart": 0.010413251592548954, "symptoms and mortality": 0.008779822144101168, "collected in patients": 0.00903465075684523, "data in patients": 0.00924470325544371, "development of lifesaving": 5.757140409303821, "in this work": 0.006327597957081721, "exposed to angiotensin": 5.753080816131349, "induced to overexpress": 5.753127411083737, "prevented the loss": 0.0044782586982981855, "role in downregulation": 5.755785094407024, "procedures and management": 0.008205656949535695, "in this summary": 0.006358417568273167, "structure and function": 0.008471029808742139, "behind the development": 0.004586847837950159, "populations of patients": 0.010418180440004931, "represent a group": 0.002601229309933355, "trends in heart": 0.009058107633187498, "adjustment for patient": 0.002673826546098608, "indicating a change": 0.0022941052922823483, "activity and hemostasis": 5.757763229489905, "hemostasis in patients": 5.758713005119679, "metoprolol in reducing": 5.75573621037393, "reducing the risk": 0.005210894022578424, "events in heart": 0.009306803811018175, "correlates with levels": 0.0054780646643699075, "serve as markers": 0.0007203516201484904, "markers for coagulability": 5.751978315746538, "study with masked": 0.0059494050652034395, "randomized to equipotent": 5.753059714778393, "dosages of carvedilol": 11.506727945371761, "carvedilol or metoprolol": 11.50076532697083, "activity as measured": 0.0009351796066203251, "markers of hemostasis": 5.75703477086503, "wk of treatment": 5.7576188170228075, "medications to adults": 0.0033817789498382035, "prescribing of guideline": 0.007398532937100719, "prescribed a \u03b2": 5.752129526743314, "reasons for nontreatment": 5.751980302014763, "identified from clinic": 0.0009472490871101975, "patients not receiving": 0.0037194422240111346, "drugs for heart": 0.005408858702113141, "nonprescribing as chart": 5.750381840993395, "in these interviews": 0.0062129043434573416, "preferences and nonadherence": 5.757673851563432, "thirds of patients": 0.010395699358938644, "receive these medications": 0.0003793426754062997, "tone by pyridostigmine": 5.750686074802282, "onset of heart": 0.010532332628459509, "alternative to slow": 0.003231542495640385, "improved by acetylcholinesterase": 5.750803315508567, "elicited in adult": 0.005952306398108708, "methylatropine and propranolol": 11.5073346077954, "caused by methylatropine": 5.750641522712518, "caused by propranolol": 5.750641522712518, "reduced the basal": 5.754601573394263, "control of heart": 0.010716092700181971, "reduced the myocyte": 5.754607244691545, "diameter and collagen": 5.757692444951299, "assessed by means": 0.0011083289304382742, "treated with pyridostigmine": 5.755107248403814, "administration of pyridostigmine": 5.757036934893329, "geometry and fiber": 0.00794816912914173, "depolarization and myofiber": 11.507345950389956, "aspects in extending": 0.005934534265409427, "culprit in extending": 0.005902231410832062, "aspects of remodeling": 0.007464818804308753, "onset of myofiber": 5.757119884625546, "examine the relationships": 0.00449915986370782, "function on body": 0.0011777179411363219, "linked to weight": 0.003287170566439444, "assessment of body": 0.007534317916412575, "defined as death": 0.0011518827156784192, "risk of event": 0.00810871717968335, "wasting of fat": 0.007351914069662663, "tolerance in heart": 0.00903638758973391, "test the effects": 0.004787813800017788, "effects of treatment": 0.00809869881088186, "ivabradine on exercise": 5.750965048241924, "filling in patients": 0.009092732747089414, "time by controlling": 0.0011187073235178623, "onset of symptoms": 0.007550429852530496, "assigned to ivabradine": 5.752985638647275, "undertaken at rest": 0.0005079087315540468, "improvement between baseline": 0.0009284197344796533, "reduction in exercise": 0.006742924342287506, "difference in heart": 0.00913535838187865, "increase in heart": 0.009254834518678118, "rate during exercise": 0.0014340846294141622, "change with treatment": 0.0059083358534674675, "correlates of increase": 0.007520140676853732, "increase in exercise": 0.006775348123300414, "correlated with increase": 0.005514750020203232, "tool to predict": 0.003272147083067307, "predict the absence": 0.0045002723700400295, "prognostic and treatment": 5.758367238340275, "rule to exclude": 0.0032331501725732315, "derived a prediction": 0.0022947399831732378, "rule of having": 0.007359218937126544, "eliminate the need": 0.004465212594346376, "need for angiography": 0.002300129427921457, "savings and risk": 0.008696558894698374, "patients in addition": 0.009098341937605454, "use in heart": 0.00927602589291987, "failure and outcomes": 0.011384789885008304, "potential of diuretics": 5.757117514629325, "diuretics to modulate": 11.502611053856358, "options and challenges": 0.00795796080840136, "older have heart": 0.0036133337463949353, "ranging from medication": 0.0008306370169413624, "stratification of patient": 5.757406677944564, "failure and delivery": 0.010878249503150087, "delivery of therapies": 0.007316222160195372, "determination of risk": 0.008034092379805916, "responses in cardiomyocytes": 5.755697513975267, "altered in heart": 0.009070794638701718, "effects on beta": 0.0008812568403708142, "property of being": 0.007279873635797471, "increase in camp": 0.006121029039255307, "radioenzymatic- and fluorescence": 11.507323264621864, "expression and activity": 0.00823364008107659, "infusions in rats": 5.755697800597329, "fold and camp": 0.007959452759208448, "enhanced by stimulation": 0.0010039779840691114, "reduced the rise": 0.004898252676149349, "rise in camp": 0.005898459150129128, "levels and l": 0.008254046098888973, "protection from norepinephrine": 5.75046587390869, "investigate the safety": 0.004608095575129688, "days of inclusion": 0.00744832731267281, "underuse of eplerenone": 5.756995248484683, "fear of inducing": 0.0072763759112355825, "analysis of subgroups": 5.757365885412945, "leading to study": 0.003994259512903253, "discontinuation or hospitalization": 0.0015209351573626973, "risk of potassium": 0.008063355820679227, "hospitalization for hyperkalemia": 5.752312933869725, "hyperkalemia or discontinuation": 5.750970227184132, "discontinuation of study": 0.008051344237065605, "including an egfr": 0.0007662457007514385, "status in patients": 0.00915796209144563, "impact on health": 0.0008974424068216597, "explore the relation": 0.004452593310713392, "relation of hemoglobin": 5.757003521745007, "hrqol and training": 0.008093569606650558, "changes in hrqol": 0.006150710815456558, "cohort of patients": 0.010628798625107839, "trial of exercise": 0.008121833972963226, "effects on hrqol": 0.0007735990801721047, "correlation with baseline": 0.005506368138005424, "hrqol as measured": 0.000802214616931407, "effects of hrqol": 0.007497814111098294, "hrqol from exercise": 0.0013960583012602318, "modulated by baseline": 5.750896306902019, "analysis of rhythm": 0.007723567487961219, "strategies in patients": 0.009138150417219413, "in a substudy": 5.757738401860502, "expenditures of patients": 0.010407451810405, "rhythm and rate": 0.008455024311905306, "using a cost": 0.0024740187347079864, "utilization and unit": 0.00796161611206629, "supplemented by disease": 0.0014538096012829892, "structure in patients": 0.00908548340471637, "failure and type": 0.011113704094793961, "alterations in skm": 0.005942689215214621, "facilitate the reversal": 0.004462124124440616, "in a pilot": 0.008061129122195344, "immunohistochemistry and electron": 5.7576302353556414, "perturbations in components": 5.755617537264509, "microstructure at baseline": 5.750473817699895, "alterations in markers": 0.006004896977675405, "markers of skm": 0.00733042756984491, "means of improving": 0.007330719205320167, "cardiomyopathy in patients": 5.758798067343157, "evaluate the effectiveness": 0.004569549113427313, "treatment for patients": 0.005940889110924033, "verify the efficacy": 0.004529090538876232, "enzymes in patients": 0.009031318737499964, "evaluating the changes": 0.004704347893270661, "period in patients": 0.009152669558453688, "measured in serum": 5.75579384892911, "serum and leukocytes": 11.50738564676941, "leukocytes of participants": 5.757106753989678, "intolerance in heart": 0.009042468358223504, "update on exercise": 0.0012194894819258543, "parameters for diagnosis": 0.0023924735861275987, "provides an update": 0.0006894202499181268, "pressure of end": 0.007920902101626487, "addition to prognosis": 0.003394089430233857, "underlie these exercise": 0.0009711902301804159, "evaluating the effect": 0.004644021525205801, "effect of interventions": 0.00757981743328329, "surgery in heart": 0.009154092274195814, "treatment for end": 0.003176531327045877, "consultations and procedures": 0.00801525675178709, "year of oht": 0.007388515998041278, "oht in recipients": 0.005919566761125574, "bridged to transplantation": 11.50267343214486, "interval from transplantation": 5.750786096750179, "transplantation to consultation": 5.7529965983108164, "interval from consultation": 0.0010298708322839761, "consultation to operation": 0.0032206095684625164, "problems in patients": 0.009029416681923783, "bridged to transplant": 5.752991713820366, "consultations and operations": 0.007942642516818837, "oxygenation as bridge": 5.750392218732259, "bridge to recovery": 0.0032267196668152595, "recovery in infarction": 5.755814899923349, "arrest in need": 0.00594282686061161, "failure with therapy": 0.008608519557648991, "half of patients": 0.01039078794286448, "incidence and mortality": 0.00869553465552188, "outcomes of heart": 0.010922685574686501, "support this contention": 0.0006592661382918519, "ratio for death": 0.0030699055727389547, "year after discharge": 0.0008057892993738954, "% of incident": 0.01043229365318556, "lack of improvement": 0.007505518669449809, "therapy during exercise": 0.0015105303689862564, "assessed the feasibility": 0.004620644656834548, "testosterone or placebo": 0.0013563514432821026, "assessed in terms": 0.006087177821007776, "terms of recruitment": 0.007281753894438437, "compliance to exercise": 0.0038896323121341133, "exercise and injections": 0.008585824249121543, "injections in patients": 0.009014245784540319, "completed the study": 0.005213381908804764, "improvements in shuttle": 0.005969670022649269, "improvements from baseline": 0.0011031636376029408, "baseline in peak": 0.006360469751452689, "exercise with placebo": 0.005951113774485053, "status in heart": 0.009169199435388084, "investigate the effects": 0.004713376902458818, "parameters in patients": 0.009065111145381515, "program or placebo": 0.001378973836005171, "completion of training": 0.007445837151144307, "warrants further investigation": 0.00011756764953104769, "candidates for cell": 0.0023088431079755696, "affects the explant": 5.754143723169554, "determine the effect": 0.004710520952769256, "number and phenotype": 5.757739734222687, "level of epithelial": 5.757102191414132, "expression of pluripotency": 5.757147316988924, "compared with shams": 5.755291287991856, "stimulated the pluripotency": 5.754144220267315, "phenotype and function": 5.758155262084483, "function and cell": 0.008483013676760038, "arrest in humans": 0.005915327692329253, "effect on pb": 0.000748295534833756, "period or amplitude": 5.751034869373894, "anticoagulants or antiplatelet": 11.500612219309433, "role in treating": 0.00608010858068022, "progress in anticoagulation": 5.755620606125703, "patients in sinus": 5.758735690501796, "agents or anticoagulants": 5.750945966550349, "tools for risk": 0.0029931021561381867, "stratification and clarity": 5.757674962044929, "regarding the need": 0.0044978663430149685, "agents in combination": 0.00596242250975923, "combination with anticoagulants": 5.754909067095818, "nutrition in heart": 0.0090250445126963, "points to alterations": 0.0032834582168981955, "provides an overview": 0.0006850062191931178, "imbalance as seen": 0.0006977239997369209, "regulation of feeding": 0.00730014358813037, "role for inflammation": 0.0024232030399697992, "interventions in heart": 0.009127206035962033, "cardiomyocytes in response": 5.755810272933656, "biomarkers in patients": 5.758769715680456, "sensitivity and time": 0.008175795470447486, "indicated an increase": 0.0009234487331177241, "levels by dnx": 0.001191957655026909, "bolus of metoprolol": 11.506790317872685, "metoprolol or atropine": 11.500714287900323, "tachycardia in response": 5.755753566231921, "prevented the increase": 0.004668556107778719, "increase in circulating": 0.006166165874986364, "centers to evaluate": 0.003297488372365135, "evaluate the effect": 0.0047117490735777545, "evidence of left": 0.008072604690938753, "composite of death": 0.007737788847147589, "hospitalization for worsening": 0.002585851341438784, "stopped for futility": 0.002225709342223236, "data and safety": 0.008286275612364866, "reduce the rate": 0.004931328066453588, "rate of death": 0.008074607691984002, "device and extracorporeal": 5.757801017603449, "investigate the impact": 0.004641029017732858, "study in children": 0.0066939145389164735, "followed by vad": 0.001017500448690828, "comparison of baseline": 0.007572963872777377, "during the study": 0.005547204453287777, "group until day": 0.0006683352025901734, "continued until day": 0.000229686824294711, "decline in egfr": 0.0059114100819967425, "scores for hospitalized": 0.002425237737398581, "mandate to ensure": 0.003192485051194325, "outcomes of nursing": 0.007839395431878473, "aspects of nursing": 0.007356592717549925, "difference in outcome": 0.006249407463142726, "exists from admission": 0.000886840834033954, "records of patients": 0.010421249202426064, "improvement in outcome": 0.006336606023652767, "ratings from admission": 0.0008759658058656234, "nursing to outcomes": 0.0037565290951362676, "outcomes of hospitalized": 0.007919099713720509, "advancement of science": 0.007280848625786628, "highlighting the contribution": 0.004460486628636406, "care to outcomes": 0.004035851356901307, "response and progression": 0.008122609704193335, "actions on adenylyl": 5.750261882968673, "desensitization and downregulation": 11.507351621590747, "activation of \u03b21ars": 0.007353167960896148, "action on camp": 0.0005618063653109284, "overexpressing both \u03b21ar": 5.749873357248232, "occur after stimulation": 0.0006843037775782955, "triggered by isoproterenol": 5.7506178447536485, "regulation in mouse": 0.005974612031311109, "demonstrate that restoration": 0.000616203747641998, "overstimulation in heart": 0.009025541610631259, "impact of physician": 0.007538121292888831, "continuity on death": 0.000962332663182077, "readmission after discharge": 5.750508917439811, "rates of death": 0.007897566489420325, "death and readmission": 5.758134024904511, "continuity further influences": 0.00014577954545954444, "outcomes after discharge": 0.0012061533965963085, "data from linked": 0.0010089729276863651, "models with time": 0.005577707239826797, "covariates to analyze": 5.7529404179475865, "analyze the effect": 0.004655334782226276, "effect of follow": 0.007826970279649813, "seen the patient": 0.0048427964031499925, "taking into account": 4.739207240681338e-05, "discharge and physician": 0.00815161147144682, "examine the state": 0.0044959981559008, "phosphorylation and ser23/24": 5.757686975060993, "demonstrated no change": 0.0005616192791569112, "change in type": 0.006270962430599909, "expression of type": 0.007692548191404669, "focusing of ri\u03b1": 0.007272634126613506, "blots with site": 5.754887869963913, "mutant as compared": 0.0010928704024848386, "instability in patients": 0.009019624960720238, "investigate the role": 0.004655754639452496, "records of surface": 0.007302452085476392, "ecgs at baseline": 0.0007638029144412863, "pacing and esmolol": 5.757686947749634, "normalized to heart": 0.006336144469294909, "group during fixed": 0.0008117308346629905, "compared with baseline": 0.005881544470622653, "blockade with esmolol": 5.754927512639498, "fluctuations in beat": 0.005922051184268935, "consequence of heart": 0.010418513708102158, "failure in survivors": 0.008862598268718309, "risk for developing": 0.002997954806943629, "exposure to anthracyclines": 5.75290004574415, "examined the association": 0.004630166190061283, "frame for selecting": 0.0022441860492804656, "length of follow": 0.007694298526484203, "variants of genes": 0.007369513553488975, "web of complicity": 0.007274241337255252, "in this guideline": 0.0064439725485582935, "moves a step": 0.0021520273661477527, "language to describe": 0.003219527852127303, "describe the development": 0.0046124298063514625, "development and defects": 0.00812197894176931, "foundation for describing": 0.0022378420163751585, "describing a uniform": 0.0021578755280462123, "view to foster": 0.003189094226064572, "effort to provide": 0.003263631346722857, "insight into mechanisms": 0.00012153235666114573, "mechanisms of disease": 0.00785293318114634, "inhibitor in heart": 0.009065211450568956, "system by preventing": 0.001003642541889777, "preventing the breakdown": 0.004427481506964139, "peptide and b": 0.008073324374269233, "signs of heart": 0.010428423591609625, "diagnosis and initiation": 0.008061494713844732, "initiation of therapy": 0.007783359582401814, "stabilize the patient": 0.004817366660938082, "summarizes the principles": 0.004427306061939831, "implications of biomarkers": 5.757056549196528, "results from dysfunction": 0.0013360355772028614, "focus of research": 0.007345331500302227, "measurement and modification": 0.008027827566220305, "provide a window": 0.002223378379385175, "use of biomarkers": 5.757285400387826, "result of shortcomings": 0.007315371463129191, "shortcomings in research": 0.005953296412065892, "dearth of biomarker": 5.757006503549033, "implications of promising": 0.0073230340427123, "discuss the need": 0.004468661871949506, "standards in biomarker": 5.75562002053946, "provide an overview": 0.0007327069141839402, "overview of biomarker": 5.757017671179687, "micrornas in heart": 0.009019899168438688, "targets in disease": 0.006468994122059873, "body of evidence": 0.007609068356436319, "pathogenesis and progression": 5.757709194515886, "expression of target": 0.007500619881432247, "genes by sequence": 0.0009817030376470786, "region of messenger": 0.007284414791769692, "results in degradation": 0.006089189053649518, "remodeling and heart": 0.01121846810782877, "give an overview": 0.00064796488247329, "potential of mirnas": 0.007390485952024938, "targets for heart": 0.005400236561439672, "inhibitors in heart": 0.009121886981906371, "abnormalities and exercise": 0.00863116500040828, "capacity in adults": 0.006226334886447013, "filling during exercise": 0.0010964470357919267, "spectroscopy as did": 5.75043832630122, "% of predicted": 0.010419373767083922, "compared with age": 0.005872801507921303, "derived from comparison": 0.0008364527827189871, "in a sample": 0.008066975672346452, "analysis to determine": 0.0036221997315413193, "determine the presence": 0.004547390269843653, "practice and research": 0.00808008566341134, "fragments of n": 0.007532328864060758, "peptides in plasma": 0.005999254632095654, "misdiagnosis of heart": 0.010407638487923943, "plasma by use": 0.001232711053979219, "use of immunoprecipitation": 5.757223018240282, "identified the presence": 0.00462512596151502, "forms of circulating": 0.007333264906232317, "concentration of circulating": 0.00732987430544485, "increased with antibodies": 0.005648410502449315, "use of antibodies": 0.007547003444869038, "support the development": 0.004800336633362225, "hypertrophy in heart": 5.7588433234995335, "rates of hypertension": 0.007722616674848458, "adjustment for covariates": 5.7520007675862, "pressure to end": 0.003838035764884283, "-1.5 to -0.5": 5.752889638380175, "evaluate the effects": 0.0047370526189161035, "effects of carvedilol": 5.75725886796706, "patients with devices": 0.008422283737734855, "received a device": 0.0023254687965306702, "types of beta": 0.007390903940424781, "delivered as antitachycardia": 5.750363247414867, "reduction in risk": 0.006849800342609375, "reduced in patients": 0.009477212016118739, "use of beta": 0.007632004292064017, "rate in patients": 0.009430370340711649, "investigate the occurrence": 0.004489220353462448, "occurrence of heart": 0.010407463041524736, "users of bisphosphonates": 5.757048419530147, "bisphosphonates and raloxifene": 11.507351622169711, "comprised the control": 0.004748009822237098, "years for alendronate-": 5.75229783237185, "etidronate- and raloxifene": 11.507334607698903, "increased in users": 0.00640420391223177, "users of bisphophonates": 5.757031405059337, "mechanism of action": 0.007364802119408249, "alendronate and etidronate": 11.507345950679444, "compliance for etidronate": 5.751971739328291, "decreased for alendronate": 5.752079970044127, "compared to age-": 5.753321499023543, "age- and gender": 5.757674261708517, "users of alendronate": 5.757048419530147, "showed a dose": 0.0025444793125663457, "alterations by metoprolol": 5.750777385715968, "metoprolol in heart": 5.758837653938555, "order to examine": 0.003252644950435476, "examine the reversibility": 5.754183039126439, "reversibility of heart": 5.760100696995224, "rates of changes": 0.007777504247476545, "changes in pressure": 0.006445182758096723, "decreases in septum": 5.75563007864447, "animals with metoprolol": 5.7550443433739895, "norepinephrine and dopamine": 5.757698289958299, "levels of epinephrine": 5.757255813751176, "level for \u03b2": 5.752312196611497, "performance by \u03b2": 5.750972342724626, "stages of heart": 0.010411731060423523, "reversal of changes": 0.007544121721710177, "associated with atherosclerosis": 0.005915485536812961, "atherosclerosis and incident": 0.007989065947292612, "within the population": 0.0046941892478010025, "association between psoriasis": 0.0005937749874045783, "events for psoriasis": 0.00253834032931621, "pressure and body": 0.00838581928886125, "risk of incident": 0.008064231423726635, "increased in psoriasis": 0.006373689779772977, "events as subjects": 0.001043674662856027, "dysfunction in patients": 0.009405359056690963, "prevalence and characteristics": 0.008095347243708237, "patients had brain": 0.0035740431986848145, "associated with age": 0.006167342551009866, "quartile of e": 5.757006735761898, "highlighting these patients": 0.0034447014935601768, "addition to indicating": 0.0032915512460808096, "training of patients": 0.010558436344482686, "variability in risk": 0.006715167157769278, "majority of studies": 0.0075614575111097385, "risk of mortality": 0.008731413127326124, "used in risk": 0.006949601799760727, "variability to identify": 0.0033467132534340895, "order to assess": 0.0033036177252057757, "assess the risk": 0.005296535277160631, "tool for risk": 0.0030095604721797585, "present with hypertension": 0.005471040248293273, "hypertension and end": 0.008493861110447141, "foundation of management": 0.007484989646525903, "revascularization with angioplasty": 11.50459218609469, "angioplasty and stenting": 11.507340279092675, "benefit for patients": 0.005454293996180734, "regarding the role": 0.00462681574684397, "role of stenting": 5.757155878027319, "guidelines on evaluation": 0.0006629811178869049, "evaluation and management": 0.00818364681214968, "provide the framework": 0.004504912350523506, "framework for determining": 0.0022389239328449383, "assessment and treatment": 0.008627477872655631, "plans for patients": 0.005337079327935216, "analysis of microarray": 5.7573148446057205, "related to heart": 0.006488766461980784, "used for diagnosis": 0.0026383372916201878, "diagnosis and treatment": 0.00864539389439812, "observe the difference": 0.004537941581111166, "groups of samples": 0.007566149206318418, "regulation of programmed": 0.007300611444825672, "biomarkers to distinguish": 5.752957428944924, "types of heart": 0.010417051659648882, "targets to develop": 0.0032931640932963675, "effects of care": 0.007827651709478113, "mortality and healthcare": 0.008643355186369784, "integrates a content": 0.002158223995225235, "system with care": 0.005597777937334785, "intervention and survival": 0.008201599235517684, "survival and utilization": 0.008151466636362629, "groups after matching": 0.0008314206027220698, "admissions from baseline": 0.0010757165169641928, "use or number": 0.0014954042309282079, "number of hospital": 0.0075476784433914645, "days for participants": 0.0024981451142679556, "admissions for individuals": 0.0023326715926765547, "disease and mortality": 0.00916182506729462, "coupled with content": 0.005210334671185191, "technology has potential": 0.00026718574250953007, "potential to improve": 0.0034376312967598134, "strength of race": 0.007422561809455987, "association with exercise": 0.005949417796791508, "association between race": 0.0006489293610435568, "race and outcomes": 0.008535735277627503, "interactions with exercise": 0.005831504373955532, "performed an analysis": 0.001160383373819201, "explored an interaction": 0.0007396119956678328, "interaction with exercise": 0.0058993816008692706, "significantly more hypertension": 0.0006735645866163239, "hypertension and diabetes": 0.008315868651560664, "interaction between race": 0.0005988931651213188, "race in patients": 0.009097815609211819, "rationale and design": 0.007960153499792507, "anticoagulation and rate": 5.7580576445067, "offset by side": 0.0009054301281086383, "effects of repeated": 0.007519447587985154, "practice of delayed": 0.007376815308473634, "safety of rhythm": 0.007499927374426702, "af at risk": 0.0012360698116252785, "spent in hospital": 0.006112002630701161, "consist of anticoagulation": 5.75699486921933, "therapy of underlying": 0.007817064846031719, "device to monitor": 0.003354294017880219, "function and quality": 0.00868146375592777, "bleeding in patients": 0.009048039929238985, "treated with implantation": 0.005487877486712013, "as the use": 0.00532897698069378, "housed on units": 0.0005683273624981813, "managing the device": 0.004591305761294643, "develop an understanding": 0.0007234460976508055, "groups to manage": 0.003436656289600451, "manage this population": 0.0006072672352961399, "management of end": 0.007833552706377762, "increase in incidence": 0.006188644254169815, "incidence and prevalence": 0.00804986877662759, "causes of death": 0.007690844472084423, "death and hospitalisation": 0.008327410646232318, "as a consequence": 0.0028142950401281, "increase in life": 0.006326880636239382, "patients with end": 0.008652935396847646, "fall into stage": 0.00014400164826348558, "failure at rest": 0.0034296871844164845, "in this article": 0.006359088589891847, "treatment of end": 0.008227314858769888, "inhibition of l": 0.007420720835282096, "supports the plateau": 0.004443355582032593, "trigger for excitation": 0.002239362451919311, "failure in humans": 0.008839825549708755, "modes of l": 0.007312889461644007, "contributes to cardiomyopathy": 5.7529971527327195, "via a mechanism": 0.0023127718221888443, "efficacy in vivo": 5.755720636043408, "situations in pediatrics": 5.7555891212347285, "preclude the provision": 0.004438678476328884, "provision of life": 0.00748412806939812, "reached the age": 0.004710004671715095, "decisions about life": 0.00018005541182815468, "presents a case": 0.002231065177136111, "disease has life": 0.0008778670417162838, "going into heart": 0.0031596793755223574, "reporting on quality": 0.0008405859455327064, "aims to help": 0.0032165416573095486, "based on outcome": 0.0009691117457924093, "measure for heart": 0.005410466942361962, "created a cohort": 0.0023888682637678463, "estimated the odds": 0.004599594443448479, "odds of future": 0.0074066892631911825, "quintile of hospitals": 0.007351825382690747, "repeated this analysis": 0.0008140793337139299, "performance on existing": 0.0006544646588545926, "chosen a hospital": 0.0023728516016276527, "quintile of performance": 0.007383679875972035, "odds of dying": 0.007357436074081012, "value for difference": 0.0024316640820381003, "measures of quality": 0.0076882648796956134, "measures at explaining": 0.0006126634112877307, "influences the safety": 0.00456971504049602, "efficacy of spironolactone": 5.757153796891009, "incidence of hyperkalemia": 5.757108229832715, "caused by mineralocorticoid": 5.75065286559656, "vary by race": 0.0010144367425477408, "antagonists in heart": 5.7587696116840785, "hyperkalemia and outcomes": 5.758218976303329, "randomized to spironolactone": 5.753150448588639, "rate and heart": 0.011481435200670577, "increased with spironolactone": 5.755415159108107, "race by treatment": 0.0015930739041514243, "throughout the trial": 0.004617362082436313, "compared with aas": 0.005592616283439667, "rates of hyperkalemia": 5.757285281931453, "rates of hypokalemia": 5.75721723041622, "adjustment for differences": 0.002363305586377601, "point of death": 0.007751548091477487, "hypokalemia with spironolactone": 11.504665905723613, "differ by race": 0.0010258669637548102, "proteomics and pathway": 5.757715245367997, "analysis of pressure": 0.007910644839943845, "approach to evaluate": 0.003322101064317272, "categories of actin": 5.757010830435182, "effects on heart": 0.003907404559594914, "changed in pressure": 0.006198573245872642, "alterations in tac": 0.005942689215214621, "rehospitalization of medicare": 11.506705262884172, "analyze the relationship": 0.0045525904560929625, "relationship between length": 0.0006099992107993805, "stay and rehospitalization": 5.757703025003337, "using the implementation": 0.004713433318097167, "declines in length": 0.0059687050714973666, "decrease in length": 0.006053504125641795, "hospitalized for ami": 0.002347655894116932, "reduction in hospital": 0.006315304732556069, "rate of rehospitalization": 5.757422628105204, "outcomes of care": 0.008118717693643512, "need to improve": 0.003358387788997847, "costs for patients": 0.005399753878861642, "association with outcomes": 0.005815759000625966, "physicians into quintiles": 5.749809736674809, "volume of patients": 0.010683482232309891, "regression to compare": 0.0033034480287261786, "strata of hospital": 0.007511875559852413, "volume and physician": 0.00833127056099426, "relationship between physician": 0.0006510352721056674, "volume and mortality": 0.008920613730052783, "antagonism in heart": 0.009025541610631259, "using an aldosterone": 5.750646914524955, "groups with heart": 0.008548378179724453, "therapy with beta": 0.005777968925751315, "reduction in mortality": 0.006790603493817418, "mortality and hospitalizations": 0.008690273408420091, "hospitalizations for patients": 0.005402358378953189, "provide the background": 0.004498509739560494, "background for aldosterone": 5.751965512163282, "impact of evidence": 0.007600888634235794, "improvement in survival": 0.006297603785705727, "changes in prognosis": 0.006269766661939272, "basis of heart": 0.010437777520927664, "dilatation and dysfunction": 5.758089342818648, "decreases in heart": 0.009053869338439735, "p<001 and hr": 0.007925921205032351, "benefits of controlled": 0.007404266578330692, "emphasizing the importance": 0.0044540547813254555, "importance of tailored": 0.007304703636804728, "continuity of care": 0.007631705924103626, "threshold in heart": 0.00903638758973391, "patients with systolic": 5.758407169192303, "investigations at study": 0.0012621208737412586, "based on lack": 0.0007558982732212042, "lack of achievement": 0.007307479901575505, "failure in detecting": 0.008841112153927771, "modification of diet": 0.007425568754425225, "associated to prognosis": 0.0040194097338877716, "compared with metabolic": 5.755347999517475, "inability to identify": 0.003284038695376812, "mortality in men": 0.0066697894796768015, "without a history": 0.002362521578127972, "underwent a baseline": 0.0025727507832817827, "quantified as duration": 0.0007628268534397052, "divided into age": 0.0003569320231930819, "grouped into categories": 9.311796773291928e-05, "risk in men": 0.006728986328468759, "goal of achieving": 0.007299937405578731, "failure after pressure": 0.003805138243555322, "alterations in energy": 0.00599083417956095, "changes in energy": 0.006198855779802887, "rates of energy": 0.007561032085382194, "increase in e": 0.0061608732853529816, "decrease in %": 0.009111142434257489, "decrease in insulin": 0.0060725619921673454, "rates of glycolysis": 5.757222901906489, "glycolysis and glucose": 5.757658592903489, "translocation of glucose": 0.007296519162580427, "oxidation of glucose": 5.756995220015572, "ratio of phosphocreatine": 5.757451695915305, "create an energy": 0.0006915504076771716, "progression from hypertrophy": 5.750621408181864, "hypertrophy to heart": 5.756142583281159, "reality of heart": 0.010403310837030139, "factors of developed": 0.007623713889311514, "risk of raised": 0.008029062967098544, "% of cases": 0.010441588733067414, "paradox of having": 0.007322531673152874, "epidemiology of developed": 0.007462060524554143, "linked to heart": 0.0063503512295884955, "assessing the link": 0.004430755340733157, "link between air": 0.00045963473315634943, "pollution and heart": 0.01108121395643898, "effects of air": 0.007512605267248609, "pollution on heart": 0.0036992975278645644, "physicians and professionals": 0.008002190388959936, "lead to hospitalisation": 0.0032148493984066745, "hospitalisation and death": 0.008327410646232318, "failure in mice": 0.0089828680580712, "implicated in heart": 0.009036621518081524, "dysfunction with conduction": 5.755273197437145, "abnormalities and hypertrophy": 5.757800270247458, "in these studies": 0.006466530296974591, "decreases in ejection": 0.0065885402402976415, "dilatation and hypertrophy": 11.507516069917546, "hearts with increased": 0.005709795271047926, "spite of developments": 0.007277545542969833, "requires the collaboration": 0.004475745194804393, "collaboration of professionals": 0.007292513340875232, "indicated by guidelines": 0.0010211052900461902, "communication and collaboration": 0.007939193311059222, "country has physicians": 0.0001811930016212899, "across the country": 0.004473158008720106, "strengthen the connection": 0.004424820579783443, "connection between certified": 0.0004448436674828804, "phase and healthcare": 0.007984973254933933, "risk for hospitalized": 0.0031088509784839105, "examine the associations": 0.00451816214162519, "saxagliptin and sitagliptin": 11.507402662783889, "insurance and health": 0.008130882481394826, "therapy with saxagliptin": 5.755408681954981, "contributed an average": 0.0006921669172408513, "observed in users": 0.006067967100894047, "users of saxagliptin": 5.757071104140349, "saxagliptin or sitagliptin": 11.500663259923613, "effectiveness of implementation": 0.007362350870297879, "strategies in improving": 0.006065015701881496, "adherence to guideline": 0.003355364330545995, "recommendations in heart": 0.009074827957865468, "review to identify": 0.003415480858054524, "adherence to class": 0.003455382851672212, "outweigh the risks": 0.00443692392619791, "methods and analysis": 0.008283960200949653, "conduct a literature": 0.002173194023082528, "uptake of class": 0.0075269659443510705, "data in duplicate": 0.006127748321080364, "level of application": 0.007416908398909912, "intervention on adherence": 0.0006674552514725957, "referred for device": 0.002392048313167656, "education at discharge": 0.0005956553941865162, "readmissions and mortality": 5.758388973296569, "examine the context": 0.004499744681909184, "synthesise the results": 5.754313607859623, "results for meta": 0.002471660170722295, "discussion and dissemination": 0.007933287807478465, "impact of implementation": 0.007457506491060712, "factors on physician": 0.0008352987269619812, "findings through briefing": 0.00013556744411195073, "publications and presentations": 0.007936562786163868, "discussions to occur": 0.0032620039418795135, "occur between physicians": 0.0005484164727497064, "physicians and heart": 0.011121525072271654, "reported the patient": 0.004855192541513634, "preferences and timing": 0.00799131719110243, "mind to engage": 0.0031996770312732676, "wished further review": 0.00022579883762567353, "preferences and decisions": 0.007977781239093084, "support the need": 0.0046698414822211355, "need to include": 0.003258894291513663, "deactivation at implant": 5.750224529629149, "discussions about end": 0.0003510073552515352, "using this process": 0.0007200942859199862, "process to help": 0.0031959591589121043, "reduce the number": 0.004562378711931839, "shocks at end": 0.0008498659106159044, "symptoms and disease": 0.008611729535213396, "compared with control": 0.005906683696814701, "change in distribution": 0.006047172179245445, "burden of heart": 0.010428774482684363, "report of using": 0.00760023536266901, "rehabilitation in patients": 0.009075546014190125, "rehabilitation in patient": 0.006347394315117253, "guide to prescribe": 0.0032121322927098333, "patients as control": 0.0040921487816543934, "intensity to exercise": 0.0038504602446810515, "min after rehabilitation": 0.0008207588732212527, "changes in control": 0.0064647782288315934, "classified as heart": 0.00382279178433151, "function in hfpef": 0.006354380712505531, "changes on exercise": 0.0014629409869437232, "history of hypertension": 0.007529718227276045, "include the patient": 0.0048422716438139704, "rate and rhythm": 0.008455024311905306, "pressure and auscultation": 5.75791906485609, "auscultation to rule": 5.7529263256441485, "referred to heart": 0.006334360768382447, "hypertension and hyperlipidaemia": 5.757834322467262, "benefits of exercise": 0.007997956913629737, "depression and dementia": 0.007947145596410308, "volumes of exercise": 0.007927538030552943, "individuals with established": 0.005277861422553581, "death in athletes": 0.006297288325853593, "death during sport": 0.0007444605584689022, "occur in males": 0.005941374237443061, "ability to detect": 0.003252209131220698, "pathways and ion": 0.00799330355289293, "individuals with cardiomyopathy": 5.755031748632877, "system in heart": 0.00911568259762856, "strength by measuring": 0.000984244202100968, "measuring the peak": 0.004618805463759836, "improvement in peak": 0.006274199338219704, "aerobic and resistance": 5.757754178489931, "resulted in benefits": 0.0060110620951324325, "benefits in exercise": 0.006615830795261492, "strength and quality": 0.008278364949794394, "need further validation": 0.00013825644691032118, "adherence with exercise": 0.005883100761079375, "describe the association": 0.004561853821312833, "barriers to participation": 0.0032402260915012017, "participation with exercise": 0.005848080229711278, "surveys to assess": 0.003308443502218322, "indicated more barriers": 0.00022597801899177332, "association between increasing": 0.0006070744148103466, "impact the effect": 0.004778874200777623, "impact on patients": 0.0038238193309264993, "given that exercise": 0.0012474249037715533, "assessment of perceived": 0.007390788421097734, "approaches to implement": 0.0032393766569080097, "reduction and exercise": 0.008782751858303977, "arguments for beta": 0.002329917728906457, "readmissions in heart": 5.7587809530244, "effect on heart": 0.0038821010142565658, "assessed the impact": 0.004766810975394199, "impact of hr": 0.007425466226372336, "blockers on exercise": 0.0013457270297399246, "analysis at baseline": 0.0011117560043608413, "doses for beta": 0.0023533637639950706, "patients with resting": 0.008334044667891016, "versus the latter": 0.004748951905139513, "decreased at follow": 0.0009761820303888207, "compared to baseline": 0.0038947410314994794, "increase in patients": 0.00924359717473566, "bpm with beta": 5.755001172146472, "achieve this target": 0.0005104704070713025, "shunting for treatment": 5.752522664270627, "treatment of patients": 0.010991672642648043, "safety and proof": 0.008060203123559364, "interventions to reduce": 0.0033849428649898442, "risk of hospital": 0.008256114366064774, "shunting in patients": 5.758713005119679, "catheterisation with transoesophageal": 5.754876471060374, "evaluations at baseline": 0.0007863428631583085, "baseline and months": 0.008397335662291523, "thrombosis or migration": 0.0012031824052671182, "hospital for worsening": 0.002489448032104052, "bleeding at month": 0.000610679531530557, "in this regard": 0.006340672361921139, "results of studies": 0.007735026839193107, "receptors and neprilysin": 11.507385649663938, "individuals with stabilized": 0.005247927074259536, "without a need": 0.0023537753489274917, "need to interrupt": 0.003233813862238566, "interrupt the treatment": 0.005023659477914957, "become a change": 0.002285068769558424, "form of heart": 0.010420557880296118, "excluded by inclusion": 0.0009760912838127566, "weeks of diet": 0.007513369284574892, "consisted of telephone": 0.0072842113239843225, "completed the trial": 0.004640866589618209, "combination of exercise": 0.007949434292030148, "score with exercise": 0.006015106899439027, "change in peak": 0.00620683580818851, "change in percent": 0.006048572742365631, "change in thigh": 0.0060269718929787715, "effect on quality": 0.001035551062239523, "life as measured": 0.001008066213915482, "support to patients": 0.006517403428050971, "hemocompatibility by incorporating": 5.75061269950534, "evaluate the performance": 0.004611633595904473, "performance and safety": 0.008154409462119927, "adults with ejection": 0.005991951175568643, "listed for transplant": 0.0023223763633436253, "continued on support": 0.0007595957563133164, "reoperation for bleeding": 5.751955486088819, "effectiveness of disease": 0.00786421623229675, "costs and survival": 0.008194522995493371, "approach to extrapolating": 5.752930651480946, "costs to generate": 0.00325495491669034, "projections of resource": 0.007300289793764467, "relationships with time": 0.005386162079051884, "estimates of resource": 0.007315725251692001, "ratios from user": 0.0008388761332582211, "validity in replicating": 0.005919859654002945, "simulations to evaluate": 0.0032754747624302635, "effectiveness of heart": 0.010464116085032312, "design a program": 0.0022389056366531918, "improvements in functioning": 0.005963764507512769, "functioning and use": 0.00818722251480559, "researchers and providers": 0.007937292657518472, "tool for conducting": 0.002259036113704855, "analyses of disease": 0.007881374013978773, "role in supporting": 0.0060670989624972554, "patients in managing": 0.00902322034318746, "managing this disease": 0.0009929569122859871, "describes the pathophysiology": 5.754183040863156, "nurses to understand": 0.003211779996270346, "understand the pathophysiology": 5.754165849639502, "management to alleviate": 0.003403731564845811, "deter the advancement": 0.0044338548785907315, "heart failure": 9035.30236915348, "patients with": 982.4396764464389, "ejection fraction": 102.4709970362833, "left ventricular": 243479.20720802873, "associated with": 125.05205235144942, "hazard ratio": 10.929970297509282, "% confidence": 39.47351501907304, "confidence interval": 5.083842150174624, "compared with": 44.704578261674975, "myocardial infarction": 84524.94541185633, "ventricular ejection": 42270.98612304441, "chronic heart": 21.47807261209116, "non -": 41.774148296069825, "preserved ejection": 5.383545887682048, "p <": -8.649933032157907, "congestive heart": 27062.0708171925, "\u03b2 -": 27083.44113900127, "risk of": 27.749657865891816, "heart rate": 12.28785636892571, "natriuretic peptide": 19871.997144856134, "exercise training": 2.6089247994953593, "this study": 3.5321443987918872, "failure with": 23.55250083660574, "heart disease": 10.651033052143605, "ventricular assist": 16699.851565752855, "% ci": 9.087363239350424, "failure patients": 16.036814691968058, "implantable cardioverter": 30428.05055990181, "post -": 20.367966375306224, "atrial fibrillation": 27599.234069904993, "reduced ejection": 2.728863774967736, "right ventricular": 12456.115817069984, "acute heart": 7.584954454482939, "functional capacity": 0.9831697386160163, "p =": 0.6340889978211932, "body mass": 0.6268061437816145, "quality of": 12.341868959379292, "changes in": 9.447491812541275, "renal function": 1.0588457635762427, "risk factors": 1.4435849753925534, "assist device": 0.4775478517190128, "type natriuretic": 8832.155666207636, "systolic heart": 8836.986239426275, "treatment of": 10.623291084676383, "resynchronization therapy": 7762.880551007011, "blood pressure": 0.5982635085630458, "primary outcome": 0.591268607265774, "mass index": 0.675938720682367, "increase in": 7.72167813302057, "pro -": 8.998540689955943, "renal dysfunction": 0.7264891931752341, "end point": 0.5372664983578495, "coronary artery": 6762.032325646504, "in conclusion": 7.014348434422899, "control group": 0.8923781407262847, "% of": 10.543041800906972, "cause mortality": 0.9759432781486104, "cardiac resynchronization": 5831.233724320278, "among patients": 3.376954010981823, "increased risk": 1.231798848744133, "in patients": 9.134783090039182, "in addition": 6.059434635354853, "terminal pro": 0.2039246701999851, "right heart": 3.441210337020256, "failure in": 8.27278320104275, "adverse events": 0.4042002119210952, "cardiovascular events": 0.536736448546812, "use of": 6.501035403531626, "glomerular filtration": 4967.852298512796, "filtration rate": 0.42310413925477447, "development of": 6.42966128242911, "independently associated": 0.6956756846849177, "consecutive patients": 2.775308909090593, "- blocker": 6.656802622746596, "exercise capacity": 0.7285614309677468, "effects of": 5.443413044657362, "acute myocardial": 4174.832366572103, "clinical trials": 0.5086758376206016, "estimated glomerular": 4174.397681122776, "effect of": 5.425042670741721, "impact of": 5.390888480346316, "dilated cardiomyopathy": 8348.694216813097, "advanced heart": 2.3768103075451745, "% versus": 2.501577922779167, "diastolic mitral": 8348.916449049764, "mitral valve": 4174.519934909895, "systolic hf": 4174.581634450764, "functional class": 0.38494483914919825, "hazard ratios": 0.3248513761945867, "mortality in": 4.35802280811688, "risk for": 1.9703646446579226, "body composition": 0.13300246484577935, "preserved left": 0.5744634219442764, "diastolic dysfunction": 3450.2374980843124, "left ventricle": 3450.240814371665, "% vs.": 1.976147997856016, "change in": 3.6128327597608125, "gene expression": 0.16935926473664698, "outcomes in": 3.844052386137267, "odds ratio": 0.33122177837201, "cardiac function": 0.8448873892043548, "functional ms": 3450.0297133314084, "diabetes mellitus": 0.1421231406346886, "pre -": 4.573150754810043, "adrenergic receptor": 3449.996087132461, "patients undergoing": 1.9174596916458584, "converting enzyme": 3449.8837497358236, "magnetic resonance": 0.07098371463020234, "peak oxygen": 0.16211480480700916, "reduction in": 3.2969797473382583, "patients in": 4.878190377964711, "treated with": 2.9133889819069534, "term mortality": 0.44107952938040995, "assist devices": 0.13561928298156642, "risk stratification": 2794.745545077578, "usual care": 0.18692540904695804, "cardiovascular death": 0.34943276904879894, "reverse remodeling": 0.10419900102375579, "% \u00b1": 2796.100241971848, "angiotensin receptor": 2794.560206008641, "artery disease": 0.32834659761156954, "cohort study": 0.4907730463204577, "cardiopulmonary exercise": 0.34554713406290394, "clinical practice": 0.23082999970494686, "systematic review": 0.07412614186935057, "management of": 2.8705314642338173, "cardiac hypertrophy": 2208.293100655211, "older patients": 1.2563750096421342, "day readmission": 2208.016915929448, "% vs": 1.2688638148691838, "- b": 2.9065435068645824, "ventricular dysfunction": 2208.3389934392753, "a total": 0.878197880504577, "stage heart": 1.2396925990774061, "medical treatment": 0.29715874959965305, "systolic dysfunction": 2208.195510289633, "adjusted hazard": 0.19554627728757448, "patients treated": 1.2789622856557676, "improvement in": 2.3380805617788987, "early diastolic": 2208.0619668042527, "pulmonary arterial": 2208.0170847223008, "arterial coupling": 2207.958293484022, "aortic valve": 0.08923450682977074, "pulmonary hypertension": 0.16324885343819734, "patients receiving": 1.2307879724821784, "receptor blockers": 0.15020897575581155, "type 2": 0.22121170263893147, "the risk": 1.9885563293877397, "rhythm control": 0.16184140954850784, "control therapy": 0.31189312095841715, "defibrillator deactivation": 4415.833906956237, "role of": 2.5110647487310414, "adults with": 1.7966727430721747, "rates of": 2.5355994033496048, "patients hospitalized": 0.9563195996575281, "diagnosis of": 2.1717214923081007, "function in": 1.8681879294766262, "clinical outcomes": 0.3026464899578765, "proportional hazards": 0.033200684131163345, "mean age": 0.13713560633643884, "levels of": 2.221799760571076, "blocker therapy": 0.18629698233182682, "therapy in": 1.8769688957721966, "cause of": 2.2134349446520067, "year survival": 0.0967696629387172, "correlated with": 1.5522655129693588, "valve plasty": 1690.463066307917, "ratio of": 2.27438686240708, "diastolic function": 1690.6374214599537, "e /": 0.3369691422032848, "older adults": 0.08836454297574717, "enzyme inhibitors": 1690.456399896758, "day follow": 0.16907566102505156, "induced heart": 0.9928942669258841, "biological phenotype": 1690.4429169009563, "skeletal muscle": 0.03650836837159165, "based on": 0.18283869642425019, "suggest that": 0.1660030228617574, "according to": 0.8201583585359996, "event rates": 0.06997743394214102, "role in": 1.308542197620325, "assessed by": 0.23657679777124863, "emergency department": 0.01774949027376445, "predictors of": 1243.5232223202665, "association between": 0.12091152448684175, "dose dopamine": 0.06114285265216443, "systolic blood": 1242.0564041575244, "% to": 1.36395592944505, "co -": 1.6408850728425477, "% in": 1.9473158166138251, "walk test": 0.03932750643512116, "endothelial function": 1242.0507624634606, "number of": 1.5813314573208035, "treatment for": 0.6087573306958349, "mitral regurgitation": 2483.917592310674, "diastolic volume": 1242.0630346747184, "min per": 0.06609174231747621, "diastolic pressure": 1242.0634186478085, "oxygen consumption": 0.02648814060122517, "median follow": 0.11316147177811141, "the objective": 0.9636796075593352, "systolic pressure": 1242.087893875375, "myocardial ischemia": 2483.961656708629, "albumin levels": 1242.007120210208, "study sought": 0.1808674937706108, "cardiovascular mortality": 0.223844328223738, "brain natriuretic": 1241.975793375554, "interquartile range": 1241.9579027340867, "outcome measures": 0.08221912680800299, "the aim": 0.9610023339030624, "insulin resistance": 0.04022662500637347, "breast cancer": 0.013683474665817385, "dash diet": 0.027887427354661633, "cardiac transplant": 0.22504514682057375, "cardiac magnetic": 0.21510145933144964, "cv events": 0.061971402797169346, "sinus rhythm": 1241.964235425879, "deficit index": 0.07413772077311116, "chronic hf": 0.078186506713503, "exercise testing": 0.15914485928512961, "sympathetic tone": 0.030421849230540816, "oxygen uptake": 0.028098357688156578, "peak early": 0.07510036024875763, "prediction rule": 0.02502346498627148, "biomedical treatment": 0.1395785480933875, "acute care": 0.15073728772625378, "exercise rehabilitation": 0.155779907127624, "inappropriate therapy": 0.12067818086205065, "hr variability": 0.014661731027466783, "gastrointestinal bleeding": 0.014624564045935965, "idiopathic dilated": 2483.896774744858, "defined as": 0.13924740753385342, "analysis of": 1.3823353808606182, "hospitalization for": 0.46110783926449606, "showed that": 0.1367871203101122, "adverse event": 0.039033294705881766, "the results": 0.6922404226809902, "natriuretic peptides": 862.4837074084247, "filling pressures": 0.01679407755217275, "cardiac death": 0.19868069903531013, "patient population": 0.08224558145611861, "coronary heart": 862.9529382926409, "clinical trial": 0.10620669351646835, "health outcomes": 0.10752772488826184, "mortality rates": 0.14199983238401392, "chronic obstructive": 0.05854541676042003, "obstructive pulmonary": 0.03655888184511642, "pulmonary disease": 0.11239549430549389, "dose nesiritide": 862.495564096516, "effect on": 0.11224433022506342, "present study": 0.12914462781541966, "left bundle": 0.09943551069289368, "bundle branch": 0.010098941693623617, "branch block": 0.00978313911690121, "analysis showed": 0.07941363329793116, "independent predictor": 0.021397851033439254, "hospital discharge": 0.05096020113174645, "determine whether": 0.03290541660820615, "beneficial effect": 0.042460722232042544, "model of": 1.1276428292315208, "increased in": 0.9509535553044555, "significantly younger": 0.054608723967895074, "ci ]": 862.5338575320856, "medical management": 0.057013313703545676, "time of": 1.1201148796479674, "cardiovascular disease": 0.1302335588222077, "significantly improved": 0.07751381717869203, "acute hf": 0.05520303227514765, "salt loading": 0.010033134852754554, "clinical characteristics": 0.0932764835856428, "patients requiring": 0.47591865928371885, "the purpose": 0.6664813488445183, "all patients": 0.5132982581320802, "history of": 1.0979983010195178, "degenerative mr": 0.005950577307374406, "quality improvement": 0.0734869952033654, "hazards models": 0.037690463226203584, "dose bb": 0.03310721916987278, "protein kinase": 0.02794288689103308, "failing hearts": 0.021744425959686724, "regression analysis": 0.0683460136786781, "device implantation": 0.04006019690828007, "right atrial": 862.5193005638256, "receptor antagonists": 862.4990217831153, "acute kidney": 0.0661739625553686, "kidney injury": 0.017337930656154507, "recommended medications": 0.016754906209198756, "growth factor": 0.029235641173705907, "- adrenergic": 863.5978254347151, "analysis revealed": 0.06256299425227582, "higher risk": 0.1597780751440123, "severe heart": 0.5046678681909899, "ventricular contractile": 1725.0353716047337, "- brain": 1.14079279806425, "ischemic heart": 862.9461356872324, "hr reduction": 0.030376735383977626, "significant improvement": 0.08123297234925904, "nordic walking": 0.005639160809250553, "pulmonary embolism": 862.4913639518974, "transcription factor": 862.4834187038832, "diet scores": 0.0310035454885401, "term outcomes": 0.10893496506185767, "significantly associated": 0.15537336063361987, "criteria cardiac": 0.15183129803445228, "baseline characteristics": 0.06030328037672113, "readmission rate": 862.5367699270965, "per patient": 0.07784699253085887, "dialysis patients": 0.4777383154939611, "ventricular diastolic": 1725.0727846636366, "resistin levels": 862.5091975568688, "catheter ablation": 862.4667061957217, "major complications": 0.032361562270601676, "treatment strategies": 0.10955599387601168, "sympathetic activity": 0.032669426841762925, "health care": 0.07890432146330009, "contextual reasons": 0.015548978789261605, "severe cad": 0.03459704627756837, "high risk": 0.15722545386455147, "this review": 0.08717081338715545, "membrane oxygenation": 862.4650048499572, "familiar physician": 0.02085800569787794, "sudden cardiac": 0.14758703152408453, "disease management": 0.111154226111803, "end stage": 0.0679156523415198, "recent onset": 0.03220863123342402, "physician volume": 0.06080240339428622, "social support": 0.034364240050863165, "occurred in": 0.727360052334925, "rate of": 0.9343262913173445, "efficacy of": 0.894773551740287, "treatment with": 0.7014245555601621, "decrease in": 0.7267990421324377, "observed in": 0.7294196072190755, "relationship between": 0.06541319497908434, "found that": 0.08689835249285556, "addition to": 0.39791658042576394, "subjects with": 0.6407197642149794, "related to": 0.40762775938079393, "led to": 0.3092119543192669, "cardiac cachexia": 552.0651100238028, "individuals with": 0.5032649389646834, "body weight": 0.02266089191639931, "the prevalence": 0.4294722604890551, "presence of": 0.7017004687520969, "fraction of": 0.7597323366329612, "adult patients": 0.30558128662853884, "impact on": 0.06732011476283001, "% increase": 0.3229624957502717, "strongly associated": 0.07231366688776103, "randomized trial": 0.0359985293634648, "end points": 0.03837307887933404, "significant effect": 0.05214586880840422, "vs placebo": 0.028772478534794903, "therapy with": 0.5443498718930501, "resulted in": 0.5698218310014652, "multivariate analysis": 552.0099202870998, "severely reduced": 0.0476469909034568, "among older": 0.034272292739780094, "hospitalized for": 0.22537496583522548, "reduced mortality": 0.1123726490109625, "level of": 0.7101934194190976, "statistically significant": 0.03578947803866385, "measured by": 0.10077473316332881, "significant difference": 0.043618040494561736, "activation of": 0.7059041242460302, "ambulatory patients": 0.3041137129476189, "spironolactone use": 552.0043710953418, "- blockers": 0.7407865809628862, "inhospital mortality": 552.040097703821, "assessment of": 0.7074136104214888, "cohort of": 0.7205981270042386, "declined from": 0.07756328305171233, "retrospective cohort": 0.026632130691697134, "ed visits": 0.013527854245896495, "the rates": 0.44755241635827203, "hypothesized that": 0.05982617743380746, "vascular resistance": 0.016245444231925234, "cardiac index": 0.11947202079858998, "cardiac output": 0.0922779775960128, "adverse outcomes": 0.06735167660670689, "patients had": 0.3396366330287677, "protective effects": 0.025276925198498876, "mediated dilatation": 551.9846802716754, "these results": 0.0488474718466316, "beneficial effects": 0.029604002580988706, "term survival": 0.03978481298617581, "objective of": 0.70198679506532, "% sensitivity": 0.3052722101413165, "study aimed": 0.08040800977435636, "lung weight": 0.008941010296853125, "mean follow": 0.051909324480802946, "biventricular support": 551.993905007926, "total of": 0.7116384065757684, "medical therapy": 0.06442756477629202, "pulmonary artery": 0.03428182321409688, "rs synchrony": 551.9732503177448, "mitral stenosis": 1103.9633743602997, "ring annuloplasty": 551.9758687596673, "annular size": 551.981001336769, "size reduction": 0.023925656947311844, "volume index": 0.057344244567659304, "systolic volume": 552.0388932899043, "significant ms": 552.0068731350384, "coronary angiography": 551.9928435507422, "the patient": 0.4619283321428232, "reasons for": 0.21903650940935684, "patient with": 0.5343910412325673, "cause hospitalization": 0.05602303336284217, "patients developed": 0.3167446400083384, "health status": 0.03316718191919131, "low sst2": 0.025747979321810777, "cardiovascular event": 0.03970755712573288, "high sst2": 0.027549562374083045, "similar results": 0.033506914764037055, "systolic elastance": 1103.9856782339027, "stroke volume": 0.037314279177829354, "echocardiographic score": 551.9984358208769, "safety of": 0.7096831472418398, "newly diagnosed": 0.007358445306034958, "findings suggest": 0.014261506165588692, "volume eds": 0.028098651786759556, "less likely": 0.022077421854232143, "adjusted odds": 0.022715225088147446, "contractile function": 552.0209279557565, "effects on": 0.07426551169652205, "ventricular filling": 552.054736234097, "blood flow": 0.027164835874323095, "flow velocity": 0.021051596559545145, "bottleneck stent": 551.9781447321053, "arterial elastance": 1103.9584766001667, "treated patients": 0.3197405714139419, "significantly reduced": 0.07577972919201628, "contribute to": 0.3110334114411573, "revealed that": 0.06156580340621182, "month survival": 0.029306786137857734, "patients underwent": 0.3133533451723465, "outcomes of": 0.7477324891453144, "young adults": 0.019678599815459785, "year mortality": 0.07894026491828851, "cardiac rehabilitation": 0.0966473102283039, "randomized controlled": 0.02268656141582347, "randomly assigned": 0.00809938005966232, "grip strength": 0.008407868234175596, "regression models": 0.030146362342177095, "receptor antagonist": 551.9999183301597, "cardiac dysfunction": 0.12830936230838436, "angiotensin converting": 551.9939185614548, "mineralocorticoid receptor": 551.996107412898, "beta blockers": 0.024485849225816647, "followed up": 0.044201853245804654, "trend toward": 0.0070805675666107595, "adjustment for": 0.21882337053034823, "after adjustment": 0.06090544731357918, "improvement initiative": 0.021975347927735114, "extracellular matrix": 1103.9454117464115, "obese zsf1": 0.006499482052675272, "cardioverter defibrillator": 1103.9655531937165, "weight loss": 0.011065224675134532, "length of": 0.7046245260090562, "dependent patients": 0.3094815783310002, "human resistin": 551.9897021852775, "increased significantly": 0.07434419204558274, "results suggest": 0.026905582628921367, "mitochondrial oxidative": 1103.9568433221266, "medical records": 0.019529037138603277, "aortic constriction": 551.9814136600356, "human hf": 0.011552283477331629, "contrast agent": 0.005761687718843553, "contractile reserve": 551.97898651018, "survival rates": 0.04353788509359213, "systolic function": 552.0557501923726, "acute rv": 0.035329940656094495, "onset hf": 0.01250950479864704, "cardiac remodeling": 0.1054656046615566, "remodeling aspects": 0.018873503704764125, "dyssynchronous hf": 551.9748835957852, "myofiber shortening": 551.9786891025457, "mitral annular": 1103.965551971733, "annular velocity": 551.9846774274904, "exercise time": 0.08193905353415337, "- ar": 0.7266358767161456, "extracorporeal membrane": 551.9770586594335, "male patients": 0.30654371625100413, "therapeutic implications": 0.015111113132757393, "autonomic balance": 0.007350052181893914, "renal dnx": 0.02122230596850864, "mechanical cardiac": 0.09398426895358625, "cardiac support": 0.11033668292284501, "ecmo+vad group": 0.04269672347732608, "physician continuity": 0.014045144146192835, "- hct": 0.7266358767161456, "muscle mass": 0.028025559522204237, "shock therapy": 0.051488014040552185, "high bnp": 0.027549562374083045, "- ischemic": 552.7113173905203, "care management": 0.05154817399404092, "black race": 0.010697198117604705, "type channel": 0.03033792700764252, "volume physicians": 0.034031297017142796, "aldosterone antagonist": 1103.9519447937419, "air pollution": 0.00348272910087674, "saxagliptin versus": 552.0052620570006, "deactivation discussions": 551.9780071546007, "exercise group": 0.10551135554565641, "management programs": 0.02450585939830544, "resource use": 0.027156088354426504, "suggests that": 0.045196325356785805, "alterations in": 0.4367876573182747, "caused by": 0.06888268717400214, "prevalence of": 0.538354584058767, "predictor of": 0.5383739270183407, "expression of": 0.5470585664898494, "compared to": 0.2650272440572623, "accompanied by": 0.06923300659101245, "age of": 0.5548077698421335, "data from": 0.07186687763995124, "value of": 0.5414736474236781, "purpose of": 0.536115745555648, "effectiveness of": 0.5387778295122985, "lack of": 0.5367602758192358, "inhibition of": 0.5425415859948082, "improvements in": 0.43795635928322224, "trends in": 0.31991231630329314, "patient safety": 0.02801138829079603, "patients admitted": 0.171215449659479, "fat mass": 0.014203386170366516, "x -": 0.40901526629074275, "- ray": 0.40960726525177527, "ray absorptiometry": 310.4852153830134, "general population": 0.010032115662056904, "iron deficiency": 0.003875477611160743, "exercise tolerance": 0.03622360528837769, "thromboembolic events": 310.50013990437753, "hospitalized patients": 0.1756505387126072, "stimulating agents": 0.0038881409360715766, "the benefits": 0.24260877246316126, "benefits of": 0.39655644279757, "observational studies": 0.01637319501499934, "strength evidence": 0.012992973761865626, "relative risk": 0.04501143608826889, "trial of": 0.4032458040015784, "acute coronary": 310.5137053810809, "admitted to": 0.1746058577582037, "clinical studies": 0.0420097020799556, "factors associated": 0.048256522240536955, "peripheral vascular": 0.007029378564756709, "vascular disease": 0.03280886104370688, "ischemic cardiomyopathy": 620.9800112495226, "independent predictors": 310.4929687784252, "diuretic therapy": 310.5127723524417, "placebo group": 0.030747347112437866, "hour cumulative": 0.0034192743383213656, "cumulative urine": 0.0033403960122679105, "urine volume": 0.016703761460687735, "cystatin c": 310.4876763323411, "chromatin structure": 310.49155148192864, "association with": 0.2859353304883056, "outcomes associated": 0.06672567805070584, "events in": 0.3333419099061498, "enrolled in": 0.3224220483425341, "study patients": 0.21029644095484853, "death in": 0.3386217450996184, "artery bypass": 0.00886762966225995, "data suggest": 0.017210274599109704, "value for": 0.12507506290429957, "older age": 0.023189058536994402, "age group": 0.03914690907800428, "progenitor cells": 0.006661338571013481, "prognostic factor": 310.4989296090682, "cardiovascular diseases": 0.01949921292299959, "+ cells": 0.011453341366755382, "patients without": 0.17771548292073677, "increased peak": 0.03450840596645286, "cause readmission": 310.50453031982875, "readmission rates": 310.50367694881635, "differences in": 0.32237941494792705, "improve outcomes": 0.0351362863452588, "office hours": 0.0020346733610116323, "study assessed": 0.052058048420498826, "related quality": 0.024670604123378258, "induced by": 0.06190675151387996, "treating patients": 0.1698089932675897, "incidence of": 0.39613509120412627, "the patients": 0.4071548785802732, "ejection fractions": 0.037013363609507965, "recommended target": 0.006708850258356337, "blocker dose": 0.019236082169984597, "point of": 0.39781091104702343, "levels in": 0.33345085991708784, "primary end": 0.02960995700005774, "multivariate models": 310.49793292538675, "odds ratios": 0.009441117924313482, "% female": 0.1705663800064214, "median bnp": 0.009149543394474975, "difference among": 0.017453905776898107, "clinical variables": 0.031142645072946146, "this article": 0.025541724647302273, "cognitive impairment": 0.002712142214143016, "confidence intervals": 0.016658907541735577, "\u00b1 14": 310.5120622927051, "ventricular function": 310.551536801128, "\u00b1 6": 310.52604301386145, "major cause": 0.02174866428707403, "identify patients": 0.17366667482984946, "minute walk": 0.004132737734604086, "adherence to": 0.17506682484719913, "functional status": 0.025170626035330563, "no production": 0.015613150808411497, "hdl function": 0.025287499268441174, "predictive cutoff": 310.4877048327913, "cutoff value": 310.4905930525929, "% specificity": 310.65362694862483, "hypertensive heart": 310.6554037477306, "new therapeutic": 0.010926361610311615, "fractional shortening": 310.4877063701287, "oxidative stress": 310.4891553553507, "significantly impaired": 0.020377387702442764, "laboratory report": 0.006092992346130176, "cardiogenic shock": 310.48640247649973, "duration of": 0.3967522397939834, "heart transplantation": 310.65754720635675, "used in": 0.3341739626312625, "basis of": 0.3944144902412622, "% for": 0.288721453832245, "acute right": 0.03390731782005754, "old man": 0.0015244562803252797, "years later": 0.021948464581478117, "developed heart": 0.178775676577583, "severe hypertension": 0.023780332565804658, "aggressive medical": 0.010802001077239283, "develop even": 0.005177189290454535, "successful valve": 0.009541618127274795, "another disease": 0.029421069833839884, "index of": 0.408934515537999, "valve opening": 0.009232220502786265, "mean pressure": 0.025959655372967676, "pressure gradient": 0.017124958204770394, "without major": 0.01678006194228672, "mild mr": 0.004560357008229801, "resulting in": 0.31991231630329314, "clinic outpatients": 310.4879715970203, "renal disease": 0.040768450948397456, "hazard models": 0.030412915784273166, "median age": 0.02427954551648333, "measure of": 0.3956820297118109, "significant interaction": 0.0222372530336228, "prognosis in": 0.32427807491692406, "ventricular systolic": 621.0323212858007, "event rate": 0.0270545834239738, "failure hospitalization": 0.17611080349021863, "myocardial function": 310.53013588821904, "months of": 0.40233812818285675, "left atrial": 310.52687795046353, "atrial area": 310.4954331782643, "during follow": 0.03847590412434937, "randomized trials": 0.01985015598189155, "seen in": 0.3195253781466191, "- fold": 0.4105433845783411, "vascular endothelial": 310.49138107379935, "endothelial growth": 310.4903816898659, "- myocardial": 310.9135810696034, "infarction heart": 310.66397605118885, "receptor blocker": 0.020480849345699846, "increased cardiac": 0.07524658646269722, "cardiac angiogenesis": 310.53601191433415, "signaling pathway": 0.008568273857557748, "of patients": 0.5611025489146819, "cases exhibited": 0.005436606437369921, "volume overload": 310.50290239985196, "wall stress": 0.007447581894404281, "filling pressure": 0.020441314722600648, "severe systolic": 310.51852692060106, "mitral annulus": 620.9781730878764, "/ e": 0.06189229142509312, "cardiac catheterization": 310.53601191433415, "measurement of": 0.3964618268013384, "diagnostic performance": 0.010823466718143725, "chronic myocardial": 310.524395015629, "left anterior": 310.5189172774188, "anterior descending": 310.4858626266809, "collateral growth": 0.003891054253763126, "sudden death": 0.023151651481480573, "the study": 0.2802139609032435, "at baseline": 0.04124535737982946, "preoperative hypoalbuminemia": 620.970825336781, "improved survival": 0.02185861228938695, "poor prognosis": 0.008888413204086282, "- lvad": 0.4087326806528319, "lvad ai": 0.0, "well defined": 0.014603468985998694, "severe ai": 0.012454936659924613, "valve replacement": 0.009118614184099573, "controlled trial": 0.01403588683512286, "standard cardiac": 0.055435750664730464, "rehabilitation care": 0.021422976555980473, "mean ejection": 0.0461558950595575, "per week": 0.008931424165962662, "physical activity": 0.009132836093499741, "right ventricle": 310.50174354596356, "day mortality": 0.04982179342049747, "followed by": 0.05494502422930471, "right atrium": 310.49868127987924, "retest reliability": 0.002427993186010946, "standard error": 0.005554811475184795, "total sample": 0.009896518354148596, "mean difference": 0.016292967996156628, "users of": 0.39596760094965444, "significant improvements": 0.022215146845493982, "expressed in": 0.32007801927563717, "secondary outcomes": 0.030172596598157, "aim of": 0.3941982538101743, "pathophysiology of": 310.87896834544335, "the use": 0.25236704238631785, "gene programs": 0.008405552315519977, "transcription factors": 310.49613097557994, "demonstrated that": 0.040017095473409175, "energy metabolism": 0.005659144525174881, "optimal combined": 0.006326952777899874, "combined treatment": 0.03572962127220511, "cancer patients": 0.17054140496225886, "patients at": 0.19426191458788733, "years old": 0.021684708028748396, "in total": 0.32566179330698447, "diet score": 0.01715792574262199, "lower mortality": 0.053498652501563465, "heart transplant": 0.1747344168340244, "standard criteria": 0.008590286437231767, "chart review": 0.008259784064048356, "t1 mapping": 0.0024200199489014438, "resonance imaging": 0.006102837518251003, "first hf": 0.005898644886568669, "clinical benefit": 0.033644112855267375, "myocardial dd": 310.5048483889506, "myocardial collagen": 620.9904141771573, "adverse cv": 0.009769662545776112, "clinical status": 0.03553468967836041, "enzyme inhibitor": 310.4889313390796, "matched controls": 0.008492522752219919, "echocardiographic measures": 310.4961047157642, "\u00b1 0.4": 310.50973093350694, "induced cardiotoxicity": 310.4993210906945, "mrna levels": 0.015601800710230313, "remained elevated": 0.010263345243399188, "strain rate": 0.026732847888514252, "mitochondrial dysfunction": 310.5121927155032, "anti -": 0.4093972575606997, "ultrastructural changes": 310.49863012324226, "logistic regression": 0.006732316107097744, "leading cause": 0.016068570592787407, "the deficit": 0.24061998351835578, "recent years": 0.025171627734594085, "recent studies": 0.01909573761165623, "risk patients": 0.20972321387175594, "signal transduction": 310.48578841822405, "transverse aortic": 0.005815348130240899, "cardiac gene": 0.056557989723061655, "clinically significant": 0.02013316041455173, "arterial hypertension": 310.5020964608706, "significantly lower": 0.03291513510340622, "peak o2": 0.010931403302135994, "per kilogram": 0.007642068765454479, "common cause": 0.023249475435731914, "human heart": 0.17572365534483075, "channel mrna": 0.003588061067876978, "important role": 0.016182207911364595, "high mortality": 0.05340453355647279, "cardiac sympathetic": 0.05533324997978383, "receptor haplotype": 310.4978104197551, "patient preferences": 0.023652188979611168, "lean mass": 0.012708583494481097, "mitral flow": 310.50108345420125, "unclear etiology": 310.48857457615185, "acute \u03b2": 310.51799022092973, "risk factor": 0.048650792109195914, "antiarrhythmic drugs": 310.4877583688178, "sarcomeric microstructure": 620.9686815968289, "pilot study": 0.043445832184771355, "adjunctive treatment": 310.51678857220276, "treatment alone": 0.03464831189944261, "effective rate": 0.030250620181759193, "exercise intolerance": 0.0365519667868158, "exercise variables": 0.039003400348288905, "low testosterone": 0.016923785532628702, "testosterone status": 0.010502761579377505, "the exercise": 0.2738694298027699, "improves exercise": 0.04144028936617417, "group compared": 0.04672171313442281, "rate variability": 0.02643769263249917, "group included": 0.03441906698157932, "included patients": 0.1790208393415225, "study period": 0.049454179272611996, "hospitalized older": 0.015090915811654157, "nursing care": 0.020539058489708464, "proportional hazard": 0.022942433863257627, "first month": 0.011105686661161997, "adjusted hr": 0.008228010208098465, "- translational": 310.89337973433106, "ventricular tachycardia": 621.0115088504338, "- adrenoceptor": 310.8930734790673, "adrenoceptor blockade": 310.48709546988016, "< 0\u00b701": 310.4416456005888, "receptor neprilysin": 310.4984229146511, "neprilysin inhibitor": 310.48770641180926, "\u03b2 coefficient": 620.9833766778848, "primary endpoint": 0.011796321368914574, "% lower": 0.18457064272711116, "partially reversed": 0.004232308100471276, "elevated levels": 0.02140426663926226, "cardiac patients": 0.21937104507588986, "public health": 0.010238899816602812, "service beneficiaries": 0.002007915134021897, "lower risk": 0.056695282336329214, "exercise performance": 0.04095869569637281, "rate control": 0.03973190019788433, "cardiovascular complications": 0.022020081414810967, "- aas": 0.4087326806528319, "global proteomics": 310.48719008032595, "pathway analysis": 0.022153423081524688, "day rehospitalization": 310.49747967690615, "volume groups": 0.028895944319025806, "hospital volume": 0.028047263242990464, "therapeutic options": 0.00837841753443489, "period 4": 0.018082028141283596, "exercise test": 0.042940884074497206, "study end": 0.061021120625428076, "cardiovascular risk": 0.05915771189070024, "unfit men": 0.005627246187835586, "cardiac insulin": 0.055648916833681714, "weeks post": 0.013206317446318885, "- aac": 0.4087326806528319, "per capita": 0.007613646463738492, "cardiovascular health": 0.028647502749161165, "sitagliptin versus": 310.5029599070628, "implementation strategies": 0.008722558300223998, "physician adherence": 0.009141111024426125, "life score": 0.02130205514109664, "aerobic exercise": 310.5208990187451, "resting hr": 0.002123259622860678, "right interatrial": 310.4983750246155, "magnetically levitated": 620.9686815968289, "decline in": 0.22167787807487785, "symptoms of": 0.27825459415792214, "years after": 0.03578183612223197, "reductions in": 0.221783145443469, "difference in": 0.22505823384209403, "involved in": 0.22161861150543954, "decreased in": 0.22623529793461997, "used for": 0.09449059882642445, "performed in": 0.22723901920230247, "percentage of": 0.2739702260465111, "disease in": 0.24074997433886727, "patients having": 0.1189225050049535, "survival of": 0.28039020487964894, "results in": 0.22813848063033323, "understanding of": 0.27352624854561647, "reversed by": 0.03533173485254464, "outpatients with": 215.80914478871978, "time to": 0.1269212322841592, "rate at": 0.03362187163026437, "end of": 0.28599113096198714, "randomized to": 0.12603911512415084, "absence of": 0.273573399515169, "variation in": 0.22241237236343558, "days of": 0.2778399814542812, "contribution of": 0.27376742844261953, "onset of": 0.27744476808887625, "occur in": 0.22259542502259108, "training on": 0.02668699417785537, "national trends": 0.0014333320769727058, "study used": 0.02577896225036197, "hospitalized with": 0.12725703667732588, "results show": 0.00547965294589626, "cross -": 0.182002759383728, "adipose tissue": 137.99425902278568, "prospective study": 0.020419099467190727, "free mass": 0.005740066154181975, "energy x": 0.0012810727611611327, "followed for": 0.05596563131276808, "total adiponectin": 137.9965126811176, "correlated inversely": 0.0029914387062932933, "developed countries": 0.004635271254830037, "lv diastolic": 137.9999791897998, "mechanism of": 0.17632801273332618, "increases in": 0.14191103636800612, "leading to": 0.07733877869238498, "evidence of": 0.17864741316594204, "anemia in": 138.13553154107944, "this guideline": 0.013389092629017964, "identified using": 0.01033643742351379, "acp recommends": 0.00025890455985651956, "hemoglobin levels": 138.0002467130852, "quality evidence": 0.011104270446461426, "moderate anemia": 137.99669475365837, "treatment in": 0.15568748133118668, "trials of": 0.179043016540676, "blood transfusions": 137.9966088239353, "study design": 0.01921451857830966, "risk among": 0.02325495235864759, "decreased mortality": 0.02037229979557613, "intravenous iron": 0.0019946590791584924, "alleviate symptoms": 0.003915798007349904, "cardioverter defibrillators": 275.9888025827843, "cardiac transplantation": 138.01736625610127, "low left": 0.021532094247040744, "outpatient settings": 0.0014572647690171046, "important component": 0.0034457480719920414, "focused on": 0.013520579139842484, "studies in": 0.14772723823276446, "implantable cardiac": 138.0183187909507, "mortality using": 0.023185302373685216, "studies evaluating": 0.006998439538376661, "found for": 0.05665133135184005, "male sex": 0.003869073253221718, "this meta": 0.012026820820240508, "enhance decongestion": 137.9936872480311, "preserve renal": 0.005699193249099924, "addition of": 0.17658959809184036, "main outcomes": 0.013011507754077582, "c level": 0.004593539000509158, "secondary end": 0.009511244461857382, "patient outcomes": 0.021961841382889098, "associated proteins": 0.019879170868298865, "proteins alter": 0.002989293989482394, "alter chromatin": 137.9946715182776, "expression profile": 0.0047785280140138645, "altered expression": 0.0054155845588404064, "protein expression": 0.00757675861815312, "protein 4": 0.007962936682328106, "mouse heart": 0.07669028210681103, "ischemic events": 138.00305608987296, "receive cardiac": 0.023108760047385175, "limited data": 0.008024277353915683, "data regarding": 0.00656515472808015, "study population": 0.02221674817649253, "population comprised": 0.0040918278099626995, "coronary syndromes": 137.99753033201145, "among study": 0.023509719951133202, "dependent analysis": 0.010779633489290882, "subsequent heart": 0.07614587924848563, "d recipients": 0.00103488873264077, "percutaneous coronary": 275.9904352636178, "benefit of": 0.1771802254181854, "outcomes among": 0.017482117242949676, "differential effect": 0.005988367615078522, "\u226550 %": 138.06827864383325, "patients enrolled": 0.07697407486738474, "risk associated": 0.03542869202712273, "p value": -0.016961943650433117, "circulating progenitor": 0.0016263481838214519, "ambulatory hf": 0.00108679298537624, "hospital admissions": 0.00652196608511408, "cd34+vegfr2 +": 0.0026728431466057976, "without diabetes": 0.008368253249531762, "higher eo": 0.007295809998234491, "improved functional": 0.012306221547332668, "metric choice": 0.0011022302164726237, "readmission metrics": 137.9967086620307, "percent of": 0.1750897108035617, "hospitals in": 0.1430019474344911, "remote monitoring": 0.0010439841709878011, "recent hospital": 0.007466792181214177, "network meta": 0.0016340104511506418, "outcomes for": 0.06571431752495233, "recently discharged": 0.001937768502415064, "electronic databases": 0.0013035905628296697, "observational cohort": 0.006528242239679198, "studies with": 0.13059275553074562, "implanted monitoring": 0.0019946729686040696, "monitoring devices": 0.004105392790733584, "medical support": 0.009178752781461456, "support provided": 0.006491025279588968, "inclusion criteria": 0.0026786680544973107, "mortality for": 0.07006642826964325, "% cri": 0.07510217553182168, "protein levels": 0.010316798994616667, "western blot": 0.00027153669506242115, "dna fragmentation": 0.00040624888996062766, "remained unchanged": 0.0025186593001454653, "found in": 0.1446991092723784, "widely used": 0.007626672313979023, "pump replacement": 0.0022738690338746778, "redo sternotomy": 275.98580847816885, "angiotensin system": 137.99942155360668, "target dose": 0.006680663571806834, "blocker uptitrations": 137.99615645387058, "hospital admission": 0.008408233442919359, "significant reductions": 0.008808453548520436, "composite end": 0.010634400551548764, "remained significant": 0.010116102029689052, "blocker uptitration": 137.99697311373245, "younger patients": 0.07597930338732778, "predicts clinical": 0.012746035277356935, "clinical outcome": 0.018158498462304398, "peptide levels": 0.010471809710676383, "in heart": 0.21647758004252854, "higher mortality": 0.02414376765203497, "adjusting for": 0.053754516887380574, "ability of": 0.17564258019527168, "predict inhospital": 137.994517216308, "p for": 0.03388608073489706, "mortality among": 0.021834227987640592, "pediatric heart": 0.07574878134814074, "the guidelines": 0.10765704732280018, "children with": 0.12499601661468344, "patients presenting": 0.07547066367448431, "patients as": 0.09067395283870462, "regression analyses": 0.0044864539482967975, "relative decrease": 0.0040353950350667574, "correlation coefficient": 137.99453548124058, "intubation rates": 137.99864013652964, "rates declined": 0.0074610950774068475, "adult population": 0.005146984964805658, "liver disease": 0.013219282144764198, "systemic vascular": 0.002576247204218172, "underwent catheterization": 137.99684538929677, "randomly selected": 0.0022626683188537683, "venous pressure": 138.0002437949248, "\u00b1 3": 138.0102271833386, "comparison of": 0.17481685645426537, "using data": 0.012002339062624202, "outcome of": 0.1803857848337043, "distance covered": 0.0015273689376904941, "training in": 0.14528981017521808, "density lipoprotein": 137.99343888410164, "stimulation of": 0.17592675274937045, "nitric oxide": 137.99317367042224, "molecular pathways": 0.0028519807135189623, "healthy individuals": 0.00297328505707364, "vascular effects": 0.007278244268071384, "year follow": 0.011394141709128482, "patients died": 0.07558779074596962, "area under": 0.0019606992067172837, "case of": 0.176318718784073, "therapeutic targets": 0.004299040839381429, "experimental procedures": 0.0024169794927421805, "male mice": 0.005499877258236986, "significant differences": 0.010146980441556758, "mice showed": 0.008160890616614108, "showed significant": 0.012488796170681056, "decreases in": 0.14208153261640621, "severe lv": 0.005535527404410939, "mouse model": 0.007464527900487898, "failure risk": 0.08878568343512075, "significant value": 0.010503935231593979, "evaluated whether": 0.006798850752029554, "risk prediction": 0.020033855861105832, "includes age": 0.007159435233468388, "receiver operating": 0.00045885947068785565, "operating characteristic": 0.0005956770224689071, "characteristic curve": 0.0010784062951342838, "integrated discrimination": 0.0007521443292720779, "discrimination improvement": 0.005247578353237989, "net reclassification": 0.0011331130973795476, "reclassification improvement": 0.005543663621633595, "participants developed": 0.007601224123623392, "adding ctnt": 6.992834143300077e-06, "failure after": 0.08425599122196378, "poor outcomes": 0.013588912462007222, "for patients": 0.12816010586737125, "requiring biventricular": 137.99465403848907, "requiring isolated": 0.003369664806132314, "favorable outcome": 0.006760986393877357, "ineligible patients": 0.07521317194659091, "destination therapy": 0.012194956750307635, "highly effective": 0.0041873835332299405, "transplantation eligibility": 137.99521028370302, "eligibility status": 0.003983841012955869, "porcine model": 137.99888981638424, "improves cardiac": 0.025270855372306278, "linear models": 0.005763175921469181, "during rvpo": 0.008593368699687328, "free wall": 0.0024772338818011123, "functional mitral": 138.0048625338142, "frequently develops": 0.0014691672933022126, "ischemic mitral": 275.9934291737674, "the mechanism": 0.10790682591803341, "combination of": 0.17508276499164097, "reduction by": 0.026533127733090987, "valve tethering": 0.003807862430913245, "anterior leaflet": 137.99426467180538, "leaflet opening": 0.0016550915121403753, "opening due": 0.003147766522254126, "posteriorly displaced": 137.99316314364427, "displaced papillary": 137.99316314364427, "papillary muscles": 137.9932894344305, "ventricular dilatation": 276.0060677415361, "plasty for": 138.04680326537436, "degenerative mitral": 137.99821088768556, "edge anastomosis": 137.99352446455697, "gradient of": 0.17498104128930858, "mitral filling": 137.99927649745862, "filling flow": 0.005240442026393583, "clear organic": 0.0007261432191095843, "organic lesion": 137.99315893293698, "improvement of": 0.1793010619520191, "also confirmed": 0.0036145182711474454, "causes of": 0.1753479624887991, "surgical indications": 0.0017476986754841658, "case report": 0.00351247201380644, "hospitalization in": 0.1490207153439428, "clinical data": 0.0178749833485586, "month risk": 0.020582922813515623, "cause medical": 0.010402480588321638, "medical hospitalization": 0.011905655862734427, "risk group": 0.028942862894139, "month event": 0.004217495699082068, "stage renal": 0.007575032428317609, "important prognostic": 137.9992351418791, "identified in": 0.14526534124001017, "included in": 0.14588943076997374, "egfr group": 0.01067418086933152, "uncontrolled hypertension": 0.005303642415001027, "reduced ef": 0.011245204598940146, "commonly used": 0.007510206485623803, "year event": 0.004790363486145569, "internal consistency": 0.0007486331520321179, "sst2 concentrations": 0.0005395551981373974, "remains unclear": 0.002710922734333081, "mg daily": 0.002724159385107672, "cumulative hazard": 0.009650138318710722, "sst2 treated": 0.004993507601956988, "ratios for": 0.05539261018043344, "benefit from": 0.02054469125412935, "pure hno": 0.00037747572717986954, "reduced left": 0.0263403040155282, "ventricular end": 138.02026340482047, "in conscious": 0.14179597874391917, "arterial pressure": 138.00296557771878, "these data": 0.013134483237365206, "data show": 0.0064022682216035645, "potential usefulness": 0.0033378292189515965, "echocardiographic predictors": 275.989891462581, "multiparametric echocardiographic": 275.98798605256854, "global longitudinal": 0.0022170085263569905, "longitudinal strain": 0.003119255753518717, "% reduction": 0.07996245319325809, "diastolic dimension": 138.00024230506918, "index <": -0.01180035873342005, "cause death": 0.015483596374375946, "reduce morbidity": 0.003845967225946806, "spironolactone in": 138.13621198098426, "diagnosed heart": 0.07641527817177471, "excluded patients": 0.07575270861797256, "serum potassium": 137.99507987483736, "severe hyperkalemia": 138.00007300285444, "eligible patients": 0.07546294404815533, "fold increased": 0.01169107761255806, "reduced compared": 0.021336229567129873, "contributes to": 0.07698593313739943, "cardiac failure": 0.09307360841473583, "myocardial perfusion": 275.99546741896984, "failing heart": 0.07667343930124113, "revealed reduced": 0.01290440952123496, "reduced cardiac": 0.03380181160336271, "b treatment": 0.014421232794805556, "coronary perfusion": 275.99057137475256, "test whether": 0.006512609903157381, "via activation": 0.004239500795900658, "failure via": 0.07271774652192542, "twofold increase": 0.006045399081457023, "isolated cardiomyocytes": 137.99697396366912, "improve symptoms": 0.006765945239301024, "hospitalizations in": 0.1427627437638864, "stable severe": 0.007955865331370052, "the ratio": 0.11724304685059134, "early transmitral": 137.99707020376744, "annulus velocity": 137.9950805141066, "pulmonary capillary": 137.99820989889926, "capillary wedge": 137.99331189154594, "wedge pressure": 0.0073388633184263774, "stable hf": 0.0024203379269591135, "transmitral flow": 137.9963992081856, "p values": -0.017614235537341462, "predictive value": 0.003457239215888832, "showed good": 0.004569856616710499, "good diagnostic": 0.002524772362758264, "annular plane": 137.99435090767224, "plane systolic": 138.00292036958476, "systolic excursion": 138.00296949443864, "arterial systolic": 275.99859691062477, "force relationship": 0.002973126616370571, "regression line": 0.0027479227462893392, "patients exhibited": 0.07629922609467125, "similar distribution": 0.004253171535435267, "study shows": 0.01870863905966056, "step forward": 0.00015779792448340966, "the bottleneck": 0.10683137264195135, "novel therapeutic": 0.0051261301825867925, "therapeutic approaches": 0.004331322857901508, "vessel model": 0.006648611504150349, "proximal left": 138.00854378767178, "timing of": 0.17496068952574215, "ventricle in": 138.13580372398638, "proximal lad": 137.9934486882552, "rate reduction": 0.01498128205060641, "reduction with": 0.1289920434957987, "isolated heart": 0.07737564607841323, "effective arterial": 137.99922196678702, "derived from": 0.019695285708209345, "fraction \u226435": 138.0085361636319, "\u226435 %": 138.0681425303827, "ivabradine group": 138.00507556602344, "isolated hr": 0.0021643145722657895, "prognostic indicator": 137.99642928301088, "postoperative survival": 137.99832503518195, "normal albumin": 137.9965094923248, "postoperative normalization": 137.99371882832617, "survival compared": 0.015103480713946012, "lvad implantation": 0.002583786244769029, "circulatory support": 0.00584354959212727, "surgical intervention": 0.002948073913803726, "patient died": 0.010112149968220676, "few studies": 0.00693868890138751, "youngest patients": 0.07573937470625093, "vs. oldest": 0.004206157866720379, "radiological signs": 137.9935377983997, "multivariable adjustment": 0.0024394643859241933, "hospitalization rates": 0.013626482335203412, "less common": 0.0071479756012825385, "assigned to": 0.07725394238052247, "exercise per": 0.01869318234824046, "kg vs": 0.008533358375045735, "\u00b1 3.1": 138.00459918927822, "depressive symptoms": 137.9965499039683, "aerobic capacity": 137.99811895426834, "hand grip": 0.0007387799261938354, "ejection time": 0.020824538517192973, "arterial tonometry": 275.98893860594626, "prognostic value": 137.99854082468156, "precapillary ph": 137.99304035485088, "clinical deterioration": 0.01274954420395653, "unfavorable outcome": 0.006220046151547686, "prognostic factors": 138.00045771166674, "higher serum": 138.0015611025413, "serum levels": 138.00119942619207, "higher furosemide": 138.00020004908265, "furosemide dose": 137.9982013941516, "oxygen flow": 0.005256583070345883, "the change": 0.10926315041597764, "atrial myxoma": 275.9897548954294, "day test": 0.008676240993559016, "advanced chronic": 0.01204829970042754, "% men": 0.0770629168538833, "advanced copd": 0.003360910065593875, "ranging from": 0.01831673395742363, "absolute value": 0.0032930636485759574, "confidence level": 0.009565753158694517, "rheumatoid arthritis": 275.98580847816885, "severe hf": 0.005535527404410939, "used data": 0.012920506975808346, "study cohort": 0.024235705991133713, "these groups": 0.013287467867502876, "propensity score": 0.004933390625052441, "adjusted for": 0.05687536404166431, "new users": 0.003281320273724143, "the hr": 0.10601608856192626, "mg hr": 0.002302503277806224, "chronic disease": 0.0215011246753276, "methods study": 0.01876551136123897, "secondary outcome": 0.006862705479889925, "demonstrated significant": 0.012186618837782881, "sub -": 0.18190173270626991, "groups based": 0.01007203678041922, "prognosis of": 0.17729461569280416, "improved clinical": 0.016912472055345934, "vasopressin receptor": 137.99929907317826, "antagonist therapy": 138.00608489975576, "embryonic gene": 0.0029872279926489525, "linked to": 0.07719709800397645, "induction of": 0.17511083635395633, "occurs in": 0.14179457517481805, "inotropic effect": 137.9979433330519, "long time": 0.009196365274463977, "decrease mortality": 0.019146952007777433, "molecular mechanism": 0.003247626413684447, "specific irs1": 0.002480624409067884, "impaired cardiac": 0.023913496061999866, "ventricular cardiomyocytes": 276.0064760054789, "dysfunction during": 0.018114102272360863, "level variation": 0.0041887492537730124, "median rate": 0.014187468120047755, "rate ratio": 0.021347962677835067, "blockers therapy": 0.015493378200585379, "improves outcomes": 0.015210095276993279, "among trastuzumab": 137.9988432711524, "% compared": 0.0851932005000114, "nontrastuzumab users": 137.99445256412926, "large cohort": 0.00751942614285387, "frequency of": 0.17523361126357911, "women with": 0.12530189248469756, "dietary recommendations": 0.0022675761725415534, "across quartiles": 137.99469310763354, "randomized 2331": 137.99712078946848, "plasma samples": 0.003097500437844224, "modestly associated": 0.017975995868153828, "measures of": 0.17762422445495632, "extended criteria": 0.0018219926540116495, "transplant recipients": 0.0032517630396071964, "chronic kidney": 0.01044273847966902, "kidney disease": 0.014569083885329286, "- transplant": 0.18410737848801093, "part of": 0.1744160990848218, "hospital quality": 0.0123349200412665, "review of": 0.17771677911338354, "average age": 0.007628074396825303, "cause readmissions": 138.00051658407622, "increased from": 0.02868806152549474, "resonance postcontrast": 137.99453614829258, "myocardial extracellular": 275.99533130783504, "major role": 0.007542110460316798, "resonance t1": 0.0014957934416918045, "observational study": 0.01933943548313166, "invasive hemodynamic": 137.99426045414444, "pulmonary vascular": 0.006937525027316439, "cardiac events": 0.029442318426330265, "greater risk": 0.019945431372328185, "heart magnetic": 0.07655488664966373, "chelation choices": 137.99328662729548, "patient compliance": 0.01066502865250956, "response to": 0.0798191360699682, "mild heart": 0.07723815684313846, "current guidelines": 0.004099059621456399, "less severe": 0.008601694345183725, "% subgroup": 138.06841475496802, "clinical composite": 0.014247341118915175, "composite response": 0.005408004887658104, "titin hypophosphorylation": 275.9866251496094, "hypophosphorylation importantly": 137.9932817148116, "metabolic risk": 138.01239787964167, "collagen deposition": 137.9938556296678, "titin modification": 137.9942625664481, "lean zsf1": 0.000942969158418901, "underlying myocardial": 138.00337141832225, "global left": 0.01595311352848489, "ventricular longitudinal": 138.01302535079648, "longitudinal systolic": 138.00405765394385, "systolic strain": 138.00445892086844, "persistent af": 0.000261009914340191, "- fatal": 0.18205328772065119, "fatal stroke": 0.002698225389382232, "predicting adverse": 0.005423250944153146, "the impact": 0.10979000261764328, "interaction between": 0.012233745129737595, "assessed in": 0.14587970932819863, "significant reduction": 0.012993766662517808, "continuous relationship": 0.0032306431241960185, "extent of": 0.17507644894869384, "reduced hospitalizations": 0.012741699826445439, "peritoneal dialysis": 137.99426461622951, "consecutive case": 0.00403172229673083, "case series": 0.0020743522825581538, "potential benefit": 0.005677337512345856, "- pd": 0.1816589691790364, "majority of": 0.17501399057025038, "significant decrease": 0.010432483355058341, "control analysis": 0.015888492079070143, "patients demonstrated": 0.07899476508822997, "cause hospitalizations": 0.007747786760654169, "animal models": 0.005326771149914499, "hypertensive hfpef": 137.99385700081856, "cardiovascular function": 0.01926252293481093, "diastolic filling": 138.00199689194204, "e -": 0.18261523108538058, "- wave": 0.1822988445328156, "\u00b1 16": 138.00536312428687, "\u00b1 18": 138.005515357602, "elevated resistin": 137.99711634919626, "explored whether": 0.0038007808199080682, "serum resistin": 275.9888027679931, "showed increased": 0.01524162748193143, "factor for": 0.05657236286178904, "month follow": 0.010821273922064981, "complications occurred": 0.004172879664065694, "dysfunction in": 0.15078698210905464, "several cancers": 0.0011877566046612615, "administration of": 0.1754377491847135, "aortic blood": 0.005745415791895214, "adenine nucleotides": 275.98580847816885, "nucleotides contents": 137.9931519150964, "oxidative phosphorylation": 275.9875778719793, "phosphorylation capacity": 137.99879945205288, "creatine kinase": 137.99399243564136, "kinase activity": 0.004279356309473911, "preoperative renal": 137.99889037125067, "bypass grafting": 137.99344449606807, "primary isolated": 0.006727247022727619, "isolated cabg": 0.0021643145722657895, "significantly increased": 0.018586048011395684, "coronary disease": 138.01007253035687, "onset heart": 0.0783387077058092, "maladaptive remodelling": 275.98689737419477, "maladaptive cardiac": 138.01586918644063, "cardiac remodelling": 138.01614140176295, "erk1/2 signalling": 0.0009485834407334236, "proportion of": 0.17495647882250367, "% male": 0.07679646934304422, "recent trials": 0.006631745961143038, "current status": 0.00604130726736798, "clinical care": 0.020126091366934815, "care delivery": 0.008254980105628036, "care systems": 0.009035133606403893, "day risk": 0.023563743669005873, "show that": 0.01446951980812224, "bromodomain proteins": 137.99575951571686, "pathological changes": 0.007573004106516026, "pathological gene": 0.003802470388877903, "in vivo": 138.13498714748266, "- activating": 0.18233884622586993, "activating transcription": 137.9946729774222, "nuclear factor": 0.003576304082811204, "tidal respiration": 275.98608070970175, "myocardial t1": 138.0021548395336, "mapping values": 0.002793718765338223, "myocardial tissue": 138.00350962323486, "control animals": 0.008843978579600044, "healthy control": 0.008826434071265904, "prognostic relevance": 137.99656750413183, "severe pulmonary": 0.01070507145279603, "\u00b1 1.8": 138.00472757845938, "multivariate analyses": 137.99603116353464, "low pasp": 0.006436994830452694, "significantly different": 0.009026999346391153, "independent prognostic": 137.99823574198763, "hypertension patients": 0.07997514454303073, "data in": 0.14693124287912057, "fluid overload": 137.99466803250522, "cardiovascular hospitalization": 0.015778101178620964, "unfolded protein": 0.003515276815366057, "protein response": 0.006753318120187479, "mrna splicing": 137.99290423908442, "cardiac na+": 0.02255660700442256, "tested whether": 0.004179625417682314, "stem cell": 0.002386726394663553, "na+ channel": 0.0015946938079453236, "mrna splice": 0.00027083490924893327, "splice variants": 0.001349908255427806, "reduction of": 0.17929755303865547, "diagnostic procedures": 0.004052939646333112, "management strategies": 0.008078667362750862, "assess whether": 0.005963506618918189, "differential response": 0.004456042188620918, "stable heart": 0.07763166943310655, "outcomes included": 0.017119029142702184, "carvedilol resulted": 137.99545450175705, "lower von": 0.0071979507879646855, "contextual factors": 0.005234513085486586, "biomedical reasons": 0.0026281515076228296, "parasympathetic tone": 137.99492905168646, "evidence suggests": 0.005235875649435753, "sympathovagal balance": 137.99365355557296, "response caused": 0.004190108718908195, "vagal tone": 137.99452072522936, "reduced sympathetic": 0.01328115314108818, "cardiac vagal": 138.01573307530586, "electromechanical delay": 137.9938254621992, "dyssynchronous heart": 138.06893223045245, "electrical activation": 0.0025572573459143734, "abnormal ca(2": 0.0012186841444166885, "the goal": 0.1066615422854536, "advanced hf": 0.003360910065593875, "lower fat": 0.00853654713904015, "lean body": 0.0049131965469485185, "channel inhibition": 0.004313854673928933, "hemodynamic status": 137.99730410535307, "clinical tool": 0.01295228769748308, "clinical prediction": 0.013975162842117488, "derivation cohort": 0.005983793068903045, "multivariate logistic": 137.9945368500784, "diuretic use": 137.99986794033384, "current knowledge": 0.002761187914841967, "aged 20": 0.0042182933256956195, "diseased cardiomyocytes": 137.99535060786607, "cross talk": 0.0005921388659233599, "poorly understood": 0.0011675002171145335, "chronic \u03b2": 138.00785055821737, "therapeutic strategy": 0.004250618055847138, "worsening renal": 0.006393071263253549, "potassium <": -0.01829717463437005, "optimal therapy": 0.013309082269570142, "- specified": 0.1819276987312178, "potassium >": -0.029174685360617646, "exclusion criteria": 0.0020030248767577367, "treatment group": 0.025095413664137076, "control strategies": 0.01064534414635714, "rich cocoa": 0.00044412198346444016, "detrimental alterations": 0.0016263203953857288, "mitochondrial structure": 137.9977419690207, "chinese herbal": 0.00027153669506242115, "herbal medicine": 0.0006426963759725637, "diastolic end": 138.00857623823825, "end diameter": 0.00940882359033914, "analysis indicated": 0.009543592286649402, "week follow": 0.009487030653737915, "metabolic enzymes": 137.99467296352896, "healthy volunteers": 0.0015329832442603482, "biosynthetic enzymes": 137.9934480049965, "therapeutic interventions": 0.005698530307379781, "review provides": 0.003986011759553065, "pathophysiological origin": 137.99329224156648, "care surgery": 0.011136736899286664, "abdominal problems": 0.0009036636825314902, "cardiac arrest": 0.022885659837627786, "posterior wall": 137.9943466969845, "refractory cardiogenic": 275.9866251496094, "heart team": 0.07475444765924653, "effective treatment": 0.01774494848641743, "complicating ami": 137.99304035485088, "linked administrative": 0.0009990978560399006, "fatality rate": 0.010391137512668774, "concurrent hf": 0.00040624888996062766, "day survivors": 0.006214170146743439, "rehabilitation in": 0.14287146908903453, "testosterone supplementation": 137.99398892671292, "key health": 0.005317550793814489, "shuttle walk": 0.001254465998160448, "muscular strength": 0.0018332467687319919, "inflammatory markers": 0.002783907788292089, "living with": 0.12413176583436228, "functional electrical": 0.008122240159431714, "electrical stimulation": 0.00200797903377725, "emotional status": 0.003957173218754857, "minute walked": 0.001222195550585002, "walked distance": 0.00168874884823432, "transforming growth": 0.0015890309668128554, "derived c": 0.0033760040180001575, "cardiac explant": 138.01573307530586, "improve cardiac": 0.025676887359872464, "mesenchymal transition": 0.0007837223065383324, "transition markers": 0.0020051719105347223, "clinical application": 0.0126674357248826, "periodic breathing": 0.0006623416763552501, "defibrillator device": 137.99958802920685, "antiplatelet agents": 137.99436287038486, "prognostic information": 137.99629024999584, "unilateral renal": 0.005576411401376094, "renal denervation": 137.99820981557656, "increased sympathetic": 0.012922268854479795, "cardiac autonomic": 0.023644803561362435, "- dnx": 0.1816589691790364, "sham levels": 0.008291724492134016, "narrow qrs": 0.00024135996071802658, "primary efficacy": 0.006871050009595794, "worsening heart": 0.07629882627727383, "mean of": 0.17890757336406293, "divided into": 0.0018419231690746975, "sensitive outcome": 0.006464905767507664, "outcome ratings": 0.006202501524705983, "provide insight": 0.0023663174474289447, "phosphate receptor": 137.99889073977394, "receptor 1": 0.01293552144773592, "coupled receptors": 137.99425414502466, "coupled receptor": 0.006519735189164396, "plasma membrane": 0.0028533703932382315, "urgent readmission": 137.99642802528857, "early physician": 0.006597457062388353, "physician follow": 0.01121075472975274, "lower rates": 0.012801236763425032, "index admission": 0.0102788442546162, "better outcomes": 0.014324659390286092, "subunit expression": 137.99750667270874, "disease progression": 0.01416360624579549, "significantly decreased": 0.011224069840839575, "autonomic nervous": 0.001477602607348019, "nervous system": 0.002688208350965057, "spontaneous vt": 0.0005423623405259156, "atrial pacing": 137.998211054331, "higher baseline": 0.014230086490626154, "cell transplantation": 137.99694097985457, "performed better": 0.005995536234268991, "outcomes trial": 0.017278928865925365, "pharmacological treatment": 138.00732547187923, "new targets": 0.002908870581436452, "the treatment": 0.12043732135673182, "clinical symptoms": 0.01585565388967025, "guided clinical": 0.01246187572140306, "aldosterone system": 137.9961558031191, "cardiac filling": 0.024574309146658892, "score <": -0.014584615193553174, "factor analysis": 0.011704766404015583, "forms of": 0.17491507369203024, "antibodies targeting": 0.0015905572114296054, "nonterminal epitopes": 275.98580847816885, "these findings": 0.009050848845824733, "wall thickness": 0.0021216331611007746, "inappropriate implantable": 137.99721516856982, "defibrillator therapy": 138.00771788608517, "therapy due": 0.014400469518193902, "therapy compared": 0.02204672710708997, "inappropriate atp": 0.0014529846235498249, "receiving carvedilol": 137.9962479055717, "carvedilol compared": 138.00435631751125, "lower rate": 0.017050225624953275, "refill compliance": 0.001470570873792443, "trend <": -0.01808531728753804, "matched control": 0.009566548612104365, "failure due": 0.07296176878960693, "myosin heavy": 137.99321644924058, "heavy chain": 0.0003949973196803827, "reference subjects": 0.0036221792449995047, "psoriasis patients": 0.07575762111736706, "brachial index": 138.00048786649666, "peripheral artery": 0.004757099027210762, "index \u2264": 138.00048786649666, "intensive transitions": 0.0006609427400530391, "care program": 0.00954372741496272, "care system": 0.010214904661672599, "abnormal hr": 0.0012186841444166885, "various measures": 0.0036836621163255164, "- linear": 0.1824700425454805, "artery stenosis": 137.99698570651367, "common form": 0.004526590904250076, "progressive disease": 0.013478874598193738, "major public": 0.003256814551028498, "health problem": 0.005002523125956565, "differentially expressed": 137.99403100377035, "failure samples": 0.07184932801185914, "functional enrichment": 0.00787387162130465, "enrichment analysis": 0.008621007281568102, "analysis using": 0.014688218877954053, "driven telehealth": 137.99380300980198, "inpatient admissions": 0.0018971645674245594, "hospital days": 0.008821100137048994, "without exercise": 0.0197466818414371, "walk distance": 0.002303325624140023, "increased mortality": 0.02773427796613224, "the hazard": 0.11458083746657813, "lower exercise": 0.022632879252865865, "early treatment": 0.018314968260798002, "applied early": 0.004676035682276119, "early rhythm": 0.006471205641773364, "cardiac nurses": 0.023219641208748597, "article describes": 0.0010678429936808065, "life expectancy": 0.005203553596993956, "terminal heart": 0.07805323254807994, "ventricular action": 138.01209359451448, "sustaining treatment": 0.014823972756935332, "composite quality": 0.008931484770834448, "quality measures": 0.010081081735475695, "help patients": 0.07491908003359829, "future high": 0.008188744686674772, "low performers": 0.006700110099828845, "adjusted mortality": 0.02050485107962202, "versus best": 0.007409982439369804, "best quintile": 8.620204476547286e-05, "using 2005": 0.007481639962985745, "vs. hospital": 0.009384531765947057, "race influences": 0.0028132518099113508, "aa participants": 0.0033566993730672727, "combined end": 0.01005564732018277, "signaling pathways": 0.00380812171447011, "proteomics changes": 137.99979949928976, "ingenuity pathway": 0.0017659265651905891, "significantly changed": 0.008131910440262275, "actin cytoskeleton": 275.9859445939353, "mitochondrial function": 138.00713713965916, "global attenuation": 137.9941705935481, "targeted peptide": 0.0043080459777648785, "- acute": 0.19049145434306003, "care transfer": 0.008271822838800727, "transfer policy": 0.0005303834320534485, "percentage points": 0.0018998905739288836, "kidney infection": 0.0024099616412051883, "patients cared": 0.07520545230603916, "across hospital": 0.007229655932648314, "chronic advanced": 0.01204829970042754, "anaerobic threshold": 137.99343607696196, "primary study": 0.02308638206775492, "at multivariable": 0.012349085823379116, "metabolic exercise": 138.00983285563396, "kidney index": 0.009066747040060292, "index score": 0.011838539930316751, "following variables": 0.002588109073255322, "cardiorespiratory fitness": 137.99301298987947, "lower hf": 0.006929221235783285, "mortality risk": 0.03511663967860795, "decreased mitochondrial": 137.9994225932372, "% decrease": 0.07740116988579863, "health service": 0.005061440601106889, "lower total": 0.010401547502506357, "total expenditure": 0.0038582233966878913, "health per": 0.007698113404170212, "rheumatic fever": 137.99329785584138, "cardiac injury": 0.023575327064571924, "terminal phase": 0.0038886923412725597, "antihyperglycemic agents": 137.99409064116784, "versus pioglitazone": 138.00063497015472, "versus insulin": 0.009770860225511468, "parasympathetic activity": 137.99677595451107, "ongoing gdmt": 0.0004735876355802304, "major adverse": 0.007756853725895629, "adverse neurological": 0.004611503580375583, "physical examination": 0.0016656179659660815, "young athletes": 0.0019243871681950964, "atherosclerotic cad": 137.99290423908442, "assisted gait": 0.0008082847517980824, "gait therapy": 0.012227238833962668, "resistance training": 0.006316941717886922, "inflammatory biomarkers": 137.99555621403232, "peak quadriceps": 137.9973549880905, "quadriceps force": 137.99344025132697, "events occurred": 0.009295522606005599, "higher psss": 0.007295809998234491, "lower btes": 0.006929221235783285, "resting hr<70": 0.0009436709434936348, "versus \u226570": 138.0007710836053, "\u226570 bpm": 275.9864890477377, "dose uptitration": 137.99901805401348, "kg increase": 0.009969993883289677, "interatrial shunting": 275.9859445939353, "principle cohort": 0.006096048152278556, "atrial pressure": 138.00391798296835, "mean score": 0.008997439721935716, "min walk": 0.005342546180881206, "caloric restriction": 137.9935806072028, "obese older": 0.005206673364273729, "stable hfpef": 0.0024203379269591135, "- primary": 0.18622190162949823, "diet group": 0.013772783908738368, "performance goal": 0.0031456604603882264, "failure disease": 0.08333073645080721, "the model": 0.11200166586175057, "attention to": 0.04337639247814273, "talk between": 0.006036952062122843, "loss of": 0.09872357959993075, "follow up": 0.009455813858184017, "agents in": 0.08012961597363727, "studies of": 0.10175527410390135, "data on": 0.010530623799973094, "evidence from": 0.012381681938560875, "symptoms in": 0.08151295129888064, "participating in": 0.07973971089037317, "known about": 0.00045320745547342917, "setting of": 0.09883763672074691, "hearts of": 0.09925553010131732, "mortality at": 0.015887784998249825, "outcome in": 0.08280830137098734, "factor in": 0.08134882919005915, "increase of": 0.10129259462791798, "implications of": 0.09848918709764373, "performance of": 0.09952733368916995, "approaches to": 0.04368186037489957, "hospital for": 0.03299583262464611, "supplemented by": 0.012418703657042517, "months after": 0.010191746415081887, "findings from": 0.010902994404953611, "accounting for": 0.030145351300287428, "recommendations for": 0.030676928378673057, "association of": 0.09978068173993333, "presenting to": 0.0432998503415786, "phenotype of": 77.71989519445516, "characterized by": 0.012415940377102735, "recognized as": 0.009062942998625144, "median of": 0.10040835324830445, "effects in": 0.08256178790185564, "determination of": 0.09818411348842565, "survival in": 0.08228177115870229, "admission to": 0.04467146026207353, "measured in": 0.08144273348750179, "targets for": 0.030596819607227637, "wk after": 77.62934930073021, "hypertrophy to": 77.66561850032345, "group of": 0.10412519413868469, "bridge to": 0.04320947016351015, "types of": 0.09832382343305199, "importance of": 0.09854127367090071, "annuloplasty for": 77.65109715314097, "dilated by": 77.63434795266726, "evaluated in": 0.08152518866322032, "developed for": 0.03232293489359937, "need of": 0.09870177299755013, "dose of": 0.10110061712497426, "evidence for": 0.032303592227568255, "prediction of": 0.09911387768260353, "remodeling in": 0.08160527401725809, "echocardiography at": 77.6287208731837, "failure of": 0.13778678069298692, "pressure in": 0.0834376360273566, "% had": 0.04785170542733538, "reduced in": 0.08578769238861822, "normalization of": 0.09834948240028857, "analyzed in": 0.08014777463294877, "levels by": 0.01609142834286327, "signs of": 0.09847734451452203, "care in": 0.08391507237984194, "error of": 0.09833882404228697, "found between": 0.007828240104178447, "worsening of": 0.09873268320844429, "result in": 0.08002579721986015, "programs in": 0.08011224688981665, "years of": 0.1032742466346358, "documented in": 0.07998992167556786, "insights from": 0.010013479432404175, "patients from": 0.05216814926138895, "care for": 0.03438819729953913, "associations of": 0.09857719616831051, "study of": 0.10854040780941307, "subset of": 0.09834987715477303, "outcomes after": 0.014757095655427538, "experience with": 0.0701125796026963, "rate for": 0.03562845469031968, "parallel with": 0.07020141731461958, "contributions of": 0.09840828230025397, "results from": 0.012681067657609768, "average of": 0.09862925871739785, "coupling in": 0.08030325385818157, "reserve in": 0.07988612383462082, "maintenance of": 0.09832856046214442, "composite of": 0.09926697796330224, "days after": 0.009629607692908916, "result of": 0.09868449981783148, "testing of": 0.09923421347039735, "consequence of": 0.09834356108717118, "tissue from": 0.010775545264355472, "means of": 0.09829735809989937, "tool for": 0.03035293273547253, "drugs for": 0.03071321850631948, "declines in": 0.07961066189487663, "blockers on": 0.00933400726688003, "progression of": 0.09888026995266783, "insight into": 0.0009547822294133971, "goal of": 0.09848403511916984, "aspects of": 0.09863204464262446, "suggesting that": 0.008094976553530597, "need for": 0.030516195319275977, "potential of": 0.09977156035233667, "stratification of": 77.71966553036013, "eplerenone in": 77.70077715194526, "reversal of": 0.09827331203613823, "exercise with": 0.07865742591643773, "period of": 0.10006507180811133, "phase of": 0.09870978750556449, "overview of": 0.09834711387410602, "lead to": 0.043173530895480795, "regulation of": 0.09848405530779804, "biomarkers in": 77.70123649185719, "modification of": 0.0985022139750742, "odds of": 0.09925829337568183, "fragments of": 0.09834908764583773, "metoprolol on": 77.62988375387876, "baseline to": 0.04690280238063625, "consist of": 0.09834553485734458, "attenuation of": 77.71935929333254, "done in": 0.07966192800162403, "subjected to": 0.04322486554115142, "score of": 0.10066748462567485, "common conditions": 0.001459802012884905, "the effects": 0.027881587962766574, "decade of": 0.04365264066438572, "national efforts": 0.00013381298346395835, "efforts dedicated": 6.0158266554277907e-05, "improve patient": 0.003146568707307361, "safety remain": 0.0009121536914110219, "remain largely": 0.0004579638823568497, "largely unclear": 0.0006259978209354566, "assess national": 0.0008371012470306886, "conditions requiring": 0.0007406874062240984, "requiring surgery": 0.001106496193009376, "the analysis": 0.028591740679998895, "analysis included": 0.003243514097915485, "large study": 0.005082654846576584, "study sample": 0.004862393988103459, "patients across": 0.019182625950162176, "significant decline": 0.0021852706081555225, "rates for": 0.014772621535871128, "estimated 81,000": 34.49878009655916, "hospital adverse": 0.002445714906523814, "events averted": 0.0017551070621789698, "measurable overall": 0.0002143437438398391, "overall improvements": 0.0005817878621941274, "surgical conditions": 0.0007754140797354813, "some events": 0.0015810525690600867, "pressure ulcers": 0.0018006863089964045, "surgical patients": 0.019071473044860135, "actually increased": 0.002699643534874955, "increased despite": 0.0030935859721444164, "considerable national": 0.00019328203223250385, "national attention": 0.00029535806385112373, "study suggests": 0.004887296869501455, "national patient": 0.002495580849195216, "safety initiatives": 0.0008039370544033057, "real progress": 0.00020836402952470714, "progress in": 0.03546354804149763, "created across": 0.0004986023102237295, "board improvements": 0.0004540880516105218, "- talk": 0.04547682946006704, "cachectic heart": 34.517028892647645, "increased energy": 0.0030104498641609074, "energy expenditure": 0.0003853440685691722, "expenditure caused": 0.00030133826857773775, "b natriuretic": 34.499110624137586, "progressive loss": 0.00043411253397830695, "fat free": 0.0006605254712443131, "takes place": -0.00011036376149893627, "body fat": 0.0013943883229466205, "fat distribution": 0.0005565369536787579, "dual energy": 0.00038657219083215873, "- diabetic": 0.045516479963686796, "diabetic patients": 0.018837146481809817, "- cachectic": 34.543640802065866, "cachectic chf": 34.498226059771106, "prior myocardial": 34.50089599090096, "neurohormonal stimulation": 34.49863245805576, "endothelial dysfunction": 34.5009805296817, "midregional proanp": 34.4981920302505, "elevated in": 0.03596128057065438, "inverse correlation": 0.0003395824201096653, "- adrenomedullin": 34.54360677254526, "groups even": 0.001676843099928038, "increased by": 0.008139792595996582, "decreased by": 0.0062992980533575545, "cc patients": 0.01873540881288212, "latter correlated": 0.0007369820255844564, "baseline nt": 0.0017335691230979159, "no correlation": 0.00181636599859731, "plasma nps": 0.0004412934590745888, "stable body": 0.0015976413288721826, "clinical doppler": 0.003052497251454783, "failure show": 0.017813568822294346, "show preserved": 0.0021551778350117753, "steadily increasing": 0.00034957184823829137, "combination with": 0.031194313862196052, "figure 1": 0.0017788219883497446, "major underlying": 0.001157840067992611, "underlying mechanism": 0.0007768290361872789, "even mild": 0.0007290546909565097, "mild clinical": 0.003559203585702539, "clinical diastolic": 34.5030472947014, "pronounced increases": 0.00025995203948584367, "dysfunction leading": 0.002602757242413098, "critical importance": 0.0002683642166826942, "guidelines based": 0.0014737541421039994, "based definition": 0.001126661576819326, "definition of": 0.043672465969238565, "- dilated": 34.54415117540673, "dilated left": 34.50251020796612, "impaired lv": 0.00033922226439432655, "diastolic stiffness": 68.998322942309, "elevated lv": 0.0006447184365591051, "assessed non": 0.002154343232161747, "- invasively": 34.54367483100748, "invasively using": 34.49984442489269, "practice guideline": 0.0012345380497444138, "provide clinical": 0.003515328427246856, "clinical recommendations": 0.0033820699880154504, "recommendations on": 0.0035936013953082866, "published literature": 0.00021819692464701259, "english language": 7.559631940468728e-05, "additional studies": 0.0017915235418539085, "outcomes evaluated": 0.004040816776835589, "evaluated for": 0.014221472703518891, "guideline included": 0.0018361121142075577, "included mortality": 0.005367784971848276, "failure exacerbation": 34.51582128060308, "including hypertension": 0.00202295076225943, "venous thromboembolic": 68.99658823415072, "ischemic cerebrovascular": 68.99723462486327, "cerebrovascular events": 34.49991345810598, "the target": 0.026849899266638364, "target audience": 0.0003504324349718758, "guideline includes": 0.0007890640172866818, "target patient": 0.002712375744601682, "population is": 0.006861566089729135, "deficient adult": 0.00039657446883671475, "guideline grades": 0.0007108377289874469, "recommendations using": 0.0019139089165318515, "practice guidelines": 0.0009644611841534902, "guidelines grading": 34.49860226994072, "grading system": 34.498766730825636, "recommendation 1": 0.0019003832089263077, "recommends using": 0.0016490623199353139, "restrictive red": 4.402417228685744e-05, "red blood": 0.0009024622366906946, "blood cell": 0.0014249499605340965, "cell transfusion": 0.0007028019511366002, "transfusion strategy": 0.00045183240396529047, "trigger hemoglobin": 34.49842602270991, "hemoglobin threshold": 34.49842707538682, "higher hemoglobin": 34.50015209735861, "weak recommendation": 0.00018873728486248995, "recommendation 2": 0.002088084945497578, "strong recommendation": 0.0002467859775122648, "anemia treatment": 34.50217163133447, "treatments for": 0.013573508759394186, "trial registries": 34.49942183026031, "reference lists": 0.00036097576528065507, "technical advisors": 5.209462578998893e-05, "study selection": 0.004630862404323272, "language trials": 0.001227031610268926, "population characteristics": 0.0016018867317707892, "assessed for": 0.014457982851915067, "studies suggests": 0.001871681889274022, "liberal transfusion": 0.00020031498872592472, "transfusion protocols": 0.00027135603777595077, "improve short": 0.0009689687754395113, "rates compared": 0.003990760123957869, "less aggressive": 0.0009289668133154826, "aggressive protocols": 0.0002638118541898521, "combined relative": 0.000798749890704963, "among trials": 0.0023980028743242673, "rates occurred": 0.00207045667793491, "small trial": 0.0014235975056758094, "coronary syndrome": 34.49944765771951, "iron found": 0.0011870861385339304, "found improved": 0.0020338359463810208, "improved short": 0.0013645194489587359, "term exercise": 0.005159351379467562, "life in": 0.03655167171599973, "stimulating agent": 0.0003336218803419841, "agent therapy": 0.003187132276358157, "therapy found": 0.003847140718724381, "consistent benefits": 0.0007168376430607618, "venous thromboembolism": 68.99648614732587, "few trials": 0.001270860092115278, "examined transfusions": 34.49879941289472, "potentially confounded": 0.00042586118092401886, "data supporting": 0.0014704479823260362, "supporting iron": 0.0003830703511757803, "iron use": 0.001865631301421694, "use come": 0.0014328942701716217, "come mainly": -1.440962125934966e-05, "large trial": 0.0016475629314572622, "term effects": 0.002611002697481926, "higher transfusion": 0.001993921761267007, "transfusion thresholds": 0.00020382391486379982, "consistently improve": 0.0008402346332508538, "improve mortality": 0.004992059502312596, "large trials": 0.0016032277331175504, "also warrants": 0.0007906760474254632, "warrants further": 0.0005699992896102222, "benefit patients": 0.019421146323123712, "serious harms": 0.00020013395675104855, "remote ischemic": 34.49904259461276, "ischemic conditioning": 34.49907434390949, "nonischemic cardiomyopathies": 68.996384060501, "inroads made": 0.00011466857283850998, "pharmacological armamentarium": 68.9964180900216, "eventual resort": 6.10423478951576e-05, "both patients": 0.0197154635895582, "hospital frequently": 0.0016608326202905937, "keep physicians": 0.00031481840935718635, "physicians busy": 0.00038903030599758226, "also prompting": 0.0007548920649775916, "better ways": 0.0004519335953684197, "worldwide epidemic": 0.0001536562593853905, "medical resources": 0.001078838309195097, "financial costs": 0.0003907588896002699, "failure clinical": 0.0206817476040331, "enriching patient": 0.0023664986184448846, "patient identification": 0.0023970197916229293, "authors suggest": 0.0006226469847653447, "patient categorization": 34.50055852886894, "modern acute": 0.002284243942936426, "highly heterogeneous": 34.498476005673126, "appropriate risk": 0.004927960426505291, "conducting studies": 0.0016792717794482876, "cardiac defibrillator": 34.504579697737675, "many current": 0.0006251826185199369, "current predictors": 34.49931693748936, "identify factors": 0.0016327216943597786, "reviewers selected": 0.00032817843171573867, "selected citations": 0.00029467525041904845, "included ambulatory": 0.0014274938047422157, "ambulatory icd": 0.00027169824634406, "using multivariable": 0.0018223592722661603, "multivariable regression": 0.0008841450999247706, "analyzed mortality": 0.004516660449554292, "using random": 0.0016153836917235306, "effects models": 0.002615591461041283, "studies reviewed": 0.001915005968778344, "evaluating 63": 0.00023276664974151767, "patients proved": 0.018752596121711294, "proved eligible": 0.00014751450798588283, "high confidence": 0.0033355160686649784, "confidence in": 0.036930230554380064, "year increase": 0.0021313892453794737, "baseline glomerular": 34.500299892258866, "min decrease": 0.001663249236745774, "inappropriate icd": 0.0003632461558874562, "congestive hf": 34.49914463803226, "analysis identified": 0.003087491715424593, "identified strong": 0.0011174600756639287, "strong reliable": 0.00024748776107782523, "reliable mortality": 0.00434179027477128, "mortality predictors": 34.50291440168766, "strong predictors": 34.49882009917397, "further research": 0.000875161174873788, "potential predictors": 34.49943600914206, "particularly biomarkers": 34.49883660698531, "failure randomized": 0.01868338794859092, "small studies": 0.0018430744405676972, "studies suggest": 0.0021112515716453836, "neither strategy": 0.0003399223383499818, "rigorously tested": 34.498454078966475, "independent hypotheses": 0.0005498446444096292, "min without": 0.002099256604340165, "without bolus": 34.499236815727194, "controlled clinical": 0.0034162697439311506, "randomized within": 0.0017919263025371912, "enrollment occurred": 0.0008730983640651835, "randomized in": 0.036370699730107876, "allocation ratio": 0.00283708529918381, "ratio to": 0.0219188603960178, "nesiritide strategy": 34.4987801382361, "active treatment": 0.0036565250281407513, "the dopamine": 0.02687814594735789, "independently compared": 0.003063834885113879, "pooled placebo": 0.0007815058907511489, "points included": 0.0014048508787433528, "included 72": 0.0013238349099686025, "decongestion end": 34.50047740696866, "serum cystatin": 68.99682641184849, "function end": 0.004958984250551088, "points reflective": 0.00028203274138899234, "in participants": 0.036155736977362095, "nesiritide enhanced": 34.498731561137305, "enhanced decongestion": 34.49856143090251, "improved renal": 0.002502014885413491, "added to": 0.019249791058284005, "multihospital study": 34.50282289265483, "promote adoption": 4.595401111989128e-05, "failure guidelines": 0.0180394900427968, "nurse leaders": 0.00012418049769408502, "many multisite": 34.49823671717448, "multisite studies": 34.499841307195204, "practice settings": 0.0007494456565925237, "settings focus": 0.0002871290638271967, "focus on": 0.003355933559917304, "improving processes": 0.0004904211184745779, "processes of": 0.04380313944192472, "adopting evidence": 0.001084810082812109, "based practices": 0.0011871747153585383, "improving patient": 0.0026630991392995046, "specific research": 0.0009909213586058912, "research questions": 0.0003718116904203197, "implementation issues": 0.0001634628355253408, "profoundly transformed": 6.279680996370094e-05, "utilizing voluntary": 2.981938862748266e-05, "voluntary testimonies": 6.314770246939846e-05, "participating nurses": 0.0002890679238187507, "multisite study": 34.50285692217543, "study extend": 0.004756628013505975, "extend beyond": 0.0001622451130293866, "beyond meeting": 4.857248124888875e-05, "meeting magnet": 1.2092977402204547e-05, "research requirements": 0.0004260173248193785, "systems proteomics": 34.49864192987512, "cardiac chromatin": 34.50423949803963, "chromatin identifies": 34.4986671777838, "identifies nucleolin": 34.49829289126638, "regulator of": 0.043671062401369136, "cellular plasticity": 34.49836094857064, "plasticity in": 34.5335426219052, "hypertrophy antecedent": 34.49900807926745, "failure involves": 0.017723970176002163, "involves changes": 0.0016824225820679163, "global gene": 0.0008595728572087539, "preceding mechanisms": 0.00033799934988496916, "coordinate dna": 3.297742104379512e-05, "dna accessibility": 3.350376026450632e-05, "genomic scale": 0.0002478446195281468, "thereby altering": 0.0001315570569395488, "global changes": 0.0018022062866182849, "chromatin subproteomes": 68.99679237653902, "accompany heart": 0.018836161190378776, "study tests": 0.004753820886385855, "fundamental hypothesis": 0.00026082927783067136, "cardiac growth": 0.005970104336567309, "disease recapitulates": 34.50139546401062, "recapitulates conserved": 34.498225884903654, "conserved developmental": 0.00010015980939695942, "developmental chromatin": 34.498666651444765, "chromatin remodeling": 34.499552794828766, "remodeling events": 0.0026738763957185746, "used quantitative": 0.0018807096535447866, "quantitative proteomics": 34.498429003559075, "identify chromatin": 34.49916123467896, "proteins extracted": 0.0007813524389860592, "extracted via": 0.0006517485003931904, "via detergent": 0.000584040931058449, "quantify changes": 0.001825374958048142, "study identified": 0.005630635580230536, "identified 321": 0.0010336278290626793, "modest conservation": 0.00019592883201549898, "revealed using": 0.0019991374105448874, "using strong": 0.0017020230797278489, "strong acid": 0.00015066432080046004, "exhibited altered": 0.0006447705323638674, "conducted extensive": 0.00021329101844187677, "extensive functional": 0.0019614500604379368, "functional characterization": 0.0019346138311535097, "based knockdown": 0.0011313986256511262, "knockdown of": 0.04367720301807036, "nucleolin nearly": 34.498263591937466, "nearly abolished": 0.00010401276893029772, "abolished protein": 0.0009121469389777004, "little impact": 0.0010827276879044267, "gross morphological": 34.49828622373651, "morphological development": 34.49923313697862, "fish lacking": 7.38429951366481e-05, "displayed severe": 0.001444397287089205, "severe developmental": 0.0014501870073442787, "developmental impairment": 0.00023504629310130615, "abnormal chamber": 0.00033343774836797557, "chamber patterning": 34.49822079696276, "functional deficits": 0.002034595299783603, "cardiac looping": 0.005672830957807683, "myocyte differentiation": 34.49842953163512, "the mechanisms": 0.026808868622931376, "mechanisms underlying": 0.0006089911796103028, "defects involve": 0.00016400640456593616, "involve perturbed": 34.49825482648337, "perturbed bone": 34.498256580944286, "bone morphogenetic": 34.49822255142368, "morphogenetic protein": 34.4990376965869, "decreased rrna": 0.0008810855354439127, "rrna transcription": 34.498498275093844, "heterochromatic chromatin": 68.99679237653902, "study reports": 0.004723118190719007, "quantitative analysis": 0.002154550034794896, "new chromatin": 34.499033595095746, "chromatin subproteome": 68.99682640605963, "diseased mouse": 0.00050497734246803, "validation studies": 0.0016822543657498234, "complementary model": 0.0015639276058307735, "model system": 0.002071094900095306, "zebrafish examine": 34.49859421261816, "orchestrate genomic": 0.00010173882692102073, "genomic reprogramming": 34.49825991442427, "reprogramming events": 34.49991345810598, "events shared": 0.0017347553780596829, "myocardial ischemic": 68.99958130449616, "regarding risk": 0.00479221060253704, "factors for": 0.014376450957885985, "comprised 1,045": 34.49829166256319, "used multivariate": 34.500346177562484, "hazards regression": 0.000915714897921664, "regression modeling": 0.000712953502907361, "identify risk": 0.005128058896636355, "comprising hospitalization": 0.0019694887674360866, "coronary interventions": 34.499958540034235, "patients included": 0.019891204371280276, "included previous": 0.001255595392051878, "previous revascularization": 34.49842794469271, "bypass surgery": 0.0009402228804535127, "coronary intervention": 34.49971565307557, "increased systolic": 34.50339624496043, "block pattern": 0.00028713686105435624, "baseline electrocardiogram": 34.4999255993736, "reduced risk": 0.007378471655936906, "risk compared": 0.007089926748249301, "ies among": 0.0012465675834600284, "dependent effect": 0.0018329343830603077, "fraction on": 0.0071379808540029364, "contemporary heart": 0.018831073250826596, "improved outcomes": 0.004299582489659091, "mortality after": 0.007646736866362747, "acute decompensated": 34.500468210003724, "decompensated hf": 34.49826008871272, "world setting": 0.00018219461735105618, "categorized as": 34.502193168109514, "severe reductions": 0.001552622987962497, "similar risk": 0.0054757579121961445, "mortality as": 0.008145068810244153, "moderate reduction": 0.0018224346941864847, "conferred increased": 0.002753855713714294, "increased increase": 0.004131192179519502, "increase rate": 0.003939863198729059, "rate compared": 0.005053007339339929, "interaction term": 0.0016708705175513257, "term analysis": 0.003321155414714246, "patients \u226475": 34.51692743906338, "\u226475 years": 34.500482376577146, "preserved versus": 0.003869513191259067, "experience similar": 0.0010367924374909505, "similar long": 0.002012402382996328, "moderate reductions": 0.0007761064156871418, "significantly attenuated": 34.50018502063749, "longitudinal study": 0.00497061100793831, "endothelial repair": 34.498664019751665, "serial measurements": 0.00023223915342199562, "included 156": 0.001189299318662662, "consecutive consenting": 0.0005712489291712602, "consenting ambulatory": 0.00030537745304610347, "measured as": 0.004813287701588442, "outgrowth colony": 34.498223604100964, "forming units": 0.00014716363947406697, "cd133 +": 0.0006682107866514494, "recorded mortality": 0.004332140772332114, "a decrease": 0.013428508904697486, "increased functional": 0.004622514702534407, "cell decrease": 0.0011075812779224542, "interaction effect": 0.0016631781926093256, "noted differential": 0.00038114747972090637, "differential relations": 0.0003302837777947929, "lower cd34+vegfr2": 0.0017323053089458214, "nondiabetic patients": 34.51692743906338, "lower eo": 0.0017323053089458214, "the basis": 0.02671853554520594, "differences requires": 0.0007948854641835589, "choice for": 0.013377582312813463, "common applications": 0.0010714935495759793, "differential impact": 0.0012148258674439696, "hospital performance": 0.001985248530097246, "calculated 30": 0.0018596472204702678, "rates using": 0.0030523400618816207, "using three": 0.0019985447076028254, "disease groups": 0.004657928503342767, "absolute change": 0.0010424198180286857, "correlation between": 0.00289270088642405, "hospitals remaining": 0.0005225039533356583, "extreme deciles": 34.49831691979, "longitudinal performance": 0.0009648002878302601, "principal findings": 0.0004549781949066386, "average hospital": 0.001586104098198532, "hospital rates": 0.0028282007277924603, "generally higher": 0.0019451565291717893, "rates calculated": 0.0019066656469587705, "calculated using": 0.002022997945019518, "moderately correlated": 0.0007817125927612734, "extreme decile": 0.00015874419265865248, "decile according": 0.00036779550461228753, "metric remained": 0.0006982461524173002, "different metric": 0.0005344108070971915, "correlations among": 0.0012804222366154438, "among metrics": 0.0014831871045607454, "measuring hospital": 0.0014563202364365419, "hospital longitudinal": 0.0016999454494970613, "longitudinal change": 0.0011515140671278822, "different approaches": 0.0006338572546023057, "computing readmissions": 34.498595616186144, "produce different": 0.0003782977319166143, "different hospital": 0.0016920147577138308, "hospital rankings": 0.0014256247707045294, "impact pay": 0.0009031206910550305, "careful consideration": 0.00015611248916671335, "readmission metric": 34.499143138881834, "discharge in": 0.03599477333348312, "recent discharge": 0.001184712398809355, "deliver specialised": 8.015901450473619e-05, "specialised care": 0.0020114766722400773, "growing needs": 0.00017363364992906716, "failure population": 0.01855257499237818, "strategies improve": 0.0015570016452015546, "unplanned admission": 0.0008092193492999216, "admission due": 0.0013530533596712298, "searching relevant": 0.00017680527000490595, "relevant articles": 0.0001475060336136164, "all randomised": 34.50002258128351, "controlled trials": 0.001515207783340606, "cohort studies": 0.0030433115175559945, "contemporaneous control": 0.0019182591334056215, "rm interventions": 0.0006438412051400667, "interventions included": 0.0017996367635382225, "included home": 0.0011013919860903497, "home telemonitoring": 34.498137626678194, "including implanted": 0.0010022456387879363, "provided during": 0.0025142075632468997, "structured telephone": 0.0001285750497563108, "telephone support": 0.001320038056505979, "programmes delivered": 0.0001838248114170622, "delivered via": 0.0006045611198124969, "via human": 0.0012722039952362603, "human contact": 0.0007442863314889342, "machine interface": 5.7708874735853145e-05, "assessed independently": 0.0016944438410208228, "enrolled 6317": 34.49870014015446, "studies evaluated": 0.0025321024736540366, "studies assessed": 0.0027686126220502136, "no trial": 0.0027404382414572006, "devices met": 0.0007962174680739236, "reaching statitistical": 34.49825008944659, "statitistical significance": 34.498321831111824, "% credible": 0.01880448604124121, "credible interval": 0.0015926750818601437, "provided better": 0.0008230685086192004, "usual support": 0.001585586440638414, "support to": 0.020369011755423706, "group rendered": 0.0026995927290852264, "comparisons statistically": 0.000372035817660269, "also observed": 0.0014292318864067063, "cause hospitalisations": 34.49985693995865, "hospitalisations for": 34.51159873472932, "care packages": 0.0020435762840671557, "packages generally": 0.00018575472340140112, "generally improved": 0.0012968247919948673, "improved health": 0.0023527680306347836, "hours showed": 0.0012324705869638476, "showed beneficial": 0.0015615111314267022, "beneficial trends": 0.00070193512751963, "discharged patients": 0.018904149949741884, "care is": 0.007917267040208197, "less good": 0.0008201790969709047, "apoptosis in": 34.53361067920945, "canine model": 0.0015634012666100622, "failure induced": 0.01908956578065134, "induced dilated": 34.50019674854005, "fully understood": 0.00029291923029039536, "weeks rapid": 0.0007913168184071639, "rapid right": 0.0016544291818925434, "ventricular pacing": 34.50325668859201, "gene expressions": 0.0006780467502783392, "interventricular septum": 68.99648614848383, "septum biopsies": 68.99652017742544, "taken weekly": 9.207579740858587e-05, "beagle dogs": 34.49831849764208, "evaluated protein": 0.0017625213859645524, "genes by": 0.005756206657998021, "autopsy samples": 0.0003655327323476234, "pacing period": 0.0012041459002506741, "expression transiently": 34.49924055356863, "transiently decreased": 34.49907311578595, "moderate heart": 0.01941019815536424, "significantly altered": 0.002230304746344157, "expression increased": 0.003770103396214866, "weeks of": 0.044305564947597645, "no band": 0.0015550127178380639, "paced myocardium": 34.49853143606624, "difference between": 0.0033137579207197514, "apoptotic cells": 34.49883044246965, "cells in": 0.03592094483263887, "positive cells": 0.0007082177319463905, "paced groups": 0.0015557060728800948, "pump sternal": 34.49859737064753, "sternal sparing": 34.4982257094572, "sparing approach": 0.00031343701802409596, "approach for": 0.013584375465282746, "pump dysfunction": 0.0027855237901954566, "dysfunction requiring": 0.0026815209516350145, "requiring pump": 0.0007066779554937043, "when dysfunction": 0.002536176975093688, "pump failure": 0.01803459074960539, "driveline injury": 34.498480739786146, "isolated pump": 0.0009464190400935205, "safe pump": 0.0006877298723638645, "exchange technique": 0.00022013456661884337, "cardiopulmonary bypass": 0.0004751637424167145, "exchange malfunctioning": 0.00011910041996243245, "extubated within": 34.49896384847763, "blood loss": 0.0011599449156592364, "transfusion requirements": 0.0002252213301888426, "periprocedural deaths": 34.4985501937034, "system blocker": 0.0013877542716759393, "reduced versus": 0.0047099549756983525, "in ambulatory": 0.035588260380439336, "dose reduce": 0.0018779839277423798, "benefits in": 0.0357690702672983, "remain uncertain": 0.00023223009672845987, "study assesses": 0.004664541611025316, "in consecutive": 0.0358541318565645, "dose changes": 0.002911991525438986, "followed during": 0.002835132349153158, "dose increase": 0.002733900868231473, "\u226510 %": 34.51696757413345, "without uptitration": 34.49944098069266, "received uptitration": 34.498572815884415, "higher heart": 0.020626785376095483, "better renal": 0.0017835972433259224, "received spironolactone": 34.498879024259814, "readmissions in": 34.53388288526986, "hr 0.51": 34.498226059771106, "after correction": 0.003500175377735132, "association remained": 0.0012333040750397524, "ci 0.39": 34.498226059771106, "no benefit": 0.0022304052624948422, "neurohumoral blockers": 34.49907644926592, "frequently performed": 0.0013423167126816854, "low co": 0.001774647325147061, "- morbidity": 0.045822538940298335, "morbidity burden": 0.0005682918208038062, "uptitration independently": 34.49897130337964, "independently predicts": 0.0006750902109508979, "inhospital outcomes": 34.50141807880264, "get with": 0.03103294145859057, "known differences": 0.0009092133318950336, "plasma b": 0.0004412934590745888, "explored sex": 0.00071103242702762, "sex differences": 0.0010470677206186356, "determine prognostic": 34.49957595363864, "prognostic significance": 34.49917239547408, "included hospitals": 0.0015897202829256495, "admitted 99,930": 34.49848056028867, "compute odds": 34.49869750846205, "hospital clustering": 34.49955222709638, "women compared": 0.0028152879046312545, "men had": 0.0029820660819312663, "higher admission": 0.0025658140144064387, "admission median": 0.0017584774475672576, "levels with": 0.032766474870838384, "greatest difference": 0.0007125742661807692, "smallest difference": 0.000723802792392108, "women vs": 0.001342984886959399, "vs men": 0.0015406385548909847, "ef reduced": 0.0028113011497350364, "reduced 1,259": 34.501003331400234, "preserved 559": 0.0020047140184511663, "heterogeneity =": 0.007061031700627806, "= .47": 34.50521920729797, "large registry": 0.0005870321345554443, "important cause": 0.00232901374030287, "article presents": 0.0002332826987106462, "presents guidelines": 0.0004725095851184061, "early medical": 0.0020112311302913025, "assist practitioners": 0.0009421128480736085, "emergency room": 0.0003132502102603444, "room practice": 0.0005454431115126178, "encounter children": 0.00023956603383575037, "undiagnosed heart": 0.018836687529692274, "possible hf": 0.0002488798788936696, "already received": 0.00010801721295992176, "received surgical": 0.0004786553798198421, "surgical palliation": 34.49852809448248, "developed using": 0.002645467367610214, "practical recommendations": 0.0003579885568262217, "clinical setting": 0.0033710169497042086, "online material": -2.6855019988631074e-05, "this work": 0.0026490256083950537, "include recommendations": 0.0005126818405180422, "advanced management": 0.0020829628007471056, "management involving": 0.001399195214200879, "involving ventricular": 34.50307304902536, "device therapies": 0.0011597559958783337, "relationships with": 0.031121696132697364, "the authors": 0.026630664977697366, "authors evaluated": 0.0010434978867739982, "nurse assessment": 0.0007364643589228008, "elderly patients": 0.018930282084188236, "authors analyzed": 0.000431313873319972, "month mortality": 0.004790549610627156, "failure declined": 0.018026520240019595, "many advances": 7.555898953017562e-05, "made recently": 0.0003975675869151371, "fewer chf": 0.000262575052791158, "patients seen": 0.018921666472855626, "suburban hospitals": 0.00046567402126134177, "classified patients": 0.01893624724554029, "year of": 0.04433109598824767, "determined chf": 0.0002243383151705405, "chf visit": 5.629755577116813e-05, "visit rates": 0.0015243014376816048, "total ed": 0.000868081566680768, "patients intubated": 34.5169954975256, "calculated 95": 0.00519146098434422, "performed regression": 0.0016878029459029098, "% were": 0.030861734224238054, "failure visits": 0.01847474124294685, "visits declined": 0.001242760777809806, "% relative": 0.01920964405322787, "coefficient r(2": 34.4983621720638, "annual ed": -3.5711408827692197e-07, "these decreases": 0.002071193243662706, "better chf": 0.0004572031202941324, "chf treatments": 0.00026889110543349375, "hemodynamic phenotype": 68.99699654787234, "occur even": 0.0005210542262280504, "normal systolic": 34.50133778775891, "systolic ventricular": 69.00359125397785, "context of": 0.04370158242761974, "significant liver": 0.002134759026337913, "hemodynamically distinct": 34.49846022651865, "traditional heart": 0.018882464415513747, "low systemic": 0.0018113152639348794, "preserved cardiac": 0.00761001111640139, "symptomatic adult": 34.49875962029103, "study group": 0.007299407621656153, "predominantly asymptomatic": 0.00023522289766838688, "asymptomatic pediatric": 0.00023574923656589312, "pediatric fontan": 0.00013436246049832674, "case cohort": 0.0018984249451736467, "cohort analysis": 0.0035157826329774854, "clinical comparisons": 0.0032210629419689085, "made between": 0.002702869238251123, "the adults": 0.027411929447618544, "mean catheterization": 34.49947974656051, "catheterization findings": 34.4987575120516, "central venous": 34.498475130187515, "pressure 18": 0.0021651412127798248, "index 1,680": 34.500019879799304, "\u00b1 368": 34.50101438449672, "index 2.7": 0.0019634401339377132, "\u00b1 0.8": 34.5010812148341, "\u00b1 0.7": 34.50104788767802, "by imaging": 0.0057223572150741355, "cohort demonstrated": 0.002441346552635529, "greater incidence": 0.0008248786263672197, "abnormal liver": 0.00040605781217173853, "liver texture": 0.00013313607280141426, "texture changes": 0.001619452055377923, "lower svr": 0.0017323053089458214, "similar cardiac": 0.006547739157099915, "index compared": 0.004350605790853666, "pediatric cohort": 0.0015624265539584828, "distinct circulatory": 0.0003701059097548716, "circulatory derangement": 34.49839602671696, "hemodynamic features": 34.49849687342423, "features similar": 0.0009752360936508912, "portal hypertension": 0.0012890739422295008, "limited ability": 0.0008911469573072123, "augment cardiac": 0.005706509585557746, "related hospitalization": 0.0029562617733867322, "versus without": 0.0029094097820519457, "cardiovascular morbidity": 0.0024137052383040574, "an ability": 0.00413422696963792, "careful management": 0.001338858674903155, "enrolled 902": 0.0005412627713992233, "recently hospitalized": 0.0010970186994849048, "management counseling": 0.0012750109199799909, "final multivariate": 34.498630512350715, "male gender": 0.0006194993983515218, "covered on": 0.003317175384104003, "% adherence": 0.019115292486570457, "prescribed medications": 0.0004032535660857274, "- morbidities": 34.54360677254526, "age >": -0.005816205566833329, "prescribed therapy": 0.003121533532770079, "predicting death": 0.0025783708857032633, "failure promotes": 0.017695204616205988, "promotes restoration": 0.0001294522806828473, "restoration of": 0.04367281686135994, "lipoprotein functional": 34.50016102333717, "functional properties": 0.0019561866929319245, "exerts endothelial": 68.99686043500125, "effects via": 0.0019277521001880426, "via stimulation": 0.0009225556209408838, "endothelial cell": 34.49913317897796, "this function": 0.0054766787423829975, "impaired in": 0.035655784398489605, "mediated protective": 0.0006444126938073797, "respective molecular": 0.0003972814604874023, "isolated from": 0.004991513946357193, "healthy controls": 0.0007585850039259312, "bound malondialdehyde": 0.00015997231147414176, "the proteome": 34.524730081911585, "hdl particles": 3.227563563135415e-05, "lower stimulation": 0.002104674651983672, "phosphorylation at": 34.50141557149932, "higher phosphorylation": 34.500390275635326, "elevated activation": 0.0011544073576312363, "higher amount": 0.0018511335086076057, "amount of": 0.043636499853353744, "malondialdehyde bound": 0.00015997231147414176, "in healthy": 0.03563876617166155, "improved hdl": 0.0011756207623817008, "a correlation": 0.013125458562547309, "dilatation improvement": 34.49981629293222, "results demonstrate": 0.0013862577532403136, "demonstrate that": 0.0036337244687968083, "mediated vascular": 0.0008841659359190462, "exerts beneficial": 34.49873277305175, "main objective": 0.0003937710585197497, "plasma n": 0.0019245610230668147, "successfully predict": 0.00046130350198618183, "best knowledge": 2.9613547444005495e-05, "first research": 0.001026170243735439, "research done": 0.00045950445629876446, "plasma obtained": 0.0007357886334807769, "obtained from": 0.004744930477696933, "the end": 0.028653284250094745, "\u00b1 10.3": 34.50101438449672, "- survivors": 0.04564451942039536, "years vs": 0.0033407995510200653, "\u00b1 11.07": 34.50101438449672, "optimal nt": 0.00033834503266747413, "cutoff point": 34.49895406555805, "predicting 4": 0.0014153625095721686, "elevated nt": 0.0006447184365591051, "optimal cutoff": 34.49870051709647, "cutoff level": 34.49913994193319, "predict 4": 0.0014802548358119954, "high sensitivity": 0.002025816899257054, "additional prospective": 0.0006501885802324794, "multicenter studies": 34.49990936449946, "novel heart": 0.019303574050478677, "failure mice": 0.01858064621433193, "mice model": 0.0024477901867096872, "model using": 0.0030807305049272613, "using simple": 0.0017290413108938124, "simple experimental": 0.0003132708214367535, "stable phenotypes": 34.49883114425285, "novel mouse": 0.000870478824107717, "combining salt": 0.0003332692477828638, "old c57bl/6": 0.0001190656765497771, "significantly elevated": 0.002569650361325086, "significant decreases": 0.002237193270276618, "high incidence": 0.0021275389378672327, "this phenotype": 34.501233279737214, "early deaths": 0.0012975677987958922, "deaths in": 0.03564069606639306, "small gtpase": 0.00022782701647185876, "rac1 activity": 0.0007977899381335085, "infusion mouse": 0.0006756368110109566, "mice developed": 0.00201252704939264, "useful mouse": 0.0006310845839260981, "transition from": 0.004578481706159722, "biomarker approach": 34.49867595650095, "predict heart": 0.019138019878173183, "atherosclerosis risk": 0.004737139767910253, "risk in": 0.03988373264029715, "communities study": 0.004640681036781586, "various cardiovascular": 0.0021300868524118813, "largest increases": 0.00018592176800059375, "coming decades": 7.874067053206723e-05, "cardiac troponin": 34.50386521152221, "troponin t": 34.49824833499137, "sensitivity assay": 0.0004058823662579298, "biomarkers strongly": 34.498795924815674, "using sex": 0.002128031040470977, "specific models": 0.001858181741023245, "added ctnt": 0.0001376702344324712, "antihypertensive medication": 34.498596668862795, "medication use": 0.00194139895917935, "former smoking": 2.3836269649129936e-05, "prevalent coronary": 34.49941538381963, "participants without": 0.0018499307993554476, "without prevalent": 0.0011114409466210732, "prevalent hf": 0.0001006849905324438, "model fit": 0.0016796882161903867, "developed incident": 0.0012700303794922173, "model significantly": 0.003421326249722058, "statistical parameters": 0.0005048053686069159, "aucs increased": 0.00272158007808294, "continuous nris": 0.00019838218759396566, "simpler laboratory": 0.0003018685261386935, "report model": 0.0019041514766941965, "value in": 0.035909173691723424, "simple sex": 0.0006883999914224214, "specific model": 0.002116550427223048, "good model": 0.0015500316867337852, "characteristics results": 0.00186415685872897, "excellent hf": 0.00012155491998001435, "prediction model": 0.0019376877840306661, "survival after": 0.004687861389351698, "without temporary": 0.0011047739963162852, "temporary right": 0.0016533765070059212, "ventricular support": 34.50417348002708, "historically results": 0.0012157650476300231, "requiring temporary": 0.000395355598694287, "temporary rv": 9.401804022765585e-05, "heterogeneous group": 34.50092863393005, "patients consisting": 0.01880188941545347, "consisting of": 0.04367579944687611, "chronic decompensated": 34.50043193612143, "decompensated heart": 34.51706292158926, "hybrid system": 0.000601888273895938, "system consisting": 0.0006411811777105748, "isolated lvad": 0.0005410786430664474, "temporary centrimag": 9.401804022765585e-05, "preoperative demographics": 34.49849776091212, "operative outcomes": 0.003155711024011238, "patients required": 0.018966579344518116, "required biventricular": 34.498593342595434, "mean duration": 0.001591837851737698, "\u00b1 11.9": 34.50101438449672, "successfully explanted": 34.49831814675085, "significantly greater": 0.002344119261646158, "required isolated": 0.0007722491747024428, "support using": 0.002841227111543358, "limited mortality": 0.004801810166244174, "however biventricular": 34.4986128063579, "biventricular dysfunction": 34.50074235545697, "isolated heartmate": 0.0005410786430664474, "device use": 0.002493221662026029, "recommendations based": 0.0013930871884461884, "chronic end": 0.0043211095183215975, "evidence on": 0.004316563105928374, "clinical effects": 0.004430063073739792, "systematically searched": 0.00020101908862030915, "scientific literature": 0.00015242697398273685, "identified 14": 0.0013594980773487713, "economic evaluations": 0.000270286888180812, "using simulation": 0.0016855475096319947, "simulation models": 0.0013392369684170847, "studies per": 0.0023626285068853088, "per outcome": 0.0022345084469107867, "made policy": 0.00012553233676323473, "policy recommendations": 0.00037323847515276893, "across transplantation": 34.49914962941149, "survival reaching": 0.0013111731325321473, "reaching 86": 0.00019224621027699105, "currently meet": 3.8045878840038204e-05, "meet traditional": 0.00010435634907122912, "traditional cost": 0.0004856474510503758, "effectiveness limits": 0.0004648083726672401, "models using": 0.002822361818727458, "using historical": 0.001609067637973069, "historical data": 0.0014409800436867516, "standard practice": 0.0010745975944660903, "limited number": 0.0009063757229560562, "many regions": 0.00010186831328061336, "implantation strategies": 0.0014228781175313358, "strategies tend": 0.0007990313311651052, "mutually exclusive": 5.648075356559991e-05, "carefully selected": 0.0003562422041299098, "program infrastructure": 0.0004188302292558222, "evidence gaps": 0.0011176114795432913, "economic models": 0.0013730728346349533, "canadian data": 0.0014162485856848667, "data point": 0.0020081420799382644, "systematic monitoring": 0.0005993410754144245, "monitoring of": 0.04387031488705171, "biventricular pacing": 34.498702271560305, "left heart": 0.022576607730683873, "heart twist": 0.018933861859689625, "selected cardiac": 0.0058999723483692725, "cardiac surgery": 0.006444310385648385, "surgery patients": 0.019540567447424866, "response remains": 0.001186084105544387, "remains variable": 0.00040955062183100374, "better understanding": 0.0006120840432880092, "used speckle": 34.50000590840877, "speckle tracking": 34.498254475591374, "tracking echocardiography": 34.498866918392295, "analyze bivp": 0.0002022420026211707, "ventricular pressure": 34.50468342075135, "pressure overload": 34.50033315479161, "inferior vena": 34.498259212638544, "vena cava": 68.996384060501, "control model": 0.0033807988052062836, "heart block": 0.018993846347036696, "artery snared": 0.0009181121125503876, "ventricular midpapillary": 69.00114264886662, "midpapillary level": 34.49900382964049, "varying atrioventricular": 34.49835936781703, "atrioventricular delay": 34.49838830708758, "interventricular delay": 34.498422336608186, "regional circumferential": 34.49827429403779, "circumferential strain": 34.49866612510587, "radial strain": 34.498700154047484, "ventricular base": 34.502958331917455, "bivp setting": 0.00031851969824942553, "basal rotations": 34.49832779628206, "mixed linear": 0.0003306392987196512, "apical rotation": 34.49825833540674, "wall rs": 0.00036061447502018116, "septal wall": 34.49858667424613, "open chest": 0.0001883697080700718, "chest model": 0.00156024323419375, "noninvasive surrogates": 34.49829359247298, "varying regional": 0.00021557183321367317, "regional strain": 0.0004882996014504878, "strain contributions": 0.0005677608461283144, "primary mechanism": 0.0016134174516422425, "remaining indices": 0.00025819759762563967, "reflect postsystolic": 34.49820658588608, "postsystolic function": 34.50100175239144, "stenosis reversed": 34.49863106374813, "stenosis frequently": 34.49869683446404, "develops after": 0.0035014035018296093, "muscles with": 0.03112924029510596, "successful mitral": 34.49952482612867, "mild mitral": 34.499821405163345, "significant mitral": 34.50134807107936, "reported in": 0.035577196624250636, "potentially improve": 0.0011722520630844517, "severe mr": 0.0013838818511027347, "grade 4/6": 34.498254475591374, "holosystolic murmur": 68.996384060501, "third heart": 0.018800364256913994, "heart sound": 0.018847558251559222, "underwent mitral": 34.50016387408949, "chordal ruptures": 34.4982257094572, "underwent triangular": 0.0008828544670915756, "triangular resection": 34.49825973897781, "postoperative echocardiography": 68.99713261791047, "echocardiography confirmed": 34.498983029942856, "normal sized": 0.0006883806716089376, "sized lv": 2.525779505251356e-05, "normal lv": 0.0006631228765564241, "preserved mitral": 34.50128555819439, "valve area": 0.001129963768808029, "continuity equation": 0.000268371712609422, "lv end": 0.0021492621096131804, "flow volume": 0.002561850707711785, "\u00d7 velocity": 34.49873609958504, "velocity time": 0.0017053161555461997, "time integral": 0.0012598270354021758, "continuous wave": 0.0003583510260387692, "utilized even": 0.00029005708402098736, "successfully performed": 0.0011677974386229738, "performed without": 0.0020524368943617447, "major concerns": 0.0008612332280111538, "this time": 0.0038622329430590303, "grade 2": 0.0020214312086177222, "diastolic murmurs": 34.50006268162372, "demonstrated moderately": 0.0011490484907443893, "moderately dilated": 34.49887219914354, "dilated lv": 34.49873643311197, "limited mitral": 34.49990451958189, "angiography revealed": 0.0006528243228686797, "significant lesions": 34.50032748932563, "lesions in": 34.53361067920945, "major branches": 0.0008850937750444329, "diagnosed as": 0.004234066063200852, "hypertensive lv": 34.49846425020464, "dysfunction with": 0.03341312485175895, "mitral leaflet": 34.49955272192139, "leaflet motions": 0.0002704741742561325, "restricted without": 0.0011438902927079484, "the etiology": 34.52490022083011, "etiology of": 34.54200551753394, "as significant": 0.005966451647064381, "surgical indication": 0.0005005946607965373, "the possibility": 0.026558923318287367, "highly dynamic": 0.000380973727243277, "potentially respond": 0.0004132290767469973, "cardiac murmurs": 0.005707035924871245, "murmurs disappeared": 0.00019943949507756752, "repeated echocardiography": 34.498934273912745, "echocardiography 4": 34.499949540885595, "months later": 0.0012432895806435134, "later demonstrated": 0.0011616544193617858, "volume of": 0.04536548458097723, "direct observation": 0.00018049136836169593, "surgery also": 0.001530231310892854, "possible reasons": 0.0006340440630177799, "modest reduction": 0.0013815297509296143, "surgical ring": 0.0005337446358217317, "ring implantation": 0.0008436269650359748, "mild restriction": 0.0006757983638445197, "leaflet motion": 0.00026380722453663366, "leaflet resection": 34.4984640828634, "degree of": 0.04365544777525395, "symptoms disappeared": 0.001042971542274742, "patient developed": 0.0034276298060839146, "moderate lv": 0.0006073652788273796, "valve demonstrated": 0.0018633349515226184, "demonstrated restricted": 0.0011464167957946922, "restricted closure": 0.00022995951110877318, "opening without": 0.001186505741828747, "diastolic tethering": 34.50009671056533, "functional etiology": 34.500297133314085, "reports demonstrating": 0.00015803460373977246, "demonstrating development": 0.0011068855454636508, "following ring": 0.0004369110266183151, "ischemic mr": 34.49904259461276, "this patient": 0.0050334552198899735, "patient showed": 0.0034553254108448013, "potentially vary": 0.0005256672033012638, "vary considerably": 0.00016453274083163497, "second hf": 8.469643130950332e-05, "considered indicative": 0.0004781377358230462, "after aggressive": 0.0035971725310349123, "symptom disappeared": 0.00026661956722272994, "insignificant ms": 34.4984297024499, "considered as": 0.004242651442102954, "indications need": 0.00035899625816610177, "carefully evaluated": 0.001012276656424475, "leaflet configurations": 0.00027100051333877137, "serial evaluation": 0.0003674672675930042, "evaluation strongly": 0.0005332200382615821, "strongly suggested": 0.0003146720059702527, "therefore dynamic": 0.00038588617988075916, "annular ms": 68.99692849809385, "fixed ring": 0.0002511780195669492, "ring size": 0.0004779645476916029, "this case": 0.0031373174531585802, "report demonstrates": 0.0004738868616652518, "thus requires": 0.0005176053726081045, "requires careful": 0.0003876359946192346, "careful evaluation": 0.00039974174890984994, "evaluation of": 0.04391293720266009, "failure clinic": 0.017862536396041497, "most heart": 0.019351682095265457, "stratification models": 34.4997022758434, "inpatient use": 0.0017407568133467265, "available outpatient": 0.0004321720128308967, "outpatient models": 0.001407117668353038, "models use": 0.002774785985643357, "complex set": 0.00026131443028408615, "set of": 0.04355263990997336, "routinely collected": 0.0002888924845066192, "collected clinical": 0.00320843084554876, "improvement database": 0.0013120700342545326, "multivariable cox": 0.00023802309229497623, "reached primary": 0.0012156276555346467, "externally validated": 0.00023504397724237534, "patients for": 0.032040026466842814, "recently calculated": 0.0007543627537923378, "arbitrary start": 1.156130152654396e-05, "start date": 7.698018438910046e-05, "model included": 0.0026521898833542328, "included blood": 0.0020479128295040365, "blood urea": 34.49908414752161, "urea nitrogen": 34.498225884903654, "diabetes status": 0.001977108957990685, "hospitalization within": 0.002676405408415008, "the concordance": 34.52469605239098, "concordance c": 34.49856264513124, "c statistics": 0.00046182579064474555, "rank testing": 0.0005926538822805325, "testing demonstrated": 0.0015080584906027724, "demonstrated excellent": 0.0011348373791553875, "excellent risk": 0.0046887254261818835, "rates in": 0.036784566016005715, "cohorts 8%/12%/12": 68.99648614732587, "cohorts 57%/58%/79": 68.99648614732587, "uses readily": 4.437504421583681e-05, "readily available": 0.0002951801725510754, "available data": 0.0016793285689189993, "potentially help": 0.00038654316973942736, "help allocate": 2.7514062952612058e-05, "allocate specialized": 6.455127164747594e-05, "resources within": 0.0007788297519264982, "within health": 0.0019149359747776744, "health systems": 0.0014569050795751354, "dysfunction progresses": 0.0024131608142121787, "examined incidence": 0.0009450154714853419, "onset esrd": 0.00078184404991544, "estimated by": 0.00600627882656912, "patients grouped": 0.018802942093756818, "group iii": 0.00266854521733288, "group iv": 0.00266854521733288, "median left": 0.004790390786866454, "median egfr": 0.0010166159327194416, "mainly observed": 0.0007936156655127091, "low egfr": 0.0016092487076131735, "hypertension identify": 0.001819265713310047, "comparable performance": 0.0007587123595473595, "growing epidemic": 0.0001985537573038484, "valid measure": 0.000449720055469192, "validated measure": 0.0005581194652852458, "prospective hf": 0.00047391246247440935, "dichotomized patients": 34.51692743906338, "the associations": 0.026706790482092586, "used criterion": 0.0018475573649692635, "criterion standard": 0.0005540553072331222, "total symptom": 0.0010031458125915357, "evaluated using": 0.0025011912295293823, "using spearman": 0.001584336179971184, "spearman correlations": 3.385465315541544e-05, "interaction terms": 0.000490573236351407, "predictive validity": 0.00044061482956440576, "validity of": 0.043778235427525104, "assessed with": 0.03218630665654495, "made using": 0.0016662027781423172, "internal reliability": 0.0002899451609323099, "summary scores": 0.0006324777337885308, "free rates": 0.0017266978773405337, "category among": 0.001269018249175737, "log rank": 0.00015014735056195286, "domains demonstrated": 0.0011820235960351352, "demonstrated high": 0.0027351301075555635, "high internal": 0.0018439289040256834, "consistency among": 0.0013116446158225649, "overall summary": 0.00031379713706378186, "reliable measure": 0.0004851519849953849, "offers excellent": 0.00012172413633988396, "excellent prognostic": 34.49916414953274, "prognostic ability": 34.499343920817275, "future studies": 0.001940585947384341, "clinical change": 0.0038642627149676275, "soluble concentrations": 34.49836094857064, "interleukin receptor": 34.49965462648127, "receptor family": 0.0014980025839320197, "family member": 5.153449067524851e-05, "predict prognosis": 0.0010495220805326062, "recently found": 0.0011739161727433237, "found changing": 0.0009050458932808561, "changing doses": 0.00021644907809901162, "doses of": 0.04377893721312223, "affect sst2": 0.00015523181329916278, "concentrations identify": 0.0006957771899688354, "identify benefit": 0.0012466259006760783, "failure attributable": 0.017730988021506015, "post hoc": 0.0008037490301604499, "hoc analysis": 0.0021203450678241227, "taking bb": 3.3842697664109174e-07, "medication regimen": 0.00043761603333606204, "sst2 values": 0.000429538585901062, "function of": 0.04641904098524267, "baseline sst2": 0.0017335691230979159, "sst2 status": 0.0008958016016963739, "low \u226435": 34.499869337420336, "versus high": 0.0036205014743435062, "final achieved": 0.0002569536662348397, "versus low": 0.0035079025335764897, "daily equivalent": 0.0002015374173798804, "equivalent dose": 0.0014204121573494295, "metoprolol succinate": 68.9970985588712, "sst2 titrated": 34.498226059771106, "titrated to": 34.517338180594955, "bb had": 0.0024918807514158576, "lowest cardiovascular": 0.002096944057157024, "lowest cumulative": 0.00036238281790691295, "intermediate outcomes": 0.0032930537568741543, "highest cardiovascular": 0.0021500873910226628, "highest cumulative": 0.0004155261517725522, "intermediate odds": 0.0006745702411505947, "therapy exerted": 0.003022604741427105, "exerted dose": 0.0013579679734969548, "related benefits": 0.0014701532046993361, "benefits across": 0.000899725270483075, "study participants": 0.00547003724759009, "sst2 measurement": 0.0004419952447328371, "measurement identifies": 0.0005088267400104037, "identifies patients": 0.018802240308159687, "particularly benefit": 0.0009560213597829623, "higher bb": 0.0018239524995586228, "novel approach": 0.0007804989852638721, "acute treatment": 0.005813429489707295, "the nitroxyl": 34.52469605239098, "exerts positive": 34.49836392374612, "positive inotropic": 34.49836392374612, "vasodilator effects": 34.49956959607279, "camp independent": 0.0005163408841451229, "clinical usefulness": 0.0031533576883478105, "limited by": 0.006008033270707696, "chemical instability": 9.19138411222255e-05, "isolated myoctyes": 34.49873310889357, "intact hearts": 0.0005354730475889056, "experimental models": 0.0014065913292703991, "converts solely": 0.00013173250308510674, "inactive cxl-1051": 3.385465315541544e-05, "in adult": 0.035679983735496835, "adult mouse": 0.0007331592515674519, "mouse ventricular": 34.50328632674567, "ventricular myocytes": 69.00117667780822, "dose dependently": 34.499516319017296, "dependently increased": 34.50091361032858, "increased sarcomere": 34.50094763984919, "sarcomere shortening": 34.49856598382116, "% rise": 0.01884973664963491, "rise in": 0.03539075490077477, "higher doses": 0.001993570868376098, "neither inhibition": 0.0007378494125889781, "kinase a": 0.013125809455438217, "soluble guanylate": 68.9964180900216, "guanylate cyclase": 68.9964180900216, "cyclase altered": 34.498531432592685, "contractile response": 34.49934093828748, "unlike isoproterenol": 34.498226059771106, "equally effective": 0.0009237188431305047, "anesthetized dogs": 34.49831849764208, "dogs with": 0.031159408850169146, "coronary microembolization": 68.99750672907959, "myocardial oxygen": 34.501047170679946, "increasing ejection": 0.004294651318578556, "maximal ventricular": 69.00134681383207, "ventricular power": 34.50288078709869, "power index": 0.0017920475519897494, "conscious dogs": 0.0002588999434630898, "increased contractility": 34.50104972493713, "contractility assessed": 34.49948151005701, "provided venoarterial": 34.498557895638825, "venoarterial dilation": 68.996384060501, "minimally altered": 34.49849740307208, "heart filling": 0.01930725841209594, "increasing cardiac": 0.005922944781999893, "pressure declined": 0.0021641015432822645, "declined modestly": 0.0006012663539009186, "functional efficacy": 0.0024779640142349574, "novel pure": 0.0005951101057367871, "enhance myocardial": 34.500632377032126, "present first": 0.0011903276956900335, "man evidence": 0.001102852801778231, "remodeling after": 0.004387195993154275, "subsequent events": 0.0019550647910614766, "largely involved": 0.0004341037560311034, "involved single": 0.00046829231888331367, "single parameters": 0.0006645725374199555, "combining parameters": 0.0004376264530830083, "score for": 0.014436403087733645, "strain of": 0.0440493841790694, "standard echocardiographic": 34.49929082947157, "echocardiographic measurements": 34.49893884361522, "underwent baseline": 0.002582744383487448, "baseline echocardiography": 34.50053804217452, "underwent follow": 0.002975933543728741, "score with": 0.03216472689236352, "57\u00b122 months": 34.49928694787096, "lv reverse": 0.0003339588798047191, "- crt": 0.0454147422947591, "dimension index": 0.001893628366150272, "ventricle <": 34.49385642963034, "diastolic area": 34.50027470872641, "area index": 0.002107760825267018, "ventricular fractional": 69.00121070617087, "fractional area": 34.49857402835182, "area change": 0.0010916767399736281, "change \u226535": 34.499037825234616, "\u226535 %": 34.51700160365406, "score allowed": 0.0011282703399040992, "allowed prediction": 0.0004377783652057345, "heart transplantations": 34.51699486312704, "lv assist": 0.0009089599806384484, "device implantations": 34.49914849156564, "failure admissions": 0.017899545027974816, "the score": 0.02763580757425452, "failure admission": 0.018371111867426137, "ischemic cause": 34.50060541749605, "initial functional": 0.0020573945543037086, "selecting patients": 0.018835567464424715, "patients likely": 0.019348705943578435, "undergo reverse": 0.00039973769714875685, "symptomatic systolic": 68.99907086357197, "diagnosed systolic": 34.50097565154876, "previous spironolactone": 34.49883623294563, "baseline serum": 34.500299892258866, "serum creatinine": 68.99686044021112, "creatinine level": 34.49907188694475, "potassium level": 0.0009814154429575758, "varying covariates": 34.49849548242558, "independent association": 0.0012539917020329594, "initiated spironolactone": 34.49886869021771, "ratio 0.91": 34.50113488443122, "interval 0.77": 34.49989187778262, "ratio 0.93": 34.50103279934327, "interval 0.60": 0.0016652951460645086, "crude rates": 0.0015606183564849147, "diverse community": 0.00018502788936952837, "based cohort": 0.002491578545345677, "incident systolic": 34.5008835640742, "factor blockade": 0.0011445476687849975, "blockade prevents": 0.0004072859369592419, "therapy on": 0.00625295419347268, "impaired angiogenesis": 34.498701394328194, "angiogenesis in": 34.53367873419789, "heart contributes": 0.018937195337035185, "progression to": 0.01944958862517692, "the inhibition": 0.02718381235697747, "compensatory hypertrophy": 34.49897387430041, "also shown": 0.0010430660409655955, "improve myocardial": 34.501318779972266, "enhancing neoangiogenesis": 34.49825693183666, "surgically induced": 0.0015280241553852546, "induced myocardial": 34.50199902531148, "failure rats": 0.018307461551966154, "week treatment": 0.003850307578796659, "treatment period": 0.0044693546024461165, "echocardiography revealed": 34.499219274282, "cardiac diameters": 0.005673006404261056, "improved cardiac": 0.0068147725134873405, "treated compared": 0.003771133142536679, "treated rats": 0.0019265880998770813, "vivo coronary": 68.99774492356568, "cardiac fibrosis": 34.50403535044074, "weeks after": 0.0041309935562055125, "cardiac vegf": 0.00563915175110564, "no synthase": 34.499736698002756, "synthase activation": 34.49870171917157, "comparing b": 3.227563563135415e-05, "untreated failing": 0.0004327093368187711, "proangiogenic effects": 34.49956959607279, "b act": 3.7532166358951584e-05, "act via": 0.0005877184442619852, "intravenously injected": 0.00010156338046764875, "adenoviral vector": 34.49822500767154, "vector encoding": 0.0001008615948094004, "control adenovirus": 34.50007643473075, "histological analysis": 34.50031377831063, "reduced capillary": 34.50107138986245, "rats compared": 0.0032009674414352663, "c rats": 0.0010488260801262824, "inhibition counteracted": 34.498871820466995, "positive effects": 0.0014814008556878065, "promotes cardiac": 0.005705106014733307, "induced enhancement": 0.001561000418605465, "enhancement of": 0.043710003834837204, "favorable effects": 0.001580685056633032, "do outcomes": 0.0027678360859129184, "failure vary": 0.01776273558165761, "vary by": 0.005551697746992931, "department volume": 0.0019271785404831908, "common emergency": 0.001342480757810176, "volume influences": 0.0019245559808567954, "influences patient": 0.0025348888626292075, "adults presenting": 0.001040164412875935, "responsible diagnosis": 0.0007672991659558193, "cases seen": 0.0004509273311178065, "less comorbidities": 34.49919676647177, "aor ]": 34.50135430128342, "exhibited higher": 0.002163350210344314, "day death": 0.003631841621356366, "discharge patients": 0.019413620012269955, "failure home": 0.017574846780270513, "exhibited worse": 0.000525498718305658, "worse outcomes": 0.003310062734797357, "driven largely": 0.00044832342439154034, "repeat ed": 9.296536589553986e-05, "improve management": 0.002022805373211113, "volume sites": 0.0018894670242104322, "oxidase inhibition": 34.498939878929214, "inhibition preserves": 0.0007136448696513178, "preserves left": 0.0038076295073024282, "cardiac volume": 0.0073953174877781115, "rat left": 0.003941989652016925, "aortocaval fistula": 68.996384060501, "decrease mitochondrial": 34.499549311362344, "mitochondrial respiration": 68.99723465148656, "inhibition improves": 0.0013583523084668317, "improves cardiomyocyte": 34.498904621863076, "cardiomyocyte bioenergetics": 68.9964180900216, "chronic acf": 0.0021718474087084167, "acf \u00b1": 34.50098052984357, "\u00b1 allopurinol": 68.99924061855629, "wk demonstrated": 34.49951155755302, "groups versus": 0.0033531485691826, "sham group": 0.0030079429281185716, "lv ejection": 0.0040108582876843026, "circumferential shortening": 34.49856598382116, "maximal systolic": 68.99910488961892, "contractile efficiency": 34.49862509337671, "significantly depressed": 0.0019912370810075248, "improved in": 0.03649218289647698, "allopurinol rats": 34.498938299912105, "maximum o2": 0.00015365627988612194, "consumption rate": 0.002757571984112705, "rate measured": 0.003410459402086906, "cardiomyocytes using": 34.50028674845419, "extracellular flux": 34.498327971728514, "flux analyzer": 34.498225884903654, "allopurinol improves": 34.49893865080469, "efficiency possibly": 0.00028450633002787137, "myofilament ca(2": 34.4981920302505, "diastolic properties": 34.50005004951843, "usefulness of": 0.04371017928119779, "assessing left": 0.003806225936108169, "transmitral blood": 34.49918623434647, "found unreliable": 0.0008915434978412355, "estimating pulmonary": 0.0013599192929709687, "decompensated systolic": 68.99893475359507, "underwent right": 0.0024085337271677974, "sided cardiac": 0.005671427386736994, "transthoracic echocardiography": 68.99699650330192, "flow velocities": 0.0008733936983515461, "annulus velocities": 34.498327797440034, "\u00b1 8": 34.50158015908356, "/ e'mean": 34.50482988604337, "the area": 0.02678393341694235, "ci 0.70": 34.49843022473657, "negative predictive": 0.0004955102258029502, "negative likelihood": 0.00028836267324712495, "likelihood ratio": 0.0028712902659545044, "e'lateral showed": 34.4993148865635, "e'septal showed": 34.49938294386776, "detecting normal": 0.0007639833134494514, "normal filling": 0.001167548412115507, "pressure relationship": 0.002376110249296028, "derived pulmonary": 0.001765772135857864, "tricuspid annular": 68.99675835917532, "basic relevance": 0.00014628757410393918, "relevance in": 0.035415843554295785, "clinical follow": 0.005179255534793992, "carrying two-": 5.525264638587674e-05, "threefold increase": 0.0014434667545919772, "cardiac risk": 0.010206322257307509, "longitudinal rv": 0.00033974860361503774, "fiber shortening": 0.0004057028673966126, "force generated": 0.00019293948491768282, "vivo rv": 34.49843022473657, "ratio better": 0.003263942692460402, "better disclosing": 0.0004908823269961759, "disclosing prognosis": 0.0007480142855983263, "underwent echo": 0.0009158313093065152, "peptide assessment": 0.001488450822459571, "relationship showed": 0.001698105385854956, "downward regression": 0.0007120762712574622, "line shift": 0.00012750801047976365, "shift in": 0.0354032114656325, "frequently presenting": 0.0004328928801475251, "higher pasp": 0.0018239524995586228, "lower tapse": 0.0017323053089458214, "distribution along": 0.00015258773885121603, "separate cox": 0.00011787057419917944, "individual measures": 0.0009700308409215138, "ratio form": 0.0029179351331013507, "variables retained": 0.0004400722811705871, "multivariate regression": 34.49917842141185, "class <": -0.0034975115495945457, "< /\u2265": 34.493482149480556, "/\u2265 3": 34.4998363547038, "shows that": 0.003479358842906403, "shifted downward": 0.00013015406510984002, "ratio improves": 0.003485301664137199, "improves prognostic": 34.49972115670473, "prognostic resolution": 34.499067326070765, "possible index": 0.002076729427699904, "efficient rv": 2.4205121089327763e-05, "function evaluation": 0.00311334049929324, "stent model": 34.499926619061526, "model for": 0.01480101197891677, "large animal": 0.0005454595909756624, "animal model": 0.0015900614736784281, "novel percutaneous": 34.498794858249305, "percutaneous one-": 34.49832779628206, "ischemia using": 34.49998053486961, "stent coated": 34.498463903943275, "polytetrafluoroethylene tube": 34.498224481332464, "tube formed": 0.00012155664671182876, "bottleneck shape": 0.00022574534941009888, "implanted in": 0.03555423433349934, "proximal circumflex": 68.9965542023143, "circumflex artery": 34.499042258189284, "proximal lcx": 34.4983621720638, "mid lad": 2.2626111184079294e-05, "wk later": 34.49864664705403, "infarct size": 34.49847231439435, "given antiarrhythmic": 34.498419690511405, "antiarrhythmic medication": 34.498698755687656, "prevent sudden": 0.00038062108080037056, "the occlusion": 34.52486619420428, "occlusion time": 34.49955744840541, "modulated by": 34.50364427228902, "antiplatelet medication": 34.498698755687656, "fractional flow": 34.4990998020464, "flow reserve": 0.0009940667634421704, "reserve measurements": 0.00035677203658718087, "positron emission": 34.49822483222517, "emission tomography": 34.49822483222517, "tomography imaging": 34.49849617494766, "imaging showed": 0.0013929714895604107, "showed severe": 0.002472708643502652, "severe ischemia": 34.49978008054074, "bottleneck stenting": 34.49849793809537, "stenting covering": 34.49831779585968, "complete coronary": 34.49934837123562, "coronary occlusion": 68.99767687089289, "significant collateral": 0.002134759026337913, "occurred already": 0.0005678788611425673, "first wk": 34.49915368008124, "stent occlusion": 68.99679239680037, "competitive collateral": 0.00012032853565319995, "growth patterns": 0.0003923452507124859, "model 4": 0.0026414621591317492, "% infarcted": 34.51706966095831, "infarcted left": 34.50206789192951, "the mortality": 0.030716011553931687, "vessel disease": 0.003369192311204993, "disease model": 0.00469982808507956, "the implantation": 0.027149968701673823, "implantation of": 0.04425526540549701, "novel bottleneck": 0.0007045621939480911, "novel porcine": 34.49872680094505, "reversible myocardial": 34.50067412502211, "open stent": 34.49855474553541, "occluded stent": 68.99665628450768, "selective heart": 0.018869138032778402, "ivabradine unloads": 68.99679237653902, "ivabradine reduces": 34.49870050494007, "reduces afterload": 34.49836024736426, "afterload of": 34.54186940755702, "represents resistive": 34.49828534650778, "pulsatile afterload": 68.99648614848383, "heart derived": 0.01927621900029845, "pressure volume": 0.0035229973925134613, "volume relation": 0.0018398325033626326, "hr modulates": 6.788417376560529e-05, "afterload burden": 34.498420583887984, "ivabradine 7.5": 34.498632271031546, "echocardiographic substudy": 68.99703054208376, "total arterial": 34.49984264434053, "arterial compliance": 34.49927432131854, "arm cuff": 0.0001234865518939843, "differ significantly": 0.002126998481087687, "marked reduction": 0.0013755645906236783, "improved tac": 0.0011756207623817008, "contractility remained": 34.498823798116206, "markedly improved": 0.0012424522576592674, "higher sv": 0.0018239524995586228, "ivabradine improves": 34.4992789083805, "improves tac": 0.0006785620919709293, "thus reducing": 0.0004202642573305021, "improved ventricular": 34.50409220985789, "relation of": 0.04369298561099492, "preoperative serum": 68.9969625218254, "serum albumin": 68.99703057334041, "indicator in": 0.03538128827405941, "postoperative mortality": 34.5025401342725, "undergoing left": 0.004212962957723477, "studied 272": 0.0002990613921235964, "preoperative clinical": 34.501448695941086, "laboratory variables": 0.0006770386433711332, "variables associated": 0.004697799146118047, "albumin concentration": 34.49856335617862, "levels compared": 0.004256289654295245, "preoperative albumin": 68.99686044889427, "ratio 0.521": 34.500998769822665, "interval 0.290": 34.49975576317407, "levels during": 0.0038818755871696444, "support on": 0.004520919590319793, "subgroup analysis": 34.50041586339857, "showed improved": 0.0022644475547816175, "remained hypoalbuminemia": 34.498857825320954, "decreasing albumin": 34.498531958931956, "albumin level": 34.49924202007403, "correcting nutrition": 34.498222902316044, "hepatic function": 34.50100175239144, "effective way": 0.0007228436499206179, "improve prognosis": 0.001494405167758759, "patients evaluated": 0.01965226386244032, "surgical correction": 0.00040149215680051976, "valve insufficiency": 0.0009179366661128505, "onset aortic": 0.0013260807267833628, "aortic insufficiency": 0.000612120850633528, "instituting mechanical": 34.498426895308995, "mechanical circulatory": 0.00043886152495314424, "continuous flow": 0.0010040671586332784, "pulsatile devices": 34.49899141192604, "treatment algorithms": 0.0036389874054034324, "de novo": 34.49818290098267, "present report": 0.0009426798600316339, "described 6": 0.0020531065051927204, "underwent aortic": 0.0013934119372574548, "valve surgery": 0.0016552111268899902, "surgery for": 0.014109776288503437, "onset post": 0.0015529665517690968, "underwent lvad": 0.0008491752603895321, "cf devices": 0.0007653521549364457, "onset severe": 0.002165725901018175, "requiring surgical": 0.0006374017904446452, "developed new": 0.0014943799948576642, "after medical": 0.004472544716705816, "valve procedures": 0.0012857316750186651, "bioprosthetic valve": 34.49907611226345, "dacron patch": 3.192474301747791e-05, "patch closure": 0.00012874991750693194, "valve repairs": 0.0008809245578929153, "underwent transcatheter": 34.4990752350315, "transcatheter aortic": 34.49877029644797, "valve procedure": 0.0010156355973452039, "requiring revision": 0.00033396408677342435, "open surgery": 0.0009296794333751442, "experienced significant": 0.0022896312703649226, "died postoperatively": 34.49838759864472, "postoperatively secondary": 34.49845460877696, "multiorgan failure": 34.51582128060308, "surgical treatment": 0.003941372430679403, "valve oversewing": 34.49904208274285, "leaflet repair": 0.0003016965554337069, "bioprosthetic aortic": 34.49877029644797, "restoring functional": 0.001967766119729033, "develop symptomatic": 34.49874909358742, "performed safely": 0.0011402605736768108, "good results": 0.0012392321285357485, "various transcatheter": 34.49835023803075, "transcatheter approaches": 34.49852809911388, "difficult problems": 0.00011206646839655718, "also available": 0.0009881526595842416, "offer less": 0.0007879331372447682, "less invasive": 0.0009014305347275461, "invasive alternatives": 0.0001659363112866959, "conventional surgery": 0.0008651477331549401, "age groups": 0.0031356060901091016, "index \u226535": 34.50005390931991, "black ethnicity": 0.00020013277662812558, "salt intake": 0.0002997666448340489, "dietary measures": 0.0010340585760090432, "youngest age": 0.0018805462105704303, "rates across": 0.0019152210191904916, "respective age": 0.001739170542982893, "age categories": 0.001876686400960735, "referent age": 34.49987314159739, "youngest group": 0.0028679800810134932, "group even": 0.002890893574041634, "ages 20": 0.0006541523415355447, "beyond divergent": 6.980781768860001e-05, "divergent etiology": 34.49842952700347, "exhibited striking": 0.0003669363013251811, "striking differences": 0.0005309114506583322, "outcomes compared": 0.0056467179693248225, "older counterparts": 0.000924217425040031, "nonfatal outcomes": 34.501315991977776, "better survival": 0.001710317056733204, "higher hospitalization": 0.003762569201449039, "growing population": 0.0010571522571395783, "population within": 0.0016611133463244514, "within cardiac": 0.006376940457630232, "\u00b1 11.4": 34.50104841401733, "groups performed": 0.0024961756814923996, "performed 200": 0.0011537618399586594, "minutes of": 0.043836278751376904, "measured after": 0.004314955757707035, "capacity assessed": 0.0022869050754041943, "standard care": 0.0024994016908099995, "walking led": 0.000439192753472672, "higher functional": 0.003724887124010089, "\u00b1 59.4": 68.99917256009407, "\u00b1 71.3": 68.99917256009407, "greater self": 0.000585989499505705, "reported physical": 0.0004776041179662603, "\u00b1 118.5": 68.99917256009407, "minutes vs": 0.0012774131314477204, "\u00b1 125.6": 68.99920658961467, "increased right": 0.004280938544861205, "right grip": 0.0016937209272765922, "\u00b1 3.5": 34.501113839626406, "fewer depressive": 34.4984886348239, "\u00b1 2.4": 34.501080337602524, "peak aerobic": 34.499508885941154, "waist circumference": 34.49822500767154, "improving functional": 0.002197535145306086, "important outcomes": 0.003890152584293041, "this exercise": 0.006592871105715735, "exercise modality": 34.50211794475477, "promising alternative": 0.00038869330193784545, "alternative for": 0.013528078743021954, "failure complicating": 34.515889339065296, "complicating precapillary": 68.99652017742544, "precapillary pulmonary": 34.499552474724815, "noninvasive tools": 34.498346913489385, "experiencing heart": 0.018864225541787676, "major right": 0.0024130538376103826, "ventricle overload": 68.99720069199827, "overload leads": 34.49858982647452, "decreased stroke": 0.0014570622473857753, "shortens left": 0.0038076295073024282, "tonometry study": 34.502890951117045, "study tested": 0.00489291112029466, "carries prognostic": 34.49914064790973, "ph with": 0.03103294145859057, "radial artery": 34.4991103166515, "artery tonometry": 34.4991103166515, "tonometry variables": 34.49866788535826, "prospectively obtained": 34.49862264003346, "day 3": 0.0029000314021316404, "reconstructed aortic": 0.0005773895443030828, "aortic pressure": 0.002311068332708912, "pressure curve": 0.0019359236854377532, "overall icu": 0.0001468104629651429, "median stay": 0.0012830400329198837, "at admission": 0.0035911098783976184, "tonometric indices": 34.498361648619316, "specificity for": 34.51159873472932, "identifying death": 0.0023740304739344347, "other prognostic": 34.49995026357424, "lower natremia": 34.49992433555945, "higher oxygen": 0.0023324132961057807, "second evaluation": 0.000388314789664835, "norepinephrine requirement": 34.498358142009685, "poor outcome": 0.0017603937523457316, "previously documented": 0.0003846580760560993, "documented prognostic": 34.49927710877892, "myxoma complicated": 34.498253422915745, "common type": 0.0025178991511187643, "type of": 0.04510676583029609, "cardiac benign": 0.005671778279412433, "benign tumors": 6.648118146220865e-05, "located in": 0.035366726293819685, "left atrium": 34.50206789192951, "rarely embolize": 34.49821956884104, "arterial vasculature": 68.99716659302436, "report of": 0.044017075996042876, "massive embolism": 34.498372867918214, "pulmonary arteries": 0.0013599192929709687, "arteries treated": 0.0013159101813639432, "treated surgically": 0.0013160856278014803, "atrial mass": 34.50038898662936, "mass removal": 0.0012045629174051344, "pulmonary embolectomy": 34.4994844162626, "atrium mass": 34.49947043961848, "mass presented": 0.0012257849233373455, "tricuspid valve": 34.49907611226345, "valve causing": 0.0008723277126104175, "stenotic physiology": 34.498225884903654, "left pulmonary": 0.0050661608662432855, "completed occluded": 34.49837146667913, "right pulmonary": 0.002851744478874538, "partially obstructed": 34.49842742164761, "surgical tactics": 0.0003676380824431785, "tactics included": 0.0011873694088633201, "brief hypothermic": 34.49828604829073, "hypothermic circulatory": 34.49839602671696, "circulatory arrest": 0.0002862596747609505, "uneventful recovery": 0.00018996369248690484, "reliability of": 0.043777182749591574, "go test": 0.0008452948373401552, "test in": 0.03616185697143543, "chronic organ": 0.0022041230443397707, "organ failure": 0.017661525988209675, "chronic renal": 0.0034982415317402066, "renal failure": 0.01895564447561011, "- sectional": 34.54360677254526, "home environment": -5.6866006803995526e-05, "median body": 0.002009172779851846, "performed on": 0.0043057095970207345, "the intraclass": 34.52469605239098, "intraclass correlation": 34.498463728496844, "kappa coefficient": 68.9965882318349, "relative minimal": 0.0005000544339001188, "minimal detectable": 9.980891678308321e-05, "detectable change": 0.0008456201166682598, "good agreement": 0.000132742567304898, "values ranging": 0.0005582867719662254, "kappa coefficients": 68.9964180900216, "statistical improvement": 0.0013820560869952426, "improvement occurred": 0.0018183994397244878, "second trial": 0.001280466920513454, "large limits": 0.0005440560255682899, "third trial": 0.0011933018695810867, "trial added": 0.0013334407236364218, "added little": 0.00027691940840764205, "measurement value": 0.0010346068023609851, "relative value": 0.0010267117279005992, "similar values": 0.0013381259918953373, "values found": 0.0012877537699003817, "daily clinical": 0.0031579112782801452, "represents true": 9.17310393492396e-05, "true change": 0.0008101802455839199, "repeated measures": 0.0009265381307554826, "arthritis starting": 34.49823184318753, "elevations in": 0.03538444630786088, "tumor necrosis": 34.4982257094572, "necrosis factor": 34.499030503311985, "several trials": 0.0013836483020654244, "antagonists showed": 34.49958710188624, "possibly worsening": 0.0004295617399406109, "known severe": 0.0017897223228789257, "recurrent hf": 3.350376026450632e-05, "treat rheumatoid": 34.49828166273032, "different us": 0.00033181791183180726, "healthcare programmes": 0.00022206444408207673, "receiving methotrexate": 34.498687683507654, "- biological": 0.045683457954016696, "biological disease": 0.003472149419381082, "disease modifying": 0.0032372884132788986, "modifying antirheumatic": 34.498225884903654, "antirheumatic drug": 34.498423200782135, "models stratified": 34.49946408540986, "score decile": 0.0011996696075385587, "oral glucocorticoid": 34.49822342865471, "glucocorticoid dosage": 34.49822535856434, "loop diuretics": 34.49842847722004, "compared 8656": 34.500714786492544, "similar baseline": 0.002642156529092191, "baseline covariates": 34.50006171398215, "antagonists compared": 34.50102103133589, "elevated prior": 0.0010019994541183646, "ci 0.45": 34.49826008871272, "test for": 0.014149912491300848, "oral glucocorticoids": 34.49822342865471, "related gradient": 0.0011535865495187038, "hr 1.30": 6.788417376560529e-05, "hr 1.54": 6.788417376560529e-05, "admissions compared": 0.002793050917443928, "using exercise": 0.005510250684241829, "improve quality": 0.002503603253297078, "current economic": 0.0007495724110243004, "economic climate": 0.00014346227401120366, "climate within": 0.0007462037846571158, "change interventions": 0.0014556066686529112, "interventions in": 0.03596040333923534, "exercise programmes": 0.004055364473778244, "limited within": 0.0013276094593186456, "within acute": 0.0029459099975304975, "acute hospital": 0.00356831813688793, "hospital facilities": 0.0014056239987446802, "the challenge": 0.02650752478623033, "deliver cost": 0.0004537238446170673, "specific health": 0.001797303370520054, "health interventions": 0.0018209884733931497, "measurable benefits": 0.0005200414140777165, "structured exercise": 0.003991342429093151, "exercise programme": 0.0040667598655372405, "primary outcomes": 0.004264694839892847, "measures related": 0.0018143823409306381, "patient satisfaction": 0.0024301720815836153, "intervention post": 0.001172076748326574, "post study": 0.005401984906176929, "overall significant": 0.00218018271323549, "participants demonstrated": 0.0018524573024421914, "others showing": 3.629129918425027e-05, "showing minor": 3.805897864499436e-05, "minor improvement": 0.0012403272104116187, "anecdotal evidence": 0.0010525344471807548, "perceived benefit": 0.0008171173854849499, "participant satisfaction": 0.00013032951205571374, "satisfaction responses": 0.00022978290643395886, "based programmes": 0.0011929644213931198, "completion of": 0.04366913249715661, "composition study": 0.004968330205648661, "adverse health": 0.002262665328894873, "participants aged": 0.0012666080860438056, "aged 70": 0.0006445783152097891, "- frail": 0.045550683772781486, "frail participants": 0.0009751163212892062, "ci 1.08": 0.00020399646645964342, "severe frailty": 0.0016559309903377039, "ci 1.02": 34.49832814485905, "linearly associated": 34.50248203275108, "per sd": 0.0007473810827894702, "sd decrease": 0.0005747485884942384, "competing risk": 0.004627335050590247, "across age": 0.0021283284841698722, "- groups": 0.046869237037978385, "improved discrimination": 0.0012715687069911837, "ci 0.018": 34.498226059771106, "appropriately reclassified": 6.700752059057553e-05, "reclassified 13.4": 34.498225884903654, "improvement 0.073": 34.4994079768942, "ci 0.021": 34.4981920302505, "the role": 0.027535854384728647, "abnormalities contribute": 0.0006330156592057315, "successful approaches": 0.0005121666423426749, "based largely": 0.0013552025011415786, "therapeutic interruption": 0.0008144705784069219, "activated neurohormonal": 34.49846373428629, "neurohormonal systems": 34.49853984652404, "sympathetic nervous": 0.0006063386481390442, "nervous systems": 0.00037710932392408817, "excessive secretion": 34.498223604100964, "arginine vasopressin": 68.9965542023143, "potential for": 0.014038214521805564, "deleterious effects": 0.0014452745495972424, "various physiologic": 34.49831620851015, "physiologic processes": 34.49838585084812, "potentially beneficial": 0.0008648663132487606, "beneficial new": 0.0009059331462454195, "therapeutic approach": 0.0010605491830269309, "approach to": 0.019391878635173585, "mir-25 cooperate": 3.262652830679321e-05, "aberrant reactivation": 6.770930631083088e-05, "intricately linked": 0.00022100833029799517, "pathological heart": 0.01910838114452179, "factors driving": 0.0010798974936301622, "programs remain": 0.0004551567611462454, "remain ill": 0.0001894282807814391, "increased calcineurin": 34.50091361032858, "decreased mir-25": 0.0008810855354439127, "expression integrate": 0.0011488574159889305, "- express": 0.045438070187969234, "basic helix": 34.49827306592501, "factor dhand": 0.0008384730614865663, "also known": 0.0011309131481263, "diseased human": 0.0008572574096353595, "mouse myocardium": 34.49879996238674, "in line": 0.03535742081303782, "mutant mice": 0.0010527826378211762, "mice overexpressing": 34.499211484574474, "otherwise healthy": 0.0003757016532895016, "healthy heart": 0.019125036914103128, "heart muscle": 0.019378107803559228, "muscle cells": 0.001179657625565961, "cells developed": 0.0016655138861826227, "pathological hypertrophy": 34.49924609425456, "conditional gene": 0.0006789239823899595, "mice demonstrated": 0.001964678320928983, "marked resistance": 0.0007338401950270633, "induced hypertrophy": 34.50040086141465, "fetal gene": 0.0006778713039019209, "gene program": 0.0010519755926963032, "vivo inhibition": 34.49911001495307, "specific antagomir": 34.498812186352765, "antagomir evoked": 34.4982257094572, "evoked spontaneous": 0.00016926979183352238, "spontaneous cardiac": 0.005774742336237118, "murine myocardium": 68.99669031344929, "dependent manner": 0.0006219209131613836, "results reveal": 0.0012447066367215146, "signalling cascades": 0.00027100051333877137, "cascades integrate": 0.00013418875101242018, "bhlh transcription": 34.498498275093844, "postnatal mammalian": 6.753385985745891e-05, "mammalian myocardium": 34.49846407938973, "the base": 0.026545764962430975, "hormonal system": 0.0006078534425743887, "inhibitors intolerance": 0.0007473420195149823, "beta receptor": 0.0021085427919555295, "negative inotropic": 34.49848390069218, "past decades": 0.00011644813176383589, "decades several": 0.0003434166912406763, "several studies": 0.001847460435297024, "blockers decrease": 0.0014591676039155217, "the effectiveness": 0.02687656692983383, "reducing mortality": 0.004406160902237234, "myocardial loss": 34.50080653752796, "causes heart": 0.01903050465443188, "links diabetes": 0.0011028807949003557, "failure remains": 0.017972671264482192, "hallmark of": 0.043711056513232455, "insulin receptor": 0.002006657461177823, "receptor substrates": 34.49965462648127, "substrates 1": 34.499963314381674, "major insulin": 0.001397756601246668, "signaling components": 0.0007068302548753666, "components regulating": 0.000160322036977101, "regulating cellular": 0.00016663809626819723, "cellular metabolism": 0.00047481284958692427, "examine whether": 0.0011850400061077491, "hyperinsulinemia causes": 34.49841970202839, "causes myocardial": 34.50076638166129, "myocardial insulin": 34.501082771113815, "cellular dysfunction": 0.002515072192702733, "dysfunction via": 0.0029303696710714167, "generated heart": 0.018861769300816938, "gene double": 0.0008623898463041864, "reduced ventricular": 34.50572789024524, "ventricular mass": 34.50409291163862, "developed cardiac": 0.00670028293874467, "cardiac apoptosis": 34.503933268826465, "showed diminished": 0.0011558337340539019, "box class": 0.001285509323123151, "class o-1": 0.0012804276825667013, "o-1 signaling": 0.0005782575146321135, "cardiac metabolic": 34.50417145115532, "metabolic gene": 34.499177368733456, "decreased cardiac": 0.006520237286549552, "cardiac irs1": 0.00563915175110564, "exhibited features": 0.00040604639844230754, "cardiac energy": 0.005928021537183607, "metabolism gene": 0.000984993379287119, "p38\u03b1 mitogen": 68.996384060501, "activated protein": 0.0010493119099750886, "using neonatal": 0.0016181908331265994, "neonatal rat": 0.0002020694510253271, "rat ventricular": 34.50308480389337, "chronic insulin": 0.0027159086391229676, "insulin exposure": 0.000640184620969069, "exposure reduced": 0.002907424540289555, "prevented insulin": 0.0006417636351687422, "insulin action": 0.0006508707635325021, "fundamental mechanism": 0.0005640706944625717, "medications among": 0.0015172131515007385, "among outpatients": 34.49967679232003, "examine practice": 0.0009564038615935706, "recommended treatment": 0.004004858879028629, "treatment variation": 0.0038747256427558007, "practice site": 0.0006564695683262903, "patient factors": 0.003438331922370177, "cardiology practices": 34.498383748976195, "practices participating": 0.0002469696362102583, "practice rates": 0.0020222253758454484, "treatment measure": 0.003960659322375613, "documented contraindications": 34.49842654441666, "multivariable hierarchical": 34.498430053342794, "hierarchical regression": 34.49883815225813, "insurance status": 0.0009484219916181365, "calculated for": 0.013743279419009026, "given comorbidities": 34.49855579817262, "selected practices": 0.00038448086073665034, "identified 12": 0.0017426496363180527, "unadjusted practice": 34.498746251744436, "level prescription": 0.0008072383658338312, "prescription rates": 0.0014974723783554263, "rates ranged": 0.0015346599308274198, "ranged from": 0.004517091352207728, "adjusted median": 0.0019308392891748266, "fraction exists": 0.00400270038132048, "exists in": 0.03544531032016044, "outpatient setting": 0.00048761172784618956, "addressing practice": 0.0005542214939350116, "level differences": 0.0012811427295076842, "component of": 0.04370456500528712, "improving quality": 0.0020201336852892215, "related cardiotoxicity": 34.49948189527614, "cardiotoxicity among": 34.4997108177881, "adjuvant setting": 34.49851054994875, "setting improves": 0.0009970817902203548, "cardiotoxicity manifested": 68.99665628045514, "related chf": 0.0010176450714963158, "chf among": 0.0012465675834600284, "full medicare": 34.49830374632349, "trastuzumab use": 34.50000101055153, "version 9": 0.0002667687560106554, "analyses included": 0.0016312870378425606, "included descriptive": 0.0012917370364205437, "descriptive statistics": 0.00022715238792868562, "received trastuzumab": 34.49860684135248, "entire cohort": 0.0014291105275415555, "trastuzumab users": 34.49885133146585, "weekly trastuzumab": 34.4985259937617, "trastuzumab administration": 34.498714368656515, "older breast": 0.0010619110483467368, "cardiac comorbidities": 34.50406937648768, "further studies": 0.0021196433426307064, "studies need": 0.0018733832453689129, "administration plays": 0.00026221786221262224, "current dietary": 0.000851846521720342, "largely based": 0.0013552025011415786, "- hf": 0.0454147422947591, "hf populations": 0.00016435498284270663, "dietary patterns": 0.00029871397182553697, "therefore evaluated": 0.0011376844626001963, "evaluated associations": 0.0011196233911692193, "among postmenopausal": 34.49943859783396, "postmenopausal women": 34.49848456191308, "date of": 0.043706837916484255, "last participant": -0.00010966956743823686, "participant contact": 8.892466307269044e-05, "frequency questionnaires": 34.49839111422209, "models adjusted": 0.002152248995211659, "health behaviors": 0.0012104755820949986, "calculate hazard": 0.0021734628617943205, "hospitalization died": 0.002100155575500701, "quartiles of": 34.54183537861541, "p trend=0.08": 34.49335893278026, "p trend=0.01": 34.49335893278026, "score components": 0.0012603581740162067, "whole grain": 1.5953169953007198e-05, "grain intake": 9.507186735104653e-05, "inversely associated": 0.00439191561595988, "higher dash": 0.0018239524995586228, "modestly lower": 0.0019363017754054647, "nonsignificant trend": 34.49848266968138, "inverse association": 0.0008055349916534419, "data provide": 0.0018790797614769395, "provide support": 0.001719722107364247, "support for": 0.014561508585532866, "recommendations developed": 0.0013907039241996973, "cardiovascular conditions": 0.002445258440522292, "general populations": 0.0003557098610491694, "cardioprotective signaling": 34.49883834622735, "signaling in": 0.03589481964872739, "potentially promising": 0.0005574141870985596, "promising biomarker": 34.49856143090251, "term clinical": 0.0042859341266516995, "randomized study": 0.005685000000335872, "evaluable plasma": 34.498633323709576, "relationship among": 0.0018558461769150674, "median baseline": 0.0027501850558173573, "in univariable": 34.53350859238459, "univariable analysis": 34.50027974879002, "log2 ng": 34.498360595941016, "in multivariable": 0.03555458522639025, "multivariable models": 0.0014760487310512503, "add significantly": 0.0019698327442255544, "reclassification of": 0.04377928810601314, "c statistic": 0.00040394319458036374, "treated cohort": 0.0026764409939494032, "significantly affect": 0.0020801637380651436, "affect reclassification": 0.00032520107500754716, "year experience": 0.0008499821754395869, "programs expand": 0.00034553655983972245, "transplant pool": 0.0006677052864598657, "matching donors": 0.00016576202277185462, "recipients typically": 0.00026012574832087146, "typically excluded": 0.00026205565727372457, "excluded from": 0.004653203644901766, "transplant process": 0.0006813752613472752, "data examining": 0.0014811501718407264, "examining long": 0.0011687165631579129, "undergoing isolated": 0.000980266746642911, "prospectively classified": 34.49852898329171, "classified as": 0.004133917829452201, "prespecified criteria": 34.498626130420774, "compared between": 0.0051437588821274215, "identify clinical": 0.0036133856418892694, "variables contributing": 0.0005039200360937512, "contributing to": 0.01920824421440605, "additional risk": 0.004743446623959939, "underwent heart": 0.019652008136926392, "underwent standard": 0.0013695513609206108, "years versus": 0.004189000152607805, "higher frequency": 0.002023036471148643, "median estimated": 0.0016046822413749195, "transplant survival": 0.0018652162636827027, "multivariate model": 34.50002869372917, "included listing": 0.0011863167315762004, "listing criteria": 0.00046462134345049593, "significant predictor": 0.002372945407462794, "transplant mortality": 0.004824091740693751, "acceptable alternative": 0.00031695279205360143, "failure therapy": 0.020618175887303383, "select patients": 0.018791011772098357, "important determinants": 0.0008000455101710659, "transplant morbidity": 0.001019898972782864, "failure readmission": 34.51656979633915, "readmission quality": 34.50066407915101, "study objectives": 0.004661208131340812, "day readmissions": 34.49989008854682, "characterize events": 0.0017891365827891596, "events at": 0.004570676219026729, "some data": 0.001275873299268027, "outpatient assessments": 0.00030415627550753175, "failure within": 0.018367039059102912, "prevent readmissions": 34.49868261470671, "patient needs": 0.002406304651034233, "retrospective chart": 0.0003343219256240482, "failure discharges": 0.017663105005733735, "year before": 0.0008685352618985743, "year after": 0.004156524596855538, "included mandatory": 0.0012208725907606921, "readmissions decreased": 34.499447408671216, "decreased from": 0.005331520838734657, "visits increased": 0.0035670709684514712, "day visits": 0.0021692563014181297, "visits occurred": 0.0014479436863930044, "failure nurse": 0.017761682904462832, "nurse practitioner": 0.00016593631214901924, "blood work": 0.0008741862780558452, "work drawn": 5.572345705424079e-06, "medication dose": 0.0017289273790871782, "dose changed": 0.0014323344520944994, "medication lists": 0.0004676102911882488, "failure decreased": 0.01851033588802223, "diagnostic testing": 0.0010723317603392574, "medication changes": 0.001992341370936342, "the underlying": 0.02680816683764206, "underlying pathophysiology": 34.498802419791005, "incompletely understood": 34.49835129730673, "matrix accumulation": 34.498361825802675, "estimate myocardial": 34.50059747086201, "matrix using": 34.499878453255334, "using cardiac": 0.007223487931076824, "confirmatory diagnostic": 34.49876958597941, "diagnostic tests": 0.0007005142109744408, "imaging including": 0.0010687181365443628, "including t1": 0.0007645734393838691, "hemodynamic assessments": 34.49856528898248, "performed at": 0.003890929301822918, "longitudinal outcome": 0.0018268759677363539, "monitoring phase": 0.0005226938675819636, "cardiac event": 0.00611496547869912, "t1 time": 0.001195276341613941, "ventricular biopsies": 69.00117667780822, "tissuefaxs technology": 4.085867894254035e-05, "technology correlated": 0.0006868052401347976, "time also": 0.00192034901796405, "also correlated": 0.0013710192375423662, "present preliminary": 0.0006663025835368723, "preliminary study": 0.00476224227956663, "possible biomarker": 34.49864507856853, "imaging on": 0.003568173355908113, "compliance with": 0.031332700003273074, "thalassaemia major": 34.49904572562133, "institution cohort": 0.0015201522311686926, "abnormal cardiac": 0.005943822787209812, "cardiac t2": 0.00563915175110564, "values determined": 0.0006538769010716025, "determined changes": 0.0018120410738146154, "highly predictive": 0.0004876152067485761, "the choice": 0.02657698679933434, "chelation regimens": 68.99645211896322, "regimens known": 34.49859787072228, "remove heart": 0.018817739401683596, "heart iron": 0.01913170383107147, "iron efficiently": 0.00036026935874692656, "remarkable role": 0.0010918213428592774, "clinical response": 0.003895160445095299, "guidelines recommend": 0.0004730359230924719, "recommend cardiac": 0.005701947983979633, "\u226430 %": 34.51700160365406, "results of": 0.0447949136110628, "blinded core": 8.419424272629753e-05, "core laboratory": 0.00028748197693053004, "end systolic": 34.50282392699196, "\u00b1 21.1": 68.99917256009407, "\u00b1 17.6": 34.50101438449672, "\u00b1 50.5": 34.50101438449672, "\u00b1 42.4": 34.50101438449672, "the time": 0.027699298482095507, "significantly prolonged": 0.0020589434926504314, "remodeling parameters": 0.0012911444655533363, "important covariates": 34.499094335716066, "improved time": 0.002370897103995642, "interaction with": 0.031470375100944976, "among subjects": 0.0018541083083252314, "mild hf": 0.0005067063342477557, "produced reverse": 0.0005505776184188972, "similar clinical": 0.003961084657449058, "benefit compared": 0.003208493752289024, "myocardial titin": 68.99893490857303, "importantly contributes": 0.00019470245067783337, "fraction in": 0.0391905143293506, "rat metabolic": 34.498700514202085, "risk model": 0.006063564831157947, "important metabolic": 34.49929849026123, "frequent comorbidities": 34.49849249463147, "myocardial diastolic": 69.00053350733336, "relative importance": 0.0006209029574791165, "investigated in": 0.03568665067644367, "diabetic zsf1": 0.00010173766892769406, "fraction development": 0.00491505892337493, "groups of": 0.045063813587524044, "fat diet": 0.0011764822356659281, "repeat metabolic": 34.49862526477011, "echocardiographic evaluations": 34.49890569306334, "hemodynamically assessed": 34.49944748227332, "collagen cross": 34.498482146240804, "- linking": 0.045447368823065895, "titin isoforms": 68.99662225846075, "also determined": 0.0009494109915206495, "resting tension": 0.00026643890905145355, "fpassive)-sarcomere length": 0.0004297140312612549, "length relations": 0.000488650455541334, "small muscle": 0.0008031019434942268, "muscle strips": 0.0006084277944575282, "unanchors titin": 68.99658822894014, "allows contributions": 0.0001741753314484799, "increased lung": 0.002856644323993708, "ventricular dd": 34.502916589095506, "high muscle": 0.0022971225754025585, "muscle strip": 0.0006059715463763082, "strip stiffness": 34.49835884147841, "latter occurred": 0.0006934882604166726, "occurred specifically": 0.0006610383289834907, "site of": 0.043711566918696036, "elastic n2bus": 34.4981920302505, "n2bus segment": 9.331625727816414e-05, "rats developed": 0.0017393423870268642, "week time": 0.001440275721709211, "time span": 0.001224920284142482, "importantly contributed": 0.000154533476183345, "contributed to": 0.01920631430985537, "major predictor": 0.0011932685280245643, "sensitive measure": 0.00048445020142982447, "ventricular mechanics": 34.502949215623815, "adverse cardiovascular": 0.003091426653406615, "predicting cv": 0.0002702946753964964, "university hospital": 0.0013642258230946876, "patients referred": 0.01882661972278842, "referred for": 0.01339582856386699, "echocardiographic examination": 34.49896988823472, "index beat": 0.002011318884693219, "beat method": 0.00030625237263510183, "hazards analyses": 0.0007450843697362745, "average follow": 0.002352665535655717, "\u00b1 10": 34.50174599969586, "showed worsening": 0.0013607004851815142, "in direct": 0.035433380039318244, "direct comparison": 0.00021171317448455157, "outperformed left": 0.003807103167988929, "systolic mitral": 68.99998936371145, "p \u2264": 34.49346101960512, "\u2264 0.043": 68.99648614732587, "model containing": 0.0015914650400703553, "containing chronic": 0.0022669181238226944, "age \u2265": 34.50000925620594, "prior stroke": 0.0009332577295011219, "stroke score": 0.001707762145714816, "additional benefit": 0.0008620136279996622, "major parameter": 0.0008870236846740329, "additional prognostic": 34.499218870730516, "prognostic benefit": 34.499728332123, "conventional clinical": 0.0031124863500669783, "echocardiographic systolic": 68.99944511825339, "systolic parameters": 34.50101336080766, "parameters in": 0.03565525805940697, "duration on": 0.003738292013774342, "usually assessed": 0.0011961606851863056, "assessed separately": 0.0012524711719323724, "the interaction": 0.026941455782835976, "simple ecg": 0.0001447051309226283, "systematically assessed": 0.001254576527615186, "scale clinical": 0.003232457697217325, "previous pacemaker": 0.00013330359391822846, "all baseline": 0.003530090635499001, "baseline ecgs": 0.0017335691230979159, "panel of": 0.04366264101483665, "experienced electrocardiographers": 34.4984482892706, "receiving implantable": 34.499436199243725, "individual component": 0.0002685397324695515, "- lbbb": 0.0454147422947591, "ratio for": 0.01611135722612696, "broader qrs": 9.735151260203567e-05, "greater benefit": 0.0011049248471217694, "delayed benefit": 0.0007830890228436279, "refractory congestive": 68.9975408367219, "term management": 0.0024761721595455534, "diuretic resistant": 34.49849512632273, "resistant volume": 0.001821067322828332, "provide potential": 0.0011964280436369446, "adverse consequences": 0.0011430509200074396, "status hospitalizations": 0.001269925408572697, "severe end": 0.003533143960715915, "series of": 0.04365754606323081, "transplant ineligible": 0.0006799865010092363, "volume management": 0.002998901021021109, "data reviewed": 0.0017160071303673721, "reviewed pre-": 0.00033361319783792087, "pd initiation": 0.00010191311538106603, "\u00b1 6.0": 34.501081565726835, "% with": 0.049808485341545986, "severe right": 0.002943240317881, "average weight": 0.000649656149959061, "diuretic response": 34.49927288793021, "peripheral edema": 0.00037272602471995165, "- hospitalization": 0.04735335899664952, "\u00b1 2.5": 34.5011803155994, "admissions per": 0.0010176757581859667, "reduced average": 0.003037208402051545, "average length": 0.0006556212835777633, "\u00b1 36.7": 68.99917256009407, "\u00b1 2.3": 34.50104736133884, "objective criteriabased": 34.49845688609778, "criteriabased institution": 34.498284118388206, "diuretic refractory": 68.9968264234262, "refractory severe": 34.49978008054074, "well tolerated": 0.0009842162748750975, "demonstrated favorable": 0.0012164016935233962, "favorable outcomes": 0.0033270809616254135, "included improved": 0.0023314163207798565, "easily treatable": 34.49820535777308, "treatable pdrelated": 34.4981920302505, "pdrelated complications": 0.0004407671199919499, "viable option": 3.876078745098102e-05, "stage congestive": 34.49971200201631, "often deferred": 0.00036919321663215294, "perceived lack": 0.0003392264039374426, "potentially higher": 0.0022161344737805983, "higher risks": 0.0019079701560000119, "therefore studied": 0.0004860361520101792, "descriptive assessment": 0.0007399732850606759, "analysis matching": 0.002186999959717838, "branch morphology": 34.49849442916954, "cardiomyopathy origin": 34.498833433732486, "angiotensin ii": 34.499280687826534, "blocker use": 0.0023498140434237936, "month echocardiograms": 34.49880461996828, "term complications": 0.0016742039951888666, "observed among": 0.0019507267935166255, "among dialysis": 0.0016206913903363514, "heterogenous improvement": 0.0012159466437000144, "+3.1 \u00b1": 68.99917256009407, "\u00b1 9.2": 68.99920658961467, "patients derived": 0.019208794936643712, "derived absolute": 0.0007040404782774328, "absolute improvements": 0.0006656317537448257, "following 3": 0.001815496613856639, "controls demonstrated": 0.0014496634255350344, "demonstrated superior": 0.0011127393256133396, "superior reverse": 0.0004334157462426856, "+9.2 \u00b1": 68.99917256009407, "\u00b1 9.5": 34.501013682711005, "serious complications": 0.0005051350451739824, "certain dialysis": 0.0003977959611988409, "demonstrated compelling": 0.0010431018478028558, "compelling improvement": 0.001245766032327497, "worsened echocardiographic": 34.498837986651914, "echocardiographic outcomes": 34.50189441509831, "sodium dash": 0.0002715227999214695, "diet improves": 0.0014532128518226412, "improves diastolic": 34.50067335954192, "involves failure": 0.017723970176002163, "cardiovascular reserve": 0.0021942903851676823, "multiple domains": 0.00038711432207497946, "dietary sodium": 0.0005088441064961904, "sodium restriction": 0.0004406148295182336, "restriction improves": 0.0008476541215676934, "improves ventricular": 34.503595151187476, "vascular stiffness": 34.49877014010379, "restricted dietary": 0.00037045564319404, "dietary approaches": 0.0005393606493452194, "stop hypertension": 0.001243984781262921, "hypertension diet": 0.0020330280827272726, "improve left": 0.004553844943009489, "treated hypertension": 0.0025067542233648075, "target sodium": 0.0006173999260782667, "mmol/2100 kcal": 68.996384060501, "measured baseline": 0.0026137774278923247, "- dash": 0.0454147422947591, "central blood": 0.0010731303832594923, "via radial": 34.498810274990625, "radial arterial": 68.99723465148656, "invasively validated": 34.49846285705433, "quantified via": 0.0007198046467205088, "parametrized diastolic": 68.99818682770045, "filling formalism": 34.49869645578606, "yields relaxation": 9.858079211914944e-05, "mitral inflow": 34.4993483780358, "inflow velocity": 0.0005437190206343023, "ratio ees": 0.0028067395721662696, "determined using": 0.0018086744951417244, "using previously": 0.001734480089870182, "previously published": 0.00023801363538930045, "published techniques": 0.00015013962039022984, "pairs signed": 7.472022047642663e-05, "rank tests": 0.00022083633291571585, "- post": 0.046185864796612755, "post comparisons": 0.0009396881923677819, "the dash": 0.026504022140481566, "reduced clinic": 0.0030445871931982123, "hour brachial": 34.49840268909277, "brachial systolic": 68.9989687819577, "\u00b1 35": 34.50123398174442, "\u00b1 30": 34.50240151529899, "central end": 0.002330275221766792, "pressure trended": 0.0018347158296065944, "trended lower": 0.0018001894827114266, "in conjunction": 0.03538128827405941, "function improved": 0.0039853429033196094, "\u00b1 8.1": 34.50101403360383, "\u00b1 37": 34.501345179564, "coupling improved": 0.0015493936763671147, "restricted dash": 0.00013313433661931915, "favorable changes": 0.001790821992992098, "resistin in": 34.533950930996596, "humanized male": 34.49864963322391, "women treated": 0.00154090856307307, "circulating mediator": 34.49846285126489, "resistance mainly": 0.000662801475218602, "mainly expressed": 0.00033711868532052284, "human monocytes": 34.49891404796784, "inflammatory stimuli": 0.00042464348768938545, "recent clinical": 0.0035589984508763036, "connected elevated": 0.0006682217753145648, "humanized mouse": 34.498595797421274, "model lacking": 0.0015611204649202072, "lacking murine": 34.49832481485268, "murine resistin": 68.99689445757522, "human retn": 0.0007220177173332268, "exhibits basal": 34.49832691905003, "stimulated resistin": 34.49876960855481, "levels similar": 0.0026421208182420878, "resistin underlies": 34.498668048069206, "underlies acute": 0.0022418004977079495, "acute anthracycline": 34.50063834602758, "kg ip": 34.49927491661989, "fold induction": 0.00036957956924089767, "littermate controls": 34.49862841121686, "expressing human": 0.0007876210884085811, "cardiac mrna": 0.00563915175110564, "cell adhesion": 34.49872486293993, "adhesion genes": 34.49853002439058, "genes compared": 0.002860750382131811, "mice treated": 0.002199772762242857, "doxorubicin in": 34.53388288526986, "showed dramatic": 0.0011517984712958987, "dramatic induction": 0.00023136192308030492, "also examined": 0.0012643968583484083, "examined resistin": 34.499173693044504, "treated breast": 0.0014148372360597563, "without cardiotoxicity": 34.49947500616073, "women undergoing": 0.0007317197661602865, "undergoing anthracycline": 34.49886941284015, "containing chemotherapy": 0.00023031040741641054, "chemotherapy increased": 0.002856819770385073, "subsequent cardiotoxicity": 34.498697887140224, "resistin correlated": 34.4992803154237, "direct effects": 0.0014943837275079742, "implicate resistin": 34.49866787262277, "link between": 0.0026690614620362087, "ablation for": 34.51173484239053, "precipitating factor": 34.499030503311985, "free probability": 0.00029096963106145106, "factors relating": 0.0010958629794081784, "procedure drug": 0.000396753636633954, "free success": 0.0003528796516717173, "success rates": 0.001562189538152057, "multiple procedures": 0.0006540523678866372, "pharmaceutically assisted": 34.49832621726468, "assisted success": 0.00022837267042553569, "success rate": 0.002624436753534118, "occurred during": 0.0027507949709463055, "analyses revealed": 0.0008902927100181083, "standing persistent": 0.00011559208322332263, "lv systolic": 34.50067466488235, "systolic indices": 34.50084428325116, "diastolic indices": 34.500164415818766, "patients maintaining": 0.01876101749937882, "maintaining sinus": 34.4983877807503, "safely treated": 0.0013469565358929425, "repeat procedures": 0.0005286445485669597, "current study": 0.0052453876194688935, "arm analysis": 0.0021777013311468072, "larger randomized": 0.0011700782775118086, "randomized control": 0.0029385420762628057, "control studies": 0.0034996519043460446, "ameliorates mitochondrial": 68.99716659302436, "possible mechanism": 0.0007215642179204547, "known cardiotoxicity": 34.49887009067642, "effective anti": 0.000904770801554955, "- neoplastic": 34.54360677254526, "neoplastic agent": 34.49839023699214, "cardioprotective effect": 34.49948583326297, "hemodynamic alterations": 34.498769797893765, "dysfunction induced": 0.0038404988212414047, "cumulative administration": 0.0005214658053883305, "cumulative dose": 0.001595636120309625, "given orally": 34.498317603686544, "without doxorubicin": 34.49957707909186, "doxorubicin treatment": 34.50217163133447, "recorded 24": 0.0005242505304363312, "last dose": 0.0011479631504396914, "rapidly excised": 34.49821886705754, "cytochrome c": 34.49856264513124, "caspase 3": 34.499768296241584, "stress markers": 0.000840141199122775, "measured together": 0.0008922948494782931, "examination of": 0.04380875370798537, "state of": 0.043679103271569444, "stress induced": 0.0019272100524310935, "doxorubicin cardiotoxicity": 68.99703057334041, "also preserved": 0.0026959320416458598, "preserved phosphocreatine": 34.500264976440654, "restoring mitochondrial": 34.49904139426913, "significant cardioprotection": 34.50025943202137, "cardioprotection via": 34.49877624604901, "via inhibition": 0.0012299764943989359, "apoptotic signaling": 34.49880431728574, "mitochondrial ultrastructural": 68.99723465148656, "cytotoxic effect": 34.499417774800754, "solid ehrlich": 2.36787843157298e-05, "ehrlich carcinoma": 3.385465315541544e-05, "indicated by": 0.005716392050058663, "hemodynamic perturbations": 68.99669031344929, "changes without": 0.002598458714732704, "antitumor activity": 34.49898982018863, "isolated coronary": 34.49985577747216, "early risk": 0.005540604372699981, "swedish web": 3.1517581829635595e-06, "based care": 0.003042540042164442, "disease evaluated": 0.004120288809681682, "evaluated according": 0.0012167663804048805, "underwent primary": 0.001989908373004989, "failure \u226490": 34.51582128060308, "\u226490 days": 34.499037108438884, "death from": 0.006758511513597512, "developed acute": 0.0032692524786449356, "injury postoperatively": 34.498480739786146, "became nonsignificant": 34.49825271445155, "statistical model": 0.0016625037682513055, "ratio 1.76": 34.500998769822665, "interval 1.38": 34.49982382163629, "postoperative months": 34.49942306247951, "enormous clinical": 0.0030803867338386154, "clinical burden": 0.0032129924267193565, "adult medicine": 0.0004562115216290903, "atheromatous coronary": 68.99750672907959, "in children": 0.03553262482917557, "important disease": 0.003969624617139134, "paediatric cardiac": 0.005706860478417873, "cardiac transplants": 0.005706860478417873, "cardiac symptoms": 0.00655056797206842, "congenital lesions": 68.99658823415072, "septal defects": 34.49836129946341, "congenital heart": 34.5170969499519, "heart lesions": 34.5170969499519, "small subgroup": 34.498555971875525, "diastolic failure": 34.51762404780253, "failure from": 0.022079685655869066, "cardiomyopathic restriction": 34.498361122280095, "the remaining": 0.02659260136928973, "remaining patients": 0.018823988041690286, "principally related": 0.0010509733853382316, "poor myocardial": 34.50081197627163, "largely comprise": 0.0003243145775628508, "dilated poorly": 34.49886904111002, "poorly contracting": 0.00016540997271239418, "contracting ventricles": 6.66566278227922e-05, "specific aetiologies": 34.498812186352765, "particular topics": 2.9293050376385086e-05, "paediatric heart": 0.018870541603849093, "failure concern": 0.017642577875161075, "versus dilated": 34.50063508693793, "appropriate investigations": 0.0004534043948778994, "new onset": 0.0012150928571340743, "cellular responses": 0.00030099824282957754, "increasing population": 0.0012071176706941135, "population of": 0.04453264348410462, "anthracycline treated": 34.499678601637065, "treated survivors": 0.001478154026125508, "survivors of": 0.04383909596994102, "childhood malignant": 0.00012962715183525376, "malignant disease": 0.0032372884132788986, "key role": 0.0011840726744476214, "molecular scaffolds": 34.498531252514894, "heart pathology": 0.018870190710988964, "the ability": 0.026805348344994723, "detect mechanical": 0.00033467281745299933, "humoral stimuli": 34.49829394336588, "new conditions": 0.0008725986549761016, "increased workload": 0.0027545574991267355, "certain stimuli": 0.00012558526970358385, "stimuli mediate": 0.00013576776853648146, "beneficial adaptation": 0.000538463156370823, "stress conditions": 0.0009062444721155394, "others result": 0.00027307173976009324, "ultimately leading": 0.0003134338681377618, "specific signalling": 0.0008573019624503269, "signalling pathways": 0.0006109187741687699, "pathways activating": 0.0005437421756937983, "transduction pathways": 34.49866788998935, "pathways involved": 0.0005161886207604599, "opposing responses": 0.0002643381863928612, "responses engage": 0.00025574134412692355, "signalling proteins": 0.0009169360766792582, "notable example": 5.2965191032711777e-05, "signalling pathway": 0.0006109187741687699, "signalling requires": 0.0005286584642480723, "signalosome complex": 34.49851002361512, "scaffold protein": 34.49907172610751, "protein drives": 0.0008735558187901865, "linear pathway": 0.0005765412555964352, "sequential phosphorylation": 34.49860017778892, "ultimately targeting": 0.00035255784372806054, "targeting specific": 0.0008818539271019843, "specific effector": 0.0006531335233107661, "effector molecules": 6.630573488571092e-05, "different raf": 0.00033181791183180726, "erk1/2 scaffold": 34.498226059771106, "scaffold proteins": 34.4989058499876, "promising field": 0.00015241865194348618, "therapeutic strategies": 0.0015577229280439569, "strategies capable": 0.0007979786588641004, "selectively potentiating": 34.4982257094572, "adaptive response": 0.0009775519931748652, "cardiac amyloidosis": 34.503831182001605, "atypical case": 0.0005036891655554066, "the described": 0.026643990282410657, "described report": 0.0005477252936672091, "report deals": 0.0004279270277690989, "hypertensive cardiomyiopathy": 68.99665628045514, "cardiomyiopathy based": 34.499255544702386, "inducible myocardial": 68.99873074013391, "normal coronary": 34.499977821705656, "coronary arteries": 34.49938223210997, "typical amyloidotic": 34.498249914001, "amyloidotic pattern": 34.498288153641056, "final diagnosis": 0.0008097408839910055, "multiple myeloma": 34.49841040343571, "osteomedullary biopsy": 34.498225884903654, "measuring frailty": 0.00036817252978948734, "community perspective": 0.00021554791777525717, "each method": 0.00027658475708414, "recruited from": 0.00455076940114775, "frailty according": 0.0005719604700816514, "weak grip": 0.00019400066760521682, "physical exhaustion": 0.00025012249524606744, "low activity": 0.002407038645746682, "unintentional weight": 0.00045742810434459607, "intermediate frailty": 0.00044114116883173314, "deficits present": 0.0006685833836256517, "age 71": 0.0018131930064990492, "% intermediate": 0.018944635912552184, "intermediate frail": 0.0003050335076191521, "frail according": 0.0004358528088690703, "index ranged": 0.0018945055977232174, "patients categorized": 34.5169954975256, "death compared": 0.0048308324523541986, "unit increase": 0.0015236228920975975, "% increased": 0.02149712396103836, "both measures": 0.001776792046110402, "measures predicted": 0.0009281171446776799, "predicted death": 0.0024394560855501247, "death equally": 0.0024008661305343023, "phenotype equally": 34.498659113056, "equally predict": 0.000427976921863859, "predict mortality": 0.0045471764150864435, "routinely assessed": 0.0012863240883670178, "assessed clinically": 0.0013570107715231096, "feasible alternative": 0.00039272856504939037, "ascertain frailty": 0.0003045002211961254, "future of": 0.04393465736759326, "failure trials": 0.018780685643442558, "last decade": -0.00013300379627425956, "large phase": 0.000713490267088325, "phase 2": 0.002220683692576991, "pharmacologic studies": 34.49994339228315, "therapeutics including": 34.49899063321049, "including calcium": 0.000831755827429219, "sensitizing agents": 34.498488630771355, "pharmacologic management": 34.4995708801434, "changed little": 0.00024729485927475905, "rates remain": 0.0016342797150112288, "remain higher": 0.001990228332659415, "neutral results": 0.0012510226915805464, "many acute": 0.0022187786943802215, "studies including": 0.0023798208634797074, "appropriate timing": 0.0004916434574341974, "patient enrollment": 0.0026371441864855944, "selecting appropriate": 0.00046094857184601475, "appropriate end": 0.0025100520299166018, "describe lessons": 0.0001890881766144889, "lessons learned": 7.524651157139983e-05, "outline strategies": 0.0008090317456560213, "future trials": 0.0014767738141527413, "ambulatory setting": 0.0005902179445934855, "future perspectives": 0.0003576141589198567, "the measurement": 0.026946017385214405, "important tool": 0.0009517655299316375, "acute dyspnea": 34.50043418106211, "international guidelines": 0.00037935564712375167, "subsequent meta": 0.0005733855391995882, "routine np": 0.00013067809112417817, "used also": 0.002538950834617329, "guide treatment": 0.003733003710065062, "assess risk": 0.005275189522482226, "developing heart": 0.01891877355803607, "receiving chemotherapy": 0.0006308929494540486, "measurement together": 0.00045408178941672156, "potential contribution": 0.0009270665743592358, "several poc": 0.0002322130112011855, "produce test": 0.0008917746574249623, "test results": 0.002030889604098196, "results within": 0.0019233834732826321, "appear sufficiently": 6.12110743520839e-05, "sufficiently sensitive": 0.000161374713386954, "used routinely": 0.0019468370486798625, "diagnostic evaluations": 0.0007127954212139909, "community outpatient": 0.0002936044829798221, "time frame": 0.0012556163317934477, "patient consultation": 0.0025315553852836457, "appropriately designed": 0.00020521833292707302, "designed clinical": 0.003224562716946696, "potential benefits": 0.001186105001047892, "also important": 0.0014912635333657594, "take full": -8.249316746887192e-05, "full advantage": 0.00012609626381418772, "advantage of": 0.04365772855573518, "faster turnaround": 5.4550855032651165e-05, "turnaround times": 9.295199174824208e-05, "times provided": 0.00042671719075636737, "measuring heart": 0.01889895626709138, "failure care": 0.01960827594285724, "operationalized hospital": 34.49955222709638, "care outcomes": 0.005102987317556311, "publicly reported": 0.0002858922852078666, "reported 30": 0.0016816199455772867, "standardized mortality": 0.00431320074311093, "associated penalties": 0.0043184183208443685, "expected rates": 0.001573059006594746, "motivate hospitals": 0.0004667266991948706, "provide patients": 0.019198239988674193, "expected future": 0.00043039364797281185, "future expansion": 0.00038181870961440085, "inhibition halts": 34.498871820466995, "halts heart": 34.51699486312704, "modern society": 0.00010488264761499724, "pathological remodelling": 34.49870174695762, "involves cardiac": 0.005733871574529481, "robust predictor": 0.00043587199370783553, "subsequent hf": 0.00023363693558455046, "molecular level": 0.001116992133783168, "chromatin hyperacetylation": 68.99679237653902, "family bromodomain": 34.49829549506589, "family of": 0.043644725197473505, "lysine reader": 34.49822097240879, "reader proteins": 0.0007087323747816943, "promising targets": 0.00045920105101706287, "the remodelling": 34.52490022083011, "neuronal stressors": 68.996384060501, "these activate": 0.0019343791653104196, "transduction cascade": 34.498327620835624, "defined set": 0.000613461752638316, "cardiomyocytes occur": 34.49900111814373, "epigenetic changes": 34.499881819834, "histone acetyltransferases": 68.9964180900216, "histone deacetylases": 68.9964180900216, "implicated in": 0.03541689623195229, "cardiac development": 0.006680258479225253, "the group": 0.029172567357814445, "group utilized": 0.002736253944645113, "recently developed": 0.0013768321763830338, "developed first": 0.0017165361750355486, "class inhibitor": 0.0015523013753482985, "displaces bets": 34.4981920302505, "downstream signalling": 0.0003378308507157997, "bets in": 0.03531656213409528, "vitro model": 0.0016323358029784654, "neurohormonally induced": 34.49965234567858, "authors showed": 0.0012154696296157168, "nanomolar doses": 34.498361648619316, "significantly blocked": 0.0019531722990557185, "blocked phenylephrine": 34.49828832908701, "mediated hypertrophy": 34.49938271667776, "gene induction": 0.0008134595734188672, "containing protein": 0.000940737051520632, "highly expressed": 0.000463579190268927, "cardiac tissues": 0.005740538527173206, "expression profiling": 0.0010815007391757208, "cultured cardiomyocytes": 34.49873574058805, "cardiomyocytes in": 34.534018974408305, "drug abrogated": 34.498423200782135, "substantial subset": 0.0002280296148839944, "induced genes": 0.0017983095681574006, "vivo experiments": 34.49846214947959, "mice via": 0.0015015821396566435, "via phenylephrine": 34.498810274990625, "haemodynamic stress": 34.49879503948341, "surgical method": 0.00045884726872613127, "several pathological": 0.0005377612791861171, "including cardiac": 0.006403725190489509, "systemic blood": 0.0010941838274275866, "detailed transcriptional": 34.498226059771106, "transcriptional analysis": 34.50031377831063, "cardiac tissue": 0.005977847676417327, "vehicle revealed": 0.0004960117707294355, "inhibition suppresses": 34.498871820466995, "pathological cardiac": 0.005944700019090572, "expression programme": 0.0011893686793985215, "also found": 0.0015832878603494287, "further molecular": 0.0008436181829291943, "molecular analysis": 0.002426940803911656, "bets play": 0.00011048568895242408, "crucial role": 0.0012566968952677877, "mediated signal": 0.0005689889740550667, "factor networks": 0.0009268768450114904, "including nuclear": 0.0008201763986001037, "activated t": 0.00022592079383190655, "t cells": 0.0006266579188067651, "promoting transcriptional": 34.4982879787741, "transcriptional pause": 34.49825833540674, "pause release": 1.8760305353349997e-05, "pathological stress": 0.0007724428923430039, "study implicates": 34.50282289265483, "implicates epigenetic": 68.99648614732587, "epigenetic readers": 34.498333052792596, "cardiac biology": 0.005671076494123118, "gene control": 0.00252947380948475, "control via": 0.0024345907581532393, "dependent signal": 0.0007340081156742486, "potentially abrogate": 34.49858421222472, "abrogate pathological": 34.49849757851849, "mapping mri": 0.00026889110543349375, "breathing pulse": 0.0002674967975793668, "pulse sequence": 0.00026890036741879984, "quantify myocardial": 34.500776382082805, "t1 changes": 0.001587702758644075, "swine model": 0.0015979565474462342, "ventricularly paced": 34.498293241580164, "induce heart": 0.018869664371814424, "scanned twice": 0.0001864547820777754, "t mri": 2.227522026317225e-05, "mri scanner": 3.280197466737676e-05, "mapping sequence": 0.00040290267331794427, "chelate contrast": 34.49835392899129, "failure scans": 0.01766187688088511, "the percentage": 0.02672993946361859, "failure myocardial": 34.51816796023598, "similar left": 0.004682362260141288, "ventricular tissue": 34.50325528502082, "animals using": 0.001910926344620989, "using trichrome": 34.499776366430474, "trichrome blue": 34.4982129019077, "blue histologic": 34.4982129019077, "histologic analysis": 34.50027974879002, "failure t1": 0.01762925035257832, "\u00b1 96": 34.501114365965165, "\u00b1 94": 34.501046659553495, "agent administration": 0.00044832519350671246, "\u00b1 180": 34.50104560687593, "\u00b1 171": 68.99917256009407, "the animals": 0.026830612305131372, "animals with": 0.03135953162324037, "failure also": 0.018354323028928428, "difference histologically": 34.49888478553114, "collagen compared": 34.50091895493168, "the proposed": 0.02651541977273403, "mapping technique": 0.0004032535659318205, "quantify diffuse": 0.00027152685255948255, "diffuse myocardial": 34.500572564536554, "myocardial changes": 34.50212641264204, "changes associated": 0.005877705259222888, "failure without": 0.01864000630866695, "without breath": 0.0010363646425853297, "changes appear": 0.0016166381973648047, "traditional myocardial": 34.500618341422374, "myocardial delayed": 34.500636061396, "delayed enhancement": 0.00019803650313447946, "enhancement imaging": 0.00040482968769293753, "useful technique": 0.00039570939425852747, "detecting early": 0.0010742943033911394, "significant myocardial": 34.50257208213367, "myocardial fibrosis": 68.99893490857303, "new approach": 0.0007130066185406867, "assess exercise": 0.004633933520551002, "induced pulmonary": 0.002752701440169294, "artery systolic": 34.50152489282113, "possible measure": 0.0006042310025678942, "invasively diagnosed": 34.49856107537913, "diagnosed pulmonary": 0.0015933726785030918, "inoperable chronic": 34.50036387765921, "chronic thromboembolic": 34.50046596448407, "thromboembolic pulmonary": 34.49958650308746, "impaired right": 0.001898580731172592, "ventricular pump": 34.503321929492536, "pump function": 0.0032150625379649815, "stable targeted": 0.0007976769607597148, "targeted pulmonary": 0.001484978491116209, "hypertension medication": 0.0016630159351678276, "medication underwent": 0.0012538138726817991, "broad panel": 8.173799079744461e-05, "noninvasive assessments": 34.49839515295863, "including stress": 0.0012314680637419413, "stress echocardiography": 34.49927136767578, "groups according": 0.0017544060740659663, "factors predicting": 0.001342127979321789, "predicting survival": 0.001523408611835568, "median exercise": 0.004942530436990087, "high pasp": 0.0017218476483801903, "terms of": 0.04366245843830176, "resting hemodynamics": 34.49842794798637, "minute walking": 0.00043762361702393243, "walking distance": 0.000554261941436262, "model analysis": 0.0035841128644734065, "analysis adjusted": 0.003001941895972714, "kilogram remained": 0.0005973909260796099, "remained independent": 0.0010119941412970387, "prognostic markers": 34.49941584118753, "high clinical": 0.004774344899834974, "indicate right": 0.0016544291818925434, "useful tool": 0.00044692160667618767, "prognostic assessment": 34.499646626419796, "contemporary use": 0.001565000721176821, "improves symptoms": 0.001589978312933709, "most data": 0.0019650978044134667, "preserved systolic": 34.50264552424764, "interesting therapeutic": 0.000791838115006418, "therapeutic concepts": 0.0008125406684387263, "therapeutic functions": 0.0008763884244700187, "diagnostic features": 0.0006442044165684742, "early detection": 0.0010392126838421499, "alone diagnostic": 0.0008220599634818706, "diagnostic devices": 0.001342907883848304, "disease complex": 0.0035214271247389697, "challenging therapeutics": 34.49831446355463, "significant portion": 0.002060559949027056, "care budget": 0.0020148033194249356, "commoner among": 34.49943859783396, "among women": 0.0015390992460438515, "underlying hypertension": 0.0015625220200360544, "significant progress": 0.0021803581576726994, "lifesaving drugs": 34.49853773193268, "still poses": 5.820168829962877e-05, "poses significant": 0.002063542531142329, "significant challenges": 0.0020754659605854062, "response regulates": 0.0009098455816858657, "regulates cardiac": 0.00570633413915099, "cardiac sodium": 0.005910674551027109, "sodium current": 0.0008860480150670907, "systolic human": 34.50139668259968, "increases alternative": 0.0003846580469675143, "alternative mrna": 0.0002234610890612613, "type v": 0.0014974469859913265, "gated cardiac": 34.50386521152221, "channel \u03b1": 34.49865876216471, "generating variants": 0.00033361724578239067, "variants encoding": 0.0003376525103103235, "encoding truncated": 0.0001697972891466713, "nonfunctional channels": 34.49838795619605, "endoplasmic reticulum": 68.996384060501, "channels activate": 0.00026293288719987044, "electric remodeling": 0.0009740219788476934, "human ventricular": 34.50363860681284, "tissue samples": 0.0006717775756981549, "human induced": 0.002182333145406248, "induced pluripotent": 34.49965234567858, "pluripotent stem": 34.498255879159736, "derived cardiomyocytes": 34.49917579839797, "known activators": 34.49859787072228, "abnormal scn5a": 0.0003046710361041721, "kinase r": 0.000508493214005884, "like er": -0.00021351993326415076, "exogenous variants": 34.498461798587044, "variants induced": 0.0017300837646177394, "concomitant downregulation": 68.9965882318349, "downregulation of": 34.541971490908104, "perk activation": 0.0005096889210721311, "activation destabilized": 34.49870171917157, "transient receptor": 0.0015303049580755056, "receptor potential": 0.002196193098608144, "potential cation": 34.498925627118346, "cation channel": 34.49859070370249, "channel m7": 0.0003986734519863309, "perk inhibition": 0.0006797902164959024, "inhibition prevented": 0.0007774926212500938, "kv4.3 mrna": 0.0, "levels resulting": 0.001962784200740657, "entirely specific": 0.0006429576589343676, "multiple cardiac": 0.005857524936320857, "cardiac genes": 0.005977145891190019, "normal cardiac": 0.006302274627662064, "receives little": 0.0001688931165037117, "little attention": 0.00030552500707596293, "attention in": 0.03548283796719607, "medical literature": 0.0011681244629499004, "etiologic causes": 34.49841970202839, "failure often": 0.017965115255368556, "often differ": 0.0005379314591119431, "differ from": 0.0046525018596124505, "failure frequently": 0.01792988612698689, "frequently requires": 0.0005921483784732864, "requires diagnostic": 0.0008690683329765744, "routinely used": 0.0019468370486798625, "intrinsic left": 0.003806927721582173, "pathophysiologic mechanisms": 34.49856493519517, "mechanisms behind": 0.0002808046415495829, "distinct populations": 0.0003304644261379348, "chronic pulmonary": 0.0034642334208046894, "acute pulmonary": 0.0035005073031021787, "in chronic": 0.0374884095428037, "chronic pah": 0.0021718474087084167, "examine clinical": 0.003454679619113342, "clinical circumstances": 0.003073544353979805, "circumstances common": 0.0010414992676524596, "provoke acute": 0.002241625051270412, "pharmacologic therapies": 34.49853143953979, "failure management": 0.018871985636926956, "embolism represent": 34.498447242389865, "particularly high": 0.00199213149792156, "specific diagnostic": 0.001197711831178829, "contemporary trends": 0.00025749116278258254, "community study": 0.00475537485770633, "major changes": 0.002441398129476192, "recently occurred": 0.0009181537847684773, "epidemiology of": 0.04371123195968583, "possibly affect": 0.0003129198604581765, "affect outcomes": 0.0032791935405765533, "outcomes such": 0.003549384284089796, "data describing": 0.0014807992794731014, "describing trends": 0.00029380148228107955, "evaluated temporal": 0.0009843883304328945, "temporal trends": 0.00029678406936754103, "all residents": 0.0018338782349696645, "classified according": 0.0005007497635048503, "patient presentation": 0.0024624465630543675, "including fewer": 0.0010271484921750272, "fewer st": 0.000262575052791158, "elevation mis": 6.770872731223332e-05, "lower killip": 0.0017323053089458214, "comorbid conditions": 0.0004732045009128827, "first week": 0.0009004043674917888, "adjusted risk": 0.005481393862657254, "risk declined": 0.004964440393643145, "ratios of": 0.04415285373545243, "further adjustment": 0.0008762389227209399, "characteristics yielded": 0.0007111886202777225, "yielded hazard": 0.00217381375446976, "case mix": 0.0004891271661543986, "requires new": 0.0007247614112833507, "new prevention": 0.0006339117937009071, "prevention strategies": 0.0009775945428213513, "differential effects": 0.0016489131757997228, "versus selective": 0.00196495898220486, "selective beta": 0.0007122517174338013, "nonselective \u03b2": 68.99801685191673, "selective \u03b2": 34.49985709730187, "blocker metoprolol": 34.49971958231724, "metoprolol in": 34.53422309075479, "assessed whether": 0.0019362228364035654, "response correlates": 0.0009445763090215818, "correlates with": 0.031134854573971634, "various serum": 34.498690501395416, "serum factors": 34.499638156439694, "label crossover": 9.244018001973176e-05, "crossover study": 0.004663138039954626, "masked outcome": 0.0015197538924281095, "outcome assessments": 0.001622191610032084, "equipotent dosages": 68.996384060501, "wk periods": 34.49859474937634, "myocardial washout": 68.99876476965451, "included markers": 0.0015290421331628583, "markers of": 0.04398256541906946, "cardiac washout": 34.50386521152221, "metoprolol treatment": 34.5025118368194, "\u00b1 13": 34.50124835748812, "greater reduction": 0.0016342567522392823, "wk of": 34.54210759393815, "factor concentrations": 0.0009733618610209157, "haplotype status": 34.499189918677054, "prescribing guideline": 0.0007818787782995589, "often contextual": 0.0005726598702365912, "factors such": 0.001497255860737698, "competing priorities": 9.033482526036001e-05, "priorities impact": 0.0009736487948012382, "impact prescribing": 0.0010450407364194128, "performance measurement": 0.0010670469289480594, "measurement systems": 0.0007217530560548896, "veterans aged": 0.0004567262931533725, "aged 50": 0.0009525311862773399, "identified from": 0.005450208479198009, "clinic notes": 0.00024924523767891457, "primary care": 0.0031197587028943784, "care clinicians": 0.002080587812769078, "clinicians caring": 0.00013190794950769725, "these reasons": 0.002252536407780545, "classified using": 0.001785174612629352, "published taxonomy": 0.00012172437864571776, "receiving guideline": 0.0011759698129613179, "recommended drugs": 0.0007452523625085378, "review identified": 0.0018196491099483924, "identified biomedical": 0.001271646868688861, "reasons in": 0.03570172631821939, "clinician interviews": 0.00016137587675794544, "interviews identified": 0.001093264878899604, "identified twice": 0.0011534259833176626, "many reasons": 0.00039582158749842597, "mean 1.6": 0.001284210278441989, "reasons per": 0.0011325452669135804, "common contextual": 0.0012572471325737918, "clinician belief": 9.103662144625229e-05, "prescribing angiotensin": 34.499382250049024, "poorly documented": 0.0003671221642021186, "the structure": 0.026964951621802385, "structure of": 0.044070248325625574, "facilitate documentation": 0.00023171049820383804, "providing guideline": 0.0007222348219339415, "recommended care": 0.002378576270606161, "pyridostigmine prevents": 34.498463383393464, "prevents ventricular": 34.50301780042517, "elevated sympathetic": 0.0011537055720961136, "reduced parasympathetic": 34.50120749983937, "parasympathetic control": 34.500280603169884, "control of": 0.045493723324554966, "experimental evidence": 0.00122110013769488, "parasympathetic function": 34.50120592083057, "therapeutic alternative": 0.0010042524607661398, "parasympathetic neurotransmission": 68.99658822894014, "acetylcholinesterase inhibition": 34.4989058499876, "acetylcholinesterase inhibitor": 34.49849793346389, "inhibitor pyridostigmine": 34.49863404575658, "following myocardial": 34.500777940506175, "adult male": 0.000786995054207191, "pyridostigmine administration": 34.49861229051567, "per os": 0.0007812357359448857, "cardiac sympathovagal": 34.50386521152221, "tachycardic response": 34.49903469344414, "bradycardic response": 34.49903469344414, "conscious hf": 0.00013243255188451292, "pyridostigmine reduced": 34.501173473213534, "basal heart": 34.5170969499519, "increased vagal": 34.50101569715344, "sympathetic control": 0.0023933916157872145, "myocyte diameter": 34.49853108864702, "collagen density": 34.49849583100232, "surviving left": 0.003838676440302873, "also increased": 0.003446652754433049, "increased vascular": 0.003163575322815777, "factor protein": 0.0016841393978929205, "suggesting myocardial": 34.50070341575821, "myocardial angiogenesis": 68.99890088194721, "volume conductance": 34.49994819598717, "conductance catheter": 34.498430053342794, "catheter system": 0.0008127236674342048, "rats treated": 0.0019265880998770813, "pyridostigmine exhibited": 34.49870156977459, "higher stroke": 0.0023999292115004854, "term administration": 0.0014835553270705335, "pyridostigmine started": 34.498394083266405, "started right": 0.0015912696693804005, "artery ligation": 34.499042258189284, "ligation augmented": 34.49829376791943, "augmented cardiac": 0.0057408894200333335, "attenuating cardiac": 34.503831182001605, "mechanistic insight": 0.00012874818606516337, "prolonged electromechanical": 34.498394100280606, "computational study": 0.004664366164587779, "block type": 0.0016884604564911644, "aspects associated": 0.004517147941884923, "electromechanical behavior": 34.49828903087101, "altered ventricular": 34.503221961917085, "ventricular structure": 34.503377518576826, "sheet orientation": 5.7708874243352235e-05, "slowed conduction": 34.49825693183665, "reduced wall": 0.0031719156247552176, "wall stiffness": 34.49868875933407, "in dyssynchronous": 34.533746786870665, "time interval": 0.002759009265188293, "local myocyte": 34.49827707986969, "myocyte depolarization": 68.99652017510955, "shortening onset": 0.001121768099968015, "major hf": 0.0008536953708321171, "dyssynchronous failing": 34.49879575168535, "heart remain": 0.018969108709637653, "remain unknown": 0.00043042989718235106, "combined contributions": 0.0004923452317961847, "induced remodeling": 0.00241276396831467, "used mri": 0.00181387815826722, "based models": 0.0023015400906417948, "dyssynchronous nonfailing": 68.99662225498707, "canine electromechanics": 34.498259037192156, "constructed additional": 0.00030888411580308743, "additional models": 0.001414301756514344, "varying combinations": 0.0001994377558447696, "block electrical": 0.0003206388859063002, "activation sequence": 0.0006437004889565816, "the simulation": 0.026605233470142375, "simulation results": 0.0012868060964188513, "results revealed": 0.001600395997331744, "primary culprit": 0.001174061426457373, "remodeling contributing": 0.0010485719307961668, "contributing insignificantly": 34.498288153641056, "slows myofiber": 68.99652017510955, "shortening velocity": 0.0008499638639848338, "activated septum": 34.49846373428629, "stretch rate": 0.002558316025621365, "activated lateral": 0.00023714933383324062, "lateral wall": 0.0003941182352846875, "these changes": 0.00345507498230051, "myofiber dynamics": 34.49842619815602, "dynamics delay": 0.0002943301340503256, "thus giving": 0.00022468299397435367, "giving rise": 7.278299211045805e-05, "prolonged emd": 0.0001340115678844505, "relationships between": 0.002709757314186785, "previous studies": 0.0017150472577495608, "studies investigating": 0.0016412070020978438, "related cachexia": 34.49944786980807, "abnormal body": 0.0012972278832365765, "worsened prognosis": 0.000781868359770979, "underwent prospective": 0.0013230877228639414, "prospective assessment": 0.0010779442695126973, "skinfold thickness": 34.49836182406575, "comprehensive echocardiography": 34.49883201164196, "blood testing": 0.0013868933025332798, "circulatory assist": 0.0011129564470980919, "lower body": 0.0027248621560782256, "display cachexia": 34.498442850480636, "the extent": 0.026663815533350264, "dysfunction correlated": 0.0030261299543606407, "greater antecedent": 0.0004867206177548734, "antecedent weight": 0.0004912821785172488, "mass ratio": 0.003983062115281666, "increased body": 0.0037141369252153443, "lower event": 0.0022081190365393017, "hr per": 0.0007473810827894702, "higher fat": 0.002225783975372839, "cachexia often": 34.49876608963936, "often coexist": 0.0003693686630547435, "additive adverse": 0.0012214595386641782, "adverse impact": 0.002028996574571046, "mechanistically interrelated": 34.4982257094572, "adverse outcome": 0.0025726454247631063, "fat loss": 0.0006696591203675718, "enhanced catabolism": 34.49842531629396, "typically exertional": 34.49828534708677, "filling time": 0.001699701877173024, "controlling heart": 0.018901587958116448, "ivabradine 5": 34.49923748641445, "mg twice": 0.0007292786268619546, "twice daily": 0.0002590668342357608, "blind trial": 0.0013246941211068589, "echocardiographic assessment": 34.49937448517807, "the ivabradine": 34.525104368429005, "group demonstrated": 0.0036818276765082534, "mets vs.": 0.0009859360956047405, "\u00b1 1.9": 34.501013156371876, "\u00b1 6.1": 34.50101420905027, "kg vs.": 0.0020688224649905982, "\u00b1 3.3": 34.501013682711005, "simultaneous reduction": 0.0012826026962338012, "induced increase": 0.0028699275295095833, "\u00b1 2.7": 34.5011161204287, "work load": 5.923236841799025e-06, "corrected chronotropic": 34.49822483222517, "chronotropic response": 34.49903469344414, "time at": 0.004044524705163744, "slower increase": 0.0014411859519017263, "treated group": 0.003916922117822127, "exertional increase": 34.49963567187254, "independent correlates": 0.000618253999526189, "independently correlated": 0.0011870252042587045, "term treatment": 0.004838745073898306, "ivabradine increased": 34.50132192636661, "increased exercise": 0.006647494582353586, "improved left": 0.004949395616528714, "pressure response": 0.0026094948494815046, "therapeutic treatments": 0.0010496824771383721, "treatments targeting": 0.0005305889302685071, "targeting abnormal": 0.0005663688609391854, "abnormal exercise": 0.004230585540374817, "exercise hemodynamic": 34.502356139240845, "prove useful": 0.0002806395836819012, "simple validated": 0.0003474734725336495, "validated clinical": 0.003255265593065804, "treatment implications": 0.0037689613977938473, "undergo coronary": 34.49938047764644, "a derivation": 0.012921644489968853, "undergone coronary": 34.49938012675392, "primary diagnosis": 0.0018522610501086711, "using multivariate": 34.50011663558419, "% diameter": 0.018978487670927024, "diameter stenosis": 34.4985991424776, "left main": 0.003902690065389018, "descending artery": 0.0009512638220542281, "defined prediction": 0.0011114341460443052, "prospectively validated": 34.49853091320066, "separate cohort": 0.0015459346676593355, "cohort recruited": 0.0015283981913171607, "including 15": 0.001208120155850756, "included diabetes": 0.0022371029146924667, "ratio 5.1": 0.0029419792644684024, "electrocardiographic q": 34.498226059771106, "q waves": 2.4731458001885052e-05, "ratio 3.8": 0.0028390152077976236, "nondiabetes risk": 34.5027592007567, "tobacco use": 0.0015981530121378991, "ratio 4.8": 0.002874097406618375, "a prediction": 0.013295053775277836, "predictor identified": 0.001339346333099711, "identified 97": 0.0010655519932513016, "prospective validation": 0.0005409194041283943, "validation cohort": 0.001495071035114141, "simple clinical": 0.0031972023823774115, "accurately identify": 0.0005908832251767454, "substantial proportion": 0.0002560928072774607, "potentially significant": 0.002425554224492322, "significant cost": 0.0024393881623438344, "cost savings": 0.00046267154386775655, "risk avoidance": 0.004599972480869246, "unique indication": 0.00033712222535924556, "japanese heart": 0.01880283287653686, "vasopressin type": 34.49985961904979, "severe hyponatremia": 34.499575912101605, "optimal diuretic": 34.49876856976924, "serum sodium": 34.49883784593569, "sodium levels": 0.002005056212169282, "newly introduced": 0.0002097821046934768, "introduced drug": 0.00028203647110910664, "use in": 0.03685332248098236, "frequently administered": 0.0003327359637255128, "relieve congestive": 34.49917708911423, "congestive symptoms": 34.50005605425323, "widespread use": 0.0015648252752159509, "prospective data": 0.001890161048159276, "related morbidity": 0.0014254417170355487, "diuretic efficacy": 34.499007254126354, "adverse neurohormonal": 34.49934560677336, "neurohormonal activation": 34.49876977763379, "risk patient": 0.006933669124646754, "treatment options": 0.003755452108600387, "an estimated": 0.00442096707378024, "estimated 5.1": 0.0007233060009576106, "heart failure.(1": 34.51699486312704, "with therapies": 0.031236236139329958, "therapies ranging": 0.0003320428668045515, "physical therapy": 0.003205895162535969, "implantable defibrillators": 68.99723466306193, "possibly transplantation": 34.49886010032137, "accurate risk": 0.00462768594218834, "therapies appropriate": 0.0005640846010428096, "disease severity": 0.003269914362694829, "becoming increasingly": 0.000100678631528892, "increasingly important": 0.0008521384081885498, "associated treatment": 0.007895310699280202, "brief review": 0.0009138939742687843, "regulated in": 0.03541759801736472, "human failing": 0.0010875446661066479, "blunts beta": 34.49883797681169, "adrenergic responses": 34.498664384537136, "study investigated": 0.005000950946671663, "investigated whether": 0.0011529461807975804, "myocardial phosphodiesterase-2": 68.99873074013391, "mediated effects": 0.001819736513471218, "diminished cyclic": 0.00013489111541959027, "cyclic adenosine": 34.49829394394487, "adenosine monophosphate": 68.99645211954221, "augmented cyclic": 0.00016962184269329934, "cyclic guanosine": 34.49825991442427, "guanosine monophosphate": 68.9964180900216, "unique property": 0.0001638134141183285, "thus leading": 0.0004486666177881028, "remarkable increase": 0.001469601200048757, "camp hydrolysis": 34.4981920302505, "hydrolysis mediating": 68.996384060501, "negative cross": 0.0003097595306317896, "camp signaling": 0.0005782575146321135, "fluorescence resonance": 34.49856597861093, "resonance energy": 0.0006628181465009185, "energy transfer": 0.00037779990549922796, "based assays": 0.001165427567266587, "video edge": 0.0001332952665048197, "edge detection": 0.00022083518548264027, "epifluorescence microscopy": 68.9964180900216, "current measurements": 0.0007829154593299442, "myocardial tissues": 34.50064009665947, "experimental hf": 0.00016856569051412523, "fold higher": 0.002025141824615197, "advanced human": 0.0015622452337316955, "stimulation via": 0.0009225556209408838, "via catecholamine": 34.498742216528406, "catecholamine infusions": 68.996384060501, "rats enhanced": 0.0009114972428510105, "camp hydrolytic": 34.4981920302505, "hydrolytic activity": 34.49898982018863, "blunted cardiac": 0.005672830957807683, "cardiac \u03b2": 34.505429943896736, "in diseased": 0.035451801826397414, "higher pde2": 0.0018239524995586228, "cgmp synthesis": 34.4981920302505, "synthesis via": 34.498742216528406, "via nitric": 34.49877624604901, "oxide donors": 0.00013383843702345177, "specific pde2": 0.000620156102266971, "inhibition partially": 0.0009151816136103211, "partially restored": 0.0002997666447421489, "restored \u03b2": 34.49985516739326, "overexpression in": 34.53361067920945, "healthy cardiomyocytes": 34.49902461631178, "cardiomyocytes reduced": 34.50151371342395, "camp levels": 0.0017335334122478125, "current amplitude": 34.498840584986254, "effect following": 0.0014649751730295142, "following acute": 0.0024473519137805035, "affecting basal": 34.498391994926216, "basal contractility": 68.99662226193442, "overexpressing cardiomyocytes": 68.99696250098694, "cardiomyocytes showed": 34.49979123906661, "showed marked": 0.0012493219676644903, "marked protection": 0.0002452146113926613, "induced hypertrophic": 34.49968637519918, "hypertrophic responses": 34.4983921692144, "important defense": 0.0007902205324985364, "defense mechanism": 0.0004967140145096711, "cardiac stress": 0.006106046375463712, "antagonizing excessive": 6.542850362057992e-05, "excessive \u03b2": 34.499822365996096, "activating myocardial": 34.500708679145106, "myocardial pde2": 34.5005387098834, "novel intracellular": 34.498692771424444, "intracellular antiadrenergic": 68.996384060501, "antiadrenergic therapeutic": 34.4989728216222, "analyses of": 0.04408481032374916, "study subgroups": 34.50312913749817, "mild patients": 0.01924211514712988, "enrolled patients": 0.019243518716846184, "receiving optimal": 0.0008339982898193899, "cardiovascular reason": 0.0019911651667259716, "reason within": 0.0007230452804857385, "inducing hyperkalemia": 34.49866822351566, "specified analysis": 0.0021549009275626794, "subgroups of": 34.54210759393815, "patients \u2265": 34.51706355367193, "pressure <": -0.003011107576320258, "< median": -0.003761323299441805, "major safety": 0.001599573229142347, "safety measures": 0.0015426151277445521, "hyperkalemia leading": 34.49885694271175, "drug discontinuation": 0.00029905470540160067, "risk subgroups": 34.50306544560004, "study medication": 0.005035501016615539, "medication due": 0.001015830457115681, "primary composite": 0.0016500711408894675, "composite endpoint": 0.0006793072899823948, "meeting specific": 0.0006322490796691755, "specific inclusion": 0.0008557229456188476, "carefully monitored": 0.00012664456484113472, "developing hyperkalemia": 34.498750309544, "a comparison": 0.012948655585464834, "when treated": 0.0014043704824145515, "status in": 0.036212363735791654, "prevalence ranging": 0.0004667423261495427, "significant gaps": 0.0020984492826328833, "induced changes": 0.003048018186717096, "measured using": 0.0024645444847655926, "group effects": 0.004046111039617889, "estimated using": 0.002172402488626662, "using linear": 0.0017871045215822052, "linear mixed": 0.0003306392987196512, "mixed models": 0.001365896595864904, "models according": 0.0015379369696029562, "treat principle": 0.00015155090382571758, "baseline kccq": 0.0017335691230979159, "significantly correlated": 0.002570878485958238, "baseline hrqol.": 0.0017335691230979159, "subscales relative": 34.498626130420774, "action cohort": 0.0015348736265781073, "baseline hrqol": 0.0017335691230979159, "cost analysis": 0.002493734451590817, "control vs.": 0.0028703405758549465, "vs. rate": 0.0035161871928972377, "similar efficacy": 0.0014856167957777665, "efficacy outcomes": 0.0037009911170608817, "economic impact": 0.0010785257098079352, "strategies in": 0.03609349369043436, "province of": 0.04365720222154718, "care expenditures": 0.0020790087955220495, "control treatment": 0.005489712678951595, "payer perspective": 0.00012453922465670546, "perspective using": 0.0016753716443633831, "minimization approach": 34.49847178806182, "trial resource": 0.001356265664468524, "resource utilization": 0.0002606538268071666, "unit costs": 0.0004725075969880736, "databases supplemented": 0.00037255868317552445, "specific costs": 0.0009786529085940088, "\u00b1 9": 34.5012488838175, "n =": 0.008510444611464616, "= 149": 0.0070950612212379955, "related costs": 0.0013761418778233537, "costs accounted": 0.0003891934256809779, "total expenditures": 0.0009680647719238965, "control patients": 0.020619813293132328, "fewer cardiac": 0.005901726803896798, "cardiac procedures": 0.00607483093377706, "fewer cardioversions": 34.498454605303294, "lower costs": 0.002090802115272859, "costs related": 0.0013761418778233537, "offset by": 0.005482587765541372, "higher expenditures": 0.0019239357048017513, "expenditures due": 0.0007111750500665424, "hospitalizations for": 0.013678741460837016, "noncardiovascular diagnoses": 34.49825956353137, "cardiac arrhythmia": 0.005774917782674656, "arrhythmia devices": 0.0009011181865054617, "noncardiovascular drugs": 34.498571761453285, "total cost": 0.0012740974787542555, "cost per": 0.0011533969948629577, "strategy used": 0.002095741300524126, "failure appears": 0.017772551930036573, "little influence": 0.0002611549843831511, "overall financial": 0.00017907254623837496, "financial burden": 0.0001927572585378053, "remains substantial": 0.0004697128578601715, "perturbations in": 34.53357665084681, "muscle sarcomere": 34.49880133469813, "sarcomere structure": 34.49868698925243, "restorative effects": 0.0014114204754404245, "demonstrated recently": 0.001328983447919377, "improves skm": 0.0006785620919709293, "skm mitochondrial": 34.49897456277385, "improved mitochondrial": 34.500150183536235, "treadmill testing": 34.49872083580254, "maximum oxygen": 0.0005602039610522139, "skm biopsies": 34.49826008871272, "blot analysis": 0.002155602713282935, "electron microscopy": 34.49825991442426, "report severe": 0.0017916390028408539, "severe perturbations": 34.499643970563824, "components of": 0.043737891584548015, "associated protein": 0.005135668836985168, "protein complex": 0.0011636597010218409, "induced recovery": 0.0016164244674045107, "- ordinated": 0.04544807060860102, "ordinated fashion": 4.455050161144574e-05, "skm growth": 0.00033095258546166984, "differentiation consistent": 0.0003657162859253079, "myofibre regeneration": 34.498225534010764, "~24 %": 34.51696757413345, "reach statistical": 0.00023082825484217856, "statistical significance": 0.00029591030461638846, "initial results": 0.001342054696610283, "results warrant": 0.0012106771161113246, "rigorous investigation": 0.00016820858224344076, "pure epicatechin": 34.498320428702904, "novel means": 0.0005791370407034484, "improving muscle": 0.0008718754478769882, "muscle function": 0.003384997067960276, "cardiomyopathy in": 34.534052995246064, "versus biomedical": 0.002170527518744913, "major databases": 0.001125042724346831, "overall effects": 0.0015243762852501519, "most adverse": 0.0016343672793703902, "events observed": 0.0024255870655335234, "resolved without": 0.001040575344716112, "without special": 0.0010672289543266172, "special treatment": 0.0036617811969393765, "term follow": 0.0033601951585361255, "systemic adverse": 0.001287584616963496, "events evaluation": 0.002025046213832258, "ethnic groups": 0.0014809806585955646, "still required": 0.00025920193906364176, "aimed at": 0.003243886570123803, "activating factor": 0.0010084423231949506, "matched apparently": 0.0005289815567733482, "apparently healthy": 0.00034395292156373284, "key biosynthetic": 34.49837830020131, "paf acetyltransferase": 34.4981920302505, "acetyltransferase [": 68.99964825707733, "glycerol cholinephosphotransferase": 68.996384060501, "catabolic isoenzymes": 68.9964180900216, "associated phospholipase": 34.50248203275108, "lower median": 0.002748921241665263, "median activities": 0.0010578324222349166, "activities of": 0.04365053533382023, "higher activities": 0.0018651689890740977, "at follow": 0.004976006646889011, "levels marginally": 0.0018012421395600458, "marginally increased": 0.0027892888053951733, "remained downregulated": 34.498687683507654, "elevated compared": 0.003167474678606537, "diagnosed patients": 0.01903639547928894, "drug treatment": 0.0038364787303373843, "affected profile": 0.00019399206261396665, "update on": 0.003391022387284481, "exercise parameters": 0.004264610429582333, "hallmark feature": 0.00011418796840231127, "prognostically important": 34.498958221107515, "widely accepted": 0.00011260890576854329, "accepted peak": 0.001132506237063941, "exercise oscillatory": 34.50211794475477, "oscillatory ventilation": 34.498225884903654, "partial pressure": 0.0019680209808975637, "pressure of": 0.04537615050014575, "gain attention": 0.00022170334694144325, "also discussed": 0.0008846906236585376, "different mechanisms": 0.0006366643942816164, "mechanisms underlie": 0.0003387011356052245, "important contribution": 0.0009596605635300144, "peripheral abnormalities": 0.0006445950860028398, "different pathophysiological": 34.49855787768294, "multivariate assessment": 34.499136331211254, "aforementioned parameters": 0.00037026977577685216, "prognostic purposes": 34.499064343496755, "orthotopic heart": 0.01880283287653686, "optimal treatment": 0.003943653231368863, "institutional experience": 0.0001573226358202905, "procedures within": 0.0011734678891960114, "recipients bridged": 34.49842689820377, "bridged to": 34.517338180594955, "including intravenous": 0.0009343672546388816, "intravenous inotropes": 34.49839585358636, "the interval": 0.028067755064055917, "interval from": 0.0060141682268650964, "require consultation": 0.0001820686306771127, "inflammatory abdominal": 0.00042411714837588586, "problems occurred": 0.0007269819405897797, "per cent": 0.0006822863798367049, "deaths occurring": 0.0003904390885393242, "occurring within": 0.0008040938627661355, "in summary": 0.03548354880819392, "largest series": 7.295202902038839e-05, "undergoing oht": 0.0004391881035764636, "oht bridged": 34.498226059771106, "with similar": 0.031941528864584845, "similar incidence": 0.0013142786954813176, "refractory right": 34.49995555715641, "arrest in": 0.035398825342396585, "cardiopulmonary resuscitation": 0.0003737787032079903, "wall infarction": 34.49977734284169, "cardiac centre": 0.005739477914699632, "catheterization showed": 34.4994509988562, "thrombotic obstruction": 34.498225534010764, "right coronary": 34.500874057295874, "after percutaneous": 34.501728864528275, "coronary revascularization": 68.99764284368814, "hemodynamically stable": 34.4988992015571, "stable situation": 0.0006327918195286003, "intensive care": 0.0020770788872468307, "care unit": 0.0020930363809399566, "patient became": 0.0023931532988925395, "hemodynamically unstable": 34.49832604181838, "therapy refractory": 34.501385124224356, "decided within": 0.0007307647520810332, "extra corporeal": 34.498203603327255, "corporeal membrane": 34.498464079389734, "the extracorporeal": 34.52479813921584, "extracorporeal support": 34.49955100800693, "emergency cardiac": 0.005961180343788378, "intermediate care": 0.002148117619875685, "extracorporeal life": 34.499529226657266, "life support": 0.0024920005134766252, "feasible und": 34.49836129772649, "und effective": 34.4990229591734, "bridging therapy": 0.003022604741427105, "acute ischemic": 34.501250715903765, "ischemic right": 34.50060195307954, "successful reperfusion": 34.498402157550075, "reperfusion therapy": 34.50118095578522, "half of": 0.04360931884430476, "values observed": 0.0011336977959576593, "early research": 0.0013441991228370323, "research focused": 0.00048688138255192204, "multiple non": 0.0012193512194225889, "- diastolic": 34.54540953974471, "diastolic abnormalities": 34.50030034571794, "function also": 0.003534794817288017, "also contribute": 0.0010525400675709088, "frequently challenging": 0.0003890395579334942, "relies upon": 0.00010752106457728108, "careful clinical": 0.0031486206420093016, "clinical evaluation": 0.003356115609810115, "invasive haemodynamic": 34.49846303365859, "haemodynamic assessment": 34.49893217666609, "principal mechanisms": 0.00036448468955669916, "diagnostic approaches": 0.0008795950716823566, "novel treatment": 0.0041060493726432085, "hold promise": 5.384231302580884e-05, "mortality outcomes": 0.00733595114072751, "based study": 0.005694376856208793, "first acute": 0.0028635262784024247, "advances in": 0.03538146372025114, "beneficial impact": 0.001416162852956041, "deaths attributable": 0.0004258716012254743, "western australian": 0.0, "administrative health": 0.0012397680551204783, "health data": 0.0025933958539379495, "identify 20": 0.0011880284790814037, "aged 40": 0.0009379844828493644, "temporal incidence": 0.00047322457036173864, "death associated": 0.006598078710885581, "comprised 75": 0.00029257568266243965, "day case": 0.0017941262627630896, "declined marginally": 0.0004649786147535085, "without concurrent": 0.0011123181785787863, "rate declined": 0.0029275209847337723, "occurrence of": 0.043641945372611554, "index ami": 0.0018278495488062343, "encouraging declines": 9.226473319698457e-05, "common problem": 0.001093935678363496, "increased attention": 0.002887855911183732, "needed given": 0.00035656852481272955, "term prognosis": 0.0019477719540931995, "blind randomized": 0.001183061227915508, "controlled feasibility": 0.0004302530950477134, "feasibility study": 0.004697343006894618, "week program": 0.0006519056435570292, "program of": 0.04401622510776652, "without intramuscular": 34.49920278620659, "intramuscular testosterone": 34.49846320215762, "collected preliminary": 0.0002873134693373343, "preliminary data": 0.0015476284609282243, "age 67.2": 34.49987314159739, "range 51": 0.000599663867795451, "mean \u00b1": 34.50209810434028, "\u00b1 sd": 34.50098052984357, "sd testosterone": 0.00027117190712334883, "testosterone levels": 0.0020047053193711613, "\u00b1 2.6": 34.501012454586586, "randomly allocated": 0.00033501676332179145, "placebo groups": 0.002202321427268389, "intervention compliance": 0.0007007127911554229, "incremental shuttle": 0.00013383843702345177, "% compliance": 0.019075302427637924, "similar improvements": 0.0013435648052232596, "testosterone group": 0.002939717124456229, "group showed": 0.003757372009732797, "showed improvements": 0.0015238041916289012, "leg strength": 0.0004127027427436928, "several medical": 0.0012700102749943758, "form quality": 0.0018347287253696828, "life domains": 0.0014038507187642134, "mostly unchanged": 0.0002180292243258396, "first time": 0.0018506813290104598, "positively impact": 0.0010429353803672221, "elderly male": 0.0006184467241117494, "peripheral muscles": 0.0004353456545332965, "muscles improves": 0.0007748609284863176, "improves endothelial": 34.4992789083805, "emotional stress": 0.0005603863273504124, "impaired systolic": 34.50101388714674, "fraction 63": 0.003972356384498508, "training protocol": 0.0011737543149960574, "included 6": 0.003068933921661786, "rated depression": 0.00012489010277259385, "depression scores": 0.0005617898962052802, "dilatation diameter": 34.498803290076495, "peptide also": 0.0016094916917713921, "also declined": 0.0011223425637913842, "tendency toward": 0.00021714852061129275, "toward lower": 0.0019182308715822562, "lower mitral": 34.501047004138044, "mitral e": 34.49955376430568, "wave ratio": 0.002966708410611073, "also improves": 0.0014036347683210383, "effective evidence": 0.0018834633700837238, "based therapies": 0.0012668091326249091, "factor beta": 0.0014844196226788237, "dependent yield": 0.0006712141881578401, "functional decline": 0.002052832982336642, "atrial explant": 68.9975067811616, "kit+ cells": 0.0006043826985435929, "cells isolated": 0.0011454613416100401, "derived cells": 0.0010777688223051842, "cells modestly": 0.0008083791650032362, "modestly improve": 0.0009840665553221197, "cardiac functions": 0.00573474880387078, "full potential": 0.0008112834202286396, "for instance": 0.013326191092566737, "potential candidates": 0.0007492051723093816, "cell therapy": 0.0035217582241532774, "therapy suffer": 0.0030152360042943784, "disease affects": 0.0032676335616056555, "derived progenitor": 0.0006091521553306075, "explant c": 34.4986647319561, "kit+ progenitors": 34.4981920302505, "elucidate mechanisms": 34.49849687673295, "mechanisms of": 0.043914165326754566, "descending coronary": 34.499415734712365, "artery occlusion": 34.499212400002584, "operated animals": 0.00042288900116519324, "developed infarcted": 34.499355248263, "infarcted animals": 34.49862070724001, "ventricle end": 34.500783630972116, "pressure \u2265": 34.500094976514895, "scar size": 0.00031378790411239167, "size \u2265": 34.4986084290029, "atrial explants": 68.99743872385736, "explants produced": 34.49844267850972, "produced less": 0.000983160473807375, "less c": 0.0011371566159316447, "sham explants": 34.498565457481895, "cells exhibited": 0.0009437804093292844, "exhibited upregulated": 34.498565457481895, "upregulated transforming": 34.498292364927345, "increased level": 0.0034993499474717817, "diminished expression": 0.0011155302597859107, "pluripotency markers": 34.498599306345874, "markers compared": 0.0028960028168121344, "intervention with": 0.03143389570506349, "\u03b2 signaling": 34.500369049660264, "\u03b2 receptor": 34.5012533883764, "receptor type": 0.0029600432167545985, "using small": 0.0018121631964430427, "molecule inhibitors": 0.00071383999618716, "inhibitors improved": 0.0017875476431877947, "cell yield": 0.0005968570447806649, "attenuated epithelial": 68.99648614848383, "pluripotency marker": 34.49825903719215, "improved efficiency": 0.0013024390452505584, "cell differentiation": 0.0006342194654957822, "differentiation toward": 0.0002873123387040012, "toward cardiomyocyte": 34.498411985333746, "like cells": 0.0003908627652794421, "taken together": 4.241878502809274e-05, "\u03b2 inhibition": 34.50047058236213, "inhibition positively": 0.0007792470829338688, "positively modulates": 0.00016734104020357172, "cell phenotype": 34.4990991558252, "optimizing cardiac": 0.005672830957807683, "cardiac progenitor": 0.005774917782674656, "progenitor function": 0.002945488172506924, "cell expansion": 0.0005893128757541141, "expansion protocols": 0.0001578669623934647, "heart beat": 0.018986302212423842, "a protocol": 0.013021624221490065, "originally designed": 0.00023100188977199203, "study breathing": 0.004763470402368289, "breathing control": 0.0020170124782952236, "following cardiac": 0.005878382373880237, "taking advantage": 4.8748138407061014e-05, "pulseless ventricular": 69.00110861934601, "ventricular fibrillation": 69.00178909977174, "newly implanted": 0.00039658836462443266, "implanted cardioverter": 34.499144200820105, "a patient": 0.015220258934648134, "patient aged": 0.002793931861221872, "class iii": 0.0012804276825667013, "originally part": 5.3642351180774286e-05, "study displayed": 0.004691377840309743, "displayed permanent": 8.665045976465814e-05, "permanent periodic": 5.9112444821982883e-05, "final data": 0.0015144615321826581, "data analysis": 0.003503967125202196, "incidentally produced": 0.0002502979453162215, "ascending phase": 0.0002955524779904288, "pb cycle": 5.64801863258983e-05, "recovery period": 0.0010201554430762168, "low bp": 0.0016092487076131735, "pb characteristics": 0.0006785620919709293, "this occurred": 0.003269409397469563, "occurred despite": 0.0009744586900859496, "profound change": 0.0008433393139780089, "cerebral blood": 0.0009249192457732575, "carotid bodies": 34.49827762691157, "primary oscillations": 34.49936679288372, "oscillations originating": 34.498259212638544, "central pattern": 0.00027713650270812983, "pattern generator": 0.00012910081159831337, "antiplatelet drugs": 34.49863981875754, "treating heart": 0.018935089982275815, "new options": 0.0005833927171176325, "much work": -0.00013987088129376675, "work remains": 0.0003254899188538356, "establish efficacy": 0.0006312287864246608, "additional progress": 0.0003232620251604225, "including better": 0.0012217765596780014, "better tools": 0.0005440278969606909, "tools for": 0.01339144243062725, "clarity regarding": 0.00025503493107743006, "vascular diseases": 0.0006026658656346334, "increasingly recognized": 0.0001808428204344857, "multisystem disease": 34.50139546401062, "important comorbidities": 34.49919641559359, "autonomic dysbalance": 34.498464079389734, "recent findings": 0.0009018411872212691, "increasing evidence": 0.0013363274780750084, "evidence points": 0.001301589767525952, "intestinal morphology": 34.49839550385143, "absorption function": 0.0028435767940933237, "functional abnormalities": 0.002206482892436398, "abnormalities of": 0.04391486711228969, "different gastrointestinal": 0.0005017871735401916, "gastrointestinal regions": 0.00026118017161468195, "intestinal dysfunction": 0.0024815701692359497, "disturbed intestinal": 0.00013313607280141426, "intestinal barrier": 0.00013296062653273086, "chronic inflammatory": 0.002494577781016736, "inflammatory state": 0.0003925147995730019, "anabolic imbalance": 0.0001008615948094004, "terminal stage": 0.0012778392445307388, "particularly poor": 0.0005435502377657854, "review highlights": 0.0008467127410770642, "nutritional abnormalities": 0.0003720288705562778, "including fat": 0.0011664049151980853, "the regulation": 0.026665394544087048, "nutritional strategies": 0.0008434121589104247, "potentially anti": 0.00046602385287396143, "- inflammatory": 0.045737472667067416, "inflammatory effects": 0.0017002961945933284, "the gut": 0.026536648668788358, "role for": 0.014336449898207775, "dietary interventions": 0.0008811625117147876, "crucial target": 0.0005707417771775026, "failure research": 0.01800001560891724, "diagnostic role": 0.0016093879731589405, "stable coronary": 34.49991978331084, "terminal fragment": 0.000743979020747633, "ventricular wall": 34.503277203570526, "reliable diagnostic": 0.0007073565902330184, "prognostic biomarkers": 68.99760891774852, "diagnostic roles": 0.0006028135239643717, "great number": 0.00023654811142950535, "stable cad": 0.0006050844817397784, "limited amount": 0.0006170017618430372, "recent data": 0.001922749785106387, "data is": 0.007354490035614142, "thus providing": 0.0002680110346679277, "providing prognostic": 34.49908451287889, "unfavourable clinical": 0.0030861764581568266, "denervation improves": 34.498904621863076, "improves autonomic": 0.0009506112312058985, "balance in": 0.03550389125622868, "conscious rabbits": 0.00026819858345352896, "a hallmark": 0.012955497985130942, "tone resulting": 0.000565315020470859, "autonomic imbalance": 0.0003390560808889541, "symptomatic improvement": 34.49961214533333, "protective mechanisms": 0.0005070884850709797, "mechanisms remain": 0.00047112231555060114, "remain unclear": 0.0005005856047801912, "used conscious": 0.001946310710151733, "chronically instrumented": 68.996384060501, "white rabbits": 0.00017575441261182153, "rabbits undergoing": 0.0005749541351454797, "undergoing renal": 0.0017655822266082538, "dnx prior": 0.0003572810175592594, "treatment groups": 0.005059802941920673, "nonpace dnx": 34.498226059771106, "pace non": 0.001058861784709396, "examined several": 0.0007715371931994848, "several markers": 0.0006054595859658883, "markers indicative": 0.000541812265278828, "time domain": 0.0012913997321684593, "domain heart": 0.01889895626709138, "power spectral": 3.17312840582114e-05, "spectral analysis": 0.0021552518203920255, "ratio in": 0.03812330170626155, "normalized to": 0.019214033939232596, "rate response": 0.0033729142909330132, "intravenous bolus": 34.49839585358636, "intravenous metoprolol": 34.499076322435954, "rabbits compared": 0.0026585222736164476, "intravenous atropine": 34.49842988252797, "also prevented": 0.0008227750811043003, "circulating plasma": 0.0007121144734609356, "suggest renal": 0.001822398270581335, "dnx improves": 0.0006785620919709293, "reduces morbidity": 0.0005079552970818263, "chronic systolic": 34.50284651229106, "wide qrs": 4.314637578270806e-05, "mechanical dyssynchrony": 34.4984609248296, "dyssynchrony also": 34.49895113244746, "also occurs": 0.0008571543359593408, "trial involving": 0.0013522304190561932, "involving 115": 0.00022311597876922552, "echocardiographic evidence": 34.49982298781822, "ventricular dyssynchrony": 69.00114264886662, "underwent device": 0.0018056365755284775, "capability turned": 2.8234170698558113e-05, "efficacy outcome": 0.0020641567539048077, "first hospitalization": 0.0025940216892869354, "safety monitoring": 0.0010068739010571802, "monitoring board": 0.00028010669512848767, "at study": 0.007480110767873075, "study closure": 0.004727687578812726, "undergone randomization": 34.49829148769593, "outcome occurred": 0.0020895801601457896, "increase mortality": 0.005621601514886681, "comparative effects": 0.001377565822285009, "single center": 0.0005139075143597445, "center retrospective": 0.0004244749770223917, "retrospective observational": 0.00044044054123055837, "failure supported": 0.01768344974921949, "pediatric mechanical": 0.00036922751899182756, "receiving ventricular": 34.50341224235266, "device support": 0.0022133522467111194, "receiving extracorporeal": 34.498789770332515, "oxygenation membrane": 34.498600193998286, "membrane support": 0.0015289400708071433, "vad support": 0.001256890931572174, "steady improvement": 0.001276637525508395, "egfr in": 0.03531656213409528, "day 7": 0.00206069568313546, "egfr continued": 3.6654947560105106e-05, "day 28": 0.0016706952013808138, "steady decline": 0.00021258923969355646, "much higher": 0.0017020126113148916, "dysfunction improves": 0.0030587454851393127, "improves early": 0.0016519959584690414, "outcome change": 0.0022988928276341607, "change scores": 0.0012772565232027364, "preliminary descriptive": 0.0002673213532657457, "descriptive study": 0.00476680388234566, "social mandate": 0.00014363824846435773, "ensure effective": 0.000847758828215379, "effective practice": 0.0013851504168379807, "practice within": 0.001292010200459603, "using standardized": 0.0016855475096319947, "standardized nursing": 0.0004043033493494965, "nursing terminologies": 34.49849512227019, "terminologies makes": 34.49816869017525, "measure aspects": 0.000582496564980334, "ratings exists": 0.0001922462031203429, "retrospective descriptive": 0.000372385552793303, "descriptive research": 0.0005067067343613083, "research design": 0.0005435324965930635, "inpatient records": 0.00038676402382915805, "records of": 0.04379208640167427, "patients discharged": 0.018904149949741884, "year period": 0.001585823547687639, "outcomes demonstrated": 0.004137244186452764, "demonstrated statistically": 0.001216752586321517, "study provide": 0.005093693580115345, "possible contribution": 0.0004423495854080336, "incorporating nursing": 0.0003690462833163536, "future prospective": 0.0007992509857629119, "prospective experimental": 0.0006424781529885345, "experimental research": 0.0005393309468530455, "advancement of": 0.04367650123235011, "science regarding": 0.00023363061870483018, "regarding effective": 0.0010559690192381399, "adults hospitalized": 0.001689225017877881, "reciprocal downregulation": 34.498429880791114, "downregulation influences": 34.498530562307984, "influences cardiac": 0.005807541995289963, "cardiac hypertrophic": 34.50386521152221, "hypertrophic response": 34.49906872296474, "protective role": 0.001234074246868253, "gene therapy": 0.0036339948639596054, "receptors expressed": 34.4986438609195, "opposing actions": 0.00021346764589468708, "adenylyl cyclase": 68.9964180900216, "differential g": 0.0004718348938364821, "protein coupling": 0.0012194392503917682, "actions of": 0.043724557747101815, "triggers desensitization": 34.49822535856434, "downregulation processes": 34.49855599266142, "classic signaling": 0.0005993046171571353, "signaling paradigms": 34.49877028776513, "paradigms suggest": 34.49868803439805, "simultaneous activation": 0.0005772222019468273, "simply result": 0.00025027718188857747, "opposing action": 0.00020503827621558426, "camp production": 0.0001901267820146941, "direct interaction": 0.0005542515475773741, "regulatory involvement": 0.00014979644317312632, "human embryonic": 0.0008237553862609208, "embryonic kidney": 0.0005405748801365325, "cells overexpressing": 34.49886447141126, "\u03b21ar downregulation": 34.4983621720638, "receptor agonist": 0.0015303049580755056, "this cross": 0.0027529041526179886, "distinct g": 0.0003665969836169965, "receptors appears": 34.49853950026709, "physiological significance": 0.00019715869577326595, "show reciprocal": 0.00025202719702825785, "reciprocal regulation": 0.00022908113091771583, "mouse hearts": 0.0008739877397799451, "hearts undergoing": 0.0009434381931905113, "undergoing chronic": 0.00261103551228488, "receptor stimulation": 0.0018349655738011225, "rat model": 0.001664609122825989, "postischemic heart": 34.51699486312704, "cardiac plasma": 0.0060804452101802286, "membrane levels": 0.0020055825514827814, "produces beneficial": 0.00050320551220483, "deleterious \u03b21ar": 6.770872731223332e-05, "\u03b21ar overstimulation": 3.385465315541544e-05, "discharge among": 0.0019247787828478627, "readmission among": 34.50018711357003, "influences outcomes": 0.0032923519714617134, "administrative databases": 0.0003339681403821092, "adults aged": 0.0013353405499139674, "discharged alive": 0.00018996368473003054, "time diagnosis": 0.0019068042791071551, "dependent covariates": 34.49893533469186, "physician within": 0.0014137191056235677, "month after": 0.004013307650089663, "least twice": 0.0002794016830434695, "identified patients": 0.019735181988789385, "saw unfamiliar": 0.00014856128120066718, "unfamiliar physician(s": 34.49829096077827, "unplanned readmission": 34.499007903821024, "month observation": 0.0006422336603157673, "observation period": 0.0009277198668834581, "unfamiliar physician": 0.0007748609268702968, "hr 0.90": 34.49826008871272, "early follow": 0.003100192149837321, "month period": 0.001442606600921764, "unfamiliar physicians": 0.0004697208546702731, "hr 0.91": 34.49832814485905, "explore whether": 0.0009107285955578203, "altered protein": 0.0011510391579845302, "a subunit": 34.511181905175256, "translational state": 34.49836390150263, "receptor blockade": 0.0017686708380617035, "blockade reduces": 0.00040623325884102455, "reduces total": 0.0009682402182233614, "total mortality": 0.005080070980130888, "halt disease": 0.003233954933301528, "dependent protein": 0.001452856169211745, "signaling downstream": 0.0006789425051645573, "receptor activation": 0.0019722851518354035, "unique post": 0.000943714298394379, "translational states": 34.49829375996127, "human myocardial": 34.50126072760074, "total myosin": 34.4991281702794, "myosin binding": 34.49836130004238, "binding protein": 0.0009468776660671649, "c phosphorylation": 34.498936938016506, "ser23/24 troponin": 34.498226059771106, "phosphorylation significantly": 34.50049125506054, "subunits demonstrated": 0.0011151955745564391, "type ii": 0.0014974469859913265, "site specific": 0.0007224041766582497, "specific rii\u03b1": 0.000620156102266971, "regulatory subunit": 34.498419004877945, "ri\u03b1 demonstrated": 0.0010132824591753732, "vivo phosphorylation": 68.99699654787234, "phosphorylation sites": 34.49869962442331, "western blots": 34.4981920302505, "specific monoclonal": 0.0006538353089690145, "monoclonal antibodies": 0.0001696206847244315, "antibodies showed": 0.001224768270422305, "camp binding": 0.00010121132966081068, "wild type": 0.0016244407145281884, "mutant ri\u03b1": 0.00010138677606756639, "ri\u03b1 proteins": 0.0006797902164959024, "proteins demonstrated": 0.0016930726756712755, "demonstrated reduced": 0.0038245836089104094, "double mutant": 0.0003187072931372087, "failing myocardium": 34.49879575168535, "myocardium displays": 34.498459693233016, "displays altered": 0.0003348413180231656, "translational modification": 34.49846355999775, "impact downstream": 0.0010441635044616997, "downstream signaling": 0.0006789425051645573, "autonomic modulation": 0.0003392315272803191, "repolarization instability": 34.49829183858845, "failure prone": 0.017660297864330668, "qt variability": 0.00040727030631852176, "signifies repolarization": 34.49825956353137, "repolarization lability": 68.9964180900216, "risk predictor": 0.004906743663394317, "system activity": 0.0013724905132727371, "spontaneous ventricular": 34.50305217968064, "tachycardia [": 68.99981839889062, "without spontaneous": 0.0011463465412201084, "structurally normal": 0.0006964511903983398, "normal hearts": 0.0011673729661704718, "the beat": 0.02668749147636855, "beat qt": 0.00018346933588698464, "qt interval": 0.0015637329235743517, "min records": 0.0012712682056210502, "surface ecgs": 2.2626111184079294e-05, "atropine infusion": 34.49856598787356, "variability in": 0.0357238324404138, "rr intervals": 0.0002373213065747209, "sdrr ratio": 0.0028067395721662696, "groups compared": 0.003977250985266715, "rate atrial": 34.501742915183534, "isoprenaline infusion": 34.49853195893195, "infusion increased": 0.0030274792389279994, "group relative": 0.003102645387605331, "larger fluctuations": 0.0001482163171305632, "this appears": 0.0028102581789033435, "genuine effect": 0.0012508268996082007, "rate variation": 0.002799668541346909, "the effect": 0.02772976669073648, "acute autonomic": 0.002480170430240875, "system modulation": 0.0006418829631845785, "genetic susceptibility": 9.735266950217883e-05, "related congestive": 34.50016228310376, "haematopoietic cell": 34.49872486293993, "developing congestive": 34.49926057871376, "primarily due": 0.0006378532060216047, "hct exposure": 9.612339055451825e-05, "candidate genes": 0.00035483055894730076, "genes involved": 0.00048040984685942514, "anthracycline metabolism": 34.498770148786626, "iron homeostasis": 34.49852090120503, "- oxidant": 34.54360677254526, "oxidant defence": 34.49820816488961, "myocardial remodelling": 68.99893490857303, "nested case": 34.498662391102215, "control study": 0.006515266884573478, "this cohort": 0.004095020694905246, "cohort formed": 0.0015171696582108286, "sampling frame": 9.244017949644936e-05, "selecting controls": 0.0005365396179022546, "cumulative anthracycline": 34.49870157209009, "anthracycline exposure": 34.49852634812713, "cell source": 0.0005359844476111793, "germline dna": 34.4981920302505, "chest radiation": 9.454552859161256e-05, "genes coding": 0.00037184879323979474, "oxidase subunit": 68.99658823357177, "doxorubicin efflux": 68.99675835338627, "efflux transporter": 34.49825991442427, "a combined": 0.01321841003663576, "chf predictive": 0.00027169824634406, "predictive model": 0.0017680925713001374, "model performed": 0.0025380752632291927, "models alone": 0.0014825298733262865, "common language": 0.001096048484532125, "common syndrome": 0.0011534110555400804, "first propose": 0.0006864524991488653, "propose fundamental": 0.00012243386718813318, "fundamental definitions": 0.00015856874348113654, "distinctive components": 0.00015944480578892312, "heart circulation": 0.019038048827428766, "provide consensus": 0.0005575509992159142, "universal definition": 9.121205326267276e-05, "these definitions": 0.0019345546117017847, "uniform nomenclature": 34.49822097240879, "heart circulatory": 0.019006829342996502, "circulatory failure": 0.017833246819037963, "foster collaborative": 6.0691455019639865e-05, "collaborative research": 0.0004025145530727681, "research initiatives": 0.000428824452431996, "conjoint education": 34.49823850305268, "disease unique": 0.0033760255566642056, "class angiotensin": 34.5005611155091, "inhibitors augment": 0.0006792847152581995, "peptide system": 0.001459119590560512, "atrial natriuretic": 68.99832328822383, "inhibitor composed": 0.00030344754324676163, "inhibitor prodrug": 34.49846390394328, "antagonist valsartan": 68.99675835917532, "proven effective": 0.0009245960716253198, "shown promise": 0.0003748244418930731, "pilot trial": 0.0013922227720774955, "large outcomes": 0.003575754169530702, "a preserved": 0.014824619681498999, "fraction outcomes": 0.006997913922532708, "current treatment": 0.00421983341384701, "rapid onset": 0.0008769147650297179, "threatening situation": 8.910000303963804e-05, "treatment aims": 0.0037980761231896963, "improve clinical": 0.0038325673403172594, "increase long": 0.002513427078438615, "few treatments": 0.0003883159066845328, "review summarizes": 0.0008537305871965439, "pharmacologic treatment": 34.50193345305775, "underlying clinical": 0.003356641948615277, "new pharmacologic": 34.49876139366627, "pharmacologic targets": 34.498622113697195, "purely hemodynamic": 34.49846057046359, "hemodynamic disorder": 34.498494950876534, "interconnected molecular": 0.00037290147109637, "research investigations": 0.0004633797309133982, "maladaptive molecular": 34.498667367123446, "molecular processes": 0.0005330428620142843, "accumulating evidence": 0.0010525344471807548, "evidence shows": 0.0010988318077726226, "molecular biomarkers": 34.49890554540016, "biomarkers provide": 34.499029154311565, "important therapeutic": 0.0015469822287205288, "research studies": 0.0019860126804347586, "potential therapeutic": 0.0015143882395497502, "promising biomarkers": 34.49873155534865, "uniquely capture": 5.7182534730220575e-05, "molecular dysfunction": 0.00271940565756271, "strict statistical": 0.00019505160158102017, "statistical standards": 0.00017347185632991596, "biomarker studies": 34.50001144611373, "trial design": 0.001368537729458094, "therapeutic potential": 0.0015143882395497502, "based strategy": 0.0013453775941424271, "western society": 2.8759995684477162e-05, "fastest growing": 0.0001617170997235509, "growing subclass": 34.49832585786784, "an increasing": 0.004116693796019016, "increasing body": 0.0012763498780266579, "evidence indicates": 0.0010811257134379605, "small noncoding": 34.498419857266974, "noncoding rnas": 34.4981920302505, "regulate expression": 0.0010802726148657737, "target genes": 0.0006838712662411765, "specific binding": 0.0007213674319277817, "untranslated region": 34.49825604728938, "region of": 0.04367333588318299, "translational repression": 34.49832691905003, "to date": 0.01920963989603103, "many mirnas": 1.0657403374315764e-05, "diverse aspects": 0.00028766087729257975, "failure development": 0.018670357080697933, "cardiac pathogenesis": 34.504001323814904, "provide brief": 0.0005568492160197287, "brief insight": 0.00022276622629281923, "system inhibitors": 0.0011866274559453225, "common condition": 0.0010697391005124704, "carries significant": 0.0021314255472382566, "significant morbidity": 0.00244116889580958, "good evidence": 0.0011061718089584627, "the renin": 34.52486619420428, "effective target": 0.001176806049059766, "using angiotensin": 34.50086502400651, "aldosterone blockade": 34.49877032481194, "less clear": 0.0008844040768318623, "review aims": 0.0010126438585294358, "look first": 0.000582766474093772, "newer drugs": 0.00037710008639361346, "direct renin": 34.49847898996902, "renin inhibitors": 34.49897409894461, "neutral endopeptidase": 34.498257458175324, "endopeptidase inhibitors": 34.49880395713131, "vasopeptidase inhibitors": 34.49880395713131, "muscle abnormalities": 0.0008808231950072998, "capacity in": 0.036450102011545096, "peripheral muscle": 0.0009143217450402763, "muscle pump": 0.0009806153240494414, "promoting cardiac": 0.005701070754099662, "subpulmonary ventricle": 68.996826399113, "a muscle": 0.013429035243225616, "wasting syndrome": 0.00023329298826964734, "syndrome exists": 0.000261707076477806, "acquired heart": 0.018861769300816938, "investigate whether": 0.001181531090435521, "circulation exhibit": 0.0002652107856341666, "exhibit reduced": 0.002841295984477296, "reduced skeletal": 0.002981094964990049, "metabolic abnormalities": 34.498837847672206, "underwent cardiopulmonary": 0.001189274756895479, "mass quantification": 0.00124403127042763, "dual x": 0.00012910080896650727, "calf muscle": 0.0006084277944575282, "resonance spectroscopy": 34.49856597861093, "healthy age": 0.002003315384456087, "australian reference": 0.0002980040863846733, "reference data": 0.0017142526720695399, "single tertiary": 0.00035850314041506107, "tertiary referral": 6.507761026794948e-05, "referral centre": 0.00013277724555514858, "predicted values": 0.0005609184611444197, "mass assessed": 0.002329687741069772, "relative appendicular": 34.498626130420774, "appendicular lean": 34.498427772540104, "matched reference": 0.0008052367591605586, "reference values": 0.0007275426722857353, "score -1.46\u00b10.22": 34.49932381568427, "low skeletal": 0.001779042522868186, "mass correlated": 0.001822269104307654, "poorer vo2": 3.1749296733847885e-05, "mass t": 0.001198597763378569, "young normal": 0.0009851280578856807, "normal reference": 0.0009611269629410974, "reference mean": 0.0014155785830956484, "sarcopenic range": 34.49866048968911, "range muscle": 0.0010437343656272313, "muscle wasting": 0.0006756090248793728, "less marked": 0.00092703691045777, "significant wasting": 0.0021337063481273516, "muscle aerobic": 34.498971473616656, "rate constant": 0.002554456218381825, "postexercise phosphocreatine": 68.99648614732587, "phosphocreatine resynthesis": 68.99648614732587, "adults versus": 0.0028065611331002964, "versus controls": 0.0023350347923229773, "the self": 0.026670824303107094, "psychometric profile": 34.49833813893587, "still questioned": 5.25874197764737e-05, "performed confirmatory": 34.49923371118877, "confirmatory factor": 34.499030503311985, "original construct": 3.332206971275361e-05, "v.6.2 scales": 34.49836130004238, "limited success": 0.0006840064090356746, "used exploratory": 0.0018473819185317263, "exploratory factor": 0.0008719768217510727, "separate scale": 0.000297831019961721, "scale dimensions": 0.00021258697406933475, "separate sub": 0.00017856145600756007, "- sample": 0.045646273878539284, "construct validity": 0.00020119221885169986, "individual scales": 0.0002745049011480022, "scales showed": 0.0011900381220607277, "showed excellent": 0.0012103817123799313, "excellent fit": 0.00030484881121432383, "fit indices": 0.0003529122600517847, "confidence scale": 0.0017936288660473294, "contrasting groups": 0.001454494743219284, "groups validity": 0.0016234113264396298, "this evidence": 0.003719491048625844, "evidence provides": 0.0012291614530278926, "new understanding": 0.0005881297302125111, "circulating fragments": 0.0003722077904539133, "nonstandardized n": 34.49967529781449, "common consensus": 0.0011151719885512791, "consensus regarding": 0.0003197599197590122, "circulating forms": 0.0003902705930891474, "current assays": 0.0007164383305266872, "various forms": 0.0002436278383498574, "collected from": 0.004606368897384722, "\u00b0 c": 34.49856264513124, "patient plasma": 0.0028077920775194734, "immunoprecipitation followed": 34.49887882042473, "mass spectrometric": 34.49936835279362, "spectrometric analysis": 34.50027974879002, "customized homogeneous": 34.4981920302505, "homogeneous sandwich": 34.498224130439816, "sandwich alphalisa": 3.210018931694272e-05, "\u00ae immunoassays": 68.99652017684647, "quantify 6": 0.0021508105626676976, "spectrometry identified": 34.499191803426406, "several n-": 0.0002322130112011855, "terminally processed": 34.49825693183665, "processed forms": 0.00015032164424847054, "physiological proteolysis": 34.49825938808495, "immunoassays demonstrated": 34.49923934223028, "extreme n": 0.001574127582885273, "termini measured": 34.49907223855529, "low apparent": 0.0017058984360960297, "apparent concentration": 0.0001957557024608533, "apparent circulating": 0.00036747074286920306, "circulating nt": 0.0002708210143863469, "increased with": 0.03375452153667351, "targeting nonglycosylated": 34.49845372807533, "in plasma": 0.035757855593169866, "plasma collected": 0.0005972270531685653, "immunoreactive nt": 34.4981920302505, "multiple n-": 0.00021837318521521727, "terminally truncated": 34.498327972886486, "truncated fragments": 0.0002032998914486324, "full length": 0.0005074005836450227, "terminal regions": 0.0008016861703894242, "findings support": 0.0016522309193719225, "next generation": -8.931548325471788e-05, "assay targeting": 0.00036361094021607936, "targeting nonterminal": 34.49848775759594, "central glycosylated": 34.498373043362655, "glycosylated region": 34.49825604728938, "versus concentric": 0.0020005669413443823, "concentric left": 0.003875687969528079, "ventricular hypertrophy": 69.00185713508208, "hypertrophy in": 34.53425710812066, "concentric remodeling": 0.0010543616556227145, "concentric hypertrophy": 34.49904245910195, "common forms": 0.0011399017438302383, "eccentric hypertrophy": 34.499007728374615, "also occur": 0.0010237785458694054, "well described": 0.0010924351200703394, "prospectively studied": 34.49859335159802, "studied 402": 0.00033309091273378625, "normal geometry": 0.0007308316038686574, "relative wall": 0.0007947146452926322, "compared clinical": 0.005575253493502215, "outcome data": 0.002903375949806183, "data among": 0.0026628161691448953, "among groups": 0.0027010623266793127, "lower systolic": 34.502406970191295, "less renal": 0.002092935858224987, "renal impairment": 0.0014951352598915522, "similar rates": 0.0023765912879047117, "contractility compared": 34.500850901101096, "lower lvef": 0.0017323053089458214, "-1.1 %": 34.51696757413345, "also associated": 0.005015075176928923, "compliance compared": 0.002822514786729937, "similarly elevated": 0.0006754150559130452, "elevated cardiac": 0.006283870187664745, "equivalent adverse": 0.0011816414511963084, "distinct subset": 0.00026784711222292224, "pathophysiologically similar": 34.499100617656495, "endpoint of": 0.04377928810601314, "using time": 0.002779612521585125, "dependent cox": 0.000607189832805391, "compared patients": 0.021258165054929553, "different types": 0.00042197614888348444, "antitachycardia pacing": 34.498532129747005, "secondary endpoints": 34.498420579256354, "atrial tachyarrhythmias": 68.99740469433675, "also evaluated": 0.001641927725908307, "therapy occurred": 0.003591378330749535, "\u00b1 1.1": 34.50104525598353, "decreased risk": 0.005448256041645782, "the reduction": 0.02771909155584067, "inappropriate shock": 0.0005923214986969063, "therapy caused": 0.003193789520811594, "also reduced": 0.0035363738260851454, "general use": 0.001728115225093546, "rate in": 0.03784681323138778, "receiving metoprolol": 34.499402181877855, "nationwide retrospective": 0.0002976612941378142, "matched subjects": 0.0011147733976410884, "hazard analyses": 0.0026166787056073715, "absolute risk": 0.004797824860717711, "exposed group": 0.0027606333550414166, "crude rr": 9.261447457447793e-05, "rr 1.71": 34.49829411707536, "ci 1.34": 0.00010191311538106603, "by comparison": 0.005513107787175228, "different mechanism": 0.0008045022508585925, "hr 1.07": 34.498226059771106, "ci 0.76": 34.498226059771106, "used bisphosphonates": 34.50010799523363, "analysed separately": 0.00013155705593915343, "significant trends": 0.0022626230387631915, "observed across": 0.001151376347336652, "across refill": 0.00051510131104566, "compliance strata": 0.0004014962136101995, "failure increased": 0.02035083043066126, "increasing refill": 0.00035167720465985894, "failure compared": 0.02015200659462575, "control subjects": 0.002491945205115409, "alendronate showed": 34.49938294386776, "dependent reduction": 0.001822259248164496, "subcellular alterations": 34.49853160340769, "alterations by": 0.00575778567510609, "in order": 0.035318128645198045, "weeks infarcted": 34.498990363178656, "infarcted rats": 34.498972328274746, "without metoprolol": 34.49991728457679, "depressed left": 0.003840080010388557, "negative rates": 0.001691815861369327, "pressure development": 0.0028079383839606023, "weeks mi": 0.000696246103292886, "mi animals": 0.00032659016464980494, "induced decreases": 0.0016641364480792927, "internal diameter": 0.0003250250436170978, "fully reversible": 0.00026906731276566786, "metoprolol partially": 34.49914192001781, "plasma norepinephrine": 34.498701382171795, "dopamine without": 0.0013848797629649524, "sarcoplasmic reticular": 68.996384060501, "protein content": 0.0009073953383991014, "infarcted hearts": 34.49879836716497, "partially reversible": 0.0003708065358233071, "depressed myofibrillar": 34.49825833540674, "myofibrillar ca(2+)-stimulated": 34.4981920302505, "increased mrna": 0.00272158007808294, "mrna level": 0.0007777698693888415, "- myosin": 34.54367483100748, "partial improvement": 0.001417135968756589, "cardiac performance": 0.006264203435320862, "advanced stages": 0.0008984621580979864, "partial reversal": 0.00026889805236880786, "complete reverse": 0.00036763128632663205, "reverse cardiac": 0.005973110630910359, "partial reduction": 0.0014162587404156796, "plasma catecholamines": 34.498633323709576, "incident cardiovascular": 0.002214807784618012, "independent risk": 0.005083511390346992, "available studies": 0.0018783274073299711, "shown inconsistent": 0.00034991810763296456, "inconsistent results": 0.0012175195097755185, "embedded within": 0.0007690116644994494, "cardiovascular outcomes": 0.005129870320042215, "adjusted means": 0.0009926192232170136, "subclinical atherosclerosis": 34.498361999512206, "atherosclerosis using": 0.0017543054416795684, "using general": 0.0017756910581776468, "general linear": 0.000394123219817484, "dependent variable": 0.0006733195427325236, "% systemic": 0.018977610439277124, "uv treatment": 0.003605308198701389, "higher diastolic": 34.50181874994951, "diastolic blood": 34.50088691472106, "index levels": 0.0035613829610540468, "adjusted carotid": 34.49917431206917, "carotid intima": 68.99645211896322, "media thickness": 0.00012066401407953965, "adjusted ankle": 0.0009805285126969288, "wave velocity": 0.0006700086523770624, "artery calcium": 0.0009174103268301323, "calcium scores": 0.0005326734477352418, "ratio 0.73": 34.501100856647525, "interval 0.50": 0.001801756015869328, "analyzed separately": 0.0004037770100821693, "predominantly mild": 0.0006405424558485761, "mild disease": 0.003710140094371239, "develop atherosclerosis": 0.0005228641594945787, "subjects without": 0.0016182966809538324, "without psoriasis": 0.0012147524225482728, "share many": -1.7068703154866377e-05, "many risk": 0.004577827909576185, "fully examined": 0.0006729763560550788, "investigated 120": 0.00039832891663812796, "defined by": 0.006088353204883358, "levels \u2265": 34.5000616782713, "low bnp": 0.0016092487076131735, "transmitral e": 34.498533182551945, "analysis established": 0.0023008283895461024, "highest quartile": 34.49833620904876, "pad suggests": 0.00025643446517818345, "routine bnp": 0.00013067809112417817, "hospital readmission": 34.50030074283245, "readmission reduction": 34.50015561540193, "reduction program": 0.001621975678820864, "rate following": 0.0027694817200670948, "following hospital": 0.0015994274686566212, "hospital stay": 0.0016266209460824657, "approaches 30": 0.0017230247981924322, "percent nationally": 0.00019363002976370927, "indicating possible": 0.0003479858528716668, "possible suboptimal": 0.0003507929942747356, "suboptimal care": 0.002080938705659987, "care of": 0.04558834443458368, "significant economic": 0.002168419446149026, "economic considerations": 0.00016802461692247444, "- randomized": 0.0464688798907717, "center pilot": 0.0003844831851250215, "pilot project": 0.00014574352969002352, "cardiac specialty": 0.005738257725083637, "specialty hospital": 0.0014593028198600208, "predominantly rural": 0.00015751490591655028, "rural south": 2.36787843157298e-05, "transitions of": 0.04367650123235011, "ensure adequate": 7.94506921798054e-05, "adequate self": 0.00022942294949292318, "management training": 0.002248625694057877, "training of": 0.044615209254014, "patient follow": 0.004493256901784093, "percent relative": 0.0005972090268581155, "relative reduction": 0.001649169585631556, "patients participating": 0.018858718185619364, "pilot program": 0.0006033585463353038, "this represented": 0.0027911432011380887, "net economic": 0.0002483562085151818, "economic savings": 0.00019170282767294844, "even accounting": 0.00031566461398691817, "added cost": 0.0005436861465059587, "program decreases": 0.0006107272834680306, "- urbanized": 34.54360677254526, "urbanized midwestern": 34.4981920302505, "midwestern state": 6.978442726468244e-05, "state like": -0.00014373550599946832, "extensively studied": 0.0002978332672749742, "patients surviving": 0.01880031039903798, "the majority": 0.026648200938739406, "mortality within": 0.004949778119974711, "hr dynamics": 9.805329696790984e-05, "linear measures": 0.0009995056110453434, "prognostic power": 34.499006792615944, "reflecting rapid": 0.0001603231936993256, "rapid r": 0.00033151478988519283, "r interval": 0.0018001769983452666, "interval oscillations": 34.49978979269468, "almost identical": 3.559650545694239e-05, "linear hr": 0.0002027683416110212, "variability measures": 0.001204007575752844, "term fractal": 34.4994254671257, "fractal scaling": 34.49822500767154, "scaling exponent": 34.49822500767154, "provided somewhat": 0.0003932285329656942, "somewhat better": 0.0004845662649347586, "better prognostic": 34.49949979773305, "variability predicts": 0.0005412818742029723, "- sudden": 0.04567907180461684, "arrhythmia substrate": 34.498361825802675, "early measurement": 0.001415429111230949, "repeated later": 0.00027817282150757283, "fatal arrhythmia": 0.0002343456669727115, "arrhythmia events": 0.0018571938870459424, "future randomized": 0.0013794761193011021, "trials using": 0.002735771470835423, "using hr": 0.001584336179971184, "- defined": 0.04608488298172882, "defined inclusion": 0.000905707530321593, "show whether": 0.0009671761081652148, "routine measurement": 0.0005726733358570153, "routine clinical": 0.003183175342578961, "renal artery": 0.0021766220618165723, "form of": 0.043720514405239844, "peripheral arterial": 34.49931360959187, "arterial disease": 34.50217799653397, "predominantly unilateral": 0.0002015448489130538, "pathophysiologic mechanism": 34.49873277305175, "mechanism stems": 0.000506012652868701, "renal underperfusion": 34.499518424373534, "underperfusion resulting": 34.49842128103899, "renin- angiotensin": 68.99747271807703, "aldosterone pathway": 34.49883802311863, "clinically present": 0.0007385682818622489, "resistant hypertension": 0.0013232789090314204, "stage kidney": 0.0010062011952564505, "kidney failure": 0.01806808756378716, "screening patients": 0.018759263042773956, "computed tomographic": 34.498259738977815, "tomographic angiography": 34.498430053342794, "resonance angiography": 0.0006119714527179274, "adequate blood": 0.0009547380579732761, "pressure control": 0.003651236136091195, "directed lipid": 34.49824324707994, "lowering therapy": 0.003020323938937377, "smoking cessation": 9.40191950812857e-05, "preventive measures": 0.0008297146904781173, "measures form": 0.0009079328303694034, "based percutaneous": 34.499357631527246, "percutaneous revascularization": 68.99662226193442, "stenting showed": 34.49938294386776, "showed modest": 0.0012552871279704263, "modest clinical": 0.0032189575870252922, "small retrospective": 0.0004642710912427737, "retrospective studies": 0.0018516914988667534, "randomized clinical": 0.004106634847467382, "trials failed": 0.0011879147947109231, "beneficial results": 0.0016582791057848257, "current ongoing": 0.0007329221240406788, "ongoing cardiovascular": 0.002124305501659882, "concrete data": 0.0014458925282134075, "surgical revascularization": 34.49866420909103, "based revascularization": 34.49939165931094, "determining individualized": 0.00013418933000714926, "individualized assessment": 0.0006719159808038931, "treatment plans": 0.003587757699469875, "bioinformatic analysis": 0.0020877185395173294, "microarray data": 34.499608278836185, "data reveals": 0.0014436117303254928, "reveals several": 0.00025957615584181176, "several key": 0.00038445344140172473, "key genes": 0.0004902345702849186, "genes related": 0.001355639211580695, "problem worldwide": 0.00016241363265731893, "still unclear": 0.00036234117910704546, "study aims": 0.004823630328811579, "discover differentially": 34.498289381763094, "expressed genes": 0.0005856563699487903, "including 3": 0.0023408394304659103, "normal samples": 0.0009962045269428913, "ischemic samples": 34.49937567626315, "data processing": 0.0014427345010611472, "differential analysis": 0.0023590658930320433, "also performed": 0.0017667536146232243, "globally observe": 5.8059764302379396e-05, "overlapping part": 2.8034240742610976e-05, "obtained for": 0.01359911282836688, "programmed cell": 0.0005658101104720109, "cell death": 0.0028409088997349828, "common degs": 0.0010204521651274378, "develop treatments": 0.000621786003219688, "longitudinal analysis": 0.002427467143132367, "using medicare": 34.49981039595108, "medicare data": 34.49964230835679, "evaluate mortality": 0.004752717164180168, "healthcare utilization": 0.00019277312611707125, "utilization effects": 0.0014777244738276023, "combined care": 0.002343675310711433, "targeting individuals": 0.0006828150515371535, "retrospective matched": 0.0007436767475468004, "matched cohort": 0.0019352967662360414, "demonstration participating": 0.00015453233071209885, "participating clinics": 0.00015488322320240543, "score matched": 0.0016390181065488389, "telehealth system": 34.4988688176505, "year study": 0.0053526395482661835, "negative binomial": 34.49841584222996, "binomial regression": 34.49883815225813, "controlling for": 0.013403372735540283, "health characteristics": 0.0018557093602240122, "statistically different": 0.000535288038977951, "participants offered": 0.00087933866833085, "quarterly inpatient": 0.00023223684074938112, "% greater": 0.019194731219835597, "time period": 0.0020593227453586686, "no relationship": 0.0021539463457082887, "fewer admissions": 0.0005328697281876543, "management coupled": 0.0014100728508764635, "telehealth technology": 34.498334975754304, "improve health": 0.001957217357115559, "the strength": 0.026895151444619216, "contemporary chronic": 0.0022000877829981545, "training response": 0.0018485536033497562, "well established": 0.0011655768281700226, "explore interactions": 0.00015804123798061244, "examined characteristics": 0.0012178862739692287, "race using": 0.0021192588882646985, "using adjusted": 0.002498559536426569, "identified black": 0.0011334253499640432, "black patients": 0.018869060986938902, "less ischemic": 34.499809136347956, "ischemic etiology": 68.9974387933024, "lower socioeconomic": 0.0017647563909069777, "socioeconomic status": 0.0009282526836575302, "status versus": 0.00279445542765969, "versus whites": 0.0019316312470071112, "lower peak": 0.002844992560468755, "after multivariable": 0.0036727705452076027, "hazard associated": 0.00643118972674178, "largely caused": 0.0004965520353425905, "given similar": 0.0010341608420384148, "similar cardiovascular": 0.0029144959987590997, "increased prevalence": 0.0030595742181673195, "modifiable risk": 34.5027592007567, "improving outcomes": 0.0034205622481320104, "fibrillation for": 34.512177128330194, "therapy including": 0.0037534989741089307, "including anticoagulation": 34.4990246621521, "major cardiovascular": 0.0028596039635969414, "prevent adverse": 0.0012018096315844192, "outcomes related": 0.004141606798773706, "moderately effective": 0.0009666949544719851, "published trials": 0.0012393050163545412, "side effects": 0.001327558825395467, "repeated interventions": 0.0007736420664612271, "therapy applied": 0.003184500588795979, "first diagnosis": 0.001366932924889733, "preserve atrial": 34.49931106827549, "atrial structure": 34.499673593567564, "maintain sinus": 34.49837935937263, "current practice": 0.0011687467090806328, "delayed rhythm": 0.0007417190565472645, "symptoms persist": 0.0009782477162403463, "otherwise effective": 0.0008844265386262006, "new antiarrhythmic": 34.49872736588258, "potential effectiveness": 0.0011061416571971337, "modern rhythm": 0.000720490195875749, "reduce cardiovascular": 0.002559603753712293, "randomize approximately": 34.4984498682769, "onset af": 0.00078184404991544, "mandated usual": 0.0003614974837336166, "blinded outcome": 0.0015530816277489839, "outcome assessment": 0.0020911591711596043, "assessment trial": 0.0017998022962422385, "composite primary": 0.0016500711408894675, "nights spent": -4.743195770340435e-06, "coprimary outcome": 34.49967915761462, "underlying heart": 0.019106977573697354, "initial approach": 0.000436217741174295, "operated electrocardiographic": 34.49832235860762, "electrocardiographic device": 34.49918252108625, "ongoing rhythm": 0.0007627644528402865, "key secondary": 0.0003807894360517044, "outcomes include": 0.003307070831234765, "include cognitive": 0.0003157171020023922, "cognitive function": 0.002942330138982926, "initial diagnosis": 0.0008679878673454565, "prevent cardiovascular": 0.0021222001637074537, "complications associated": 0.004730769620570764, "bleeding in": 0.035552830762551786, "cardiac nurse": 0.005771584302990153, "term ventricular": 34.5041500259707, "care providers": 0.0020367338952048406, "managing clinically": 0.0002909966857160854, "significant gastrointestinal": 0.0022033415119787313, "units accustomed": 0.0001482163171305632, "often asked": 0.00029884044175852015, "possible causes": 0.0004765516567886901, "subspecialty groups": 34.49964652499372, "dependent increase": 0.002016801934241953, "leading causes": 0.00045024562713973505, "hospitalisation among": 0.0013474280203530557, "worldwide increase": 0.0014985422208578223, "advanced phase": 0.0011019253412334821, "called end": 0.0020673254506108087, "steadily growing": 0.00019960643468375623, "failure fall": 0.01763029678665972, "functional classification": 0.0020351216386353815, "advanced structural": 0.000869345120722084, "structural heart": 0.018831950480860473, "pronounced symptoms": 0.0010101713025423705, "minimal physical": 0.00028292389143857506, "physical exertion": 0.00028467835512314065, "maximal medical": 34.499468022000364, "treatment according": 0.003905219529548071, "mortality rate": 0.006742240510742617, "requires special": 0.0003479856023027041, "special therapeutic": 0.0008372643699428662, "every attempt": -9.498090843024908e-06, "correct reversible": 0.00015962025979821616, "reversible causes": 0.00036308691660390886, "poor patient": 0.0026397650066692997, "myocardial ischaemia": 68.99873074013391, "valvular regurgitation": 68.99665628740235, "describe current": 0.0007439751846532199, "current strategies": 0.0013914567714846996, "potent inhibition": 0.0006797902164959024, "type ca2": 0.0014974469859913265, "variant associated": 0.004355781317922852, "influx via": 0.00058123378965538, "via l": 0.0007854022287949408, "type voltage": 34.4997235067571, "channels supports": 0.00031853353699537186, "plateau phase": 0.00029520158509951965, "action potentials": 0.00014048873981999474, "monomeric g": 34.49839251779082, "g proteins": 0.0008802777568176707, "regulates ventricular": 34.50298377148355, "action potential": 0.0008404064009628231, "potential duration": 0.0012078602228715945, "coupling gain": 0.0004292004278260651, "inhibit cardiac": 34.50386521152221, "cardiac l": 0.005874367701997547, "channel activity": 0.0011964633901198395, "potential dysfunction": 0.0031137802610132553, "naturally occurring": 9.559820661792908e-05, "occurring rad": 6.630515624154399e-05, "rad variant": 6.577881734403774e-05, "even eliminates": 0.00025620300986416947, "inhibitory actions": 0.0001485672166389699, "channel isoforms": 34.498624733223096, "isoforms known": 34.498631900242884, "murine equivalent": 34.498356212103275, "human rad": 0.0007220177173332268, "inhibits l": 0.0002688951575939508, "type currents": 0.0015651557133035598, "currents conducted": 0.00022048430976763972, "cav1.3 channels": 0.00019592594554588544, "channels as": 0.004129005342339918, "% inhibition": 0.01945533409945132, "gating movement": 4.595406349442089e-05, "differentially impair": 68.99645211896322, "described modes": 0.00017277011659646668, "inhibit l": 34.498461275722, "dependent processes": 0.0008010104304253488, "processes per": 0.000941201680409428, "per se": 0.0007801830574568471, "rule out": -3.3041050530839805e-05, "decreased expression": 0.0019296088535758385, "altered regulation": 0.00046674522518365847, "young adult": 0.0006854267827308112, "severe anemia": 34.499950204986874, "ethically complex": 0.0003518480177709021, "complex situations": 0.0003441283883936744, "involving families": 0.00015276939280862436, "religious beliefs": 5.24455086149925e-05, "beliefs preclude": 9.94580240460812e-05, "involving young": 0.00047846511118149903, "legal majority": 0.00013697940094687468, "face decisions": 2.138539543839765e-05, "decisions about": -0.0001547771109355229, "this month": 0.003245516798622126, "complexities overlapped": 34.49822500767154, "old jehovah": 0.0001190656765497771, "sickle cell": 34.49872486293993, "cell disease": 0.003736266449551699, "threatening anemia": 34.49862771580102, "doctors urgently": 7.875545399241922e-05, "urgently recommend": 9.489642219093603e-05, "recommend blood": 0.000954913503979874, "young woman": 0.00030743719749603724, "family adamantly": 34.49822743660367, "adamantly refuse": 34.498221323300875, "doctors let": 3.331537671039184e-05, "common inpatient": 0.0012244486315870812, "inpatient medical": 0.0012417937302528336, "medical conditions": 0.0014771471115506574, "public reporting": 1.6462116939024618e-05, "quality aims": 0.0019163010889229088, "patients select": 0.018791011772098357, "select better": 0.000512806079510367, "better hospitals": 0.0008911278448216263, "individual quality": 0.001896826735921793, "identifying superior": 0.0001654111300656342, "inferior hospitals": 0.0005011071125728438, "hospitals based": 0.0014974391764130148, "outcome performance": 0.0021121790483365384, "combine structure": 0.0004914506544988624, "empirically derived": 0.0005072407769170069, "derived composite": 0.000982724152035602, "quality measure": 0.0020788842881088263, "composite measure": 0.0008646891519482351, "measure predicts": 0.0004893626915586751, "predicts future": 0.00045935009117295306, "explains variance": 5.384908156377986e-05, "future hospital": 0.0016855353691705261, "hospital mortality": 0.005572186259332143, "using national": 0.0017134184107215156, "national medicare": 34.498355142001856, "care hospital": 0.0033392224361609444, "ranked hospitals": 0.0004600597483056816, "performance on": 0.0038890803429628418, "quintile of": 0.04367702757161699, "existing quality": 0.0017612407745993155, "quality indicators": 0.0017898383206761456, "including mortality": 0.004976562852833989, "the composite": 0.027013360168755576, "explained 68": 0.00020820316783155558, "future ami": 0.00032533852328850253, "performance using": 0.0022093878641864066, "composite measures": 0.0013060752977083327, "existing measures": 0.0008344448795990362, "explaining variation": 0.00029941227879667085, "future mortality": 0.004537327936738622, "predicting future": 0.0005956331986849989, "the incidence": 0.026909713429968608, "hyperkalemia caused": 34.49883923284859, "influences efficacy": 0.0007454196339678143, "assessed hyperkalemia": 34.49978773406046, "african americans": 0.0, "ischemic hf": 34.49904259461276, "class iv": 0.0012804276825667013, "higher estimated": 0.002412018808214101, "less hypertension": 0.0020249190580687573, "infarction compared": 34.50193948460871, "- aa": 0.0454147422947591, "potassium increased": 0.0029252256516516745, "treatment interaction": 0.004042741841055798, "remained higher": 0.0023196057567105386, "attain maximal": 34.49846267581854, "maximal spironolactone": 68.99716665784854, "spironolactone dose": 34.50006072187877, "higher rates": 0.0032919563814690594, "achieved study": 0.00478960312406032, "study drug": 0.004862032935959267, "drug dose": 0.0015554592984309066, "spironolactone reduced": 34.501547734261706, "exhibited less": 0.0011059394459788884, "less hyperkalemia": 34.4994009105977, "spironolactone compared": 34.501259189354016, "derive less": 0.0008337241232385467, "less clinical": 0.0038190389866479798, "these hypothesis": 0.0020368151460513195, "generating findings": 0.00045918889703742104, "targeted peptides": 0.0004302646784240036, "targeted antioxidant": 0.00022644713217535186, "protective peptides": 0.0004399142020252378, "proteomic remodeling": 34.499178508311346, "improved label": 0.0012357853067700784, "free shotgun": 0.00032622727630479307, "shotgun proteomics": 34.49842970534468, "proteomics approach": 34.49864192987512, "tac)-induced heart": 0.01880283287653686, "associated signaling": 0.004868260015210927, "pathway changes": 0.001961475672629489, "changes using": 0.0031720389386152587, "using ingenuity": 0.0016520449072834173, "proteins significantly": 0.002604722141261883, "top pathways": 0.00033218149249180864, "categories of": 0.04380489389837568, "intermediate metabolism": 0.0005090160796493389, "citrate cycle": 34.498248510436824, "concomitant treatment": 34.50183136796981, "failure phenotypes": 34.51585531012368, "mitochondrial damage": 34.49898420596197, "damage induced": 0.0014699586161869115, "mitochondrial proteome": 68.99720062254497, "proteome changes": 34.49981376252975, "% protection": 0.018860263319083508, "nonmitochondrial protein": 34.4990376965869, "protein changes": 0.0024333690950504292, "this included": 0.003822752159843245, "included significant": 0.0031891678086685025, "significant amelioration": 34.50022540250077, "analysis noted": 0.002197518665723522, "modest effects": 0.0015440261578555184, "partial attenuation": 34.498529334184106, "cytoskeleton pathways": 34.498599832685095, "significantly protected": 0.00198439468614286, "metabolic pathways": 34.498906072318206, "pathways essentially": 0.0004009606127421233, "study elucidates": 34.50282289265483, "pathways significantly": 0.0022987048387513947, "induced proteomic": 34.49968637519918, "proteomic alterations": 34.4985656329283, "perturbed mitochondrial": 68.99720062254497, "upstream signal": 0.0001604974895709011, "pathway alterations": 0.0007133460711778613, "potential clinical": 0.003786094119299655, "peptide drugs": 0.0012301206976025809, "treatment heart": 0.02240814107523825, "reducing length": 0.0006238855200483688, "stay increase": 0.0016760362016370039, "increase rehospitalization": 34.49980581079107, "rehospitalization of": 34.54200551753394, "medicare fee": 34.498319200582685, "beneficiaries discharged": 0.0003036299363941115, "skilled nursing": 0.0003309815020725182, "nursing facilities": 0.0003485191725513423, "hospitals nationwide": 0.0004951419438943931, "beneficiaries associated": 0.004424891300113163, "rehospitalization derived": 34.49886958481339, "hospital claims": 0.0013626468291185181, "claims using": 0.0015867861632076785, "quasi -": 0.045448421501461146, "- experiment": 0.045440877318537284, "policy led": 0.0002572920596947514, "immediate declines": 8.875582029506436e-05, "day decrease": 0.0018985139995438371, "absolute increase": 0.001640266455952403, "= 0.03": 0.007161890400646157, "urinary tract": 6.613028847895522e-05, "tract infection": 0.0001966306201362537, "individuals hospitalized": 0.0012024349374430412, "ami without": 0.0010107559560886294, "day reduction": 0.002538834826408704, "hospital length": 0.0017899108771432786, "consistently associated": 0.004350167044967192, "higher rate": 0.00435420359685112, "urgent need": 0.00042459615684358376, "reduce costs": 0.0009121919672745065, "undergoing procedures": 0.0008748672862478836, "medically managed": 7.314125331058576e-05, "managed diseases": 0.00020030811394787572, "well understood": 0.0011117340343748654, "inpatient data": 0.00162024505214451, "care hospitals": 0.002412950314806415, "divided physicians": 0.0005356716477157248, "quintiles according": 34.49849194158135, "used patient": 0.004180376776712105, "level regression": 0.001423891877018636, "compare 30": 0.0014834307962976777, "costs across": 0.0008057139436070926, "across volume": 0.002203382873952527, "hospital characteristics": 0.002038758937852953, "examined physician": 0.0012152545810972756, "volume within": 0.0024939544431970637, "within strata": 0.0008395263754522855, "physician specialty": 0.0007750363730769734, "cared for": 0.01337057191758836, "physicians had": 0.00286267107831481, "volume hospitals": 0.0021900904611999662, "in contrast": 0.03547846087488991, "higher readmission": 34.50076449848613, "the relationship": 0.027113300733936606, "volume institutions": 0.0018035227798654187, "among noncardiologist": 34.49943859783396, "noncardiologist physicians": 34.4985628205774, "clinician expertise": 9.331741453229484e-05, "neurohormone known": 34.49859787072228, "affect electrolytes": 0.00018891102000120625, "major clinical": 0.0039061926222869, "trials designed": 0.0013235007563561518, "analyze clinical": 0.003254739254075954, "outcomes using": 0.004708297907248574, "symptomatic chronic": 34.500568046098344, "mortality significantly": 0.006136921338216101, "significantly compared": 0.004447688166813412, "standard therapy": 0.00350930163525614, "beta blockade": 0.0009520211684906886, "another study": 0.004696436403515332, "infarction patients": 34.51815213717955, "patients randomized": 0.019789546408894722, "antagonist eplerenone": 68.99689447146801, "these trial": 0.0030631427128603853, "trial results": 0.002381365255961991, "results provide": 0.0016484259425501135, "improving survival": 0.0015497144572936918, "based management": 0.0023062497362341576, "contemporary therapeutic": 0.0008090317459946161, "substantial improvement": 0.0013422385896563148, "limited evidence": 0.0016423551999748091, "available specifically": 0.00032166551619314986, "thus examined": 0.0007654169505416876, "examined changes": 0.0021270269406423745, "large idiopathic": 34.49884799113189, "cardiomyopathy cohort": 34.50016449720543, "cohort systematically": 0.0015292754231209667, "systematically followed": 0.0007880015038921369, "53\u00b112 years": 34.500482376577146, "32\u00b110 %": 34.51696757413345, "including negative": 0.0009883854188427593, "negative coronary": 34.499538510808556, "enrollment periods": 0.0003671198505319148, "failure treatment": 0.02123455855127971, "treatment eras": 0.003638636512543305, "receiving angiotensin": 34.49977634108369, "angiotensin receptors": 68.99767688651616, "receptors blockers": 34.499280617705054, "final evaluation": 0.00040183130485312317, "evaluation increased": 0.003025198436438272, "period 1": 0.0026353305349154353, "toward enrollment": 0.0004565711306771448, "severe left": 0.0051576567052497475, "point including": 0.001356466933637267, "including death": 0.0030726496496906357, "failure related": 0.018646895424074637, "recent enrollment": 0.0007771467674622305, "enrollment period": 0.0011346919717854374, "period represented": 0.0009882330034377265, "powerful independent": 0.0005687858289524967, "period 2": 0.002823032271486705, "period 3": 0.0024403123948267685, "each period": 0.00101784812408075, "% risk": 0.02334271438915729, "risk reduction": 0.005782239921560974, "reduction versus": 0.003113723241322421, "reflecting marked": 0.000225747653849621, "marked decreases": 0.0003643161952708447, "related mortality": 0.005229634484946436, "based treatment": 0.00466882265058691, "dramatic improvement": 0.0012789183225959961, "controlled randomized": 0.001417910088488967, "real world": -7.494695877601477e-05, "tailored follow": 0.0021588584726561512, "term continuity": 0.0014353279852349927, "indeterminable anaerobic": 68.99645211896322, "maximal cardiopulmonary": 34.49877032423308, "always identified": 0.0009332749712001742, "prognostic meaning": 34.49906486983302, "prospectively followed": 34.49901493503328, "dedicated hf": 5.542751384065115e-05, "stable clinical": 0.0036575817331945615, "clinical conditions": 0.0034918470992122506, "underwent clinical": 0.0039016725118443153, "test investigations": 0.0009379093119146331, "study enrollment": 0.004901507972363982, "excluded 921": 34.49839479859211, "maximal exercise": 34.502356139240845, "anaerobic metabolism": 34.49860001276277, "peak respiratory": 0.001180045085975039, "respiratory quotient": 0.00010103704115414913, "quotient \u22641.05": 34.4982257094572, "urgent cardiac": 0.005805612086676149, "multivariable logistic": 0.00033993620767604226, "logistic analysis": 0.0021896316548983955, "resulted significantly": 0.0022222342282622806, "reduced peak": 0.003923988401257969, "higher metabolic": 34.500356251903774, "score value": 0.0017243969914011014, "powerful prognostic": 34.49909503955757, "prognostic composite": 34.49955193264103, "composite hf": 0.0005093380282740104, "multivariable analysis": 0.0023257416318123057, "% pred": 34.51696757413345, "ventilatory efficiency": 34.498318848533366, "efficiency slope": 0.00019364977814642425, "at nonidentification": 34.50104127861405, "prognosis also": 0.0014394077552463917, "secondary study": 0.004859411410174437, "the inability": 0.026535245098456423, "identify at": 0.003410136753984289, "often occurs": 0.000467946562399469, "prognostic role": 34.500074426857005, "failure mortality": 0.02184123976602844, "joint associations": 0.00025766951941682105, "associations among": 0.0014493359250710497, "among cardiorespiratory": 34.49943859783396, "additive effect": 0.0013616860282773047, "increasing number": 0.0006003480010562557, "factors on": 0.004335861962672912, "versus unfit": 0.002033718071874084, "men without": 0.0015009412866040378, "disease underwent": 0.004052609020513015, "baseline examination": 0.0019330039867785289, "measures included": 0.0019525328278324778, "included body": 0.0021483524055305597, "maximal treadmill": 68.99665628450768, "treadmill exercise": 34.50215197427538, "specific low": 0.0022294048098801447, "high crf": 0.0017218476483801903, "deaths occurred": 0.0009265867283222537, "ratios across": 0.000990752028427722, "across high": 0.0021690647856602453, "low crf": 0.0016092487076131735, "obese body": 0.0013987744754246087, "index categories": 0.0020234246028771516, "when grouped": 0.00022352686280000065, "fit compared": 0.0027060501332817413, "overweight body": 0.001092890944989409, "index strata": 0.0019295872177339283, "obese men": 0.0008964029588076131, "within men": 0.0012279740370400001, "men matched": 0.0009974180032912938, "fit men": 0.000673479221749718, "factors present": 0.0016067560122188071, "moderate level": 0.001385135148216221, "presumably decreasing": 9.875623906457989e-05, "mitochondrial energy": 34.49926343255993, "energy production": 0.00047899656809266143, "production precede": 0.0002580109557802994, "overload hypertrophy": 68.99750686912233, "significant alterations": 0.002372945407462794, "metabolism precede": 0.0004078082238181802, "hypertrophied heart": 34.51699486312704, "hypertrophy secondary": 34.499169094992425, "abdominal aortic": 0.0006456234529354891, "energy substrate": 34.49851492955718, "substrate metabolism": 34.49856598382116, "isolated working": 0.00048317690206336014, "working hearts": 0.0004463483486109605, "hearts obtained": 0.0007987452640202358, "obtained 1": 0.002065779305576896, "mice subjected": 0.0010503263895249306, "progressive development": 0.0012073916175445642, "vivo assessment": 34.49903425654361, "via echocardiography": 34.49935465932933, "demonstrated diastolic": 34.50100807990913, "dysfunction by": 0.007798395911082025, "% ejection": 0.022786402170639722, "marked cardiac": 0.005799646926370213, "stimulated rates": 0.0016032435742125693, "glucose oxidation": 34.49836200124913, "membrane translocation": 0.00030590379239038454, "glucose transporter": 0.0002038256517879933, "transporter 4": 0.0012129520079412774, "overall atp": 0.0001468104629651429, "production rates": 0.0016581306639251309, "decreased at": 0.003730333898993715, "mitochondrial oxidation": 68.99720062254497, "fatty acids": 6.595484208759024e-05, "myocardial glycolysis": 68.99879879859611, "glycolysis rates": 34.49972809259463, "reduced mitochondrial": 34.50178586392359, "mitochondrial complex": 34.49929255613847, "complex v": 0.00031799336461548665, "v activity": 0.0007977899381335085, "the development": 0.02754512886860118, "oxidative metabolism": 34.498668068909105, "early metabolic": 34.499505733270716, "metabolic changes": 34.50012000216286, "energy deficit": 0.0005204013698581544, "the reality": 0.026511735441820786, "guide health": 0.0013048427796167558, "service planning": 9.294363473726596e-05, "relevant health": 0.0013274666228817083, "service provision": 0.00014855287220314585, "provision related": 0.0010779850616758225, "well delineated": 34.49914449722864, "systematic search": 0.0004176256826626546, "reduced gross": 0.002905494635738875, "gross income": 0.00012260259566153662, "expenditure on": 0.0033605029412388243, "heterogeneous region": 34.4983241057516, "factors of": 0.044681152148230055, "nondeveloped countries": 34.49828971687657, "including lower": 0.0024968787483296904, "raised blood": 0.0008900057231905154, "blood glucose": 0.0010280587491282686, "glucose levels": 0.0018694748902702005, "systemic hypertension": 0.0014604438791972665, "main etiologies": 34.49835497498235, "alcohol related": 0.0010344814903592372, "the prognosis": 0.027218357219377848, "main cause": 0.0016917380945292246, "awful paradox": 6.209502696759775e-05, "added factors": 0.0012095035383577638, "lower gross": 0.0018264987949496597, "gross national": 0.00022327571675416995, "national income": 0.0001574913404080299, "income per": 0.0007757901924471685, "new strategies": 0.001210180363557713, "previously linked": 0.00033729758704157786, "individuals aged": 0.0008485504694791276, "renal chloride": 34.499518424373534, "chloride channel": 34.49859070370249, "channel gene": 0.001043742781220875, "the following": 0.026743252763256162, "total cholesterol": 0.0009352639547261179, "novel finding": 0.0005482736618023877, "partly explain": 0.00011541661871725383, "reported greater": 0.0006798218270355303, "failure linked": 0.0178164040297209, "requires confirmation": 0.0003220337772427612, "ambient air": 8.874693690188792e-05, "recognised risk": 0.004592077409871759, "important trigger": 0.0008640687078687837, "colleagues provide": 0.00048370283298768287, "new systematic": 0.0007715938398861085, "common disorder": 0.0010851783050915677, "disorder associated": 0.004354728640542944, "high morbidity": 0.0021296442939194235, "elderly people": -0.00017089919109836095, "pollution experienced": 0.000385182651997484, "experienced in": 0.03557282115418985, "industrial areas": 1.647316969683693e-05, "aggravate cardiovascular": 0.0020390614601999845, "cardiac overexpression": 34.503933268826465, "exacerbates heart": 0.018836687529692274, "key regulator": 0.00021398398726491682, "cytoskeletal actin": 68.99645211896322, "actin dynamics": 34.498358142009685, "previously demonstrated": 0.0011634263690743713, "cardiac mena": 0.00563915175110564, "deletion produced": 0.0002501224988786843, "produced cardiac": 0.005855770489719817, "conduction abnormalities": 34.498531608039094, "expression correlates": 0.0011504364335129917, "precise role": 0.0010630552022219402, "cardiac pathophysiology": 34.50413742684495, "evaluated mice": 0.0018682509113118083, "cardiac myocyte": 34.503967296610156, "specific mena": 0.000620156102266971, "cardiac pathology": 0.005706509585557746, "morphologically comparable": 34.49832569092583, "type littermates": 34.499689477236494, "mildly increased": 0.002788937912535046, "increased heart": 0.0215244129546198, "heart mass": 0.019979155419652256, "transgenic mice": 34.49917745563286, "particularly susceptible": 0.0003030858242087468, "animals experienced": 0.0005828491847443807, "experienced pronounced": 0.00035501410167416633, "pronounced decreases": 0.0003025761015858621, "heart dilatation": 34.517403179165065, "levels eliminated": 0.001765107262712977, "eliminated cardiac": 0.005670725601570804, "preclude post": 0.00083883122916589, "- tac": 0.0454147422947591, "tac cardiac": 0.00563915175110564, "cardiac functional": 0.007540086375557106, "functional deterioration": 0.0020358234239858156, "findings indicate": 0.0004904107029140264, "increased levels": 0.004455113490330753, "fare worse": 0.00021416593584883416, "mechanical support": 0.0014917559900656748, "support devices": 0.0020222430865086197, "a cardiology": 34.51111384902892, "considerable number": 0.00038075477164417425, "patients eventually": 0.01874505200099601, "eventually reach": 7.436199966084059e-05, "diagnostic procedure": 0.0007431388339098168, "alternative treatments": 0.0004923521944947551, "slow progression": 0.00039114086225490864, "palliative care": 0.0020128802434343364, "accurate recognition": 0.00012138176363259598, "advanced disease": 0.004043661276521952, "overall management": 0.0013895457473137795, "failure requires": 0.017920762956643035, "multiple disciplines": 0.00025082426717637355, "collaboration among": 0.0013055040077401075, "among cardiologists": 34.499472627354564, "cardiovascular surgeons": 0.0020388860138086198, "medical staff": 0.0010479603848926782, "staff responsible": 6.593434956209315e-05, "patient care": 0.0043455242087238055, "physicians experienced": 0.0006270493469935282, "distributed evenly": 6.086690388934782e-05, "equitable access": 4.27896494062811e-05, "made regarding": 0.00030690669450630405, "regarding appropriate": 0.0005858300166385923, "appropriate referrals": 0.00039376734134721655, "patient circulation": 0.002601714569336792, "the aims": 0.026696790064969875, "present consensus": 0.000629642531717356, "consensus report": 0.0005024769751619606, "experienced centers": 0.0003883406797038075, "patients irrespective": 0.018870648505184252, "disease phase": 0.0034651315849584963, "healthcare staff": 0.00010277759567396582, "raise awareness": 6.542159841600973e-05, "provide information": 0.000492799061991182, "information regarding": 0.00025500798253428, "regarding conditions": 0.0006643899440926381, "other antihyperglycemic": 34.49913372873259, "recent postmarketing": 34.498698531449925, "postmarketing trials": 34.499343465541365, "trials produced": 0.001368054029478417, "produced conflicting": 0.0002834502338917446, "conflicting results": 0.0012524262620356072, "hospitalized heart": 0.01958415058727776, "dipeptidyl peptidase-4": 68.996384060501, "creating uncertainty": 3.9287091858341854e-05, "user cohort": 0.0014673506985710706, "health insurance": 0.0012297676581748455, "health system": 0.0017518478433923115, "system data": 0.001990949160824095, "data partners": 0.0014295761082676233, "patients aged": 0.01916284205565911, "aged 18": 0.000825742799715823, "initiated therapy": 0.0031211826404640166, "generation sulfonylureas": 34.498300603425875, "acting insulin": 0.0006017695353404705, "insulin products": 0.0005265107311830366, "codes 402.x1": 34.49829236434836, "principal discharge": 0.0007378494064947245, "discharge diagnosis": 0.0013897391368810485, "saxagliptin users": 34.49881730599778, "sitagliptin users": 34.49881730599778, "users contributed": 0.0004812747472162399, "pairwise comparisons": 34.498360595941016, "study drugs": 0.00497656408650457, "ratios from": 0.004993970194438412, "disease risk": 0.007770604266325353, "risk score": 0.005698955939974822, "versus sitagliptin": 34.500328878562534, "stratified hazard": 34.50036724699727, "matched analyses": 0.0009827241522202903, "also similar": 0.0016336600823443842, "without prior": 0.0013680369736478889, "prior cardiovascular": 0.0023631896103240837, "subgroup defined": 34.49899828554602, "highest drs": 0.00014417879825783843, "residual confounding": 3.385465315541544e-05, "short follow": 0.002315656969916244, "sitagliptin compared": 34.50095298097862, "selected antihyperglycemic": 34.49848688036837, "improving physician": 0.0009725309199535964, "guideline recommendations": 0.0010098892923700695, "recommendations in": 0.035646134870655946, "review protocol": 0.0009877398393279453, "the uptake": 0.026776071279716537, "uptake of": 0.043881367983539726, "remains suboptimal": 0.00044533402728493725, "identify implementation": 0.0007531299785647407, "improve physician": 0.0014560004879614523, "clear evidence": 0.0011703967888194201, "benefits outweigh": 0.0004860118934675266, "use american": 0.0015367603468870832, "literature search": 0.00020960784915189078, "include prospective": 0.0006570215664317841, "prospective studies": 0.002089159886570248, "evaluating implementation": 0.0003266040486285813, "implementation interventions": 0.0008360827932703213, "interventions aimed": 0.0010384794117140668, "improving uptake": 0.0005686496600895892, "extract data": 0.001447822436150031, "classify interventions": 0.0007113744860147629, "interventions according": 0.000943752535986749, "systems level": 0.001057527680710894, "common underlying": 0.0013245968622879315, "underlying characteristics": 0.000982706789131423, "financial incentives": 6.330959502557863e-05, "include proportion": 0.00031290996527853505, "recommended pharmacological": 34.498625610451434, "device consideration": 0.0010164504137511407, "provided self": 0.0005326675509505958, "care education": 0.002025498392460381, "provided left": 0.004139640242472081, "function assessment": 0.003413753947976196, "include clinical": 0.003235606355412158, "common elements": 0.0010420256037334825, "failing interventions": 0.001009368153913488, "contextual framework": 0.0002994157543137494, "results narratively": 34.49937762501726, "pool results": 0.0012411977259742751, "briefing reports": 0.00012295240574967476, "patient perceptions": 0.0023996514858800446, "qualitative study": 0.004664541611025316, "determine patient": 0.0028998576443239406, "patient awareness": 0.002423154250239154, "grounded theory": 2.4731458001885052e-05, "analyze interview": 0.00020486742957108594, "interview data": 0.001418874012634782, "the sample": 0.026735553724261753, "predominately male": 0.00045742810596105185, "patients identified": 0.019735181988789385, "identified three": 0.0014139817035389054, "felt implantable": 34.49893931165538, "significant deterioration": 0.0021682610498046963, "sound mind": 4.103483797874572e-05, "engage in": 0.03540619403492697, "patients wished": 0.018765929986060165, "previously established": 0.0003632537599277711, "established preferences": 0.00047463222931846266, "most patients": 0.01928425803161072, "consider deactivation": 34.498472138950156, "never turn": -5.633458277126077e-05, "preferences identified": 0.0012612955551969535, "study support": 0.005887753335895446, "include information": 0.00021307699015648394, "within broader": 0.0008351402191266272, "broader discussions": 0.0002585484705082887, "life treatment": 0.00484041778060584, "treatment preferences": 0.0038668305779910785, "patients determine": 0.019268767838761178, "deactivation preferences": 34.49872577258393, "patients experiencing": 0.018796801478132938, "experiencing distressing": 9.48964255153224e-05, "distressing implantable": 34.498974049746835, "defibrillator shocks": 34.499041230977106, "carotid baroreflex": 68.99645211896322, "baroreflex activation": 34.49870171917157, "activation therapy": 0.0034986144557971927, "decreased parasympathetic": 34.49927728422508, "activity contribute": 0.0011252573293543083, "bat results": 0.0011855947667580406, "centrally mediated": 34.49863420094169, "mediated reduction": 0.0016572401065453142, "sympathetic outflow": 0.0005421400029721686, "increased parasympathetic": 34.501117778767714, "fractions <": -0.004676201563233553, "chronic stable": 0.002776931890448195, "stable guideline": 0.0012854010375491804, "directed medical": 0.0010890140932325527, "enrolled at": 0.0033573582675138656, "receive ongoing": 0.00025643516963571146, "gdmt alone": 0.0002445042345700124, "primary safety": 0.001886610970925687, "safety end": 0.0028951399679234104, "related major": 0.001871340442328433, "efficacy end": 0.0027262914993966716, "minute hall": 0.00023643775136551466, "hall walk": 0.00027151646368037016, "free rate": 0.002788945092722594, "confidence bound": 0.0017057565579933244, "bound 91.4": 34.498284118388206, "patients assigned": 0.018936773584161206, "group patients": 0.021403954030215, "experienced improvements": 0.00069123641932356, "distance walked": 0.00042218721205858, "\u00b1 13.2": 34.50101438449672, "points vs.": 0.0012349914159499376, "class ranking": 0.001309896179011691, "bat significantly": 0.0019249319247659808, "reduced n": 0.0042945687137272625, "toward fewer": 0.0004485006154275928, "fewer days": 0.0011076532411713829, "days hospitalized": 0.001626395899121126, "improves functional": 0.0025794967164223955, "failure hospitalizations": 0.018003374159454643, "preliminary report": 0.0005391370269814769, "using cardiopulmonary": 0.0019244356764771308, "testing guide": 0.0006224715427910721, "guide exercise": 0.004053610015634318, "standard clinical": 0.0035728733519858617, "rare using": 0.0016741435261942975, "prescribe exercise": 0.0039588919253144405, "performed symptom": 0.001176745184183883, "symptom limited": 0.0007248849987048219, "limited maximal": 34.49902004548937, "maximal cpet": 34.49843022473657, "randomly divided": 0.0004697278032665815, "control without": 0.0028951604363388356, "exercise patients": 0.022661323317152766, "patients used": 0.02054928697114934, "used \u03b450%w": 0.00181387815826722, "\u03b450%w intensity": 6.472613996412989e-05, "exercise 30": 0.005346899959692579, "x12 w.": 68.996384060501, "w rehabilitation": 0.0004690138654755872, "evaluated functions": 0.0010124521023233384, "groups patients": 0.020189903556101407, "exercise duration": 0.0044001778592973675, "distance 6": 0.00224183387232987, "minutes walking": 0.00045252633944216646, "nosignificant changes": 34.49977973300914, "guiding exercise": 0.003958190139901999, "failure affects": 0.017693450154060493, "affects nearly": 0.00010173196784112385, "newer imaging": 0.00033554310137280956, "imaging techniques": 0.00036641459206042127, "hfpef patients": 0.01873540881288212, "completely normal": 0.000670836177895644, "reduced long": 0.003915116126737089, "long axis": 0.0011702955795733993, "axis function": 0.002876202743509254, "subtle changes": 0.001618399377998015, "older women": 0.0011879823753600505, "other cardiovascular": 0.0029135775542494177, "often nonspecific": 34.49852789515329, "primary symptoms": 0.002052149333578237, "fluid retention": 0.00013313607249360008, "single diagnostic": 0.000903432341020126, "diagnostic test": 0.0014228505662520134, "assessment remains": 0.0009474527189421591, "thorough medical": 0.0010684938831471303, "medical history": 0.001348410460269145, "the duration": 0.02697828549550829, "classify patients": 0.018802942093756818, "patients according": 0.019035320143728805, "functional assessment": 0.002504966431489754, "standing blood": 0.0009424568757441555, "valvular disease": 34.50146352247284, "pulmonary congestion": 0.0013599192929709687, "jugular venous": 68.99648614732587, "peripheral oedema": 0.00037290147117332364, "oedema allows": 8.03344732402225e-05, "allows assessment": 0.0006505116271230949, "volume status": 0.0026519673383688463, "failure nurses": 0.01779500890365983, "local cardiology": 34.498209023723355, "cardiology services": 34.498203590479505, "reduce mortality": 0.004765684574397589, "regular physical": 0.0002169696278109073, "activity controls": 0.0012341709044931697, "controls acquired": 0.0004953173906397404, "acquired cardiovascular": 0.0020648450170449037, "generally associated": 0.004411206530191981, "exercise extend": 0.004051680113453348, "extend well": 0.001078232587323952, "cardiovascular system": 0.002580609167904053, "recent evidence": 0.0015590356466022755, "exercise prevents": 0.0040271258339314555, "prevents cell": 0.0006340440190890265, "cell senescence": 34.49872486293993, "active individuals": 0.00047233405614150256, "developing certain": 0.00013961283582172688, "certain malignancies": 34.49821570240482, "malignancies including": 34.498956603689884, "including cancer": 0.0009782096223082872, "exercise regularly": 0.003946961606795667, "regularly extend": 0.0001468127117077243, "even lower": 0.0019546536656545755, "lower volumes": 0.0017623001436880806, "recommendations confer": 0.00036342738971608285, "confer health": 0.0012110019214084983, "health benefits": 0.0016296554014561032, "highly relevant": 0.0003662363150331415, "established cardiac": 0.005852261601134412, "cardiac disease": 0.008842585511229123, "disease including": 0.0039680071995073524, "including heart": 0.01956740631592073, "rare with.estimates": 34.49828183759672, "with.estimates ranging": 34.498320778436565, "congenital abnormalities": 34.49859966534335, "nontraumatic death": 34.500500106460805, "in middle": 0.035323573658887, "aged recreational": 0.00045830530832265744, "recreational athletes": 0.0001899636762651875, "cardiac deaths": 0.00596328568340342, "deaths occur": 0.0006228398018170765, "advocate pre": 0.00034640919586987105, "- participation": 0.04554436771016556, "participation screening": 0.00015347964529829682, "detect congenital": 34.49839392483432, "congenital accessory": 34.4983274453892, "accessory pathways": 0.00040710122782732975, "ion channelopathies": 34.49822255142368, "frequently abnormal": 0.0006053068105127422, "older athletes": 0.001054542323495745, "limited value": 0.0011824323104222022, "value given": 0.0007181849936722876, "overwhelming contribution": 0.00022328909514184665, "assisted training": 0.0011400774238931558, "training for": 0.014310508063669933, "small pilot": 0.00042427929934540356, "assess robot": 0.0007343294858496738, "\u00ae system": 34.4988688176505, "% completed": 0.01892095079097916, "week aerobic": 34.49864119806973, "aerobic training": 34.49940208909934, "training period": 0.0018699368134539678, "trainings per": 34.49893941133329, "integrated dynamic": 0.0002571449045472974, "dynamic resistance": 0.000738401786601251, "lower limbs": 0.0017651072836131982, "underwent testing": 0.0013439512918169312, "combined training": 0.0013705401301417524, "training resulted": 0.0013031927132055403, "peak work": 0.0010947562584728977, "work rate": 0.0025123201042424616, "+ 61": 0.000801169677064092, "oxygen pulse": 0.0006433495960815074, "+ 44": 0.0009344702010598708, "the quality": 0.028227555304916167, "life assessment": 0.001839141388942739, "assessment indicated": 0.000902211339183309, "indicated better": 0.0007553826524391535, "better well": 0.0014096700984353818, "combined aerobic": 34.498760848410065, "training intervention": 0.0014068446561821578, "augmented feedback": 0.00012927625946718366, "feedback resulted": 0.00032484089403578953, "muscle strength": 0.0009664042311600162, "larger studies": 0.0017311881055950475, "psychosocial factors": 0.0010718333039252926, "influence adherence": 0.000461654414023018, "exercise adherence": 0.004265663107885683, "completed surveys": 0.00017592808120178428, "assess social": 0.0008256976867427095, "perceived social": 0.00024905854570571014, "support score": 0.0023886763653451276, "exercise score": 0.005057699938043598, "indicated higher": 0.0021221320317036437, "higher levels": 0.003557485911806435, "higher btes": 0.0018239524995586228, "btes indicated": 0.0002981795321450211, "months correlated": 0.001740864181649358, "r= 0.13": 34.49836200124913, "higher exercise": 0.005749867003829268, "time associated": 0.0054852788421927545, "for cardiovascular": 0.015310526246725516, "randomization group": 34.50089460498844, "borderline association": 34.49903176789325, "increasing btes": 0.00028379303089425364, "ratio 1.25": 0.0028737465138202545, "interval 0.99": 34.49992590498737, "care group": 0.0046475708076118005, "ratio 0.83": 34.50123696430874, "interval 0.66": 0.0016654705925020457, "poor social": 0.0003909450586867678, "high barriers": 0.001921457958129408, "greater impact": 0.001362665850809433, "training improves": 0.0016844525016801698, "perceived barriers": 0.0003309901849925753, "facilitate individualized": 0.00026889805261550326, "individualized approaches": 0.0003699235165361038, "implement exercise": 0.003948014279096672, "training therapy": 0.003994815944434302, "blocker hypo": 34.49900508394704, "hypo -": 34.54360677254526, "- response": 0.046257405488399614, "blockers reduce": 0.001438114176368752, "standardized exercise": 0.0040271258339314555, "exercise protocol": 0.004093778409557462, "respiratory gas": 5.980755145338955e-05, "gas analysis": 0.002080168256518613, "patients participated": 0.018765228201509603, "care programme": 0.0021198709515455167, "programme aiming": 0.0001717174268122657, "achieve guideline": 0.0007303052706353303, "target doses": 0.0005154954949742724, "hr<70 bpm": 34.49832814485905, "hr<70 versus": 0.0018986538259633161, "similar dose": 0.0022328761727891866, "significantly larger": 0.00204087260626519, "larger hr": 0.00011594068149920905, "17\u00b122 versus": 34.50009068407646, "significantly higher": 0.0037488844243246033, "lower resting": 0.00196822304481923, "in recent": 0.0358230633335168, "controlled <": -0.00441416673968488, "aggressive dose": 0.001486713844917197, "many patients": 0.01874606621625644, "little hr": 0.00013924917397517087, "unidirectional left": 0.003773774854147013, "reduce elevated": 0.0011984135975065737, "elevated left": 0.004418493290706118, "pressure improve": 0.0025469017447034654, "potential efficacy": 0.0013106262576283632, "therapeutic left": 0.004554566225851891, "aged \u226518": 34.49861946349328, "canadian special": 5.647299823798777e-05, "special access": 6.663611933747566e-05, "access programme": 0.0001510084823660836, "shunt implants": 0.0001013879340301116, "transseptal catheterisation": 34.498225884903654, "transoesophageal echocardiographic": 68.99696248362153, "echocardiographic guidance": 34.49879834285342, "general anaesthesia": 34.498383385128705, "echocardiography evaluations": 34.49893971274373, "months 1": 0.0028662017516278087, "shunt implantation": 0.0007138307349578625, "enrolled ten": 0.0005235427635758221, "the device": 0.02746048345562051, "successfully implanted": 0.0003637886997539256, "procedural adverse": 0.001118846374483706, "month showed": 0.0016673869895769537, "from baseline": 0.00618400442638866, "recorded improvements": 0.0005551287581109789, "sd 6\u00b72": 34.4981920302505, "[ 12\u00b79": 68.99964825707733, "sd 9\u00b78": 34.4981920302505, "test distance": 0.001173990346406395, "sd 112": 3.31528674351601e-05, "pulmonary resistance": 0.0018657310318587626, "no patient": 0.003911166370698134, "month 1": 0.0023498443283477446, "incessant ventricular": 34.50295026830221, "tachycardia storm": 34.49838374550241, "failure 2": 0.0195882362203203, "months post": 0.0018660401223107575, "- procedure": 0.04558032539975706, "man experience": 0.00017852338609415148, "implanted left": 0.00401144705355108, "interatrial shunt": 34.498327972886486, "shunt demonstrates": 0.00013401388369273785, "demonstrates initial": 0.00022258963977937505, "initial safety": 0.0009023377881624724, "early beneficial": 0.0014461182055248972, "beneficial clinical": 0.003525181590481568, "haemodynamic outcomes": 34.50145210658633, "further large": 0.0009561883607881793, "scale randomised": 34.49840602021687, "randomised studies": 34.499841307195204, "study paradigm": 0.004697869345977258, "paradigm shift": 0.00015365627319120827, "crucial problem": 0.0002983481642567637, "current cardiology": 34.49887461392787, "major development": 0.0018948020989517302, "first results": 0.0018409997541545594, "neprilysin inhibitors": 34.49897409894461, "considered hopeful": 0.00033904054175391065, "dual inhibition": 0.0007774926212500938, "neprilysin blocks": 34.49838725441315, "blocks renin": 34.49838725441315, "concurrently supports": 0.0001561113517139927, "supports natural": 0.00012944367214302527, "natural vasodilatory": 34.498198866331194, "diuretic effect": 34.49965596928683, "scale prospective": 0.0006538729082369509, "prospective randomized": 0.001528050058487009, "randomized multicenter": 34.499348254671375, "multicenter trial": 34.499489887564565, "trial paradigm": 0.0012627774308579356, "stabilized chronic": 0.002205351168972923, "elevated bnp": 0.0006447184365591051, "pro bnp": 0.000496179592771223, "shown 20": 0.0009451334532624041, "group treated": 0.003916922117822127, "consistent also": 0.0009894021862078505, "specified subgroup": 34.498395327247096, "subgroup analyses": 34.498803636338494, "including quality": 0.0024881066038184704, "typical adverse": 0.0011434018111438145, "dual ras": 9.770240475419142e-05, "neprilysin inhibition": 34.499041962280295, "time become": 0.0012401631792483914, "stable chronic": 0.002776931890448195, "dysfunction treatment": 0.005985491591869773, "significantly contributed": 0.0020191254107698193, "study sites": 0.0047641636918612324, "quality work": 0.001705602171384566, "work provided": 0.0003479343952750324, "failure among": 0.018875817936038347, "older persons": 0.0009138661369734115, "primary symptom": 0.001275797358526225, "chronic hfpef": 0.0021718474087084167, "major determinant": 0.0008871991310966234, "reduced quality": 0.004534834314169638, "factorial trial": 34.499387800739704, "trial conducted": 0.001348546071659357, "urban academic": 7.893085259611081e-05, "academic medical": 0.00106130060254865, "medical center": 0.001225828166044667, "initially screened": 5.384907242130533e-05, "screened participants": 0.000871099586284296, "older obese": 0.0013016683410684321, "obese participants": 0.0012453924715590226, "declined participation": 0.0005268953028477374, "attention control": 0.002050680313350998, "control consisted": 0.0019172064549175828, "telephone calls": 7.156220306632945e-05, "capacity measured": 0.0020137481822442276, "score range": 0.0016002448723778167, "higher scores": 0.0022894435592485146, "scores indicate": 0.0005605617748041697, "indicate worse": 0.0002811717226342443, "worse heart": 0.018988933884056824, "enrolled participants": 0.0013472847472308814, "participants completed": 0.0009845817512905575, "exercise attendance": 0.003956260231288185, "diet adherence": 0.0011143993634667498, "by main": 0.005547127729155647, "main effects": 0.0015064810335270143, "effects analysis": 0.0034652843618023384, "kg body": 0.0020754432165182623, "the combination": 0.026665394544087048, "joint effect": 0.0012806457280607165, "significant change": 0.002845137713783191, "total score": 0.0019998670004537215, "main effect": 0.001354659761496922, "-1 unit": 0.00014768999736307917, "-6 units": 34.498307970932, "positively correlated": 0.0007454034276302237, "percent lean": 0.0003988511461903897, "thigh muscle": 0.0006087786872868745, "intermuscular fat": 34.49859386172631, "fat ratio": 0.003208571047980486, "related serious": 0.0010820129966783482, "serious adverse": 0.0011498859858238225, "weight decreased": 0.0013048344330864653, "among obese": 0.0016527852117522329, "clinically stable": 0.0008087300553085127, "training increased": 0.003727470487792181, "neither intervention": 0.00045901344256599316, "assist system": 0.0014836605557776768, "provide long": 0.001566646152794126, "term support": 0.002490327806769091, "centrifugal flow": 34.49903174474215, "flow pump": 0.0012110253680663859, "enhanced hemocompatibility": 34.49842531629396, "levitated rotor": 34.49829271524103, "wide blood": 0.0009352636468885888, "flow paths": 0.0008376097140567907, "artificial pulse": 0.0001662872037466652, "multicenter study": 34.50292497947969, "support)-derived performance": 0.0006250516842152224, "fraction \u2264": 34.50216806927062, "without inotropes": 34.499236815727194, "optimal medical": 0.0013761422964606643, "the indications": 0.026604882577374592, "patients continued": 0.018772063760442225, "% received": 0.018918135030797246, "received transplants": 0.00021029987515406136, "% died": 0.018937082756565703, "survival 92": 0.0014215041806233948, "% performance": 0.019400595567170643, "levitated lvas": 34.49826008871272, "predicted survival": 0.0013844938116824293, "key adverse": 0.0012377584908423293, "events included": 0.0028772234138750817, "included reoperation": 34.4993478258089, "driveline infection": 34.4983897129702, "debilitating stroke": 0.0006435099928165587, "pump exchanges": 0.000436738801239389, "pump malfunctions": 34.49859737064753, "pump thrombosis": 0.0004732245707926785, "hemolysis events": 34.49991345810598, "life scores": 0.001700600641594343, "scores showed": 0.0015543178520898088, "showed progressive": 0.0012551116818248682, "sustained improvement": 0.0012433097883406405, "levitated centrifugal": 68.99648614848383, "flow chronic": 0.0029775323797477295, "favorable adverse": 0.0012886372949898132, "event profile": 0.0006219224129650209, "improved quality": 0.0028991539268163023, "a web": 0.012856912074386212, "based program": 0.0014704207153472802, "program designed": 0.000578971728953672, "influence medical": 0.0011597030742011704, "medical resource": 0.0011982924390577636, "adjusted survival": 0.0021673372928944566, "projecting long": 0.0011371432908439689, "term costs": 0.0015919336815239547, "valid approach": 0.00037412674311701987, "extrapolating short": 34.498380928937074, "based simulation": 0.0011647257815463317, "simulation tool": 0.00028678600257679764, "tool designed": 0.0003576401384078999, "integrate data": 0.0015165826835418714, "laboratory characteristics": 0.0009478040898028296, "based medications": 0.0013341600199262308, "generate predicted": 0.0001904917452068316, "predicted outcomes": 0.0032553416025207483, "survival projections": 0.0012850386794565495, "modified seattle": 6.437524762773019e-05, "modeled using": 0.0016181908331265994, "using relationships": 0.0016730908540779793, "evaluate parallel": 0.0007084162097481811, "study designs": 0.004659804562609064, "hypothetical programs": 0.0003220337954806134, "simulations consist": 9.980775895949848e-05, "virtual cohorts": 34.49832428735623, "cohorts used": 34.50010799523363, "generate estimates": 0.00018364936054615495, "incremental cost": 0.00047337374652559305, "effectiveness ratios": 0.0009160796804999292, "user inputs": 7.191313341770784e-05, "model demonstrated": 0.0025096767841314505, "demonstrated acceptable": 0.0011067741621677133, "acceptable internal": 0.0002155729586378332, "external validity": 0.00018838467833338747, "replicating resource": 0.00019417438196661673, "survival estimates": 0.0013776514270217527, "programs across": 0.0007360980653255082, "scenarios demonstrate": 0.00023188594445713073, "term improvements": 0.0016684142744259013, "based treatments": 0.0013324055573190148, "demonstrate good": 0.0002543003482599807, "good long": 0.001157452338779761, "term value": 0.0018260484328250647, "provides researchers": 0.0001871474158379366, "conducting long": 0.0011678393323545022, "term cost": 0.0016394527872704043, "effectiveness analyses": 0.0008480362687966667, "debilitating chronic": 0.002239380689583113, "upcoming years": 0.002313323328811038, "years due": 0.002901538171467903, "demographic changes": 0.0016864578402236655, "essential role": 0.0011535626094333843, "supporting patients": 0.01878960820952329, "nursing interventions": 0.0009469332248287526, "nursing actions": 0.0004183309224857399, "enhancing medical": 0.00110269884994905, "pathophysiologic state": 34.49832987313999, "ultimately reduce": 0.0006445551798405157, "optimize quality": 0.0017568614782765173, "safety for": 0.0035126238780677304, "rates between": 0.0010222516304976067, "sample with": 0.007816118260592688, "translating to": 0.004786406146029009, "averted in": 0.008837560335199331, "improvements for": 0.0034348987632974192, "admitted with": 0.007830367874190418, "ulcers in": 0.008837604196812674, "tissue in": 0.008913814514851742, "respect to": 0.004780177836555298, "composition in": 0.008913507483855167, "composition with": 0.00784260231497899, "regard to": 0.0047931590649595, "biomarkers of": 8.635543910495018, "observed between": 0.0008312904625341468, "correlation to": 0.004845954767548898, "adiponectin at": 8.625277334269068, "correlate to": 0.004786406146029009, "adiponectin during": 8.62510210772191, "weight in": 0.008935077757934458, "prognosis is": 0.0016631441322063894, "guideline from": 0.0012826879647750368, "deficiency in": 0.008854574950755744, "literature in": 0.008861722333312998, "language on": 0.0008349062445380767, "deficiency from": 0.0011380432430546097, "reassessed in": 8.633377148096148, "audience for": 0.003327293240693943, "threshold of": 0.01092706234301902, "recommends against": 1.577748096743272e-05, "harms of": 0.010936271218968443, "transfusions in": 8.633394162711703, "confounded by": 0.0013629729311539214, "effects are": 0.0009949084626053725, "conditioning for": 0.0033340917376736352, "stemming from": 0.0011209409042831652, "made in": 0.008849607183066602, "resort to": 0.004785221884028834, "search for": 0.003345974575988968, "deal with": 0.007751128396987372, "comments on": 0.0008160071646869048, "department in": 0.0088718937344765, "categorization in": 8.633377148096148, "single most": 0.00021868145770921697, "stratification is": 8.626100622913643, "evaluated before": 0.0002659032918784652, "searched in": 0.008854092473263695, "predictors on": 8.62549161023324, "estimates was": 0.0028384838731515287, "predictors in": 8.633504743602076, "shocks during": 0.000562256791363569, "sex were": 0.003157471300445607, "study other": 0.0013846328414519665, "nesiritide in": 8.633453709306984, "hours of": 0.010938240659717172, "occurred from": 0.0012632220248288046, "sites in": 0.00886246585540831, "c from": 0.0012052625460072983, "enrollment to": 0.004845691597973061, "dopamine had": 0.0007165011395730452, "nesiritide had": 8.625247538961315, "nesiritide on": 8.625440575938148, "participants with": 0.007968029075464346, "function when": 0.0007414289307158032, "adoption of": 0.010908995051375738, "lessons for": 0.0033410639652668955, "reveal how": 1.2398831416690418e-05, "conversations with": 0.007765514765728546, "involvement in": 0.00884387463959384, "proteomics of": 8.635492872727026, "nucleolin as": 8.625539784791975, "accessibility on": 0.0008243831047530314, "structure by": 0.001469785499808615, "mechanisms by": 0.0014307647500908629, "abundance during": 0.0005449790063467491, "proteins in": 0.008999088087647796, "expression during": 0.0007992163732634394, "characterization of": 0.010910749512751701, "surprisingly had": 0.0006391517228449969, "defects in": 0.008862950456599353, "shift to": 0.004799692538847189, "subproteome in": 8.6333856554763, "system of": 0.011046004854860996, "shared between": 0.0006585825406656866, "interventions during": 0.0006980458450154747, "predictors for": 8.628001757482043, "pattern on": 0.0008400380123255345, "attenuated after": 8.625423709041408, "ies in": 0.00882914053352382, "evident only": 9.04418583059159e-05, "mortality between": 0.0017082480133825274, "attenuated in": 8.633394162711703, "process of": 0.0109196479446021, "measurements of": 0.01094442727212227, "months for": 0.0035998838186044485, "min in": 0.009101265695586704, "relations between": 0.0006699847660900173, "basis for": 0.003379782764671267, "requires further": 0.00019897713064989604, "applications of": 0.010915090057188326, "remaining in": 0.008851285340725861, "correlations between": 0.0006637143233088513, "remained when": 0.00016291170976930508, "modest when": 8.061347937395345e-05, "placed on": 0.0008210934950117232, "monitoring after": 0.0009239358739148942, "readmission to": 8.629513166702605, "strategies have": 0.0006896626113489007, "needs of": 0.010912281219223528, "searched to": 0.004802982145702758, "exclusion of": 0.010918993723305435, "observed with": 0.007934275167161792, "investigation of": 0.010936181362970206, "participation of": 0.010934736064927805, "apoptosis during": 8.62511061481257, "expressions of": 0.010910574066337138, "dogs during": 0.0005687023916251022, "fragmentation by": 0.0013799436851009497, "method from": 0.0011433045850097155, "dogs only": 8.925759890291316e-05, "band of": 0.010904915952472394, "numbers of": 0.010903029928745872, "detected in": 0.008845365930062785, "favour of": 0.01090798623887221, "pathogenesis of": 8.635492872727026, "attributed to": 0.004785572776180878, "become more": 0.0002257412774227129, "dysfunction is": 0.0020796062107744148, "requirements were": 0.003035360602440773, "blockers at": 0.0009334168447427715, "uptitration after": 8.625466243047372, "uptitrations in": 8.6333856554763, "hfpef with": 0.007758235364647642, "spironolactone more": 8.624898627846006, "correction for": 0.0033425113946957993, "uptitration of": 8.63550988589522, "blockers after": 0.0010797916170834775, "associations with": 0.007808927450050397, "levels between": 0.0010886340130819507, "significance of": 0.01093477992640648, "relates to": 0.004784651684806953, "patients above": 0.004723754454331032, "level had": 0.0008174126552011748, "guidelines for": 0.003428714336044793, "practitioners in": 0.00883742875038261, "application in": 0.008857730953465287, "article by": 0.0013973063304310901, "evaluated how": 0.0002268346263153715, "impairment at": 0.0007544973751023912, "documented by": 0.0014131816710176858, "physician at": 0.0008812946906621947, "impairment with": 0.007800420648862583, "intubations for": 8.627874161976115, "hypothesize that": 8.625406272933203, "seen by": 0.0014011175444717872, "physicians in": 0.008921838115248559, "visits in": 0.009040513256115953, "visits for": 0.003537527136082306, "catheterization from": 8.625703151841773, "catheterization during": 8.62512762855968, "dyn s": 8.624599662168219, "circulation had": 0.0006817741755769412, "derangement with": 8.632306242927273, "counseling on": 0.0008240760735947433, "indicators of": 0.010918906000136576, "therapy were": 0.003768778969001924, "pathways in": 0.008922583762020174, "incubated with": 8.632306242927273, "phosphorylation of": 8.635543910495018, "production by": 0.001402084824982084, "proteome of": 8.635458844653852, "profiled by": 8.625902560692104, "incubation of": 0.01090232971107619, "production of": 0.010949861406579863, "bound to": 0.004801052240390017, "improvement by": 0.001658539790403414, "mechanism how": 0.00011579194868251823, "testing for": 0.003449848421347023, "survival from": 0.001425887309932454, "inclusion through": 0.00015573372521747312, "point for": 0.0034741277870535226, "survival at": 0.0010255905749972185, "levels at": 0.0011456954439494037, "survival had": 0.0009362486719637323, "disease by": 0.002155411569509281, "uninephrectomy with": 8.632331764633488, "parameters between": 0.0007399246413479193, "weight with": 0.00786417258905828, "upregulated in": 8.6333856554763, "uninephrectomy to": 8.629351559474802, "incidence over": 0.00012047665556899796, "measured with": 0.007978287440846244, "prediction in": 0.008939463898292466, "incorporated in": 0.008836814688362305, "device with": 0.00799735069343238, "insertion of": 8.635467351889256, "support after": 0.0011729095961212001, "insertion are": 8.625215539185215, "shock after": 0.0009159556989305191, "conjunction with": 0.007774416899638675, "examined from": 0.001247439871322261, "support at": 0.0010265348237804943, "survival to": 0.005091308690072651, "outcome at": 0.0010840939319177797, "year when": 0.00021944268146705404, "eligibility for": 0.0033511940763758215, "transplantation be": 8.625340865024857, "requirement for": 0.0033506677377321504, "failure as": 0.0053905824373430885, "limited to": 0.0049254853941613965, "complications after": 0.0009688786432261441, "implantation are": 0.0008120036473321844, "limits in": 0.008852206429352565, "practice for": 0.003464709786973926, "budget are": 0.0006594614393206238, "limitations in": 0.008845716822584206, "point to": 0.0049260035795262325, "pacing on": 0.0009010320388133916, "strain in": 0.00893915686721498, "bivp during": 0.000537085543730458, "taken at": 0.0007198951509735027, "taken of": 0.010909912771162242, "setting for": 0.0034057843380525294, "correlated against": 0.00016108258627446458, "rvpo with": 0.007758235364647642, "analyzed by": 0.0014307208885044535, "surrogates for": 0.0033345303535562997, "mechanism in": 0.008947311618280517, "correlation of": 0.010970254272662204, "reported that": 0.0009234239931174721, "reduction for": 0.0036299217673299495, "improve such": 0.00030137316141872037, "man had": 0.0006355497765033334, "prolapse of": 8.635467351889256, "valve in": 0.00904165365661063, "sound in": 0.00884032187727941, "prolapse with": 8.632323257542827, "annuloplasty with": 8.632331764633488, "opening with": 0.007802172811082672, "obtained by": 0.0014281769230799575, "flow by": 0.0015559743722382386, "hypertension of": 0.01121692404179508, "systolic as": 8.626151936069785, "indication for": 0.003367287020694804, "possibility of": 0.01091605500552764, "improve after": 0.0010537043854437756, "considered because": 8.935153376635224e-05, "respond to": 0.004783291981594139, "hypertension with": 0.008072829695366532, "symptom as": 0.0010170359106762001, "disappeared with": 0.007791124194975633, "pressure to": 0.00521973811992313, "disappearance of": 0.01091022317369248, "opening to": 0.0048219676523979125, "surgery by": 0.0015558427881140968, "observation at": 0.0007282304566721333, "findings of": 0.011001164708026126, "restriction of": 0.010944602718475381, "motion by": 0.001360999162538825, "regurgitation as": 8.625582319521607, "disappeared after": 0.0008915756935561471, "reversed to": 0.004836746470586259, "suggested that": 0.0008795329520946344, "opposed to": 0.004783906040651748, "demonstrates that": 0.000874797798060417, "stratification for": 8.62794221696465, "months from": 0.0013863382309369614, "date for": 0.003350534181535048, "statistics in": 0.008851943261000394, "grouped by": 0.0013714364496970847, "models for": 0.0036356608231792415, "fraction was": 0.0037758375493196876, "egfr was": 0.0028073495005058583, "epidemic of": 0.010918511246067223, "patients into": 0.004757752071083506, "associations between": 0.0007059427454227527, "differences between": 0.0007810938750497081, "tested with": 0.00782374754364049, "curves for": 0.0033430377337088472, "class in": 0.009149247454165494, "p=0.27 for": 0.003326154413490173, "rates by": 0.0017215540999560197, "interaction by": 0.0014639115400670128, "establishment of": 0.010908512575576661, "responsiveness to": 0.004803508484808149, "concentrations of": 0.010936051910959777, "examined in": 0.008963971579023395, "bb at": 0.0007123120908874507, "obtained during": 0.000610709337332005, "examined as": 0.001118100894698083, "cogeneration of": 8.635450337273701, "report on": 0.0009179464526214347, "hearts in": 0.008955203055927332, "shortening by": 0.0014395341419915543, "transient only": 7.456793283632726e-05, "myocytes from": 8.625677631004002, "fraction from": 0.0020810968746365153, "index by": 0.001811515516679969, "usefulness in": 0.008854355642747077, "response after": 0.0010693526616382856, "measurements in": 0.0088712380945699, "echocardiography before": 8.624737807792345, "echocardiograms at": 8.625268827033665, "hospitalization during": 0.0010217397192030621, "remodeling with": 0.007996347499708055, "sensitivity of": 0.010978322023795405, "specificity of": 8.635475858979916, "spironolactone for": 8.628010262691483, "shown in": 0.008908638874677691, "use from": 0.001496798912544457, "regression with": 0.00791976586655509, "injury during": 0.0006007555474897934, "cohort with": 0.008115251388012681, "risks of": 0.010923334125186536, "perfusion by": 8.625936589344242, "neoangiogenesis in": 8.633377148096148, "weeks from": 0.0012866703516459077, "observed by": 0.0015305929319925598, "injected with": 0.007775162546475701, "start of": 0.01089719498912859, "perfusion in": 8.633411176748286, "b on": 0.0008160071646869048, "eds between": 0.0006552506600199974, "eds had": 0.0006229701878539644, "visit in": 0.008843214922466612, "hospitalized at": 0.000907641518572676, "required at": 0.0007701047237964495, "myocytes with": 8.632323257542827, "velocity of": 0.011029839664559254, "paralleled by": 8.625902560692104, "attenuation in": 8.633411176748286, "imaging for": 0.0034021905877802965, "velocity over": 0.00014656378668030206, "reliability in": 0.008871106509845524, "echocardiography with": 8.632459353627503, "velocities during": 0.0005540127255585163, "correlated more": 0.00037600620831216463, "aucs of": 0.01090232971107619, "vary with": 0.007791606671917465, "cutoff of": 8.635492872727026, "performance only": 0.00021390367206207455, "s'lateral of": 8.635458844653852, "performance for": 0.0034824173345439787, "relationship in": 0.00898146018188758, "two- to": 0.004786493869251737, "risk when": 0.0011807910220317935, "generated by": 0.0013692872355484302, "tracked for": 0.003342423671580807, "presenting with": 0.007791299641082381, "retained in": 0.008837209442431658, "nonsurvivors with": 8.632314750307424, "distribution in": 0.008867816902989956, "relationship as": 0.001135589497562268, "affected by": 0.001366523973789017, "coated with": 0.007766655166323153, "formed in": 0.008851416924711489, "ischemia after": 8.625457736535637, "covering over": 2.4973529276169793e-05, "stenting with": 8.632331764633488, "stent in": 8.633436696717666, "ivabradine in": 8.633479227105655, "calculated at": 0.0008219775321495342, "unloading of": 0.010910661789536669, "levels to": 0.005211413559024836, "hypoalbuminemia with": 8.632348778380598, "implantation from": 0.0012740954661207505, "surgery was": 0.0030086391591415446, "hypoalbuminemia before": 8.62462723254544, "prognosis after": 0.0010372706329522274, "correction of": 0.010918686692281816, "insufficiency after": 0.000875657906669558, "encountered after": 0.0008750877059969952, "seems more": 0.00022083235256104933, "algorithms for": 0.0033345742151656838, "examined for": 0.003460985458989748, "sternotomy for": 8.627882669356266, "revision by": 0.0013627097615551088, "replacement is": 0.0015253420778427178, "capacity for": 0.003609539382852628, "alternatives to": 0.00478579208390097, "categorized into": 8.624638922046042, "adhere to": 0.0047843446547260115, "nonadherence in": 8.6333856554763, "mortality was": 0.003860346853868388, "life was": 0.0031161268959819712, "walking in": 0.008885532141616326, "care on": 0.001310763562256635, "week for": 0.0033874042585139907, "travelled during": 0.0005441894987968465, "time in": 0.009127959618927305, "leads to": 0.004783906040651748, "obtained at": 0.0007859358844889976, "measured from": 0.0013326609020212884, "indices were": 0.0030639521775250272, "factors at": 0.0009802704168687738, "confirmed in": 0.008873779756383008, "complicated by": 0.0013613939156385672, "revealed by": 0.0014582534371218364, "embolize to": 8.629326037768587, "embolism to": 8.629368573221912, "presented with": 0.007770600959703129, "prolapse through": 8.624661864192559, "patient had": 0.0012145948424651856, "coefficients from": 8.625660616388448, "sample from": 0.0011704917217677329, "trial with": 0.008057177986948631, "limits of": 0.010925395606904935, "information to": 0.00478552217751266, "values of": 0.011009714357551456, "practice with": 0.007896790738131395, "switched to": 0.004785748222349301, "compared in": 0.009459829594035678, "stratified by": 8.625911068072256, "antagonist with": 8.632391310215702, "hr for": 0.003326154413490173, "life for": 0.003634931808966286, "people with": 0.007666792249046524, "disease such": 0.0009072140792339722, "participation in": 0.008861546887375435, "programme for": 0.003361365753806822, "sustainability of": 0.010918423522983122, "improvements with": 0.007866979714454889, "met in": 0.00883685686180819, "relation to": 0.004798946897635423, "sustainability with": 0.007774329176554575, "commissioning of": 0.010910530204743033, "programmes on": 0.0008483696570638046, "frailty on": 0.0008840194494956471, "risk after": 0.002000479489778624, "significant when": 0.0005473414580489128, "controlled for": 0.003417097536609265, "death as": 0.0015602889017752, "disease at": 0.0015131705309183213, "scores to": 0.004894402970885356, "vasopressin in": 8.633419683549473, "interruption of": 0.010910749512751701, "inhibitors of": 0.011055311431277713, "secretion of": 8.635450337273701, "processes in": 0.00887759568292881, "therapy is": 0.002231791746163584, "reactivation of": 0.010910793374365044, "report that": 0.0009602046585131637, "known as": 0.0010847299671425561, "resistance to": 0.004921366460903505, "mir-25 by": 0.0013545531294784105, "myocardium to": 8.629385586390105, "reveal that": 0.0008730433380695023, "integrate with": 0.0077833188891118935, "myocardium with": 8.632365791548791, "subjects over": 0.00017093901441353807, "base of": 0.010912765416563542, "blockade of": 0.010978848362900797, "blockers in": 0.009050245287379141, "neglected for": 0.0033340917376736352, "time from": 0.0014114279112261716, "bisoprolol in": 8.633394162711703, "controlled by": 0.0014454962525975023, "diabetes to": 0.0050483570450364605, "features of": 0.010918991882990343, "action through": 0.00012354439765899176, "registry from": 0.0011464187488982194, "determined for": 0.003382238992282808, "differ at": 0.0007628287299678772, "medications for": 0.0033938158055003506, "trastuzumab in": 8.633445203084683, "manifested as": 8.625531277411824, "diagnosed with": 0.007833482031249348, "cancer between": 0.0007086597057511019, "plays in": 0.008832165386108572, "patterns with": 0.007773583530960347, "scores with": 0.007874608129570115, "hospitalization through": 0.0005814961898521081, "contact before": 4.22566830278425e-05, "calculated from": 0.0012222742670847696, "also be": 0.0008465301253912463, "identified as": 0.0012332131431753244, "biomarker in": 8.633428190205931, "risk as": 0.0021250624757489754, "pool by": 0.001368453869282469, "paucity of": 0.010910705651142317, "outcomes with": 0.00853922579646699, "survival between": 0.0009685291441297653, "assignment to": 0.004794474910298893, "determinants of": 0.010910793374365044, "visits as": 0.001194642571790641, "readmissions as": 8.625624850633141, "assessments of": 0.010936095772553882, "needs at": 0.0007222635990347878, "discharges at": 0.0007207757541763045, "rate after": 0.001491249637551281, "years in": 0.009401727115184942, "% having": 0.004766933967716464, "% after": 0.005552572833967011, "discrepancy between": 0.0006634511536868416, "often had": 0.0007069364135515237, "changes at": 0.0011092377805484695, "times below": 5.4325710789998426e-05, "rest of": 0.010927235808668886, "matrix of": 8.635475858979916, "quantified by": 0.0013969577216827794, "biomarker for": 8.627925204085898, "compliance in": 0.008904080169694446, "cohort as": 0.0013402858725635473, "year for": 0.003506598699475901, "choice of": 0.010920570875789383, "treatment had": 0.0015242972375293117, "determined by": 0.0014106377082710457, "trend for": 0.0033903068910593574, "response with": 0.00796890116305777, "prolonged with": 0.007791738256618755, "comorbidities in": 8.633436696717666, "importance for": 0.0033728551102918396, "dd of": 0.01090232971107619, "rats after": 0.0010282396630751152, "development at": 0.000972588772917354, "weeks with": 0.007932296890470864, "assessed at": 0.0010006533903760444, "obtained in": 0.008902764327125367, "strips before": 4.497774634770568e-05, "matrix to": 8.629351559474802, "groups were": 0.0033851712711254795, "fraction during": 0.0015055735925442871, "strain as": 0.0010932861828896686, "relationship with": 0.007910555013011402, "cardiology in": 8.633394162711703, "method for": 0.0033568501726772026, "hospitalisation for": 0.00335136952271343, "failure during": 0.004944398131875038, "benefit in": 0.009000574911084218, "benefit over": 0.0001904882107576354, "reviewed by": 0.0014294927656490369, "duration is": 0.0016031262012389993, "benefit when": 0.00021043277304172417, "needs further": 0.0001360504877810541, "overload in": 8.633470721317465, "benefit with": 0.00792966974220804, "complications of": 0.011012521491074177, "management between": 0.0009659344811071566, "evaluated with": 0.007987449127037192, "hospitalization from": 0.0015972630012952905, "stay from": 0.0011792148508727967, "institution of": 0.010925351745503324, "option in": 0.008831682913822263, "consequences of": 0.010916712925917602, "deferred in": 0.008837472611984299, "matching for": 0.0033509747685403, "improvements of": 0.011011074060883436, "improvement after": 0.0011626735241531602, "function with": 0.00846066589988212, "constants through": 0.00010530567766835781, "treated for": 0.0036382486386124847, "mediator of": 8.635450337273701, "severity of": 0.010918949861719027, "transgenic for": 8.627882669356266, "months in": 0.009102869938638096, "elevation in": 0.008846067715351878, "biomarker of": 8.635501379383484, "contribute in": 0.008911007381329019, "results further": 0.00042249767132322713, "resistin as": 8.625641862064825, "ablation of": 8.63550988589522, "fibrillation in": 8.633547268202582, "deterioration of": 0.010936051910959777, "probability after": 0.0008667557721359951, "relating to": 0.004784037624833605, "diastole with": 8.632323257542827, "improved only": 0.00035154594160369414, "rhythm at": 0.0008734039768737579, "pharmaceuticals in": 0.008837472611984299, "ablation in": 8.633436696717666, "agent in": 0.008878692218932093, "investigated on": 0.0009085293002740024, "h after": 0.0006500388139786328, "excised for": 8.627874161976115, "estimation of": 0.010919081446489686, "contents in": 0.008844620284272325, "decrement of": 8.635450337273701, "contents by": 0.001370032880226916, "interfere with": 0.007766479719908591, "doxorubicin against": 8.624641176729918, "growth of": 0.010985067857441607, "rats as": 0.0011528226490454669, "relation between": 0.0006761673516925375, "infarction after": 8.625712868954896, "system for": 0.0034698295572749803, "cabg from": 0.0011126088258226862, "rehospitalization for": 8.627925204085898, "ratios with": 0.00789411908743456, "intervals for": 0.0033854847401338533, "events after": 0.001289043827097388, "stroke was": 0.002951343678491324, "introduced into": 8.661635273125332e-05, "events during": 0.0009674425075996895, "burden in": 0.008869264327339962, "transplants in": 0.008846067715351878, "expand on": 0.0008301710726354722, "subgroup of": 8.635484365925839, "aetiologies in": 8.633377148096148, "topics of": 0.010909652973670286, "debate in": 0.008829884612129663, "investigations for": 0.0033493080321337926, "responses to": 0.00481955756678669, "scaffolds in": 8.633377148096148, "adaptation of": 0.010918774415412199, "myocardium in": 8.633436696717666, "workload during": 0.0005453298989914068, "adaptation to": 0.004794474910298893, "complex where": 4.835345422119453e-05, "assembly of": 0.010909389804648624, "kinases into": 8.624621907430488, "remodelling is": 8.626083610034891, "field of": 0.010899126320842915, "investigation for": 0.003360006065384189, "deals with": 0.007763277833655388, "ischemia with": 8.632357285037056, "made at": 0.000732778740430234, "frailty in": 0.008897152818332562, "accumulation of": 0.010919256892904248, "method has": 0.00023786048625447132, "residents with": 0.0077675745452897875, "lb in": 0.008837253304014109, "phenotype had": 8.625264550971796, "ascertained from": 0.0011210724891115402, "learning from": 0.0011126088258226862, "disappointments in": 0.00883742875038261, "antagonists of": 8.635526898484537, "management for": 0.0036368382345773323, "learned from": 0.0011165109019388136, "trials in": 0.00911699935623988, "success in": 0.008852686947584225, "peptides at": 0.0007717301407384674, "tool in": 0.008875534201752817, "mixed on": 0.0008479749039640624, "like other": 0.00017353725705511065, "measured at": 0.0009323641670860529, "status of": 0.011126280111500284, "nps to": 0.004778030205962883, "delivery in": 0.008850320392555842, "systems for": 0.0033960938663206864, "frame of": 0.010917414708621067, "consultation in": 0.00887040472523351, "disposition of": 0.010910749512751701, "provided by": 0.0014460194765596776, "care by": 0.0018493095270481407, "outcomes through": 0.0008778324461988516, "penalties for": 0.0033332583685565615, "conditions such": 0.00021619310114246815, "expansion to": 0.004792150252544357, "remodelling of": 8.635501379383484, "reporting in": 0.008843128996027324, "prevention of": 0.010952495457696759, "converges on": 8.625364014727312, "occur through": 0.00017151848175932805, "interplay between": 0.000663626600086124, "bets from": 0.0011126088258226862, "suppression of": 0.010910661789536669, "signalling to": 0.004837316671008722, "hypertrophy of": 8.635637466207719, "achieved through": 0.000136527194313766, "profiling of": 0.010910574066337138, "experiments of": 0.010910310896830559, "induced in": 0.009194219390542074, "method of": 0.01093302547026322, "protected against": 1.44616363206201e-05, "targets of": 0.01097582192061131, "transduction to": 8.629351559474802, "factor of": 0.011111947976447831, "thereby re": 4.2842211469933355e-05, "readers in": 0.008838874462833147, "manipulation of": 0.010910574066337138, "targeting of": 0.010967754167284943, "mri during": 0.000537085543730458, "respiration for": 8.62789117659167, "quantification of": 0.010919256892904248, "t1 in": 0.00882914053352382, "swine with": 0.007783625920270182, "implanted with": 0.007817653414498658, "paced at": 0.0007376149233026533, "performed during": 0.0007975057782987369, "respiration before": 8.624601711707669, "minutes after": 0.0009154268399961927, "fibrosis of": 8.635501379383484, "values before": 0.00014407417596418116, "also had": 0.0008042383569414916, "detected by": 0.0013707785260173755, "technique for": 0.0033597450286147546, "relevance of": 0.010927150066126316, "increase by": 0.001706956154837551, "echocardiography as": 8.625684388112054, "classified into": 0.0001241094760275175, "increase above": 0.00039230527646964196, "patients were": 0.007705399788541189, "increase during": 0.0008894885690895985, "assessment in": 0.008980148485283392, "devices in": 0.00902047857225793, "cornerstone of": 0.010919169169689217, "collected in": 0.008868123932047315, "features such": 0.00012301781111725534, "detection of": 0.010918774415412199, "portion of": 0.010909126635765367, "achieved in": 0.008868825713458081, "current in": 0.008982771837310225, "splicing of": 8.635458844653852, "trapped in": 0.008836946273017534, "exposed to": 0.004801052240390017, "activators of": 8.635450337273701, "induced to": 0.005143109062981138, "variants with": 0.007825677448783822, "resulting from": 0.0011699215229458975, "initiated by": 0.0013876174059131493, "effect is": 0.001790996500046048, "genes in": 0.008913639068544914, "encountered in": 0.008845541376292659, "concentrating on": 0.0008243392431473838, "populations of": 0.010943418456786867, "management in": 0.009139824354610979, "group with": 0.008425371668980863, "fraction after": 0.0018271749120419858, "distinguish between": 0.0006717830875017806, "residents of": 0.010911668891718334, "diagnosed in": 0.008904387200125525, "days to": 0.004989299753057939, "observed for": 0.003502194216004322, "mix of": 0.010907021289686417, "hemostasis in": 8.6333856554763, "response in": 0.009039806331933948, "activity by": 0.0015540006140117876, "imaging when": 0.00011503456977144955, "serve as": 0.00098721578653156, "markers for": 0.003419466057181349, "study with": 0.008915950965728461, "dosages of": 8.635450337273701, "metoprolol for": 8.628052786568665, "activity as": 0.0011827173337318855, "washout was": 8.627363864443282, "activity after": 0.0010581343477615336, "concentrations in": 0.008862862733407407, "medications to": 0.004845691597973061, "prescribing of": 0.01092772026669873, "interviews with": 0.007781608290395727, "caring for": 0.0033337408452445583, "nonprescribing in": 8.633394162711703, "nonprescribing as": 8.625548292027378, "cited in": 0.008836025181158693, "indicated in": 0.008903685416560074, "blockers are": 0.0008716217608894409, "thirds of": 0.010909696835187437, "documentation of": 0.010910003865914675, "tone by": 0.001438569187472914, "improved by": 0.0016484583200738357, "pyridostigmine on": 8.625406550180637, "elicited in": 0.008837604196812674, "density of": 0.010927237789248893, "protein in": 0.009040557117625409, "contractility of": 8.635484365925839, "delay in": 0.008878209742794423, "behavior of": 0.010909565250647638, "interval between": 0.0010461838909135853, "aspects in": 0.008885926893850347, "aspects to": 0.00483481656628941, "models of": 0.011211836120765258, "models in": 0.009138646943212888, "combinations of": 0.010910354758405426, "simulated in": 0.008837384888784768, "culprit in": 0.008837472611984299, "handling in": 0.00885308365819378, "velocity at": 0.0008398220443705153, "rise to": 0.004796578397632756, "function on": 0.0015184376999213818, "mediated by": 0.0014650958022749629, "wasting of": 0.010927413235540442, "surrogate of": 0.010910486343152889, "inhibition on": 0.0009859547188108804, "tolerance in": 0.00885387316546665, "ivabradine on": 8.625466093736819, "filling in": 0.008955246917413591, "optimization of": 0.010910793374365044, "time by": 0.0016533722148818959, "days in": 0.009040410080618877, "testing with": 0.007881929372504492, "undertaken at": 0.0007369569997383745, "improvement between": 0.000959237320945001, "rate during": 0.0011696483180535823, "change with": 0.007961176730525854, "correlates of": 0.010927807989921457, "contribution from": 0.0011609762524512773, "exercise as": 0.00196474847526617, "reflected by": 0.0013619641151105457, "formed of": 0.010924606102263859, "angiography with": 0.007817741137721386, "rule for": 0.003389605111126189, "stenosis in": 8.633428190205931, "validated in": 0.008879832618926576, "rule of": 0.010965780408712206, "rule had": 0.0006864208854899803, "sensitivity for": 0.003402146726209389, "angiography in": 0.008888646306597563, "experience of": 0.010934380968950358, "indication in": 0.008870273140728451, "indicated for": 0.0034006992965264285, "hyponatremia in": 8.633377148096148, "indication is": 0.0015256929696869496, "experience in": 0.008861191791397988, "knowledge on": 0.0008349501055781225, "older have": 0.0007192924004581879, "therapy to": 0.005525261589644149, "delivery of": 0.010923509570108212, "subject of": 0.010904740508104662, "responses in": 0.008870667894347628, "altered in": 0.008905483738918364, "property of": 0.010900135115470591, "stimulated by": 0.0013883630525539437, "cardiomyocytes from": 8.625788211894376, "infusions in": 8.633377148096148, "enhanced by": 0.0014128746403442045, "protection from": 0.0011337886848547083, "desensitizes against": 8.624547603508601, "mechanism during": 0.0006552566284871542, "strategy in": 0.008899606319088047, "underuse of": 0.01090232971107619, "fear of": 0.01090610020356452, "discontinuation of": 0.01091930075451759, "endpoint in": 0.008871632848950916, "safe when": 0.00010959576431552394, "subgroups at": 8.62533688086435, "gaps in": 0.008845409791614453, "hrqol in": 0.00882914053352382, "correlation with": 0.007826159926233657, "hrqol as": 0.0009832698491985083, "hrqol from": 0.0011126088258226862, "substudy of": 8.635467351889256, "expenditures of": 0.010927325512386971, "compared from": 0.0017432978863345442, "estimated from": 0.0012596254029865557, "costs from": 0.0012022330274044457, "accounted for": 0.003333828568328658, "driven by": 0.0013937119732622813, "drugs in": 0.008915565954069143, "influence on": 0.0008464836172888999, "structure in": 0.008944372903854024, "microstructure at": 8.625277334269068, "warrant further": 0.00013236956697203797, "medicine as": 0.0010064673292553923, "studies on": 0.0012198190207108645, "retrieved from": 0.0011295798692640875, "indicated that": 0.0009328102536148891, "activity of": 0.011101777195609567, "enzymes in": 0.008863125903029416, "enzymes over": 5.303920270283435e-05, "period in": 0.009045152134460001, "leukocytes of": 8.635450337273701, "treatment have": 0.0013967567719394784, "profile of": 0.010938856882419076, "intolerance in": 0.008862994318201043, "parameters for": 0.003410828394818095, "feature of": 0.010905442285944844, "interpretation of": 0.010910047727462607, "variables with": 0.007860184526032451, "assessment with": 0.007909243316407214, "inclusion of": 0.010961221421914158, "surgery in": 0.009030430192159506, "experience between": 0.0006873019178941662, "oht in": 0.00882914053352382, "transplantation with": 8.632433838433201, "required in": 0.008886933166432819, "transplantation to": 8.629453633274515, "consultation to": 0.004819294397672573, "operation was": 0.0028189694555270602, "consultation for": 0.0033674186051998634, "occurred after": 0.001009300062234275, "cent with": 0.0077419616889094515, "problems in": 0.008860272819665147, "transplant with": 0.00791126094645855, "incidence in": 0.008930563355895581, "oxygenation as": 8.625565306063962, "recovery in": 0.008868167793356693, "man with": 0.007770814953297012, "hospitalized in": 0.009024469961209045, "obstruction of": 0.010910705651142317, "became again": 8.158094943023135e-08, "team for": 0.0032975991730588667, "applied during": 0.0005859793072481873, "needed for": 0.0033839031856823204, "transferred to": 0.0047853096070437865, "support is": 0.001798783095375362, "abnormalities in": 0.008905527600520052, "discussion of": 0.010905003674679233, "promise for": 0.0033403621828095695, "trends from": 0.0011699215229458975, "infarction in": 8.63368332262519, "data are": 0.0010045791534553368, "ami between": 0.0006552506600199974, "concurrent with": 0.007783625920270182, "problem with": 0.007776606242956657, "therapy during": 0.0012843169274117233, "feasibility of": 0.010918949861719027, "data for": 0.00368021655991139, "injections in": 0.008837516473589947, "improvements from": 0.0012213531756299324, "baseline in": 0.0092625328142983, "shows for": 0.00333772875363814, "supplementation during": 8.625093600486506, "rehabilitation is": 0.0015848866470231573, "range of": 0.011019444570727406, "therapies in": 0.008879964203708667, "functions after": 0.0008825861264194416, "candidates for": 0.0033300564896063005, "suffer from": 0.0011191864432150153, "unclear how": 8.11983068456717e-05, "created by": 0.001367399422714329, "used as": 0.0014367393887653134, "selected on": 0.000881212314002813, "signaling by": 0.0014991175081364389, "efficiency of": 0.010934034281793405, "considered in": 0.008906533544851051, "protocols for": 0.0033515011075070647, "breathing with": 0.007791387364158897, "control during": 0.0010081866637930096, "produced while": 8.448711599736905e-05, "aged in": 0.008935998844218068, "60s with": 0.007766172688831104, "presented in": 0.008841506128579308, "produced during": 0.0005912402283840025, "recovery had": 0.0006619974476868367, "perfusion of": 8.635484365925839, "concluded that": 0.000863658730230145, "produced by": 0.001408707814131955, "originating from": 0.0011208970426814762, "drugs have": 0.0005818551428094554, "options for": 0.0033636903909649227, "anticoagulants for": 8.62789117659167, "nutrition in": 0.008836858549910237, "disease with": 0.008559093804678513, "comorbidities such": 8.624713911823346, "points to": 0.004840294036049182, "imbalance as": 0.0010000215846120047, "stage of": 0.011044170707088092, "knowledge of": 0.010921272651967408, "strategies with": 0.007952468253732413, "target of": 0.010988798992615388, "released from": 0.001116026813854035, "roles of": 0.010908644159839317, "information for": 0.0033336463850399504, "elucidated in": 8.633377148096148, "rabbits with": 0.007792176872539897, "hypothesized in": 0.008905659185348427, "restored to": 0.004794124017869815, "withdrawal of": 0.010910267035259652, "bolus of": 8.635458844653852, "exacerbated in": 0.008837384888784768, "normalized in": 0.008854618812369087, "tachycardia in": 8.633419683549473, "turned on": 0.0008156108602046737, "stopped for": 0.0033301880732687274, "futility on": 0.0008243831047530314, "recommendation of": 0.01093460448051509, "oxygenation on": 8.62539804337945, "study in": 0.009986856134604639, "supported on": 0.0008295570138471972, "group until": 0.0006715614511228605, "continued until": 1.3588883679666794e-05, "group in": 0.00949627683785704, "scores for": 0.003442527178412646, "exists from": 0.001144795872338977, "discharge for": 0.0034957072133371316, "discharged with": 0.007800420648862583, "ratings from": 0.0011284833300864812, "insight on": 0.0008481942112031957, "nursing to": 0.0048538032108850545, "measures in": 0.0090283248508824, "care to": 0.0052727866035326134, "actions on": 0.0008448168903861684, "regulated by": 0.001379812100295772, "action on": 0.0008427095479663926, "involvement of": 0.01091706381714621, "occur after": 0.0009333633306079806, "stimulation with": 0.007851327700407106, "triggered by": 0.0013702521876969088, "regulation in": 0.00886948363442519, "overstimulation in": 0.008837604196812674, "continuity on": 0.0008664799421964238, "readmission after": 8.625593823359871, "continuity further": 0.0001765717571432359, "databases for": 0.0033939912518688516, "hospital between": 0.0009952998714905033, "models with": 0.008067741774336711, "discharge on": 0.0009855599645338634, "readmission over": 8.62475419032984, "patient at": 0.0013039367454986718, "readmission during": 8.625272222040373, "taking into": 7.398447460713577e-05, "visits over": 0.00023042655578937009, "visits with": 0.007969608087239776, "settings other": 0.00027572328103552636, "persist through": 0.00011354988819889561, "focusing of": 0.01090895118992026, "demonstrated up": 0.0007722770282017094, "blots with": 8.632306242927273, "phosphorylation in": 8.633470721317465, "binding by": 0.001379855961893613, "mutant as": 0.0010086165432154, "modulation of": 0.010919125308087528, "instability in": 0.008845585237859829, "predictor for": 0.003411047702788285, "activity on": 0.001015454649220282, "measured on": 0.001036059240885507, "ecgs at": 0.0007123120908874507, "expressed as": 0.001045185406664611, "sd of": 0.01090232971107619, "calculated as": 0.0010929352904605917, "group during": 0.001204221848063678, "blockade with": 0.00783475401647225, "fluctuations in": 0.008837209442431658, "modulation on": 0.0008328027616982423, "limited in": 0.008976595721722333, "susceptibility to": 0.004786406146029009, "exposure to": 0.004802061053601513, "polymorphisms in": 8.633377148096148, "frame for": 0.00334123941103505, "matched on": 0.0009428153328808761, "cases with": 0.007824402782433718, "variants of": 0.01096977179521237, "coding for": 0.003334618076779027, "web of": 0.01090311765062193, "syndrome of": 0.01093556943367935, "definitions of": 0.010919125308087528, "consensus on": 0.0008396871205428652, "foundation for": 0.0033406253511156793, "nomenclature for": 8.627874161976115, "view to": 0.00477640579952541, "education in": 0.008840758734069185, "inhibitor in": 0.008897108956719219, "system by": 0.0014982282732632177, "breakdown of": 0.010910310896830559, "composed of": 0.01091022317369248, "promise in": 0.008843348302843217, "tested in": 0.008894652712516667, "situation in": 0.008836067367971025, "initiation of": 0.010927807989921457, "therapy are": 0.0013977483907153855, "principles of": 0.010908819605576691, "progressed from": 0.0011205022884389773, "concept of": 0.010915221640943095, "disorder to": 0.004794211740953916, "focus of": 0.01092530593636861, "window into": 7.981956394190794e-05, "therefore have": 0.0005506370755246306, "remains in": 0.008914995761499787, "shortcomings in": 0.008837253304014109, "dearth of": 0.010910705651142317, "standards in": 0.008830981136782491, "micrornas in": 0.00882914053352382, "targets in": 0.00890263274305894, "subclass of": 8.635450337273701, "body of": 0.011150468922859291, "binding to": 0.004803333038378085, "mirnas as": 0.0009832698491985083, "inhibitors in": 0.008982122253725343, "target in": 0.008915609815063019, "evidence in": 0.009092274145319008, "act on": 0.0008253902062766427, "filling during": 0.0006631919276202287, "quantification with": 0.007775162546475701, "spectroscopy as": 8.625531277411824, "comparison with": 0.007781959181963039, "subjects had": 0.0007748553690702651, "sample of": 0.010960212607021236, "construct of": 0.010910398619984028, "supported as": 0.0009968196983588006, "peptides in": 0.008888558583374836, "plasma of": 0.011012653075844836, "misdiagnosis of": 0.010910749512751701, "circulation of": 0.010961133698799167, "stored at": 0.0007196353534815469, "enriched from": 0.0011209847658888129, "plasma by": 0.0014648764942470577, "proteolysis between": 8.625203258222646, "concentration of": 0.01092710620457069, "immunodetection of": 0.01090232971107619, "improved with": 0.008052140555243068, "epitopes as": 8.625539784791975, "described in": 0.008864132569006093, "volume at": 0.0011513535250555688, "delivered as": 0.0009968635596758742, "evaluated as": 0.0012124836115880579, "patients during": 0.005220937746950988, "adherence in": 0.00891407768442758, "study from": 0.0022703244269035045, "raloxifene between": 8.6252202728382, "years for": 0.0038987409951512955, "compliance for": 0.0034010940496607992, "decreased for": 0.0035464257973511514, "reversibility of": 8.635450337273701, "thickness as": 0.0010257183030122614, "diameter were": 0.00307228353231356, "content for": 0.00334158666398836, "levels for": 0.0037595377665521263, "level for": 0.0035205968808373835, "performance by": 0.0015108160505322161, "blockade at": 0.0007888307427120584, "stages of": 0.010916888371501069, "hazards of": 0.010969727933649157, "events for": 0.0037565113773594047, "smoked more": 0.00022223758440051783, "differ between": 0.000705767299100424, "similar when": 0.00026614524697989494, "disease from": 0.001913467265853557, "events as": 0.00141362681306774, "characteristics of": 0.011071970234068923, "established that": 0.0009115428330858271, "quartile of": 8.635450337273701, "program for": 0.003427880979355613, "stay for": 0.003392760438540284, "community of": 0.010933457824421955, "population in": 0.009059971693473785, "admitted between": 0.0007273831695627726, "appropriate out": 1.848651980712955e-05, "patient by": 0.0019461777840896317, "documented for": 0.0033847829550294486, "cost of": 0.011003833689094562, "studied in": 0.008895442218265865, "shown that": 0.0009377637117325055, "variability have": 0.0005972472988437614, "power of": 0.010893379211872068, "remodeling of": 0.011140441846136603, "substrate after": 8.625415201806005, "turbulence as": 0.0010000215846120047, "stems from": 0.0011209409042831652, "present with": 0.007891966041721021, "angiography is": 0.0015440661355560627, "foundation of": 0.010916800648701696, "revascularization with": 8.63234027157941, "benefit for": 0.0034975887910505712, "provide more": 0.00033022736196211853, "stenting in": 8.633402669802363, "considered only": 0.00013503376233549918, "revascularization is": 8.626066596577246, "guidelines on": 0.0009185670872415245, "framework for": 0.003341809610207022, "plans for": 0.0033217667886822947, "downloaded from": 0.0011207215963129752, "carried out": -6.763343926170456e-05, "packages of": 0.010918467384523248, "performed for": 0.003586574648058452, "interactors of": 0.01090232971107619, "retrieved with": 0.007775206408089044, "selected out": -6.505810952817559e-06, "applied with": 0.007807129128165372, "represented in": 0.00886018718344707, "system with": 0.007901910508432449, "visits during": 0.0007484582663225907, "groups after": 0.0012223105490329776, "admissions from": 0.0011801824946718103, "controls during": 0.0006461807853203733, "days for": 0.0035374239605852295, "admissions for": 0.003393728082339297, "coupled with": 0.0078000697562795995, "technology has": 0.00021737939680307712, "strength of": 0.011000112037110602, "race as": 0.001117000526271887, "interactions with": 0.007765777934865638, "care with": 0.008252991762217372, "significantly more": 0.0006957525492055955, "blacks had": 0.0006229701878539644, "race in": 0.008962871210597198, "design of": 0.010945521521139725, "rhythm more": 0.00037561145400040756, "practice of": 0.011040885084559943, "persist after": 0.0008753947370475483, "complications in": 0.008939332313521807, "af at": 0.0007123120908874507, "trial for": 0.0036250970357911607, "spent in": 0.008827954734581235, "counted as": 0.0009911633118147994, "therapy of": 0.011649561094757455, "control as": 0.0014543709692610598, "therapy by": 0.002101784513159676, "faced with": 0.007763453278946545, "housed on": 0.0008235058733724697, "accustomed to": 0.004786099114870722, "asked about": -6.035984926048487e-05, "array of": 0.010909828419761755, "procedures for": 0.003435074209158028, "topic so": -5.754621660073063e-05, "partner with": 0.007758847860456766, "fall into": 7.416147638332536e-05, "classification of": 0.010935876464622168, "characterised by": 0.0013625781768076461, "failure at": 0.005119624679032031, "population has": 0.000437995887017407, "causes for": 0.003383072357963928, "strategies for": 0.003520387302574943, "currents by": 0.001371480311306469, "trigger for": 0.003350623876203456, "member of": 0.010906361745452816, "gain through": 0.00011069889283966675, "dysfunction of": 0.011497375559368285, "equivalent of": 0.010926360558714819, "conducted by": 0.0013927470250922622, "movement of": 0.010905354563660942, "indicating that": 0.0008830418640731331, "modes of": 0.010910530204743033, "inhibition by": 0.001524500683602386, "conclude that": 0.0008744469055696663, "efficacy in": 0.008973397880969692, "situations in": 0.008835674289468366, "provision of": 0.010917414708621067, "case in": 0.008946730746452192, "disease has": 0.0010080231670983129, "going into": 3.881084414932174e-05, "measures for": 0.0035253387308487537, "reporting on": 0.0008299956271904091, "measures into": 0.00027308418522155607, "measure for": 0.003414992194408729, "assess how": 0.0001746256179959112, "variance in": 0.008837516473589947, "treated at": 0.0010244063160097625, "hospitals on": 0.0009244883458187783, "hospital in": 0.009169189744994326, "dying in": 0.008836595380680691, "quality for": 0.0037570377045988233, "measures at": 0.0009114964082460312, "antagonists in": 8.633453709306984, "race by": 0.001488283806551789, "aas with": 0.007758235364647642, "hypokalemia with": 8.632314750307424, "differ by": 0.001405069768558837, "attenuation by": 8.625936589344242, "changed after": 0.0008856982845530536, "mapped to": 0.004786274561223831, "protection of": 0.010923509570108212, "amelioration of": 8.635450337273701, "noted above": 6.735228266204965e-05, "tracked with": 0.0077745046227382765, "protected in": 0.00884400622386804, "essentially were": 0.003028344510009836, "changed in": 0.008856151954848717, "signal to": 0.004809734776680097, "application of": 0.010930920131017657, "discharged to": 0.004820215490177824, "implementation of": 0.010950390108108754, "policy as": 0.0009941862838465337, "complications had": 0.0007331619678519519, "costs for": 0.0034157786150719326, "admissions to": 0.004845603874812007, "physicians into": 0.00016659744958771362, "strata of": 0.010927764128308114, "antagonism in": 0.008837604196812674, "implicated as": 0.0010083533736627596, "groups with": 0.008121859050452464, "very few": 1.34019797410411e-05, "background for": 0.003332205693762505, "criteria for": 0.0034346794560582857, "subdivided in": 0.008837604196812674, "periods on": 0.0008401257353097061, "devices at": 0.0009036501296215621, "enrollment of": 0.010969991103086368, "cardiomyopathy during": 8.625221193821723, "replicated in": 0.008837341027190663, "continuity of": 0.01095280248858571, "threshold in": 0.00885387316546665, "finding has": 0.00021904784903258403, "investigations at": 0.0007354657095310701, "achievement of": 0.010909258220189736, "point was": 0.002955322874069208, "diet in": 0.009022803223486748, "associated to": 0.005850530831107587, "examination between": 0.0007051093759401507, "quantified as": 0.0010256744414028772, "computed with": 0.007775162546475701, "categories were": 0.003070441348838388, "grouped into": 9.078318808164954e-05, "men in": 0.008951686866152673, "matched for": 0.0034529625816841444, "counseled on": 0.0008244708279757587, "activity with": 0.00795768284918102, "achieving at": 0.0007195476304588987, "overload as": 8.625624850633141, "resistance by": 0.0014978893844190331, "evidenced by": 0.0013626658999686995, "translocation of": 0.010910793374365044, "oxidation of": 8.635458844653852, "phosphocreatine to": 8.629351559474802, "progression from": 0.0011969757761540335, "reality of": 0.010904258036410994, "planning in": 0.008830323221702227, "adequacy of": 0.010910661789536669, "search of": 0.010922149873574986, "undertaken for": 0.0033507993223410967, "region with": 0.0077742396243672, "etiologies of": 8.635458844653852, "varies from": 0.0011209409042831652, "paradox of": 0.010910749512751701, "countries with": 0.007782657021164762, "scenario of": 0.010908819605576691, "genotyped for": 8.627882669356266, "confirmation on": 0.000823637457981416, "trigger of": 0.010926799173789473, "pollution on": 0.000848238072662632, "professionals in": 0.008850846727690459, "overexpression of": 8.635475858979916, "pathophysiology is": 8.626109129135944, "mice with": 0.007996084330086044, "mass in": 0.009123221169302668, "shortening as": 0.001068250861711652, "hypertrophy after": 8.625593823359871, "turning off": -5.972113037055464e-06, "discovered that": 0.00086343942354892, "indicate that": 0.0008820330493572033, "hearts with": 0.007884297887051155, "worse when": 8.552364736131774e-05, "spite of": 0.010909916142830574, "developments in": 0.008835542705147996, "recognition of": 0.010917546292987721, "collaboration of": 0.01091706381714621, "professionals from": 0.0011343150199893258, "managed by": 0.0013644625027399303, "country has": 0.00017909192070719672, "access to": 0.004780570986237755, "progress has": 0.00024391120391803017, "aims of": 0.010950521692198267, "connection between": 0.0006599422386302244, "conditions in": 0.008938977995463187, "results about": 0.00024529495768695455, "uncertainty about": -4.500859232465455e-05, "partners in": 0.008832472414169509, "products from": 0.0011082212010148076, "identified by": 0.0016044964234552266, "recorded as": 0.0010133076889190069, "data to": 0.0051320923523841, "guidelines as": 0.001085829771753128, "search in": 0.008848960696022616, "databases of": 0.010970166549454869, "intervention on": 0.0009162457263051342, "education at": 0.0007239302914328157, "elements of": 0.0109077230707277, "context in": 0.008852206429352565, "results for": 0.0036225531051796832, "explore why": 1.5869501350536424e-05, "succeed in": 0.008836376073095268, "fail in": 0.008834446170491388, "findings through": 0.00019567701132944108, "perceptions of": 0.01091061792793498, "recommendation for": 0.003358429182929073, "occur between": 0.0007299271273998215, "perspective on": 0.0008387660307849547, "stages where": -1.6586226507797734e-05, "wished further": 0.00013372927292822816, "information on": 0.0008234991362366821, "deactivation at": 8.625328374642049, "discussions about": -1.0804494525992368e-05, "shocks at": 0.0007374833385205616, "comment on": 0.0008160071646869048, "% on": 0.005509893135425759, "centers in": 0.008862160948426128, "walked in": 0.008852513459271905, "burden of": 0.010942453504892332, "cpet in": 0.00882914053352382, "min to": 0.005050155368025767, "min after": 0.0011308120252910404, "changes were": 0.003418473274981677, "people in": 0.0087376974179227, "patients have": 0.005179281925484661, "confirmed that": 0.0009029045934378219, "changes on": 0.0012129328543479235, "signs in": 0.008868737990727855, "symptoms are": 0.000878371062274815, "cornerstone in": 0.008845979992136847, "referred to": 0.004800832933439457, "services as": 0.0009691452908944653, "events from": 0.0015429657896919179, "individuals are": 0.0007557963137096551, "cancer of": 0.010955738756807294, "expectancy by": 0.00137099783381442, "volumes of": 0.010909828419761755, "exercise below": 0.0010205913862498348, "athletes under": 9.233878398451367e-05, "death during": 0.0011141045963071498, "sport in": 0.008831726774920024, "athletes more": 0.0002542924706939797, "screening of": 0.010908293268549148, "screening with": 0.007764198922120601, "system in": 0.008972815677308626, "period with": 0.007974246965583824, "strength by": 0.0014523354555128225, "+0.5 to": 8.629326037768587, "+0.2 to": 8.629326037768587, "need further": 0.00019063293495198556, "validation in": 0.008845892268937316, "adherence with": 0.007843172515551403, "participation with": 0.0077906417184992575, "indicated more": 0.0002890644510503556, "corresponded to": 0.004786362284423362, "association in": 0.009013553237995778, "training had": 0.0008744427902812745, "performance in": 0.008985403454577625, "arguments for": 0.003333389953061621, "explained by": 0.0013647695298043426, "protocol with": 0.007800201340969347, "analysis at": 0.0012342417257667831, "baseline as": 0.0014166621299729872, "participated in": 0.008836595380680691, "doses for": 0.0033685590056945418, "dose after": 0.0011897590549268845, "latter had": 0.0006457290539520142, "higher when": 0.0004949865203709818, "hr was": 0.0028073495005058583, "observed after": 0.0010347266657423058, "baseline had": 0.0010563624686284433, "better when": 0.00015329917555485922, "bpm with": 8.63234027157941, "target as": 0.0010697391307377077, "shunting for": 8.627882669356266, "shunting in": 8.6333856554763, "study at": 0.0018700276919682687, "centre in": 0.008854222074422317, "enrolled under": 0.00017959335729565007, "done after": 0.0008808716632181177, "catheterisation with": 0.007766699027936496, "guidance under": 5.9538251900592384e-05, "evaluations at": 0.0007461220139629839, "reduced from": 0.0018154341132564453, "hospital with": 0.008098284576118149, "bleeding at": 0.0007713792480015765, "died after": 0.0008990715816307277, "problem of": 0.010920700589385204, "treated by": 0.0016666473546007223, "thanked for": 0.0033340040145432522, "symptom of": 0.010936095772553882, "determinant of": 0.010910705651142317, "conducted from": 0.001150802721436538, "excluded by": 0.0014052452148811659, "consisted of": 0.010910530204743033, "adherence was": 0.0028922866514096176, "-8 to": 8.629326037768587, "intervention had": 0.0007232087494721938, "life as": 0.001292047244674621, "designed for": 0.0033691707798631514, "hemocompatibility by": 8.625902560692104, "rotor with": 0.00776639199672434, "listed for": 0.0033305389632045305, "indications for": 0.00335136952271343, "continued on": 0.0008251709015769311, "support with": 0.008072458097540687, "risk by": 0.002496345756028878, "reoperation for": 8.627874161976115, "projections of": 0.010910310896830559, "pairs of": 0.010918598969166823, "estimates of": 0.01093346408372186, "validity in": 0.008871369679328906, "estimates from": 0.0011437431984683566, "demonstrate how": 4.7786610546390144e-05, "program in": 0.00893086709938926, "treatments are": 0.0007177397833924936, "value to": 0.00492618309536992, "providers with": 0.007772662440879123, "nurses in": 0.008870580171294197, "settings have": 0.000544235762928509, "actions have": 0.0005242394479633946, "heart": 3984.3296879545987, "patients": 3349.928566560949, "failure": 2754.402889712013, "%": 2933.5003640448963, "hf": 0.0, "the": 868.4837974993, "-": 1079.1451064080657, "/": 126.20223326191706, "cardiac": 96.49998434079527, "p": -80.04576030205571, "study": 56.348333735805575, "ventricular": 347858.4050512609, "risk": 46.046213043527246, "95": 46.57743234909969, "exercise": 35.24686041934185, "results": 10.172995896167368, "associated": 34.596725165917846, "mortality": 33.96758862476849, "in": 275.91064167261936, "ejection": 29.84880737694658, "treatment": 25.10015567935907, "left": 25.82960198920923, "fraction": 26.063950369677773, "ci": 0.0, "outcomes": 18.21894479348174, "=": 40.2270750082557, "clinical": 15.569262231045121, "disease": 15.070554124500926, "therapy": 13.20507301241532, "compared": 10.217162780292098, "hr": 0.0, "reduced": 10.396191651720164, "function": 10.150121234138194, "increased": 9.601734515476613, "ratio": 9.902177210602598, "group": 9.191804001103105, "\u00b1": 118838.62743504616, "methods": 0.18408795627084287, "years": 6.967233525652536, "<": -14.534491144234513, "patient": 7.01548515437986, "rate": 7.500929377923608, "systolic": 102277.25004404371, "myocardial": 99637.55579414326, "chf": 0.0, "lv": 0.0, "may": 6.201939764746192, "conclusions": 0.0, "care": 4.98813400029802, "chronic": 5.321026151335621, "dysfunction": 5.83144931326254, "death": 5.6547867152515785, "hfpef": 0.0, "background": 0.05762029075314474, "acute": 5.105176424805655, "end": 4.824018805026784, "analysis": 4.410305414730359, "hazard": 4.523258015269267, "follow": 4.3556009642786995, "cardiovascular": 4.1081007979823605, "using": 3.1441151491528148, "significant": 3.9081414650196065, "n": 2.759619302807536, "higher": 3.3934636254288177, "2": 3.64469320693395, "functional": 3.536688868791953, "this": 4.800521882601161, "preserved": 3.4302807252972545, "data": 2.4649806633845106, "a": 22.371969830351752, "hospitalization": 3.2607532925796807, "6": 3.2178987270094264, "high": 2.89614774457548, "index": 3.074442941092086, "used": 2.9466450681050986, "baseline": 2.8161830404725645, "among": 2.025049039330816, "significantly": 3.1270519117823357, "control": 3.0612150781664598, "1": 2.77737351767567, "versus": 2.9770891991104795, "diastolic": 52181.24213114305, "low": 2.433988670264925, "quality": 2.512911353745649, "right": 2.273544644562711, "age": 2.4510603437653535, "pressure": 2.481515060628669, "model": 2.1016858294008105, "events": 2.3273704606048042, "levels": 2.3437371733590426, "health": 1.591503106678168, "volume": 2.3743360759811822, "lower": 2.3420767776947504, "studies": 2.100629275036638, "use": 1.9985568311266517, "ml": 0.4856353385134661, "time": 1.5544568822689302, "changes": 1.9846284483050938, "confidence": 2.0170855253559847, "trial": 1.4355224722893427, "3": 1.8923073222939908, "new": 0.5201151930659704, "renal": 1.592336144699664, "\u03b2": 39743.75899255177, "rates": 1.6214102875700773, "cause": 1.7261378745907339, "management": 1.3726011215630691, "outcome": 1.6425321736719938, "however": 0.26517108315655724, "interval": 1.6544294331416642, "type": 1.5842989111788235, "hospital": 1.377199306455549, "association": 0.7468714531114345, "and": 48.14997132057154, "day": 1.3403124786877187, "effects": 1.3334837159718889, "groups": 1.407950911436267, "increase": 1.3645045141905918, "30": 1.375513920848432, "cohort": 1.3202452544039143, "induced": 1.3500616132535082, "survival": 1.1585038342379217, "receptor": 1.3521702153406452, "life": 1.089366651239726, "severe": 1.220583792672612, "class": 1.0761994671973125, "support": 1.0564168279864123, "ii": 0.0, "crt": 0.0, "pulmonary": 0.9828595621992152, "dose": 1.00712160714753, "effect": 0.9321787304688641, "ms": 26236.030309103466, "based": 0.7678574342613461, "hypertension": 0.9085484271161548, "term": 0.8905414238921739, "also": 0.5235024723247786, "treated": 0.9013281221532363, "infarction": 23614.850750566984, "mass": 0.805192780762489, "long": 0.7555613517579054, "models": 0.8474285497286695, "reduction": 0.8317150148133073, "peak": 0.7616344236674478, "primary": 0.7808318155852805, "training": 0.688531985445975, "improvement": 0.8323154776126599, "evidence": 0.6820423217731291, "coronary": 22355.555924841254, "medical": 0.6724926269379873, "year": 0.4677115892750068, "atrial": 22355.489806327885, "randomized": 0.6830811622161646, "development": 0.6746371598215092, "4": 0.7420039565458355, "early": 0.6307851454907767, "mean": 0.7241882738687119, "mitral": 22355.555924841254, "included": 0.7079247795188703, "months": 0.6706370425299742, "trials": 0.7052541156543463, "improved": 0.7200677169587917, "impact": 0.5778805897816692, "well": 0.5833860241115153, "score": 0.693218578185934, "assessed": 0.6666450844176289, "probnp": 0.0, "nt": 0.0, "participants": 0.4850430594082209, "capacity": 0.6551860491659954, "body": 0.5404472032635941, "factors": 0.5836132339873218, "without": 0.5503566180902587, "showed": 0.5928661884617548, "respectively": 0.6039476075579846, "similar": 0.49472584256388286, "angiotensin": 18784.85833452155, "median": 0.553547375365736, "common": 0.5224715085452482, "adverse": 0.5557852470485966, "role": 0.5282981090545061, "kg": 0.5544378211255592, "developed": 0.5432991680711833, "min": 0.5573123319047862, "diabetes": 0.5536293664226872, "expression": 0.536843938883546, "e": 0.12240152401205472, "congestive": 16576.8389985745, "non": 0.480969945436642, "conclusion": 0.22628180650702942, "performed": 0.500527690840232, "related": 0.4889784568539797, "first": 0.31492209644402724, "major": 0.3841629168744527, "identified": 0.4498979291582687, "vs": 0.47270395096900925, "l": 0.10584717790135831, "ef": 0.0, "demonstrated": 0.45597710662891794, "mice": 0.42812813778912445, "at": 1.2821617635974112, "natriuretic": 14506.876017449855, "found": 0.36087948487171395, "population": 0.38825801103584107, "vs.": 0.41458612820179336, "remodeling": 0.40050461117161323, "one": 0.10849254427625915, "device": 0.4021919830159266, "adjusted": 0.38443092138948937, "total": 0.340287974138861, "evaluated": 0.3594071794268137, "blood": 0.34970997027350526, "assist": 0.3563123124102718, "within": 0.2892131729576399, "measures": 0.3123210096182543, "change": 0.31821206169703503, "older": 0.3510166794082812, "days": 0.33127064984504817, "status": 0.3511542278649786, "b": 0.0, "prognostic": 12574.901025736352, "symptoms": 0.3322112125409332, "including": 0.2786870186554203, "ischemic": 12574.901025736352, "adults": 0.3309322134514292, "defibrillator": 12574.863829012105, "objective": 0.09653995633273786, "period": 0.3149449141649531, "effective": 0.3028735923981322, "ed": 0.0, "per": 0.27242040467676193, "measured": 0.2975104070205101, "decreased": 0.29780691098004247, "review": 0.2771180657059014, "10": 0.25872881007519183, "test": 0.28570965502097245, "interventions": 0.21761832733734257, "human": 0.24404198845863068, "advanced": 0.28399690054268245, "blockers": 0.29893362721239375, "peptide": 0.29893362721239375, "bnp": 0.0, "response": 0.2848201594504943, "safety": 0.23308683072194683, "improve": 0.24377190276952382, "hospitalized": 0.24416178460653157, "surgery": 0.25161207329460783, "less": 0.23954429224787402, "important": 0.23943464281739077, "level": 0.24305308418401297, "protein": 0.26427073012698565, "artery": 0.2656962308702445, "lvef": 0.0, "factor": 0.262022831714552, "readmission": 10780.918920620803, "blocker": 0.2540792801677221, "visits": 0.2642159032401659, "underwent": 0.2653672688717288, "activity": 0.2493093556667214, "valve": 0.26564140385851415, "post": 0.2409757818292677, "system": 0.16551376564009784, "12": 0.2139484205983072, "diagnosis": 0.20492004599804564, "practice": 0.15961579025328335, "implantable": 9935.694877244132, "devices": 0.22042142062169637, "potential": 0.21127589793932308, "strategies": 0.22375628822565463, "c": 0.10673708565267301, "flow": 0.23203727165932206, "therapeutic": 0.22486791505100498, "lvad": 0.0, "arterial": 9935.70467407887, "mitochondrial": 9935.70467407887, "diet": 0.22309941883729306, "7": 0.19491805696671036, "design": 0.04569693504722089, "resynchronization": 9124.90678804653, "two": 0.05536715997903358, "cardiomyopathy": 9124.915786558116, "placebo": 0.19780015793098837, "hypertrophy": 9124.969774413448, "gene": 0.1706208375825369, "implantation": 0.17085286543535205, "cox": 0.0, "physician": 0.17878359056167922, "mm": 0.20624088457579706, "rv": 0.0, "onset": 0.20679775120263388, "subjects": 0.16069452172684615, "af": 0.0, "guideline": 0.16463660650587528, "cardioverter": 8348.73537992621, "current": 0.14871510206524033, "fibrillation": 8348.72714758365, "admission": 0.17953048659317145, "recent": 0.12257329026000797, "weeks": 0.16849155699687843, "assessment": 0.14617569730326566, "nyha": 0.0, "metoprolol": 8348.73537992621, "assess": 0.15611819308981872, "followed": 0.1514372334180074, "terminal": 0.15665979493652943, "p<0.001": 7606.851342670236, "observed": 0.15526710581747968, "echocardiography": 7606.986386307838, "prognosis": 0.15751088489663037, "benefit": 0.15120512100827108, "york": 0.0, "setting": 0.07023359346399832, "point": 0.13051251548287426, "difference": 0.15275253938106742, "due": 0.13476780178356276, "20": 0.1382843895466453, "performance": 0.13782389636945655, "discharge": 0.14954556946501749, "could": 0.08625713158712377, "beta": 0.14243121674289272, "inhibition": 0.14989374273734646, "rats": 0.14954556946501749, "pasp": 0.0, "5": 0.14048939776708225, "rhythm": 0.14208304343992298, "cad": 0.0, "objectives": 0.006069145403508067, "mr": 0.0, "elevated": 0.12894368731182101, "defined": 0.1340281373939433, "characteristics": 0.13571241839418585, "regression": 0.12922440152595888, "specific": 0.1240312204533942, "proteins": 0.1359580432991805, "normal": 0.1326245753112848, "0.001": 6899.76769843063, "+": 0.1336421573302899, "three": 0.0828417055263283, "likely": 0.12265942613926242, "relationship": 0.12185571869100781, "month": 0.11571203943540732, "these": 0.37347444473128694, "iii": 0.0, "m(2": 6899.76769843063, "improves": 0.13571241839418585, "echocardiographic": 6899.754090674207, "correlated": 0.11659335429520244, "8": 0.10823307781903485, "moderate": 0.10962943282834202, "addition": 0.0971235624972871, "efficacy": 0.10415380485592017, "value": 0.10696638615188071, "cells": 0.10909107708711852, "after": 0.619971915250729, "hfref": 0.0, "race": 0.09655354884697939, "stage": 0.10240919912059397, "stroke": 0.10396379650550619, "estimated": 0.0952667420021874, "stable": 0.0980236860418441, "occurred": 0.09759735295596471, "of": 7.064709652777371, "limited": 0.09555096195263678, "multivariate": 5588.762232503484, "dependent": 0.09836475291447334, "transplant": 0.09916057701346823, "ami": 0.0, "spironolactone": 5588.79530216414, "men": 0.07941002354349617, "case": 0.07619845797758551, "hg": 0.0, "diagnostic": 0.09356402808372102, "inhibitors": 0.09913215469058721, "muscle": 0.09319453817762363, "t1": 0.0, "paf": 0.0, "medicare": 4984.993665636925, "dilated": 4985.06741458468, "present": 0.07729633134841286, "cell": 0.07699432362237718, "better": 0.06606585088250214, "predictors": 4985.062498573624, "identify": 0.08104837241778325, "decrease": 0.08305117103741745, "sex": 0.0785639073422201, "independent": 0.07461125775897026, "mg": 0.08317793091074983, "via": 0.07950191715698834, "reduce": 0.08000895075690921, "findings": 0.05712662823706366, "isolated": 0.07818586392310165, "composite": 0.07359934508559451, "odds": 0.07304160156952852, "resistance": 0.08284835535567982, "50": 0.07587665283580092, "cost": 0.05866929929461893, "effectiveness": 0.05383272206140183, "standard": 0.07519434652674087, "program": 0.05879795507022419, "signaling": 0.0835582108643404, "insulin": 0.07861684779490259, "event": 0.06090415713196551, "large": 0.05782943260842388, "across": 0.057243793571847015, "individuals": 0.053903005017873935, "no": 0.197717472288416, "mild": 0.06485841078371272, "provide": 0.05924239050138532, "evaluate": 0.0692131520934461, "examined": 0.06903349529578232, "transplantation": 4415.833908771099, "controlled": 0.046562879036975015, "independently": 0.06925806631250526, "cardiomyocytes": 4415.833908771099, "40": 0.06535055872926425, "consecutive": 0.06880892447605974, "determine": 0.06826995531251916, "activation": 0.06524018189723278, "ratios": 0.06957246606690143, "2008": 0.06588952174654364, "or": 0.9112460887705808, "testing": 0.0633313320227071, "novel": 0.06409487026455292, "report": 0.05219291542247926, "oxygen": 0.06508298195803623, "qrs": 0.0, "aortic": 0.06966229463909411, "sd": 0.0, "prospective": 0.05331515202837105, "pro": 0.05582020418676258, "even": 0.025014190129734826, "guidelines": 0.04615196514957884, "filling": 0.05674787275039685, "benefits": 0.05090716498533978, "suggest": 0.05580046659932379, "15": 0.049899005602524776, "research": 0.04171109133812853, "0.01": 0.05735974134315619, "hearts": 0.05672813508158037, "enrolled": 0.05716236419595711, "differences": 0.056629446763369784, "remained": 0.05576099142959053, "different": 0.03732951508107832, "beneficial": 0.05317698814051333, "co": 0.01860734447256235, "women": 0.03290981204068008, "analyses": 0.05349279143749556, "stress": 0.05252564524028312, "therefore": 0.0248433089672248, "range": 0.0527016868430471, "velocity": 0.05737947906737912, "future": 0.036600583869956536, "receiving": 0.05576099142959053, "sympathetic": 0.05726105274791346, "action": 0.012016072475769517, "matched": 0.0570636756872871, "resistin": 3881.096366497032, "dnx": 0.0, "conditions": 0.04305628508023179, "surgical": 0.032934294733845376, "endothelial": 3380.862833936276, "during": 0.21053753314233953, "plasma": 0.0432467589893097, "either": 0.04217942178412661, "mechanism": 0.04632306522462495, "ventricle": 3380.8661681485255, "anemia": 3380.8594996673055, "physicians": 0.03633745203609734, "recommendations": 0.032298128182945404, "vascular": 0.04331553398381804, "male": 0.041510198374952366, "chromatin": 3380.862833936276, "structure": 0.04517108916944012, "known": 0.03977236623406672, "intervention": 0.039293516154345905, "0.02": 0.046649746233706255, "interaction": 0.042868496950732075, "morbidity": 0.039964071262844826, "values": 0.04209478141830408, "fontan": 0.0, "self": 0.01634661193730172, "duration": 0.04647780879261883, "complications": 0.04319517775921109, "reasons": 0.0377460900441628, "derived": 0.04639184012863596, "kidney": 0.04300604669846617, "egfr": 0.0, "scores": 0.0456181238496094, "bb": 0.0, "measurement": 0.04331553398381804, "hyperkalemia": 3380.8661681485255, "ivabradine": 3380.862833936276, "obese": 0.03980932757263604, "users": 0.03793396359881535, "2011": 0.032026426339343064, "hospitals": 0.03666663922257323, "overall": 0.012405484120554576, "improvements": 0.036755590234849186, "fat": 0.03395475970630127, "controls": 0.03687419165739138, "biomarkers": 2915.1288543049723, "weight": 0.035806781850795694, "relative": 0.03668146438802212, "as": 0.3323452090290958, "inappropriate": 0.03069430017249005, "evaluation": 0.02565575128102553, "24": 0.03414637999634145, "revealed": 0.03505070398347794, "vo2": 0.0, "calculated": 0.03706691914658422, "according": 0.02534250745654465, "criteria": 0.03668146438802212, "greater": 0.035421329966374974, "incidence": 0.03428091396165509, "ras": 0.0, "recommended": 0.03376203248765179, "with": 2.6222835532509032, ".001": 2915.1317292613803, "18": 0.03365715756133161, ">": -0.6335232792096058, "mediated": 0.037363423405234665, "dilatation": 2915.1317292613803, "procedures": 0.03681489093573498, "prediction": 0.037289297291802755, "medication": 0.034191962738696555, "number": 0.026748894978689167, "strain": 0.03718552078761221, "need": 0.02181247689757479, "dialysis": 0.031613461681049296, "measure": 0.030027169950471982, "sst2": 0.0, "sham": 0.028679106561390933, "100": 0.0330345128740704, "length": 0.03631083564157604, "tac": 0.0, "undergoing": 0.037111394752211174, "aged": 0.03611810901465544, "frailty": 0.02298815226535489, "doxorubicin": 2915.1288543049723, "carvedilol": 2915.1288543049723, "variability": 0.03441434088391509, "nursing": 0.025611275663693953, "rad": 0.0, "four": 0.012828832331884572, "g": 0.014435102903167319, "strength": 0.028161309897910658, "potentially": 0.02823710214398223, "costs": 0.025811770055546728, "emergency": 0.023186058673157154, "et": 0.009573040109710267, "single": 0.023463116071795284, "glomerular": 2483.8967752657754, "filtration": 0.02937399062232745, "serum": 2483.8967752657754, "growth": 0.02382858615324023, "examine": 0.028957130471416247, "proportional": 0.02937399062232745, "sought": 0.02831289442994593, "all": 0.12934954889287814, "readmissions": 2483.8967752657754, "recently": 0.022730471189568276, "provided": 0.026342307959404898, "pump": 0.02918450858594927, "heartmate": 0.0, "cardiopulmonary": 0.024487163748428173, "14": 0.02590019290378853, "often": 0.024182273000897075, "variables": 0.029361358478824772, "declined": 0.028603431895771816, "retrospective": 0.017023973383505878, "phenotype": 2483.8967752657754, "adherence": 0.024461899460282717, "hdl": 0.0, "16": 0.025938088426789914, "phosphorylation": 2483.8967752657754, "investigate": 0.028704488543015824, "aimed": 0.02841395087332801, "week": 0.017639955366859444, "overload": 2483.8967752657754, "history": 0.022364150146268743, "st2": 0.0, "aldosterone": 2483.889426014734, "tapse": 0.0, "young": 0.023184373055706472, "rehabilitation": 0.02889396994776148, "drugs": 0.024890521117053428, "channel": 0.028704488543015824, "mi": 0.0, "pde2": 0.0, "prior": 0.021615501562335195, "stimulation": 0.022528345253789946, "doppler": 0.0, "prevalence": 0.02044864547510495, "impaired": 0.020522946995856755, "adult": 0.021987006884794057, "target": 0.02092556613248623, "systematic": 0.020469874476382186, "combined": 0.02206130808616697, "appropriate": 0.021827790178357, "area": 0.016934632225877422, "meta": 0.020554790518709783, "peripheral": 0.020512332490083447, "dopamine": 0.022634490316017546, "main": 0.007799370280141315, "0.05": 0.022613261296117546, "secondary": 0.013827214853995488, "improving": 0.017944331511704516, "global": 0.012977463442439696, "37": 0.02206130808616697, "abnormal": 0.018432597684302415, "mouse": 0.02236912783503679, "25": 0.019418336262545997, "remains": 0.02077696517018421, "longitudinal": 0.020554790518709783, "2009": 0.02039484924801584, "28": 0.020989252315038495, "usual": 0.019886078298507512, "genes": 0.02044864547510495, "mrna": 0.0, "failing": 0.022114380400791982, "pathways": 0.022613261296117546, "healthy": 0.019493344272759332, "pathophysiology": 2087.1591456431775, "develop": 0.021350141316064757, "wall": 0.02181717573872096, "annular": 2087.161204113955, "thus": 0.013678612496874987, "questionnaire": 0.0, "kccq": 0.0, "adjustment": 0.022496501753257365, "reverse": 0.020204512228185506, "would": -0.01126350874544897, "adrenergic": 2087.1591456431775, "pathway": 0.022613261296117546, "cases": 0.016012515104230133, "hospitalizations": 0.022634490316017546, "coupling": 0.022613261296117546, "crf": 0.0, "antagonist": 2087.161204113955, "metabolic": 2087.161204113955, "trastuzumab": 2087.1570871373806, "dash": 0.0, "resonance": 0.022623875805588542, "investigated": 0.022390356812077614, "markers": 0.022581417773264518, "animals": 0.019758704961313198, "unclear": 0.016715488583969953, "tissue": 0.016934796265584386, "alterations": 0.01697865785962236, "composition": 0.016873390066269468, "energy": 0.014443489303898367, "free": 0.012934699771504845, "poor": 0.013663319411220766, "iron": 0.016443547726730536, "short": 0.009444934328851753, "small": 0.011391350823592938, "and/or": 0.0166365379363406, "many": 0.0005328701687157883, "ambulatory": 0.013584912317203001, "predictor": 0.01697865785962236, "nesiritide": 1724.9249137546922, "diuretic": 1724.9215112368286, "multicenter": 1724.914705853768, "systems": 0.013987890566102626, "exhibited": 0.016969885539284576, "transcription": 1724.9249137546922, "circulating": 0.013541050719317346, "r": 0.011822203738545747, "approaches": 0.015101967138524925, "pacing": 0.01700497482529734, "samples": 0.01665408251932336, "safe": 0.014119473766839565, "deaths": 0.01620669661488901, "registry": 0.006761984615106634, "ability": 0.015066310225657907, "predict": 0.016759350081816168, "subgroups": 1724.9249137546922, "children": 0.010803134754014536, "possible": 0.012443993944683481, "1996": 0.016715488583969953, "distance": 0.01643477545331199, "molecular": 0.01696111321971633, "optimal": 0.016917251633373705, "parameters": 0.016934796265584386, "wk": 1724.9249137546922, "shortening": 0.016996202502628746, "mva": 0.0, "mellitus": 0.016996202502628746, "considered": 0.01547860226544605, "available": 0.013153999161706634, "complex": 0.015899668230774332, "va": 0.0, "esrd": 0.0, "contractile": 1724.9249137546922, "pre": 0.015838262667066512, "antagonists": 1724.9249137546922, "shown": 0.015899668230774332, "blockade": 0.015303730364921563, "progression": 0.016873390066269468, "given": 0.006278671802206978, "compliance": 0.014987927234125271, "contribute": 0.01637336956103999, "several": 0.011610650560059275, "converting": 0.01696111321971633, "enzyme": 1724.9249137546922, "metabolism": 0.016996202502628746, "magnetic": 0.016794439293953613, "cv": 0.0, "inflammatory": 0.016136518615415974, "tone": 0.016803211598900702, "eplerenone": 1724.91810860319, "$": 0.003505280916277312, "vad": 0.0, "inv": 0.0, "psoriasis": 0.01019982332298217, "aas": 0.0, "mena": 0.0, "national": 0.005227830345388431, "2005": 0.011585989336397718, "largely": 0.011813365994870331, "monitoring": 0.010570339731251486, "requiring": 0.01220417111789856, "show": 0.007464898023498994, "admitted": 0.011685466545929587, "loss": 0.010847019604410903, "an": 0.15523248098755285, "increasing": 0.011493617751217272, "underlying": 0.012317860234999997, "general": 0.007749872567361743, "presence": 0.010001898334402418, "cardiology": 1397.179533592865, "requires": 0.01180626046462101, "strategy": 0.011415457261404695, "agents": 0.012012321094612114, "reference": 0.012069165498579268, "26": 0.011436773751140047, "consistent": 0.01070534514923853, "made": 0.0033155972259308955, "frequently": 0.012175748863547088, "department": 0.0069260185543341055, "enrollment": 0.010961145505648754, "stratification": 1397.187802133288, "multivariable": 0.009639935237946538, "analyzed": 0.012339176962218971, "reviewed": 0.01214022105964147, "particularly": 0.010946495906425487, "points": 0.010086740473980489, "mechanisms": 0.012346282539217266, "scale": 0.007288398053382932, "little": 0.00563959154599442, "altered": 0.012367599273916124, "resulted": 0.012040743291600146, "differential": 0.010989567817345908, "average": 0.00914924371881859, "following": 0.009688840222371198, "9": 0.010868335944552988, "approach": 0.011330191358543127, "uptitration": 1397.186424101831, "48": 0.011948371187821704, "hemodynamic": 1397.186424101831, "occur": 0.012097587715531504, "hypothesized": 0.012396021595586466, "randomly": 0.012346282539217266, "imaging": 0.012317860234999997, "predictive": 0.011003778976934431, "obtained": 0.011927054563450617, "sensitivity": 0.012310754660512981, "hypertensive": 1397.187802133288, "infusion": 0.012388916014224902, "targets": 0.011905737944689387, "preoperative": 1397.1850460469302, "economic": 0.005469411433086512, "rs": 0.0, "variation": 0.01091140648420367, "reported": 0.010555696851291797, "size": 0.011351507825839355, "diagnosed": 0.012189959989476182, "summary": 0.006762960300994878, "camp": 0.0, "drug": 0.009362406531257812, "sudden": 0.01070534514923853, "ea": 0.0, "inhibitor": 0.011010884557654685, "albumin": 1397.187802133288, "13": 0.010847019604410903, "physical": 0.008787269926341747, "stay": 0.010790176058117903, "result": 0.010143583526623938, "abnormalities": 0.012374704853389732, "programs": 0.011699677585840859, "pathological": 0.012374704853389732, "45": 0.01184889365541272, "cardiotoxicity": 1397.187802133288, "administration": 0.010129797300881479, "center": 0.007615251541184808, "catheter": 0.009639935237946538, "indicated": 0.012076271051873356, "key": 0.00616573742312184, "scn5a": 0.0, "mmol": 1397.187802133288, "testosterone": 0.010982462238495628, "autonomic": 0.011017990139016248, "eh": 0.0, "la": 0.0, "saxagliptin": 1397.186424101831, "sitagliptin": 1397.186424101831, "deactivation": 1397.187802133288, "trends": 0.007336025231771036, "suggests": 0.00820590288570187, "led": 0.006836042275284797, "cachexia": 1103.9497671915703, "tested": 0.008385558911084426, "fm": 0.0, "correlation": 0.00869434388300992, "p<0.05": 1103.944322838807, "alone": 0.007824135506240396, "leading": 0.007122363175830868, "importance": 0.005977689190613294, "treatments": 0.0086045153738718, "databases": 0.00868311531247084, "17": 0.007666937835436335, "unknown": 0.008452930050609887, "needed": 0.0073918428405948785, "selected": 0.008346259112436256, "0.83": 1103.9497671915703, "60": 0.007812907088389416, "cumulative": 0.00868311531247084, "hazards": 0.008626972489339826, "therapies": 0.006505429783660419, "diseases": 0.005141459868857481, "measurements": 0.005388487813898339, "admissions": 0.008649429612687885, "11": 0.007049379295227679, "good": 0.001716395576886652, "21": 0.007779221846613594, "myocardium": 1103.9497671915703, "injury": 0.008149760481194935, "younger": 0.008301345086394307, "fewer": 0.008402401689317055, "seen": 0.005960245119152218, "classification": 0.004293984453885289, "for": 0.42574776492674216, "76": 0.0086045153738718, "seven": 0.005938089231238469, "iv": 0.0, "studied": 0.00848661564698179, "walk": 0.007908348703000508, "medications": 0.00866065817730272, "0.0001": 1103.9497671915703, "predicting": 0.008649429612687885, "required": 0.007397457012351852, "useful": 0.008363101880326422, "old": 0.003810101649592867, "laboratory": 0.008615743930620808, "biventricular": 1103.9475895060416, "approximately": 0.008250816844764261, "lack": 0.006651088918210719, "cs": 0.0, "successful": 0.006724073586309645, "0.70": 1103.9497671915703, "84": 0.008626972489339826, "clinic": 0.007465153390821633, "outpatients": 1103.9497671915703, "35": 0.008110460827340685, "vivo": 1103.9497671915703, "minutes": 0.0072627170263086195, "kinase": 0.008705572455519011, "consumption": 0.00727426837824665, "maximal": 1103.9497671915703, "elastance": 1103.9497671915703, "importantly": 0.0019308796857442126, "moreover": 0.0, "plus": 0.00818344591798347, "comorbidities": 1103.9497671915703, "aor": 0.0, "atp": 0.0, "stent": 1103.9497671915703, "44": 0.008520301261069483, "mechanical": 0.007515681871792027, "experienced": 0.008200288643026422, "dietary": 0.007594281810391069, "yet": 0.006504809890367187, "\u03b4": 0.0, "depression": 0.003081562768492425, "aerobic": 1103.9486783580683, "worsening": 0.00869995816901111, "biological": 0.008598901096243153, "0.85": 1103.9497671915703, "expressed": 0.00792519135566115, "irs1": 0.0, "irs2": 0.0, "cancer": 0.006836357853581377, "initiative": 0.005040403257069768, "trend": 0.008211517128855605, "ecct": 0.0, "mapping": 0.0086045153738718, "phase": 0.008374330394720427, "titin": 1103.9486783580683, "zsf1": 0.0, "resting": 0.007549367547949078, "pd": 0.0, "sodium": 0.008688729597487024, "multiple": 0.006987941926886953, "anthracycline": 1103.9497671915703, "ablation": 1103.9497671915703, "nicorandil": 1103.9454117464115, "targeting": 0.008374330394720427, "variants": 0.008632586769430982, "contextual": 0.007577438958283328, "preferences": 0.00836871613727007, "biomedical": 0.00869995816901111, "pyridostigmine": 1103.9475895060416, "dyssynchronous": 1103.9497671915703, "uptake": 0.008705572455519011, "rule": 0.00812168929741003, "membrane": 0.008705572455519011, "ecmo": 0.0, "f": 0.0, "kit+": 0.0, "sample": 0.005672523802614582, "attention": 0.004073757910969407, "caused": 0.005019167659120056, "peptides": 0.005822968885399645, "2012": 0.00419388814039299, "additional": 0.004318764885072715, "purpose": 0.003803179425829488, "observational": 0.004997913428261264, "both": 0.024011342028563958, "highly": 0.005289965529910644, "strongly": 0.005625241157703133, "further": 0.012357700004104261, "double": 0.005324352668206236, "2010": 0.004563542872878866, "enhanced": 0.005715508064847813, "added": 0.0033729207435955447, "quantify": 0.005822968885399645, "regarding": 0.005513482360211685, "d": 0.0014181518872995991, "ie": 0.0008036483793507306, "subsequent": 0.005724104921821486, "experience": 0.003141023271668544, "eo": 0.0, "basis": 0.005255578415747182, "examination": 0.00488615416017502, "metrics": 0.005797178266967569, "centers": 0.0032360006604261796, "absolute": 0.005651031685638112, "percent": 0.0039961669863487785, "0.50": 0.005831565761226918, "implanted": 0.005822968885399645, "sts": 0.0, "inclusion": 0.005771387662120977, "renin": 845.2098732155631, "accompanied": 0.005719806493140674, "work": -0.00043930932972587175, "include": 0.004486173046955682, "documented": 0.005745597070848978, "determined": 0.0054962887216782426, "percentage": 0.00553497441685708, "intervals": 0.005814372011080662, "symptomatic": 845.210706867896, "circulation": 0.005762790796851731, "circulatory": 0.004997913428261264, "minute": 0.005195401024020804, "80": 0.005457603057052771, "diuretics": 845.2098732155631, "protective": 0.004954929064218682, "production": 0.004658106159360006, "survivors": 0.005629539578088396, "furthermore": 0.0008294390023076783, "especially": 0.004404505029897287, "salt": 0.005741298640282808, "established": 0.005221191325704938, "fibrosis": 845.210706867896, "t": 0.0005457428964477201, "biomarker": 845.210706867896, "various": 0.0030423673613528927, "incident": 0.005118030200403095, "auc": 0.0, "shock": 0.005612345898831527, "31": 0.005289965529910644, "stenosis": 845.210706867896, "reversed": 0.005754193933090771, "ring": 0.004843169894171081, "regurgitation": 845.210706867896, "leaflet": 0.005831565761226918, "plasty": 845.210706867896, "degenerative": 0.005831565761226918, "later": 0.0036351130245671076, "another": 0.0016065629802054604, "postoperative": 845.2090395490468, "resulting": 0.005616644318074699, "angiography": 0.005831565761226918, "etiology": 845.210706867896, "causes": 0.005577958558428001, "second": 0.0020750625670828316, "inpatient": 0.004997913428261264, "70": 0.0053200542746036404, "city": 0.0, "ca(2": 0.0, "27": 0.005079344834401847, "0.98": 845.210706867896, "potassium": 0.004989316552433991, "community": 0.003050555107884921, "crucial": 0.005509183950007283, "negative": 0.0054833934967428105, "brain": 0.005315755881367229, "form": 0.00272429124290949, "ischemia": 845.210706867896, "lad": 0.0, "hypoalbuminemia": 845.2098732155631, "ai": 0.0, "69": 0.005724104921821486, "idiopathic": 845.210706867896, "walking": 0.005526377593065541, "alternative": 0.005474796682000902, "lvet": 0.0, "partially": 0.005767089229303258, "aim": 0.004666934797785786, "signalling": 0.00581007357449222, "frequency": 0.0048775573039554895, "investigating": 0.0006360096610491288, "produced": 0.005307159096047361, "collagen": 845.210706867896, "lean": 0.005775686095315769, "gls": 0.0, "refractory": 845.210706867896, "still": 0.0006867694819773359, "rehospitalization": 845.210706867896, "remodelling": 845.210706867896, "minnesota": 0.0, "deficit": 0.005672523802614582, "np": 0.0, "parasympathetic": 845.210706867896, "aspects": 0.005565063311999679, "ar": 0.0, "hrqol": 0.0, "hgb": 0.0, "skeletal": 0.004159948473747804, "mt": 0.0, "gastrointestinal": 0.0041642469118554175, "s1pr1": 0.0, "receptors": 845.210706867896, "hct": 0.0, "neprilysin": 845.2098732155631, "bleeding": 0.005788581397184336, "btes": 0.0, "remain": 0.0029929649958142577, "cc": 0.0, "nps": 0.0, "play": 0.0019887424011436334, "ffm": 0.0, "19": 0.0031603381517631233, "inflammation": 0.0036498301489983815, "prospectively": 620.9699066074629, "least": 0.0022634797613952764, "combination": 0.0029047032648986853, "american": 0.0, "recommendation": 0.002323783399600797, "hemoglobin": 620.9699066074629, "dl": 620.9686815968289, "1.8": 0.003624565883023546, "intravenous": 0.003056288674590224, "agent": 0.003567721349395722, "settings": 0.0035140349278352167, "icd": 0.0, "min/1.73": 620.9705190971484, "hours": 0.002585588302150751, "open": 0.0022413743789831873, "processes": 0.0034887707571592402, "implementation": 0.0034603485863445825, "nurses": 0.002983653919467176, "proteomics": 620.9705190971484, "myocyte": 620.9699066074629, "dna": 0.0, "recipients": 0.0036150917878470246, "bundle": 0.0036656203242372174, "branch": 0.003605617695171787, "block": 0.003438242468997084, "0.87": 620.9705190971484, "reductions": 0.003037340463475719, "0.92": 620.9705190971484, "involved": 0.0025634827219508253, "cfus": 0.0, "implications": 0.0029457575836642543, "metric": 0.003646672114776917, "cms": 0.0, "0.67": 0.0036719363962735814, "75": 0.0034729806594892424, "tm": 0.0, "hm": 0.0, "1.08": 0.0036719363962735814, "statistically": 0.003662462288630588, "reducing": 0.0034950867981680496, "investigation": 0.002437318936369152, "tachycardia": 620.9705190971484, "fully": 0.0024057391330220296, "western": 0.0, "activated": 0.0036656203242372174, "pathogenesis": 620.9705190971484, "lvads": 0.0, "received": 0.002566640661152905, "]": 621.0243774231016, "0.54": 620.9705190971484, "associations": 0.0036498301489983815, "female": 0.0031729701196452596, "pg": 620.9705190971484, "article": 0.0030782304685929357, "elderly": 0.003507718883510034, "protocol": 0.003021550295162703, "classified": 0.0036150917878470246, "coefficient": 620.9705190971484, "1.7": 0.0036498301489983815, "decreases": 0.0036687783601128863, "systemic": 0.003637198013790706, "catheterization": 620.9705190971484, "central": 0.0032582360187650085, "comparison": 0.0017081148467085541, "facilitate": 0.0036182498192981636, "gender": 0.003526667019825938, "0.004": 620.9705190971484, "unique": 0.0031066523377330023, "ec": 0.0, "iiib": 0.0, "demonstrate": 0.003611933756680911, "cutoff": 620.9705190971484, "died": 0.002907699724985124, "experimental": 0.0030341824292542544, "ang": 0.0, "oxidative": 620.9699066074629, "atherosclerosis": 0.003059446710750919, "ctnt": 0.0, "fit": 0.0032992900422175704, "continuous": 0.003570879376691382, "provides": 0.0031792861052484804, "favorable": 0.0036561462182644155, "btt": 0.0, "bivp": 0.0, "understanding": 0.002787856613889783, "analyze": 0.0036403560471810724, "delay": 0.0035329830674834836, "occlusion": 620.9705190971484, "indices": 0.003053130638714555, "linear": 0.0036498301489983815, "opening": 0.003163496143322116, "dynamic": 0.0029710218030976968, "confirmed": 0.003214024045861542, "cm2": 620.9705190971484, "continuity": 0.0036340399806853657, "modestly": 0.0036719363962735814, "restriction": 0.003043656532741753, "hfpsi": 0.0, "validated": 0.0036498301489983815, "1.73": 620.9705190971484, "kansas": 0.0, "intermediate": 0.003043656532741753, "cxl-1020": 0.0, "0.96": 620.9705190971484, "newly": 0.0028604909739665795, "excluded": 0.0036498301489983815, "2.5": 0.0035961436049898386, "fold": 0.003621407851018342, "angiogenesis": 620.9705190971484, "vegf": 0.0, "worse": 0.003349818135359397, "acf": 0.0, "0.63": 620.9705190971484, "individual": 0.0031192842867694475, "bottleneck": 0.0036687783601128863, "proximal": 620.9705190971484, "lcx": 0.0, "reserve": 0.0033908722632514394, "ees": 0.0, "differ": 0.003637198013790706, "marked": 0.0028889131547623187, "subgroup": 620.9699066074629, "procedure": 0.002980495889963255, "youngest": 0.003589827546251035, "black": 0.0024057391330220296, "categories": 0.0035203509732765156, "1.00": 0.0036719363962735814, "assigned": 0.003624565883023546, "tools": 0.0015628459799980525, "icu": 0.0, "90": 0.0033782402189098384, "previously": 0.0027025903781819666, "embolism": 620.9705190971484, "interquartile": 620.9705190971484, "tnf": 0.0, "vasopressin": 620.9705190971484, "hand2": 0.0, "linked": 0.003368766188566435, "targeted": 0.003466664622358856, "induction": 0.003031024395317816, "breast": 0.0029962860402691673, "toward": 0.003346660127455827, "aims": 0.003469822640789531, "0.99": 620.9705190971484, "modification": 0.0030499726031079258, "beat": 0.0033024480459657233, "lbbb": 0.0, "2007": 0.0032361300255261275, "retn": 0.0, "sinus": 620.9705190971484, "state": 0.0012561196907642839, "clinically": 0.0036656203242372174, "records": 0.0032898160326512633, "tool": 0.0033403441124877655, "contribution": 0.0034824547172585514, "designed": 0.0030971783788544325, "bets": 0.0, "prevention": 0.003611933756680911, "na+": 0.0, "channels": 0.003526667019825938, "upr": 0.0, "downregulation": 620.9705190971484, "balance": 0.00337192419840121, "diameter": 0.0036529881834888854, "goal": 0.002904541755873015, "states": -6.4280535889845954e-06, "pilot": 0.003536141091723806, "five": 0.0016350606105429415, "partial": 0.003621407851018342, "extracorporeal": 620.9692941073565, "applied": 0.0035203509732765156, "fes": 0.0, "social": 0.0021182160683223443, "sdqt": 0.0, "ch": 0.0, "aac": 0.0, "bat": 0.0, "barriers": 0.0035929855754859175, "pneumonia": 0.002120229610218441, "decline": 0.0018987294735646977, "problems": 0.0015566143070663268, "progress": 0.001837323842529407, "cross": 0.001074344389661242, "hypothesis": 0.0021180365299360597, "progressive": 0.002078561117811892, "distribution": 0.0019338184733067706, "dual": 0.0012212800594273928, "countries": 0.0012210828258559937, "increases": 0.0020149619738281626, "signs": 0.001979872860201765, "stiffness": 431.22910181073814, "pressures": 0.0020917195815978356, "literature": 0.0016290899894588783, "medline": 0.0, "2013": 0.001354856275297335, "arrhythmia": 0.0016970753946127007, "transfusion": 0.002124615771354805, "grade": 0.0007805667609468013, "strong": 0.0014710862469583118, "aggressive": 0.002030313476528572, "indication": 0.00205663036023154, "outpatient": 0.0021136503699595507, "conducted": 0.00190969478069258, "72": 0.0021004918946305857, "obstructive": 0.002124615771354805, "1.2": 0.0020763680411903522, "0.77": 431.22910181073814, "decongestion": 431.22910181073814, "neither": 0.0007257399511634468, "sites": 0.0016662660942244989, "relevance": 0.0012410177525063561, "participating": 0.0015413671592155117, "nucleolin": 431.2278257471388, "profile": 0.001826358567144254, "modest": 0.002080754194631366, "impairment": 0.002109264210747027, "receive": 0.0017254782592581736, "previous": 0.0012474979206715268, "revascularization": 431.22910181073814, "contemporary": 0.0003530046786217211, "severely": 0.0020829472716376723, "0.04": 0.002122422690687655, "1.02": 431.22910181073814, "cpcs": 0.0, "process": 0.000865911676295552, "2000": 0.0019513629916436176, "office": 0.0010303877915781349, "highest": 0.0018022349782229803, "between": 0.03276253300099987, "measuring": 0.001201542381931478, "rm": 0.0, "growing": 0.0016728452167464813, "discharged": 0.002109264210747027, "january": 0.0, "relevant": 0.001878991932857818, "validity": 0.002111457290254321, "comparisons": 0.0021070711314265652, "participation": 0.0016203176925807775, "understood": 0.0019908382029201993, "bax": 0.0, "treating": 0.0016532138217369373, "replacement": 0.0020390857680199527, "ras-": 0.0, "0.81": 431.22910181073814, "burden": 0.0020061896908071656, "inhospital": 431.228676463442, "explored": 0.0020917195815978356, "pediatric": 0.0016795307562290842, "involving": 0.001955749123153031, "international": -0.0003860505386840861, "1.3": 0.002087333426232987, "1.6": 0.0020829472716376723, "distinct": 0.0020763680411903522, "77": 0.0020829472716376723, "final": 0.0012276618312223931, "hdl(nyha": 0.0, "quantified": 0.002120229610218441, "done": 0.0011092399994980528, "curve": 0.0021136503699595507, "loading": 0.002087333426232987, "simple": 0.0018088141365328538, "ans": 0.0, "fractional": 431.228676463442, "lung": 0.001688303073884596, "reclassification": 0.002124615771354805, "described": 0.001749601774113624, "over": 0.0009526916598618671, "statistical": 0.0020763680411903522, "interestingly": 0.0, "dt": 0.0, "june": 0.0, "varying": 0.0020917195815978356, "synchrony": 431.22910181073814, "mixed": 0.0015983869638578755, "anterior": 431.22910181073814, "man": 0.0006289794324684524, "edge": 0.0019382046017325314, "wave": 0.001999610480560044, "lesions": 431.228676463442, "clear": 0.0014732792704833175, "discussed": 0.0019952243413553575, "symptom": 0.001688303073884596, "repeated": 0.0016225107665145037, "66": 0.0020719818885188723, "direct": 0.0014602238152870654, "indicative": 0.0021070711314265652, "most": 0.0068606152341075, "collected": 0.0019491699261747074, "university": 5.03622151582993e-05, "epidemiology": 0.0012739139422633253, "59": 0.0020961057377266675, "68": 0.0020917195815978356, "comparable": 0.001670758441651713, "domains": 0.002109264210747027, "internal": 0.001526015695568663, "reliability": 0.0020982988160852104, "concentrations": 0.0016861099941793667, "family": 0.0004425794146093425, "doses": 0.002120229610218441, "affect": 0.0019403976662395346, "ng": 0.0021070711314265652, "achieved": 0.001984258996713103, "hno": 0.0, "usefulness": 0.001260755461162842, "here": 0.0, "contractility": 431.22910181073814, "3.1": 0.002115843449851613, "0.97": 431.22910181073814, "initial": 0.001955749123153031, "5.0": 0.002120229610218441, "covariates": 431.22910181073814, "22": 0.0016706521757097429, "0.91": 431.22910181073814, "perfusion": 431.22910181073814, "influences": 0.002104878052304039, "eds": 0.0, "driven": 0.0019579421891935344, "xo": 0.0, "rat": 0.002102684973373896, "absence": 0.002030313476528572, "extracellular": 431.228676463442, "attenuation": 431.22910181073814, "possibly": 0.0019711005894876713, "force": 0.0016750382579700464, "vessel": 0.0020719818885188723, "feasible": 0.002115843449851613, "relation": 0.0010458345836270042, "twice": 0.0019206600926299831, "0.002": 431.22910181073814, "from": 0.055630441291134314, "programme": 0.0017605670158324462, "nordic": 0.0, "centre": 0.001254077044924904, "parallel": 0.0020961057377266675, "promising": 0.0020654026609573024, "milliseconds": 0.002122422690687655, "73": 0.002087333426232987, "completed": 0.0018175863502967432, "recovery": 0.0019513629916436176, "information": 0.0003745985774888644, "populations": 0.002054437285533833, "expected": 0.0013131890585538666, "responses": 0.0020763680411903522, "site": 0.0012781009298909846, "92": 0.002104878052304039, "full": 0.0009710819047970974, "chemotherapy": 0.0016904961537766586, "mediterranean": 0.0, "p<0.0001": 431.2274003781313, "part": -6.617591374131035e-05, "thirty": 0.0003837077419242506, "p<0.01": 0.0, "p=0.03": 431.2274003781313, "preliminary": 0.001642248440541971, "suggesting": 0.0020588234351271817, "on": 0.04080035823434524, "dd": 0.0, "\u2265": 431.22910181073814, "extent": 0.0019974174108587347, "majority": 0.0018022349782229803, "appears": 0.0017912697182281756, "hum": 0.0, "maintenance": 0.0011532947914372296, "assisted": 0.0016773376772989412, "cabg": 0.0, "maladaptive": 431.22910181073814, "activating": 0.002124615771354805, "pharmacologic": 431.22910181073814, "like": -0.0026689991658018844, "poc": 0.0, "consultation": 0.002063209585484512, "haemodynamic": 431.22910181073814, "jq1": 0.0, "contrast": 0.00202373425993283, "subunit": 431.22910181073814, "late": 0.0014140677027702974, "emd": 0.0, "myofiber": 431.22910181073814, "thickness": 0.002122422690687655, "united": 0.0, "options": 0.001876798873737477, "wrf": 0.0, "endpoint": 0.002124615771354805, "resource": 0.0020061896908071656, "chm": 0.0, "lyso": 431.22910181073814, ".05": 0.002124615771354805, "acs": 0.0, "oxygenation": 431.22910181073814, "concurrent": 0.0012695277811269614, "regulation": 0.0020171550450685314, "divided": 0.002061016510209655, "ecmo+vad": 0.0, "coupled": 0.0020917195815978356, "urgent": 0.002080754194631366, "familiar": 0.001979872860201765, "qt": 0.0, "qtv": 0.0, "hnorm": 0.0, "mirnas": 0.0, "service": 0.00110266102529549, "infection": 0.002045664988655732, "q66p": 0.0, "tta": 0.0, "tgtetmena": 0.0, "discussions": 0.0020149619738281626, "athletes": 0.001988645133993969, "psss": 0.0, "bpm": 431.22910181073814, "lvas": 0.0, "real": 0.0004910249769788367, "neurohormonal": 275.98608070970175, "society": 0.0002300799654758173, "college": 0.0, "acp": 0.0, "published": 0.0007029578039224185, "july": 0.0, "cochrane": 0.0, "harms": 0.0010861282525521285, "venous": 275.9863529366029, "thromboembolic": 275.9863529366029, "includes": 0.0008699796918182378, "erythropoiesis": 275.98608070970175, "stimulating": 0.0010833211096711072, "embase": 0.0, "syndrome": 0.0010636711233011408, "few": 0.0009553984100083126, "help": -4.511043586038436e-05, "defibrillators": 275.9863529366029, "al": 0.0009696322369053312, "authors": 0.0010131426977263993, "focused": 0.0009289290097040144, "ahf": 0.0, "essential": 0.0009738429214904162, "evaluating": 0.001074899683986614, "eligible": 0.001042617593253682, "estimates": 0.0009962999246614483, "1.56": 275.9863529366029, "1.71": 275.9863529366029, "0.73": 275.9863529366029, "reliable": 0.0010384068905692823, "0.005": 275.9863529366029, "blind": 0.0010313890552232667, "m2": 275.9863529366029, "america": 0.0, "hour": 0.0008685761392790592, "0.13": 0.0010875318241791042, "nurse": 0.0010594604150761034, "focus": 0.0007352392093574768, "practices": 0.0009892821077841388, "extend": 0.0010061248734616192, "\u00ae": 275.9863529366029, "cellular": 0.0010791103962747948, "tests": 0.000983667856500661, "deficits": 0.0010692854026570964, "defects": 0.0010819175384170615, "shift": 0.0006931946522977864, "reports": 0.0007380462911658777, "diseased": 0.0010819175384170615, "automatic": 0.0, "bypass": 0.0010805139672861416, "percutaneous": 275.9863529366029, "decompensated": 275.98608070970175, "world": -0.0010906006471869548, "\u226550": 275.9863529366029, "49": 0.001029985488521307, "moderately": 0.0010861282525521285, "39": 0.0010370033232516976, "1.01": 0.0010875318241791042, "evident": 0.0010496354335247026, "0.86": 275.9863529366029, "0.03": 0.0010777068253901264, "progenitor": 0.0010861282525521285, "every": -0.00015313023165532103, "units": 0.0009275254519936724, "recorded": 0.0009612108710559565, "55": 0.0010075284380704575, "noted": 0.0008784010096495407, "generally": 0.0009696322369053312, "correlations": 0.0002708372252433235, "careful": 0.000768987124436146, "network": 0.0005500320733809817, "context": 0.0007381086665198269, "home": -0.00043522857846244804, "programmes": 0.0010355997560607905, "hh": 0.0, "twenty": 0.0, "significance": 0.0010384068905692823, "1.18": 0.0010847246810518313, "hospitalisations": 275.9863529366029, "apoptosis": 275.9863529366029, "bcl-2": 0.0, "taken": 0.0002426579227536664, "dogs": 0.0010117391326286151, "method": 0.0009822642939849376, "unchanged": 0.001072092543075604, "positive": 0.0008306802672223808, "become": 0.00035909470107560297, "when": 0.001247948655402436, "technique": 0.001074899683986614, "ref": 0.0, "0.36": 0.0010875318241791042, "0.32": 275.9863529366029, "predicts": 0.001072092543075604, "borderline": 275.9863529366029, "2.7": 0.0010847246810518313, "adjusting": 0.001072092543075604, "presentation": 0.0007675835568758637, "canadian": 0.0, "application": 0.0009148934381269333, "cognitive": 0.0010608639843601394, "relationships": 0.0007100373928543616, "presenting": 0.00105805684591164, "liver": 0.0008110942085405311, "hemodynamically": 275.9863529366029, "saf": 0.0, "fifty": 0.0, "predominantly": 0.0010706889728065638, "pf": 0.0, "2.8": 0.001074899683986614, "by": 0.043345700143309136, "96": 0.0010706889728065638, "42": 0.0010187569593558892, "output": 0.001025774789161283, "0.008": 275.9863529366029, "prescribed": 0.0010608639843601394, "enos": 0.0, "successfully": 0.0010089320027988678, "specificity": 275.9863529366029, "confirm": 0.0009850714191359559, "hhd": 0.0, "uninephrectomy": 275.9863529366029, "eight": 0.00020341264732997238, "might": 0.00040962106118477663, "transition": 0.0010243712229518226, "decades": 0.0008896294403159264, "aric": 0.0, "net": 0.0009064721010920201, "excellent": 0.0009724393598401148, "2006": 0.0009612108710559565, "56": 0.0010510390019468614, "200": 0.0008966472134843516, "evaluations": 0.0010819175384170615, "86": 0.0010734961134713224, "78": 0.0010636711233011408, "twist": 0.0010482318652221166, "ste": 0.0, "pigs": 0.000799865641945028, "initiated": 0.00105805684591164, "echocardiograms": 275.98580847816885, "basal": 275.9863529366029, "contributions": 0.0010215640909093826, "annuloplasty": 275.9863529366029, "disappeared": 0.001052442570495698, "71": 0.0010566532768738546, "gradient": 0.0010875318241791042, "restricted": 0.0010650746929545532, "vary": 0.0010678818326343073, "routinely": 0.0010636711233011408, "um": 0.0, "rt": 0.0, "date": 0.0007801525774359938, "cohorts": 275.9863529366029, "collaboration": 0.0004714913942406329, "constructed": 0.0010608639843601394, "q": 0.0, "61": 0.0010636711233011408, "51": 0.0010496354335247026, "exists": 0.001029985488521307, "soluble": 275.98580847816885, "daily": 0.0008433122146028971, "conscious": 0.0010594604150761034, "93": 0.0010706889728065638, "creatinine": 275.9863529366029, "crude": 0.0007409157965958235, "3.5": 0.001066478262734644, "contributes": 0.001074899683986614, "ad": 0.0, "enhancement": 0.0008054799242595504, "efficiency": 0.001014546262950861, "o2": 0.0008153049230485282, "transmitral": 275.9863529366029, "pcwp": 0.0, "130": 0.0010608639843601394, "e'septal": 275.9863529366029, "89": 0.001062267553767301, "separate": 0.0009429645935934355, "5.1": 0.0010819175384170615, "antiarrhythmic": 275.9863529366029, "prevent": 0.0009303325675410325, "timing": 0.0010468282970462082, "antiplatelet": 275.9863529366029, "stenting": 275.9863529366029, "infarcted": 275.9863529366029, "reversible": 0.0010833211096711072, "cf": 0.0, "invasive": 0.0010791103962747948, "\u226570": 275.9863529366029, "23": 0.0008812081165747365, "62": 0.0010468282970462082, "fatal": 0.0007886370832295636, "compare": 0.0004995627270059529, "grip": 0.001074899683986614, "ph": 0.0, "deterioration": 0.0010791103962747948, "atrium": 275.9863529366029, "copd": 0.0, "mdc": 0.0, "ranging": 0.001029985488521307, "healthcare": 0.0007409157965958235, "perceived": 0.0010510390019468614, "battery": 0.0, "frail": 0.0010875318241791042, "1.24": 275.9863529366029, "spontaneous": 0.0010847246810518313, "occurs": 0.0010566532768738546, "intolerance": 0.0010833211096711072, "mineralocorticoid": 275.9863529366029, "components": 0.001028581921946025, "dko": 0.0, "content": 0.0004938320159419776, "1.05": 275.9863529366029, "i": 0.0, "descriptive": 0.0010875318241791042, "assessments": 0.0010805139672861416, "changed": 0.0008643654823967054, "matrix": 275.9863529366029, "1.03": 0.0010875318241791042, "times": 0.0004868144194503949, "rest": 0.0007969951229662646, "influence": 0.000975246483263842, "p=0.04": 0.0, "prolonged": 0.001072092543075604, "p=0.02": 275.985536242004, "n=11": 275.9863529366029, "specifically": 0.00046868426367213754, "sensitive": 0.0010327926220447987, "univariate": 275.98580847816885, "\u2264": 275.9863529366029, "morphology": 275.9863529366029, "srd": 0.0, "brachial": 275.9863529366029, "stimulated": 0.0010819175384170615, "vitro": 0.0010875318241791042, "success": 0.0007534852499329632, "larger": 0.0009275254519936724, "phosphocreatine": 275.9863529366029, "perturbations": 275.98608070970175, "web": 2.5214065463708476e-05, "logistic": 0.0008153049230485282, "congenital": 275.9863529366029, "poorly": 0.0010608639843601394, "investigations": 0.0007409157965958235, "erk1/2": 0.0, "adaptive": 0.0010791103962747948, "transduction": 275.9863529366029, "proportion": 0.0010384068905692823, "unit": 0.0009120863252882856, "predicted": 0.0010510390019468614, "describe": 0.0010355997560607905, "routine": 0.0010454247289934254, "guide": 0.0010215640909093826, "developing": 0.0009275254519936724, "bromodomain": 275.98608070970175, "signal": 0.001014546262950861, "epigenetic": 275.9863529366029, "substantial": 0.0010103355676504028, "constriction": 275.9863529366029, "breathing": 0.0010608639843601394, "pulse": 0.0010791103962747948, "sequence": 0.001072092543075604, "means": 0.0006271669340930299, "age-": 275.9863529366029, "123)i": 0.0, "haplotype": 275.9863529366029, "\u03b22": 275.9863529366029, "irrespective": 0.0010819175384170615, "vagal": 275.9863529366029, "insight": 0.001029985488521307, "electrical": 0.0010370033232516976, "represented": 0.0009934927975439934, "additive": 0.0010875318241791042, "wasting": 0.0008026727828560379, "million": -0.00021212277157417665, "cgmp": 0.0, "overexpression": 275.9863529366029, "explore": 0.0010229676568690403, "canada": 0.0, "skm": 0.0, "vo2max": 0.0, "dcm": 0.0, "enzymes": 0.0010875318241791042, "[": 276.01164981461466, "update": 0.0010159498282948948, "problem": 0.0005878681058884664, "beck": 0.0, "inventory": 0.0, "living": 0.0, "explant": 275.9863529366029, "tgf": 0.0, "pb": 0.0, "lead": 0.00060892103756391, "rabbits": 0.0010861282525521285, "\u03b21ar": 0.0, "actions": 0.0009219112223764327, "translational": 275.9863529366029, "pka": 0.0, "antibodies": 0.0010875318241791042, "wild": 0.0010159498282948948, "hfvt(+": 0.0, "0\u00b701": 275.9863529366029, "consensus": 0.000757758587390731, "supports": 0.0009808607315958911, "forms": 0.0009555966296224043, "lvh": 0.0, "rwt": 0.0, "madit": 0.0, "0.64": 0.0010875318241791042, "36": 0.0010243712229518226, "bisphosphonates": 275.9863529366029, "alendronate": 275.9863529366029, "sr": 0.0, "pad": 0.0, "ongoing": 0.0009471752711604608, "public": -0.00031593386459994113, "degs": 0.0, "telehealth": 275.9863529366029, "beneficiaries": 0.0010791103962747948, "buddy": 0.0, "pna": 0.0, "unfit": 0.0010805139672861416, "glucose": 0.0010875318241791042, "c'd": 0.0, "clcnka": 0.0, "air": 0.0007099754952151034, "pollution": 0.0010313890552232667, "hhf": 0.0, "gdmt": 0.0, "paradigm": 0.0005360555332318798, "qol": 0.0, "magnetically": 275.98608070970175, "levitated": 275.98608070970175, "database": 0.0004325552574953321, "created": 0.0002312332782465362, "board": 8.599793571691821e-05, "talk": 0.00027939224388573284, "expenditure": 0.0004341342712104218, "suggested": 0.00038281646728801055, "x": 0.00014129281895542127, "ray": 0.00043729229947169623, "absorptiometry": 155.24217039920723, "dxa": 0.0, "diabetic": 0.00045781951017462324, "proanp": 0.0, "adiponectin": 155.24217039920723, "inversely": 0.00045860901921479714, "bmi": 0.0, "1.35": 0.00045781951017462324, "latter": 0.0004096595897648962, "pronounced": 0.0004443978671081578, "critical": 0.0003670264326421293, "invasively": 155.24217039920723, "deficiency": 0.00045781951017462324, "language": 0.0003401834373210928, "tolerance": 0.0004451873749709427, "clinicians": 0.0004570300012057061, "trigger": 0.00044045032883909967, "threshold": 0.0004451873749709427, "sources": 0.0, "transfusions": 155.24217039920723, "extracted": 0.0004570300012057061, "protocols": 0.0004562404923040488, "limitations": 0.00029837320308694797, "mainly": 0.0004025540495525035, "serious": 0.0002896556633191462, "remote": 0.0, "pharmacological": 155.24201726897, "search": 0.00035676292497831237, "worldwide": 0.0004001855373956728, "financial": 0.00014517937472954427, "component": 0.00042860772442061986, "modern": 0.0003425519336873403, "heterogeneous": 155.24217039920723, "searched": 0.00044913491531774316, "63": 0.0004428188515943592, "1.38": 155.24217039920723, "shocks": 0.0004530824573959971, "enhance": 0.00042150216925057875, "preserve": 0.0004428188515943592, "march": 0.0, "1:1": 155.24217039920723, "urine": 0.00044913491531774316, "cystatin": 155.24217039920723, "0.06": 155.24217039920723, "similarly": 0.00013813478709273023, "beyond": 0.00016415776731007893, "involves": 0.00042623920540728615, "thereby": 0.0004420293439393485, "fundamental": 0.0004112385994610397, "gross": 0.00042387068701727257, "differentiation": 0.0004562404923040488, "validation": 0.00030153123744293235, "ies": 0.0, "ic": 0.0, "comprised": 0.0004483454071086678, "0.003": 155.24217039920723, "pattern": 0.0004325552574953321, "twofold": 0.00045781951017462324, "attenuated": 155.24217039920723, "categorized": 155.24217039920723, "0.90": 155.24217039920723, "1.20": 0.0004570300012057061, "cd34+vegfr2": 0.0, "0.25": 0.00045387196601862306, "0.09": 0.00045860901921479714, "0.69": 155.24217039920723, "choice": 0.00032834096483747266, "acr": 0.0, "medicaid": 0.0, "remaining": 0.00039860652963673976, "extreme": 0.0004088700850187124, "agreement": 0.00035597342487235555, "principal": 0.00026837193198100544, "47": 0.00042466019307735325, "way": -0.00048638372842057967, "needs": 0.00017912714665206891, "supplemented": 0.0004554509834736481, "hand": 0.00022649634472559455, "cri": 0.0, "0.55": 155.24217039920723, "0.49": 0.00045781951017462324, "exclusion": 0.0002999522201264238, "acceptable": 0.0004207126634655307, "rapid": 0.0004278182180142503, "caspase-3": 155.24186413612725, "septum": 155.24217039920723, "biopsies": 155.24217039920723, "fragmentation": 0.0004570300012057061, "tunel": 0.0, "paced": 0.0004554509834736481, "assay": 0.00045860901921479714, "exchange": 0.0003859744775423249, "widely": 0.0004175546410239104, "fractions": 0.00045781951017462324, "immediately": 0.00032597247221106924, "0.60": 0.0004570300012057061, "1.09": 0.0004562404923040488, "accounting": 0.00041992315775173864, "childhood": 0.00043097624405927243, "advances": 0.0002920571377013694, "intubated": 155.24217039920723, "revision": 0.00014681937738056947, "codes": 0.0004515034403565213, "visit": 0.0002533390009702566, "2.4": 0.00044913491531774316, "53": 0.0004428188515943592, "traditional": 0.00035834192539599776, "characterized": 0.00044992442359407825, "svr": 0.0, "asymptomatic": 0.0004562404923040488, "0.8": 0.0004530824573959971, "features": 0.00029991909445477213, "recognized": 0.00042702871167713853, "hart": 0.0, "mwt": 0.0, "1.63": 155.24217039920723, "density": 0.0004483454071086678, "lipoprotein": 155.24217039920723, "rationale": 0.00014681937738056947, "exerts": 155.24217039920723, "hdl(healthy": 0.0, "bound": 0.00041439661968841417, "k": 0.0002991627115710576, "determination": 0.0001262921774799045, "to": 0.08600454370733189, "best": -0.00020771197254389296, "knowledge": 0.0003409729360419177, "combining": 0.0004451873749709427, "compensated": 0.00045387196601862306, "troponin": 155.24201726897, "prevalent": 0.0004530824573959971, "characteristic": 0.00045229294884063093, "integrated": 0.00041439661968841417, "discrimination": 0.00043176575074267335, "temporary": 0.0004230811810244513, "insertion": 155.24217039920723, "cardiogenic": 155.24217039920723, "centrimag": 0.0, "rvad": 0.0, "demographics": 0.0004570300012057061, "eligibility": 0.00045071393194166993, "requirement": 0.00044123983635559427, "bridge": 0.00041439661968841417, "types": 0.00040571206673254735, "heartware": 0.0, "systematically": 0.0004554509834736481, "simulation": 0.0004554509834736481, "policy": 0.00019649582366445674, "currently": 5.9944809355638594e-05, "limits": 0.0004151861249174026, "regions": 0.0004104490945783392, "sufficient": 0.0004301867374431309, "regardless": 0.0004325552574953321, "carefully": 0.00042939723089824565, "adequate": 0.00028179354090327943, "rvpo": 0.0, "materials": 0.0, "ivc": 0.0, "avd": 0.0, "vvd": 0.0, "radial": 155.24217039920723, "apex": 0.0004467663909022882, "noninvasive": 155.24217039920723, "tethering": 0.00045860901921479714, "muscles": 0.0004333447643192473, "prolapse": 155.24217039920723, "4.4": 0.0004546614747125057, "fig": 0.0, "started": 0.00014360041170960794, "rheumatic": 155.24217039920723, "closure": 0.0004357132852025432, "indications": 0.00045387196601862306, "severity": 0.0002991627115710576, "reached": 0.00033702544313635256, "statistics": 0.0004104490945783392, "kaplan": 0.0, "meier": 0.0, "rank": 0.00044045032883909967, "85": 0.0004380818067091605, "rare": 0.00040413305800401055, "valid": 0.00042466019307735325, "terms": 0.00023912817298649155, "\u03b1": 155.24217039920723, "0": 0.00027939224388573284, "responsiveness": 0.00045860901921479714, "attributable": 0.00045781951017462324, "taking": 1.5229213948849129e-06, "\u226435": 155.24217039920723, "equivalent": 0.0004325552574953321, "lowest": 0.0004096595897648962, "p=0.001": 0.0, "donor": 0.0004515034403565213, "inotropic": 155.24217039920723, "pure": 0.00042466019307735325, "solely": 0.0004428188515943592, "myocytes": 155.24217039920723, "rise": 0.0003338674500577167, "equally": 0.0004175546410239104, "power": -0.0001611089856741815, "robust": 0.0004333447643192473, "cm": 0.0004554509834736481, "79": 0.00044755589897084897, "selecting": 0.00045071393194166993, "risks": 0.00037807945398625096, "prevents": 0.0004554509834736481, "bisoprolol": 155.24217039920723, "vehicle": 0.0003654474307007944, "capillary": 155.24217039920723, "1999": 0.00042150216925057875, "responsible": 0.00025097052808172363, "medium": 0.000404922562332651, "1.16": 155.24217039920723, "0.79": 155.24217039920723, "repeat": 0.0004183441465299294, "oxidase": 155.24217039920723, "respiration": 155.24217039920723, "allopurinol": 155.24217039920723, "depressed": 0.00029837320308694797, "annulus": 155.24217039920723, "estimating": 0.0003038997639361328, "systole": 155.24217039920723, "diastole": 155.24217039920723, "0.71": 0.00045860901921479714, "detecting": 0.00045387196601862306, "tricuspid": 155.24201726897, "echo": 0.0002999522201264238, "hundred": 0.00042702871167713853, "line": 0.0001838640552414316, "/\u2265": 155.24217039920723, "shows": 0.00020833812266340493, "animal": 0.00042150216925057875, "formed": 0.00040097504137802614, "descending": 0.0004546614747125057, "collateral": 0.0004562404923040488, "complete": 0.00015152582934860816, "mostly": 0.00037807945398625096, "64": 0.00043097624405927243, "41": 0.00042544969920868997, "selective": 0.00029837320308694797, "reduces": 0.00045071393194166993, "afterload": 155.24217039920723, "represents": 0.00041992315775173864, "substudy": 155.24217039920723, "arm": 0.000404922562332651, "sv": 0.0, "institution": 0.00041439661968841417, "concentration": 0.0004459768829009872, "normalization": 0.0004570300012057061, "safely": 0.0004436083593166295, "0.42": 0.00045781951017462324, "54": 0.00043887131401788116, "0.3": 0.0004546614747125057, "superior": 0.00044755589897084897, "complicating": 155.24217039920723, "precapillary": 155.24217039920723, "tonometry": 155.24217039920723, "carries": 0.00044123983635559427, "shorter": 0.0004467663909022882, "identifying": 0.00029679418632450494, "other": 0.00408451032668067, "norepinephrine": 155.24217039920723, "brief": 0.0004230811810244513, "arrest": 0.0003701844373558818, "retest": 0.00045860901921479714, "tug": 0.0, "error": 0.0004357132852025432, "ra": 0.0, "nbdmard": 0.0, "propensity": 0.0004570300012057061, "0.45": 155.24217039920723, "people": -0.0016459760808201329, "undertaken": 0.0004436083593166295, "others": 0.00010175799262887098, "abc": 0.0, "habc": 0.0, "74": 0.0004436083593166295, "white": 0.00017994771469262452, "1.13": 155.24217039920723, "nervous": 0.0004380818067091605, "nfat": 0.0, "mir-25": 0.0, "embryonic": 0.00045781951017462324, "integrate": 0.0004515034403565213, "mutant": 0.0004562404923040488, "overexpressing": 155.24217039920723, "murine": 155.24217039920723, "micrornas": 0.0, "mammalian": 0.00015234593919936947, "past": 2.3600032759552935e-05, "hallmark": 0.00045781951017462324, "h": -0.0037556648864914286, "diminished": 0.00030153123744293235, "exposure": 0.0004325552574953321, "prevented": 0.0004396608213938614, "december": 0.0, "insurance": 0.0002367917546479315, "describes": 0.00043176575074267335, "1.11": 155.24217039920723, "version": -7.1334806801604575e-06, "1.34": 0.00045860901921479714, "last": -0.0007934652735984896, "cardioprotective": 155.24217039920723, "subset": 0.00045781951017462324, "matching": 0.0004467663909022882, "contributing": 0.0004325552574953321, "p=0.035": 0.0, "0.1": 0.00045387196601862306, "chart": 0.00044045032883909967, "postcontrast": 155.24217039920723, "technology": 0.0001838640552414316, "p=0.01": 0.0, "chelation": 155.24217039920723, "verify": 0.0004207126634655307, "prolongation": 0.00045860901921479714, "2.1": 0.00044755589897084897, "hypophosphorylation": 155.24217039920723, "obesity": 0.00029442566170127566, "segment": 0.00041992315775173864, "contributed": 0.00042387068701727257, "referred": 0.0004104490945783392, "hospitalisation": 0.00045387196601862306, "sa": 0.0, "containing": 0.0004278182180142503, "separately": 0.0004459768829009872, "ecg": 0.0, "0.88": 155.24217039920723, "broader": 0.0004380818067091605, "delayed": 0.0004380818067091605, "series": 0.00021702248516721444, "initiation": 0.00045860901921479714, "6.0": 0.0004546614747125057, "origin": 0.0004365027923014916, "certain": 0.00010652469445133021, "0.4": 0.0004530824573959971, "stimuli": 0.00045860901921479714, "humans": 0.000419133652105206, "effectively": 0.0003891324889027554, "anti": 0.00033228845393393696, "together": 5.4389451077479985e-05, "ultrastructural": 155.24217039920723, "affecting": 0.00044045032883909967, "1.06": 0.00045860901921479714, "medicine": 0.0004175546410239104, "detect": 0.00044913491531774316, "sustaining": 0.0004530824573959971, "ultimately": 0.0004088700850187124, "opposing": 0.0004420293439393485, "engage": 0.0004033435537426291, "perspective": 0.0004096595897648962, "recruited": 0.0004515034403565213, "delivery": 0.0003812374625763963, "services": -0.00025424204947277387, "standardized": 0.0004554509834736481, "consequence": 0.0004451873749709427, "bet": 0.0, "implicated": 0.0004515034403565213, "downstream": 0.0004530824573959971, "phenylephrine": 155.24217039920723, "tissues": 0.0004562404923040488, "transverse": 0.00045860901921479714, "operated": 0.0004333447643192473, "networks": 0.00039781702586215857, "mri": 0.0, "tidal": 155.24217039920723, "swine": 0.0004570300012057061, "1.0": 0.0004562404923040488, "124": 0.0004570300012057061, "kilogram": 0.00045781951017462324, "indicate": 0.0004278182180142503, "scarce": 0.0004530824573959971, "functions": 0.0004301867374431309, "fluid": 0.0004530824573959971, "challenging": 0.00039781702586215857, "truncated": 0.00045860901921479714, "exposed": 0.00041439661968841417, "perk": 0.0, "concomitant": 155.24201726897, "pathophysiologic": 155.24217039920723, "pah": 0.0, "represent": 0.00038281646728801055, "1990": 0.0004365027923014916, "0.66": 0.00045781951017462324, "declines": 0.00029679418632450494, "indicating": 0.0004459768829009872, "mibg": 0.0, "correlates": 0.00045860901921479714, "periods": 0.0004341342712104218, "prescribing": 0.0004570300012057061, "interviews": 0.0004207126634655307, "nonprescribing": 155.24217039920723, "clinician": 0.00030547878194522377, "augmented": 0.00045781951017462324, "electromechanical": 155.24217039920723, "handling": 0.00043097624405927243, "dynamics": 0.00044123983635559427, "protection": 0.0003812374625763963, "exertional": 155.24201726897, "controlling": 0.0004443978671081578, "congestion": 0.0003038997639361328, "tolvaptan": 155.24201726897, "increasingly": 0.0003867639802780471, "regulated": 0.0004546614747125057, "transfer": 0.0004001855373956728, "assays": 0.00045860901921479714, "emphasis": 0.0, "5.5": 0.00045229294884063093, "principle": 0.00043176575074267335, "scales": 0.0004554509834736481, "qu\u00e9bec": 0.0, "expenditures": 0.00044992442359407825, "utilization": 0.00045071393194166993, "reversal": 0.0003046892729050499, "sarcomeric": 155.24217039920723, "microstructure": 155.24217039920723, "erc": 0.0, "reach": 0.00029123465196127666, "adjunctive": 155.24217039920723, "special": 0.000254128492070945, "cpt": 0.0, "ah": 0.0, "lp": 0.0, "pla2": 0.0, ".02": 155.24217039920723, "proven": 0.00042150216925057875, "interpretation": 0.00013892429495551505, "oht": 0.0, "consultations": 0.0004515034403565213, "abdominal": 0.0004562404923040488, "88": 0.0004467663909022882, "cpr": 0.0, "intensive": 0.00044123983635559427, "2.2": 0.00044123983635559427, "feasibility": 0.0002991627115710576, "apparent": 0.00043492377817285274, "positively": 0.00044755589897084897, "emotional": 0.0004207126634655307, "walked": 0.0004207126634655307, "molecule": 0.00045860901921479714, "pvf": 0.0, "carotid": 155.24217039920723, "anticoagulants": 155.24217039920723, "anticoagulation": 155.24217039920723, "intestinal": 0.0004562404923040488, "overview": 0.00045229294884063093, "unilateral": 0.0003046892729050499, "baroreflex": 155.24186413612725, "domain": 0.0004325552574953321, "normalized": 0.00045860901921479714, "atropine": 155.24217039920723, "sphingosine-1": 155.24217039920723, "phosphate": 155.24217039920723, "regulatory": 0.0004088700850187124, "saw": 0.00022333839043205958, "unfamiliar": 0.0004451873749709427, "subunits": 0.00045860901921479714, "myosin": 155.24217039920723, "binding": 0.0004554509834736481, "ri\u03b1": 0.0, "ser83": 0.0, "hfvt(-": 0.0, "rr": 0.0, "adrenoceptor": 155.24217039920723, "genetic": 0.0002873200915695263, "foundation": 0.00026047687725911, "education": 0.00020912760981657048, "region": 0.00028807667495204007, "schfi": 0.0, "v.6.2": 155.24217039920723, "cfi": 0.0, "rmsea": 0.0, "fragments": 0.0004562404923040488, "concentric": 0.00045860901921479714, "raloxifene": 155.24217039920723, "strata": 0.00045781951017462324, "ca(2+)-pump": 0.0, "suboptimal": 0.00045860901921479714, "specialty": 0.0004459768829009872, "screening": 0.00010734403451325572, "atherosclerotic": 155.24201726897, "differentially": 155.24217039920723, "fee": 0.000419133652105206, "demographic": 0.0004443978671081578, "east": 0.0, "consist": 0.00044913491531774316, "managing": 0.0003930800046630799, "valvular": 155.24217039920723, "rgk": 0.0, "q65p": 0.0, "ss20": 0.0, "actin": 155.24217039920723, "glycolysis": 155.24217039920723, "six": -7.742497334751817e-05, "anaerobic": 155.24217039920723, "overweight": 0.0004515034403565213, "subjected": 0.0004451873749709427, "capita": 0.0004436083593166295, "sh": 0.0, "professionals": 0.00039071149499951313, "antihyperglycemic": 155.24201726897, "pioglitazone": 155.24217039920723, "sulfonylureas": 155.24217039920723, "cpg": 0.0, "cpet": 0.0, "robot": 0.00011839711306192558, "hscrp": 0.0, "interatrial": 155.24217039920723, "shunt": 0.00030547878194522377, "arni": 0.0, "caloric": 155.24201726897, "mlhf": 0.0, "seattle": 0.0, "decade": 8.66436401619207e-05, "dedicated": 0.0001108550276813023, "measurable": 0.00013506656174939235, "some": -0.000280750572833679, "considerable": 0.0001283996029643445, "initiatives": 0.00011611839218615149, "areas": -7.042522163367061e-06, "adipose": 68.99645211954221, "cachectic": 68.99645211954221, "regard": 0.00012103087197294075, "inverse": 0.00013576834753121057, "proadm": 0.0, "unaltered": 0.00013576834753121057, "steadily": 0.00013155763468807548, "hence": 0.0, "european": 0.0, "definition": 0.00012629424986761018, "relaxation": 0.00013401388330796995, "english": 0.0, "library": 0.0, "grading": 68.996384060501, "recommends": 0.00012945227992825978, "weak": 0.00011927641421378019, "uncertain": 0.00013190852725533553, "registries": 68.99645211954221, "lists": 0.00012594335779196364, "selection": 0.0, "extraction": 0.0, "synthesis": 68.996384060501, "0.94": 68.99645211954221, "0.61": 0.00013576834753121057, "13.0": 68.99645211954221, "offered": 8.032765012806371e-05, "supporting": 0.0001083987932823391, "consistently": 0.00012032908877675523, "alleviate": 0.00013506656174939235, "warrants": 0.00013120674215070865, "epidemic": 0.00012945227992825978, "resources": 8.208209080381334e-05, "conducting": 0.0001280487107048982, "icds": 0.0, "cinahl": 0.0, "reviewers": 0.0001347156689042113, "1.45": 0.00013541745462446663, "1.25": 0.00013401388330796995, "1.15": 68.99645211954221, "1.54": 0.00013576834753121057, "1.79": 68.99645211954221, "1.59": 0.00013576834753121057, "rose": 0.0, "\u03bcg": 68.99645211954221, "bolus": 68.99645211954221, "optimization": 6.770930631083088e-05, "september": 0.0, "north": 0.0, "active": 0.00010243365887872485, "119": 0.0001347156689042113, "coprimary": 68.996384060501, "8296": 68.99645211954221, "7762": 68.99645211954221, "8830": 68.99645211954221, "0.11": 0.00013506656174939235, "0.16": 0.00013576834753121057, "0.10": 0.00013541745462446663, ".49": 68.99645211954221, "lessons": 0.00011927641421378019, "multisite": 68.99645211954221, "reveal": 0.00011822373992694783, "involvement": 0.00011787284856015823, "meeting": 2.4185954804409093e-05, "requirements": 0.00011050413696091644, "identifies": 0.00013366299055513322, "regulator": 0.00012348711412875514, "plasticity": 68.99645211954221, "antecedent": 0.00013506656174939235, "genomic": 0.00013576834753121057, "alter": 0.00013506656174939235, "changing": 9.366141856307271e-05, "developmental": 0.00013261031248308798, "quantitative": 0.00013366299055513322, "subproteome": 68.99645211954221, "demonstrating": 0.00013155763468807548, "extensive": 0.00012103087197294075, "knockdown": 0.00013576834753121057, "nearly": 7.506433271790317e-05, "abolished": 0.00013296120514269227, "surprisingly": 0.00012945227992825978, "lacking": 0.00012945227992825978, "displayed": 0.00012103087197294075, "perturbed": 68.99645211954221, "complementary": 0.00013506656174939235, "modeling": 0.00013366299055513322, "syndromes": 0.00013576834753121057, "1.88": 0.00013576834753121057, "0.51": 68.99645211954221, "survey": 0.0, "israel": 0.0, "mildly": 0.0001347156689042113, "0.40": 68.99645211954221, "repair": 0.00012734692627746136, "serial": 0.00012769781847534503, "0.2": 0.00013331209783396612, "relations": 0.00011787284856015823, "applications": 0.00010208276889708323, "ppr": 0.0, "california": 0.0, "planning": 9.461505427253513e-06, "deciles": 68.99645211954221, "0.84": 68.99645211954221, "decile": 0.00013576834753121057, "produce": 9.295964016961414e-05, "rankings": 0.0001308558496450114, "consideration": 0.00011997819722439022, "deliver": 9.541586508715982e-05, "meet": 4.944962018868148e-05, "unplanned": 0.0001347156689042113, "electronic": 0.00010910057438540732, "randomised": 68.99645211954221, "rcts": 0.0, "structured": 0.0001308558496450114, "telephone": 0.00012629424986761018, "delivered": 0.00010874968381892677, "contact": 4.4537228311414774e-05, "met": 6.173062627495578e-05, "reaching": 0.00011611839218615149, "trended": 0.00013576834753121057, "0.76": 68.99645211954221, "packages": 0.0001291013875764694, "canine": 0.00013401388330796995, "interventricular": 68.99645211954221, "weekly": 0.00012348711412875514, "blot": 0.00013576834753121057, "caspase": 68.996384060501, "apoptotic": 68.99645211954221, "detected": 0.00012980317231171972, "driveline": 68.99645211954221, "redo": 68.99645211954221, "sternotomy": 68.99645211954221, "extubated": 68.99645211954221, "periprocedural": 68.99645211954221, "uptitrations": 68.99645211954221, "correction": 0.0001308558496450114, "0.93": 68.99645211954221, "0.39": 68.99645211954221, "get": 0.0, "65": 0.00011646928339903522, "presents": 0.00012453978979985508, "recognition": 0.0001217326552922512, "infancy": 0.0001347156689042113, "intended": 0.00011155680921530543, "rather": 3.611599912919461e-05, "already": -6.914786976381257e-05, "methodology": 6.63057348703202e-05, "ninth": 0.0, "57": 0.00012699603411035906, "r(2": 0.0, "intubation": 68.996384060501, "2001": 0.0001154166098518393, "perform": 0.0001073461218590386, "52": 0.00011857463132540681, "94": 0.00013225941985426515, "0.7": 0.0001347156689042113, "augment": 0.0001347156689042113, "retention": 6.490216392231256e-05, "covered": 0.00010629345071276733, "620": 0.00013576834753121057, "feet": 8.243297903094988e-05, "0.018": 68.99645211954221, "indicators": 0.00013261031248308798, "promotes": 0.00013190852725533553, "restoration": 0.00012699603411035906, "properties": 0.00011050413696091644, "nitric": 68.99645211954221, "oxide": 0.0001347156689042113, "respective": 0.00011611839218615149, "ser(1177": 0.0, "thr(495": 0.0, "pkc": 0.0, "\u03b2ii": 0.0, "malondialdehyde": 0.00013576834753121057, "proteome": 68.99645211954221, "shotgun": 0.00013506656174939235, "triggered": 0.00012559246574798662, "amount": 5.436201809796591e-05, "99": 0.0001280487107048982, "dyspnea": 68.99645211954221, ".002": 68.99645211954221, "phenotypes": 68.99645211954221, "upregulated": 68.99645211954221, "communities": 1.9637264916627143e-05, "largest": 4.944962018868148e-05, "former": -7.406011599399133e-05, "smoking": 0.0001217326552922512, "receiver": 0.00013261031248308798, "operating": 9.681942286083985e-05, "10.4": 0.00013506656174939235, "adding": 3.4964170716500384e-06, "aucs": 0.0, "consisting": 0.00013296120514269227, "conjunction": 0.00012945227992825978, "34": 0.0001175219572241498, "should": 0.0007656139353679032, "ineligible": 0.00013576834753121057, "destination": 0.00011962730570369459, "frequent": 0.00012453978979985508, "longer": 5.0853161832493094e-05, "conclude": 0.00012945227992825978, "budget": 7.155545829202973e-05, "gaps": 0.00013015406472507282, "mandatory": 0.00013015406472507282, "porcine": 68.99645211954221, "variable": 0.00013225941985426515, "accordingly": 0.0, "tracking": 0.00012489068175148822, "nine": 7.716965885053688e-05, "inferior": 0.0001343647760906999, "snared": 0.00013576834753121057, "establish": 0.0001083987932823391, "midpapillary": 68.99645211954221, "regional": 9.646853337169264e-05, "circumferential": 68.99645211954221, "base": 8.348564389881971e-05, "apical": 68.99645211954221, "septal": 68.99645211954221, "chest": 0.00012769781847534503, "develops": 0.00013331209783396612, "restricting": 0.00013366299055513322, "posteriorly": 68.99645211954221, "displaced": 0.00012945227992825978, "papillary": 68.99645211954221, "acting": 0.0001154166098518393, "third": -4.937239245727989e-06, "sound": 8.945075004472764e-05, "resection": 68.99645211954221, "anastomosis": 68.99645211954221, "equation": 0.00013296120514269227, "\u00d7": 68.99645211954221, "integral": 0.0001291013875764694, "utilized": 0.00013541745462446663, "murmurs": 0.00013576834753121057, "organic": 0.00012734692627746136, "lesion": 68.99645211954221, "possibility": 0.00010980235561159975, "4.6": 0.0001343647760906999, "observation": 0.00012734692627746136, "degree": 9.22578618983906e-05, "fixed": 0.00010699523144646322, "demonstrates": 0.00013225941985426515, "set": -0.00011335786866280097, "veterans": 5.858610075277017e-05, "start": -4.1077775580797515e-05, "curves": 0.00013506656174939235, "log": 0.00010453899941763922, "danish": 0.0, "grouped": 0.00013506656174939235, "29": 9.717031238076789e-05, "forty": 6.45512712627083e-05, "uncontrolled": 0.00013506656174939235, "commonly": 0.00012734692627746136, "cronbach": 0.0, "consistency": 0.00013015406472507282, "seems": 5.050227637559202e-05, "member": 3.225627501300222e-05, "titrated": 68.99645211954221, "0.53": 0.00013576834753121057, "1.19": 0.00013576834753121057, "p=0.18": 0.0, "nitroxyl": 68.996384060501, "instability": 0.00013155763468807548, "sarcomere": 68.99645211954221, "transient": 0.00013541745462446663, "cyclase": 68.99645211954221, "isoproterenol": 68.99645211954221, "multiparametric": 68.99645211954221, "create": 5.5063789720600435e-05, "dimension": 0.00013155763468807548, "cm(2": 68.99645211954221, "\u226535": 68.99645211954221, "134": 0.00013506656174939235, "0.95": 68.99645211954221, "undergo": 0.00013155763468807548, "l.": 68.996384060501, "diverse": 0.00012103087197294075, "enhancing": 0.00012980317231171972, "surgically": 0.00013541745462446663, "untreated": 0.0001343647760906999, "act": 7.506433271790317e-05, "injected": 0.00013541745462446663, "encoding": 0.00013576834753121057, "flk": 0.0, "histological": 68.99645211954221, "do": -0.0007122512827289441, "1.95": 0.00013576834753121057, "released": 2.734390425078948e-05, "21.9": 68.99645211954221, "xanthine": 0.0, "ros": 0.0, "cardiomyocyte": 68.99645211954221, "maximum": 0.00010348632901011179, "explain": 0.00010699523144646322, "assessing": 6.490216392231256e-05, "wedge": 0.00013576834753121057, "velocities": 0.00013541745462446663, "e'lateral": 68.99645211954221, "estimation": 0.00013401388330796995, "0.82": 68.99645211954221, "emean": 68.99645211954221, "likelihood": 0.0001291013875764694, "s'lateral": 68.99645211954221, "4.5": 0.00012734692627746136, "plane": 0.0001108550276813023, "excursion": 0.00013541745462446663, "abstract": 0.0, "basic": 9.401230780686139e-05, "fiber": 0.00013155763468807548, "generated": 0.00011787284856015823, "46": 0.00012418889787811502, "tracked": 0.00013015406472507282, "downward": 0.00013190852725533553, "nonsurvivors": 68.99645211954221, "along": -4.235478026651279e-06, "shifted": 0.0001283996029643445, "step": 6.48886053625306e-05, "forward": 1.4010356879174226e-05, "affected": 9.576675448485264e-05, "modulated": 68.99645211954221, "necessary": 7.822232233327938e-05, "patterns": 0.00012278533050163215, "32": 0.00010945146498266892, "occluded": 68.99645211954221, "pulsatile": 68.99645211954221, "modulates": 0.00013576834753121057, "143": 0.0001347156689042113, "markedly": 0.00013366299055513322, "indicator": 0.00012945227992825978, "decreasing": 0.00013541745462446663, "nutrition": 6.174413109134002e-05, "insufficiency": 0.00013576834753121057, "encountered": 0.00013120674215070865, "271": 0.0001343647760906999, "framingham": 0.0, "failed": 7.295900769336841e-05, "bioprosthetic": 68.99645211954221, "transcatheter": 68.99645211954221, "postoperatively": 68.99645211954221, "restoring": 0.00013366299055513322, "offer": 4.278280410314271e-05, "conventional": 0.00011997819722439022, "oldest": 0.00013120674215070865, "ethnicity": 0.00013296120514269227, "nonadherence": 68.99645211954221, "intake": 0.0001308558496450114, "radiological": 68.99645211954221, "0.049": 68.99645211954221, "11.4": 0.00013576834753121057, "6mwt": 0.0, "125.6": 68.99645211954221, "2.3": 0.00013366299055513322, "depressive": 68.99645211954221, "anxiety": 5.12173729934005e-05, "0.014": 68.99645211954221, "experiencing": 0.00012278533050163215, "unfavorable": 0.00013576834753121057, "237": 0.00013576834753121057, "dobutamine": 68.996384060501, "furosemide": 68.99645211954221, "myxoma": 68.99645211954221, "myxomas": 0.0, "located": 0.00010032831944881279, "arteries": 0.00013506656174939235, "presented": 9.892476044389765e-05, "timed": 0.0, "up": 0.00415165130726293, "&": -4.586358651135212e-06, "go": 0.0, "icc": 0.0, "kappa": 68.99645211954221, "minimal": 0.00013190852725533553, "seconds": 0.00011120591843246923, "define": 0.00012769781847534503, "rheumatoid": 68.99645211954221, "arthritis": 68.99645211954221, "elevations": 0.00013576834753121057, "treat": 0.00011120591843246923, "stratified": 68.99645211954221, "oral": 6.279680842463168e-05, "loop": 0.00013261031248308798, "2.17": 0.00013576834753121057, "1.30": 0.00013576834753121057, "facilities": 9.085430572531295e-05, "satisfaction": 0.00012734692627746136, "sustainability": 0.00012875049525546038, "participant": 0.00013331209783396612, "completion": 0.00011962730570369459, "aging": 0.00012559246574798662, "gill": 0.0, "1.36": 68.99645211954221, "competing": 0.00012032908877675523, "sub": 0.00012138176361676126, "appropriately": 6.63057348703202e-05, ".006": 68.99645211954221, "excessive": 6.314770093032894e-05, "avp": 0.0, "deleterious": 0.00013541745462446663, "helix": 68.99645211954221, "bhlh": 0.0, "otherwise": 0.00010699523144646322, "conversely": 0.0, "induce": 0.00013366299055513322, "knockout": 0.00013155763468807548, "p38": 68.99645211954221, "insights": 0.0, "ranged": 0.00013331209783396612, "1.17": 0.00013576834753121057, "1.26": 68.99645211954221, "coding": 6.770930631083088e-05, "nontrastuzumab": 68.99645211954221, "1.50": 0.00013576834753121057, "1.33": 68.99645211954221, "stop": -2.8785083225279563e-05, "food": -4.562750169807561e-05, "0.89": 68.99645211954221, "quartiles": 68.99645211954221, "nonsignificant": 68.99645211954221, "concept": 0.00010313543893523913, "2331": 68.99645211954221, "0.35": 0.00013541745462446663, "1.48": 68.99645211954221, "2.14": 0.00013541745462446663, "add": 8.980163891914691e-05, "ten": 3.086571922351796e-05, "extended": 4.2795986460922604e-05, "expand": 0.00011331126358853828, "pool": 0.00011120591843246923, "donors": 0.00013296120514269227, "typically": 0.00011857463132540681, "examining": 0.00012980317231171972, "assignment": 0.00013155763468807548, "select": 0.00011120591843246923, "characterize": 0.00013541745462446663, "connecticut": 0.0, "19.1": 68.99645211954221, ".01": 68.99645211954221, "only": 0.00046112600806615144, "accumulation": 0.00013541745462446663, "estimate": 0.0001175219572241498, "confirmatory": 68.996384060501, "sixty": 0.0, "choices": 0.00012313622229935891, "arrhythmias": 68.99645211954221, "t2": 0.0, "remarkable": 0.00011997819722439022, "recommend": 0.00012559246574798662, "\u226430": 68.99645211954221, "blinded": 0.00013190852725533553, "0.58": 68.99645211954221, "deposition": 0.00013541745462446663, "wistar": 0.0, "isoforms": 68.99645211954221, "allows": 9.295964016961414e-05, "persistent": 0.0001305049571700955, "besides": 0.0, "defibrillation": 0.0, "usually": 8.55909744638609e-05, "ecgs": 0.0, "panel": 0.00010664434106378068, "\u2265160": 68.99645211954221, "160": 0.00012664514197314986, "peritoneal": 68.996384060501, "resistant": 0.00012980317231171972, "consequences": 0.00011506571873129901, "almost": 9.799772206004685e-06, "0.007": 68.99645211954221, "0.78": 68.99645211954221, "9.2": 68.99645211954221, "82": 0.00012980317231171972, "worsened": 0.00013506656174939235, "consumed": 0.0001280487107048982, "techniques": 0.00012453978979985508, "pairs": 0.00013015406472507282, "155": 0.0001347156689042113, "123": 0.00013366299055513322, "116": 0.0001343647760906999, "115": 0.00013331209783396612, "2.0": 0.0001283996029643445, "humanized": 68.99645211954221, "transgenic": 68.99645211954221, "expressing": 0.00013120674215070865, "retn(-/-": 0.0, "macrophages": 68.996384060501, "dramatic": 0.00012594335779196364, "elevation": 0.00013541745462446663, "link": 9.611764391243813e-05, "33": 0.00011717106591803438, "standing": 0.00010067920927654975, "1.81": 68.99645211954221, "cardioprotection": 68.99645211954221, "cancers": 0.00012945227992825978, "obtain": 0.00012489068175148822, "adenine": 68.99645211954221, "nucleotides": 68.99645211954221, "contents": 0.00012383800598804445, "creatine": 68.99645211954221, "grafting": 68.99645211954221, "swedish": 0.0, "confounders": 68.99645211954221, "became": 5.330936089530977e-05, "introduced": 0.00010173187894622255, "paediatric": 0.00013541745462446663, "transplants": 0.00013541745462446663, "pathology": 0.0001347156689042113, "adaptation": 0.00013155763468807548, "example": 4.8747849551012396e-05, "raf": 0.0, "mek1/2": 0.0, "scaffold": 68.99645211954221, "determining": 0.00013261031248308798, "typical": 0.00011576750100404891, "each": 0.00030760344067204556, "never": -9.86212566554049e-05, "residents": 7.471344513715881e-05, "therapeutics": 68.99645211954221, "calcium": 0.0001343647760906999, "adenosine": 68.99645211954221, "neutral": 0.0001308558496450114, "appear": 5.787087744145951e-05, "monitor": 0.00011436393658167371, "frame": 0.00012067998035901329, "advantage": 9.681942286083985e-05, "expansion": 0.0001129603726517966, "reporting": 0.00011190770002803452, "acetyl": 68.99645211954221, "activate": 0.00013401388330796995, "histone": 68.99645211954221, "readers": 7.787143447462192e-05, "rna": 0.0, "pol": 0.0, "protected": 0.00011892552275375882, "transcriptional": 68.99645211954221, "nuclear": 0.00011120591843246923, "\u03bab": 0.0, "promoting": 0.00012383800598804445, "quantification": 0.00013541745462446663, "1.5": 0.00011717106591803438, "180": 0.00013015406472507282, "9.4": 0.0001347156689042113, "breath": 5.12173729934005e-05, "cornerstone": 0.0001347156689042113, "detection": 0.00013155763468807548, "challenges": 8.418742063011865e-05, "unfolded": 6.63057348703202e-05, "regulates": 0.0001343647760906999, "splicing": 68.99645211954221, "v": 0.0, "voltage": 68.99645211954221, "gated": 68.99645211954221, "generating": 0.00012769781847534503, "stem": 0.00012769781847534503, "angii": 0.0, "hypoxia": 68.99645211954221, "kv4.3": 0.0, "splice": 0.00013541745462446663, "describing": 0.0001291013875764694, "conflicting": 0.00013366299055513322, "distinguish": 0.00013225941985426515, "temporal": 0.00013506656174939235, "nonselective": 68.99645211954221, "hemostasis": 68.99645211954221, "label": 0.00012032908877675523, "arg16": 0.0, "gln27": 0.0, "gly16": 0.0, "glu27": 0.0, "8)": 68.99645211954221, "washout": 68.99645211954221, "von": 0.0001343647760906999, "willebrand": 0.0, "149": 0.00013576834753121057, "295": 68.99645211954221, "taxonomy": 6.770930631083088e-05, "providing": 8.383653224907885e-05, "slow": 0.0001073461218590386, "acetylcholinesterase": 68.99645211954221, "sympathovagal": 68.99645211954221, "methylatropine": 68.99645211954221, "propranolol": 68.99645211954221, "surviving": 0.00012980317231171972, "geometry": 0.00013541745462446663, "conduction": 68.99645211954221, "local": -0.00010212997872442229, "extending": 0.00012699603411035906, "mechanistically": 68.996384060501, "150": 0.00010559167010219547, "4.2": 0.0001347156689042113, "mets": 0.0, "simultaneous": 0.00013506656174939235, "exertion": 0.00013541745462446663, "derive": 0.0001343647760906999, "derivation": 0.00013576834753121057, "undergone": 0.0001308558496450114, "institutions": 9.471408638589303e-05, "electrocardiographic": 68.99645211954221, "\u22652": 68.99645211954221, "tobacco": 0.00012278533050163215, "4.8": 0.0001347156689042113, "\u22651": 68.99645211954221, "97": 0.00013155763468807548, "savings": 0.00011331126358853828, "japan": 0.0, "americans": 0.0, "accurate": 0.00012103087197294075, "phosphodiesterase-2": 68.996384060501, "cyclic": 0.00013576834753121057, "monophosphate": 68.99645211954221, "microscopy": 68.99645211954221, "ca2(+": 0.0, "restored": 0.00012875049525546038, "amplitude": 68.99645211954221, "hypertrophic": 68.99645211954221, "specified": 0.0001343647760906999, "discontinuation": 0.00013576834753121057, "hrqol.": 0.0, "province": 9.576675448485264e-05, "offset": 0.00012875049525546038, "noncardiovascular": 68.99645211954221, "manage": 0.00010664434106378068, "rich": 9.7521201932365e-05, "cocoa": 0.00012453978979985508, "t2d": 0.0, "detrimental": 0.00013401388330796995, "epicatechin": 68.99645211954221, "treadmill": 68.99645211954221, "dapc": 0.0, "chinese": 0.0, "herbal": 0.00013576834753121057, "retrieved": 0.00013576834753121057, "volunteers": 0.00012208354699763422, "biosynthetic": 68.99645211954221, "catabolic": 68.99645211954221, "activities": 8.243297903094988e-05, ".07": 68.99645211954221, "marginally": 0.00013541745462446663, "slope": 0.00013366299055513322, "gain": 0.0001108550276813023, "pathophysiological": 68.99645211954221, "bridged": 68.99645211954221, "inotropes": 68.99645211954221, "operation": 9.295964016961414e-05, "occurring": 0.00013261031248308798, "posterior": 68.99645211954221, "situation": 5.541467557764394e-05, "team": -0.00022844192345044983, "half": 0.0, "discussion": 2.1391708824347937e-05, "promise": 0.00011366215455517291, "australian": 0.0, "administrative": 0.00012524157373479085, "fatality": 0.00013506656174939235, "occurrence": 6.525305661358643e-05, "supplementation": 68.99645211954221, "attrition": 6.700752052901264e-05, "incremental": 0.0001347156689042113, "shuttle": 0.00013296120514269227, "muscular": 0.0001343647760906999, "zung": 0.0, "transforming": 0.00013261031248308798, "yield": 0.0001280487107048982, "affects": 0.0001283996029643445, "explants": 68.99645211954221, "epithelial": 68.99645211954221, "mesenchymal": 0.00013576834753121057, "pluripotency": 68.99645211954221, "periodic": 6.595484208759024e-05, "originally": 0.00011787284856015823, "cycle": 0.0001129603726517966, "oscillations": 68.99645211954221, "much": -0.00024387977648746237, "imbalance": 0.00013401388330796995, "nutritional": 0.00013296120514269227, "denervation": 68.99645211954221, "nonpace": 68.99645211954221, "pace": 0.00011576750100404891, "spectral": 0.00013506656174939235, "narrow": 0.00012067998035901329, "wide": 8.629275156541612e-05, "dyssynchrony": 68.99645211954221, "msec": 68.99645211954221, "randomization": 68.99645211954221, "102": 0.00013366299055513322, "6.4": 0.0001347156689042113, "supported": 0.0001083987932823391, "smaller": 0.00010313543893523913, "steady": 0.00012138176361676126, "continued": 7.330989512021021e-05, "ensure": 3.3659810624819925e-05, "ratings": 0.00012699603411035906, "noc": 0.0, "top": -8.318284298721061e-05, "incorporating": 0.00013190852725533553, "advancement": 0.0001343647760906999, "highlighting": 0.0001308558496450114, "reciprocal": 0.00013541745462446663, "kinase-2": 68.99645211954221, "293": 68.99645211954221, "agonist": 0.00013541745462446663, "physiological": 0.0001347156689042113, "43.6": 68.99645211954221, "persist": 0.00013366299055513322, "rii\u03b1": 0.0, "c\u03b1": 0.0, "ser77": 0.0, "modulation": 0.0001343647760906999, "repolarization": 68.99645211954221, "vt": 0.0, "esmolol": 68.99645211954221, "isoprenaline": 68.99645211954221, "sdrr": 0.0, "haematopoietic": 68.996384060501, "genotyped": 68.99645211954221, "2\u00b79": 68.99645211954221, "0\u00b705": 68.99645211954221, "transporter": 0.00013576834753121057, "working": -0.0001158034820061745, "definitions": 0.0001343647760906999, "lcz696": 0.0, "valsartan": 68.99645211954221, "threatening": 0.00012278533050163215, "disorder": 0.00012945227992825978, "partly": 0.00012383800598804445, "guided": 0.00012594335779196364, "discuss": 9.96265398847934e-05, "condition": 9.85738707700652e-05, "raas": 0.0, "newer": 6.279680842463168e-05, "acquired": 0.00011787284856015823, "psychometric": 68.996384060501, "6.2": 0.0001347156689042113, "cfa": 0.0, "construct": 6.45512712627083e-05, "alphalisa": 0.0, "immunoassays": 68.99645211954221, "n-": 0.0, "terminally": 68.99645211954221, "leu3": 0.0, "nonterminal": 68.99645211954221, "epitopes": 68.99645211954221, "generation": 8.102942630619934e-05, "eccentric": 0.0001343647760906999, "cr": 0.0, "402": 0.00013576834753121057, "\u22640.42": 68.99645211954221, "1,790": 68.99645211954221, "1.1": 0.00012945227992825978, "0.48": 68.99645211954221, "nationwide": 0.00012243443873379846, "1.07": 68.99645211954221, "etidronate": 68.99645211954221, "refill": 0.00013576834753121057, "order": 3.1330222055325502e-06, "phospholamban": 68.99645211954221, "heavy": 8.804719485752243e-05, "chain": 0.00010945146498266892, "stages": 0.00011646928339903522, "rotterdam": 0.0, "cvd": 0.0, "ankle": 0.00013261031248308798, "south": 0.0, "dakota": 0.0, "transitions": 0.0001343647760906999, "reflecting": 0.0001305049571700955, "substrate": 68.99645211954221, "turbulence": 0.00013401388330796995, "computed": 0.00013541745462446663, "directed": 0.00010243365887872485, "framework": 0.00012524157373479085, "individualized": 0.00013576834753121057, "enrichment": 0.00013506656174939235, "0.74": 68.99645211954221, "blacks": 0.0, "providers": 0.0001154166098518393, "europe": 0.0, "expectancy": 0.00013155763468807548, "aha": 0.0, "currents": 0.00013541745462446663, "variant": 0.00013155763468807548, "inhibit": 68.99645211954221, "cav1.2": 0.0, "cav1.3": 0.0, "jehovah": 0.0, "witness": 0.0, "preclude": 0.00013541745462446663, "provision": 0.00012067998035901329, "decisions": 9.927565014939918e-05, "doctors": 9.331052935095302e-05, "performers": 0.00013155763468807548, "worst": 9.401230780686139e-05, "quintile": 0.00013541745462446663, "existing": 7.541522032942805e-05, "explained": 8.173120260745743e-05, "1.39": 0.00013576834753121057, "aldactone": 0.0, "aa": 0.0, "9.7": 0.00013506656174939235, "hypokalemia": 68.99645211954221, "5.6": 0.00013506656174939235, "proteomic": 68.99645211954221, "ingenuity": 0.00013541745462446663, "cytoskeleton": 68.99645211954221, "ss31": 0.0, "uti": 0.0, "managed": 7.927498609215888e-05, "cared": 0.00013190852725533553, "strongest": 0.00012453978979985508, "cardiologists": 68.99645211954221, "playing": -1.5802337250704355e-05, "1977": 0.00013331209783396612, "organization": 0.0, "powerful": 0.00010488988961474758, "p<001": 0.0, "finding": 9.5064975721136e-05, "respiratory": 0.0001347156689042113, "ci=0.94": 0.0, "nonidentification": 68.996384060501, "cardiorespiratory": 68.996384060501, "fitness": 0.00012243443873379846, "joint": 0.00010980235561159975, "precede": 0.00013576834753121057, "oxidation": 68.99645211954221, "latin": 0.0, "income": 5.6818219315396556e-05, "fever": 0.00012875049525546038, "etiologies": 68.99645211954221, "rs10927887": 68.99645211954221, "snp": 0.0, "cholesterol": 0.0001343647760906999, "urban": 0.0001108550276813023, "enabled": 0.00012278533050163215, "staff": 2.032624219897578e-05, "country": -0.0002245824508819624, "access": 2.032624219897578e-05, "awareness": 0.00011331126358853828, "dpp-4": 0.0, "user": 7.857321022182925e-05, "drs": 0.0, "conduct": 0.00011015324627042347, "dissemination": 6.700752052901264e-05, "classify": 0.00013506656174939235, "organisation": 3.9637971082015317e-05, "cpgs": 0.0, "communicate": 0.00012594335779196364, "neurological": 0.0001347156689042113, "intensity": 0.00012945227992825978, "w": 0.00013541745462446663, "axis": 0.00013296120514269227, "gait": 0.00013576834753121057, "lokomat": 0.0, "quadriceps": 68.99645211954221, "il6": 0.0, "psychosocial": 0.0, "r=": 68.99645211954221, "achieve": 9.997742965185672e-05, "hr<70": 0.0, "shunting": 68.99645211954221, "proof": 0.00011962730570369459, "transoesophageal": 68.996384060501, "thrombosis": 0.00013576834753121057, "p=0\u00b7016": 68.99645211954221, "centrifugal": 68.99645211954221, "debilitating": 0.00013506656174939235, "modified": 0.00012875049525546038, "generate": 0.00011822373992694783, "projections": 6.384948603495582e-05, "simulations": 0.0, "efforts": 2.3653763568133782e-06, "mpsms": 0.0, "60,000": 1.5260586589022425e-05, "4372": 17.24909601512525, "translating": 1.675188013225316e-05, "81,000": 17.24909601512525, "averted": 1.6839603351021735e-05, "2010\u20132011": 17.24909601512525, "ulcers": 1.692732657770772e-05, "actually": -1.096827160399265e-05, "respect": 4.295261184829675e-06, "lipolysis": 0.0, "a-": 0.0, "neurohormones": 17.24909601512525, "adipokines": 17.24909601512525, "takes": -3.8628629099756125e-06, "place": -5.1319017839492525e-05, "38": 1.3769295269744806e-05, "midregional": 17.24909601512525, "adrenomedullin": 17.24909601512525, "0.5": 1.5874648366923943e-05, "correlate": 1.675188013225316e-05, "38\u201354": 17.24909601512525, "figure": 3.7689285895183434e-06, "description": 0.0, "1947": 1.5786925232582235e-05, "reassessed": 17.24909601512525, "april": 0.0, "exacerbation": 17.24909601512525, "cerebrovascular": 17.24909601512525, "audience": 2.277654407539297e-06, "anemic": 1.675188013225316e-05, "deficient": 1.657643371758005e-05, "grades": 1.5260586589022425e-05, "restrictive": 1.6839603351021735e-05, "red": 5.172482792406987e-06, "technical": 9.558602373096908e-06, "advisors": 1.648871052189756e-05, "liberal": 1.5172863508770167e-05, "1.42": 17.24909601512525, "i2": 0.0, "16.8": 1.692732657770772e-05, "0.032": 17.24909601512525, "moderate-": 0.0, "thromboembolism": 17.24909601512525, "confounded": 1.6839603351021735e-05, "come": -5.1933038357730775e-05, "thresholds": 1.692732657770772e-05, "seem": 3.1548742452293584e-06, "conditioning": 1.5874648366923943e-05, "stemming": 1.6664156920957902e-05, "nonischemic": 17.24909601512525, "cardiomyopathies": 17.24909601512525, "continues": 2.8039862179447967e-06, "problematic": 1.5874648366923943e-05, "inroads": 1.640098733368838e-05, "armamentarium": 17.24909601512525, "eventual": 1.6137817815677075e-05, "resort": 1.4383356131901727e-05, "serially": 17.24909601512525, "keep": -2.7985958770883074e-05, "busy": 9.11998954931488e-06, "prompting": 1.490969431374133e-05, "ways": -2.634762462856343e-06, "deal": -1.4213935320540478e-05, "comments": 0.0, "enriching": 0.0, "identification": 1.5260586589022425e-05, "collins": 0.0, "categorization": 17.24909601512525, "perhaps": 4.382983310870298e-06, "citations": 1.692732657770772e-05, "addressed": 1.262889752625678e-05, "random": 1.5523755876173285e-05, "10,420": 17.24909601512525, "257,692": 17.24909601512525, "proved": 8.59365441458629e-06, "1.37": 1.692732657770772e-05, "1.43": 1.692732657770772e-05, "1.72": 17.24909601512525, "2.34": 17.24909601512525, "3.44": 17.24909601512525, "rigorously": 17.24909601512525, "hypotheses": 1.675188013225316e-05, "360": 1.5085140435991204e-05, "allocation": 1.5172863508770167e-05, "2:1": 17.24909601512525, "122": 1.648871052189756e-05, "pooled": 1.6839603351021735e-05, "8524": 17.24909601512525, "7917": 17.24909601512525, "9131": 17.24909601512525, "229": 1.6664156920957902e-05, "-714": 17.24909601512525, "1171": 17.24909601512525, ".59": 17.24909601512525, "0.12": 17.24909601512525, "0.18": 1.6839603351021735e-05, "-0.08": 17.24909601512525, ".72": 17.24909601512525, "8574": 17.24909601512525, "8014": 17.24909601512525, "9134": 17.24909601512525, "279": 17.24909601512525, "-618": 17.24909601512525, "1176": 17.24909601512525, "0.07": 1.692732657770772e-05, "-0.04": 17.24909601512525, "-0.13": 17.24909601512525, ".36": 17.24909601512525, "reflective": 1.648871052189756e-05, "multihospital": 17.24909601512525, "promote": 9.646324960850247e-06, "adoption": 1.3330680599095393e-05, "leaders": -4.126027095213952e-06, "adopting": 1.6137817815677075e-05, "questions": 5.232170406997317e-07, "issues": -1.4389376302456884e-05, "organizations": 1.1927114945917303e-05, "profoundly": 1.657643371758005e-05, "transformed": 1.4821971264270417e-05, "utilizing": 0.0, "voluntary": 1.490969431374133e-05, "testimonies": 1.6664156920957902e-05, "conversations": 1.4558802161807624e-05, "magnet": 0.0, "preceding": 1.657643371758005e-05, "coordinate": 1.648871052189756e-05, "accessibility": 1.675188013225316e-05, "altering": 1.6664156920957902e-05, "subproteomes": 17.24909601512525, "accompany": 1.6664156920957902e-05, "recapitulates": 17.24909601512525, "conserved": 1.692732657770772e-05, "detergent": 1.692732657770772e-05, "abundance": 1.5786925232582235e-05, "321": 1.692732657770772e-05, "conservation": 1.4734248222494837e-05, "acid": 1.648871052189756e-05, "176": 1.6839603351021735e-05, "characterization": 1.6839603351021735e-05, "morpholino": 0.0, "morphological": 17.24909601512525, "fish": 4.558427586259105e-06, "chamber": 1.4383356131901727e-05, "patterning": 17.24909601512525, "ostensibly": 1.692732657770772e-05, "looping": 1.6839603351021735e-05, "involve": 1.4383356131901727e-05, "bone": 1.5260586589022425e-05, "morphogenetic": 17.24909601512525, "rrna": 0.0, "heterochromatic": 17.24909601512525, "zebrafish": 17.24909601512525, "orchestrate": 1.692732657770772e-05, "reprogramming": 17.24909601512525, "shared": 6.663761291378333e-06, "1,045": 17.24909601512525, "comprising": 1.5436032772835006e-05, "3.21": 17.24909601512525, "1.67": 17.24909601512525, "electrocardiogram": 17.24909601512525, "0.62": 1.692732657770772e-05, "1,620": 17.24909601512525, "conferred": 1.6137817815677075e-05, "\u226475": 17.24909601512525, "1.49": 17.24909601512525, "156": 1.675188013225316e-05, "consenting": 1.6839603351021735e-05, "outgrowth": 17.24909601512525, "colony": 1.5786925232582235e-05, "forming": 1.5611478987428954e-05, "cd34": 0.0, "vegfr2": 0.0, "cd133": 0.0, "cfu": 0.0, "0.28": 1.692732657770772e-05, "nondiabetic": 17.24909601512525, "m": 5.707677871550147e-05, "preventable": 0.0, "statewide": 0.0, "nonpublic": 0.0, "file": 8.944544473624384e-06, "computing": 1.4646525188192543e-05, "pay": -2.0178911437112692e-05, "placed": 1.017266064963677e-05, "specialised": 1.622554098057814e-05, "fourteen": 0.0, "psycinfo": 0.0, "searching": 1.3242957688140263e-05, "articles": -1.4066605075045153e-06, "contemporaneous": 1.692732657770772e-05, "telemonitoring": 17.24909601512525, "24/7": 1.640098733368838e-05, "machine": 1.297978900100263e-05, "interface": 1.5874648366923943e-05, "6317": 17.24909601512525, "statitistical": 17.24909601512525, "credible": 1.447107914289599e-05, "tm24/7": 0.0, "0.20": 1.675188013225316e-05, "rendered": 1.5523755876173285e-05, "where": -6.228977386535427e-05, "expressions": 1.648871052189756e-05, "rtq": 0.0, "pcr": 0.0, "beagle": 17.24909601512525, "autopsy": 1.622554098057814e-05, "transiently": 17.24909601512525, "band": 5.172482792406987e-06, "numbers": 1.400435339363205e-06, "favour": 1.1313055592039647e-05, "attributed": 1.5085140435991204e-05, "sternal": 17.24909601512525, "sparing": 1.6839603351021735e-05, "curative": 1.675188013225316e-05, "quick": 3.5934844526425485e-06, "avoids": 1.6839603351021735e-05, "malfunctioning": 1.6664156920957902e-05, "nominal": 1.622554098057814e-05, "strokes": 1.640098733368838e-05, "pef": 0.0, "assesses": 1.6839603351021735e-05, "209": 1.692732657770772e-05, "108": 1.6664156920957902e-05, "\u226540": 17.24909601512525, "\u226510": 17.24909601512525, "0.22": 1.6839603351021735e-05, "0.31": 1.692732657770772e-05, "0.027": 17.24909601512525, "0.65": 1.692732657770772e-05, "0.101": 17.24909601512525, "neurohumoral": 17.24909601512525, "relates": 1.3242957688140263e-05, "99,930": 17.24909601512525, "40%-49": 17.24909601512525, "compute": 17.24909601512525, "clustering": 17.24909601512525, "47,025": 17.24909601512525, "13,950": 17.24909601512525, "38,955": 17.24909601512525, "greatest": 9.909492770503829e-06, "smallest": 1.5523755876173285e-05, "1,259": 17.24909601512525, "1,113": 1.692732657770772e-05, "821": 17.24909601512525, "732": 17.24909601512525, "559": 1.692732657770772e-05, "540": 1.6664156920957902e-05, "heterogeneity": 1.692732657770772e-05, ".47": 17.24909601512525, "adolescence": 17.24909601512525, "practitioners": 1.657643371758005e-05, "room": -4.389191211196919e-06, "encounter": 1.175166937772983e-05, "undiagnosed": 1.692732657770772e-05, "palliation": 17.24909601512525, "practical": 1.4207910132777135e-05, "online": -1.6670106265770446e-05, "material": 3.242596271454909e-06, "read": -1.2459523808943862e-05, "dodson": 0.0, "interest": -1.526658075012408e-05, "subsequently": 0.0, "intubations": 17.24909601512525, "hypothesize": 17.24909601512525, "suburban": 1.5874648366923943e-05, "jersey": 0.0, "student": 0.0, "cis": 0.0, "2,374,428": 17.24909601512525, "32,036": 17.24909601512525, "21%-30": 17.24909601512525, "778": 1.692732657770772e-05, "3.6": 1.6664156920957902e-05, "31%-68": 17.24909601512525, "annual": -1.7855704413846098e-07, "constituted": 1.6137817815677075e-05, "classes": 1.1927114945917303e-05, "1,680": 17.24909601512525, "368": 1.692732657770772e-05, "1,960": 17.24909601512525, "550": 1.6313264153396606e-05, "dyn": 17.24909601512525, "cm(5)/m(2": 17.24909601512525, "texture": 1.5874648366923943e-05, "nodularity": 17.24909601512525, "derangement": 17.24909601512525, "portal": 1.5348309676970024e-05, "902": 1.657643371758005e-05, "counseling": 1.6137817815677075e-05, "208": 1.447107914289599e-05, "692": 17.24909601512525, "1,080": 1.692732657770772e-05, "3.45": 1.6839603351021735e-05, "3.05": 1.692732657770772e-05, "2.81": 17.24909601512525, "0.013": 17.24909601512525, "2.61": 17.24909601512525, "3.06": 17.24909601512525, "\u22653": 17.24909601512525, "morbidities": 17.24909601512525, "2.11": 1.692732657770772e-05, "1.94": 17.24909601512525, "1.90": 1.692732657770772e-05, "ecs": 0.0, "incubated": 17.24909601512525, "ser(660": 0.0, "p70s6k": 0.0, "ser(411": 0.0, "particles": 1.6137817815677075e-05, "profiled": 17.24909601512525, "lc": 0.0, "incubation": 0.0, "p70s6": 0.0, "prescriptive": 1.692732657770772e-05, "71.1": 17.24909601512525, "10.3": 1.692732657770772e-05, "64.26": 17.24909601512525, "11.42": 17.24909601512525, "72.83": 17.24909601512525, "11.07": 1.692732657770772e-05, "2300": 17.24909601512525, "85.9": 17.24909601512525, "39.1": 1.692732657770772e-05, "0.639": 17.24909601512525, ".044": 17.24909601512525, "nephrectomy": 17.24909601512525, "c57bl/6": 0.0, "reproducible": 17.24909601512525, "perioperative": 17.24909601512525, "gtpase": 0.0, "rac1": 0.0, "projected": 1.490969431374133e-05, "coming": -1.6231504753711786e-05, "antihypertensive": 17.24909601512525, "9868": 17.24909601512525, "nri": 0.0, "970": 17.24909601512525, "0.040": 17.24909601512525, "0.057": 17.24909601512525, "nris": 0.0, "50.7": 17.24909601512525, "54.7": 17.24909601512525, "simpler": 1.6313264153396606e-05, "incorporated": 1.5348309676970024e-05, "historically": 1.5085140435991204e-05, "hybrid": 1.3593849378354692e-05, "operative": 1.5874648366923943e-05, "139": 17.24909601512525, "11.9": 1.692732657770772e-05, "91.8": 17.24909601512525, "rvads": 0.0, "explanted": 17.24909601512525, "95.2": 17.24909601512525, "88.2": 17.24909601512525, "87": 1.6137817815677075e-05, "scientific": 1.10498874130133e-05, "2900": 17.24909601512525, "historical": 1.2365729000942526e-05, "tend": 1.10498874130133e-05, "mutually": 1.569920210615792e-05, "exclusive": 1.2541174676642034e-05, "infrastructure": 5.961982897031556e-06, "necessitating": 17.24909601512525, "speckle": 17.24909601512525, "vena": 17.24909601512525, "cava": 17.24909601512525, "atrioventricular": 17.24909601512525, "rotations": 1.6839603351021735e-05, "rotation": 1.6137817815677075e-05, "variations": 1.569920210615792e-05, "surrogates": 1.675188013225316e-05, "reflect": 7.277817790097051e-06, "postsystolic": 17.24909601512525, "4/6": 17.24909601512525, "holosystolic": 17.24909601512525, "murmur": 17.24909601512525, "120/70": 17.24909601512525, "p3": 0.0, "chordal": 17.24909601512525, "ruptures": 1.6839603351021735e-05, "triangular": 1.6839603351021735e-05, "physio": 0.0, "edwards": 0.0, "lifesciences": 0.0, "irvine": 0.0, "ca": 0.0, "sized": 1.262889752625678e-05, "1a": 0.0, "concerns": 3.7689285895183434e-06, "191/104": 17.24909601512525, "3/6": 17.24909601512525, "audible": 1.640098733368838e-05, "8.4": 1.6839603351021735e-05, "1b": 0.0, "branches": 1.569920210615792e-05, "motions": 1.622554098057814e-05, "respond": 1.0523551262510945e-05, "consequently": 0.0, "vasodilators": 17.24909601512525, "140/80": 17.24909601512525, "disappearance": 1.5786925232582235e-05, "1c": 0.0, "motion": 1.2892066120828725e-05, "considerably": 1.5523755876173285e-05, "insignificant": 1.675188013225316e-05, "configurations": 1.648871052189756e-05, "subvalvular": 17.24909601512525, "opposed": 1.175166937772983e-05, "michigan": 0.0, "1,536": 17.24909601512525, "314": 17.24909601512525, "externally": 1.6137817815677075e-05, "ann": 0.0, "arbor": 0.0, "affairs": 0.0, "445": 1.692732657770772e-05, "106": 1.6313264153396606e-05, "486": 17.24909601512525, "141": 1.6664156920957902e-05, "arbitrary": 1.605009465847136e-05, "urea": 17.24909601512525, "nitrogen": 1.692732657770772e-05, "flutter": 1.657643371758005e-05, "concordance": 17.24909601512525, "0.71/0.68/0.74": 17.24909601512525, "8%/12%/12": 17.24909601512525, "57%/58%/79": 17.24909601512525, "uses": 6.137427449447046e-06, "readily": 1.605009465847136e-05, "allocate": 1.657643371758005e-05, "specialized": 1.569920210615792e-05, "progresses": 1.648871052189756e-05, "egfr)-group": 0.0, "\u226560": 17.24909601512525, "8204": 17.24909601512525, "1.3/1000": 17.24909601512525, "p=0.049": 0.0, "p=0.016": 0.0, "dichotomized": 17.24909601512525, "ef\u2264": 0.0, "ef\u226550": 0.0, "criterion": 1.6839603351021735e-05, "spearman": 0.0, "anova": 0.0, "covariate": 0.0, "849": 17.24909601512525, "r=-0.62": 17.24909601512525, "r=-0.55": 17.24909601512525, "p=0.27": 0.0, "category": 1.1225332857854225e-05, "25=13.8": 17.24909601512525, "50=59.1": 17.24909601512525, "75=73.8": 17.24909601512525, "100=77.8": 17.24909601512525, "p=0.37": 0.0, "\u03b1=0.96": 17.24909601512525, "\u22650.69": 17.24909601512525, "subdomains": 17.24909601512525, "offers": 8.460817993480348e-08, "replicate": 1.622554098057814e-05, "establishment": 1.2365729000942526e-05, "interleukin": 17.24909601512525, "s)st2": 0.0, "151": 1.692732657770772e-05, "hoc": 1.6313264153396606e-05, "regimen": 1.648871052189756e-05, "succinate": 17.24909601512525, "p=0.003": 0.0, "those": 0.0006408455415564107, "2.08": 1.692732657770772e-05, "6.77": 17.24909601512525, "exerted": 1.6839603351021735e-05, "angeli": 0.0, "lusitropic": 17.24909601512525, "vasodilator": 17.24909601512525, "chemical": 1.3067511889093883e-05, "cogeneration": 17.24909601512525, "nitrite": 17.24909601512525, "myoctyes": 17.24909601512525, "intact": 1.5611478987428954e-05, "converts": 1.6664156920957902e-05, "inactive": 1.692732657770772e-05, "cxl-1051": 0.0, "t1/2": 17.24909601512525, "dependently": 17.24909601512525, "210": 1.5962371508738954e-05, "500": 6.9269283161182334e-06, "\u03bcmol": 17.24909601512525, "\u224830": 17.24909601512525, "guanylate": 17.24909601512525, "unlike": 0.0, "anesthetized": 17.24909601512525, "microembolization": 17.24909601512525, "tachypacing": 17.24909601512525, "venoarterial": 17.24909601512525, "dilation": 17.24909601512525, "minimally": 17.24909601512525, "334": 17.24909601512525, "224": 1.6839603351021735e-05, "65\u00b112": 17.24909601512525, "\u226515": 17.24909601512525, "57\u00b122": 17.24909601512525, "n=161": 17.24909601512525, "-7": 1.692732657770772e-05, "10.0": 17.24909601512525, "cm(2)/m(2": 17.24909601512525, "allowed": -1.7575469344271171e-06, "transplantations": 17.24909601512525, "implantations": 17.24909601512525, "helpful": 1.5172863508770167e-05, "kaiser": 0.0, "permanente": 0.0, "northern": 0.0, "meq": 0.0, "2,538": 17.24909601512525, "521": 17.24909601512525, "1.44": 1.6839603351021735e-05, "compensatory": 1.6664156920957902e-05, "neoangiogenesis": 17.24909601512525, "diameters": 1.692732657770772e-05, "akt": 0.0, "synthase": 17.24909601512525, "comparing": 1.6137817815677075e-05, "proangiogenic": 17.24909601512525, "intravenously": 1.692732657770772e-05, "adenoviral": 17.24909601512525, "vector": 1.648871052189756e-05, "decoy": 1.692732657770772e-05, "adenovirus": 17.24909601512525, "b.": 0.0, "counteracted": 17.24909601512525, "n=44": 17.24909601512525, "925": 1.692732657770772e-05, "76.4": 17.24909601512525, "54.5": 17.24909601512525, "61.8": 17.24909601512525, "1.10\u20131.23": 17.24909601512525, "73.6": 17.24909601512525, "1.83\u20132.07": 17.24909601512525, "22.0": 17.24909601512525, "44.9": 17.24909601512525, "16.3": 17.24909601512525, "0.73\u20130.90": 17.24909601512525, "35.3": 17.24909601512525, "0.73\u20130.86": 17.24909601512525, "0.61\u20130.78": 17.24909601512525, "30.2": 17.24909601512525, "0.61\u20130.74": 17.24909601512525, "24.3": 17.24909601512525, "0.76\u20130.91": 17.24909601512525, "18.1": 17.24909601512525, "0.70\u20130.85": 17.24909601512525, "preserves": 1.692732657770772e-05, "vo": 0.0, "aortocaval": 17.24909601512525, "fistula": 17.24909601512525, "demand": 1.7232993683079722e-07, "bioenergetics": 17.24909601512525, "sprague": 0.0, "dawley": 0.0, "mg\u00b7kg(-1)\u00b7day(-1": 17.24909601512525, "\u22657": 17.24909601512525, "flux": 1.692732657770772e-05, "analyzer": 17.24909601512525, "paralleled": 17.24909601512525, "diminishing": 1.6664156920957902e-05, "myofilament": 17.24909601512525, "unreliable": 1.6664156920957902e-05, "sided": 1.6137817815677075e-05, "transthoracic": 17.24909601512525, "0.41": 1.692732657770772e-05, "e'mean": 17.24909601512525, "0.72": 17.24909601512525, "elateral": 17.24909601512525, "eseptal": 17.24909601512525, "s'septal": 17.24909601512525, "width": 1.640098733368838e-05, "0.15": 1.6664156920957902e-05, "\u22644.5": 17.24909601512525, "0.38": 17.24909601512525, "carrying": 1.0698996615230651e-05, "two-": 1.692732657770772e-05, "threefold": 1.692732657770772e-05, "disclosing": 1.6839603351021735e-05, "ninety": 1.6839603351021735e-05, "247": 1.675188013225316e-05, "20.8": 1.692732657770772e-05, "mo": 1.6839603351021735e-05, "collinearity": 17.24909601512525, "retained": 1.6137817815677075e-05, "follows": 1.2804343248350124e-05, "mmhg": 0.0, "4.1": 1.6137817815677075e-05, "resolution": 1.2365729000942526e-05, "efficient": 1.2102560544663882e-05, "one-": 1.6839603351021735e-05, "coated": 1.6839603351021735e-05, "polytetrafluoroethylene": 17.24909601512525, "tube": 1.622554098057814e-05, "shape": 1.0962164701913708e-05, "circumflex": 17.24909601512525, "mid": 1.1313055592039647e-05, "infarct": 17.24909601512525, "positron": 17.24909601512525, "emission": 1.640098733368838e-05, "tomography": 17.24909601512525, "covering": 1.18393921578649e-05, "competitive": 9.47087979281678e-06, "unloads": 17.24909601512525, "resistive": 17.24909601512525, "275": 1.675188013225316e-05, "132": 1.6664156920957902e-05, "7.5": 1.5962371508738954e-05, "cuff": 1.675188013225316e-05, "ivabradine-": 17.24909601512525, "unloading": 1.6664156920957902e-05, "272": 1.692732657770772e-05, "125": 1.605009465847136e-05, "\u22653.5": 17.24909601512525, "147": 1.675188013225316e-05, "93.2": 17.24909601512525, "82.4": 17.24909601512525, "88.4": 17.24909601512525, "75.2": 17.24909601512525, "0.521": 17.24909601512525, "0.290": 17.24909601512525, "0.934": 17.24909601512525, "0.029": 17.24909601512525, "81": 1.5085140435991204e-05, "92.6": 17.24909601512525, "63.6": 17.24909601512525, "65.0": 17.24909601512525, "correcting": 17.24909601512525, "hepatic": 17.24909601512525, "instituting": 17.24909601512525, "algorithms": 1.6839603351021735e-05, "de": -4.564633916784393e-06, "novo": 17.24909601512525, "225": 1.657643371758005e-05, "203": 1.640098733368838e-05, "thoratec": 0.0, "corp": 0.0, "pleasanton": 0.0, "calif": 0.0, "hvad": 0.0, "intl": 0.0, "inc": 0.0, "dacron": 0.0, "patch": 1.5962371508738954e-05, "repairs": 1.5436032772835006e-05, "multiorgan": 17.24909601512525, "sepsis": 1.692732657770772e-05, "oversewing": 17.24909601512525, "difficult": -6.23133808437448e-06, "alternatives": 1.5523755876173285e-05, "charm": 0.0, "candesartan": 0.0, "adhere": 1.262889752625678e-05, "referent": 17.24909601512525, "0.186": 17.24909601512525, "ages": 1.3506126444313628e-05, "divergent": 1.6664156920957902e-05, "striking": 1.3769295269744806e-05, "counterparts": 1.4383356131901727e-05, "nonfatal": 17.24909601512525, "discordant": 1.6839603351021735e-05, "62.4": 17.24909601512525, "26.9": 1.692732657770772e-05, "400": 1.1137610131586125e-05, "59.4": 17.24909601512525, "57.0": 17.24909601512525, "71.3": 17.24909601512525, "travelled": 1.4207910132777135e-05, "158.5": 17.24909601512525, "118.5": 17.24909601512525, "155.5": 17.24909601512525, "0.026": 17.24909601512525, "-1.7": 17.24909601512525, "waist": 1.648871052189756e-05, "circumference": 17.24909601512525, "modality": 17.24909601512525, "leads": 1.175166937772983e-05, "shortens": 1.692732657770772e-05, "biologic": 17.24909601512525, "reconstructed": 1.657643371758005e-05, "228": 1.6664156920957902e-05, "25th-75th": 17.24909601512525, "percentiles": 17.24909601512525, "212": 1.640098733368838e-05, "278": 17.24909601512525, "257": 1.692732657770772e-05, "277": 1.692732657770772e-05, ".032": 17.24909601512525, "tonometric": 17.24909601512525, "entry": 9.47087979281678e-06, "natremia": 17.24909601512525, "shortened": 0.0, "complicated": 1.3681572320313113e-05, "benign": 1.6313264153396606e-05, "tumors": 1.692732657770772e-05, "rarely": 1.3769295269744806e-05, "embolize": 17.24909601512525, "vasculature": 17.24909601512525, "massive": 5.347927206086984e-06, "removal": 1.4120187144868845e-05, "embolectomy": 17.24909601512525, "causing": 1.1137610131586125e-05, "stenotic": 17.24909601512525, "physiology": 1.692732657770772e-05, "obstructed": 17.24909601512525, "tactics": 1.5786925232582235e-05, "hypothermic": 17.24909601512525, "uneventful": 1.692732657770772e-05, "organ": 1.6137817815677075e-05, "sectional": 17.24909601512525, "environment": -1.2312172480947602e-06, "n=235": 0.0, "70y": 17.24909601512525, "77y": 17.24909601512525, "25.6kg": 17.24909601512525, "22.8": 17.24909601512525, "29.4kg": 17.24909601512525, "n=95": 17.24909601512525, "n=68": 17.24909601512525, "n=72": 17.24909601512525, "applicable": 1.4734248222494837e-05, "assessors": 17.24909601512525, "intraclass": 17.24909601512525, "detectable": 1.692732657770772e-05, ".85": 17.24909601512525, ".98": 17.24909601512525, "coefficients": 17.24909601512525, "3.00": 1.692732657770772e-05, "-4.94s": 17.24909601512525, "p<.01": 0.0, "mdc95": 0.0, "mdc95%%": 0.0, "true": -7.92608964462273e-07, "starting": 2.8917082131677013e-06, "tumor": 1.6839603351021735e-05, "necrosis": 17.24909601512525, "tnf)\u03b1": 0.0, "recurrent": 1.675188013225316e-05, "us": 0.0, "methotrexate": 17.24909601512525, "enter": 8.155042014042513e-06, "switched": 1.5436032772835006e-05, "modifying": 1.692732657770772e-05, "antirheumatic": 17.24909601512525, "glucocorticoid": 17.24909601512525, "dosage": 1.6664156920957902e-05, "8656": 17.24909601512525, "587": 17.24909601512525, "1.14": 1.692732657770772e-05, "but": 0.0007483907982596665, "2002": 1.0874441998731431e-05, "10.50": 17.24909601512525, "p=0.036": 17.24909601512525, "glucocorticoids": 17.24909601512525, "1\u22645": 17.24909601512525, "1.85": 1.692732657770772e-05, "\u22655": 17.24909601512525, "2.19": 1.692732657770772e-05, "nbdmards": 0.0, "climate": 4.2075390662621796e-06, "nhs": 0.0, "behavioural": 1.657643371758005e-05, "challenge": 1.7513228743808678e-06, "participatory": 1.6839603351021735e-05, "showing": 6.839205966695029e-06, "minor": 1.2190283355802152e-05, "anecdotal": 0.0, "commissioning": 1.640098733368838e-05, "hospital-": 17.24909601512525, "2825": 17.24909601512525, "7.1": 1.6839603351021735e-05, "11.7": 17.24909601512525, "466": 17.24909601512525, "3.47": 17.24909601512525, "linearly": 17.24909601512525, "1.55": 1.692732657770772e-05, "0.010": 1.6839603351021735e-05, "reclassified": 1.692732657770772e-05, "13.4": 17.24909601512525, "0.073": 17.24909601512525, "0.021": 17.24909601512525, "0.125": 17.24909601512525, "8.3": 1.6664156920957902e-05, "interruption": 1.6839603351021735e-05, "secretion": 17.24909601512525, "arginine": 17.24909601512525, "physiologic": 17.24909601512525, "cooperate": 1.6313264153396606e-05, "reactivate": 1.675188013225316e-05, "aberrant": 1.692732657770772e-05, "reactivation": 1.692732657770772e-05, "intricately": 1.692732657770772e-05, "driving": 4.032094852434737e-06, "ill": 1.1576223840323502e-05, "calcineurin": 17.24909601512525, "express": 1.1663946605068002e-05, "dhand": 0.0, "conditional": 1.692732657770772e-05, "fetal": 1.640098733368838e-05, "antagomir": 17.24909601512525, "evoked": 1.6839603351021735e-05, "sensitized": 17.24909601512525, "manner": 7.3655401779963255e-06, "cascades": 1.692732657770772e-05, "postnatal": 1.6839603351021735e-05, "hungary": 0.0, "neuro": 1.675188013225316e-05, "hormonal": 1.657643371758005e-05, "neglected": 1.5874648366923943e-05, "p38alpha": 17.24909601512525, "mapk": 0.0, "links": 1.0786719303022383e-05, "substrates": 17.24909601512525, "regulating": 1.5874648366923943e-05, "hyperinsulinemia": 17.24909601512525, "akt\u2192forkhead": 0.0, "box": 2.5408202782249215e-06, "o-1": 0.0, "p38\u03b1": 17.24909601512525, "mitogen": 17.24909601512525, "neonatal": 1.692732657770772e-05, "revealing": 1.5172863508770167e-05, "ncdr": 0.0, "pinnacle": 0.0, "innovation": 0.0, "excellence": 0.0, "contraindications": 17.24909601512525, "hierarchical": 17.24909601512525, "556": 17.24909601512525, "unadjusted": 17.24909601512525, "prescription": 1.4734248222494837e-05, "75%-89": 17.24909601512525, "83%-95": 17.24909601512525, "66%-85": 17.24909601512525, "addressing": 0.0, "adjuvant": 17.24909601512525, "manifested": 17.24909601512525, "coverage": 9.207712098591973e-06, "seer": 0.0, "texas": 0.0, "9,535": 17.24909601512525, "2,203": 17.24909601512525, "23.1": 17.24909601512525, "entire": 5.232170406997317e-07, "29.4": 1.692732657770772e-05, "18.9": 1.692732657770772e-05, "1.75": 1.6664156920957902e-05, "1.53": 17.24909601512525, "2.10": 17.24909601512525, "1.82": 17.24909601512525, "2.48": 1.692732657770772e-05, "1.68": 1.692732657770772e-05, "trastuzumb": 17.24909601512525, "plays": 6.049705169502724e-06, "postmenopausal": 17.24909601512525, "august": 0.0, "questionnaires": 17.24909601512525, "behaviors": 1.6664156920957902e-05, "calculate": 1.6137817815677075e-05, "1385": 17.24909601512525, "3215": 17.24909601512525, "43.1": 17.24909601512525, "trend=0.08": 17.24909601512525, "1.04": 1.6839603351021735e-05, "1.21": 17.24909601512525, "trend=0.01": 17.24909601512525, "vegetables": 1.5085140435991204e-05, "nuts": 1.640098733368838e-05, "whole": -6.8453862877668186e-06, "grain": 1.4821971264270417e-05, "910": 17.24909601512525, "evaluable": 17.24909601512525, "23.7": 17.24909601512525, "18.6": 17.24909601512525, "31.8": 17.24909601512525, "univariable": 17.24909601512525, "2.33": 1.692732657770772e-05, "log2": 17.24909601512525, "amino": 1.6839603351021735e-05, "statistic": 1.6664156920957902e-05, "comorbidity": 17.24909601512525, "paucity": 1.675188013225316e-05, "prespecified": 17.24909601512525, "454": 17.24909601512525, "18.5": 17.24909601512525, "66.6": 17.24909601512525, "53.2": 17.24909601512525, "46.4": 1.675188013225316e-05, "24.6": 17.24909601512525, "61.6": 17.24909601512525, "listing": 1.5260586589022425e-05, "determinants": 1.692732657770772e-05, "discharges": 1.692732657770772e-05, "398": 1.6839603351021735e-05, "79.9": 17.24909601512525, "45.9": 17.24909601512525, "27.5": 1.692732657770772e-05, ".024": 17.24909601512525, "19.6": 1.692732657770772e-05, "46.9": 17.24909601512525, "eighty": 0.0, "cardiologist": 1.692732657770772e-05, "practitioner": 1.675188013225316e-05, "drawn": 1.175166937772983e-05, "discrepancy": 1.640098733368838e-05, "incompletely": 17.24909601512525, "thought": -1.4038494307844534e-05, "pathobiology": 17.24909601512525, "suspected": 1.227800617441367e-05, "n=100": 17.24909601512525, "entered": 1.0523551262510945e-05, "22.9\u00b15.0": 17.24909601512525, "p=0.046": 0.0, "388.3": 17.24909601512525, "n=9": 17.24909601512525, "tissuefaxs": 0.0, "r=0.98": 0.0, "r=-0.36": 0.0, "r=0.28": 0.0, "thalassaemia": 17.24909601512525, "regimens": 17.24909601512525, "remove": 7.453262573368775e-06, "efficiently": 1.569920210615792e-05, "reverses": 0.0, "n=177": 17.24909601512525, "n=431": 17.24909601512525, "core": 9.11998954931488e-06, "off": -2.299411348712423e-05, "p=0.06": 0.0, "-6.7": 17.24909601512525, "21.1": 17.24909601512525, "17.6": 1.692732657770772e-05, "50.5": 1.692732657770772e-05, "42.4": 1.692732657770772e-05, "0.26": 17.24909601512525, "p=0.012": 0.0, "p=0.047": 0.0, "kyoto": 0.0, "euthanization": 17.24909601512525, "linking": 1.6313264153396606e-05, "tension": 1.5260586589022425e-05, "fpassive)-sarcomere": 0.0, "strips": 1.657643371758005e-05, "kcl": 0.0, "ki": 0.0, "unanchors": 17.24909601512525, "fpassive": 0.0, "discerned": 1.692732657770772e-05, "obvious": 1.0084938015489849e-05, "strip": 1.5348309676970024e-05, "\u00b180": 17.24909601512525, "s3991": 0.0, "elastic": 17.24909601512525, "n2bus": 0.0, "s12884": 0.0, "pevk": 0.0, "span": 1.4821971264270417e-05, "mechanics": 1.6313264153396606e-05, "196": 1.675188013225316e-05, "1.121": 17.24909601512525, "1.023": 17.24909601512525, "1.228": 17.24909601512525, "p=0.014": 17.24909601512525, "outperformed": 1.6664156920957902e-05, "0.043": 17.24909601512525, "p=0.022": 17.24909601512525, "parameter": 1.6664156920957902e-05, "stronger": 1.2541174676642034e-05, "raft": 0.0, "pacemaker": 1.675188013225316e-05, "electrocardiographers": 17.24909601512525, "1483": 17.24909601512525, "1175": 17.24909601512525, "308": 1.622554098057814e-05, "0.52": 17.24909601512525, "0.29": 17.24909601512525, "p=0.033": 0.0, "p=0.155": 0.0, "pre-": 1.692732657770772e-05, "24.5": 17.24909601512525, "9/10": 1.692732657770772e-05, "ckd": 0.0, "0.016": 17.24909601512525, "edema": 1.6839603351021735e-05, "3.2": 1.622554098057814e-05, "36.7": 17.24909601512525, "0.019": 17.24909601512525, "criteriabased": 17.24909601512525, "tolerated": 1.5874648366923943e-05, "easily": 6.663761291378333e-06, "treatable": 17.24909601512525, "pdrelated": 0.0, "viable": 1.429563312860279e-05, "option": 5.084760596887724e-06, "deferred": 1.6664156920957902e-05, "heterogenous": 0.0, "+3.1": 17.24909601512525, "+9.2": 17.24909601512525, "9.5": 1.657643371758005e-05, "0.038": 17.24909601512525, "0.047": 17.24909601512525, "compelling": 1.490969431374133e-05, "thirteen": 0.0, "mmol/2100": 17.24909601512525, "kcal": 17.24909601512525, "parametrized": 17.24909601512525, "formalism": 17.24909601512525, "yields": 1.5786925232582235e-05, "viscoelastic": 17.24909601512525, "passive": 1.6313264153396606e-05, "constants": 1.692732657770772e-05, "inflow": 1.6839603351021735e-05, "contours": 1.6839603351021735e-05, "wilcoxon": 0.0, "signed": 4.82159405694511e-06, "138": 1.6839603351021735e-05, "111": 1.6137817815677075e-05, "p=0.12": 0.0, "c=24.3": 17.24909601512525, "5.3": 1.648871052189756e-05, "22.7": 1.692732657770772e-05, "8.1": 1.675188013225316e-05, "k=252": 17.24909601512525, "170": 1.648871052189756e-05, "s(2": 17.24909601512525, "p=0.007": 0.0, "ea=1.5": 0.0, "mediator": 17.24909601512525, "monocytes": 17.24909601512525, "responsive": 1.657643371758005e-05, "connected": 1.175166937772983e-05, "exhibits": 1.640098733368838e-05, "underlies": 1.6839603351021735e-05, "remarkably": 0.0, "25mg": 17.24909601512525, "ip": 17.24909601512525, "littermate": 17.24909601512525, "adhesion": 17.24909601512525, "hretn": 0.0, "intriguingly": 0.0, "implicate": 1.675188013225316e-05, "precipitating": 17.24909601512525, "probability": 1.6137817815677075e-05, "relating": 1.2014837741442948e-05, "single-": 17.24909601512525, "pharmaceutically": 17.24909601512525, "3.17": 17.24909601512525, "0.24": 17.24909601512525, "maintaining": 1.2804343248350124e-05, "pharmaceuticals": 1.6664156920957902e-05, "ameliorates": 17.24909601512525, "neoplastic": 17.24909601512525, "orally": 17.24909601512525, "sacrificed": 1.6313264153396606e-05, "rapidly": 1.3418403517967878e-05, "excised": 17.24909601512525, "cytochrome": 17.24909601512525, "bcl2": 0.0, "alleviating": 17.24909601512525, "decrement": 17.24909601512525, "interfere": 1.648871052189756e-05, "cytotoxic": 17.24909601512525, "solid": 1.18393921578649e-05, "ehrlich": 0.0, "carcinoma": 1.692732657770772e-05, "antitumor": 17.24909601512525, "36,284": 17.24909601512525, "sweden": 0.0, "\u226490": 17.24909601512525, "2,462": 17.24909601512525, "617": 1.6839603351021735e-05, "1.76": 17.24909601512525, "2.25": 1.6664156920957902e-05, "enormous": 1.3944741191916188e-05, "atheromatous": 17.24909601512525, "amenable": 1.675188013225316e-05, "cardiomyopathic": 17.24909601512525, "principally": 1.6664156920957902e-05, "comprise": 1.6313264153396606e-05, "contracting": 1.640098733368838e-05, "ventricles": 1.692732657770772e-05, "aetiologies": 17.24909601512525, "particular": 0.0, "topics": 1.4646525188192543e-05, "debate": 1.488157211685947e-06, "concern": 6.663761291378333e-06, "myocarditis": 17.24909601512525, "malignant": 1.692732657770772e-05, "scaffolds": 17.24909601512525, "humoral": 17.24909601512525, "workload": 1.648871052189756e-05, "mediate": 1.692732657770772e-05, "paradoxically": 0.0, "notable": 1.429563312860279e-05, "signalosome": 17.24909601512525, "drives": 1.3944741191916188e-05, "assembly": 1.4120187144868845e-05, "kinases": 17.24909601512525, "sequential": 1.692732657770772e-05, "effector": 1.648871052189756e-05, "molecules": 1.6664156920957902e-05, "field": -6.406780466549006e-06, "capable": 1.0523551262510945e-05, "selectively": 1.6839603351021735e-05, "potentiating": 17.24909601512525, "amyloidosis": 17.24909601512525, "atypical": 1.6664156920957902e-05, "deals": 1.0084938015489849e-05, "cardiomyiopathy": 17.24909601512525, "angina": 17.24909601512525, "inducible": 17.24909601512525, "amyloidotic": 17.24909601512525, "myeloma": 17.24909601512525, "osteomedullary": 17.24909601512525, "biopsy": 1.692732657770772e-05, "strengths": 1.5523755876173285e-05, "utility": 1.447107914289599e-05, "southeastern": 0.0, "exhaustion": 1.657643371758005e-05, "slowness": 17.24909601512525, "unintentional": 1.6839603351021735e-05, "lb": 1.622554098057814e-05, "223": 1.692732657770772e-05, "0.75": 1.692732657770772e-05, "0.687": 17.24909601512525, "0.700": 17.24909601512525, "ascertained": 1.692732657770772e-05, "ascertain": 1.622554098057814e-05, "learning": 0.0, "shaping": 1.622554098057814e-05, "disappointments": 1.657643371758005e-05, "sensitizing": 17.24909601512525, "endothelin": 17.24909601512525, "relax": 0.0, "astronaut": 0.0, "pronto": 0.0, "highlighted": 1.3155234784658399e-05, "learned": 7.804152232254868e-06, "outline": 1.605009465847136e-05, "perspectives": 1.6137817815677075e-05, "sufficiently": 1.6137817815677075e-05, "accelerate": 1.640098733368838e-05, "throughput": 1.6664156920957902e-05, "disposition": 1.6839603351021735e-05, "redesigned": 1.657643371758005e-05, "take": -8.008985992631986e-05, "faster": 1.1225332857854225e-05, "turnaround": 1.605009465847136e-05, "rethinking": 0.0, "operationalized": 17.24909601512525, "publicly": 1.262889752625678e-05, "penalties": 1.4207910132777135e-05, "motivate": 1.640098733368838e-05, "halts": 17.24909601512525, "hyperacetylation": 17.24909601512525, "now": -9.368858762733481e-05, "anand": 0.0, "lysine": 17.24909601512525, "reader": 1.447107914289599e-05, "precedes": 1.692732657770772e-05, "neuronal": 17.24909601512525, "stressors": 17.24909601512525, "cascade": 1.675188013225316e-05, "converges": 17.24909601512525, "interplay": 1.675188013225316e-05, "writer": 6.839205966695029e-06, "acetyltransferases": 17.24909601512525, "erasers": 17.24909601512525, "deacetylases": 17.24909601512525, "displaces": 17.24909601512525, "suppression": 1.6664156920957902e-05, "polymerase": 17.24909601512525, "neurohormonally": 17.24909601512525, "nanomolar": 17.24909601512525, "blocked": 1.4120187144868845e-05, "brd4": 0.0, "profiling": 1.648871052189756e-05, "cultured": 1.6664156920957902e-05, "abrogated": 17.24909601512525, "experiments": 1.5962371508738954e-05, "toxicity": 1.657643371758005e-05, "detailed": 0.0, "tac-": 0.0, "suppresses": 17.24909601512525, "causal": 1.692732657770772e-05, "nf": 0.0, "gata4": 0.0, "pause": 1.6137817815677075e-05, "release": -6.7576651390020765e-06, "implicates": 17.24909601512525, "biology": 1.5962371508738954e-05, "manipulation": 1.648871052189756e-05, "abrogate": 17.24909601512525, "multiacquisition": 0.0, "yorkshire": 0.0, "pacemakers": 17.24909601512525, "ventricularly": 17.24909601512525, "beats": 1.5436032772835006e-05, "scanned": 1.640098733368838e-05, "scanner": 1.640098733368838e-05, "gadolinium": 17.24909601512525, "chelate": 17.24909601512525, "scans": 1.6313264153396606e-05, "trichrome": 17.24909601512525, "blue": 1.0435828597805015e-05, "histologic": 17.24909601512525, "960": 17.24909601512525, "726": 1.692732657770772e-05, "546": 17.24909601512525, "300": 8.856821947433022e-06, "171": 17.24909601512525, "histologically": 17.24909601512525, "5.4": 1.675188013225316e-05, "proposed": 5.698816126233314e-06, "diffuse": 1.692732657770772e-05, "holding": 7.979597107869257e-06, "inoperable": 17.24909601512525, "broad": 1.4207910132777135e-05, "assumption": 1.5436032772835006e-05, "3.0": 1.640098733368838e-05, "58": 1.5085140435991204e-05, "hemodynamics": 17.24909601512525, "1-": 17.24909601512525, "3-": 1.692732657770772e-05, "2.56": 1.657643371758005e-05, "2.84": 17.24909601512525, "interesting": 5.52337165076977e-06, "concepts": 1.5874648366923943e-05, "evolving": 1.5611478987428954e-05, "stand": -5.294439017640486e-07, "consumes": 1.6839603351021735e-05, "portion": 1.3593849378354692e-05, "commoner": 17.24909601512525, "lifesaving": 17.24909601512525, "poses": 1.5085140435991204e-05, "nonfunctional": 17.24909601512525, "trapped": 1.5611478987428954e-05, "endoplasmic": 17.24909601512525, "reticulum": 17.24909601512525, "electric": 1.0786719303022383e-05, "pluripotent": 17.24909601512525, "hipsc": 0.0, "activators": 17.24909601512525, "overexpress": 17.24909601512525, "effectors": 1.6313264153396606e-05, "er": 0.0, "calreticulin": 17.24909601512525, "chop": 0.0, "exogenous": 17.24909601512525, "destabilized": 17.24909601512525, "mrnas": 0.0, "cation": 17.24909601512525, "m7": 0.0, "trpm7": 0.0, "entirely": 1.1400778333698304e-05, "transcript": 1.6664156920957902e-05, "receives": 1.4821971264270417e-05, "etiologic": 17.24909601512525, "intrinsic": 1.657643371758005e-05, "concentrating": 1.6664156920957902e-05, "behind": -1.2020920450113074e-05, "circumstances": 1.0523551262510945e-05, "provoke": 1.675188013225316e-05, "decompensation": 17.24909601512525, "olmsted": 0.0, "county": 0.0, "2,596": 17.24909601512525, "ever": -1.912627117846156e-05, "st": 0.0, "mis": 0.0, "killip": 0.0, "comorbid": 1.692732657770772e-05, "715": 1.6839603351021735e-05, "475": 1.692732657770772e-05, "2004": 1.0698996615230651e-05, "yielded": 1.6313264153396606e-05, "early-": 17.24909601512525, "mix": 9.383157220453942e-06, "iodobenzylguanidine": 17.24909601512525, "serve": 7.891874666103429e-06, "coagulability": 17.24909601512525, "crossover": 1.6137817815677075e-05, "masked": 1.6313264153396606e-05, "homozygous": 17.24909601512525, "equipotent": 17.24909601512525, "dosages": 17.24909601512525, "12.9": 1.692732657770772e-05, "3.9": 1.6664156920957902e-05, "22.1": 1.6839603351021735e-05, "157": 1.692732657770772e-05, "priorities": 1.5085140435991204e-05, "nontreatment": 17.24909601512525, "notes": 7.979597107869257e-06, "caring": 1.5172863508770167e-05, "42%-58": 17.24909601512525, "11%-17": 17.24909601512525, "cited": 1.3769295269744806e-05, "50%-70": 17.24909601512525, "64%-70": 17.24909601512525, "comanagement": 17.24909601512525, "32%-35": 17.24909601512525, "15%-24": 17.24909601512525, "belief": 1.1576223840323502e-05, "12%-20": 17.24909601512525, "thirds": 1.4734248222494837e-05, "documentation": 1.5348309676970024e-05, "evolution": 1.447107914289599e-05, "neurotransmission": 17.24909601512525, "elicited": 1.692732657770772e-05, "os": 1.692732657770772e-05, "tachycardic": 17.24909601512525, "bradycardic": 17.24909601512525, "conductance": 17.24909601512525, "ligation": 17.24909601512525, "attenuating": 17.24909601512525, "mechanistic": 0.0, "computational": 1.675188013225316e-05, "behavior": 1.447107914289599e-05, "sheet": 1.3067511889093883e-05, "orientation": 1.5786925232582235e-05, "slowed": 1.5436032772835006e-05, "depolarization": 17.24909601512525, "nonfailing": 17.24909601512525, "electromechanics": 17.24909601512525, "combinations": 1.605009465847136e-05, "simulated": 1.648871052189756e-05, "deranged": 1.692732657770772e-05, "culprit": 1.6664156920957902e-05, "insignificantly": 17.24909601512525, "slows": 17.24909601512525, "depresses": 17.24909601512525, "stretch": 1.4032464164433833e-05, "lateral": 1.675188013225316e-05, "giving": -7.048872845172778e-07, "408": 1.6664156920957902e-05, "skinfold": 17.24909601512525, "comprehensive": 1.3769295269744806e-05, "display": 6.31287203264333e-06, "541": 17.24909601512525, "3.09": 17.24909601512525, "2.18": 1.6839603351021735e-05, "4.45": 17.24909601512525, "2.90": 17.24909601512525, "2.00": 17.24909601512525, "4.12": 17.24909601512525, "coexist": 1.675188013225316e-05, "interrelated": 1.6839603351021735e-05, "surrogate": 1.6313264153396606e-05, "catabolism": 17.24909601512525, "5.7": 1.675188013225316e-05, "1.9": 1.6313264153396606e-05, "14.0": 17.24909601512525, "6.1": 1.6839603351021735e-05, "17.0": 17.24909601512525, "3.3": 1.657643371758005e-05, "load": 1.1927114945917303e-05, "corrected": 1.640098733368838e-05, "chronotropic": 17.24909601512525, "slower": 1.5786925232582235e-05, "0.34": 17.24909601512525, "reflected": 1.4821971264270417e-05, "prove": 9.646324960850247e-06, "shortness": 0.0, "actrn12610001087044": 0.0, "controversial": 1.2453451834944633e-05, "validate": 1.6839603351021735e-05, "exclude": 1.648871052189756e-05, "waves": 1.2365729000942526e-05, "3.8": 1.6137817815677075e-05, "nondiabetes": 17.24909601512525, "\u226555": 17.24909601512525, "\u226565": 17.24909601512525, "dyslipidemia": 17.24909601512525, "98": 1.640098733368838e-05, "accurately": 1.4997417371129622e-05, "eliminate": 1.4558802161807624e-05, "avoidance": 1.640098733368838e-05, "japanese": 0.0, "hyponatremia": 17.24909601512525, "administered": 1.605009465847136e-05, "relieve": 1.622554098057814e-05, "widespread": 1.4032464164433833e-05, "modulate": 17.24909601512525, "herein": 0.0, "failure.(1": 17.24909601512525, "becoming": 7.3655401779963255e-06, "subject": 4.82159405694511e-06, "blunts": 17.24909601512525, "guanosine": 17.24909601512525, "pde": 0.0, "superfamily": 17.24909601512525, "property": -4.389191211196919e-06, "able": -2.912630889801693e-05, "hydrolysis": 17.24909601512525, "mediating": 17.24909601512525, "immunoblotting": 0.0, "radioenzymatic-": 17.24909601512525, "fluorescence": 17.24909601512525, "video": -1.0880550816891414e-05, "epifluorescence": 17.24909601512525, "~2": 17.249113029885553, "catecholamine": 17.24909601512525, "infusions": 17.24909601512525, "hydrolytic": 17.24909601512525, "blunted": 1.6839603351021735e-05, "desensitizes": 17.24909601512525, "constitute": 1.605009465847136e-05, "defense": 1.2014837741442948e-05, "antagonizing": 1.692732657770772e-05, "drive": 3.418040346769435e-06, "intracellular": 17.24909601512525, "antiadrenergic": 17.24909601512525, "reason": -7.371713019426458e-06, "underuse": 0.0, "fear": 7.540984976658488e-06, "inducing": 1.692732657770772e-05, "efficacious": 17.24909601512525, "monitored": 1.5611478987428954e-05, "medicines": 0.0, "nct00232180": 0.0, "annually": 1.3330680599095393e-05, "intention": 1.3067511889093883e-05, "subscales": 17.24909601512525, "rhythm-": 0.0, "payer": 1.675188013225316e-05, "minimization": 17.24909601512525, "ontario": 0.0, "costing": 0.0, "304": 1.657643371758005e-05, "accounted": 1.5348309676970024e-05, "146": 1.657643371758005e-05, "238": 1.692732657770772e-05, "cardioversions": 17.24909601512525, "21-$96": 17.24909601512525, "1319": 17.24909601512525, "1124-$1522": 17.24909601512525, "diagnoses": 1.675188013225316e-05, "72,764": 17.24909601512525, "61,575-$85,145": 17.24909601512525, "78,767": 17.24909601512525, "67,101-$92,139": 17.24909601512525, "restorative": 1.692732657770772e-05, "associate": 1.4032464164433833e-05, "taub": 0.0, "ramirez": 0.0, "sanchez": 0.0, "ciaraldi": 0.0, "perkins": 0.0, "murphy": 0.0, "naviaux": 0.0, "hogan": 0.0, "ceballos": 0.0, "maisel": 0.0, "henry": 0.0, "clin": 0.0, "trans": 0.0, "sci": 0.0, ".": 0.027497283062548044, "43": 1.429563312860279e-05, "immunohistochemistry": 17.24909601512525, "electron": 1.692732657770772e-05, "dystrophin": 17.24909601512525, "ordinated": 1.6664156920957902e-05, "fashion": 5.611093884764967e-06, "myofibre": 17.24909601512525, "regeneration": 1.675188013225316e-05, "~24": 17.24909601512525, "warrant": 1.2541174676642034e-05, "rigorous": 1.640098733368838e-05, "pubmed": 0.0, "1980": 1.4734248222494837e-05, "1887": 1.6839603351021735e-05, "5.88": 1.692732657770772e-05, "3.92": 17.24909601512525, "7.85": 17.24909601512525, "-2.78": 17.24909601512525, "-5.15": 17.24909601512525, "-0.42": 17.24909601512525, "resolved": 1.490969431374133e-05, "ethnic": 1.3242957688140263e-05, "platelet": 17.24909601512525, "sex-": 17.24909601512525, "apparently": 1.0874441998731431e-05, "acetyltransferase": 17.24909601512525, "dithiothreitol": 17.24909601512525, "dtt]-insensitive": 0.0, "cdp": 0.0, "choline": 17.24909601512525, "alkyl-2": 17.24909601512525, "sn": 17.24909601512525, "glycerol": 17.24909601512525, "cholinephosphotransferase": 17.24909601512525, "isoenzymes": 17.24909601512525, "acetylhydrolase": 17.24909601512525, "phospholipase": 17.24909601512525, "a2": 0.0, "leukocytes": 17.24909601512525, ".1": 1.692732657770772e-05, "downregulated": 17.24909601512525, ".004": 17.24909601512525, "feature": 6.225149737308609e-06, "prognostically": 17.24909601512525, "accepted": 9.909492770503829e-06, "ven": 0.0, "vco2": 0.0, "oscillatory": 17.24909601512525, "ventilation": 1.692732657770772e-05, "eov": 0.0, "co2": 0.0, "petco2": 0.0, "underlie": 1.692732657770772e-05, "aforementioned": 1.5786925232582235e-05, "encouraged": 1.2365729000942526e-05, "purposes": 1.0874441998731431e-05, "orthotopic": 0.0, "institutional": 1.4558802161807624e-05, "169": 1.6839603351021735e-05, "vads": 0.0, "0.015": 17.24909601512525, "require": 8.505931919175883e-06, "cent": -3.2547351476382665e-05, "operations": -3.1135690440410634e-09, "infrequent": 17.24909601512525, "resuscitation": 1.6839603351021735e-05, "thrombotic": 17.24909601512525, "obstruction": 1.675188013225316e-05, "course": 0.0, "unstable": 1.5962371508738954e-05, "decided": -3.5119772217791617e-06, "extra": 5.786538375618895e-06, "corporeal": 17.24909601512525, "transferred": 1.4558802161807624e-05, "und": 17.24909601512525, "bridging": 1.6839603351021735e-05, "reperfusion": 17.24909601512525, "relies": 1.605009465847136e-05, "cardiography": 17.24909601512525, "hold": -1.494382125888806e-06, "20,812": 17.24909601512525, "australia": 0.0, "contention": 1.5874648366923943e-05, "812": 17.24909601512525, "1998": 1.3506126444313628e-05, "28.1": 1.6839603351021735e-05, "16.5": 1.692732657770772e-05, "0.44": 17.24909601512525, "20.5": 17.24909601512525, "15.9": 17.24909601512525, "11.0": 17.24909601512525, "encouraging": 1.3155234784658399e-05, "intramuscular": 17.24909601512525, "67.2": 17.24909601512525, "10.7": 1.692732657770772e-05, "2.6": 1.5962371508738954e-05, "nmol": 17.24909601512525, "309": 17.24909601512525, "allocated": 1.5085140435991204e-05, "recruitment": 1.4032464164433833e-05, "injections": 1.675188013225316e-05, "-1.3": 17.24909601512525, "leg": 1.0786719303022383e-05, "rated": 1.429563312860279e-05, "21.61": 17.24909601512525, "8.68": 17.24909601512525, "6.43": 17.24909601512525, ".017": 17.24909601512525, "6.66": 1.692732657770772e-05, ".015": 17.24909601512525, "6.25": 1.692732657770772e-05, ".019": 17.24909601512525, "11.98": 17.24909601512525, "0.249": 17.24909601512525, ".622": 17.24909601512525, "tendency": 1.5611478987428954e-05, "3.066": 17.24909601512525, ".091": 17.24909601512525, "realized": 1.3418403517967878e-05, "instance": 1.0786719303022383e-05, "candidates": 7.804152232254868e-06, "suffer": 1.3155234784658399e-05, "progenitors": 17.24909601512525, "elucidate": 17.24909601512525, "scar": 1.675188013225316e-05, "shams": 17.24909601512525, "inhibiting": 1.675188013225316e-05, "smad": 0.0, "2/3": 1.692732657770772e-05, "marker": 1.648871052189756e-05, "nanog": 0.0, "optimizing": 1.6839603351021735e-05, "pulseless": 17.24909601512525, "60s": 1.5874648366923943e-05, "permanent": 1.3067511889093883e-05, "8-": 17.24909601512525, "incidentally": 1.6839603351021735e-05, "ascending": 1.692732657770772e-05, "bp": 0.0, "profound": 1.5786925232582235e-05, "paco2": 0.0, "cerebral": 1.640098733368838e-05, "bodies": 8.769099428714858e-06, "concluded": 1.0786719303022383e-05, "originating": 1.657643371758005e-05, "generator": 1.648871052189756e-05, "clarity": 1.4997417371129622e-05, "multisystem": 17.24909601512525, "dysbalance": 17.24909601512525, "apart": 0.0, "permeability": 17.24909601512525, "absorption": 1.692732657770772e-05, "sonographic": 17.24909601512525, "disturbed": 1.5874648366923943e-05, "barrier": 1.5786925232582235e-05, "anabolic": 1.692732657770772e-05, "highlights": 1.3418403517967878e-05, "carbohydrates": 1.6839603351021735e-05, "water": -2.3161386152377293e-05, "micronutrients": 17.24909601512525, "feeding": 1.5085140435991204e-05, "gut": 1.6313264153396606e-05, "fragment": 1.675188013225316e-05, "roles": 1.262889752625678e-05, "great": -4.0003429366248315e-05, "unfavourable": 1.6839603351021735e-05, "indistinct": 1.692732657770772e-05, "elucidated": 17.24909601512525, "chronically": 17.24909601512525, "instrumented": 17.24909601512525, "zealand": 0.0, "innervated": 0.0, "hrv": 0.0, "lf": 0.0, "withdrawal": 1.5874648366923943e-05, "bradycardia": 0.0, "exacerbated": 1.648871052189756e-05, "ne": 0.0, "capability": 1.490969431374133e-05, "turned": -7.92608964462273e-07, "stopped": 8.06731955710827e-06, "futility": 1.675188013225316e-05, "809": 17.24909601512525, "19.4": 17.24909601512525, "404": 1.692732657770772e-05, "405": 1.657643371758005e-05, "28.7": 17.24909601512525, "25.2": 17.24909601512525, "1.57": 1.692732657770772e-05, "p=0.15": 0.0, "11.1": 17.24909601512525, "2.93": 1.692732657770772e-05, "comparative": 0.0, "mandate": 1.297978900100263e-05, "accountable": 1.5348309676970024e-05, "terminologies": 17.24909601512525, "makes": -1.167003762467312e-05, "268": 17.24909601512525, "validating": 0.0, "science": 4.295261184829675e-06, "beta1": 17.24909601512525, "\u03b21": 17.24909601512525, "adenylyl": 17.24909601512525, "triggers": 1.6664156920957902e-05, "desensitization": 17.24909601512525, "classic": 1.0523551262510945e-05, "paradigms": 17.24909601512525, "\u03b21ars": 0.0, "s1pr1s": 0.0, "simply": -9.08353103277844e-08, "uncovered": 1.6137817815677075e-05, "hek": 0.0, "interact": 1.5611478987428954e-05, "postischemic": 17.24909601512525, "produces": 1.5260586589022425e-05, "counterbalance": 17.24909601512525, "overstimulation": 1.692732657770772e-05, "alberta": 0.0, "alive": 1.0611273935134186e-05, "5336": 17.24909601512525, "373": 1.692732657770772e-05, "855": 17.24909601512525, "69.2": 17.24909601512525, "2182": 17.24909601512525, "9.0": 1.692732657770772e-05, "physician(s": 17.24909601512525, "exclusively": 1.4997417371129622e-05, "62.9": 17.24909601512525, "account": -5.7927319938314085e-06, "nonetheless": 0.0, "halt": 1.5260586589022425e-05, "ser23/24": 0.0, "catalytic": 17.24909601512525, "ser96": 0.0, "thr197": 0.0, "ri": 0.0, "isoelectric": 0.0, "focusing": 1.3242957688140263e-05, "blots": 17.24909601512525, "monoclonal": 1.6839603351021735e-05, "fluo": 17.24909601512525, "phosphomimic": 17.24909601512525, "kd": 0.0, "wt": 0.0, "displays": 1.4734248222494837e-05, "prone": 1.5523755876173285e-05, "signifies": 1.675188013225316e-05, "lability": 17.24909601512525, "structurally": 1.6664156920957902e-05, "surface": 1.1313055592039647e-05, "fluctuations": 1.6137817815677075e-05, "genuine": 1.2541174676642034e-05, "susceptibility": 1.675188013225316e-05, "primarily": 1.3330680599095393e-05, "anthracyclines": 17.24909601512525, "polymorphisms": 17.24909601512525, "candidate": 8.418209431460712e-06, "homeostasis": 17.24909601512525, "oxidant": 17.24909601512525, "defence": 8.06731955710827e-06, "nested": 17.24909601512525, "2950": 17.24909601512525, "1988": 1.4821971264270417e-05, "hope": 0.0, "survived": 1.2892066120828725e-05, "sampling": 1.605009465847136e-05, "source": 1.5758790914817797e-06, "allogeneic": 17.24909601512525, "autologous": 17.24909601512525, "seventy": 0.0, "germline": 17.24909601512525, "178": 1.692732657770772e-05, "females": 1.6313264153396606e-05, "radiation": 1.5348309676970024e-05, "4\u00b77": 17.24909601512525, "nad(p)h": 0.0, "rac2": 0.0, "rs13058338": 17.24909601512525, "7508t\u2192a": 0.0, "2\u00b78": 17.24909601512525, "hfe": 0.0, "rs1799945": 17.24909601512525, "63c\u2192g": 0.0, "2\u00b75": 17.24909601512525, "efflux": 17.24909601512525, "abcc2": 0.0, "rs8187710": 17.24909601512525, "1515g\u2192a": 0.0, "4\u00b73": 17.24909601512525, "0\u00b779": 17.24909601512525, "0\u00b767": 17.24909601512525, "0\u00b769": 17.24909601512525, "complicity": 1.648871052189756e-05, "moves": 1.297978900100263e-05, "exemplify": 1.6839603351021735e-05, "propose": 1.5523755876173285e-05, "distinctive": 1.5436032772835006e-05, "universal": 1.4032464164433833e-05, "uniform": 1.447107914289599e-05, "nomenclature": 17.24909601512525, "view": -3.2488128749448153e-06, "foster": 1.447107914289599e-05, "collaborative": 1.5874648366923943e-05, "conjoint": 17.24909601512525, "effort": 3.418040346769435e-06, "preventing": 1.447107914289599e-05, "breakdown": 1.5962371508738954e-05, "composed": 1.5786925232582235e-05, "prodrug": 17.24909601512525, "beginning": 7.102373037828235e-06, "stabilize": 1.6839603351021735e-05, "summarizes": 1.692732657770772e-05, "principles": 1.297978900100263e-05, "progressed": 1.5786925232582235e-05, "purely": 1.5172863508770167e-05, "interconnected": 1.6839603351021735e-05, "accumulating": 0.0, "window": 1.18393921578649e-05, "shortcomings": 1.622554098057814e-05, "dearth": 1.675188013225316e-05, "summarize": 17.24909601512525, "uniquely": 1.5348309676970024e-05, "capture": 1.3242957688140263e-05, "strict": 1.447107914289599e-05, "standards": 3.6812065173438863e-06, "multimarker": 17.24909601512525, "fastest": 1.3944741191916188e-05, "subclass": 17.24909601512525, "indicates": 1.429563312860279e-05, "noncoding": 17.24909601512525, "rnas": 0.0, "regulate": 1.5874648366923943e-05, "untranslated": 17.24909601512525, "messenger": 1.657643371758005e-05, "degradation": 1.648871052189756e-05, "repression": 1.640098733368838e-05, "give": -2.2810507235914333e-05, "look": -3.6319256651373374e-05, "namely": 1.5786925232582235e-05, "endopeptidase": 17.24909601512525, "vasopeptidase": 17.24909601512525, "subpulmonary": 17.24909601512525, "exhibit": 1.4997417371129622e-05, "sixteen": 0.0, "30\u00b12": 17.24909601512525, "calf": 1.657643371758005e-05, "31)p": 0.0, "spectroscopy": 17.24909601512525, "tertiary": 1.6313264153396606e-05, "referral": 1.622554098057814e-05, "1.9\u00b10.1": 17.24909601512525, "66\u00b13": 17.24909601512525, "appendicular": 17.24909601512525, "z": 0.0, "-1.46\u00b10.22": 17.24909601512525, "poorer": 1.5874648366923943e-05, "max": 1.675188013225316e-05, "r=0.67": 17.24909601512525, "p=0.004": 17.24909601512525, "-1.47\u00b10.21": 17.24909601512525, "4/16": 17.24909601512525, "sarcopenic": 17.24909601512525, "-2.0": 17.24909601512525, "9/16": 17.24909601512525, "\u2265-2.0": 17.24909601512525, "constant": 1.2102560544663882e-05, "postexercise": 17.24909601512525, "resynthesis": 17.24909601512525, "1.48\u00b10.13": 17.24909601512525, "2.40\u00b10.33": 17.24909601512525, "min(-1": 17.24909601512525, "questioned": 1.227800617441367e-05, "659": 17.24909601512525, "italy": 0.0, "original": 5.232170406997317e-07, "exploratory": 1.675188013225316e-05, "dimensions": 1.6313264153396606e-05, ".92": 17.24909601512525, ".95": 17.24909601512525, ".99": 17.24909601512525, "contrasting": 0.0, "nonstandardized": 17.24909601512525, "misdiagnosis": 1.6839603351021735e-05, "stored": 1.4646525188192543e-05, "-80": 17.24909601512525, "\u00b0": 17.24909601512525, "enriched": 1.675188013225316e-05, "immunoprecipitation": 17.24909601512525, "spectrometric": 17.24909601512525, "customized": 0.0, "homogeneous": 17.24909601512525, "sandwich": 1.605009465847136e-05, "spectrometry": 17.24909601512525, "processed": 1.5436032772835006e-05, "proteolysis": 17.24909601512525, "pro2": 0.0, "gly4": 0.0, "pro6": 0.0, "gly7": 0.0, "pro75": 0.0, "arg76": 0.0, "termini": 17.24909601512525, "nonglycosylated": 17.24909601512525, "immunoreactive": 17.24909601512525, "immunodetection": 0.0, "next": -6.491509820390877e-05, "avoiding": 1.6137817815677075e-05, "glycosylated": 17.24909601512525, "-3.2": 17.24909601512525, "-5.4": 17.24909601512525, "-1.1": 17.24909601512525, "-1.5": 1.6839603351021735e-05, "-0.5": 17.24909601512525, "idealized": 17.24909601512525, "14.2": 1.6839603351021735e-05, "denotes": 17.24909601512525, "pathophysiologically": 17.24909601512525, "antitachycardia": 17.24909601512525, "endpoints": 17.24909601512525, "tachyarrhythmias": 17.24909601512525, "253": 1.675188013225316e-05, "3.4": 1.657643371758005e-05, "0.009": 17.24909601512525, "0.80": 17.24909601512525, "nct00180271": 0.0, "denmark": 0.0, "342": 1.692732657770772e-05, "307.026": 17.24909601512525, "4.9": 1.675188013225316e-05, "alendronate-": 17.24909601512525, "etidronate-": 17.24909601512525, "3.7": 1.675188013225316e-05, "bisphophonates": 17.24909601512525, "1.41": 17.24909601512525, "analysed": 1.622554098057814e-05, "bisphosphonate": 0.0, "subcellular": 17.24909601512525, "reversibility": 17.24909601512525, "epinephrine": 17.24909601512525, "sarcoplasmic": 17.24909601512525, "reticular": 17.24909601512525, "ca(2+)-uptake": 0.0, "myofibrillar": 17.24909601512525, "ca(2+)-stimulated": 0.0, "atpase": 0.0, "unaffected": 1.6664156920957902e-05, "catecholamines": 17.24909601512525, "inconsistent": 1.5962371508738954e-05, "embedded": 1.5611478987428954e-05, "subclinical": 17.24909601512525, "262": 17.24909601512525, "uv": 0.0, "8,009": 17.24909601512525, "smoked": 1.5436032772835006e-05, "intima": 17.24909601512525, "media": -2.4564900587736385e-05, "1.02\u00b10.18": 17.24909601512525, "1.02\u00b10.16": 17.24909601512525, "share": -1.386305326459107e-05, "120": 1.4120187144868845e-05, "0.9": 1.657643371758005e-05, "quartile": 17.24909601512525, "nationally": 1.5260586589022425e-05, "considerations": 1.648871052189756e-05, "project": -2.5354376591760622e-05, "150,000": 1.6313264153396606e-05, "rural": 1.18393921578649e-05, "implemented": 1.3418403517967878e-05, "urbanized": 17.24909601512525, "midwestern": 0.0, "extensively": 1.6313264153396606e-05, "identical": 1.5348309676970024e-05, "fractal": 17.24909601512525, "scaling": 1.648871052189756e-05, "exponent": 17.24909601512525, "somewhat": 1.3681572320313113e-05, "stems": 1.6664156920957902e-05, "underperfusion": 17.24909601512525, "renin-": 17.24909601512525, "nephropathy": 17.24909601512525, "ultrasonography": 17.24909601512525, "tomographic": 17.24909601512525, "preferred": 1.4997417371129622e-05, "lipid": 17.24909601512525, "lowering": 1.569920210615792e-05, "cessation": 1.657643371758005e-05, "preventive": 1.648871052189756e-05, "angioplasty": 17.24909601512525, "coral": 0.0, "concrete": 1.4821971264270417e-05, "unsuitable": 1.6664156920957902e-05, "unsuccessful": 1.5611478987428954e-05, "plans": -8.775249615757094e-06, "bioinformatic": 0.0, "microarray": 17.24909601512525, "reveals": 1.3681572320313113e-05, "discover": 1.4646525188192543e-05, "gse9128": 0.0, "downloaded": 1.622554098057814e-05, "omnibus": 0.0, "processing": 1.3242957688140263e-05, "carried": 8.155042014042513e-06, "r.": 0.0, "cluster": 0.0, "globally": 1.3593849378354692e-05, "observe": 1.5436032772835006e-05, "interactors": 0.0, "osprey": 0.0, "overlapping": 1.6664156920957902e-05, "cytoscape": 0.0, "david": 0.0, "133": 1.6839603351021735e-05, "programmed": 1.648871052189756e-05, "northwest": 0.0, "1,767": 17.24909601512525, "demonstration": 1.5611478987428954e-05, "clinics": 1.5786925232582235e-05, "integrates": 1.692732657770772e-05, "binomial": 17.24909601512525, ".03": 17.24909601512525, "quarterly": 1.4120187144868845e-05, "-0.054": 17.24909601512525, "-0.010": 17.24909601512525, ".005": 17.24909601512525, "interactions": 1.5085140435991204e-05, "749": 1.675188013225316e-05, "socioeconomic": 1.622554098057814e-05, "whites": 1.648871052189756e-05, "1.46": 17.24909601512525, "1.77": 17.24909601512525, "1.58": 1.6839603351021735e-05, "1.27": 1.6839603351021735e-05, "1.96": 17.24909601512525, ".5": 17.24909601512525, "modifiable": 17.24909601512525, "conceptually": 0.0, "side": -2.5003498444771068e-05, "maintain": 8.59365441458629e-06, "randomize": 17.24909601512525, "3,000": 1.3681572320313113e-05, "cha\u2082ds\u2082vasc": 0.0, "mandated": 1.640098733368838e-05, "nights": 0.0, "spent": -2.3715978851702173e-06, "counted": 1.5786925232582235e-05, "know": -6.851144983664555e-05, "grown": 9.909492770503829e-06, "faced": 1.0435828597805015e-05, "uncommon": 1.5874648366923943e-05, "housed": 1.4997417371129622e-05, "accustomed": 1.6137817815677075e-05, "asked": -1.8512230515858495e-05, "array": 1.4997417371129622e-05, "complication": 1.692732657770772e-05, "topic": 8.944544473624384e-06, "partner": 1.2249916182471778e-06, "subspecialty": 17.24909601512525, "called": -4.096832950118578e-05, "fall": 5.232170406997317e-07, "abcd": 0.0, "acc)/american": 0.0, "characterised": 1.605009465847136e-05, "structural": 1.4558802161807624e-05, "attempt": 4.82159405694511e-06, "correct": 1.2102560544663882e-05, "ischaemia": 17.24909601512525, "tachy-": 17.24909601512525, "bradyarrhythmias": 17.24909601512525, "potent": 0.0, "ca2": 0.0, "influx": 1.5523755876173285e-05, "plateau": 1.675188013225316e-05, "potentials": 1.6839603351021735e-05, "excitation": 1.6839603351021735e-05, "contraction": 1.657643371758005e-05, "rem": 0.0, "rem2": 0.0, "gem": 0.0, "kir": 0.0, "monomeric": 17.24909601512525, "naturally": 1.4646525188192543e-05, "eliminates": 1.692732657770772e-05, "inhibitory": 1.6664156920957902e-05, "inhibits": 1.6839603351021735e-05, "potently": 17.24909601512525, "attenuates": 17.24909601512525, "gating": 1.692732657770772e-05, "movement": 6.049705169502724e-06, "substitution": 1.675188013225316e-05, "impair": 17.24909601512525, "modes": 1.640098733368838e-05, "se": 1.640098733368838e-05, "mistargeting": 17.24909601512525, "ethically": 1.692732657770772e-05, "situations": 1.3067511889093883e-05, "pediatrics": 17.24909601512525, "families": -1.8452685218090499e-06, "whose": -2.283876343736681e-06, "religious": 1.0348105940572307e-05, "beliefs": 1.5874648366923943e-05, "legal": -3.5996986554818672e-06, "face": -1.4126214818150969e-05, "ethics": 0.0, "rounds": 0.0, "complexities": 1.648871052189756e-05, "overlapped": 17.24909601512525, "sickle": 17.24909601512525, "going": -7.017804742730752e-05, "urgently": 1.605009465847136e-05, "woman": -7.283991916609652e-06, "adamantly": 17.24909601512525, "refuse": 1.4646525188192543e-05, "let": -6.669943982542335e-06, "die": 1.10498874130133e-05, "is": 0.0029691207249646374, "combine": 1.5260586589022425e-05, "empirically": 1.692732657770772e-05, "explains": 1.017266064963677e-05, "variance": 1.675188013225316e-05, "n=1,203,595": 17.24909601512525, "n=625,595": 17.24909601512525, "n=1,234,299": 17.24909601512525, "ranked": 1.3067511889093883e-05, "chosen": 1.1576223840323502e-05, "1.61": 1.692732657770772e-05, "dying": 1.490969431374133e-05, "explaining": 1.4997417371129622e-05, "african": 0.0, "n=120": 17.24909601512525, "n=1543": 17.24909601512525, "rales": 0.0, "4.29\u00b10.5": 17.24909601512525, "4.55\u00b10.49": 17.24909601512525, "4.32\u00b10.54": 17.24909601512525, "4.31\u00b10.49": 17.24909601512525, "throughout": 2.189932466182399e-06, "attain": 1.622554098057814e-05, "13.9": 1.6839603351021735e-05, "5.8": 1.692732657770772e-05, "potassium>5.5": 17.24909601512525, "p<0.046": 0.0, "potassium<3.5": 17.24909601512525, "17.9": 1.6664156920957902e-05, "interaction=0.032": 17.24909601512525, "seemed": 9.03226700751099e-06, "antioxidant": 1.692732657770772e-05, "szeto": 0.0, "schiller": 0.0, "ss": 0.0, "tac)-induced": 0.0, "538": 1.692732657770772e-05, "mapped": 1.648871052189756e-05, "gluconeogenesis": 17.24909601512525, "citrate": 17.24909601512525, "ameliorated": 17.24909601512525, "damage": 4.82159405694511e-06, "nonmitochondrial": 17.24909601512525, "amelioration": 17.24909601512525, "essentially": 1.3593849378354692e-05, "elucidates": 17.24909601512525, "upstream": 1.6839603351021735e-05, "does": 2.8836131220158308e-05, "skilled": 1.3944741191916188e-05, "thousand": 1.2453451834944633e-05, "2,101,481": 17.24909601512525, "claims": 1.2249916182471778e-06, "quasi": 1.6839603351021735e-05, "experiment": 1.3067511889093883e-05, "immediate": 1.1400778333698304e-05, "0.30": 1.6839603351021735e-05, "2.82": 17.24909601512525, "1.60": 17.24909601512525, "urinary": 1.657643371758005e-05, "tract": 1.648871052189756e-05, "medically": 1.675188013225316e-05, "quintiles": 17.24909601512525, "8.9": 1.6839603351021735e-05, "25.8": 17.24909601512525, "21.5": 1.675188013225316e-05, "p<0001": 0.0, "finally": 0.0, "8982": 17.24909601512525, "8731": 17.24909601512525, "p=0.002": 0.0, "internists": 17.24909601512525, "10.6": 17.24909601512525, "weakest": 1.657643371758005e-05, "6.7": 1.675188013225316e-05, "p=0.485": 0.0, "noncardiologist": 17.24909601512525, "expertise": 1.271662038334478e-05, "antagonism": 1.692732657770772e-05, "neurohormone": 17.24909601512525, "electrolytes": 1.6839603351021735e-05, "very": -3.2908441143437336e-05, "ephesus": 0.0, "tuscany": 0.0, "603": 17.24909601512525, "53\u00b112": 17.24909601512525, "32\u00b110": 17.24909601512525, "fulfilling": 1.5611478987428954e-05, "8.8\u00b16.3": 17.24909601512525, "subdivided": 1.692732657770772e-05, "eras": 1.6664156920957902e-05, "1984": 1.5172863508770167e-05, "n=66": 17.24909601512525, "1985": 1.5348309676970024e-05, "n=102": 17.24909601512525, "1991": 1.4032464164433833e-05, "n=197": 17.24909601512525, "n=238": 17.24909601512525, "n=142": 17.24909601512525, "n=71": 17.24909601512525, "noncardiac": 17.24909601512525, "n=22": 17.24909601512525, "n=36": 17.24909601512525, "0.14": 1.675188013225316e-05, "replicated": 1.640098733368838e-05, "emphasizing": 1.675188013225316e-05, "tailored": 1.605009465847136e-05, "indeterminable": 17.24909601512525, "always": -3.3249102353544795e-05, "meaning": 1.1137610131586125e-05, "3058": 17.24909601512525, "921": 17.24909601512525, "achievement": 1.385701822709386e-05, "quotient": 1.6839603351021735e-05, "\u22641.05": 17.24909601512525, "3.01": 1.692732657770772e-05, "4.98": 17.24909601512525, "1935": 1.6839603351021735e-05, "2137": 17.24909601512525, "90.54": 17.24909601512525, "pred": 17.24909601512525, "hr]=0.977": 0.0, "ci]=0.97": 0.0, "ventilatory": 17.24909601512525, "hr=1.02": 0.0, "ci=1.01": 0.0, "hr=0.931": 0.0, "ci=0.87": 0.0, "hr=0.948": 0.0, "hr=0.990": 0.0, "ci=0.98": 0.0, "hr=0.967": 0.0, "hr=1.41": 0.0, "ci=1.06": 0.0, "1.89": 17.24909601512525, "hr=1.459": 0.0, "ci=1.09": 0.0, "1.10": 1.692732657770772e-05, "inability": 1.5611478987428954e-05, "cooper": 0.0, "674": 17.24909601512525, "1971": 1.5786925232582235e-05, "19.8\u00b110.4": 17.24909601512525, "153": 1.6839603351021735e-05, "3.97": 1.692732657770772e-05, "3.71": 1.692732657770772e-05, "upper": 1.2014837741442948e-05, "p<0.002": 0.0, "p\u22640.02": 0.0, "counseled": 1.692732657770772e-05, "achieving": 1.447107914289599e-05, "presumably": 1.5523755876173285e-05, "hypertrophied": 17.24909601512525, "evidenced": 1.622554098057814e-05, "translocation": 1.692732657770772e-05, "lactate": 17.24909601512525, "fatty": 1.648871052189756e-05, "acids": 1.648871052189756e-05, "reality": 3.8566506696100055e-06, "adequacy": 1.6664156920957902e-05, "delineated": 17.24909601512525, "website": -1.9740311464018917e-05, "nondeveloped": 17.24909601512525, "raised": -1.0557739576826234e-06, "chagas": 0.0, "alcohol": 8.418209431460712e-06, "6.3": 1.6664156920957902e-05, "varies": 1.6664156920957902e-05, "awful": 1.4207910132777135e-05, "paradox": 1.6839603351021735e-05, "scenario": 1.297978900100263e-05, "polymorphism": 17.24909601512525, "p.": 17.24909601512525, "arg83gly": 0.0, "renastur": 0.0, "569": 17.24909601512525, "caucasian": 0.0, "ka": 0.0, "chloride": 17.24909601512525, "min./1.73": 17.24909601512525, "ldl": 0.0, "gg": 0.0, "genotype": 1.692732657770772e-05, "or=1.65": 0.0, "ci=1.04": 0.0, "2.62": 17.24909601512525, "confirmation": 1.5260586589022425e-05, "ambient": 0.0, "recognised": 1.2453451834944633e-05, "lancet": 0.0, "anoop": 0.0, "shah": 0.0, "colleagues": 1.0435828597805015e-05, "aware": 4.64614973538525e-06, "industrial": 9.997215389260231e-06, "aggravate": 1.657643371758005e-05, "exacerbates": 1.692732657770772e-05, "cytoskeletal": 17.24909601512525, "deletion": 1.675188013225316e-05, "precise": 1.5611478987428954e-05, "functionally": 17.24909601512525, "morphologically": 17.24909601512525, "littermates": 17.24909601512525, "susceptible": 1.640098733368838e-05, "turning": 1.10498874130133e-05, "discovered": 1.0348105940572307e-05, "normalizing": 17.24909601512525, "eliminated": 1.5786925232582235e-05, "fare": 1.4032464164433833e-05, "eventually": 4.82159405694511e-06, "spite": 1.5172863508770167e-05, "developments": 1.2804343248350124e-05, "palliative": 1.692732657770772e-05, "vital": 1.18393921578649e-05, "disciplines": 1.622554098057814e-05, "communication": 1.0348105940572307e-05, "surgeons": 1.648871052189756e-05, "distributed": 1.385701822709386e-05, "evenly": 1.657643371758005e-05, "equitable": 1.6313264153396606e-05, "referrals": 1.648871052189756e-05, "strengthen": 1.3067511889093883e-05, "connection": 9.383157220453942e-06, "certified": 1.4646525188192543e-05, "raise": 4.382983310870298e-06, "turkey": 0.0, "postmarketing": 17.24909601512525, "dipeptidyl": 17.24909601512525, "peptidase-4": 17.24909601512525, "creating": 7.453262573368775e-06, "uncertainty": 1.2190283355802152e-05, "partners": 6.663761291378333e-06, "u.s.": 0.0, "mini": 0.0, "sentinel": 0.0, "products": -8.775249615757094e-06, "402.x1": 17.24909601512525, "404.x1": 17.24909601512525, "404.x3": 17.24909601512525, "428.xx": 17.24909601512525, "553": 17.24909601512525, "298": 17.24909601512525, "pairwise": 17.24909601512525, "drs)-stratified": 0.0, "0.47": 1.6839603351021735e-05, "limitation": 0.0, "residual": 0.0, "confounding": 1.692732657770772e-05, "introduction": 0.0, "outweigh": 1.675188013225316e-05, "healthstar": 0.0, "campbell": 0.0, "joanna": 0.0, "briggs": 0.0, "institute": 0.0, "reviews": 0.0, "centres": 0.0, "extract": 1.5786925232582235e-05, "duplicate": 1.6839603351021735e-05, "provider": 1.1663946605068002e-05, "eg": 1.675188013225316e-05, "decision": -1.8512230515858495e-05, "incentives": 1.5523755876173285e-05, "elements": 1.0786719303022383e-05, "redesign": 0.0, "synthesise": 17.24909601512525, "narratively": 17.24909601512525, "succeed": 1.447107914289599e-05, "fail": 1.0611273935134186e-05, "disseminate": 1.6664156920957902e-05, "briefing": 1.5348309676970024e-05, "publications": 1.5348309676970024e-05, "presentations": 1.657643371758005e-05, "perceptions": 1.657643371758005e-05, "qualitative": 1.6839603351021735e-05, "grounded": 0.0, "theory": 1.2365729000942526e-05, "collect": 1.2190283355802152e-05, "interview": 1.3127134749576289e-06, "toronto": 0.0, "predominately": 1.692732657770772e-05, "felt": -6.171655970992327e-07, "mind": -1.8452685218090499e-06, "wished": 1.5260586589022425e-05, "said": -0.0005897579106250723, "consider": 3.944372757174789e-06, "undecided": 1.6664156920957902e-05, "adamant": 1.622554098057814e-05, "turn": -3.5119772217791617e-06, "implant": 1.6839603351021735e-05, "distressing": 1.675188013225316e-05, "comment": 0.0, "centrally": 17.24909601512525, "outflow": 1.657643371758005e-05, "system-": 17.24909601512525, "hall": 1.2190283355802152e-05, "97.2": 17.24909601512525, "91.4": 17.24909601512525, "59.6": 1.6839603351021735e-05, "13.2": 1.692732657770772e-05, "17.4": 1.692732657770772e-05, "ranking": 1.4734248222494837e-05, "0.08": 1.675188013225316e-05, "prescribe": 1.648871052189756e-05, "china": 0.0, "\u03b450%w": 0.0, "x12": 17.24909601512525, "w.": 17.24909601512525, "before": 7.33790589778313e-05, "394": 1.692732657770772e-05, "470": 1.675188013225316e-05, "nosignificant": 17.24909601512525, "p>0.05": 0.0, "guiding": 1.6137817815677075e-05, "uk": 0.0, "completely": 3.8566506696100055e-06, "subtle": 1.5348309676970024e-05, "nonspecific": 17.24909601512525, "breathlessness": 17.24909601512525, "fatigue": 1.6313264153396606e-05, "thorough": 1.5348309676970024e-05, "lying": 1.3155234784658399e-05, "auscultation": 17.24909601512525, "jugular": 17.24909601512525, "oedema": 1.692732657770772e-05, "regular": 0.0, "hyperlipidaemia": 17.24909601512525, "senescence": 17.24909601512525, "malignancies": 17.24909601512525, "prostate": 1.657643371758005e-05, "colon": 1.675188013225316e-05, "osteoporosis": 17.24909601512525, "dementia": 1.5523755876173285e-05, "regularly": 1.0523551262510945e-05, "volumes": 1.4997417371129622e-05, "confer": 1.692732657770772e-05, "with.estimates": 17.24909601512525, "50,000": 1.3681572320313113e-05, "200,000": 1.490969431374133e-05, "hereditary": 0.0, "nontraumatic": 17.24909601512525, "sport": 5.172482792406987e-06, "middle": 3.5057623958584124e-06, "recreational": 1.5436032772835006e-05, "males": 1.648871052189756e-05, "esc": 0.0, "advocate": 1.4821971264270417e-05, "accessory": 1.6664156920957902e-05, "ion": 1.5260586589022425e-05, "channelopathies": 17.24909601512525, "overwhelming": 1.490969431374133e-05, "trainings": 17.24909601512525, "limbs": 1.640098733368838e-05, "+233": 17.24909601512525, "733": 17.24909601512525, "il": 0.0, "+0.5": 17.24909601512525, "+0.2": 17.24909601512525, "6.5": 1.622554098057814e-05, "feedback": 1.3769295269744806e-05, "2279": 17.24909601512525, "97.8": 17.24909601512525, "surveys": 1.5260586589022425e-05, "r=-0.11": 17.24909601512525, "r=-0.12": 17.24909601512525, "p<0.005": 0.0, "corresponded": 1.6664156920957902e-05, "implement": 1.10498874130133e-05, "arguments": 1.447107914289599e-05, "hypo": 17.24909601512525, "gas": -3.7751414993580514e-06, "participated": 1.490969431374133e-05, "aiming": 1.5436032772835006e-05, "value=0.631": 17.24909601512525, "17\u00b122": 17.24909601512525, "4\u00b115": 17.24909601512525, "value=0.027": 17.24909601512525, "17.5\u00b15.5": 17.24909601512525, "14.4\u00b13.3": 17.24909601512525, "value=0.038": 17.24909601512525, "2.0\u00b13.2": 17.24909601512525, "1.2\u00b17.7": 17.24909601512525, "value=0.033": 17.24909601512525, "unidirectional": 0.0, "\u226518": 17.24909601512525, "implants": 1.675188013225316e-05, "transseptal": 17.24909601512525, "catheterisation": 1.692732657770772e-05, "guidance": 1.3944741191916188e-05, "anaesthesia": 17.24909601512525, "oct": 0.0, "2015": -3.044209589016569e-05, "procedural": 1.6664156920957902e-05, "shunts": 17.24909601512525, "patent": 1.5348309676970024e-05, "migration": 1.605009465847136e-05, "p=0\u00b70004": 17.24909601512525, "duke": 0.0, "6\u00b72": 17.24909601512525, "24\u00b78": 17.24909601512525, "12\u00b79": 17.24909601512525, "44\u00b73": 17.24909601512525, "9\u00b78": 17.24909601512525, "79\u00b71": 17.24909601512525, "13\u00b70": 17.24909601512525, "p=0\u00b70001": 17.24909601512525, "244": 1.692732657770772e-05, "112": 1.657643371758005e-05, "318": 17.24909601512525, "p=0\u00b7035": 17.24909601512525, "incessant": 1.6839603351021735e-05, "storm": 1.0786719303022383e-05, "warranted": 1.675188013225316e-05, "hopeful": 1.4734248222494837e-05, "at1": 0.0, "blocks": 1.2541174676642034e-05, "aldosteron": 17.24909601512525, "concurrently": 1.675188013225316e-05, "natural": 3.418040346769435e-06, "vasodilatory": 17.24909601512525, "8000": 1.6313264153396606e-05, "stabilized": 1.675188013225316e-05, "sacubiltril": 17.24909601512525, "hypotension": 17.24909601512525, "interrupt": 1.6313264153396606e-05, "czech": 0.0, "republic": 0.0, "congratulated": 1.648871052189756e-05, "thanked": 1.569920210615792e-05, "more": 0.0004290391360282006, "persons": 9.207712098591973e-06, "determinant": 1.675188013225316e-05, "factorial": 17.24909601512525, "february": 0.0, "november": 0.0, "2014": -3.2196475853242174e-05, "academic": 1.175166937772983e-05, "577": 17.24909601512525, "initially": 1.0962164701913708e-05, "screened": 1.5962371508738954e-05, "67": 1.5348309676970024e-05, "39.3": 17.24909601512525, "366": 17.24909601512525, "consisted": 1.640098733368838e-05, "calls": 4.2075390662621796e-06, "105": 1.6137817815677075e-05, "attendance": 1.5172863508770167e-05, "-1": 1.6839603351021735e-05, "-8": 17.24909601512525, ".70": 17.24909601512525, "-6": 17.24909601512525, "-12": 17.24909601512525, ".08": 1.692732657770772e-05, ".003": 17.24909601512525, "thigh": 1.675188013225316e-05, "intermuscular": 17.24909601512525, "0.27": 1.692732657770772e-05, "hemocompatibility": 17.24909601512525, "rotor": 1.6313264153396606e-05, "paths": 1.5962371508738954e-05, "artificial": 1.569920210615792e-05, "intermacs": 0.0, "interagency": 0.0, "mechanically": 0.0, "support)-derived": 0.0, "inotrope": 17.24909601512525, "listed": 8.769099428714858e-06, "exceeded": 1.5874648366923943e-05, "0.0093": 17.24909601512525, "reoperation": 17.24909601512525, "rankin": 0.0, "exchanges": 1.569920210615792e-05, "malfunctions": 17.24909601512525, "hemolysis": 17.24909601512525, "sustained": 1.3681572320313113e-05, "projecting": 1.6664156920957902e-05, "extrapolating": 17.24909601512525, "valuable": 1.0523551262510945e-05, "modeled": 1.692732657770772e-05, "designs": 1.447107914289599e-05, "hypothetical": 1.657643371758005e-05, "10,000": 1.175166937772983e-05, "virtual": 1.5085140435991204e-05, "inputs": 1.6313264153396606e-05, "external": 9.73404755652088e-06, "replicating": 1.6839603351021735e-05, "scenarios": 1.5611478987428954e-05, "functioning": 1.5523755876173285e-05, "researchers": 5.260204995399393e-06, "upcoming": 1.1488501083274284e-05, "understand": -3.5996986554818672e-06, "deter": 1.5962371508738954e-05, "such": 0.0002127112784062027, "optimize": 1.6664156920957902e-05}